<SEC-DOCUMENT>0001396814-21-000063.txt : 20211103
<SEC-HEADER>0001396814-21-000063.hdr.sgml : 20211103
<ACCEPTANCE-DATETIME>20211103154320
ACCESSION NUMBER:		0001396814-21-000063
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		87
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211103
DATE AS OF CHANGE:		20211103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pacira BioSciences, Inc.
		CENTRAL INDEX KEY:			0001396814
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				510619477
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35060
		FILM NUMBER:		211375141

	BUSINESS ADDRESS:	
		STREET 1:		5401 WEST KENNEDY BOULEVARD
		STREET 2:		SUITE 890
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609
		BUSINESS PHONE:		813-553-6680

	MAIL ADDRESS:	
		STREET 1:		5 SYLVAN WAY
		STREET 2:		SUITE 300
		CITY:			PARSIPPANY
		STATE:			NJ
		ZIP:			07054

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pacira Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20101029

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIRA INC
		DATE OF NAME CHANGE:	20080318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Acquisition Corp
		DATE OF NAME CHANGE:	20070418
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>pcrx-20210930.htm
<DESCRIPTION>10-Q - PCRX - 9.30.2021
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:72021cac-ffd9-4fc5-b071-994f9d22f7d5,g:6c0c4d51-64cc-433e-9997-2f3b5b13ef74,d:caeef1316917487cbff6510a43882f61--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:pcrx="http://www.pacira.com/20210930" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pcrx-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV8zLTEtMS0xLTA_ad4b05bd-618e-4291-b9c1-e65c48c17432">0001396814</ix:nonNumeric><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV80LTEtMS0xLTA_a573f5a0-0384-4e9a-ac68-eff927e8623b">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV82LTEtMS0xLTA_2be70e96-6e24-403c-a21a-c71c1664ec28">2021</ix:nonNumeric><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV83LTEtMS0xLTA_a239e709-8834-485b-a91d-a5311fe53f27">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV84LTEtMS0xLTA_e618aa83-178f-43fb-89aa-f7c3546bdee0">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i394d1f729acb4158a8f1b548947619fa_D20210101-20210930" name="pcrx:AccountsReceivablePaymentTerms" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMjYzOQ_a82865c6-0aeb-4bca-a017-866bd6d1661c">P0D</ix:nonNumeric><ix:nonNumeric contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401" name="pcrx:DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM0MjA_0a6e4989-0f64-4ad2-a49d-950959b333c7">P5D</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i1c1cb32c967149daac72034c56d3895d_I20210930" decimals="INF" name="pcrx:DebtInstrumentMarketPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81OC9mcmFnOjU2YmY4YTc4MWRlMzRjN2Y4NjkyMGRhNzNlMDRkOTg5L3RleHRyZWdpb246NTZiZjhhNzgxZGUzNGM3Zjg2OTIwZGE3M2UwNGQ5ODlfMzE_855c56fc-1edc-4609-9b2c-010224a3cada">1.038</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81OC9mcmFnOjU2YmY4YTc4MWRlMzRjN2Y4NjkyMGRhNzNlMDRkOTg5L3RleHRyZWdpb246NTZiZjhhNzgxZGUzNGM3Zjg2OTIwZGE3M2UwNGQ5ODlfNzc_34938b2a-19fb-4436-9bae-29e9e6fc5185">0.0149491</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i684590e84b124a17aead86fc30460d60_I20210930" decimals="INF" name="pcrx:DebtInstrumentMarketPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81OC9mcmFnOjU2YmY4YTc4MWRlMzRjN2Y4NjkyMGRhNzNlMDRkOTg5L3RleHRyZWdpb246NTZiZjhhNzgxZGUzNGM3Zjg2OTIwZGE3M2UwNGQ5ODlfMTA5_c5cfad47-a33e-4024-8aaa-59319def4ef6">1.086</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="iecb17ba904c14ce8b2ecbe73f2cec747_D20210101-20210930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81OC9mcmFnOjU2YmY4YTc4MWRlMzRjN2Y4NjkyMGRhNzNlMDRkOTg5L3RleHRyZWdpb246NTZiZjhhNzgxZGUzNGM3Zjg2OTIwZGE3M2UwNGQ5ODlfMTU0_45c8a4f6-6aca-4160-a354-ee7a8fdaf74a">.0139324</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pcrx-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="icd4be343c5c04ff3a57d3cb3f3dfe956_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i2b38381b6d0a45889401a583757402a5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39c6077ecfb343b7b02e61046eb86e03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i12dead7e93d941fa9ed3c4a6d9cdd283_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie63b52bbc6f8429686e59ef4517c7bf4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a4d517e9454a9a888918ce80188a4e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b7287c7614e46d8ab1553c11a8c6b9d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a291ee19594ddfab77fce82e32a1c6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9842d334ede6470cba57f5223fd23c14_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48ad93bee00549d8bdd6a51f78347c23_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e97b7d115ac489bb255e8dbdd6a3227_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i117249baf38443f781c1edf946e8991e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if09bc71a12134a489569878485158a10_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5220037f26804a09aca54e93634fae07_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i343da0f70b794c348d0831e6aeaf9c59_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7edff5520a404b2b83447444f9eb459f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i122a17173a484439aee4c4ca9b399085_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b693b61cc3b4215a6ee287c335a9063_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d65492b3924412b7973c03af1fe9e6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8495ec90002a45e0bf0887939ab74508_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i948ca81132a24b4d8ef57d52788a5385_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21fe54e97dd84dc997ccfb0ebc078b9a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f9c6243a10041a9a851d8813a74c05e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i077b7247a4a24b37a42640d85ace320b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifff9414f8ec14f648d23be05a58aa2b5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib557a2279d86475996731b3fc97be752_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20e70406d1a045e4bd52905aacc53fa2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55cda46fa2334de29508526999af243a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i014f2a1fc24b43b18ee6280f20cdf1ce_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0782a595bbfb44b29916dbcc9517713f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if774c56400c143a986cc56ea80547ef8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0697b721fc9e45f69f060f8f46d77072_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c52d1fdd134b989a3e678be437266e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a8a218cb3b1417390af7c5813a511e9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39a912dcf7aa45e69c293537f5fa8875_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5abf6e142c09447396ea931fa4051312_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:A2022ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28f2bef137d34763a6e0945cc7109ba5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:A2022ConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7254f3d070d24fedba65bee5b312cfb6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i255a01006e2448ef9f48b2f549fa8a87_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide7713099e5342bc91935b76d0493eb3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97143ff422764b1eb3afddc0d216dca4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8d0686e48b449de8494030e085a5ba6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41a7036c745f4bed845b3722cfd852b4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e471ced5e9c4e899d18dd16de8c4d8e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide22db36ba124396977f4e0de495a2cf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c1289967bb1472eb59cfee843fc6864_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ae279ae07c24b808b12769dd2e5d56b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaacf91e289d4f41a577e6a6fc15dd78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71ef8fa3f6ef4295b34719dd5bcd1ea2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i633a7f9223744608a36564a7e357408f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i948705b5248d4d66bb924c0499f8f0dd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7fe3f4d4a2545b2bcf7893e525bd645_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i906da711ad9f492aa726ba7c1e3c3da3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4956ecea465b41aca59fcfcd35dcac46_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46c78db21b3e43b48cc5600bf97beeb0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1a3131f4134e8897f0cf6d5e2ffd17_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa26d8ae002340a3ad3e4dd57c59814b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c6d0b8cddef42e7b5f9944be6d07888_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffeb5e781f954b4e84f040966bddc6b8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28039b2d361d4a4fab500d11195dad95_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:A2022ConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e525b059b864af98aeec5d4a4a0628d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53046ca604b24b22afbf86b490b8b1a7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f2b75905cb47d0a73cb049beed27cf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb17ba904c14ce8b2ecbe73f2cec747_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb7245efd2d449f81aae47fd4200c45_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i856232cea6c64e2ea98e0dc82a006dac_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3443c6210e4129b77b12cacc1af29e_I20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>pcrx:product</xbrli:measure></xbrli:unit><xbrli:context id="i9252be06dfb84136b1c245c17afd18b9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>pcrx:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i766f22ea0ac24a77a51e08e7ca35945f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56f4b02fe95c4104bfdc2b5350e072e8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28fae669275407da1afd4ccaffe03be_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b9a9fb65e1404983d517a01cb75626_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacef49a3ede14eda8bd8c641ad091a60_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5badbb37b7a4f1b94a0f02f00cf2590_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia74009bf8abb4b0b991b74490d2554f6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i844e9fe2488b4442bcf86bf11b9e76ed_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205e1c4172cd4d2b809c620611b5e0b0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb78eb77b14d47f892d26f89746691ff_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8688a00c06e54c5f8d4c92616c5ac6ea_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30925928a2bd4e02a8ed2ea04199236d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i150082df5ab74269aac685d70ddd9809_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44d32a7bfbd0444d949387c037771a01_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifed03345c8384bd697f0693a26aaf05a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14236b4e4c5c46349502a9255c70ff12_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb8afdaa87d44b849e4d16d61dab0781_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EuropeanUnionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefd0f799d2934f3c879017bae1f70cac_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EuropeanUnionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i394d1f729acb4158a8f1b548947619fa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41b00db28bd24e8298f3daa38843e448_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib583d9b057b942b68b4eaeb985e512fd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9363f54932e4fbba77650e2de1ba4de_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1129d76aea6423ca3b15e9965559c8f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5accd35363b841d5bd616a756fec67a4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fde0359479247adb32995272e9e92e8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5ff86ece96a40f6ba1006fbc2ee4fa1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26bec4aae3774657b312c164cf9e6b95_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29692bf80ec74a828827091f01d350e8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99bdc6f6fda24e0fb4e3bc0f687562ff_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ed0e5100a704244a6604a6ffdca5f84_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f18cccc5ab4371abe468c2835247ca_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i898a223b5d1b4effbcd726f575d3e5e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa288b76e0a42ed96cf349f5192edb1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia34fa7325b3e40089d0092964f4fc930_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic665add04b7e4b1e909cb5ea8efd8516_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9e89c1e0d94c15900cc25867cdaf15_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c2f20e3bb0c4ee4a9973bd9ac272cba_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie78554782b924c2e943917d448e44ec6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0379cda4d5d444419b2c756629bfe8be_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0e6245f12984622bb9ff0bf0fe46d7b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5263cd5b15ec419ea569ba7621aacc70_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89ff104d4b684eac9d78a0eec97980e2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie510ad82e9ae4ed9b7453890873a7867_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="pcrx:MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis">pcrx:UponFirstCommercialSaleInMajorEUCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:SkyePharmaHoldingIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib955ef045d0147b4a41342834ab1923b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="pcrx:MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis">pcrx:UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:SkyePharmaHoldingIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1f022a2e3f45c38d8813642eb0a4b7_D20190401-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a81ffb612a403a924df2a487b03db8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7501d0ecec348a18e56ac1ec8c99ddf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cee35c07c974bff9beb7fa6c64d6aee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if16cf2053195434b94be734f2e6e754f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie965653fafce4fce912093bbf34f3347_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01af4a06a1ff4be181f27dd6fc5dccd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6a3944a915b4b7dacce440712764ef6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie438d7046d4b414a88a04918bfbd3568_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77e86ff9a584425992768831eb59a2b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f322fb012d64653a2090e9d08a6fa7a_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ee5be00954e45748d8b246245010a0f_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a7be408192f4f12b6d240abce12cdf8_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb1bbaf7e7374ecb8bb7e29a54a2e98f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2987763b470247b1b64487558ed62361_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8676c39077d849cf9a97ed7b875cf79c_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3b1ed3537724b41a9d822235c8817fd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsOnOrAfterAugust12023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7110286438e148d29048a9c4ae47c6b4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice3f2f561e0548b1b29b92f1b74cc3b5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7de6bbd42d241129b6517fae46c1feb_D20170301-20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-01</xbrli:startDate><xbrli:endDate>2017-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i484fffcf3bfc42da8b6f439297ac33b8_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76cecef789bf42e8a15eea314c8c854e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsonorafterApril12020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c1cb32c967149daac72034c56d3895d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i684590e84b124a17aead86fc30460d60_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2333c4061860489582acbe97375bee03_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i958bf8263a504b278937ce35716db65f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c75da8d059b4e2596b5ff5b06924a84_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7181147be8bc4623ae8e9c54c8d545ad_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02f839d9a53d4f3ca875382af344df93_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i583c220156b344feaaa6d77b90257b90_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee07277d2a1a4c99b0127e42c9b1dd5f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c7c1373cd042e1a4d460c0d974dd24_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae7f0c9606944edf9be67213b6c85881_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec15b75fb0c42b2b08037d3e0496138_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95fecb89ac048679a3ab7c3be07bf21_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i893cdc48adac4ec98ca312b73931a78d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i263034570486452a8b85ec7f5288179e_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14f382f05018464aad3ae04a610ed007_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d903a7704504ea2b8d765a75def60a0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a69013f0d0b4c429435e8c27ee9bb03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:TELABioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e0d7a6d98784688b9dd3fddc1b5a08c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:TELABioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib87f4d8c58fd4e109cfee6b9060ba4d0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:GeneQuineBiotherapeuticsGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f39cd86209f4b77984b8ebe031d7b5a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:GeneQuineBiotherapeuticsGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i091d6864fe7b45dfae7464d8dfbc754e_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:GeneQuineBiotherapeuticsGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaddf1add92a940f384b1684b15e084d1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:GeneQuineBiotherapeuticsGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a1ec36dd33e4facb2801b28ac07812b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cfdc64ff7694ae3b4874240596655b1_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pcrx:CodaBioTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2642fc1d446c40c890cec918384252cb_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:SpineBioPharmaLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3838cbd889d145a097da4753fd5b7d52_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="pcrx:AchievementOfMilestoneAxis">pcrx:AchievementofRegulatoryMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c092d61fa44c89a1f992840f0cce80_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia60b65aa2ebd44c6a2368109e2845fd1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcabd81228924ca98368c5d31fc89917_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfac6863101f4d0cbbcb816ebbd63709_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie57c515402bb4f8eb1ac59b13452a7bb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fba2629f05d45e2a951a1a3b00a7381_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9551ea61dd8e42de921cd6cb340713fa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i923a86d2b61a4ed5afa25b07cbdcf5a8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8336fab865c64a01a14d247bad7a374b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad8f7b4b2d424119bbbb3f917cb3b346_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia52993d557b44575b5efa778c644c50f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4e113d16ac64bae9b930524840237b5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22316fe6c9c9417c99464765f80e9ff2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic08f2b904bb04e27a90834e3f466dbd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia66d87b3e37142af9057b01f7429fa1a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28d6c7359df4b11873f7e1849924a7e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaaea71e25214e7182cb2fdf114dd014_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9cd891a11904cbca9a869e4c48499a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">pcrx:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaabd093cc73463987f26acf4772c0bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">pcrx:LongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a59f89178947969b3cba1e3274e2dc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied43576ff808456488d1b300724244f6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id114c1b120324ca1a1669aa5d23a5abb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b036912429349368955de8ecae55a89_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7ed73dae03a470482270000763fd063_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1718ddd31a954033b183d8735f99a0a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e0a781126c0441dacaff2fa6d34f7a5_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib22ffaf6dc27448ab2156941699b6b1a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c7ce8a3a5fc418d9801116dc3b6610c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a5860adea844fa8b07fe21a35e0f561_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia516abbffb1e4c0ba991b35223d79126_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie261cb366710463b836156aa4c632d01_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a6a43537be9433b9fc3bf5d2c98e1a4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfbabdf3eb7c47d9a56eb08fb08ae3f7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a1ff59e16c64e2e9bc827316216d3ba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bcecc3df2a2449395525e8d81ac6047_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7583ce2665944358a76869e7bdebea3a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22815de90a2e44529cacea918876ba77_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f3f4a3e1d854d6688e4b30b04ac8976_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i033c3bf91fa74d9f8777d9d69a2050e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2748d7cb585c451096424351db231a1b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d2ac06eaefc41a4919773d11bc58522_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="offeringperiod"><xbrli:measure>pcrx:offeringPeriod</xbrli:measure></xbrli:unit><xbrli:context id="i5328ec671a74439b9a01511fe23d4b0c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92cfc444422b4d0b8bace3222b587d3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e2148bdfe694503807898f469458f04_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07396e9494fe4b07b8f774fda1e27972_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5902e825304da38fccdd9ed1ae795a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i467a1ba8b0124cfd8c7cc340c2972c7b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0600e264da44709593ccef5269505a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dded111553f45dd92378a98c5010846_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i209c230b69834a4f9828d93ba9cc1546_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6964e7e50494461b1d33b90b39ec59c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1e6c6a626ee44d78fb558955fed8879_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d5224e2aea7473884ab3ab568b5f742_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i801a1368563548fbb45290c7dfac40e5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice17e0310ab24f19b2477b0ea0b3a5c0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia740c361205a40759e18df3c4efb99c0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34dbb38f3ce9455eb1cb8977c02233dc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70609b807c243d69cf4588104e93c8e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0de685059e34723aae25d71c24a900e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3131d879dea24998a48d584e912182a8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41071c327f3940bcaa6bb301df7449bb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i218c8db6e4454704b8551048521d1831_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d011ec249be45c6b176c6e6198e14cb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25c7e05a7fd8439d9f81fa9758796010_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9405e0168d3f418b965e10a3716b7c99_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f66d871d84f43da953d2139367fb6c2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d79527b591541b2b5cd79a11907b8f0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80f1189a3be5472b8a2576c5439a28f3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia50e9b50fa274d2a877186bfca0244a2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84c3ad13f8e54c46b927d50478630682_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:EurofarmaLabatoriesSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2483978d600d43fb9c6740ff2f1e9576_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:EurofarmaLabatoriesSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="pcrx:AchievementOfMilestoneAxis">pcrx:AchievementOfDevelopmentAndCommercialMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90361c4a697b4f3e8ec723bc57e3d9f1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61de8fd8c9c45ff8bf796f260c5aa91_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:FortisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8646cd5d4ebd458eab95c35c7d751c0e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib40c1bb9a8fc4a669685de4cfb5bf7b9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia161505b12724f2880a881bb1734845e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0268792e6564110bccd672d24ff62fc_D20211022-20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-22</xbrli:startDate><xbrli:endDate>2021-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37b82df25f6144808d51c0943de2a4b1_I20211015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6c3e67d137a4219a0590be4ad4df4ae_I20211118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396814</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-18</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icaeef1316917487cbff6510a43882f61_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDc0_6a25b9f0-9663-4a32-be37-45e1aae718d9">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Mark One)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt:fixed-true" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6YjI1MDcyNmVhNzk2NDFhNThkYmUwNjZkNGZmNzc2MWUvdGFibGVyYW5nZTpiMjUwNzI2ZWE3OTY0MWE1OGRiZTA2NmQ0ZmY3NzYxZV8xLTAtMS0xLTA_f99b020a-295c-4068-a2e3-86cf30a4e1d4">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8xMjg_af30ca44-4ea4-49bc-af9e-40778f359fdb">September&#160;30, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6NGY1ZmFiOGE1MDVjNDYwZmE5MGM0YzMzNjIzZjU1ZmQvdGFibGVyYW5nZTo0ZjVmYWI4YTUwNWM0NjBmYTkwYzRjMzM2MjNmNTVmZF8wLTAtMS0xLTA_02bcdeb8-8216-4572-92e8-c16723340620">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160; to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY4_9d9fedb5-1e63-4540-8f1e-77208799f51a">001-35060</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="pcrx-20210930_g1.jpg" alt="pcrx-20210930_g1.jpg" style="height:96px;margin-bottom:5pt;vertical-align:text-bottom;width:246px"/></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDc1_d9c413fd-7820-4b47-9ddc-8c144eac7b56">PACIRA BIOSCIENCES,&#160;INC.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:34.946%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.435%"><tr><td style="width:1.0%"></td><td style="width:48.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjViZTA0NmE0ZGU4NDEzOGJlOTJhMjA5ZmNhYWNjODYvdGFibGVyYW5nZToyNWJlMDQ2YTRkZTg0MTM4YmU5MmEyMDlmY2FhY2M4Nl8wLTAtMS0xLTA_0af50c56-f4eb-48dc-95e3-c4c4c4302f19">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjViZTA0NmE0ZGU4NDEzOGJlOTJhMjA5ZmNhYWNjODYvdGFibGVyYW5nZToyNWJlMDQ2YTRkZTg0MTM4YmU5MmEyMDlmY2FhY2M4Nl8wLTItMS0xLTA_2d254be8-32c5-4d97-aadc-3c19fc5d6272">51-0619477</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>&#160;Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY5_d530aec5-a783-4d62-9c9f-7210c95c6282">5401 West Kennedy Boulevard, Suite 890</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDcw_83d9765c-5813-4189-83b3-27878908649a">Tampa</ix:nonNumeric>, <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8zMjk4NTM0ODg2MDM3_19bc991f-6760-4da9-884e-b35d70f552f4">Florida</ix:nonNumeric>, <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY1_b9f4543c-abf2-494a-9efb-322868f70e0b">33609</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address and Zip Code of Principal Executive Offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY2_b4804586-ca0e-45af-a19c-204ed49f2565">813</ix:nonNumeric>) <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDcx_4dd58876-6600-4392-a2d2-458437f0f4af">553-6680</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.758%"><tr><td style="width:1.0%"></td><td style="width:37.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjRjOWFiYjgzNzE5NDg5ZGFlZmNmYTBkYWMxOWEwNTQvdGFibGVyYW5nZToyNGM5YWJiODM3MTk0ODlkYWVmY2ZhMGRhYzE5YTA1NF8xLTAtMS0xLTA_f7433a1b-27b6-4384-bc59-1ea2a9ecccf2">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjRjOWFiYjgzNzE5NDg5ZGFlZmNmYTBkYWMxOWEwNTQvdGFibGVyYW5nZToyNGM5YWJiODM3MTk0ODlkYWVmY2ZhMGRhYzE5YTA1NF8xLTItMS0xLTA_723dfc84-ce5e-4941-a9b7-cab615c6ddf7">PCRX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjRjOWFiYjgzNzE5NDg5ZGFlZmNmYTBkYWMxOWEwNTQvdGFibGVyYW5nZToyNGM5YWJiODM3MTk0ODlkYWVmY2ZhMGRhYzE5YTA1NF8xLTQtMS0xLTA_44ce007b-13df-4f44-83ae-e7f27d125152">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDcy_c35c8a6a-328a-40da-bd2f-3a7575a86f9b">Yes</ix:nonNumeric>   &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files.)&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY3_32420f2a-0241-43b3-9ada-327e6262f7df">Yes</ix:nonNumeric>&#160;   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.168%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.168%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6ZjExNmY1ZjhiNTFiNGFkNjhlZjA1NmY1NWM0NjBlNjEvdGFibGVyYW5nZTpmMTE2ZjVmOGI1MWI0YWQ2OGVmMDU2ZjU1YzQ2MGU2MV8wLTEtMS0xLTA_d88883e5-1623-46c3-b00a-a4e884fc34c3">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt:fixed-false" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6ZjExNmY1ZjhiNTFiNGFkNjhlZjA1NmY1NWM0NjBlNjEvdGFibGVyYW5nZTpmMTE2ZjVmOGI1MWI0YWQ2OGVmMDU2ZjU1YzQ2MGU2MV8xLTUtMS0xLTA_b6d93991-4081-4aa9-9139-b7a1014772f9">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6ZjExNmY1ZjhiNTFiNGFkNjhlZjA1NmY1NWM0NjBlNjEvdGFibGVyYW5nZTpmMTE2ZjVmOGI1MWI0YWQ2OGVmMDU2ZjU1YzQ2MGU2MV8yLTUtMS0xLTA_2ac54e91-1ef2-428b-af3f-bdbfad6a1d60">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDcz_30b5e166-e320-494f-9797-1358a4f02c45">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Yes   &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="icd4be343c5c04ff3a57d3cb3f3dfe956_I20211031" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8xOTc3_6e1491f1-52c1-41cf-943a-f7a8fa29de81">44,544,489</ix:nonFraction> shares of the registrant&#8217;s common stock, $0.001 par value per share, were outstanding.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUARTERLY REPORT ON FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR THE QUARTER ENDED SEPTEMBER 30, 2021</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page #</span></td></tr><tr><td colspan="9" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_10">PART&#160;I. FINANCIAL INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_13">Item&#160;1.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_19">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_22">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_22">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_25">Condensed Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_25">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_28">9</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_31">Condensed Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_31">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_82">Item&#160;2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_82">28</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_106">Item&#160;3.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_106">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_106">44</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_109">Item&#160;4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_109">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_109">44</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_112">PART&#160;II. OTHER INFORMATION</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f4f4;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_115">Item&#160;1.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_115">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_115">46</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_118">Item&#160;1A.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_118">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_118">46</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_121">Item&#160;2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_121">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_121">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_124">Item&#160;3.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_124">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_124">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_127">Item&#160;4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_127">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_127">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_130">Item&#160;5.</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_130">Other Information</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_130">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_133">Item&#160;6.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_133">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_133">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_136">Signatures</a></span></div></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#f4f4f4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_136">50</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 3</span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_10"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I &#8212; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%"> </span></div><div id="icaeef1316917487cbff6510a43882f61_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FINANCIAL STATEMENTS (Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div id="icaeef1316917487cbff6510a43882f61_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMi0xLTEtMS0w_396d6d7b-f964-4428-bc20-808e550641f3">134,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMi0zLTEtMS0w_45d3194d-5551-410a-853e-08ec35a32221">99,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Short-term available-for-sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMy0xLTEtMS0w_1622f0db-ef80-4e2d-b46f-306d0ae99ee4">559,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMy0zLTEtMS0w_dc329897-07b9-4315-b6ed-aee81d707c0c">421,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNC0xLTEtMS0w_fcd43f57-4382-465a-8f91-ec19c457e5d7">49,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNC0zLTEtMS0w_03189746-0eba-4ab1-875c-8c2def290ebd">53,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNS0xLTEtMS0w_64e45025-bf5e-43ce-a555-13baa9ec4645">67,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNS0zLTEtMS0w_fde8da7a-97e4-4626-959b-94c31a835293">64,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNi0xLTEtMS0w_5c7f6ad4-d0f9-4a8c-96a8-612a3ba6b224">11,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNi0zLTEtMS0w_b97d2ca8-5deb-4bc5-bac2-99f2528689fb">12,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNy0xLTEtMS0w_77692b9b-cd22-4d0b-9aad-0b9bfa1c7856">822,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNy0zLTEtMS0w_fd866435-9dd2-462a-83f6-2ce9ef3bbe72">651,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfOC0xLTEtMS0w_4770c973-8611-49d7-9f43-d3bb8769116d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfOC0zLTEtMS0w_5463037f-d813-4f03-a753-d0c76446c75b">95,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfOS0xLTEtMS0w_1527b66f-787b-480c-9d9d-8bc873544a64">159,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfOS0zLTEtMS0w_61fc36a0-a56a-4d20-809b-be1ff56ef809">136,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTAtMS0xLTEtMA_666f5a18-2fcc-4180-960e-384600eacd13">69,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTAtMy0xLTEtMA_bcc34eda-05a4-48c6-b9f4-b3ba76afbd97">74,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTEtMS0xLTEtMA_31ca8da6-126c-40a3-bbcd-fb1ebf7ec7a6">99,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTEtMy0xLTEtMA_530aeb86-6eee-48bc-9883-81f51376b21b">99,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTItMS0xLTEtMA_6e963276-2058-4eb8-b179-3b9c2542b746">90,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTItMy0xLTEtMA_b2d9c833-429c-42a8-8917-909af699c6e1">96,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTMtMS0xLTEtMA_5b1184ed-1140-4953-aefb-6fed70ceb6b5">93,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTMtMy0xLTEtMA_2dff5245-4d7e-4052-99d5-130dff2f599e">106,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:EquityMethodInvestmentsAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTQtMS0xLTEtMA_89ce524d-2513-4cba-8606-b33a782d998f">21,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:EquityMethodInvestmentsAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTQtMy0xLTEtMA_ba7950ba-008e-4baf-b29b-781c98d45431">14,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTUtMS0xLTEtMA_afba31e2-e0ba-4eea-980f-5bba8e8c9ec5">1,356,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTUtMy0xLTEtMA_d0c44593-36a2-49c5-980b-886a3bde59f2">1,274,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTktMS0xLTEtMA_52f52a7e-9575-4f60-945f-4a0be98f3aaa">7,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTktMy0xLTEtMA_db2e0ea8-7580-495a-a995-c619fa5ff3b2">10,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjAtMS0xLTEtMA_f7b610f8-a4d7-4052-9410-f98c37124cad">50,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjAtMy0xLTEtMA_c25c5948-f53a-48f7-8876-3a00930d8920">70,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjEtMS0xLTEtMA_98a0efbd-8035-410a-9f13-5e8f5cc11494">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjEtMy0xLTEtMA_a025291c-1441-4f84-ab6c-ae2930bf7876">7,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjMtMS0xLTEtMA_e1388514-260b-4f87-9c93-178bf7584523"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjMtMS0xLTEtMA_e848207e-5035-4121-8232-b2bfa3db6ee3">155,751</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjMtMy0xLTEtMA_6da82b5f-de7b-484d-8c18-db7424c41d04"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjMtMy0xLTEtMA_c6574f28-1633-4d06-a180-2160ee28888d">149,648</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:ContingentConsiderationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjQtMS0xLTEtMA_70881779-4905-42d0-b36e-5896140da512">5,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:ContingentConsiderationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjQtMy0xLTEtMA_a8dc62cf-2dd1-486c-a137-e1c8b39d6cb4">14,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjUtMS0xLTEtMA_eb37fbb6-b2f7-475e-9ca1-616fa2a6b9c3">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjUtMy0xLTEtMA_8c0aaee0-bd6e-4bf3-94c7-235ffb802991">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjYtMS0xLTEtMA_2f5a2cff-4bb4-4c39-b4c8-07a4c2ad5d96">225,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjYtMy0xLTEtMA_f74c39fc-cd06-406d-9733-635855fe32b2">253,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjctMS0xLTEtMA_7917ef9a-54cf-4237-9137-ec4aa26428ec">326,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjctMy0xLTEtMA_cba764fb-148e-4565-be4e-5b3f54ea972a">313,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjgtMS0xLTEtMA_7523791e-02e4-47ba-8143-2d40b21eb3b5">66,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjgtMy0xLTEtMA_507eecac-25aa-4fbb-b231-7f187678a427">71,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:ContingentConsiderationNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjktMS0xLTEtMA_3472dcf3-9673-41cb-a6d4-d5ff923caed9">11,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:ContingentConsiderationNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjktMy0xLTEtMA_67700443-13ea-448e-b15e-d945cda0191c">13,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzAtMS0xLTEtMA_eb374364-15c9-4573-8caf-c686dc454b14">7,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzAtMy0xLTEtMA_114cbc2f-c5b6-487e-a7e7-094de6cba0cf">3,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzEtMS0xLTEtMA_41147985-0d7f-4a30-a48c-ba9399c88a74">637,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzEtMy0xLTEtMA_8290e64a-d67e-4554-b331-cbb0f4bef1bc">654,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 15)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzItMS0xLTEtMA_eac524d8-b65b-4110-a1f4-0db4cabfb2e8"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzItMy0xLTEtMA_5f388161-7a0e-4b85-a42b-b6e0566ae5b2"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzM2_24c57c41-8100-4f73-a8d9-2b1f8222787c"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzM2_992387a1-a7bf-4f5d-add0-ded8403e854e">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzQw_6b24a46f-f761-4254-9c6d-ff0bc83398f8"><ix:nonFraction unitRef="shares" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzQw_a642d279-3206-4cd8-b6f2-7c7fff3f5cf9">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzYy_192e3fdd-535e-4720-8e05-093f5209bebb"><ix:nonFraction unitRef="shares" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzYy_289930ea-c2db-44bf-b9bb-d56a094a172a"><ix:nonFraction unitRef="shares" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzYy_31f1cbdc-6be5-449d-ad0e-66e2bc12c8a3"><ix:nonFraction unitRef="shares" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzYy_590bbb74-b2f1-43bc-a8ea-6e3105a161ba">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;September&#160;30, 2021 and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMS0xLTEtMA_634e3dec-7eae-4684-953a-be70112ff22b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMy0xLTEtMA_920e7b3b-0cda-46ba-a0f2-50bf2a624ff8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzMz_b35d9d07-0fd8-4ef1-aeae-e12ce32bd8b6"><ix:nonFraction unitRef="usdPerShare" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzMz_e868c0e3-6cc3-482b-9619-6b9682fafc91">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzM3_50f65503-8c48-4c9a-820d-747d7f4b2ccb"><ix:nonFraction unitRef="shares" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzM3_b90f085d-4155-4ec3-8811-05c6773c8e9e">250,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzU5_e5a7b401-3fc6-4176-8b0e-5d53bccf605b"><ix:nonFraction unitRef="shares" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzU5_f731ca46-8a44-4c87-a1b5-935371fac329">44,523,410</ix:nonFraction></ix:nonFraction> shares issued and</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;outstanding at September&#160;30, 2021; <ix:nonFraction unitRef="shares" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzEwNA_1d791dbc-24d4-43b3-ad2c-7066d73bdc6a"><ix:nonFraction unitRef="shares" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzEwNA_8ec2185b-365f-4fe2-9d1d-3ecda1d67fe4">43,636,929</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMS0xLTEtMA_fbaebeae-53d9-4416-b627-ed972e0d510e">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMy0xLTEtMA_da436c60-86ab-4725-aa65-c02debb38802">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzYtMS0xLTEtMA_664c1203-11ac-4311-b22d-7db5174e2091">925,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzYtMy0xLTEtMA_db1f299d-9c97-4981-9fa2-f48edbb05d5b">873,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzctMS0xLTEtMA_c0e93d25-b679-4115-ba06-0c6e05627c84">206,765</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzctMy0xLTEtMA_726b1ebf-a013-4331-a57d-84f31516e6c8">253,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzgtMS0xLTEtMA_8945dd41-7fe3-487d-8317-89f6e918e0c3">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzgtMy0xLTEtMA_3f52af71-8636-43cf-bad2-cedee20a7f7b">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzktMS0xLTEtMA_c3846076-4156-4060-b2a4-e7c81a2563de">718,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzktMy0xLTEtMA_ee3ef371-e12b-4def-8d60-62399e752064">619,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNDAtMS0xLTEtMA_ebcb3352-147f-4db2-ac4d-f7ebd06c945c">1,356,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNDAtMy0xLTEtMA_e9f9495f-be52-43ef-8d01-c056d8bc7f37">1,274,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying condensed notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 4</span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12dead7e93d941fa9ed3c4a6d9cdd283_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMy0xLTEtMS0w_14e60ce8-fa4b-4a4b-a650-03a2925cb8d7">126,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b52bbc6f8429686e59ef4517c7bf4_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMy0zLTEtMS0w_84bdc1b7-a5ee-4e44-9fa8-f0bf58002a6f">116,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a4d517e9454a9a888918ce80188a4e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMy01LTEtMS0w_a9fe4218-b68f-4421-89dc-19dd7ac9297f">380,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b7287c7614e46d8ab1553c11a8c6b9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMy03LTEtMS0w_e84b7b68-b299-489a-95d2-6cf8f34a343c">296,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Collaborative licensing and milestone revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a291ee19594ddfab77fce82e32a1c6_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNC0xLTEtMS0w_8b108dfc-a3d6-457d-8729-2d5e564c3af6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9842d334ede6470cba57f5223fd23c14_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNC0zLTEtMS0w_1a5c417c-3b3d-4b0f-9279-16877ff2f5c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ad93bee00549d8bdd6a51f78347c23_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNC01LTEtMS0w_7668dff2-716c-49a0-b2c7-f8fa9ea7b005">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e97b7d115ac489bb255e8dbdd6a3227_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNC03LTEtMS0w_ed3860a9-f00a-48e6-9d68-28c46b592a36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i117249baf38443f781c1edf946e8991e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNS0xLTEtMS0w_398a199e-a0d3-4855-b0ed-2617608922b0">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if09bc71a12134a489569878485158a10_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNS0zLTEtMS0w_e5db469a-d525-4191-8892-ec8f9cbf6cde">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5220037f26804a09aca54e93634fae07_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNS01LTEtMS0w_faee1660-d8b5-41b2-b12f-2124c1b3c767">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343da0f70b794c348d0831e6aeaf9c59_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNS03LTEtMS0w_a0dee5cc-ac3f-4d0b-bf5e-6e41fbadd70f">1,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNi0xLTEtMS0w_3b4b8551-73d8-49d3-8100-63b7841875f0">127,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNi0zLTEtMS0w_461a2fc4-1d93-4e68-b692-c5ab1b790a74">117,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNi01LTEtMS0w_bdd67180-e7f0-4bc7-b489-29453cb785ab">382,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNi03LTEtMS0w_8b65cf81-2b27-4b3d-ace3-2c155ebc88b6">298,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOC0xLTEtMS0w_9ede31c5-e629-41ea-aeb8-06c14d246cf9">34,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOC0zLTEtMS0w_4780e8c3-2f89-4f69-9cdb-77b1b8712045">29,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOC01LTEtMS0w_c6d6ba27-47f4-4a8f-a94d-03b2fbc7f950">101,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOC03LTEtMS0w_6579ec60-5fe3-4dd3-bfa1-3e05cf1e144b">82,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOS0xLTEtMS0w_71bd8a68-782c-44da-8a31-b92dcaba2248">11,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOS0zLTEtMS0w_17f09cea-65b3-4e5f-b98c-6dbe3d581b42">14,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOS01LTEtMS0w_24cfeb8d-f7b9-44c8-b618-67be0c946d07">40,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOS03LTEtMS0w_aa6e7e76-439c-4bfb-877d-0ff1f27bf5e7">44,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTAtMS0xLTEtMA_99fee23f-d273-42bc-9b90-6a931c1976a4">48,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTAtMy0xLTEtMA_2bb48d8e-dd67-423d-b541-875f5331ef85">52,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTAtNS0xLTEtMA_8ac63c83-2736-43b6-b177-3f79fe4f9046">148,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTAtNy0xLTEtMA_065a9ecc-a82b-40bb-94d6-84bf337afee8">140,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTEtMS0xLTEtMA_cf2062cb-18c7-480b-9040-e8c8e06e80a7">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTEtMy0xLTEtMA_3f5efae2-3592-4c1e-abb4-a57eab377034">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTEtNS0xLTEtMA_2e3c9d83-fb56-403e-b384-858776aeb34e">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTEtNy0xLTEtMA_c3bec40b-8c9a-41f0-8ba6-07f9ef881069">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Acquisition-related (gains) charges, product <br/>&#160;&#160;&#160;&#160;&#160;discontinuation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTItMS0xLTEtMA_2115a3e5-53e4-49ed-b4c0-fbd29adaa5ec">714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTItMy0xLTEtMA_024a2269-4457-4c14-9b3b-017cb2bc1313">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTItNS0xLTEtMA_a386e627-c09c-4a23-a104-ef51a9c25089">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTItNy0xLTEtMA_020152e8-ee7b-464a-851c-119d541912c6">1,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTMtMS0xLTEtMA_2a7739b3-b4fb-41ea-940d-fe2bde297689">96,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTMtMy0xLTEtMA_b200522e-5cef-4f87-8474-ae03a02bcc93">99,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTMtNS0xLTEtMA_d18e74e0-a20a-48ca-8e45-ad5ce46c06a5">296,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTMtNy0xLTEtMA_e5ae3daf-9022-48da-95c0-e78c397db9cc">271,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTQtMS0xLTEtMA_c123d32f-ec6c-4c6f-b96f-5948c54e60f2">31,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTQtMy0xLTEtMA_2c45e4d0-60fd-48a7-a2f0-09b2c61527b4">17,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTQtNS0xLTEtMA_44c5b158-3c47-4616-9a43-1167fca7e183">85,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTQtNy0xLTEtMA_6c709ef7-8b58-4d07-a663-b6049b76969e">27,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTYtMS0xLTEtMA_860de14f-eca8-4d9e-8c40-03bc50ee1b4d">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTYtMy0xLTEtMA_de911d32-2395-4e3e-92b2-27cedc34dbee">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTYtNS0xLTEtMA_a0f37fed-eb84-44d8-bc3d-fc6879c92e41">816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTYtNy0xLTEtMA_e569f78a-38e7-432d-bc49-bce4cea2744b">3,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTctMS0xLTEtMA_ee3abcc4-6976-4dd6-8ce3-f96b6c2b8a7d">7,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTctMy0xLTEtMA_82daab82-a093-4247-a005-6efbc2efff5a">7,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTctNS0xLTEtMA_406c883f-44c5-4037-af16-0f7eba7977d9">21,327</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTctNy0xLTEtMA_fbd208f8-2785-4093-92a2-af973ae7ba68">18,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTgtMS0xLTEtMA_201f4e11-e22c-4e9c-bbf7-624c4eaadb5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTgtMy0xLTEtMA_409b4125-eb92-4755-8107-3d666af1c708">8,071</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTgtNS0xLTEtMA_0c835931-bdb7-4911-a94d-f04b3fc8087b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTgtNy0xLTEtMA_4a40ba80-58b8-43a5-b570-ca9fc846cccf">8,071</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTktMS0xLTEtMA_ef4f8772-10d4-4cb8-97d9-bf2650868669">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTktMy0xLTEtMA_dcbaca48-8a0c-4bcf-8148-66badf757141">2,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTktNS0xLTEtMA_5002502c-cf04-4ff0-921c-e2e15b1bd3bb">2,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTktNy0xLTEtMA_a1f5dfd1-60e2-4ef8-9bdc-feefb911f7f4">2,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjAtMS0xLTEtMA_0c513061-f0d0-4163-9305-c3caae360645">7,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjAtMy0xLTEtMA_664af1ca-8421-4146-bcfb-01b4b0c786e8">11,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjAtNS0xLTEtMA_a0b94c11-c064-497b-9265-9cb28cb0e074">23,111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjAtNy0xLTEtMA_51e126de-a270-409a-a217-5b097263fcb2">20,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjEtMS0xLTEtMA_824f040a-cee4-4923-80a2-802fdef954ee">24,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjEtMy0xLTEtMA_5ea2eba7-ec60-4bda-ab7e-9ea57a69f311">6,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjEtNS0xLTEtMA_e4342f6c-1145-4c9a-a167-e1af0ad5ad66">62,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjEtNy0xLTEtMA_adc31784-7d39-456e-8a47-7350e577b4fe">7,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjItMS0xLTEtMA_de224121-d912-4e5b-9045-f8766950a1fa">6,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjItMy0xLTEtMA_686fe9a9-42ac-4148-b10f-e2f1e789802d">123,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjItNS0xLTEtMA_2d2c9838-ea53-4790-acd6-12cd40db1a4b">15,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjItNy0xLTEtMA_203fce1a-9e41-4871-8570-e9833114c7c7">123,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjMtMS0xLTEtMA_4ab62241-6dda-4fd0-9d50-68ffa62feddb">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjMtMy0xLTEtMA_7a4bfe7a-1f7e-4658-b0bd-132433e94fe8">130,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjMtNS0xLTEtMA_b5743bed-9a3f-4a03-ab39-90a89e4fd4f5">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjMtNy0xLTEtMA_182ccef9-51b7-4ce2-bb13-3aa8f8e02992">131,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjYtMS0xLTEtMA_ee4742ac-212c-419c-8340-addb182ff7aa">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjYtMy0xLTEtMA_30862dc6-8d2c-4ce5-b2a2-9afdc7ae9b57">3.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjYtNS0xLTEtMA_108d76af-d711-4741-9e8b-d9e1e1232583">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjYtNy0xLTEtMA_6e7f198b-cd8d-4bed-a1c7-7dc3f462d93a">3.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjctMS0xLTEtMA_cfc3509c-8412-46aa-9136-639c0e7f556b">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjctMy0xLTEtMA_07a87063-3ea5-4078-9fed-904b9eb76f08">2.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjctNS0xLTEtMA_657e2594-d48b-4a12-a59a-9951db4b4360">1.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjctNy0xLTEtMA_9324cfb3-ad26-4b41-a353-15f1a2c1437b">3.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjktMS0xLTEtMA_3c70a029-a3bc-46af-8a25-859bf67b71a2">44,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjktMy0xLTEtMA_22daa683-8eb2-43ed-b660-3763115282a6">42,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjktNS0xLTEtMA_2c7cffdc-f675-42ec-84c2-7b0f482eb625">44,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjktNy0xLTEtMA_3741a53d-1ac5-4eb6-b55e-6c90731ca14c">42,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMzAtMS0xLTEtMA_ec5aa6ce-5a5b-4426-86fa-f83fc17418f0">45,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMzAtMy0xLTEtMA_ed5e9e0f-fc5b-424d-a660-6d57a2030955">44,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMzAtNS0xLTEtMA_8e9b4e1d-59ba-4329-bdf4-6a00688633f4">45,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMzAtNy0xLTEtMA_e29f9562-ec33-4f66-9e79-30107a4d8264">43,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying condensed notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 5</span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfMi0xLTEtMS0w_4ab62241-6dda-4fd0-9d50-68ffa62feddb">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfMi0zLTEtMS0w_f0406d8d-a5bd-4f5d-897c-252f69e5a064">130,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfMi01LTEtMS0w_b5743bed-9a3f-4a03-ab39-90a89e4fd4f5">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfMi03LTEtMS0w_3a9652dc-c393-40f6-9dde-b1fc5d90e432">131,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain on investments, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNC0xLTEtMS0w_334a0a02-9792-47ac-a1bf-b65e1a81db5d">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNC0zLTEtMS0w_284bf4ee-4cf6-44c4-b371-9474e1102ab2">643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNC01LTEtMS0w_4f61c47c-cf52-41ce-8dfa-a22936cc6191">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNC03LTEtMS0w_26ae7f06-eea1-487b-bcef-859507588dab">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNS0xLTEtMS0w_33fe86b7-17e6-447c-ba9a-29829e609b8c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNS0zLTEtMS0w_32337398-693b-4d75-9a8a-5bc1884cb3a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNS01LTEtMS0w_1ef809c4-5f50-4ea6-889e-0955012cff43">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNS03LTEtMS0w_36cde35d-719d-43fc-be47-00f66b549e66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNi0xLTEtMS0w_d5444c97-134f-49f4-a63c-61b2dd6ef981">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNi0zLTEtMS0w_489c4461-7f48-4d02-9b9c-40de5405892a">643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNi01LTEtMS0w_4667d9ab-0cca-4ad3-87fe-e8bd7a0636d2">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNi03LTEtMS0w_823f21a4-2f5d-41e9-a346-d022fca7a89b">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNy0xLTEtMS0w_d21956dd-3c9e-4346-988d-30457b7bb5bd">17,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNy0zLTEtMS0w_55edd411-e822-444d-b403-3b6fb0dfc240">129,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNy01LTEtMS0w_5279bef2-7950-4a8c-9edf-a2974cddc541">46,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNy03LTEtMS0w_32939c6e-25a8-486b-abe2-f064fe9a5443">131,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying condensed notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 6</span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7edff5520a404b2b83447444f9eb459f_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi0xLTEtMS0w_3bcbb578-ac41-4997-ba50-7408e01a5aaa">44,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7edff5520a404b2b83447444f9eb459f_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi0zLTEtMS0w_f47efabd-7518-4fb4-af8d-81188632324b">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i122a17173a484439aee4c4ca9b399085_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi01LTEtMS0w_8a36058e-4dcc-4e43-a276-a7c9b2817554">911,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b693b61cc3b4215a6ee287c335a9063_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi03LTEtMS0w_b6639925-6b23-4887-b28b-5d25ff500d14">224,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d65492b3924412b7973c03af1fe9e6_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi05LTEtMS0w_acc090d9-21f9-45ab-a83a-3d2445f406a3">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8495ec90002a45e0bf0887939ab74508_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi0xMS0xLTEtMA_e991661e-62bc-4be1-9d0a-51997508c41d">687,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i948ca81132a24b4d8ef57d52788a5385_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNS0xLTEtMS0w_18a9f5a5-62c5-4468-92a2-3d3e12526a3e">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948ca81132a24b4d8ef57d52788a5385_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNS0zLTEtMS0w_1367cc8e-9a75-4387-b3fa-c5bb16e71ef7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21fe54e97dd84dc997ccfb0ebc078b9a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNS01LTEtMS0w_df8d7054-81b5-4110-9591-9653b53bd595">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNS0xMS0xLTEtMA_80cf0e21-0510-4625-a01b-2e38a3e98131">3,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i948ca81132a24b4d8ef57d52788a5385_D20210701-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNi0xLTEtMS0w_d5aa3577-c40c-47b9-84c0-273e5977889a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21fe54e97dd84dc997ccfb0ebc078b9a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfOC01LTEtMS0w_f2089068-e4a8-4180-be4a-0ae19981d8a5">10,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfOC0xMS0xLTEtMA_2a28f717-5591-42ad-bdb2-a7c1c6d30810">10,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f9c6243a10041a9a851d8813a74c05e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTItOS0xLTEtMA_7aca3d65-fde9-4064-855d-5ecc94768c18">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTItMTEtMS0xLTA_a08023a5-6e7d-4efb-9fe8-0ecda38ba746">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077b7247a4a24b37a42640d85ace320b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTMtNy0xLTEtMA_3d420ba3-b816-471d-872a-4c6f0aa2662c">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTMtMTEtMS0xLTA_bccd110d-8381-4799-9019-6d0a55454efa">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifff9414f8ec14f648d23be05a58aa2b5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtMS0xLTEtMA_f3fc7c24-5966-4b5a-ad87-9efa05373ec6">44,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff9414f8ec14f648d23be05a58aa2b5_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtMy0xLTEtMA_2fe356e1-0f32-44c2-bd20-cbd79ce4eb9b">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib557a2279d86475996731b3fc97be752_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtNS0xLTEtMA_05aedec6-efc2-4a51-aee0-4558b17e3a76">925,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20e70406d1a045e4bd52905aacc53fa2_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtNy0xLTEtMA_6b06daaa-b610-40ef-8cb1-0d22d795521f">206,765</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55cda46fa2334de29508526999af243a_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtOS0xLTEtMA_6813695b-9c7c-481f-9d9b-2fc03ece8a28">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtMTEtMS0xLTA_4a92c188-21af-454d-9bed-5de40538abe4">718,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i014f2a1fc24b43b18ee6280f20cdf1ce_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi0xLTEtMS0w_54fefd52-5df8-4c8d-8ff7-aaff2b5d2540">42,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014f2a1fc24b43b18ee6280f20cdf1ce_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi0zLTEtMS0w_1fa1f790-08db-454d-85b9-f51b43abb205">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0782a595bbfb44b29916dbcc9517713f_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi01LTEtMS0w_5e6c2373-66d4-4442-ae55-7803484d9f6b">785,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if774c56400c143a986cc56ea80547ef8_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi03LTEtMS0w_03cef44d-197e-426e-a4cf-9271ec2f4fda">398,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0697b721fc9e45f69f060f8f46d77072_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi05LTEtMS0w_f9ffd4a4-66a5-4ff0-b0f6-a1519f02fd79">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c52d1fdd134b989a3e678be437266e_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi0xMS0xLTEtMA_4efc2d97-5513-427f-a29e-2c977e0dbaf7">388,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a8a218cb3b1417390af7c5813a511e9_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNS0xLTEtMS0w_70bc413f-e139-4d02-9b32-8d604df9c711">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8a218cb3b1417390af7c5813a511e9_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNS0zLTEtMS0w_5de522ac-7405-4b1d-b839-92c9eb0bc86b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a912dcf7aa45e69c293537f5fa8875_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNS01LTEtMS0w_60270453-e6b0-4073-b177-49bd8d15f464">24,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNS0xMS0xLTEtMA_407c6787-dc02-44e7-9500-a988bf0b10da">24,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a8a218cb3b1417390af7c5813a511e9_D20200701-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNi0xLTEtMS0w_e7b5c031-e84a-4826-846f-9d3eadea1730">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a912dcf7aa45e69c293537f5fa8875_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfOC01LTEtMS0w_bfc1a923-1cfe-4453-b073-cb3546b91c20">10,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfOC0xMS0xLTEtMA_67cf0e4b-e84a-4ce4-b5dd-7730a7068ba2">10,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of equity component<br/>of 2022 convertible senior notes (Note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5abf6e142c09447396ea931fa4051312_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTAtNS0xLTEtMA_d714b983-5615-4e86-aaa0-cd59504a638b">33,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f2bef137d34763a6e0945cc7109ba5_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTAtMTEtMS0xLTA_7ad79baa-bd52-4106-89fa-71d2eccb4857">33,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity component of 2025 convertible</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">senior notes issued, net of deferred taxes</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of $<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjdjMDAwZDYyNTYyYjRhOWRiZjIwMzEyYjZiYzk2NTU4XzEwOTk1MTE2Mjc4ODY_fa9c458b-1615-4c10-bf7e-fe39a081c1d1">20,450</ix:nonFraction> (Note 8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7254f3d070d24fedba65bee5b312cfb6_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTEtNS0xLTEtMA_cbe7277c-a1ca-48db-8bdf-9e7f44263f61">64,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7254f3d070d24fedba65bee5b312cfb6_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTEtMTEtMS0xLTA_dd040558-a1e2-46db-b51c-232398f51804">64,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i255a01006e2448ef9f48b2f549fa8a87_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTItOS0xLTEtMA_ce44c9ab-67a4-4095-b52a-15f07c133ba6">643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTItMTEtMS0xLTA_780d6bb2-3da2-49a8-8dc4-5d077f19724f">643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7713099e5342bc91935b76d0493eb3_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTMtNy0xLTEtMA_c4fdea23-ef7d-489a-bdd8-9a7d526c6686">130,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTMtMTEtMS0xLTA_f20cc229-ef9a-4095-a205-daf98d50f4c6">130,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97143ff422764b1eb3afddc0d216dca4_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtMS0xLTEtMA_71b5da7f-955c-4369-8344-c565b3aed8b5">43,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97143ff422764b1eb3afddc0d216dca4_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtMy0xLTEtMA_cd0e84c5-258d-41d6-9f6e-7b6b70ed5f82">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8d0686e48b449de8494030e085a5ba6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtNS0xLTEtMA_f5f675db-2220-482f-9911-6fa9e8e3fc1b">852,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a7036c745f4bed845b3722cfd852b4_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtNy0xLTEtMA_f0d0ae7e-7d96-4ae7-9529-6a6b2e17d0f7">268,390</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e471ced5e9c4e899d18dd16de8c4d8e_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtOS0xLTEtMA_2e93ce41-05d2-47f1-942c-1b4421e49f6e">847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtMTEtMS0xLTA_f7eea33a-0c14-4f25-ac65-1e7c1fc34452">584,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying condensed notes to consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c1289967bb1472eb59cfee843fc6864_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi0xLTEtMS0w_992cf4d5-0611-421f-a0d5-197ccef47091">43,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1289967bb1472eb59cfee843fc6864_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi0zLTEtMS0w_cf6f3af1-ff07-4f23-acff-022c8dad8992">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ae279ae07c24b808b12769dd2e5d56b_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi01LTEtMS0w_38c7ac1f-a2ff-4a92-b6f5-d7d6afc09732">873,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieaacf91e289d4f41a577e6a6fc15dd78_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi03LTEtMS0w_3dd2284c-1398-4929-a315-308b500af375">253,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ef8fa3f6ef4295b34719dd5bcd1ea2_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi05LTEtMS0w_f7d231b7-27f4-4f71-bfe9-5cb580f0e70f">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi0xMS0xLTEtMA_b4811360-64fd-4107-8b2b-a3786eb2a179">619,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i633a7f9223744608a36564a7e357408f_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNS0xLTEtMS0w_c3ab2d77-4a5c-4d29-9e7c-ac609c7fff01">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i633a7f9223744608a36564a7e357408f_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNS0zLTEtMS0w_492a5976-78fa-40ee-8ebf-503d7c02ca2f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948705b5248d4d66bb924c0499f8f0dd_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNS01LTEtMS0w_6df9bed9-97fc-47fe-b91a-1d406bd65b17">19,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNS0xMS0xLTEtMA_0f5c5d0a-cc16-40c4-b5f0-744ef4887d6f">19,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i633a7f9223744608a36564a7e357408f_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNi0xLTEtMS0w_afcd9edb-6e3b-49a8-9e93-5dc762a5bdfc">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued under employee stock<br/>purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i633a7f9223744608a36564a7e357408f_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNy0xLTEtMS0w_c9b20552-b394-461a-97e6-8dfb5cc5c659">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948705b5248d4d66bb924c0499f8f0dd_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNy01LTEtMS0w_29361bb7-b155-4c35-aeb2-242e36c115c6">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNy0xMS0xLTEtMA_b37e1e48-689a-41b7-a6fe-c89ea14787e6">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948705b5248d4d66bb924c0499f8f0dd_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfOC01LTEtMS0w_21a092a8-feed-4865-bb51-ad9ad7e934b9">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfOC0xMS0xLTEtMA_38a5b95e-c76f-411d-9c4a-9c15146693df">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7fe3f4d4a2545b2bcf7893e525bd645_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTItOS0xLTEtMA_68691caa-2135-433a-86fb-85a8c6a72ccd">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTItMTEtMS0xLTA_ab31e4f1-7bab-42c7-985e-512199dece52">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i906da711ad9f492aa726ba7c1e3c3da3_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTMtNy0xLTEtMA_ae3d83cb-b89b-4cb8-978d-00fab4332837">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTMtMTEtMS0xLTA_2558379e-70c7-4ffc-956c-f1b2b7bd7645">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifff9414f8ec14f648d23be05a58aa2b5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtMS0xLTEtMA_d4f142c7-2ad5-4a7b-b766-c6dd30e46003">44,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff9414f8ec14f648d23be05a58aa2b5_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtMy0xLTEtMA_708e3c27-befa-4c9e-9569-9a462089780e">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib557a2279d86475996731b3fc97be752_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtNS0xLTEtMA_2293f4fd-82c0-4e7a-a609-f145ccb3dfda">925,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20e70406d1a045e4bd52905aacc53fa2_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtNy0xLTEtMA_9b25d112-d0ae-48b4-897d-564d69e88caa">206,765</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55cda46fa2334de29508526999af243a_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtOS0xLTEtMA_37aa1730-6d7b-4e14-b094-4d8ddd051ac4">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtMTEtMS0xLTA_788ba7ae-0cbf-4513-8a87-5768332ae2b0">718,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.850%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4956ecea465b41aca59fcfcd35dcac46_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi0xLTEtMS0w_28242e6c-071e-4248-b82a-c3215dea6bc1">41,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4956ecea465b41aca59fcfcd35dcac46_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi0zLTEtMS0w_e1c8a00a-d773-4dc3-b089-624218fc8cc4">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c78db21b3e43b48cc5600bf97beeb0_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi01LTEtMS0w_f275c70f-4421-4a58-8202-84df346fbaec">753,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1a3131f4134e8897f0cf6d5e2ffd17_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi03LTEtMS0w_8738e9e8-6600-40f8-b17f-6103c331d714">399,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa26d8ae002340a3ad3e4dd57c59814b_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi05LTEtMS0w_499f8337-7158-4260-bd8b-4b941dda0f68">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6d0b8cddef42e7b5f9944be6d07888_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi0xMS0xLTEtMA_4049b863-591e-481a-93bb-af0d3643c4a6">354,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNS0xLTEtMS0w_c697e1a8-6d89-47f4-92f7-ec381d50b8af">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNS0zLTEtMS0w_97e1e303-bb7b-4258-9889-8eb1c4fc063e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffeb5e781f954b4e84f040966bddc6b8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNS01LTEtMS0w_b1cf2cae-dec2-40fc-b2fd-1c4367ddd9e9">36,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNS0xMS0xLTEtMA_92903430-9012-4df2-a043-5854864c7ed5">36,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNi0xLTEtMS0w_93c28544-565a-497c-8eb4-d63b748a3274">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued under employee stock<br/>purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNy0xLTEtMS0w_21e0d85a-e72a-44cd-a854-6f3fd73c2256">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffeb5e781f954b4e84f040966bddc6b8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNy01LTEtMS0w_0b5625c7-b11f-4135-8e55-c56fc38e9573">1,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNy0xMS0xLTEtMA_44349d04-5ad0-4660-8aef-aa2c72c74908">1,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffeb5e781f954b4e84f040966bddc6b8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfOC01LTEtMS0w_c766d557-7dbd-4c8e-88f7-cc2eab04dae5">29,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfOC0xMS0xLTEtMA_75e5fbf9-f160-426e-8eb3-84a8c6342e4e">29,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement of equity component<br/>of 2022 convertible senior notes (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28039b2d361d4a4fab500d11195dad95_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTAtNS0xLTEtMA_476593d2-dfab-4f8e-8c56-c54d723032cf">33,089</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28039b2d361d4a4fab500d11195dad95_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTAtMTEtMS0xLTA_86b00722-6b92-415f-acf0-b06d1f29cf41">33,089</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity component of 2025 convertible</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">senior notes issued, net of deferred taxes</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of $<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjcxYmIzMDQ4MjVlMTQxNzg5MjI1N2RmMDdlOGZkMzBmXzEwOTk1MTE2Mjc4ODY_637da24b-7beb-4649-a87c-77599b2a2b19">20,450</ix:nonFraction> (Note 8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e525b059b864af98aeec5d4a4a0628d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTEtNS0xLTEtMA_51709403-f858-40f8-ab2c-08c3397042e1">64,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e525b059b864af98aeec5d4a4a0628d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTEtMTEtMS0xLTA_56026835-aa50-45e8-9765-9d7f5edb6944">64,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53046ca604b24b22afbf86b490b8b1a7_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTItOS0xLTEtMA_f6e83962-0513-4c8c-8990-73c15dae4abd">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTItMTEtMS0xLTA_a3358bbf-e905-4f09-a62d-4d2eff24c5fb">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66f2b75905cb47d0a73cb049beed27cf_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTMtNy0xLTEtMA_ab6c54cb-8b4a-4c9c-9a4f-0be8de43515b">131,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTMtMTEtMS0xLTA_f2c31e8a-4482-4a03-97cf-55cc8637c43e">131,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97143ff422764b1eb3afddc0d216dca4_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtMS0xLTEtMA_cf4ed0ec-4126-4fb6-ac4d-f9215dab377a">43,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97143ff422764b1eb3afddc0d216dca4_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtMy0xLTEtMA_366bf888-e46f-4a75-bce2-a4337279f7b8">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8d0686e48b449de8494030e085a5ba6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtNS0xLTEtMA_683c0d6f-e7d1-4cc5-acf4-8a74a7bb44d8">852,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a7036c745f4bed845b3722cfd852b4_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtNy0xLTEtMA_f4d21743-18f5-4d9b-b17a-252c77ad850d">268,390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e471ced5e9c4e899d18dd16de8c4d8e_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtOS0xLTEtMA_d39d0544-f1dc-40f2-b29e-d18ced8741ca">847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtMTEtMS0xLTA_36c1b800-c5cf-4aab-a221-a4c673929e93">584,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying condensed notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 8</span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMy0xLTEtMS0w_555082e2-2f86-47aa-a58c-2d346f9708bd">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMy0zLTEtMS0w_3617fdab-96d1-4fb3-aeb0-7c6c0e0f2c84">131,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNS0xLTEtMS0w_24586e39-1724-41aa-bda1-46b531bd097b">12,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNS0zLTEtMS0w_7cbf1f9d-d38f-441b-91e3-9ea6ec090343">124,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of fixed assets and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNi0xLTEtMS0w_ede15c72-d9b1-4995-ac88-d0ea8d814dbd">15,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNi0zLTEtMS0w_ea1c91ff-84fe-4eed-ad1d-4e81eea77451">14,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNy0xLTEtMS0w_41619a10-d2b2-4be1-bc1e-0529b5865c91">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNy0zLTEtMS0w_7c91c824-c36a-4f63-9722-21ef17faff11">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfOC0xLTEtMS0w_71311266-f833-490e-8ce1-dfcf42f06531">17,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfOC0zLTEtMS0w_9301deb3-44b8-493b-b6a1-932cc1a458c5">12,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfOS0xLTEtMS0w_0d68f974-be9e-4616-b47f-7bbe864724a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfOS0zLTEtMS0w_18d350e7-d540-483d-89be-41b5b81aa617">8,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;(Gain) loss on disposal of fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTAtMS0xLTEtMA_4ff75281-6ab7-40ab-abd9-55a9c136cb79">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTAtMy0xLTEtMA_6c362a41-8008-4388-8631-d8c6b8189ae3">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTEtMS0xLTEtMA_6c0444dc-2541-40d8-b35f-8c03b791af15">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTEtMy0xLTEtMA_c5850be3-f846-4253-a9d7-8d150e27f875">29,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Changes in contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTItMS0xLTEtMA_1f459908-b179-413d-bf60-fd2c2b938e06">2,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTItMy0xLTEtMA_ba546ad3-9dc1-43da-8ce1-4c82307a1924">1,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss (gain) on investment and other non-operating income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTMtMS0xLTEtMA_6427c6b1-5ec3-4b2b-856a-444c3cc25eac">2,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTMtMy0xLTEtMA_71596853-7de1-409b-b274-a4a55fb75ff3">2,779</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTUtMS0xLTEtMA_d5a8930b-b8cf-44c1-ad78-594b5d75def3">3,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTUtMy0xLTEtMA_b096dde4-1a53-42cf-a247-b23fa44a3bb7">1,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTYtMS0xLTEtMA_e5aaa235-ebfe-4bf4-aee4-d51a4136267d">2,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTYtMy0xLTEtMA_7e2f84ca-3c64-4e29-96ef-b364c8d8e305">10,246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTctMS0xLTEtMA_bff4cd0e-1dbf-4207-8e35-c8c7506c2495">907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTctMy0xLTEtMA_af71f057-e12b-4c15-a965-cbbeb769b228">382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTgtMS0xLTEtMA_54552b6f-b9c6-4a1f-9bc7-e24507cc69c0">825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTgtMy0xLTEtMA_27ec93b9-73cd-4652-96b4-d3217e1270e5">1,117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accrued expenses and income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTktMS0xLTEtMA_3d582c00-d3a2-4325-afba-8dd8fb440f78">17,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTktMy0xLTEtMA_ad47eb9e-2d3c-423b-913e-38143b539793">16,454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjAtMS0xLTEtMA_4e653e67-580c-4269-b2fc-4166026ea398">1,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjAtMy0xLTEtMA_ae5c54ee-14ec-410f-931d-6c1ca330fc26">1,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of contingent consideration to MyoScience, Inc. securityholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjEtMS0xLTEtMA_e515f9ee-e44f-4647-b1c0-6215babfd708">5,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjEtMy0xLTEtMA_ed479a88-84e3-4414-bdfc-1b2869179348">9,409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjItMS0xLTEtMA_0d0a5b2c-97a8-4202-a3df-a3e545175af1">102,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjItMy0xLTEtMA_d296d769-a425-4f52-8bd9-7368cfe51d3a">30,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjUtMS0xLTEtMA_98bf8eee-9afd-439d-93b9-73bafc6d271b">36,700</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjUtMy0xLTEtMA_b080988f-3eda-4f7c-a5a8-2e605909c6b7">23,393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjYtMS0xLTEtMA_551c994e-61ca-440f-954c-0cf9d00f586e">513,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjYtMy0xLTEtMA_2d54f9a1-15eb-4e5a-bf60-8cddc667f0d3">326,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Sales of available-for-sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjctMS0xLTEtMA_dfb21f43-cf87-4bdb-b6a7-7031e93c384c">470,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjctMy0xLTEtMA_9c8d5a28-9508-4415-b98d-cd000e74b48f">154,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Purchases of equity and debt investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireLongtermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjktMS0xLTEtMA_b7456bb5-4812-4e4d-9150-322348bf7b79">17,187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireLongtermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjktMy0xLTEtMA_1799d944-5587-41fd-a1dc-43987b6a5240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Sale of equity investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzAtMS0xLTEtMA_74f186f5-b745-4dfb-838f-b17c5eebc1af">9,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzAtMy0xLTEtMA_437c9ee3-1523-4902-88ff-b0ca48553e5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzItMS0xLTEtMA_66e15c6f-30e0-40d3-b89d-65840a52e436">87,708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzItMy0xLTEtMA_5312821a-70b1-4f9e-a513-c0d0addbd830">195,290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Proceeds from exercises of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzQtMS0xLTEtMA_d7847031-5f51-4cea-828b-a224782a7a27">19,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzQtMy0xLTEtMA_c6872e34-f1ca-407a-a70a-3b69d95f6341">35,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Proceeds from shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzUtMS0xLTEtMA_e50dfde2-36cb-4e57-b462-edf70136713b">1,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzUtMy0xLTEtMA_6a5c80fa-5639-41d7-88fb-40302e29c60c">1,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Proceeds from debt component of the 2025 convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb17ba904c14ce8b2ecbe73f2cec747_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzYtMS0xLTEtMA_412eae34-06bf-4068-9c23-7f78a230dcfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb7245efd2d449f81aae47fd4200c45_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzYtMy0xLTEtMA_cd65f1f3-a3d3-4551-b20e-1fa1e7d07904">314,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Proceeds from equity component of the 2025 convertible senior notes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb17ba904c14ce8b2ecbe73f2cec747_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="pcrx:ProceedsFromConvertibleOptionComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzctMS0xLTEtMA_81d824da-2989-4c85-aa64-6eb92b7224e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb7245efd2d449f81aae47fd4200c45_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:ProceedsFromConvertibleOptionComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzctMy0xLTEtMA_5acb7527-4feb-446c-8d53-e82b3624a95f">87,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Repayment of 2022 convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RepaymentsOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzktMS0xLTEtMA_06f09faa-cbd9-4613-90ff-b10d9c8abfb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i856232cea6c64e2ea98e0dc82a006dac_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzktMy0xLTEtMA_b11e0147-49c9-4c56-9b8c-737cf375d19a">176,793</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Retirement of equity component of the 2022 convertible senior notes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="pcrx:RetirementOfEquityComponentOfConvertibleSeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDAtMS0xLTEtMA_1edb09fd-ea6f-4180-a03f-b1b9bc056b2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i856232cea6c64e2ea98e0dc82a006dac_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:RetirementOfEquityComponentOfConvertibleSeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDAtMy0xLTEtMA_c8c00dda-85e8-4d61-a7b0-9e2f4ee421e7">33,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of debt issuance and financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDItMS0xLTEtMA_c7dddde4-ba80-4472-9c7e-b5ef785a022d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDItMy0xLTEtMA_307ff22b-8a8c-43ce-b40c-664b6681c29a">12,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Payment of contingent consideration to MyoScience, Inc. securityholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDMtMS0xLTEtMA_0d83c715-6506-41e1-b784-6a51f4fddaff">1,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDMtMy0xLTEtMA_71eea57f-44b2-4523-b4b7-d5d34294a2ef">5,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDQtMS0xLTEtMA_881872c9-ce21-4aa6-9003-610859692b1b">19,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDQtMy0xLTEtMA_347288c9-f30d-4238-9c1c-f5739fc6787d">211,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDUtMS0xLTEtMA_20634e05-99c1-4c1a-ac48-c52d5e498591">34,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDUtMy0xLTEtMA_f9d0cb34-5eab-4707-a0d5-0c07c589a969">47,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDYtMS0xLTEtMA_800a4839-9ac5-4917-9b84-b44e2b67e8fb">99,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6d0b8cddef42e7b5f9944be6d07888_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDYtMy0xLTEtMA_ee31bb7c-0729-4c78-9a80-8a3770c211bf">78,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDctMS0xLTEtMA_1d8b8f4f-fea2-4ee6-b9f2-3c983b8bfa16">134,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDctMy0xLTEtMA_392851f6-6039-4ccc-aa18-3876f85bbbbf">125,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash paid for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNTMtMS0xLTEtMA_82b52db3-d2f6-46a2-a19a-67ab05442bb4">5,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNTMtMy0xLTEtMA_7b96c388-e579-400f-826e-cc294781ce80">5,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash paid for income taxes, net of refunds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNTQtMS0xLTEtMA_c6aed491-5982-4570-abf8-80f069e148ee">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNTQtMy0xLTEtMA_82acc9a1-320d-4b56-909b-42b1413cf72a">2,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Fixed assets included in accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNjAtMS0xLTEtMA_21bf8d0c-4a0b-4a1d-95c7-080779e1b285">4,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNjAtMy0xLTEtMA_36310ac7-fbbb-4d74-8ec1-8729014d20dd">9,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying condensed notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 9</span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACIRA BIOSCIENCES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icaeef1316917487cbff6510a43882f61_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMzQ5Mw_e9d576ce-0318-4f63-83a6-8999ae79ba9f" continuedAt="i01df06e25d86403c8d0891852adb07c4" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i01df06e25d86403c8d0891852adb07c4"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Pacira&#8221;) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients&#8217; journeys along the neural pain pathway. The Company&#8217;s long-acting, local analgesic, EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012 and approved by the European Commission in November 2020. EXPAREL utilizes the Company&#8217;s unique and proprietary multivesicular liposome delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, the Company added iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience. The iovera&#176; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to only targeted nerves.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Pacira entered the Merger Agreement (as defined below) with Oyster Acquisition Company Inc., a Delaware corporation and wholly owned subsidiary of Pacira (&#8220;Merger Sub&#8221;), and Flexion Therapeutics, Inc., a Delaware corporation, or Flexion. Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, on October 22, 2021, Merger Sub commenced a cash tender offer (the &#8220;Offer&#8221;), to acquire all of the outstanding shares of common stock of Flexion, $<ix:nonFraction unitRef="usdPerShare" contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMzI5ODUzNDg5MzU2NQ_17efb88b-1771-4074-99eb-41557202f29c">0.001</ix:nonFraction> par value per share (the &#8220;Flexion Shares&#8221;), at an offer price of (i) $<ix:nonFraction unitRef="usdPerShare" contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionSharePrice" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMzI5ODUzNDg5MzUzOQ_70021f6b-7583-4754-b2ef-1ba360b777fe">8.50</ix:nonFraction> per Flexion Share in cash, net of applicable withholding taxes and without interest, plus (ii) <ix:nonFraction unitRef="shares" contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022" decimals="INF" format="ixt-sec:numwordsen" name="pcrx:ClassOfWarrantOrRightNumberOfRightsIssued" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMzI5ODUzNDg5MzYzMg_5a03e181-4494-442d-a930-fcc6e69e3624">one</ix:nonFraction> contingent value right per Flexion Share, which will represent the right to receive one or more contingent payments up to $<ix:nonFraction unitRef="usdPerShare" contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022" decimals="2" name="pcrx:BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfODc5NjA5MzAzMjQxMg_bbed6002-0d61-41b0-a037-3ca4d0031e34">8.00</ix:nonFraction> per Flexion Share in the aggregate upon the achievement of specified milestones on or prior to December 31, 2030. Refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from <ix:nonFraction unitRef="product" contextRef="i9252be06dfb84136b1c245c17afd18b9_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="pcrx:ConcentrationRiskNumberOfProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMTE0Nw_41af17f2-e3ab-494a-a195-89b010767894">two</ix:nonFraction> products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as <ix:nonFraction unitRef="segment" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMTk0NA_88b94782-27a1-48a5-bd7d-9d3a5f9cb0b4">one</ix:nonFraction> reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Novel Coronavirus (COVID-19) Pandemic</span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company&#8217;s net product sales were negatively impacted by the global pandemic caused by a novel strain of coronavirus (COVID-19), which mandated significant postponement or suspension in the scheduling of elective surgical procedures resulting from public health guidance and government directives. Elective surgical restrictions began to lift on a state-by-state basis in April 2020, allowing net product sales to return to year-over-year growth in June 2020. However, while many restrictions have since eased with COVID-19 vaccines now widely available, the elective surgery market faced additional pandemic-related challenges in August and September 2021 due to regional surges in COVID-19 delta variant cases, staffing shortages and surgical fatigue from care teams addressing significant procedure backlogs. While these challenges began to subside in October 2021, it is unknown how long it will take the elective surgical market to normalize, or if restrictions on elective surgical procedures will recur due to COVID-19 variant strains or otherwise. The Company&#8217;s manufacturing sites are operational and have safety protocols and guidelines as recommended by federal, state and local governments. To date, there have been no material impacts to the Company&#8217;s supply chain. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise from the COVID-19 pandemic that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.</span></div></ix:continuation><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA2Mg_6ee15b97-eecc-4437-acf9-5564b6e66ca7" continuedAt="i2b893afb57be4dcc85fbe0cfa6548c28" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i2b893afb57be4dcc85fbe0cfa6548c28" continuedAt="idb896e2395b24fff80f8d310a67afa93"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA4Mg_21b2d40d-d5ec-4560-80d8-7153d837ee4b" continuedAt="id26cfde71930446e8fc8374b6e315a7d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="idb896e2395b24fff80f8d310a67afa93" continuedAt="i3d9a50630dea4d198cf62d110a715992"><ix:continuation id="id26cfde71930446e8fc8374b6e315a7d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm">Annual Report on Form&#160;10-K for the year ended December 31, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at September&#160;30, 2021, and for the three and nine month periods ended September&#160;30, 2021 and 2020, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2020 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2020. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA1Nw_03c151ac-0251-4dd4-b870-df3591a77785" continuedAt="id370647e5bda4059a76e58fe380a7f81" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id370647e5bda4059a76e58fe380a7f81">&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee and sells iovera&#176; directly to end users.</ix:continuation> <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA4NQ_3cb7f33e-93bb-4121-818f-a3433d119757" continuedAt="ic9010da6a6a64626b213fc211e4e8b02" escape="true">The table below includes the percentage of revenues comprised by the Company&#8217;s three largest wholesalers in each period presented:</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="ic9010da6a6a64626b213fc211e4e8b02"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i766f22ea0ac24a77a51e08e7ca35945f_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMi0xLTEtMS0w_24615aeb-519b-4451-91e0-1cc9b964b5b8">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i56f4b02fe95c4104bfdc2b5350e072e8_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMi0zLTEtMS0w_f86678e4-c927-4e29-9581-232f799f5e8a">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if28fae669275407da1afd4ccaffe03be_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMi01LTEtMS0w_6647076e-48f5-43cd-819d-d7f20e8b47a8">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26b9a9fb65e1404983d517a01cb75626_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMi03LTEtMS0w_eafb37aa-291d-4cec-9fce-f1ac69f2e023">31</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iacef49a3ede14eda8bd8c641ad091a60_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMy0xLTEtMS0w_9aeafd52-59d9-4593-ad65-1c5d225cf337">28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5badbb37b7a4f1b94a0f02f00cf2590_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMy0zLTEtMS0w_ba4fec7b-9692-4c65-a1b0-205a4d13bbfd">30</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia74009bf8abb4b0b991b74490d2554f6_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMy01LTEtMS0w_706cbdc6-193d-48dd-b659-d758eb8c7f6d">28</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i844e9fe2488b4442bcf86bf11b9e76ed_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMy03LTEtMS0w_0324f861-867f-4c4e-85eb-3156512b3989">31</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i205e1c4172cd4d2b809c620611b5e0b0_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNC0xLTEtMS0w_6b8050ca-a109-419f-93cc-8932eb34c4ba">26</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb78eb77b14d47f892d26f89746691ff_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNC0zLTEtMS0w_5e8c8b20-1689-471a-8993-7f87f82fdcf5">25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8688a00c06e54c5f8d4c92616c5ac6ea_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNC01LTEtMS0w_7565fd21-315f-42c6-bc0b-99b797f4bb8c">26</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i30925928a2bd4e02a8ed2ea04199236d_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNC03LTEtMS0w_cf9b82e1-647e-4fa6-b482-1d98c45f3326">25</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i150082df5ab74269aac685d70ddd9809_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNS0xLTEtMS0w_c80231c7-fea8-4813-a10d-f66f419ee1d2">85</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44d32a7bfbd0444d949387c037771a01_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNS0zLTEtMS0w_8bf1786a-2f0f-4d5e-9a97-ae934239da71">86</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifed03345c8384bd697f0693a26aaf05a_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNS01LTEtMS0w_3b163855-7778-43fc-b31b-68edd3fac1ff">85</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14236b4e4c5c46349502a9255c70ff12_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNS03LTEtMS0w_555d157d-201d-43cb-9054-99cd46892b46">87</ix:nonFraction>%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA3Mw_906f5d88-d116-4121-88fd-a17fc4c02b39" continuedAt="ifa15212d156248e59292cea637911406" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amended the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The standard allows for certain exceptions, including the exception to the use of the incremental approach for intra-period tax allocations, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also required franchise or similar taxes partially based on income to be reported as income tax and to reflect the effects of enacted changes in tax laws or rates in the annual effective tax rate computation from the date of enactment. Lastly, in future acquisitions, the Company will be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The standard became effective for the Company beginning January 1, 2021 and there were no material impacts to the consolidated financial statements upon adoption.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2021</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative, and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The other separation models would be eliminated, including the model for convertible debt that can be settled in cash </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3d9a50630dea4d198cf62d110a715992"><ix:continuation id="ifa15212d156248e59292cea637911406">or shares. As a result, these convertible debt instruments will be accounted for as a single liability instrument. In addition, the new guidance requires diluted earnings per share calculations to be prepared using the if-converted method, instead of the treasury stock method. The guidance must be applied in fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company plans to adopt the new guidance using a modified retrospective method of transition, which would be applied to transactions outstanding at the time of adoption. At September&#160;30, 2021, the Company has recognized debt discounts of $<ix:nonFraction unitRef="usd" contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNTUxMQ_d9d76b60-3851-4c25-8809-5c57c8d6112e">68.7</ix:nonFraction>&#160;million for its <ix:nonFraction unitRef="number" contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNTUyMg_b52e931a-6218-4f13-a5ae-be82d2733b6e">0.750</ix:nonFraction>% convertible senior notes due 2025 and $<ix:nonFraction unitRef="usd" contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNTU2Mw_36c2d24a-08ff-4ce3-b788-7e4c7a05e22a">3.8</ix:nonFraction>&#160;million for its <ix:nonFraction unitRef="number" contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNTU3NA_893ad27a-9f3a-4c58-92ff-9dd08e6f2060">2.375</ix:nonFraction>% convertible senior notes due 2022. Upon adoption on January 1, 2022, these debt discounts would be eliminated along with any related future amortization. Further deferred financing costs previously allocated to the conversion features will be re-allocated to the outstanding debt, slightly increasing future annual amortization of deferred financing costs. The Company expects the impact of this standard to be material to its consolidated financial statements and related disclosures.</ix:continuation></ix:continuation></span></div><div style="margin-bottom:8pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfNDMxNg_3d28296e-44e1-4f35-ac8d-0d0dee5cb491" continuedAt="i74cdbe2243d74ca0b06cf61901c9fae7" escape="true">REVENUE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i74cdbe2243d74ca0b06cf61901c9fae7" continuedAt="i4e735be501cb4090a05d4fd5bd9ae3d8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sources of revenue include (i) sales of EXPAREL in the United States, or U.S.; (ii) sales of iovera&#176; in the U.S.; (iii) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use in the U.S. and (iv) license fees and milestone payments. To date, there has been <ix:nonFraction unitRef="usd" contextRef="icb8afdaa87d44b849e4d16d61dab0781_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMzI5ODUzNDg4NzY0NQ_54d0bdf6-cef1-42ea-8d11-105c5d37a74f"><ix:nonFraction unitRef="usd" contextRef="iefd0f799d2934f3c879017bae1f70cac_D20210101-20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMzI5ODUzNDg4NzY0NQ_eac253ab-b73d-46a8-a773-faf95fa6d5c4">no</ix:nonFraction></ix:nonFraction> revenue from sales of EXPAREL or iovera&#176; in the European Union, or E.U. The Company does not consider revenue from sources other than sales of EXPAREL to be material to its consolidated revenue, which could change in the future. As such, the following disclosure only relates to revenue associated with net EXPAREL product sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Product Sales</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL revenue is recorded at the time the product is delivered to the end-user.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, wholesaler service fees, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a quarterly basis.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers and doctors. Payment terms generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMjYzOQ_a82865c6-0aeb-4bca-a017-866bd6d1661c">zero</span> to <ix:nonNumeric contextRef="i41b00db28bd24e8298f3daa38843e448_D20210101-20210930" format="ixt-sec:durday" name="pcrx:AccountsReceivablePaymentTerms" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMjY0NQ_fdab0230-2139-4d5e-a074-9c192495ba23">37</ix:nonNumeric> days from the date of the transaction, and accordingly, there is no significant financing component.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#8217;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#8217;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4e735be501cb4090a05d4fd5bd9ae3d8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfNDMxNA_091d01b7-8a36-423e-a81d-b6b16e5f10f3" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL / bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib583d9b057b942b68b4eaeb985e512fd_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfMy0yLTEtMS0w_08fd6e05-7cd3-4dc6-80d2-ef07431244c8">122,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9363f54932e4fbba77650e2de1ba4de_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfMy00LTEtMS0w_5de12d59-99cc-4a16-a561-3b513db66c20">114,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1129d76aea6423ca3b15e9965559c8f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfMy02LTEtMS0w_2bfe469c-12ab-4e02-9e1c-0b89490fbf23">369,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5accd35363b841d5bd616a756fec67a4_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfMy04LTEtMS0w_c4f9abc1-c14e-463e-a2e2-b10625634418">290,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fde0359479247adb32995272e9e92e8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNC0yLTEtMS0w_5be81e02-8e07-4653-aed0-3104c6dcb1a8">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5ff86ece96a40f6ba1006fbc2ee4fa1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNC00LTEtMS0w_b5c98e18-9163-4296-9f3e-f2fb14c8562d">2,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26bec4aae3774657b312c164cf9e6b95_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNC02LTEtMS0w_e39de4f3-56fe-4110-a2c7-6832ed7529a1">11,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29692bf80ec74a828827091f01d350e8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNC04LTEtMS0w_a6f4af37-240d-49cc-8fef-6650436463dc">6,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12dead7e93d941fa9ed3c4a6d9cdd283_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNS0yLTEtMS0w_6a179f98-f966-4f36-a1d7-855b65c284a3">126,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b52bbc6f8429686e59ef4517c7bf4_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNS00LTEtMS0w_60fc97c4-a291-45cd-ad8b-f8ba2b7572cf">116,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a4d517e9454a9a888918ce80188a4e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNS02LTEtMS0w_66865552-d7bc-4bba-a3ed-e635ba768c66">380,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b7287c7614e46d8ab1553c11a8c6b9d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNS04LTEtMS0w_78aa6794-a8f4-41d2-9f54-bc7d2cfd13d3">296,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RleHRyZWdpb246YTI4MjE3ZTkwODNjNGE4NjlmZDIxNTczYjliYjVjOTRfOTU_7ec539fb-acb2-4352-84f3-a47c5d932e16" continuedAt="iba981b7b72c449eeac3565999b0f0389" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="iba981b7b72c449eeac3565999b0f0389"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RleHRyZWdpb246YTI4MjE3ZTkwODNjNGE4NjlmZDIxNTczYjliYjVjOTRfOTM_1c7dd047-8cba-47b9-826e-e2d3df8bd141" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfMi0xLTEtMS0w_ebb6644d-524c-491f-ada4-021b87a5f620">35,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfMi0zLTEtMS0w_0be50f03-8d00-46a9-a1aa-baf483efa78f">26,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfMy0xLTEtMS0w_369bfcf1-a678-4e30-885f-36613e718ee0">17,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfMy0zLTEtMS0w_aeb36a87-e646-45c6-b1b1-a95c02d82442">16,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfNC0xLTEtMS0w_cd78adc5-8c1c-433e-833f-9a2feddd47e9">14,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfNC0zLTEtMS0w_ac67852a-e256-4030-88d6-4f331c601141">21,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfNS0xLTEtMS0w_f9401242-4f88-489c-909f-240ec07327b5">67,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfNS0zLTEtMS0w_f6ec7306-6b59-4c2d-b810-8dea880a70c1">64,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTA1OQ_71deb4ba-7108-47c0-97d6-0a4c400c64ac" continuedAt="ic0a2ad645a4547f298765e5c41d7290d" escape="true">FIXED ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic0a2ad645a4547f298765e5c41d7290d" continuedAt="ifc260f9c588d4f2b9dd19e7c95fb3cf0"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTA1Ng_9ee5de93-50ad-470b-b13e-e6127c0c9379" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99bdc6f6fda24e0fb4e3bc0f687562ff_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfMi0xLTEtMS0w_681378bf-5729-427e-9e2e-b3e365c71215">111,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed0e5100a704244a6604a6ffdca5f84_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfMi0zLTEtMS0w_2bd1431a-95a4-4038-a075-8b4eda385910">74,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f18cccc5ab4371abe468c2835247ca_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfMy0xLTEtMS0w_e60e9d12-7363-47c1-a44d-0d514757955d">60,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i898a223b5d1b4effbcd726f575d3e5e0_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfMy0zLTEtMS0w_34fbd828-2fbf-4a63-b98b-bbdc271e69ca">54,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaa288b76e0a42ed96cf349f5192edb1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNC0xLTEtMS0w_2877b98f-d77f-41c1-a854-27148df39f15">12,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34fa7325b3e40089d0092964f4fc930_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNC0zLTEtMS0w_a0e3b315-7964-4634-91f8-c53a8ba27d5b">12,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic665add04b7e4b1e909cb5ea8efd8516_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNS0xLTEtMS0w_589af54b-dd95-4298-997c-562fb6fe088d">2,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9e89c1e0d94c15900cc25867cdaf15_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNS0zLTEtMS0w_21621889-73f1-4801-931c-045e9faa5a29">2,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2f20e3bb0c4ee4a9973bd9ac272cba_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNi0xLTEtMS0w_85f52a6b-39db-4587-95f3-57261c8e5bcd">59,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78554782b924c2e943917d448e44ec6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNi0zLTEtMS0w_9cf91b69-bd94-4c62-8ccb-370e553bbb54">71,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNy0xLTEtMS0w_0ab144a4-67ce-4a4f-8789-591a9c586dab">247,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNy0zLTEtMS0w_f5954f90-190f-4ef1-89af-3b005e6929e7">215,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfOC0xLTEtMS0w_b0552289-7b97-481f-95e1-758397a431f7">87,810</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfOC0zLTEtMS0w_2d951912-d9d8-4cdd-8ce7-ca4d05d2bc08">78,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfOS0xLTEtMS0w_76321fe2-8d12-4fe2-b7f2-775278a4dbb0">159,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfOS0zLTEtMS0w_1fa83c94-b71f-4dc1-8df0-0f2337d6b6be">136,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021 and 2020, depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTgy_76b5ca91-f539-4068-9dac-39cc05d767ec">3.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTg5_e5dc8719-7825-4a6a-a584-33a1675407bd">3.1</ix:nonFraction> million, respectively. For the three months ended September&#160;30, 2021 and 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i0379cda4d5d444419b2c756629bfe8be_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMjU1_fd6e5a08-fd73-436c-be2c-034d6d9cdc85">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia0e6245f12984622bb9ff0bf0fe46d7b_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMjYy_df08fd78-d273-4002-b988-f360565c4994">0.7</ix:nonFraction> million of capitalized interest on the construction of manufacturing sites, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021 and 2020, depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNDEw_b3642677-6c7a-493c-b3b8-7d46837e4adf">9.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNDE3_533f9ae1-8385-4d3c-88b1-49ee7647775b">8.9</ix:nonFraction>&#160;million, respectively. For the nine months ended September&#160;30, 2021 and 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i5263cd5b15ec419ea569ba7621aacc70_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNDgx_67916564-d06a-49f6-afbc-8aa96c38d0b8">3.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i89ff104d4b684eac9d78a0eec97980e2_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNDg4_abb591e6-2182-4558-ba65-3fd9bf5d994b">1.5</ix:nonFraction>&#160;million of capitalized interest on the construction of manufacturing sites, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021 and December&#160;31, 2020, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:ForeignPropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNzE1_2fcd4bae-98b9-42f4-9b66-e1144786b44f">66.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:ForeignPropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNzIy_d0e2f7d3-be3b-4ae2-a9c5-fc6963871348">67.5</ix:nonFraction> million, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the Company had asset retirement obligations of $<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetRetirementObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfODEy_d144eab5-3ab0-4715-b34c-f7b754cc88cf">2.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetRetirementObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTA5OTUxMTYyODkwOQ_56636a3d-5ba1-42aa-928e-088fe96f62f2">2.0</ix:nonFraction>&#160;million, respectively, which are included in accrued expenses and other liabilities on its condensed consolidated balance </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifc260f9c588d4f2b9dd19e7c95fb3cf0">sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.</ix:continuation></span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTc0Nw_c970f41c-f7ab-45c7-83af-92a9fe194c4a" continuedAt="id01a47bfaea54e698d39bce346b130df" escape="true">LEASES</ix:nonNumeric></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="id01a47bfaea54e698d39bce346b130df" continuedAt="i6d44649ea9dd4df0a151173272f8ef3d"><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all of its facilities, including its EXPAREL manufacturing facility in San Diego, California and its iovera&#176; manufacturing facility in Fremont, California. These leases have remaining terms up to <ix:nonNumeric contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMjM2_52693a95-39a0-4b56-8442-5872b16bc72c">8.9</ix:nonNumeric> years, some of which provide renewal options at the then-current market value. The Company also has an embedded lease with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England. A portion of the associated monthly base fees have been allocated to the lease component based on a relative fair value basis.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTc0Mg_bb2da7de-6fa4-41e3-a5b3-e914fa3e61d1" continuedAt="i6734f2ee551f4919aecb6f167339ec5a" escape="true">Total operating lease costs are as follows (in thousands):</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6734f2ee551f4919aecb6f167339ec5a" continuedAt="i25432939fbc9489ab0d3eb374b80ee86"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfMy0yLTEtMS0w_8db5a6c6-63f9-4857-aac8-7b0edb34269c">2,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfMy00LTEtMS0w_ef15b899-3c4b-4902-8b51-858441b4b631">3,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfMy02LTEtMS0w_37e1feaa-d348-4de2-9127-6180f2fa11c8">8,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfMy04LTEtMS0w_d1382d43-8a1e-4820-809f-79bc8c700e79">7,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNC0yLTEtMS0w_4ced101f-96c6-46ef-a0b6-d1478ebd37f3">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNC00LTEtMS0w_54058af2-3874-4805-849f-dba4c71bdf0a">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNC02LTEtMS0w_63d6c1de-bcd7-41de-a5c9-71c4b770e915">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNC04LTEtMS0w_549c1738-3bbd-4c87-8bae-dc8a8326acec">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNS0yLTEtMS0w_876ddaf8-3dd6-47d0-ba9c-3b5fc238886c">3,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNS00LTEtMS0w_a3c72043-9fe8-44f6-8158-47d6607de4fd">3,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNS02LTEtMS0w_a341fcf1-726c-421f-b724-f16297507745">10,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNS04LTEtMS0w_7f5a4856-e69d-4b7e-9f48-552e3f3b4a03">8,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmNlMDk2MzIzZmYwZDRhNzBhODFlOTFlZjMwOTc1MGU0L3RhYmxlcmFuZ2U6Y2UwOTYzMjNmZjBkNGE3MGE4MWU5MWVmMzA5NzUwZTRfMy0yLTEtMS0w_85a54233-9af3-41bb-8b1e-529298bd99dc">9,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmNlMDk2MzIzZmYwZDRhNzBhODFlOTFlZjMwOTc1MGU0L3RhYmxlcmFuZ2U6Y2UwOTYzMjNmZjBkNGE3MGE4MWU5MWVmMzA5NzUwZTRfMy00LTEtMS0w_1e227880-9bf6-47b4-bb53-76d59de4154b">11,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmNlMDk2MzIzZmYwZDRhNzBhODFlOTFlZjMwOTc1MGU0L3RhYmxlcmFuZ2U6Y2UwOTYzMjNmZjBkNGE3MGE4MWU5MWVmMzA5NzUwZTRfNC0yLTEtMS0w_08f4be0e-96b3-4210-834b-5ec6bc40beef">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmNlMDk2MzIzZmYwZDRhNzBhODFlOTFlZjMwOTc1MGU0L3RhYmxlcmFuZ2U6Y2UwOTYzMjNmZjBkNGE3MGE4MWU5MWVmMzA5NzUwZTRfNC00LTEtMS0w_27d43cc6-6613-473d-80e2-69f4defb498e">42,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to net the amortization of the right-of-use asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.</span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. <ix:continuation id="i25432939fbc9489ab0d3eb374b80ee86" continuedAt="id0e24b5ef2bb4491809a7456096194eb">The weighted average remaining lease term and the weighted average discount rate are summarized as follows:</ix:continuation></span><ix:continuation id="id0e24b5ef2bb4491809a7456096194eb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjhiMDIxMGUzZTcyOTRkMWVhNjE4MDE3MjliN2RjZWRjL3RhYmxlcmFuZ2U6OGIwMjEwZTNlNzI5NGQxZWE2MTgwMTcyOWI3ZGNlZGNfMi0yLTEtMS0w_0b5a3b07-8508-44fe-bec7-cc7286f9d71d">8.46</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjhiMDIxMGUzZTcyOTRkMWVhNjE4MDE3MjliN2RjZWRjL3RhYmxlcmFuZ2U6OGIwMjEwZTNlNzI5NGQxZWE2MTgwMTcyOWI3ZGNlZGNfMi00LTEtMS0w_95f569fb-b234-49c4-937b-05d43edc55fd">9.39</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjhiMDIxMGUzZTcyOTRkMWVhNjE4MDE3MjliN2RjZWRjL3RhYmxlcmFuZ2U6OGIwMjEwZTNlNzI5NGQxZWE2MTgwMTcyOWI3ZGNlZGNfMy0yLTEtMS0w_c89be1fd-aec3-4df8-ac3e-fe1eee9026b2">6.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjhiMDIxMGUzZTcyOTRkMWVhNjE4MDE3MjliN2RjZWRjL3RhYmxlcmFuZ2U6OGIwMjEwZTNlNzI5NGQxZWE2MTgwMTcyOWI3ZGNlZGNfMy00LTEtMS0w_6f851b04-1d97-4ebd-9937-73b4577a860e">6.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:22.5pt"><ix:continuation id="i6d44649ea9dd4df0a151173272f8ef3d"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTc0NQ_363d681e-7d94-41b9-a3f8-53ebc8f8195c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfMS0yLTEtMS0w_22bbe26a-8e1b-4e3a-8572-fe75aa438723">2,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfMi0yLTEtMS0w_2c3945e4-3d99-412e-b85e-15642c50cc30">10,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfMy0yLTEtMS0w_ce2b38c7-7c3a-4fb4-9577-ab32707e599f">10,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfNC0yLTEtMS0w_bdb88b03-46ac-412a-96ec-093de1882c23">10,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfNS0yLTEtMS0w_3b762944-40d3-473c-a68c-d0ba5e8b3cd9">11,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfNi0yLTEtMS0w_12e5d0c6-1c31-4260-b2ff-204aa3cafc1e">50,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfNy0yLTEtMS0w_05abd65c-9971-4213-81c9-baf51ddb4e57">97,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfOS0yLTEtMS0w_52a6107a-afe2-4361-ae14-6b4fac23fc82">24,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfMTAtMi0xLTEtMA_433a3ac4-e1ce-41cf-ba0f-4834093ce1e1">72,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTc1MA_6302d36d-ad88-471a-85df-7a5250159c88" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into <ix:nonFraction unitRef="segment" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTA5OTUxMTYzMDU0MQ_b41fa372-b637-4ec1-a610-e9d6d89bbebb">one</ix:nonFraction> lease agreement (not included in the table above) for which there are future obligations but the lease has not yet commenced as of September&#160;30, 2021 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:fixed-zero" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfMS0yLTEtMS0yMjUzNQ_736415c8-ed76-44ac-af38-b8d395fa64fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfMi0yLTEtMS0yMjUzNQ_115d0864-14fe-4fd2-b3ef-64c41bd6a9fd">439</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfMy0yLTEtMS0yMjUzNQ_b489dba0-c401-4048-8063-3ff3b82d47cb">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfNC0yLTEtMS0yMjUzNQ_4b82735c-5288-49ae-b486-a4b1a28aea61">466</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfNS0yLTEtMS0yMjUzNQ_2988169b-042a-40a8-baba-219d1f12452d">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfNi0yLTEtMS0yMjUzNQ_c40c1cd2-579e-421d-a2ff-b3470fa8db58">495</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfNy0yLTEtMS0yMjg1MA_dc4be845-4d10-44e8-a667-8b649024173c">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMjA1OA_0b780355-5dae-41a1-9252-45e358044ad2" continuedAt="ib78e1a3d490f422bb17d6c7695622c3a" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib78e1a3d490f422bb17d6c7695622c3a" continuedAt="i186051eb27ee4bafb79b9ba0248f061b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#8217;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#8220;Skyepharma Acquisition&#8221;), and the acquisition of MyoScience, Inc. (the &#8220;MyoScience Acquisition&#8221;) in April 2019.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMzk5_4adf4cdd-4b54-4760-aa7c-5b6009e2a522"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMzk5_8a9e1bca-6cf4-473e-ab6c-4ec6fd1d1e41">no</ix:nonFraction></ix:nonFraction> change in the carrying value of the Company&#8217;s goodwill during the three and nine months ended September&#160;30, 2021. The balance at both September&#160;30, 2021 and December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfNTIy_287326e5-7782-49dd-86ce-3afdd17519a9"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfNTIy_f25ca003-59d8-48d5-9f6c-c61c7cdef2d6">99.5</ix:nonFraction></ix:nonFraction>&#160;million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. As of September&#160;30, 2021, the remaining milestone payments include: $<ix:nonFraction unitRef="usd" contextRef="ie510ad82e9ae4ed9b7453890873a7867_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfODc5_29c851d6-7568-4a00-b947-13cff5d7cea5">4.0</ix:nonFraction>&#160;million upon the first commercial sale in the United Kingdom, France, Germany, Italy or Spain (the &#8220;Applicable Countries&#8221;); and $<ix:nonFraction unitRef="usd" contextRef="ib955ef045d0147b4a41342834ab1923b_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfOTcz_e55621d7-75b6-42a6-b2bd-a84454b0753b">32.0</ix:nonFraction>&#160;million when annual net sales collected reach $<ix:nonFraction unitRef="usd" contextRef="ib955ef045d0147b4a41342834ab1923b_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTAxNA_4728b212-b0ef-445a-a086-d7cafad55b3f">500.0</ix:nonFraction>&#160;million (measured on a rolling quarterly basis). Any remaining milestone payments will be treated as additional costs of the Skyepharma Acquisition and, therefore, recorded as goodwill if and when each contingency is resolved.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the MyoScience Acquisition, the Company recorded goodwill totaling $<ix:nonFraction unitRef="usd" contextRef="i6d1f022a2e3f45c38d8813642eb0a4b7_D20190401-20190430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTMyMw_1f0a8702-d680-4eee-b6e0-1b17699d7257">37.5</ix:nonFraction>&#160;million. The Company made a tax election that allows the acquired goodwill and intangible assets associated with the MyoScience Acquisition to be tax deductible.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Intangible Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMjA2MQ_c8d34ca5-bce2-4cbc-b894-0fd1c3bebeec" continuedAt="if2cacea954f74b898ab111f4d36b0744" escape="true">Intangible assets, net, consist of the developed technology and customer relationships that were acquired in the MyoScience Acquisition and are summarized as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i186051eb27ee4bafb79b9ba0248f061b"><div><ix:continuation id="if2cacea954f74b898ab111f4d36b0744"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:58.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.248%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i89a81ffb612a403a924df2a487b03db8_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMi0yLTEtMS0w_460e6fbb-c9c7-46e1-a1b2-8507fb5f17ea">14</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7501d0ecec348a18e56ac1ec8c99ddf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMi00LTEtMS0w_ec0445b9-dbae-45bc-8583-4696080f8975">110,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cee35c07c974bff9beb7fa6c64d6aee_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMi02LTEtMS0w_9d9cccf3-f0ca-43c6-9e23-ee1839a6c4bd">110,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if16cf2053195434b94be734f2e6e754f_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMy0yLTEtMS0w_e60b9730-0d63-4f65-8555-f8ec2ead3ddf">10</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie965653fafce4fce912093bbf34f3347_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMy00LTEtMS0w_247d3b3d-78e4-4d30-9bc7-9595c64fd08f">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01af4a06a1ff4be181f27dd6fc5dccd4_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMy02LTEtMS0w_2dc74f77-7307-4fd7-b4c3-408b801c84fe">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNC00LTEtMS0w_6a9a788e-639c-41b5-9096-9e2b059171df">110,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a3944a915b4b7dacce440712764ef6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNC02LTEtMS0w_af6a0cb8-e7d1-4504-afb1-5203ed27ee2f">110,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNS00LTEtMS0w_d07a9015-0170-434a-85b1-c9edd86eb657">19,469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6a3944a915b4b7dacce440712764ef6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNS02LTEtMS0w_24ee3e45-6a99-43f3-af3d-2ef4708ee158">13,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNi00LTEtMS0w_36202394-16f1-4341-986e-385f919ab864">90,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a3944a915b4b7dacce440712764ef6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNi02LTEtMS0w_2b068d7e-9604-49cb-9be1-3138469c9b15">96,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense on intangible assets was consistent for the three and nine months periods ended September&#160;30, 2021 and 2020. Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTgxMA_2e172bc9-edd3-481e-ab59-f16a75467f6c"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTgxMA_4c83f2eb-aa31-40a9-852e-0465a45bddd5">2.0</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTgxNw_34b0f824-767a-4e2d-9a36-6b49cbe3bbe6"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTgxNw_e6a668ff-dbf0-4884-b96c-515e7897056d">5.9</ix:nonFraction></ix:nonFraction> million for the three and nine month periods, respectively.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming no changes in the gross carrying amount of these intangible assets, amortization expense will be $<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTk3OA_a02d7d07-8ec6-432c-b4d1-3c398ea1c19f">2.0</ix:nonFraction> million for the remaining three months of 2021, $<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMjAxOA_ab8ca44a-2324-4464-b983-d4c5a9e61f3b">7.9</ix:nonFraction> million annually through 2032 and $<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMjA0Nw_b4c1096a-b410-451a-a5cc-6daaa142958f">2.2</ix:nonFraction> million in 2033.</span></div></ix:continuation><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;8&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3Nzg_cd284748-d209-4219-924d-f0e1eeb90b85" continuedAt="i19aee11090d34bc189cc22db3d3cf15b" escape="true">DEBT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i19aee11090d34bc189cc22db3d3cf15b" continuedAt="i758956c3ed8c484dbb1ddd172cc00abc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2025</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="ie438d7046d4b414a88a04918bfbd3568_I20200731" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTEz_d998aec5-8b2f-4018-9b86-abff6f9307c6">402.5</ix:nonFraction>&#160;million in aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="ie438d7046d4b414a88a04918bfbd3568_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTUz_1e0e5b24-0911-42cf-ab21-1a76d32968d4">0.750</ix:nonFraction>% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="ie438d7046d4b414a88a04918bfbd3568_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMzM4_653ff413-696c-44a4-94d4-659d633bd517">0.750</ix:nonFraction>% per year, payable semiannually in arrears on February 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and August 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. The 2025 Notes mature on August 1, 2025.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3ODQ_21e2a3c2-1a6d-41c4-999e-d3d3c62fd45a" continuedAt="i67d1a5e53c1543e286d0056df62331ed" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMi0wLTEtMS0wL3RleHRyZWdpb246MmQ0NzgyNjU1NWVhNDBiMDkzOGEzMzJhYjRiYjJhNzdfNA_b2d90ead-154a-4d0b-ad15-daa6dc46c828">0.750</ix:nonFraction>% convertible senior notes due 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMi0xLTEtMS0w_66fd2f63-f89c-4d49-9fc4-bf39c619a9d1">402,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77e86ff9a584425992768831eb59a2b4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMi0zLTEtMS0w_eb4ffaed-ff5e-462e-a56d-b1db8a8155bf">402,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMy0xLTEtMS0w_b360374c-3d93-4344-9829-c93791a5eb4b">7,610</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77e86ff9a584425992768831eb59a2b4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMy0zLTEtMS0w_d3d02c16-2307-46c1-912d-947c027a54a7">8,940</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfNC0xLTEtMS0w_2e741ffc-7292-4790-bd28-2d8b11ed19c9">68,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77e86ff9a584425992768831eb59a2b4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfNC0zLTEtMS0w_cf8008cd-c53e-46b2-aa4b-50f5e9c7e71f">80,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfNS0xLTEtMS0w_30b6f4b2-5285-448b-b159-dc04ad053a3e">326,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77e86ff9a584425992768831eb59a2b4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfNS0zLTEtMS0w_c8c38729-12e6-4b5f-a6df-35d1f29a7c82">313,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the issuance of the 2025 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i1f322fb012d64653a2090e9d08a6fa7a_D20200701-20200731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNjE5_c8df715f-d1b0-4cd3-9c30-77539b7bc81c">390.0</ix:nonFraction>&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $<ix:nonFraction unitRef="usd" contextRef="i5ee5be00954e45748d8b246245010a0f_I20200731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNzg3_526d6081-0519-4c11-bbc4-0d5d32afa508">185.0</ix:nonFraction>&#160;million in aggregate principal amount of its outstanding <ix:nonFraction unitRef="number" contextRef="i5ee5be00954e45748d8b246245010a0f_I20200731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODM5_ab6e7be1-6b46-450f-a2d6-9f8fa4bb6e31">2.375</ix:nonFraction>% convertible senior notes due 2022 in privately-negotiated transactions for a total of $<ix:nonFraction unitRef="usd" contextRef="i5a7be408192f4f12b6d240abce12cdf8_D20200701-20200731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfOTI4_c0e63a85-88f5-4d80-900d-18f298709c4e">211.1</ix:nonFraction>&#160;million of cash (including accrued interest).</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert the 2025 Notes at any time prior to the close of business on the business day immediately preceding February 3, 2025, only under the following circumstances:</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) during any calendar quarter (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock for at least <ix:nonFraction unitRef="segment" contextRef="ibb1bbaf7e7374ecb8bb7e29a54a2e98f_D20210701-20210930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTI5Nw_131e73d9-49ad-41bd-9343-74bebd6a5647">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="segment" contextRef="ibb1bbaf7e7374ecb8bb7e29a54a2e98f_D20210701-20210930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM2MQ_71efe645-db55-4889-a499-5d1fb78cbb1f">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="ibb1bbaf7e7374ecb8bb7e29a54a2e98f_D20210701-20210930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ5NA_5a0974af-9545-49b1-a3a8-7349c90eb90b">130</ix:nonFraction>% of the conversion price on each applicable trading day;</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) during the five business day period immediately after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the trading price (as defined in the 2025 Indenture) per $1,000 principal amount of notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i2987763b470247b1b64487558ed62361_D20210701-20210930" decimals="INF" name="pcrx:DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTgzNg_aabc4e07-7878-4fb4-9a33-575a710642b2">98</ix:nonFraction>% of the product of the last reported sale price of the Company&#8217;s common stock and the conversion rate on each such trading day;</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) upon the occurrence of specified corporate events, including a merger or a sale of all or substantially all of the Company&#8217;s assets; or</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) if the Company calls the 2025 Notes for redemption, until the close of business on the business day immediately preceding the redemption date.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended&#160;September&#160;30, 2021, none of these conditions for conversion were met.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i758956c3ed8c484dbb1ddd172cc00abc" continuedAt="ibc7f1ce3567040089576a2c86b9f07e7"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt-sec:durday" name="pcrx:SettlementPeriodConvertibleDebtConversionRequest" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMjcxNA_ccdead21-e793-47dd-984d-381314f43604">40</ix:nonNumeric> consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8676c39077d849cf9a97ed7b875cf79c_I20200731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMzE4Mw_2acbd0bb-7d97-4a60-a8ed-41555249712b">71.78</ix:nonFraction> per share of the Company&#8217;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately <ix:nonFraction unitRef="number" contextRef="i8676c39077d849cf9a97ed7b875cf79c_I20200731" decimals="3" name="pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMzQzOQ_d62cf898-360b-457d-8cdc-e31c9a11b541">32.5</ix:nonFraction>% to the closing sale price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8676c39077d849cf9a97ed7b875cf79c_I20200731" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMzQ3MQ_d39638a8-51d3-43ba-b514-1b5c3d692e3b">54.17</ix:nonFraction> per share of the Company&#8217;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the 2025 Notes had a market price o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1,086</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the $<ix:nonFraction unitRef="usd" contextRef="id3b1ed3537724b41a9d822235c8817fd_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNDEwOA_8a30432e-f72a-4144-8df1-e0964e1781e8">402.5</ix:nonFraction>&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#8217;s option).</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> scheduled trading day immediately before the maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNDY4MQ_5da2bc63-6f00-4e02-ab20-0402db41af57">130</ix:nonFraction>% of the conversion price then in effect for (i) each of at least <ix:nonFraction unitRef="segment" contextRef="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNDc0OA_0a0be323-738d-4279-9e50-e0a64862e373">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="segment" contextRef="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNDgwNA_e89bf394-b110-4653-8613-dcca054bc04e">30</ix:nonFraction> consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) <ix:nonFraction unitRef="number" contextRef="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930" decimals="INF" name="pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNTA4NA_3a2a65c0-ad49-46df-ab3d-8e89e090e518">100</ix:nonFraction>% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#8220;make-whole fundamental change&#8221; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a fundamental change, as defined in the 2025 Indenture, subject to certain conditions, holders of the 2025 Notes may require the Company to repurchase for cash all or part of their 2025 Notes at a repurchase price equal to <ix:nonFraction unitRef="number" contextRef="i2987763b470247b1b64487558ed62361_D20210701-20210930" decimals="INF" name="pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNTg1OA_de91be52-beaf-436f-86d6-f6636d58deb5">100</ix:nonFraction>% of the principal amount of the 2025 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a &#8220;make-whole fundamental change&#8221; (as defined in the 2025 Indenture) occurs prior to August 1, 2025, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its notes in connection with the make-whole fundamental change.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are the Company&#8217;s general unsecured obligations that rank senior in right of payment to all of its indebtedness that is expressly subordinated in right of payment to the 2025 Notes, and equal in right of payment to the Company&#8217;s unsecured indebtedness. The 2025 Notes are also effectively junior in right of payment to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness, and are structurally subordinated to any debt or other liabilities (including trade payables) of the Company&#8217;s subsidiaries.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the 2025 Notes are currently classified on the Company&#8217;s consolidated balance sheet at September&#160;30, 2021 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#8217;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an entity must separately account for the liability and equity components of convertible debt instruments (such as the 2025 Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer&#8217;s economic interest cost. The liability component of the instrument is valued in a manner that reflects the market interest rate for a similar nonconvertible instrument at the date of issuance. The initial carrying value of the liability component of $<ix:nonFraction unitRef="usd" contextRef="i7110286438e148d29048a9c4ae47c6b4_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODAxNg_97626dba-d004-4dec-a1b9-ecbdf57caa76">314.7</ix:nonFraction>&#160;million was calculated using a <ix:nonFraction unitRef="number" contextRef="i7110286438e148d29048a9c4ae47c6b4_I20210930" decimals="4" name="pcrx:DebtInstrumentConvertibleAssumedBorrowingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODA0Mg_6683196b-5936-4aa8-b952-b6edb59266cb">5.78</ix:nonFraction>% assumed borrowing rate. The equity component of $<ix:nonFraction unitRef="usd" contextRef="i7110286438e148d29048a9c4ae47c6b4_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODA5Mw_6af2b224-bcdc-4f62-a207-074a82041ccd">87.8</ix:nonFraction>&#160;million, representing the conversion option, was determined by deducting the fair value of the liability component from the par value of the 2025 Notes and is recorded in additional paid-in capital on the consolidated </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ibc7f1ce3567040089576a2c86b9f07e7" continuedAt="i70c776dc52844e01944bcd8d06ea3820"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balance sheet at the issuance date. The equity component is treated as a discount on the liability component of the 2025 Notes, which is amortized over the <ix:nonNumeric contextRef="ice3f2f561e0548b1b29b92f1b74cc3b5_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3NzY_fcd4190a-6583-4dc3-88de-2d1547cfa9c6">five-year</ix:nonNumeric> term of the 2025 Notes using the effective interest rate method. The equity component is not re-measured as long as it continues to meet the conditions for equity classification. A deferred tax liability was recognized in the amount of $<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODcwNg_6e63e6d1-48d7-4f4a-8a76-86d67abcb5c9">20.5</ix:nonFraction>&#160;million, with the offsetting amount recorded in additional paid-in capital.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated the total transaction costs of approximately $<ix:nonFraction unitRef="usd" contextRef="ice3f2f561e0548b1b29b92f1b74cc3b5_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODg0NQ_ded632f4-5f56-4a90-9632-3d7aa136778c">12.5</ix:nonFraction>&#160;million related to the issuance of the 2025 Notes to the liability and equity components of the 2025 Notes based on their relative values. Transaction costs attributable to the liability component are amortized to interest expense over the <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" format="ixt-sec:durwordsen" name="pcrx:AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3ODE_287db1ee-3468-4cfa-9521-31d77fb20ad0">five-year</ix:nonNumeric> term of the 2025 Notes, and transaction costs attributable to the equity component totaling $<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfOTE4MA_42c6a8ae-7db9-434b-9572-ca63e1731b61">2.7</ix:nonFraction>&#160;million are netted with the equity component in stockholders&#8217; equity.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company. The 2025 Indenture contains customary events of default with respect to the 2025 Notes, including that upon certain events of default, 100% of the principal and accrued and unpaid interest on the 2025 Notes will automatically become due and payable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2022</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="ic7de6bbd42d241129b6517fae46c1feb_D20170301-20170331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfOTgwMA_6f0aa09e-2dd6-43a1-82b1-abdcf0a4b17f">345.0</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i484fffcf3bfc42da8b6f439297ac33b8_I20170331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfOTgzNg_bcf486f0-fd1f-4d93-a359-10c47b17c14b">2.375</ix:nonFraction>% convertible senior notes due 2022, or 2022 Notes, and entered into an indenture, or 2022 Indenture, with respect to the 2022 Notes. The 2022 Notes accrue interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="i484fffcf3bfc42da8b6f439297ac33b8_I20170331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTAwMjE_1a5b18ae-f34c-4171-a057-5273c3153dde">2.375</ix:nonFraction>% per year, payable semiannually in arrears on April&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and October&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. The 2022 Notes mature on April 1, 2022. As discussed above, in July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $<ix:nonFraction unitRef="usd" contextRef="i5ee5be00954e45748d8b246245010a0f_I20200731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTAyNzU_f05193f0-2fb4-4da1-90dc-6f7294bb5eef">185.0</ix:nonFraction>&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $<ix:nonFraction unitRef="usd" contextRef="i5a7be408192f4f12b6d240abce12cdf8_D20200701-20200731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTAzODA_a5669a30-8a6f-4417-b85a-b13738414c2f">211.1</ix:nonFraction>&#160;million in cash (including accrued interest). The partial repurchase of the 2022 Notes resulted in an $<ix:nonFraction unitRef="usd" contextRef="i5a7be408192f4f12b6d240abce12cdf8_D20200701-20200731" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTA0Nzc_abbd1bb3-ff2d-4948-9888-add0b7e5993f">8.1</ix:nonFraction>&#160;million loss on early extinguishment of debt.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><ix:continuation id="i67d1a5e53c1543e286d0056df62331ed"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMi0wLTEtMS0wL3RleHRyZWdpb246ZTg1OTA2ZDIzYTA3NDcxNzk3YzlkOTUzYWM2OWNhNGNfNA_b8f798be-c7a9-46b0-a469-054d18d054ff">2.375</ix:nonFraction>% convertible senior notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMi0xLTEtMS0w_27dac8da-e5e8-4e87-86cf-08251803b452">160,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cecef789bf42e8a15eea314c8c854e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMi0zLTEtMS0w_76fec104-5111-4584-8f2c-ad7dcaa45f26">160,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMy0xLTEtMS0w_fd36d9f0-3b66-404e-80b3-1ed00b29f0b1">443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cecef789bf42e8a15eea314c8c854e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMy0zLTEtMS0w_17bcfede-2a26-48bf-827d-9c9763bda6e7">1,089</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfNC0xLTEtMS0w_2df846aa-5aae-420f-a211-8d1f97690b2c">3,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76cecef789bf42e8a15eea314c8c854e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfNC0zLTEtMS0w_a22c2ce1-f9b6-426a-8761-718ce443a269">9,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfNS0xLTEtMS0w_81fac68d-f107-4edf-a9c1-6b1b9a8c0922">155,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cecef789bf42e8a15eea314c8c854e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfNS0zLTEtMS0w_7b6ec27d-8bce-4616-9a81-3af0c99192ce">149,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 1, 2021 and until the close of business on the second scheduled trading day immediately preceding April 1, 2022, holders may convert their 2022 Notes at any time. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, holders will receive the principal amount of their 2022 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the <ix:nonNumeric contextRef="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930" format="ixt-sec:durday" name="pcrx:SettlementPeriodConvertibleDebtConversionRequest" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTE0MDM_93c56cf5-1c91-4ebb-95f1-bc707105db52">40</ix:nonNumeric> consecutive trading days during the observation period (as more fully described in the 2022 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option. The initial conversion rate for the 2022 Notes is 14.9491 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTE4NzI_a9ea8b82-fa6f-4161-a75c-365fe3221e0f">66.89</ix:nonFraction> per share of the Company&#8217;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2022 Notes represents a premium of approximately <ix:nonFraction unitRef="number" contextRef="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331" decimals="3" name="pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTIxMjg_81cd30ac-7462-44e4-bb3c-311a5298d438">37.5</ix:nonFraction>% to the closing sale price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTIxNjA_fbc8e313-9c24-4151-a7b3-69c6d1f2d9b0">48.65</ix:nonFraction> per share of the Company&#8217;s common stock on the Nasdaq Global Select Market on March 7, 2017, the date that the Company priced the private offering of the 2022 Notes.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the 2022 Notes had a market price of $1,038 pe</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2022 Notes will be paid pursuant to the terms of the 2022 Indenture. In the event that all of the 2022 Notes are settled, the Company would </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be required to repay the remaining $<ix:nonFraction unitRef="usd" contextRef="i5ee5be00954e45748d8b246245010a0f_I20200731" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTI3OTg_ad3ce176-2667-4982-889d-2f620549b5cb">160.0</ix:nonFraction> million in principal value a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd any conversion premium in any combination of cash and shares of its common stock (at the Company&#8217;s option).</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2020, the Company may redeem for cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option, all or part of the 2022 Notes if the last reported sale price (as defined in the 2022 Indenture) of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTMyNjE_bc1b6988-4ef7-4609-bb96-ec9cd5665112">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="segment" contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTMzMTY_d8e8635f-961e-4e7a-9d47-9fb79faf4ae4">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="segment" contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTMzNzI_bc43e95a-6103-4b6c-9262-3c1218aaae38">30</ix:nonFraction> consecutive trading-day period ending within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM0MjA_0a6e4989-0f64-4ad2-a49d-950959b333c7">five</span> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i70c776dc52844e01944bcd8d06ea3820"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trading days prior to the date on which the Company provides notice of redemption. This condition was not met during the quarter ended September&#160;30, 2021. The redemption price will equal the sum of (i)&#160;<ix:nonFraction unitRef="number" contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401" decimals="INF" name="pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM2MDk_bfc07e8b-8586-4742-99f0-0584acd92b48">100</ix:nonFraction>% of the principal amount of the 2022 Notes being redeemed, plus (ii)&#160;accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2022 Notes for redemption will constitute a &#8220;make-whole fundamental change&#8221; (as defined in the 2022 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2022 Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="pcrx:ScheduleOfInterestExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3NzU_e46608e7-7893-4a65-8572-b5d1ec2f44f5" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMi0xLTEtMS0w_6e0b11b1-6319-4692-bc8d-821162a3b7e9">1,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMi0zLTEtMS0w_2fca26a0-c4a0-45b6-af25-3fc113a2cb31">1,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMi01LTEtMS0w_33d217b9-e727-4d74-a94b-206820e8b08c">5,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMi03LTEtMS0w_2fe541ea-fcf2-4419-9d10-c2a6046ef9d2">5,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMy0xLTEtMS0w_32af772a-7c9d-4044-af89-68dd0d775214">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMy0zLTEtMS0w_a1ceb50d-75c9-4a46-9d5a-fd8b1864a307">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMy01LTEtMS0w_473f2038-408d-413e-a225-f4bfa3b88d40">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMy03LTEtMS0w_5fccb4ce-e758-48da-88d7-051fe3f43a3c">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNC0xLTEtMS0w_50b3b472-150d-4385-a7ef-59dd5e76467e">5,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNC0zLTEtMS0w_d55414f5-1cf5-4048-af3a-ff3ee7a553dc">5,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNC01LTEtMS0w_7cbdc0a8-5b67-4715-8aa2-e977b310b97a">17,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNC03LTEtMS0w_470cd2da-85c8-43f8-9ddf-6470a494d57a">12,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNS0xLTEtMS0w_809233d1-10e2-4808-98f8-1b7e05fa012e">881</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNS0zLTEtMS0w_13a73859-bdee-469b-9daa-826cf64e459c">691</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNS01LTEtMS0w_4a3a0521-1889-438f-877d-03e1770ad05c">3,016</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNS03LTEtMS0w_c1825cd0-6fff-4e4f-862a-8dacd99ee676">1,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNi0xLTEtMS0w_d97b41d0-a362-4e3a-ab27-d67efcb20a7b">7,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNi0zLTEtMS0w_0d916b96-9194-4e9d-be2c-3aa253b86915">7,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNi01LTEtMS0w_6ffe3871-9d6f-4796-a30e-2fb2ad51eed5">21,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNi03LTEtMS0w_144e9416-27f5-4179-b974-41a69fc269ad">18,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfOC0xLTEtMS0w_afd86071-1a93-4081-8deb-725967a1a10c">6.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfOC0zLTEtMS0w_5eef6ee8-63fe-4d09-924f-f4de234b3ef2">6.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfOC01LTEtMS0w_75166f24-d2d2-4c13-ad29-994d4fce322e">6.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfOC03LTEtMS0w_9d715deb-f633-4d30-838e-1ef6945164c2">7.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU 2020-06 will require the Company to eliminate debt discounts along with any related future amortization. Further deferred financing costs previously allocated to the conversion features will be re-allocated to the outstanding debt, slightly increasing future annual amortization of deferred financing costs. This new accounting pronouncement has not been adopted as of September&#160;30, 2021. For additional information regarding ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 9&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2ODQ_541ec515-5f3b-4430-b9a6-8d726f13ece3" continuedAt="i602d8fc81b3a47db9834996e12a2c236" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i602d8fc81b3a47db9834996e12a2c236" continuedAt="ia2da506b45604cd792e5448cce86a4c0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="padding-left:40.5pt"><span><br/></span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</span></div><div style="padding-left:40.5pt"><span><br/></span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#8217;s equity investment with a readily determinable fair value was calculated utilizing market quotations from a major American stock exchange (Level 1). The fair value of the Company&#8217;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#8217;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amount of the investments without a readily determinable fair value have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions. Certain assets and liabilities are measured at fair value on a non-recurring basis, including assets and liabilities acquired in a business combination, equity instruments measured at cost and long-lived assets, which would be recognized at fair value if deemed impaired or if reclassified as assets held for sale. The fair value in these instances would be determined using Level 3 inputs. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia2da506b45604cd792e5448cce86a4c0" continuedAt="i09fd5307cca2425281a8c2c5679fa62f"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2ODE_0867299e-019b-4f6b-9ff1-c2b61fa0db2e" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Notes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2333c4061860489582acbe97375bee03_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNC0yLTEtMS0w_b2d7213b-19ca-47ae-8192-b928d55abcf3">4,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958bf8263a504b278937ce35716db65f_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNC00LTEtMS0w_71a39c8b-63c0-499e-be08-0ef7e9cede66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c75da8d059b4e2596b5ff5b06924a84_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNC02LTEtMS0w_c3324fce-2fd5-415f-995e-36f1501ad591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7181147be8bc4623ae8e9c54c8d545ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNC04LTEtMS0w_c4d383cf-56f4-49fc-aaf8-c00a801716b8">4,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2333c4061860489582acbe97375bee03_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNi0yLTEtMS0w_da96cf82-c5ce-46aa-8463-068b9f16b8b7">16,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958bf8263a504b278937ce35716db65f_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNi00LTEtMS0w_682cd091-8d1f-4913-b79e-230ab76eb869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c75da8d059b4e2596b5ff5b06924a84_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNi02LTEtMS0w_b31f83fc-4e58-4c62-be2b-e0b55e892701">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7181147be8bc4623ae8e9c54c8d545ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNi04LTEtMS0w_c384789f-ab6b-4a9b-8647-b05f68ac0258">16,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS0wLTEtMS0wL3RleHRyZWdpb246YmZlOTg4NzBlYTM0NGM3NWFhZTRjNWNmZmQ0MzY1MTJfNw_dd895c0b-de60-41ed-901b-4d44778bb7a7">2.375</ix:nonFraction>% convertible senior notes due 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f839d9a53d4f3ca875382af344df93_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS0yLTEtMS0w_93ca297e-372b-4474-95c5-0c7de3e1c868">155,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i583c220156b344feaaa6d77b90257b90_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS00LTEtMS0w_a6e83aaf-44af-4d70-aece-005e59c4dc4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee07277d2a1a4c99b0127e42c9b1dd5f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS02LTEtMS0w_8cb36b36-685f-44f3-82a9-f26b79dfe7ea">166,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14c7c1373cd042e1a4d460c0d974dd24_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS04LTEtMS0w_35b76ac6-ce8f-4e18-8f3f-888cc3b1c23a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<ix:nonFraction unitRef="number" contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjhmMTMwMzE0NjEzZjQ3MmI4NDM4Yjg1ZjViYjQ2ZGRhXzc_1a4755ea-7025-4496-8a53-4bfbbc85205a">0.750</ix:nonFraction>% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7f0c9606944edf9be67213b6c85881_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtMi0xLTEtMA_9583ba9b-91cc-4b53-b883-5ec42cbeb94d">326,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec15b75fb0c42b2b08037d3e0496138_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtNC0xLTEtMA_9e5883e0-e8c2-4cbf-8fba-26697da0fc89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if95fecb89ac048679a3ab7c3be07bf21_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtNi0xLTEtMA_b3df5a08-e44d-4849-b259-8f153a0b05a2">437,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893cdc48adac4ec98ca312b73931a78d_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtOC0xLTEtMA_082b2fca-0610-4f42-893c-c077ba911782">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjUzMQ_54bdd5b8-15fd-473d-be12-314682128ee2">56.00</ix:nonFraction>&#160;per share on September&#160;30, 2021, compared to a conversion price of&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjU4NQ_cd21702f-6d51-4165-97c8-0b4d83a73957">66.89</ix:nonFraction>&#160;per share for the 2022 Notes and $<ix:nonFraction unitRef="usdPerShare" contextRef="i263034570486452a8b85ec7f5288179e_I20170331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjYyMQ_8add76e6-72af-45fb-b285-0f33b31612e1">71.78</ix:nonFraction> per share for the 2025 Notes. The maximum conversion premium that could have been due on the 2022 Notes and 2025 Notes at September&#160;30, 2021 was&#160;approximately <ix:nonFraction unitRef="shares" contextRef="i14f382f05018464aad3ae04a610ed007_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:DebtInstrumentConvertibleConversionPremiumShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjc2Nw_ff5e77ab-d955-4458-ab2b-c8e65d3a4350">2.4</ix:nonFraction> million&#160;and <ix:nonFraction unitRef="shares" contextRef="i9d903a7704504ea2b8d765a75def60a0_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:DebtInstrumentConvertibleConversionPremiumShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjc3NA_7b08c916-d725-4963-83bc-fe56b2e9c78c">5.6</ix:nonFraction>&#160;million shares of the Company&#8217;s common stock, respectively. These figures assume no increases in the conversion rate for certain corporate events.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity and Debt Investments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company held an equity investment in TELA Bio, Inc., or TELA Bio, in its condensed consolidated balance sheets in the amount of $<ix:nonFraction unitRef="usd" contextRef="i8a69013f0d0b4c429435e8c27ee9bb03_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzA4NQ_6b1f0783-e3b4-4aa3-b4aa-f94e9b9e6e32">11.6</ix:nonFraction>&#160;million. During the nine months ended September&#160;30, 2021, the Company sold its investment in TELA Bio for net cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i6e0d7a6d98784688b9dd3fddc1b5a08c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzE5MA_56b7db6f-0de9-410a-8226-bf9e18233b86">9.1</ix:nonFraction>&#160;million. During the nine months ended September&#160;30, 2021, the Company recognized a realized loss of $<ix:nonFraction unitRef="usd" contextRef="i6e0d7a6d98784688b9dd3fddc1b5a08c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzI3Mg_b703f9d4-11bb-4967-965e-06cf81777319">2.6</ix:nonFraction>&#160;million, which has been recorded in other, net in the condensed consolidated statements of operations. The fair value of TELA Bio was based on a Level 1 input. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021 and December&#160;31, 2020, the Company held an equity investment of $<ix:nonFraction unitRef="usd" contextRef="ib87f4d8c58fd4e109cfee6b9060ba4d0_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA5OTUxMTYzOTY0Nw_dd1bc304-e331-412e-8391-f60824edbc22">4.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0f39cd86209f4b77984b8ebe031d7b5a_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzQ5MA_8b9cf3f7-6979-4a6b-a01e-dc3449a8fe38">1.2</ix:nonFraction>&#160;million, respectively, in GeneQuine Biotherapeutics GmbH, or GeneQuine, a privately held biopharmaceutical company headquartered in Hamburg, Germany. This investment has no readily determinable fair value and is recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments. During 2021, the Company purchased a convertible note from GeneQuine in the amount of $<ix:nonFraction unitRef="usd" contextRef="i091d6864fe7b45dfae7464d8dfbc754e_I20210131" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzg5MQ_b0fe8d7d-aa9b-424b-af1e-cba278d919fe">1.2</ix:nonFraction>&#160;million and invested an additional $<ix:nonFraction unitRef="usd" contextRef="iaddf1add92a940f384b1684b15e084d1_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzg0ODI5MDcxMDExMw_0a29ba65-b4aa-4cd9-88f9-5ec7b63e97e0">3.0</ix:nonFraction>&#160;million in equity investments. During the nine months ended September&#160;30, 2021, the valuation of the convertible note was reduced by less than $<ix:nonFraction unitRef="usd" contextRef="i7a1ec36dd33e4facb2801b28ac07812b_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA5OTUxMTY0MDA2Mg_648297cd-f4d4-40ce-8c1f-1612f41be28f">0.1</ix:nonFraction>&#160;million due to changes in foreign currency exchange rates. The Company has the right to make additional investments in debt securities of $<ix:nonFraction unitRef="usd" contextRef="i091d6864fe7b45dfae7464d8dfbc754e_I20210131" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:PotentialAdditionalDebtInvestmentUponAchievingMilestones" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNDA4OA_b70d27c9-443b-4d8d-92c3-d24a594c467d">1.7</ix:nonFraction>&#160;million predicated upon GeneQuine achieving certain prespecified near-term milestones.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company purchased privately-held preferred shares in Coda BioTherapeutics, Inc., a preclinical stage biopharmaceutical company that is developing a gene-therapy platform to treat neurological disorders and diseases for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i7cfdc64ff7694ae3b4874240596655b1_D20210401-20210430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNDU1Mg_694e2425-8747-4771-9baa-9986ac1d473e">10.0</ix:nonFraction>&#160;million. There were no adjustments to this investment during the three and nine months ended September&#160;30, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company purchased a convertible note in the amount of $<ix:nonFraction unitRef="usd" contextRef="i2642fc1d446c40c890cec918384252cb_I20210430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNDcwOQ_ab77b9a2-b098-45f5-bc55-3c52c9992522">3.0</ix:nonFraction>&#160;million from Spine BioPharma, LLC, a preclinical stage biopharmaceutical company. There were no adjustments to this investment during the three and nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related Contingent Consideration</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="i6d1f022a2e3f45c38d8813642eb0a4b7_D20190401-20190430" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:ContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTEwOA_08741fff-7eb0-4960-a7c8-51c63bcf3d06">100.0</ix:nonFraction> million upon the achievement of certain regulatory and commercial milestones. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within <ix:nonNumeric contextRef="i6d1f022a2e3f45c38d8813642eb0a4b7_D20190401-20190430" format="ixt-sec:durday" name="pcrx:ContingentConsiderationPaymentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTMyNg_79b1c013-63c6-4d24-aae0-2bfc09406b05">60</ix:nonNumeric> days of the end of the fiscal quarter of achievement. As of September&#160;30, 2021, the maximum potential remaining milestone payments to be paid are $<ix:nonFraction unitRef="usd" contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:ContingentConsiderationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTQ0OA_df8cd9c4-e429-4776-aec1-c9e8671f2395">48.0</ix:nonFraction>&#160;million. The Company made a $<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="pcrx:MilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTQ3MQ_0fd48246-3037-49df-9abd-76e4a72e7117">7.0</ix:nonFraction> million milestone payment during the nine months ended September&#160;30, 2021 for the achievement of one regulatory milestone. Another regulatory milestone in the amount of $<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:MilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA5OTUxMTY0MDA5Mg_46e18621-e214-4ebd-b226-6623ee649d0b">5.0</ix:nonFraction>&#160;million was met in the three months ended September&#160;30, 2021 and is expected to be paid in November 2021. During the nine months ended September&#160;30, 2020, the Company made $<ix:nonFraction unitRef="usd" contextRef="i3838cbd889d145a097da4753fd5b7d52_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTYxNw_88943773-260a-4417-bad3-1889ce0d46c7">15.0</ix:nonFraction> million in cash payments for the achievement of two regulatory milestones. As of September&#160;30, 2021 </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i09fd5307cca2425281a8c2c5679fa62f" continuedAt="ief5ab1fe34394f9ca2a6c3a1bbc46c12"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and December 31, 2020, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $<ix:nonFraction unitRef="usd" contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTgyMw_011bb9be-69fb-4d81-b692-a5bdb32d883a">16.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic6a3944a915b4b7dacce440712764ef6_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTgzMA_94bf071a-a5d3-4df3-928c-dad813639ebc">28.3</ix:nonFraction>&#160;million, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. For the three and nine months ended September&#160;30, 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="if9c092d61fa44c89a1f992840f0cce80_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNjA4OQ_5d806299-4520-4e42-9478-de569b0c1bc3">1.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNjEwNQ_513b1c9f-9d72-4d60-b1c4-8b3fd77c0963">2.1</ix:nonFraction> million gains, respectively, related to contingent consideration. For the three and nine months ended September 30, 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="ia60b65aa2ebd44c6a2368109e2845fd1_D20200701-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNjIyNw_d9a520c4-5e4c-43c8-9d9d-ec50bdb28922">0.8</ix:nonFraction>&#160;million of charges and $<ix:nonFraction unitRef="usd" contextRef="idcabd81228924ca98368c5d31fc89917_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNjI0NQ_cca54605-9098-475d-b5f6-15de2208c1cb">1.6</ix:nonFraction>&#160;million of gains, respectively, related to contingent consideration. These amounts have been included in acquisition-related (gains) charges in the condensed consolidated statements of operations. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rate used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. At September&#160;30, 2021, the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="ibfac6863101f4d0cbbcb816ebbd63709_I20210930" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNzE3Ng_54ce5df6-0b6d-4c25-848b-f77338e6215c">3.65</ix:nonFraction>% and the weighted average probability of success for the regulatory milestone that has not yet been met was <ix:nonFraction unitRef="number" contextRef="ie57c515402bb4f8eb1ac59b13452a7bb_I20210930" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNzI4NA_f26643ee-ba27-47f9-8b11-55ab9afb0a25">2.0</ix:nonFraction>%. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2ODk_9cb78ad4-d32c-46ac-93ad-b0a7697a8764" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ranges Utilized as of September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fba2629f05d45e2a951a1a3b00a7381_I20210930" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIwOTQ4Y2IwZmVmYjQxZmM4OTc4NTcyOTI5NTg2ZmIxL3RhYmxlcmFuZ2U6MjA5NDhjYjBmZWZiNDFmYzg5Nzg1NzI5Mjk1ODZmYjFfMS0yLTEtMS0wL3RleHRyZWdpb246ZjE4MjdjNGZhNmJhNDk3NWI5ZjU3NjBlMDJiM2E3MjdfNA_2ebe4772-f90c-4c88-b131-a90eacef153a">3.49</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i9551ea61dd8e42de921cd6cb340713fa_I20210930" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIwOTQ4Y2IwZmVmYjQxZmM4OTc4NTcyOTI5NTg2ZmIxL3RhYmxlcmFuZ2U6MjA5NDhjYjBmZWZiNDFmYzg5Nzg1NzI5Mjk1ODZmYjFfMS0yLTEtMS0wL3RleHRyZWdpb246ZjE4MjdjNGZhNmJhNDk3NWI5ZjU3NjBlMDJiM2E3MjdfMTA_185deb17-67ef-4aa8-83a2-6e2b9b76e367">3.81</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i923a86d2b61a4ed5afa25b07cbdcf5a8_I20210930" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIwOTQ4Y2IwZmVmYjQxZmM4OTc4NTcyOTI5NTg2ZmIxL3RhYmxlcmFuZ2U6MjA5NDhjYjBmZWZiNDFmYzg5Nzg1NzI5Mjk1ODZmYjFfMi0yLTEtMS0wL3RleHRyZWdpb246ODRlZDg3YTM3NDRiNGNmNjgwYTI4YmNkNTRiNjkxOTNfNA_a85f0659-77c2-43e0-8931-e4389ed427f5">2</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i8336fab865c64a01a14d247bad7a374b_I20210930" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIwOTQ4Y2IwZmVmYjQxZmM4OTc4NTcyOTI5NTg2ZmIxL3RhYmxlcmFuZ2U6MjA5NDhjYjBmZWZiNDFmYzg5Nzg1NzI5Mjk1ODZmYjFfMi0yLTEtMS0wL3RleHRyZWdpb246ODRlZDg3YTM3NDRiNGNmNjgwYTI4YmNkNTRiNjkxOTNfMTA_0aa5c21f-d18c-4618-a6d3-34b708d1d8e4">100</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2023</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:22.5pt"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2NzA_bd306a9d-7fab-4049-a62c-6cf0babd1296" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad8f7b4b2d424119bbbb3f917cb3b346_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfMS0yLTEtMS0w_08281b66-4e79-4ce4-b1db-f01472696960">28,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfMy0yLTEtMS0w_8236322e-1a7f-4afd-9dee-dea373d234c6">2,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfNC0yLTEtMS0w_8e65d71a-82ae-4bfd-bfb2-fff2be72b28d">7,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Offset indemnification claims</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfNS0yLTEtMS0w_ef855c4b-0086-4139-832b-2c8af03eb9d5">3,000</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52993d557b44575b5efa778c644c50f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfNi0yLTEtMS0w_53efb043-5c42-4860-8f6a-4111bb6f5f2d">16,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available-for-Sale Investments</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate and government bonds with maturities greater than three months, but less than one year. Long-term investments consist of government bonds with maturities greater than one year but less than three years. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#8217;s short-term and long-term investments are reported in other comprehensive income (loss). At September&#160;30, 2021 and December 31, 2020, all of the Company&#8217;s short-term and long-term investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term and long-term investments had an &#8220;A&#8221; or better rating by Standard&#160;&amp; Poor&#8217;s.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ief5ab1fe34394f9ca2a6c3a1bbc46c12"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2NjM_17dacfe9-096f-4bd1-90f4-16211ed42836" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s investments at September&#160;30, 2021 and December&#160;31, 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021 Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e113d16ac64bae9b930524840237b5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMi0yLTEtMS0w_806f72f6-ecc8-47c5-bfe9-77502b7c9fe4">17,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e113d16ac64bae9b930524840237b5_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMi00LTEtMS0w_b9d7633e-0cd7-464a-afd8-566659489b15">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4e113d16ac64bae9b930524840237b5_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMi02LTEtMS0w_ac07aff7-446b-4823-8d0a-319c0fc2cf6a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e113d16ac64bae9b930524840237b5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMi04LTEtMS0w_6584c1d5-5fc6-4ef8-bb74-5a5809a45654">17,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22316fe6c9c9417c99464765f80e9ff2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMy0yLTEtMS0w_ca3a59bb-59e4-449a-904d-cd24dd1fa254">423,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22316fe6c9c9417c99464765f80e9ff2_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMy00LTEtMS0w_6c24d0a3-f234-4a4a-8741-db65aa8c3844">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22316fe6c9c9417c99464765f80e9ff2_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMy02LTEtMS0w_1042017b-6dc2-4ec5-9ad6-f2cbe154992d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22316fe6c9c9417c99464765f80e9ff2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMy04LTEtMS0w_e1fdeeac-a337-4f29-b336-a2e3b268f2ff">423,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNC0yLTEtMS0w_cb90cde6-7dc6-459f-a2af-c6593a56a01f">32,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNC00LTEtMS0w_ef3c7cb1-8117-418f-b326-99e3e1998329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNC02LTEtMS0w_ceb9b670-a07e-4769-9696-c8dd4f3f6098">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNC04LTEtMS0w_c9957bd8-10dc-4cef-89f4-376785a02e9b">32,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNS0yLTEtMS0w_8bf31b69-7d22-4672-a0e2-0c26ad7e86e7">86,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNS00LTEtMS0w_fda1494d-c0ac-4d11-83f6-0e5aaa01fefa">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNS02LTEtMS0w_96820009-a665-49d7-9047-c1e88cc98ca4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNS04LTEtMS0w_b2335061-8ca4-4dc1-b1a0-f0756307e536">86,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMTItMi0xLTEtMA_a3aab917-ced2-4833-81d6-33a8fe4d4824">559,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMTItNC0xLTEtMA_791ad2ea-b7c2-4983-ae9b-da1660a6634a">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMTItNi0xLTEtMA_d15ab037-1650-4f6d-ae08-d8bf5bba6c6d">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMTItOC0xLTEtMA_54027237-3e91-42ed-a8db-d843a8fcd366">559,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020 Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08f2b904bb04e27a90834e3f466dbd1_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMi0yLTEtMS0w_2edc9bc5-778b-4dcf-a5b2-0bc3cad291b2">34,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08f2b904bb04e27a90834e3f466dbd1_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMi00LTEtMS0w_f7003b28-cbce-46a6-9cdd-672849b638da">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08f2b904bb04e27a90834e3f466dbd1_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMi02LTEtMS0w_5ce86878-8658-4293-be53-0f85ea3ecf67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08f2b904bb04e27a90834e3f466dbd1_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMi04LTEtMS0w_b29ac6f5-8581-446f-bce1-687d04f284ef">35,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66d87b3e37142af9057b01f7429fa1a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMy0yLTEtMS0w_b69f036d-4144-4ce1-8235-4cee882305af">221,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66d87b3e37142af9057b01f7429fa1a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMy00LTEtMS0w_9372fc50-dfc5-4381-8c28-20a9c5bbf22a">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia66d87b3e37142af9057b01f7429fa1a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMy02LTEtMS0w_8524c1e3-172e-4021-b1ee-320638147fbb">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66d87b3e37142af9057b01f7429fa1a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMy04LTEtMS0w_41ca6825-5e4d-439d-8973-41b4afbf0ba6">221,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28d6c7359df4b11873f7e1849924a7e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNC0yLTEtMS0w_d39b90a7-d8dd-45f9-83f1-fc66a014441d">120,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28d6c7359df4b11873f7e1849924a7e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNC00LTEtMS0w_fde3e519-7014-4d39-aa17-fbee78d0b21c">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic28d6c7359df4b11873f7e1849924a7e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNC02LTEtMS0w_974aefc7-4702-4247-a99e-7a98c94298ea">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28d6c7359df4b11873f7e1849924a7e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNC04LTEtMS0w_ed1825a4-f260-42f4-a467-2c00f9323a75">120,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaaea71e25214e7182cb2fdf114dd014_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNS0yLTEtMS0w_1ff09ef4-a1b1-4d8c-bb7b-6c501894bf61">44,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaaea71e25214e7182cb2fdf114dd014_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNS00LTEtMS0w_b360bcdb-7c0e-4e6c-a31e-eb8bfc6cff65">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaaea71e25214e7182cb2fdf114dd014_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNS02LTEtMS0w_b74a8b21-966e-488d-ac10-024461829add">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaaea71e25214e7182cb2fdf114dd014_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNS04LTEtMS0w_f5e972d8-15c7-4b8a-9ff5-90bed5908105">44,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNi0yLTEtMS0w_187ae289-709f-44bd-b7ef-4b22e042ae4b">421,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNi00LTEtMS0w_0fa5d6c6-46f7-4527-8a32-9d31dd72bef2">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNi02LTEtMS0w_1f7df29a-af8c-4639-ac8e-cc70c1c396ce">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNi04LTEtMS0w_641dab4a-5646-4538-9c73-78e7e7754971">421,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cd891a11904cbca9a869e4c48499a0_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTAtMi0xLTEtMA_1d271480-c337-49b1-a810-fc3e7ae0fccf">95,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cd891a11904cbca9a869e4c48499a0_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTAtNC0xLTEtMA_29abf50c-3fcd-4a31-b6d7-3282a24092ec">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cd891a11904cbca9a869e4c48499a0_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTAtNi0xLTEtMA_e8aedf0c-f6fc-4ddc-a405-a4340c46abd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cd891a11904cbca9a869e4c48499a0_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTAtOC0xLTEtMA_6067fe13-b011-4ced-aab9-37617de9da92">95,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaabd093cc73463987f26acf4772c0bb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTEtMi0xLTEtMA_26ebc5be-ef36-44a7-a891-9c27db98c71c">95,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaabd093cc73463987f26acf4772c0bb_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTEtNC0xLTEtMA_a9710d89-4ac7-407f-8982-18e6baa0f3ff">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaabd093cc73463987f26acf4772c0bb_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTEtNi0xLTEtMA_7adc9a71-15df-4ff6-8048-1c8ff5371a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaabd093cc73463987f26acf4772c0bb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTEtOC0xLTEtMA_dcf7aec9-98b6-4703-ad8f-a80c635ee51a">95,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTItMi0xLTEtMA_2ff8db11-d247-4dfa-a351-e8c3f503e467">516,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTItNC0xLTEtMA_01047381-aec7-4a3d-9a8c-22de2250177e">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTItNi0xLTEtMA_e7ce11ae-4583-473a-bd6b-98c17e83b285">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTItOC0xLTEtMA_48cef763-f810-4c21-a7e1-3c046a3f8167">517,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, there were no investments available for sale that were materially less than their amortized cost.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elects to recognize its interest receivable separate from its available-for-sale investments. At September&#160;30, 2021 and December&#160;31, 2020, the interest receivable recognized in prepaid expenses and other current assets was $<ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTM2Mw_2d8686b5-0bbf-47cd-a57a-66a907da89c3">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTM3MA_4fd8c1ca-b701-4694-9704-62c3925566c4">1.6</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term and long-term investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As of September&#160;30, 2021, three wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at <ix:nonFraction unitRef="number" contextRef="i51a59f89178947969b3cba1e3274e2dc_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTg1Mg_7631f30d-e4de-4434-b1a4-f3cb725d09a8">31</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ied43576ff808456488d1b300724244f6_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTg1Ng_869a1bb0-462f-459d-8d91-a8d81aefd5ef">27</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="id114c1b120324ca1a1669aa5d23a5abb_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTg2Mw_97ded7d0-8ebd-45e8-ab96-55149e32c409">26</ix:nonFraction>%. At December&#160;31, 2020, three wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at <ix:nonFraction unitRef="number" contextRef="i4b036912429349368955de8ecae55a89_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTk1OA_9062348f-3461-4f6c-a21c-e80772abfc80">36</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ie7ed73dae03a470482270000763fd063_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTk2Mg_f89ab6df-ffff-4d66-bf28-b563d73d6dd2">28</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1718ddd31a954033b183d8735f99a0a4_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTk2OQ_632afa2a-4899-4f1b-8321-3af69c754581">23</ix:nonFraction>%. For additional information regarding the Company&#8217;s wholesalers, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EXPAREL revenues are primarily derived from major wholesalers that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the Company&#8217;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of September&#160;30, 2021 and December&#160;31, 2020, the Company did <ix:nonFraction unitRef="usd" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA1ODI_03677550-a685-4c50-9fb1-25fc146a8261"><ix:nonFraction unitRef="usd" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA1ODI_eba118b2-15c0-4e34-afc5-0f4fdf21f3df">no</ix:nonFraction></ix:nonFraction>t deem any allowances for credit losses on its accounts receivable necessary.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;10&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTQwNA_f4b1e258-647c-4cd0-8c89-849cc62f7593" continuedAt="i280634645f8e485cb15b9117e2317555" escape="true">STOCK PLANS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i280634645f8e485cb15b9117e2317555" continuedAt="i8932d45303a24eee8cadec02979b8499"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Incentive Plans</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s stockholders approved the Amended and Restated 2011 Stock Incentive Plan, or 2011 Plan. The 2011 Plan was amended to increase the number of shares of common stock authorized for issuance as equity awards under the plan by <ix:nonFraction unitRef="shares" contextRef="i7e0a781126c0441dacaff2fa6d34f7a5_D20210601-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMjk5_091eba59-cd1b-460b-91ff-5ec51eb6e325">1,500,000</ix:nonFraction> shares.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8932d45303a24eee8cadec02979b8499" continuedAt="id68b547ac32b41d281e6caabd72557e0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTM4Mg_7eb71d0c-9cf4-4ddb-a2d6-7bc983dd0499" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22ffaf6dc27448ab2156941699b6b1a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMi0yLTEtMS0w_b489a9f9-91fa-44a1-8a7b-43ddf96e90a0">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7ce8a3a5fc418d9801116dc3b6610c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMi00LTEtMS0w_01610997-fc9c-448d-afe2-f26b61b00f2d">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a5860adea844fa8b07fe21a35e0f561_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMi02LTEtMS0w_3c369342-0ff3-430d-9526-9c4c3c776222">4,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia516abbffb1e4c0ba991b35223d79126_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMi04LTEtMS0w_f864a29b-7363-4e6b-be0c-41982d477d6c">4,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie261cb366710463b836156aa4c632d01_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMy0yLTEtMS0w_78f197d5-1ba7-4761-bcdf-a7c0a32b2475">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6a43537be9433b9fc3bf5d2c98e1a4_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMy00LTEtMS0w_39110223-81b8-4988-8372-23ca77c446c9">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbabdf3eb7c47d9a56eb08fb08ae3f7_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMy02LTEtMS0w_302e9f63-b56c-4eec-b2c9-1a71801dc337">3,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1ff59e16c64e2e9bc827316216d3ba_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMy04LTEtMS0w_98ced716-21db-41d0-a4c4-c671d8113be0">3,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bcecc3df2a2449395525e8d81ac6047_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNC0yLTEtMS0w_613e3212-5e90-4ba4-802c-b4ce97e6eb80">8,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7583ce2665944358a76869e7bdebea3a_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNC00LTEtMS0w_e2922ebc-10ae-444d-8bf4-cc0c180b7fb1">8,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22815de90a2e44529cacea918876ba77_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNC02LTEtMS0w_a0c005c4-a19a-4fbe-b041-68e2284b7c8b">23,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f3f4a3e1d854d6688e4b30b04ac8976_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNC04LTEtMS0w_3774acd6-62f2-46da-ab09-8c25de55e044">21,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNS0yLTEtMS0w_b5535696-89f6-4c34-bc32-7209b77b3141">10,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNS00LTEtMS0w_0d048841-5e31-4703-994e-c6d97932d02b">10,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNS02LTEtMS0w_fc031ba6-6118-4ea0-ac5b-94b24ef2d33e">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNS04LTEtMS0w_c2ba232a-2af6-416f-8976-d3e5785d6176">29,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:Compensationexpensefromstockoptionsemployees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOC0yLTEtMS0w_e1ba8a38-eb8a-407d-bfd7-565bd82b04fe">6,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:Compensationexpensefromstockoptionsemployees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOC00LTEtMS0w_457b491c-5e3b-4a92-8014-787692f7fe55">7,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:Compensationexpensefromstockoptionsemployees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOC02LTEtMS0w_b0ef177c-2758-416b-a3cc-8ba45ddf314b">19,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="pcrx:Compensationexpensefromstockoptionsemployees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOC04LTEtMS0w_cbca9aea-5f94-49a0-b92e-64220b03b562">19,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedStockExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOS0yLTEtMS0w_d56ab2ef-285b-4600-8b7b-cc69e1bb3b2a">4,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedStockExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOS00LTEtMS0w_4e0f506a-5c71-433c-83fc-4c2a6cdc036e">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedStockExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOS02LTEtMS0w_cc4dd142-96f5-4d0d-98bf-170055a69817">11,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedStockExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOS04LTEtMS0w_957c06c8-c4d8-4eb7-99c9-c0161ab35d91">8,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTAtMi0xLTEtMA_6fe2a665-0f5f-4111-bf61-01d40df7fbfa">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTAtNC0xLTEtMA_40f3d357-64df-42a5-90cf-dbed8caee3ca">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTAtNi0xLTEtMA_588ea266-6739-4ede-84a8-8dceb80db6c6">685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" name="pcrx:CompensationExpenseFromEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTAtOC0xLTEtMA_a51020fe-edef-40dd-8cf9-8bf35ad74ecc">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTEtMi0xLTEtMA_0a4c4257-da1c-4bd1-a014-ddb8fb7ea151">10,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTEtNC0xLTEtMA_799e58ae-3aeb-41d3-83d6-60f1d9d2ba74">10,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTEtNi0xLTEtMA_dfa146db-dbc2-4cdd-b845-e0ad41689bd6">31,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTEtOC0xLTEtMA_e6c2f79c-4df8-496d-ad8a-331376974c1f">29,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTM5MA_498952ba-b7f3-4824-8408-525fd8557e43" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMS0yLTEtMS0w_36ce232c-a619-4699-a770-1679b8a16825">6,235,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMS00LTEtMS0w_943a61b9-a337-45d4-ac34-d0b6da113429">45.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMi0yLTEtMS0w_e1422e65-0609-46a8-9528-8dd50355aae2">769,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMi00LTEtMS0w_64c1751e-f45f-4e4f-bec5-08d9b2f3126e">61.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMy0yLTEtMS0w_c57ba8a7-8301-43be-9067-fb1c8aa7d477">553,023</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMy00LTEtMS0w_78c07c55-bbc3-4942-93bc-3c19d3aa863a">34.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNC0yLTEtMS0w_1918c61e-c089-49af-a8c9-78dfce16fa74">238,865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNC00LTEtMS0w_65778aff-c7d6-4f9b-9374-a7b8e57baa8c">46.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNS0yLTEtMS0w_c0161003-1f24-4e34-bae7-ed2b4f9ff9b1">42,416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNS00LTEtMS0w_ae89a51e-be0a-4d87-bce6-0ab963c97415">76.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNi0yLTEtMS0w_1d126ab2-0d8a-4e3d-999b-7acd6994b65b">6,170,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b38381b6d0a45889401a583757402a5_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNi00LTEtMS0w_5a3b2656-2fa3-44dc-9c1a-174a3e1c70ee">48.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i033c3bf91fa74d9f8777d9d69a2050e5_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMS0yLTEtMS0w_4a75081c-634e-43a9-b73c-d7476934d7ef">957,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i033c3bf91fa74d9f8777d9d69a2050e5_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMS00LTEtMS0w_0ef74d09-9396-4d29-84b6-20bfe10d05bc">46.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMi0yLTEtMS0w_f8ad2b12-18dc-436e-a3f9-06cb0239d350">401,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMi00LTEtMS0w_c298fb7f-fc17-43ea-938a-329651292334">61.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMy0yLTEtMS0w_bf985f67-3e72-4e81-a10a-df3a89ed6483">302,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMy00LTEtMS0w_c63682a8-9c26-4081-8596-2ab0122c04a7">44.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfNC0yLTEtMS0w_8dd48aca-8e01-4b34-a935-097fda5127b8">114,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfNC00LTEtMS0w_59a83f13-872c-4cd7-b6fb-4b5b086c7175">49.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d2ac06eaefc41a4919773d11bc58522_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfNS0yLTEtMS0w_9e196f97-5492-4701-817e-d5741e0399e5">942,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1d2ac06eaefc41a4919773d11bc58522_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfNS00LTEtMS0w_ac71247c-251c-44b3-8b8d-c46c7e921532">52.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the nine months ended September&#160;30, 2021 wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfNzA2_55843e81-d06a-4409-bedf-ee650ef78df4">27.36</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share. <ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTQwMw_d129d326-e736-4b3e-ab27-cebe26e13c60" continuedAt="i9c2ca79b6ad24cddba54e92985f32176" escape="true">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i9c2ca79b6ad24cddba54e92985f32176"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="3" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmZkYjliZGIwNjMwYjQ5MDU5NDVhZDVjYjYxYzJkZTVjL3RhYmxlcmFuZ2U6ZmRiOWJkYjA2MzBiNDkwNTk0NWFkNWNiNjFjMmRlNWNfMS0yLTEtMS0w_3073827d-ddd2-443e-929b-53af63510c76">None</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmZkYjliZGIwNjMwYjQ5MDU5NDVhZDVjYjYxYzJkZTVjL3RhYmxlcmFuZ2U6ZmRiOWJkYjA2MzBiNDkwNTk0NWFkNWNiNjFjMmRlNWNfMi0yLTEtMS0w_00d48dcf-529d-4fa0-b1da-440595c4b043">0.82</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmZkYjliZGIwNjMwYjQ5MDU5NDVhZDVjYjYxYzJkZTVjL3RhYmxlcmFuZ2U6ZmRiOWJkYjA2MzBiNDkwNTk0NWFkNWNiNjFjMmRlNWNfMy0yLTEtMS0w_9c40084f-2ef8-4ac9-b98b-084838ea9b81">49.26</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmZkYjliZGIwNjMwYjQ5MDU5NDVhZDVjYjYxYzJkZTVjL3RhYmxlcmFuZ2U6ZmRiOWJkYjA2MzBiNDkwNTk0NWFkNWNiNjFjMmRlNWNfNC0yLTEtMS0w_4033480c-e416-4afb-8515-bc551ac4cad4">5.42</ix:nonNumeric> years</span></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id68b547ac32b41d281e6caabd72557e0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2014 Employee Stock Purchase Plan, or ESPP, features <ix:nonFraction unitRef="offeringperiod" contextRef="i5328ec671a74439b9a01511fe23d4b0c_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfOTcx_4f0add70-5cf4-46b0-add1-0fafd4d710a0">two</ix:nonFraction> <ix:nonNumeric contextRef="i5328ec671a74439b9a01511fe23d4b0c_D20210101-20210930" format="ixt-sec:durwordsen" name="pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTM5Mw_dcdc4989-5484-475c-aec7-6371ca944144">six-month</ix:nonNumeric> offering periods per year, running from January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at <ix:nonFraction unitRef="number" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTE2Mg_94659988-85da-4e22-aed8-4062145a6cf3">85</ix:nonFraction>% of the closing fair market value of the Company&#8217;s common stock on either the offering date or the purchase date, whichever is less. During the nine months ended September&#160;30, 2021, <ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTMyOA_6954d853-b38d-4e16-9461-5085ca6d6f1b">31,230</ix:nonFraction> shares were purchased and issued through the ESPP.</span></div></ix:continuation><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RleHRyZWdpb246MWFmZGUwMThmM2VkNGI1Zjk4MWU5MzdmYzhlNGI1OGJfMzky_ebd2dc5e-6951-402a-9bee-034ebdc51941" continuedAt="i9871e69db176446bbb4ab18012e5d6b8" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9871e69db176446bbb4ab18012e5d6b8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RleHRyZWdpb246MWFmZGUwMThmM2VkNGI1Zjk4MWU5MzdmYzhlNGI1OGJfMzg5_eeedde40-1c50-4282-9d6c-65c8772c0012" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the changes in the balances of the Company&#8217;s accumulated other comprehensive income  for the periods presented (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cfc444422b4d0b8bace3222b587d3c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfMi0yLTEtMS0w_fdd44975-a285-4834-bf2e-dc6b70645328">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e2148bdfe694503807898f469458f04_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfMi00LTEtMS0w_876f0ff7-37f8-4839-88dd-e2ac5cead45a">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net unrealized (loss) gain on investments, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07396e9494fe4b07b8f774fda1e27972_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfMy0yLTEtMS0w_c3b1ab68-ec90-48d1-882d-a2c7dbc3ea48">168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5902e825304da38fccdd9ed1ae795a_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfMy00LTEtMS0w_b3ec3857-42d3-4f9c-9140-7addc4a78095">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07396e9494fe4b07b8f774fda1e27972_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNC0yLTEtMS0w_51bb897b-f671-4849-8e5c-402a5d69d2e6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5902e825304da38fccdd9ed1ae795a_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNC00LTEtMS0w_bc29ec47-248d-4a7a-b3c3-3546715aa62a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07396e9494fe4b07b8f774fda1e27972_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNS0yLTEtMS0w_e88ed860-e100-4c75-9fff-be2166e3c2fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5902e825304da38fccdd9ed1ae795a_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNS00LTEtMS0w_b23a2664-2696-4ad5-a5cf-46cecda90ab7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467a1ba8b0124cfd8c7cc340c2972c7b_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNi0yLTEtMS0w_27166b6f-67ad-4a87-9f1a-bd58a096a234">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0600e264da44709593ccef5269505a_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNi00LTEtMS0w_5fd6f04c-255d-4cb2-a9cc-fbf9578af0b5">847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net of a $<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RleHRyZWdpb246MWFmZGUwMThmM2VkNGI1Zjk4MWU5MzdmYzhlNGI1OGJfMjYz_623891ef-8877-483e-9397-7b8f4c4c3af6">54</ix:nonFraction>&#160;thousand tax benefit for the nine months ended September 30, 2021. There was <ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RleHRyZWdpb246MWFmZGUwMThmM2VkNGI1Zjk4MWU5MzdmYzhlNGI1OGJfMzI4_9abb2985-506f-4445-92fc-61edbb739892">no</ix:nonFraction> tax benefit for the nine months ended September 30, 2020.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;12&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RleHRyZWdpb246YWM0NjM4MTZiNTc4NGI1MWFmZjk3ZGJjNGMwNjQyZGFfMjA4NA_4d70c8e1-9424-45df-8f51-6ba30df8b961" continuedAt="iffc246df9c104954a37cee808dfcdab6" escape="true">NET INCOME (LOSS) PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iffc246df9c104954a37cee808dfcdab6" continuedAt="i7bf2a35a0e044076994a329ed424b814"><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period. </span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs, the purchase of shares from the ESPP (using the treasury stock method) and the conversion of the excess conversion value on the 2022 Notes and 2025 Notes, if applicable. As discussed in Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company has the option to pay cash for the aggregate principal amount due upon the conversion of its 2022 Notes and 2025 Notes. Since it is the Company&#8217;s intent to settle the principal amount of its 2022 Notes and 2025 Notes in cash, the potentially dilutive effect of such notes on net income (loss) per share is computed under the treasury stock method. ASU 2020-06 will require the Company to use the if-converted method upon adoption; this new accounting pronouncement has not been adopted as of September&#160;30, 2021. For additional information regarding ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive.</span></div></ix:continuation><div style="margin-bottom:10pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7bf2a35a0e044076994a329ed424b814"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RleHRyZWdpb246YWM0NjM4MTZiNTc4NGI1MWFmZjk3ZGJjNGMwNjQyZGFfMjA4MQ_67f6f2fa-5669-4dc5-8995-81f643d6b5c6" escape="true"><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per common share for the three and nine mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended September&#160;30, 2021 and 2020 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMy0xLTEtMS0w_4ab62241-6dda-4fd0-9d50-68ffa62feddb">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMy0zLTEtMS0w_2f857d73-314b-4696-822c-a5f4b7ca689d">130,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMy01LTEtMS0w_b5743bed-9a3f-4a03-ab39-90a89e4fd4f5">47,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMy03LTEtMS0w_ee7e38f3-417a-47ad-b7e5-27eb4806c74d">131,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTItMS0xLTEtMA_949a351e-25d4-417c-9ce6-4328034ec4c8">44,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTItMy0xLTEtMA_b802a402-43f9-4866-97d6-fb95e1eb966b">42,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTItNS0xLTEtMA_60d0e619-a60b-4267-8c9e-aa6d79708096">44,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTItNy0xLTEtMA_f8ed2592-70b7-4d3b-8b2f-a57d715680b7">42,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6dded111553f45dd92378a98c5010846_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTQtMS0xLTEtMA_14f5fe2d-51f1-4814-9311-20cf400d813a">827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i209c230b69834a4f9828d93ba9cc1546_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTQtMy0xLTEtMA_c8211827-5a70-4bb7-865e-ee1b5232de1e">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTQtNS0xLTEtMA_996f9823-9bf0-4a9a-85f1-6f60fd975c62">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6964e7e50494461b1d33b90b39ec59c_D20200101-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTQtNy0xLTEtMA_b6e3c530-5ee5-46cd-a732-4a598abb710f">740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1e6c6a626ee44d78fb558955fed8879_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTUtMS0xLTEtMA_5ca410b2-99f1-4f21-8aaf-b6f965033e3d">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d5224e2aea7473884ab3ab568b5f742_D20200701-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTUtMy0xLTEtMA_dee2295d-efc5-44e8-af58-43620b7e4948">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTUtNS0xLTEtMA_8a68c555-3853-433e-8a90-e94d6bdb8437">337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i801a1368563548fbb45290c7dfac40e5_D20200101-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTUtNy0xLTEtMA_d71328f0-cfb1-41cf-b34f-1119698d46af">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTYtMS0xLTEtMA_b813eb79-65cc-4c4d-85da-cb28758a2162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTYtMy0xLTEtMA_8b1b1dde-0ed2-411b-bad1-f50b6598a0c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTYtNS0xLTEtMA_5748173e-a315-4317-9191-360b7db6b6bc">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTYtNy0xLTEtMA_8a4fbfd8-f467-4ae7-8976-9db066699a71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice17e0310ab24f19b2477b0ea0b3a5c0_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTctMS0xLTEtMA_e0bdecd6-26bb-4e39-969a-f65b22e93b7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia740c361205a40759e18df3c4efb99c0_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTctMy0xLTEtMA_c781254f-5083-4824-82ff-9ee2addcc575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5328ec671a74439b9a01511fe23d4b0c_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTctNS0xLTEtMA_4713a001-66a8-4f96-a35d-0f724e529e3b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34dbb38f3ce9455eb1cb8977c02233dc_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTctNy0xLTEtMA_b647fdc9-249e-4718-8b7c-494251e1f843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTktMS0xLTEtMA_b5d5565a-4e23-457a-9686-e6fd60321439">45,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTktMy0xLTEtMA_982514ad-41d9-4207-aff6-6f01f2ffea67">44,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTktNS0xLTEtMA_e13cf0c0-4907-48cd-9ac9-7226a1bf6918">45,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTktNy0xLTEtMA_b8da081a-68eb-4e0c-995f-c94a0b97e0df">43,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjEtMS0xLTEtMA_2ede25ed-c1b2-4e0d-8eda-2a8881d3cddc">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjEtMy0xLTEtMA_c50f1440-c5c9-4783-94ad-e043b1d2ecd9">3.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjEtNS0xLTEtMA_d11a8db3-25cb-4d59-ac2b-789aa334dfcd">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjEtNy0xLTEtMA_c883b450-ebad-4aa4-a71a-4d66c3257748">3.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjItMS0xLTEtMA_bbb8470e-8d59-485c-84b3-3ebe81043587">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjItMy0xLTEtMA_e9728798-183f-4ba1-9766-f9c9f413c4e3">2.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjItNS0xLTEtMA_ff306559-70f3-4358-814f-652b485eba5d">1.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjItNy0xLTEtMA_29596a1d-25b6-4f0c-99ed-421cc548c51b">3.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RleHRyZWdpb246YWM0NjM4MTZiNTc4NGI1MWFmZjk3ZGJjNGMwNjQyZGFfMjA4Mw_82f8d8bb-8eb4-4085-8e74-e94baaf8f9fb" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following outstanding stock options, RSUs and ESPP purchase options are antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if70609b807c243d69cf4588104e93c8e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMi0xLTEtMS0w_3f90e4c1-7e62-4ee9-8878-f734c99a9dd0">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0de685059e34723aae25d71c24a900e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMi0zLTEtMS0w_d3c1bb5c-5151-46e4-90cd-7fc71d3dd3ef">3,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3131d879dea24998a48d584e912182a8_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMi01LTEtMS0w_9eb18cb1-822c-4e4b-892d-7045df6073eb">1,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41071c327f3940bcaa6bb301df7449bb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMi03LTEtMS0w_2380e60e-4bf7-4157-bf44-d3fe98872600">4,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i218c8db6e4454704b8551048521d1831_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMy0xLTEtMS0w_84e8834d-26dc-4e36-b4cf-d281463b593d">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d011ec249be45c6b176c6e6198e14cb_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMy0zLTEtMS0w_57017dae-cedc-4ff7-b43a-8a3b458967ab">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25c7e05a7fd8439d9f81fa9758796010_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMy01LTEtMS0w_17e5342d-f5d0-4a49-8a32-e32a15a1d86a">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9405e0168d3f418b965e10a3716b7c99_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMy03LTEtMS0w_13d77024-6312-48c3-a21d-c0e397b916b6">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average ESPP purchase options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8f66d871d84f43da953d2139367fb6c2_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNS0xLTEtMS0w_9513b250-041d-49cb-aae9-8ca502a14413">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d79527b591541b2b5cd79a11907b8f0_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNS0zLTEtMS0w_8aad258b-6940-4950-8463-b11e777107ad">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80f1189a3be5472b8a2576c5439a28f3_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNS01LTEtMS0w_d62ef8dd-f208-4712-8519-ad64cb265ac9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia50e9b50fa274d2a877186bfca0244a2_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNS03LTEtMS0w_1e048644-856e-4ca0-bbd9-8b6084bb23ea">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNy0xLTEtMS0w_44db0509-fa15-4184-93cc-b3ef6f1f8eb4">3,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNy0zLTEtMS0w_6da13914-99b5-447e-9795-f215363dc13f">3,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNy01LTEtMS0w_f6851c59-cd4a-4e83-89c1-28ae63cfd556">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNy03LTEtMS0w_793087b7-231d-4a10-90bc-439591309658">4,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTMxNQ_cd04503c-4eea-415a-8bbc-c8b18c8d5067" continuedAt="i1390a9e12bbf4d62848a726cfd114c4a" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1390a9e12bbf4d62848a726cfd114c4a"><ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTMyNA_44fb44c1-e802-4e52-a059-3c58fd647a08" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfMy0xLTEtMS0w_0ffbd4f4-771b-4a9a-b234-2460a1bd7c13">25,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfMy0zLTEtMS0w_a828102b-6cbe-458e-9917-132aa9b4251e">8,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfMy01LTEtMS0w_c0d779c2-4565-46fe-a662-d6415dcf0580">66,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfMy03LTEtMS0w_9b6539a4-06e1-434f-a8e2-ae5156a01b76">10,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNC0xLTEtMS0w_fbefa9df-6232-49a1-9720-d23c31983142">936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNC0zLTEtMS0w_05da2bf3-35ee-4283-94b4-46aa3620c502">2,025</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNC01LTEtMS0w_19bbfc30-c4c1-426c-a71c-1efff2f2ad59">4,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNC03LTEtMS0w_9765cac5-bebc-4ead-9437-ddd663783dd1">2,759</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNS0xLTEtMS0w_387a064e-760c-4ce5-bb71-7dcd109ba1be">24,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNS0zLTEtMS0w_0cb629e0-96e9-4b81-9939-fe3e8bb0de96">6,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNS01LTEtMS0w_4f801855-b5b2-4a9c-a830-2ad459c0efb8">62,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNS03LTEtMS0w_65a7a4b0-6f06-47ce-8956-329a32a594f2">7,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021 and 2020, the Company had income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTcw_9c06645d-69e7-406e-baed-4427d105d72f">6.6</ix:nonFraction> million and an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMjEy_4aac36dc-16a9-40ca-acb0-9f340802c127">124.0</ix:nonFraction> million, respectively. For the nine months ended September&#160;30, 2021 and 2020, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMzA5_d2e2812a-1b0e-47ad-a9ca-1faa684072e6">15.5</ix:nonFraction>&#160;million and an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMzE2_8cd32c17-93bb-48a7-af1a-7d46f3c0a4ae">123.6</ix:nonFraction>&#160;million, respectively. The income tax expense for the three and nine months ended September&#160;30, 2021 represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items including equity compensation and non-deductible capital losses. The income tax benefit for the three and nine months ended September&#160;30, 2020 represents the full release of a $<ix:nonFraction unitRef="usd" contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTA5OTUxMTYzMDE5MQ_2c7c746c-581a-4500-9b3e-755923f0ae41"><ix:nonFraction unitRef="usd" contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTA5OTUxMTYzMDE5MQ_c6722980-87fa-4cf6-a125-44cd6bac0847">124.6</ix:nonFraction></ix:nonFraction>&#160;million valuation allowance on the Company&#8217;s net domestic deferred assets as the Company determined that there was sufficient positive evidence to conclude that it was more likely than not that domestic deferred taxes were realizable.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the nine months ended September 30, 2021, the Company recorded a valuation allowance against U.S. capital loss carryforwards since it is more likely than not the tax benefit related to the losses are not realizable. The Company continues to maintain a full valuation allowance on its foreign net deferred tax balances.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;14&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="pcrx:CommercialPartnersAndAgreementsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83Ni9mcmFnOmM1OGQwNTlhMjFkOTQyNDdiMGVhNjQwYmE4YjM1MTNmL3RleHRyZWdpb246YzU4ZDA1OWEyMWQ5NDI0N2IwZWE2NDBiYThiMzUxM2ZfMTkzNg_2c39ca00-5bf5-4228-acdb-0cf541a70ef2" continuedAt="i273efb969b0c4b0993bcbe4efcef6f83" escape="true">COMMERCIAL PARTNERS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i273efb969b0c4b0993bcbe4efcef6f83"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eurofarma Laboratories S.A.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company entered into a distribution agreement with Eurofarma Laboratories S.A., or Eurofarma, for the development and commercialization of EXPAREL in Latin America. Under the terms of the agreement, Eurofarma obtained the exclusive right to market and distribute EXPAREL in 19 countries in Latin America, including Argentina, Brazil, Colombia, and Mexico. In addition, Eurofarma is responsible for regulatory filings for EXPAREL in these countries. The Company received a $<ix:nonFraction unitRef="usd" contextRef="i84c3ad13f8e54c46b927d50478630682_D20210601-20210630" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:CollaborativeArrangementUpfrontPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83Ni9mcmFnOmM1OGQwNTlhMjFkOTQyNDdiMGVhNjQwYmE4YjM1MTNmL3RleHRyZWdpb246YzU4ZDA1OWEyMWQ5NDI0N2IwZWE2NDBiYThiMzUxM2ZfNTU5_5ac94896-f2f2-4681-b669-140d75384b9a">0.3</ix:nonFraction>&#160;million upfront payment that is partially refundable upon certain circumstances and will receive royalties based on Eurofarma&#8217;s future commercialization of the product and is also eligible to receive milestone payments that are triggered by the achievement of certain regulatory and commercial events. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i2483978d600d43fb9c6740ff2f1e9576_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="pcrx:CollaborativeArrangementMilestonePaymentsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83Ni9mcmFnOmM1OGQwNTlhMjFkOTQyNDdiMGVhNjQwYmE4YjM1MTNmL3RleHRyZWdpb246YzU4ZDA1OWEyMWQ5NDI0N2IwZWE2NDBiYThiMzUxM2ZfODc5_72042f57-9668-49cf-98af-663e83b901bc">0.1</ix:nonFraction>&#160;million of collaborative licensing and milestone revenue in its condensed consolidated statements of operations during the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nuance Biotech Co. Ltd.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#8217;s intellectual property against the risk of a generic product. Dissolution costs of $<ix:nonFraction unitRef="usd" contextRef="i90361c4a697b4f3e8ec723bc57e3d9f1_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83Ni9mcmFnOmM1OGQwNTlhMjFkOTQyNDdiMGVhNjQwYmE4YjM1MTNmL3RleHRyZWdpb246YzU4ZDA1OWEyMWQ5NDI0N2IwZWE2NDBiYThiMzUxM2ZfMTY0MA_a690446b-7156-4001-ba3b-4d5d42cc797c">3.0</ix:nonFraction>&#160;million were included in other operating expenses in the condensed consolidated statements of operations for the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verve Medical Products, Inc.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company entered into a licensing agreement with Verve Medical Products, Inc. for the distribution of iovera&#176; in Canada.</span></div></ix:continuation><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;15&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfNDAyMw_9f5242bf-fa02-4413-be27-211ba7ddae0a" continuedAt="ic0f1fa02df64484397a2ed3c5d97dc53" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic0f1fa02df64484397a2ed3c5d97dc53" continuedAt="ic3349b2a80ba44f8a2815df5b69035ed"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Milestone Litigation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#8220;Pacira CryoTech&#8221;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#8220;Fortis&#8221;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#8220;Merger Agreement&#8221;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $<ix:nonFraction unitRef="usd" contextRef="id61de8fd8c9c45ff8bf796f260c5aa91_D20201001-20201031" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfMTc0MA_7f57260f-4699-42ab-89d9-4c2caa954d71">30.0</ix:nonFraction>&#160;million, plus attorneys&#8217; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Trial Commitments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Food and Drug Administration, or FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic3349b2a80ba44f8a2815df5b69035ed"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the United Kingdom&#8217;s withdrawal from the E.U., the agreed pediatric plan will be applicable in the United Kingdom , or UK, as well. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#8220;PLAY&#8221;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and UK to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency (MHRA) are still reviewing the Type II variations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-Time Termination Benefits</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has communicated to a select number of employees a commitment to provide one-time termination benefits in the event that a facility closure occurs. The Company is recognizing these expenses ratably over the remaining service period required. The Company currently estimates the total cost of these one-time benefits to be approximately $<ix:nonFraction unitRef="usd" contextRef="i8646cd5d4ebd458eab95c35c7d751c0e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfNDAxNA_60130dea-51ad-490e-9f81-5033ae3d9b84">1.1</ix:nonFraction>&#160;million. In the three and nine months ended September&#160;30, 2021, the Company has recognized $<ix:nonFraction unitRef="usd" contextRef="ib40c1bb9a8fc4a669685de4cfb5bf7b9_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfMTY0OTI2NzQ0NjUyNg_2abf9eba-7b17-486e-a3bc-a72a231775a9"><ix:nonFraction unitRef="usd" contextRef="ia161505b12724f2880a881bb1734845e_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfMTY0OTI2NzQ0NjUyNg_a2258fe6-87e7-4898-a54c-ccdc0aff3eda">0.4</ix:nonFraction></ix:nonFraction>&#160;million in one-time termination charges, which are included in acquisition-related (gains) charges, product discontinuation and other in the condensed consolidated statements of operations.</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="icaeef1316917487cbff6510a43882f61_1334"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE&#160;16&#8212;<ix:nonNumeric contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zMjk4NTM0OTEyNTA2_bdd98c1f-8f9e-403c-80c9-2b41f875d8b5" continuedAt="idfdceab1e79044acb9fc27abf5c6a094" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="idfdceab1e79044acb9fc27abf5c6a094"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2021, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), with Merger Sub and Flexion. Flexion is a biopharmaceutical company focused on the discovery, development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, or OA, the most common form of arthritis. Flexion has an approved product, ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(triamcinolone acetonide extended-release injectable suspension), which it markets in the U.S. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of OA knee pain. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, on October 22, 2021, Merger Sub commenced the Offer to acquire all of the outstanding Flexion Shares at an offer price of (i) $<ix:nonFraction unitRef="usdPerShare" contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg0NjE5_96543a97-dfa1-45e1-b617-f69b4d3b80db">8.50</ix:nonFraction> per Flexion Share in cash, net of applicable withholding taxes and without interest, plus (ii) <ix:nonFraction unitRef="shares" contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022" decimals="INF" format="ixt-sec:numwordsen" name="pcrx:ClassOfWarrantOrRightNumberOfRightsIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg2Njc3_2f338db5-1136-48a8-bae9-b811036f9cdb">one</ix:nonFraction> contingent value right per Flexion Share, or CVR, which will represent the right to receive one or more contingent payments up to $<ix:nonFraction unitRef="usdPerShare" contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022" decimals="2" name="pcrx:BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg0NjUw_7ec87829-ab34-49e4-b413-61c6a2a59590">8.00</ix:nonFraction> per Flexion Share in the aggregate upon the achievement of specified milestones on or prior to December 31, 2030. The Company estimates the initial cash payment to acquire all of the Flexion Shares will be approximately $<ix:nonFraction unitRef="usd" contextRef="ie0268792e6564110bccd672d24ff62fc_D20211022-20211022" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg2NDcx_4c956216-20bb-4957-905c-1ef4947a88bb">450.0</ix:nonFraction>&#160;million, which excludes merger transaction fees. In addition, the Company will assume Flexion&#8217;s cash and outstanding debt at the closing of the merger. As of September 30, 2021, Flexion&#8217;s outstanding debt and termination fees less cash was estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="i37b82df25f6144808d51c0943de2a4b1_I20211015" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg2NDU1_dc10d8f3-0b18-41fc-acef-ecb523521f94">144.0</ix:nonFraction>&#160;million. The total consideration payable pursuant to the Merger Agreement will be dependent upon, among other things, the total number of Flexion Shares outstanding at the expiration of the Offer and at the closing of the merger as well as the closing price of the Flexion Shares on the trading day immediately prior to the closing of the merger. The Company anticipates funding such cash requirements from its available cash and cash equivalents and short-term investments and expects to explore debt financing to supplement its cash position. The fair value of the CVRs will be estimated and recognized at the closing of the merger and will be paid if and when milestones are met.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligation of the Company to purchase Flexion Shares tendered in the Offer is subject to the conditions set forth in the Merger Agreement, including but not limited to, that (i) the number of Flexion Shares tendered together with other Flexion shares owned by the Merger Sub would represent more than <ix:nonFraction unitRef="number" contextRef="if6c3e67d137a4219a0590be4ad4df4ae_I20211118" decimals="2" name="pcrx:BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV80OTQ3ODAyNDE4MjM4_e6502baf-b5a5-420c-947f-723be18c4da2">50</ix:nonFraction>% of the total Flexion Shares at the time of the expiration of the Offer, and (ii) the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired or been terminated.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing description of the Merger Agreement and the transactions contemplated thereby do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the Merger Agreement, a copy of which is attached as </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm">Exhibit 2.1 to </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm">the Company</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm">&#8217;s Current Report on Form 8-K dated October 11, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 27</span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MANAGEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and in accordance with the rules and regulations of the United States Securities and Exchange Commission, or SEC.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form&#160;10-Q and certain other communications made by us contain forward-looking statements within the meaning of Section&#160;21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, including statements about our growth and future operating results and trends, development of products, strategic alliances and intellectual property. For this purpose, any statement that is not a statement of historical fact should be considered a forward-looking statement. We often use the words &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;can&#8221; and similar expressions to help identify forward-looking statements. We cannot assure you that our estimates, assumptions and expectations will prove to have been correct. These forward-looking statements include, among others, statements about: the anticipated consummation of the acquisition of Flexion (as defined below) and the timing and benefits thereof, Pacira&#8217;s strategy, plans, objectives, expectations (financial or otherwise) and intentions, future financial results and growth potential, anticipated product portfolio, development programs, patent terms and other statements that are not historical facts. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks related to Pacira&#8217;s ability to complete the Merger (as defined below) on the proposed terms and schedule or at all; whether the tender offer conditions will be satisfied; whether sufficient stockholders of Flexion tender their Flexion Shares (as defined below) in the Offer (as defined below); the outcome of legal proceedings that may be instituted against Flexion and/or others relating to the transaction; the failure (or delay) to receive the required regulatory approvals relating to the transaction; the possibility that competing offers will be made; risks associated with acquisitions, such as the risk that the businesses will not be integrated successfully, that such integration may be more difficult, time-consuming or costly than expected or that the expected benefits of the transaction will not occur; the commercial success of ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (triamcinolone acetonide extended-release injectable suspension); risks related to future opportunities and plans for Flexion and its products, including uncertainty of the expected financial performance of Flexion and its products, including whether the milestones will ever be achieved; disruption from the proposed transaction, making it more difficult to conduct business as usual or maintain relationships with customers, employees or suppliers; the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement (as defined below); the possibility that if Pacira does not achieve the perceived benefits of the proposed transaction as rapidly or to the extent anticipated by financial analysts or investors, the market price of Pacira&#8217;s shares could decline; the impact of the COVID-19 pandemic on elective surgeries, our manufacturing and supply chain, global and U.S. economic conditions, and our business, including our revenues, financial condition and results of operations; the success of our sales and manufacturing efforts in support of the commercialization of EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(bupivacaine liposome injectable suspension) and iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">; the rate and degree of market acceptance of EXPAREL and iovera&#176;; the size and growth of the potential markets for EXPAREL and iovera&#176; and our ability to serve those markets; our plans to expand the use of EXPAREL and iovera&#176; to additional indications and opportunities, and the timing and success of any related clinical trials for EXPAREL and iovera&#176;; the related timing and success of United States Food and Drug Administration, or FDA, supplemental New Drug Applications, or sNDAs; our plans to evaluate, develop and pursue additional multivesicular liposome-based product candidates; the approval of the commercialization of our products in other jurisdictions; clinical trials in support of an existing or potential multivesicular liposome-based product; our commercialization and marketing capabilities and our ability to successfully construct an additional EXPAREL manufacturing suite in San Diego, California; the outcome of any litigation; the ability to successfully integrate any future acquisitions into our existing business, including Flexion; the recoverability of our deferred tax assets and assumptions associated with contingent consideration payments. Important factors could cause our actual results to differ materially from those indicated or implied by forward-looking statements. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, and readers should not rely on the forward-looking statements as representing our views as of any date subsequent to the date of the filing of this Quarterly Report on Form&#160;10-Q.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include items mentioned herein and the matters discussed and referenced in Part&#160;I-Item&#160;1A. &#8220;Risk Factors&#8221; included in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm">Annual Report on Form 10-K for the year ended December 31, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> and in other reports as filed with the SEC.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references to &#8220;Pacira,&#8221; &#8220;we,&#8221; the &#8220;Company,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this Quarterly Report on Form&#160;10-Q refer to Pacira BioSciences,&#160;Inc. and its subsidiaries.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_85"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is the industry leader in our commitment to non-opioid pain management and regenerative health solutions to improve patient care along the neural pain pathway. EXPAREL, our long-acting, local analgesic was commercially launched in April 2012. EXPAREL utilizes our unique and proprietary multivesicular liposome delivery technology that encapsulates drugs without altering their molecular structure and releases them over a desired period of time. EXPAREL is indicated in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia, and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia in the United States, or U.S., and in the European Union, or E.U., as a brachial plexus block and femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults. Since its initial approval in 2011 for single-dose infiltration, more than nine million patients have been treated with EXPAREL. We drop-ship EXPAREL directly to the end-user based on orders placed to wholesalers or directly to us, and there is no product held by wholesalers. In April 2019, we acquired iovera&#176;, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves, which we sell directly to end users. The iovera&#176; system is highly complementary to EXPAREL as a non-opioid therapy that alleviates pain by disrupting pain signals being transmitted to the brain from the site of injury or surgery.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to pursue the expanded use of EXPAREL and iovera&#176; in additional procedures; progress our earlier-stage product candidate pipeline; advance regulatory activities for EXPAREL, iovera&#176; and other product candidates; invest in sales and marketing resources for EXPAREL and iovera&#176;; expand and enhance our manufacturing capacity for EXPAREL and iovera&#176;; and invest in complementary products, businesses and technologies.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Flexion Therapeutics, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2021, Pacira entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with Oyster Acquisition Company Inc., a Delaware corporation and wholly owned subsidiary of Pacira (&#8220;Merger Sub&#8221;) and Flexion Therapeutics, Inc., a Delaware corporation (&#8220;Flexion&#8221;). Flexion is a biopharmaceutical company focused on the discovery, development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, or OA, the most common form of arthritis. Flexion has an approved product, ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(triamcinolone acetonide extended-release injectable suspension), which it markets in the U.S. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint), injection indicated for the management of OA knee pain. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, on October 22, 2021, Merger Sub commenced a cash tender offer (the &#8220;Offer&#8221;), to acquire all of the outstanding shares of common stock of Flexion, $0.001 par value per share (the &#8220;Flexion Shares&#8221;), at an offer price of (i) $8.50 per Flexion Share in cash, net of applicable withholding taxes and without interest, plus (ii) one contingent value right per Flexion Share, which will represent the right to receive one or more contingent payments up to $8.00 per Flexion Share in the aggregate upon the achievement of specified milestones on or prior to December 31, 2030. We estimate the initial cash payment to acquire all of the Flexion Shares will be approximately $450.0 million, which excludes Merger transaction fees. In addition, we will assume Flexion&#8217;s cash and outstanding debt at the closing of the Merger. As of September 30, 2021, Flexion&#8217;s outstanding debt and termination fees less cash is estimated to be approximately $144.0 million. The total consideration payable pursuant to the Merger Agreement will be dependent upon, among other things, the total number of Flexion Shares outstanding at the expiration of the Offer and at the closing of the Merger as well as the closing price of the Flexion Shares on the trading day immediately prior to the closing of the Merger. We anticipate funding such cash requirements from our available cash and cash equivalents and short-term investments and expect to explore debt financing to supplement our cash position. The fair value of the CVRs will be estimated and recognized at the closing of the Merger and will be paid if and when milestones are met.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligation of Merger Sub to purchase Flexion Shares tendered in the Offer is subject to the conditions set forth in the Merger Agreement, including, but not limited to, that the (i) number of Flexion Shares validly tendered in accordance with the terms of the Offer and not validly withdrawn (but excluding Flexion Shares tendered pursuant to guaranteed delivery procedures that have not been &#8220;received&#8221;, as defined by Section 251(h)(6)(f) of the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;)), when considered together with all other Flexion Shares owned by Merger Sub and its affiliates, would represent at least one Flexion Share more than 50% of the total number of Flexion Shares at the time of the expiration of the Offer, which is currently scheduled for the end of the day, one minute following 11:59 p.m., Eastern Time, on November 18, 2021, subject to extension in certain circumstances as permitted by the Merger Agreement, and (ii) waiting period (or any extension thereof) applicable to the Offer under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder having expired or been terminated.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the Offer and subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Merger Sub will merge with and into Flexion, with Flexion surviving as a wholly owned subsidiary of Pacira (the &#8220;Merger&#8221;). Pacira will effect the Merger after consummation of the Offer pursuant to Section 251(h) of the DGCL. At the effective time of the Merger (the &#8220;Effective Time&#8221;), the Flexion Shares then outstanding (other than Flexion Shares held (i) by Flexion or its subsidiaries (including Flexion Shares held in Flexion&#8217;s treasury), (ii) by Pacira, Merger Sub, any other direct or indirect wholly owned subsidiary of Pacira, or (iii) by stockholders of Flexion who have properly exercised and perfected their statutory rights of appraisal under the DGCL) will each be converted into the right to receive the Offer Price.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total consideration payable pursuant to the Merger Agreement will be dependent upon the total number of Flexion Shares outstanding at the expiration of the Offer and the Effective Time.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Merger Agreement and the transactions contemplated thereby do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the Merger Agreement, a copy of which is attached as </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm">Exhibit 2.1 to Pacira&#8217;s Current Report on Form 8-K dated October 11, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Novel Coronavirus (COVID-19) Pandemic</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, our net product sales were negatively impacted by the COVID-19 pandemic due to the significant postponement or suspension in the scheduling of elective surgical procedures resulting from public health guidance and government directives. Elective surgery restrictions began to lift on a state-by-state basis in April 2020, allowing our net product sales to return to year-over-year growth in June 2020. However, while many restrictions have since eased with COVID-19 vaccines now widely available, the elective surgery market faced additional pandemic-related challenges in August and September 2021 due to regional surges in COVID-19 delta variant cases, staffing shortages and surgical fatigue from care teams addressing significant procedure backlogs. While these challenges began to subside in October 2021, it is unknown how long it will take the elective surgery market to normalize, or if restrictions on elective procedures will recur due to COVID-19 variant strains or otherwise. Our manufacturing sites are operational and have implemented new safety protocols and guidelines as recommended by federal, state and local governments. To date, there have been no material impacts to our supply chain. With the reopening of all 50 states, the ability of our sales representatives to renew their in-person engagement efforts, in conjunction with remote efforts, has occurred across all sites of care, with more focus on physician offices and ambulatory surgery centers. Our offices have re-opened with strict safety and hygiene guidelines implemented, and we continue to support remote working as appropriate.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 situation remains dynamic and is subject to rapid and possibly material changes due to variant strains or otherwise. It is not clear what the potential effects may be to our business going forward, including the impact on our revenues, results of operations or financial condition, particularly if pandemic conditions exacerbate over an extended period of time, including if states return to placing restrictions on elective surgical procedures, if patients are still reluctant to schedule an elective surgical procedure regardless of whether or not they have received a COVID-19 vaccine. Additional negative impacts may also arise from the COVID-19 pandemic that we are unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted, including the availability and efficacy of COVID-19 vaccines, the willingness of the general public to get vaccinated and the impact of variant strains, such as the Delta variant, on the elective surgery market. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to actively monitor the situation and implement measures recommended by federal, state or local authorities, or that we determine are in the best interests of our patients, employees, partners, suppliers, shareholders and stakeholders. For a description of risks facing the Company that relate to the COVID-19 pandemic or any other future pandemic, epidemic or outbreak of contagious disease, see our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm">Annual Report on Form 10-K for the year ended December 31, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Highlights</span></div><div><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;  In July 2021, we announced new data on the ability of the iovera&#176; system to reduce pain, opioid consumption and length of stay, or LOS, following total knee arthroplasty, or TKA. The findings show that patients receiving preoperative iovera&#176; as part of a multimodal pain management protocol reduced both opioid intake and in-hospital pain while optimizing outcomes during the 6-week recovery period after TKA. The results of the study, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A Multimodal Pain Management Protocol Including Preoperative Cryoneurolysis for Total Knee Arthroplasty to Reduce Pain, Opioid Consumption, and Length of Stay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, were published in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arthroplasty Today</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See below for more details.</span></div><div style="padding-left:31.5pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;  In September 2021, we announced that full results of our Phase 3 PLAY study of EXPAREL administered via infiltration in pediatric patients undergoing spinal or cardiac surgeries were published in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Journal of Clinical </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anesthesia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The study characterized the safety and pharmacokinetics, or PK, of EXPAREL in pediatric patients. The PK profile was comparable across age groups and generally consistent with the profile in adult patients. No safety concerns were identified at a dose of 4 mg/kg.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;  In September 2021, we announced that we have successfully completed process validation on our custom 200-liter manufacturing suite in Swindon, England, and that commercial production of EXPAREL is underway at this suite. The suite was developed under a partnership with Thermo Fisher Scientific Pharma Services, or Thermo Fisher.</span></div><div><span><br/></span></div><div style="padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">In October 2021, we received two Notices of Allowance from the U.S. Patent and Trademark Office. One patent claims chemical composition of EXPAREL and the other claims a novel manufacturing process. After issuance, we will submit the composition patent for listing  in the FDA Approved Drug Products with Therapeutic Equivalence Evaluations (the &#8220;Orange Book&#8221;). The patents will have an expiration date of January 22, 2041.</span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPAREL</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., EXPAREL is currently indicated in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia, and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks. In the E.U., EXPAREL is indicated as a brachial plexus block and femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Label Expansion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatrics</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the FDA approved our sNDA to expand the EXPAREL label to include use in patients 6 years of age and older for single-dose infiltration to produce postsurgical local analgesia. With this approval, EXPAREL is the first and only FDA approved long-acting local analgesic for the pediatric population as young as age six. The sNDA was based on the positive data from the Phase 3 PLAY study of EXPAREL infiltration in pediatric patients undergoing spinal or cardiac surgeries. Overall findings were consistent with the pharmacokinetic and safety profiles for adult patients with no safety concerns identified at a dose of 4 mg/kg. The PLAY study enrolled 98 patients to evaluate safety and the pharmacokinetics of EXPAREL for two patient groups: patients aged 12 to less than 17 years and patients aged 6 to less than 12 years. Per FDA guidance, the primary objectives of the PLAY study were to evaluate the pharmacokinetics and safety of EXPAREL.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are working with the FDA to finalize a regulatory pathway to expand the EXPAREL label for patients less than six years of age, as well as the administration of EXPAREL as a nerve block in the pediatric setting. We are also working with both the European Medicines Agency, or EMA, and Medicines and Healthcare Products Regulatory Agency, or MHRA, to align our pediatric clinical studies across all regions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nerve Block in Lower Extremity Surgery</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we announced topline results from our Phase 3 study for nerve block in lower extremity surgeries (known as &#8220;STRIDE&#8221;) that compared an EXPAREL nerve block in lower extremity surgeries to a bupivacaine lower extremity nerve block in patients undergoing foot and ankle surgeries. EXPAREL administered as combined sciatic (in popliteal fossa) and saphenous (in adductor canal) nerve blocks did not demonstrate statistical significance for the study&#8217;s primary endpoint of reduction in cumulative pain scores from 0 to 96 hours as measured by the area under the curve versus bupivacaine HCl. EXPAREL did achieve statistical significance versus bupivacaine HCl for secondary endpoints of reducing cumulative pain scores from 24 to 96 hours post-surgery (p&lt;0.001) and total opioid consumption from 24 to 96 hours post-surgery (p&lt;0.01). EXPAREL also achieved statistical significance versus bupivacaine HCl for area under the curve cumulative pain scores from 12 to 96 hours (p&lt;0.02). The EXPAREL group achieved and maintained mild pain at 36 hours (Least Square Mean NRS 3.0) while bupivacaine HCl was in the moderate range (Least Square Mean NRS 4.7).</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no clinically relevant safety issues observed in STRIDE, specifically no reports of falls and no serious adverse events observed in the study. The results from STRIDE informed the design of two follow-up studies that are now underway and place us on track for an sNDA submission in 2022.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EXPAREL Global Expansion</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have defined a global expansion strategy for EXPAREL that we believe provides us with the opportunity to increase our revenue and leverage our fixed cost infrastructure. In the E.U., EXPAREL was granted marketing authorization in November 2020. The launch of EXPAREL is now underway through a contracted sales force with shipments expected to begin in the fourth quarter of 2021. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Commission decision is applicable to all 27 E.U. member states plus the United Kingdom, or UK, Iceland, Norway and Liechtenstein. Despite the UK&#8217;s withdrawal from the E.U., this approval is recognized by the UK Medicines and Healthcare products Regulatory Agency.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we entered into a distribution agreement with Eurofarma Laboratories S.A., or Eurofarma, for the development and commercialization of EXPAREL in Latin America. Under the terms of the agreement, Eurofarma obtained the exclusive right to market and distribute EXPAREL in 19 countries in Latin America, including Argentina, Brazil, Colombia, and Mexico. In addition, Eurofarma is responsible for regulatory filings for EXPAREL in these countries. We will receive royalties based on Eurofarma&#8217;s future commercialization of the product and are also eligible to receive milestone payments that are triggered by the achievement of certain regulatory and commercial events.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In China, we had an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, for the development and commercialization of EXPAREL. In April 2021, we and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguarded our intellectual property against the risk of a generic product. For more information, refer to Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Partners</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently pursuing regulatory approval for EXPAREL in Canada based on our labeling discussions with Health Canada.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">iovera&#176;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The iovera&#176; System</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The iovera&#176; system is highly complementary to EXPAREL as a novel cold technology that administers a non-pharmacological nerve block to safely and immediately deliver long-term, non-opioid pain control. The iovera&#176; handheld device is 510(k) cleared in the U.S., has a CE mark in the E.U. and is cleared for marketing in Canada for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with arthritis of the knee for up to 90 days. We are currently awaiting regulatory clearance for our second-generation iovera&#176; device in the E.U., which we anticipate launching in targeted European countries in the first quarter of 2022.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our commercial strategy for iovera&#176; focuses on two broad market segments. First, iovera&#176; and EXPAREL for opioid-sparing pain management for the TKA patient, with iovera&#176; being administered before surgery and EXPAREL administered during surgery. We are enrolling patients into our PREPARE study that will evaluate iovera&#176; and EXPAREL for TKA. As many as 30% of patients with presurgical osteoarthritis of the knee use prescription opioids. With iovera&#176;, our goal is to provide patients with several months of non-opioid pain control to allow them to prepare for surgery with an appropriate regimen. We also believe that EXPAREL plus iovera&#176; for postsurgical pain control could support rapid functional recovery. In parallel, we are launching an Innovation in Genicular Outcomes Registry (&#8220;IGOR&#8221;) to capture real-world evidence for use in TKA procedures with leading academic and orthopedic centers of excellence.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second target market is iovera&#176; for OA patients who have failed conservative treatments, such as non-steroidal anti-inflammatory drugs or viscosupplementation, and are seeking drug-free, opioid-free, surgery-free pain management for several months. We are targeting patients who are seeking an active lifestyle, as well as patients who desire to delay surgery for personal or medical reasons.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also encouraged by usage of iovera&#176; in other areas. Key opinion leaders in orthopedics, spine and anesthesia are interested in replacing heat-based radiofrequency ablation with iovera&#176; cold therapy. There is interest across a wide range of treatment opportunities such as low back pain, spine, spasticity and rib fracture. We intend to use investigator-initiated studies and grants to develop data across these areas.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Knee Arthroplasty</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In July 2021, we announced new data on the ability of the iovera&#176; system to reduce pain, opioid consumption and LOS following TKA. The findings show that patients receiving preoperative iovera&#176; as part of a multimodal pain management protocol reduced both opioid intake and in-hospital pain while optimizing outcomes during the 6-week recovery period after TKA. The results of the study, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A Multimodal Pain Management Protocol Including Preoperative Cryoneurolysis for Total Knee Arthroplasty to Reduce Pain, Opioid Consumption, and Length of Stay</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, were published in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arthroplasty Today</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This retrospective analysis utilized data from patients who underwent TKA by a single surgeon at one center. Patients who received iovera&#176; before TKA were compared with a historical control group including patients who underwent TKA without iovera&#176;. Both groups received a similar perioperative multimodal pain management protocol. The primary outcome was opioid intake at various time points from hospital stay to 6 weeks after discharge. Additional outcomes included pain, LOS, and range of motion. The study population included a total of 267 patients, with 169 patients in the iovera&#176; group and 98 patients in the control group.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results showed that patients undergoing TKA who received iovera&#176; compared to those who did not demonstrated a significant:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decrease in daily opioid consumption, as the iovera&#176; group had 51% lower daily morphine milligram equivalents (MMEs) than the control group (47 vs 97 MMEs; ratio estimate, 0.49 [95% confidence interval (CI), 0.43-0.56]; P&lt;.0001)</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decrease in mean and maximum pain scores (P&lt;.0001)</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decrease in average hospital LOS (P&lt;0.0001), with 17% of iovera&#176; patients having an overall LOS of 2 or more days, compared with 99% of patients in the control group (P&lt;.0001)</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Greater range of motion, as indicated by greater flexion degree at discharge (P&lt;.0001)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of this study are consistent with findings from clinical trial and retrospective data that indicate a multimodal pain management protocol with preoperative iovera&#176; treatment of the superficial genicular nerves reduced opioid consumption without increasing pain for up to 12 weeks after TKA compared with a standard multimodal pain management protocol.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Osteoarthritis of the Knee</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a growing body of clinical data demonstrating success with the iovera&#176; treatment for OA of the knee. There are 14 million individuals in the U.S. who have symptomatic knee OA, and nearly two million are under the age of 45. Surgical intervention is typically a last resort for patients suffering from OA of the knee. In one study, the majority of the patients suffering from OA of the knee experienced pain relief beyond 150 days after being treated with iovera&#176;.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary findings demonstrated reductions in opioids, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The daily morphine equivalent was significantly lower at 72 hours (p&lt;0.05), 6 weeks (p&lt;0.05) and 12 weeks (p&lt;0.05), with an overall 35 percent reduction in daily morphine equivalents across the 12-week postoperative period in the iovera&#176; treatment group.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients who were administered iovera&#176; were far less likely to take opioids six weeks after surgery. The number of patients taking opioids six weeks after TKA in the control group was three times the number of patients taking opioids in the cryoanalgesia group (14% vs. 44%, p&lt;0.01).</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients in the iovera&#176; group demonstrated a statistically significant reduction in pain scores from their baseline pain scores at 72 hours (p&lt;0.05) and at 12 weeks (p&lt;0.05).</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe these data validate iovera&#176; as a clinically meaningful non-opioid alternative for patients undergoing TKA or those with symptomatic knee OA, and that iovera&#176; offers the opportunity to provide patients with non-opioid pain control well in advance of any necessary surgical intervention through a number of key product attributes:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is safe and effective with immediate pain relief that can last for months as the nerve regenerates over time;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is repeatable;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; does not risk damage to the surrounding tissue; </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; is a convenient handheld device with a single-use procedure-specific smart tip; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">iovera&#176; can be delivered precisely using ultrasound guidance or an anatomical landmark.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the combination of iovera&#176; and EXPAREL will become the preferred procedural solution that will empower patients and their healthcare providers to take control of the patients&#8217; OA journey, while minimizing the need for opioids. We will be investing in key clinical studies to demonstrate the synergy of iovera&#176; and EXPAREL to manage pain while reducing or eliminating opioids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iovera&#176; Global Expansion</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we entered into a licensing agreement with Verve Medical Products, Inc. for the distribution of iovera&#176; in Canada. We expect to begin selling iovera&#176; in Canada in the fourth quarter of 2021. Additionally, we expect to begin selling iovera&#176; in the E.U. through a contracted sales force in the first quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Portfolio and Product Candidate Pipeline</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are building our product development pipeline using a combination of internally and externally sourced innovation of non-opioid and regenerative medicine franchises to address medical needs along the neural pain pathway.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internal clinical team is currently supporting the following clinical and regulatory initiatives:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-24.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Two Phase 3 registration studies for EXPAREL in lower extremity nerve block. </span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-26.87pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Expansion of the EXPAREL label to include pediatric nerve block program and an indication for patients under six years of age.</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-29.64pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">EXPAREL collaborative studies at leading academic hospitals, such as Henry Ford Hospital, Shriners Hospitals and Cleveland Clinic. </span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-29.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">New opportunities, such as an EXPAREL Stellate Ganglion block for treatment of post-operative dysrhythmia from open heart procedures.</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-26.33pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The PREPARE study of EXPAREL and iovera&#176; in TKA procedures. </span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-29.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Pilot studies in potential new iovera&#176; markets, such as Spasticity, Restless Leg Syndrome and Rib Fracture.</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-31.87pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Early-stage multivesicular liposome-based assets, including a Phase 1 study for low-dose DepoBupivacaine administered intrathecally, as well as preclinical activities for a DepoDexamethasone asset and a high potency DepoBupivacaine with an extended duration of action.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business development activities have focused on investing in the musculoskeletal and chronic pain spaces. We will continue to advance these two key franchises with a focus on the knee and spine continuums of care while bridging to chronic pain. We plan to use a combination of strategic investments that support promising early-stage platforms, like our investments in GeneQuine Biotherapeutics GmbH, or GeneQuine, and Spine BioPharma, LLC, or Spine BioPharma, and in-licensing or acquisition transactions to build out a complementary pipeline of externally-sourced innovation.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current product portfolio and internal product candidate pipeline, along with anticipated milestones over the next 12 to 18 months, are summarized in the table below:</span></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><img src="pcrx-20210930_g2.jpg" alt="pcrx-20210930_g2.jpg" style="height:546px;margin-bottom:5pt;vertical-align:text-bottom;width:765px"/></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Study designs have not been finalized for infiltration in pediatric patients aged 0 to 6 years old or for nerve block in pediatric patients.</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">- NOCITA</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> is a registered trademark of Aratana Therapeutics, Inc., a wholly owned subsidiary of Elanco Animal Health, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pacira Innovation and Training Center of Tampa</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we opened the Pacira Innovation and Training center of Tampa (the &#8220;PITT&#8221;). We designed this facility to help advance clinician understanding of the latest local, regional and field block approaches for managing pain. The PITT provides an unparalleled training environment for healthcare providers working to reduce or eliminate patient exposure to opioids. The PITT supports a full range of educational events to advance clinician understanding of the latest local, regional, and field block approaches for managing pain and reducing or eliminating exposure to opioids. Our corporate headquarters are also located at the PITT.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PITT consists of approximately 13,000 square-feet of fully adaptable space and is equipped with state-of-the-art technology and audio/visual capabilities and features several distinct training spaces including a simulation lab equipped with seven ultrasound scanning stations; a lecture hall featuring a 4&#189;-foot tall by 24-foot wide liquid crystal display video wall to support live, virtual and even global presentations; and a green-screen broadcast studio designed to livestream content with single or multiple hosts.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our EXPAREL programs, we are hosting ongoing workshops to train new users on best practice techniques for iovera&#176; administration at the PITT. Led by healthcare professionals, these labs include didactic lectures and hands-on trainings including live model nerve scanning and identification using ultrasound and peripheral nerve stimulation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At no fee to the organization, the PITT also serves as a venue for national anesthesia provider organizations to host their own workshops and training sessions to educate healthcare providers.</span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three and Nine Months Ended September&#160;30, 2021 and 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales consist of sales of EXPAREL in the U.S., our bupivacaine liposome injectable suspension to Aratana Therapeutics, Inc., or Aratana, for veterinary use in the U.S. and sales of iovera&#176; in the U.S. Licensing, milestone and royalty revenues are from our collaborative licensing agreements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our revenues during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.568%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.568%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.996%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;EXPAREL</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Bupivacaine liposome injectable suspension</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total EXPAREL / bupivacaine liposome <br/>&#160;&#160;&#160;&#160;&#160;&#160;injectable suspension net product sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,609&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,163&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,128&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;iovera&#176;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total net product sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,889&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,850&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Collaborative licensing and milestone revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,673&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXPAREL revenue grew&#160;7% and 27% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively, primarily due to increases of 6% and 26% in gross vial volume and increases of 4% in gross selling price per unit in both periods, partially offset by the sales mix of EXPAREL vial sizes. Although the demand for EXPAREL has continued to increase primarily as a result of ambulatory surgery centers and anesthesiologists broadening the use of long-acting EXPAREL regional approaches as a foundation of multimodal opioid-minimization strategies that enable shifting inpatient procedures to 23-hour sites of care, the elective surgery market faced additional pandemic-related challenges in August and September 2021 due to regional surges in COVID-19 delta variant cases, staffing shortages and surgical fatigue from care teams addressing significant procedure backlogs. The three and nine months ended September 30, 2020 were impacted by the suspension of elective surgeries due to the COVID-19 pandemic. EXPAREL utilization remained above the overall sharp decline in elective surgical procedures relative to pre-pandemic baseline levels, due to increased use in the outpatient setting. EXPAREL utilization in emergency procedures also continued to grow.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bupivacaine liposome injectable suspension revenue increased 52% and 1% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively, and the related royalties increased 56% in the three months and were flat in the nine months ended September&#160;30, 2021 versus 2020 as a result of the timing of orders placed by Aratana for veterinary use.&#160;&#160;&#160;&#160;</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net product sales of iovera&#176; increased 53% and 76% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively. These increases were primarily due to an increased iovera&#176; sales force and the impact that the COVID-19 pandemic had on the first nine months of 2020. Thus far, we have seen the greatest iovera&#176; demand as a pain relief for patients in advance of TKA procedures and in chronic pain management, particularly for people with mild to severe osteoarthritis of the knee.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any renewed government suspension of, or reluctance of patients to have, elective surgeries would impact our future sales of EXPAREL and iovera&#176; during the ongoing COVID-19 pandemic.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collaborative licensing and milestone revenue recognized in the nine months ended September&#160;30, 2021 was the result of a portion of an upfront payment recognized under our distribution agreement with Eurofarma for the development and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercialization of EXPAREL in Latin America. For more information, see Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Partners,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements included herein.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of activity with respect to our sales related allowances and accruals related to EXPAREL for the nine months ended September&#160;30, 2021 and 2020 (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Returns Allowances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prompt Payment Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Wholesaler Service Fees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume<br/>Rebates and<br/>Chargebacks</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,578)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,870)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,633)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Returns Allowances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prompt Payment Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Wholesaler Service Fees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume<br/>Rebates and<br/>Chargebacks</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,997)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,736)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,992)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total reductions to gross product sales from sales-related allowances and accruals were $23.3 million and $18.4 million, or 5.8% and 5.8% of gross product sales, for the nine months ended September 30, 2021 and 2020, respectively. Sales-related allowances and accruals as a percentage of gross product sales were flat between periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Goods Sold</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold primarily relates to the costs to produce, package and deliver our products to customers. These expenses include labor, raw materials, manufacturing overhead and occupancy costs, depreciation of facilities, royalty payments, quality control and engineering.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our cost of goods sold and gross margin during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"></td><td style="width:35.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.423%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Gross margin</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin decreased one percentage point in the three months ended September 30, 2021 versus 2020, mainly due to higher usage of manufacturing supplies at our UK manufacturing facility and capacity expansion costs for EXPAREL and iovera&#176;, partially offset by the impact of an EXPAREL price increase. Gross margin increased one percentage point in the nine months ended September&#160;30, 2021 versus 2020 due to the impact of an EXPAREL price increase and reduction in inventory reserves, partially offset by capacity expansion costs for EXPAREL and iovera&#176;.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses primarily consist of costs related to clinical trials and related outside services, product development and other research and development costs, including Phase 4 trials that we are conducting to generate new data for EXPAREL and iovera&#176; and stock-based compensation expense. Clinical and preclinical development expenses include costs for clinical personnel, clinical trials performed by third-parties, toxicology studies, materials and supplies, database management and other third-party fees. Product development and manufacturing capacity expansion expenses include development costs for our products, which include personnel, equipment, materials and contractor costs for process development and product candidates, development costs related to significant scale-ups of our manufacturing capacity and facility costs for our research space. Regulatory and other expenses include regulatory activities related to unapproved products </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and indications, medical information expenses and related personnel. Stock-based compensation expense relates to the costs of stock option grants, awards of restricted stock units, or RSUs, and our employee stock purchase plan, or ESPP.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a breakout of our research and development expenses during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.267%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical and preclinical development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product development and manufacturing <br/>capacity expansion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,047&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total research and development expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;% of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total research and development expense decreased 21% and 9% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical and preclinical development expense decreased 25% in the three months ended September&#160;30, 2021 versus 2020, due to the completion of our lower extremity nerve block (&#8220;STRIDE&#8221;) clinical trial, as well as a break in the enrollment for our iovera&#176; and EXPAREL TKA (&#8220;PREPARE&#8221;) trial to adjust for a protocol amendment. PREPARE trial enrollment is expected to resume in the fourth quarter of 2021. In the nine months ended September&#160;30, 2021 versus 2020, the 7% increase was due to our PREPARE trial, as well as the ongoing enrollment and completion of our STRIDE trial. This increase was partially offset by the completion of our Phase 4 C-Section (&#8220;CHOICE&#8221;) trial, as well as the completion of our EXPAREL clinical trial for pectoral field block in breast augmentation. In addition, we made the strategic decision to conclude enrollment in our spine (&#8220;FUSION&#8221;) study due to protocol feasibility given the rapid evolution of medical practice for spinal procedures. The data from approximately 65 FUSION study subjects will be used to inform future studies for this patient population.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product development and manufacturing capacity expansion expense decreased 16% and 23% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively. In the three months ended September 31, 2021 versus 2020, the decreases were due to non-recurring Research and Development facility expenses in 2020. In the nine months ended September&#160;30, 2021, the decreases were mainly attributable to the completion of the significant scale-up of our manufacturing capacity at the Thermo Fisher site in Swindon, England.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory and other expense decreased 25% in the three months ended September&#160;30, 2021 versus 2020. Regulatory expenses remained relatively the same, while other research and development expenses decreased with lower publication spend for EXPAREL and iovera&#176; abstracts, as well as decreased iovera&#176; clinical data registry activities. For the nine months ended September&#160;30, 2021 versus 2020, regulatory expenses decreased 10% as a result of the finalization of our Marketing Authorization Application (MAA) with the EMA.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation decreased by 17% and 9% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively, primarily due to fewer equity awards outstanding for research and development personnel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses primarily consist of compensation and benefits for our sales force and personnel that support our sales, marketing, medical and scientific affairs operations, commission payments to our marketing partners for the promotion and sale of EXPAREL and iovera&#176;, expenses related to communicating the health outcome benefits of EXPAREL and iovera&#176;, and educational programs for our customers. General and administrative expenses consist of compensation and benefits for and legal, finance, regulatory activities related to approved products and indications, compliance, information technology, human resources, business development, executive management and other supporting personnel. It also includes professional fees for legal, audit, tax and consulting services. Stock-based compensation expense relates to the costs of stock option grants, RSU awards and our ESPP.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our selling, general and administrative expenses during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:39.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.648%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,170&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total selling, general and administrative expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,807&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,142&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,683&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;% of total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total selling, general and administrative expenses decreased&#160;7% and increased 5% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses decreased 21% and 6% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively. The decreases were driven by the termination of our co-promotion agreement with DePuy Synthes Sales, Inc. effective January 2021. Partially offsetting the decreases were higher compensation expenses due to an expanded sales force and set-up costs for our new E.U. sales force. We are continuing our marketing investment in EXPAREL, which includes educational initiatives and programs related to the impact of opioids and postsurgical pain management and our national advocacy campaign designed to educate patients about non-opioid treatment options. Additionally, we continue our investment in clinician training in the use of EXPAREL and  iovera&#176; at our PITT training facility in Tampa, Florida. We also continue to invest in marketing initiatives and customer outreach for iovera&#176;.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased 27% and 30% in the three and nine months ended September&#160;30, 2021 versus 2020, respectively. The increase in the three months ended September&#160;30, 2021 was primarily related to due diligence costs incurred for the proposed acquisition of Flexion and other legal expenditures. The increase in the nine months ended September&#160;30, 2021 was due to increased legal costs, which reflected an insurance recovery of $2.1&#160;million that was received in 2020 for legal expenditures related to a since-resolved Department of Justice inquiry, and maintenance costs for network updates.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased 1% and 11% in the three and nine months ended September&#160;30, 2021 and 2020, respectively, primarily due to an increase in the number of unvested grants outstanding. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the amortization of acquired intangible assets during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.266%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Amortization of acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the April 2019 acquisition of MyoScience, Inc., or MyoScience, (the &#8220;MyoScience Acquisition&#8221;), we acquired intangible assets consisting of developed technology and customer relationships, with estimated useful lives of 14 and 10 years, respectively. These amounts are amortized on a straight line basis. For more information, see Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related (Gains) Charges, Product Discontinuation and Other</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the costs related to the MyoScience Acquisition, product discontinuation activities and termination costs for our agreement with Nuance during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related (gains) charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,140)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,410)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product discontinuation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total acquisition-related (gains) charges, <br/>&#160;&#160;&#160;product discontinuation and other</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(714)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,599)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the MyoScience Acquisition, we recognized acquisition-related gains of $1.2&#160;million and $2.1&#160;million in the three and nine months ended September&#160;30, 2021, respectively, primarily related to changes in the fair value of contingent consideration. Partially offsetting these gains were $0.4&#160;million in one-time termination benefit expenses in the three and nine months ended September&#160;30, 2021. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements included herein, for more information. In the three and nine months ended September 30, 2020, we recognized acquisition-related charges in the amount of $0.8&#160;million and acquisition-related gains of $1.4&#160;million, respectively, primarily related to contingent consideration. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein, for information regarding the methods and key assumptions used in the fair value measurements of contingent consideration.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we entered into an agreement with Nuance to advance the development and commercialization of EXPAREL in China. In 2021, we agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards our intellectual property against the risk of a generic product. Dissolution costs of $3.0&#160;million were included in other operating expenses in the condensed consolidated statements of operations for the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding other expense, net during the periods indicated, including percent changes (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:34.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.488%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,708&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,202)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,470)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,111)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,173)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net decreased by 37% and increased 15% in&#160;the three and nine months ended September&#160;30, 2021 versus 2020, respectively. The most significant cost in total other expense, net represents interest expense. There was an increase in interest expense during the three and nine months ended September&#160;30, 2021 due to the increase in outstanding debt as a result of the issuance of $402.5 million aggregate principal of our 0.750% convertible senior notes due 2025, or 2025 Notes, in July 2020. In conjunction with the issuance of the new 2025 Notes, we incurred an $8.1&#160;million loss on early extinguishment of debt recognized as a result of the retirement of $185.0&#160;million aggregate principal of our existing 2.375% convertible senior notes due 2022, or 2022 Notes. In addition, our interest income decreased in the three and nine months ended September&#160;30, 2021 versus 2020 due to lower short-term interest rates. </span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net expense during the three months ended September&#160;30, 2021 was not significant. Other, net for the nine months ended September&#160;30, 2021 included a realized loss on the sale of our equity investment in TELA Bio, Inc., or TELA Bio, in the amount of  $2.6&#160;million. In the three and nine months ended September 30, 2020, we incurred unrealized gains of $2.8&#160;million on our TELA Bio investment. These unrealized gains were partially offset by foreign currency losses.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense (Benefit)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our income tax expense (benefit) during the periods indicated, including percent changes (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.413%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Increase / (Decrease)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Income tax expense (benefit)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,969)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,613)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Effective tax rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)% +</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)% +</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021 and 2020, we recorded income tax expense of $6.6 million and an income tax benefit of $124.0 million, respectively. For the nine months ended September&#160;30, 2021 and 2020, we recorded income tax expense of $15.5&#160;million and an income tax benefit of $123.6&#160;million, respectively. The significant change to the income tax provision for both the three and nine month periods was driven by the release of a full valuation allowance against domestic net deferred tax assets during the quarter ended September&#160;30, 2020. The income tax expense for the three and nine months ended September&#160;30, 2021 represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items including stock-based compensation and non-deductible capital losses. The income tax benefit for the three and nine months ended September&#160;30, 2020, respectively, represents a full release of $124.6&#160;million valuation allowance against net domestic deferred tax assets as we determined there was sufficient positive evidence to conclude it was more likely than not that domestic deferred taxes were realizable.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in December 2006, we have devoted most of our cash resources to manufacturing, research and development and selling, general and administrative activities related to the development and commercialization of EXPAREL. In addition, we acquired iovera&#176; as part of the MyoScience Acquisition in April 2019. We are highly dependent on the commercial success of EXPAREL, which we launched in April 2012. We have financed our operations primarily with the proceeds from the sale of convertible senior notes, common stock, product sales and collaborative licensing and milestone revenue. As of September&#160;30, 2021, we had an accumulated deficit of $206.8 million, cash and cash equivalents, short-term and long-term investments of $693.9 million and working capital of $596.6 million. We currently expect that our cash, short-term and long-term investments on hand will be adequate to cover any potential short-term liquidity needs, and that we would be able to access other sources of financing should the need arise, including the cash needed to purchase Flexion Shares tendered in the Offer and to consummate the Merger, in each case, if the offer is successful.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law in response to the COVID-19 pandemic. The CARES Act, among other things, allowed for certain measures to increase liquidity for businesses such as the deferral of employer payroll taxes, a tax credit for retaining employees and other provisions. We benefited from the provision to defer the payment of certain employer payroll taxes in the amount of $2.8&#160;million for the year ended December 31, 2020. One-half of these deferrals are due at each of December 31, 2021 and December 31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:73.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Cash Flows Data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Net increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,016&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, net cash provided by operating activities was $102.5 million, compared to $30.4 million during the nine months ended September&#160;30, 2020. The increase&#160;of $72.1 million was primarily attributable to an increase in gross margin on a 27% increase in EXPAREL net product sales, which were adversely impacted in the nine months ended September 30, 2020 by a suspension of elective surgeries caused by the COVID-19 pandemic. In 2021, there was also a contingent consideration payment to MyoScience securityholders of $7.0&#160;million, of which $5.7&#160;million has been classified as an operating cash outflow and $1.3&#160;million as a financing cash outflow versus a $15.0 million contingent consideration payment in 2020 of which $9.4 million was classified as an operating cash outflow and $5.6&#160;million as a financing cash outflow.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, net cash used in investing activities was $87.7 million, which reflected $42.9 million of short-term and long-term available-for-sale investment purchases (net of maturities) and purchases of fixed assets of $36.7 million. Major fixed asset purchases included equipment for a new 200-liter EXPAREL capacity expansion project at our Science Center Campus in San Diego, California, and continuing expenditures for our expanding EXPAREL manufacturing capacity in Swindon, England in partnership with Thermo Fisher. In addition, we invested $13.0&#160;million in equity investments in Coda Therapeutics, Inc. and GeneQuine, and also purchased a total of $4.2&#160;million in convertible notes from GeneQuine and Spine BioPharma. Further, we sold our investment in TELA Bio for net cash proceeds of $9.1&#160;million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2020, net cash used in investing activities was $195.3 million, which reflected $171.9 million of short-term and long-term investment purchases (net of maturities) and purchases of fixed assets of $23.4 million. Major fixed asset purchases included equipment for a new EXPAREL capacity expansion project at our Science Center Campus and continuing expenditures for expanding our EXPAREL manufacturing capacity in Swindon, England.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, net cash provided by financing activities was $19.3 million, which consisted of proceeds from the exercise of stock options of $19.0 million and $1.6 million from the issuance of shares through our ESPP, partially offset by the $1.3&#160;million financing component of the $7.0&#160;million contingent consideration payment made to MyoScience securityholders.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2020, net cash provided by financing activities was $211.9 million, which consisted of gross proceeds from the issuance of the 2025 Notes of $402.5 million, the exercise of stock options of $36.0 million and $1.4 million from the issuance of shares through our ESPP. In conjunction with the issuance of the 2025 Notes, we paid $12.5 million in financing costs and retired $185.0 million in aggregate principal amount of our 2022 Notes in privately-negotiated transactions for a total of $211.1 million of cash (including $1.2 million of accrued interest classified as an operating outflow). We also made $5.6 million of contingent consideration payments to MyoScience securityholders. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2025 Convertible Senior Notes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we completed a private placement of $402.5 million in aggregate principal amount of our 2025 Notes and entered into an indenture with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per annum, payable in arrears on February&#160;1 and August 1 of each year. The 2025 Notes mature on August 1, 2025. At September&#160;30, 2021, the outstanding principal on the 2025 Notes was $402.5 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion of the 2025 Notes, including information on convertibility factors, redemption, timeframes and balance sheet classification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Convertible Senior Notes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, we completed a private placement of $345.0 million in aggregate principal amount of our 2.375% convertible senior notes due 2022, or 2022 Notes, and entered into an indenture with respect to the 2022 Notes. The 2022 Notes accrue interest at a fixed rate of 2.375% per annum, payable semiannually in arrears on April&#160;1 and October&#160;1 of each year. The 2022 Notes mature on April 1, 2022, and since October 1, 2020, holders may convert their 2022 Notes at any time. In July 2020, we used part of the net proceeds from the issuance of the 2025 Notes discussed above to repurchase $185.0 million </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aggregate principal of the 2022 Notes in privately-negotiated transactions for an aggregate of approximately $211.1 million in cash, including accrued interest. At September&#160;30, 2021, the outstanding principal on the 2022 Notes was $160.0 million.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion of the 2022 Notes, including information on convertibility factors, redemption, timeframes and balance sheet classification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Capital Requirements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents, short-term and long-term investments and cash received from product sales will be sufficient to enable us to fund our operating expenses, capital expenditure requirements and payment of the interest and principal on any conversions of our 2022 Notes and 2025 Notes through the next 12 months. Our future use of operating cash and capital requirements will depend on many forward-looking factors, including, but not limited to, the following:</span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of the consummation of the acquisition of Flexion, which remains subject to the consummation of the Offer, the closing of the Merger and the satisfaction of certain conditions set forth in the Merger Agreement (See Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for more information);</span></div><div style="padding-left:4.5pt"><span><br/></span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of successfully integrating Flexion into our existing business and expanding the commercialization of ZILRETTA, which remains subject to the consummation of the Offer, the closing of the Merger and  the satisfaction of certain conditions set forth in the Merger Agreement (See Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for more information);</span></div><div style="padding-left:4.5pt"><span><br/></span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of the Milestone Payments under the CVR Agreement, which remains subject to the consummation of the Offer, the closing of the Merger and the satisfaction of certain conditions set forth in the Merger Agreement (See Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for more information);</span></div><div style="padding-left:4.5pt"><span><br/></span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic, including the amounts and delays of suspended elective surgical procedures, clinical trials and general economic conditions; </span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and our ability to successfully continue to expand the commercialization of EXPAREL and iovera&#176;, including outside of the U.S.;</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of expanding and maintaining our manufacturing facilities, including the current EXPAREL capacity expansion project at our Science Center Campus in San Diego, California;</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of potential remaining milestone payments to MyoScience security holders, which could be up to an aggregate of $48.0 million if certain regulatory and commercial milestones are met;</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of potential milestone payments to SkyePharma Holding, Inc., which could be up to an aggregate of $36.0 million if certain milestones pertaining to net sales of DepoBupivacaine products, including EXPAREL, are met, or upon the first commercial sale in the United Kingdom, France, Germany, Italy or Spain; </span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of additional strategic investments, including additional investments under existing agreements;</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of and extent to which the holders of our 2022 Notes and 2025 Notes elect to convert their notes;</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs related to legal and regulatory issues;</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of performing additional clinical trials for EXPAREL, including the additional pediatric trials required by the FDA and EMA as a condition of approval;</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of performing additional clinical trials for iovera&#176;;</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs for the development and commercialization of other product candidates; and</span></div><div style="margin-bottom:8pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in products, businesses and technologies.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may require additional debt or equity financing to meet our future operating and capital requirements. We have no committed external sources of funds, and additional equity or debt financing may not be available on acceptable terms, if at all. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, capital market disruptions or negative economic conditions, especially in light of the COVID-19 pandemic, may hinder our access to capital.</span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_97"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any material off-balance sheet arrangements as of September&#160;30, 2021, nor do we have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_100"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Use of Estimates </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for a discussion of recently issued accounting pronouncements and their impact or future potential impact on our financial results, if determinable. For a description of critical accounting policies that affect our significant judgments and estimates used in the preparation of our consolidated financial statements, refer to our most recent Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_103"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Contractual Obligations</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for a new lease described in Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein, there have been no material changes in our contractual obligations relating to our indebtedness, lease obligations and purchase obligations from those reported in our Annual Report on Form 10-K for the year ended December&#160;31, 2020. For more information on our contractual obligations and commercial commitments, see Part II, Item 7 in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm">Annual Report on Form 10-K for the year ended December 31, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contractual obligations are subject to change upon consummation of the Offer and the closing of the Merger, which remain subject to the satisfaction of certain conditions set forth in the Merger Agreement. See Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein, for more information.</span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of our cash equivalents and investment activities is to preserve principal while at the same time maximizing the income that we receive from our investments without significantly increasing risk. We invest in corporate bonds, commercial paper, asset-backed securities and U.S. Treasury and other government agency notes, which are reported at fair value. These securities are subject to interest rate risk and credit risk. This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate. For example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the interest rate later rises, we expect that the fair value of our investment will decline. A hypothetical 100 basis point increase in interest rates would have reduced the fair value of our available-for-sale securities at September&#160;30, 2021 by approximately $2.9 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our convertible senior notes are impacted by both the fair value of our common stock and interest rate fluctuations. As of&#160;September&#160;30, 2021, the estimated fair value of the 2025 Notes was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,086</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> per $1,000 principal amount and the estimated fair value of the 2022 Notes was $1,038 per $1,000 principal amount. See Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our condensed consolidated financial statements included herein for further discussion of our convertible senior notes, which bear interest at a fixed rate. At September&#160;30, 2021, all $402.5 million of principal remains outstanding on the 2025 Notes, and $160.0 million of principal remains outstanding on the 2022 Notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreements with certain vendors and partners that operate in foreign jurisdictions. The more significant transactions are primarily denominated in the U.S. Dollar, subject to an annual adjustment based on changes in currency exchange rates.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our accounts receivable are primarily concentrated with three large wholesalers of pharmaceutical products. In the event of non-performance or non-payment, there may be a material adverse impact on our financial condition, results of operations or net cash flow.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_109"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Rule 13a-15(b) under the Exchange Act, our management, including our Chief Executive Officer and Chairman and our Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. As defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, disclosure controls and procedures are controls and other procedures which are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chairman and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on that evaluation, our Chief Executive Officer and Chairman and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including the Chief Executive Officer and Chairman and our Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II &#8212; OTHER INFORMATION</span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information related to Item 1. Legal Proceedings, refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated financial statements included herein.</span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the factors discussed in Part I, Item 1A. &#8220;Risk Factors&#8221; in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm">Annual Report on Form 10-K for the year ended December 31, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which could materially affect our business, financial condition, cash flows or future results, including those related to the ongoing COVID-19 pandemic. Except as described below, there have been no material changes in our risk factors included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020. The risks described in our Annual Report on Form 10-K for the year ended December&#160;31, 2020 are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to realize the benefits from the acquisition of Flexion is substantially dependent on the commercial success of ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(triamcinolone acetonide extended-release injectable suspension)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and the cost savings resulting from the timely and effective integration of the operations of Pacira and Flexion.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to realize the benefits from the acquisition of Flexion is substantially dependent on our ability to successfully commercialize ZILRETTA. Combining with Pacira may not accelerate the growth and success of ZILRETTA. If we are unsuccessful at convincing hospitals and health care providers to increase their rate of adoption of ZILRETTA, our sales could be adversely affected, and our business could suffer.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our ability to realize the benefits from the acquisition of Flexion is substantially dependent on the cost savings resulting from the timely and effective integration of the operations Pacira and Flexion. The process of integrating the operations of Pacira and Flexion could encounter unexpected costs and delays, which include: the loss of key personnel; the loss of key customers; the loss of key suppliers; and unanticipated issues in integrating sales, marketing and administrative functions. If we are unable to timely and effectively integrate the operations of Pacira and Flexion, our costs could be adversely affected, and our business could suffer. Further, even if the integration is timely and effective, we may never realize the cost savings expected from the integration of the operations of our two companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The announcement and pendency of the Merger may have an adverse effect on our business, financial condition, operating results and cash flows.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2021, we entered into the Merger Agreement, relating to the proposed acquisition of Flexion. Following the completion of the Offer and subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Purchaser will merge with and into Flexion, with Flexion surviving as a wholly owned subsidiary of Pacira.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, (i) each share of Flexion&#8217;s common stock that is issued and outstanding immediately prior to the Effective Time (other than Excluded Shares (as defined in the Merger Agreement)) will cease to be outstanding and will be converted into the right to receive $8.50 per Share in cash, net of applicable withholding taxes and without interest (the &#8220;Cash Amount&#8221;), plus (ii) one contingent value right per Share (the &#8220;CVR&#8221;, and together with the Cash Amount, the &#8220;Offer Price&#8221;), which will represent the right to receive one or more contingent payments up to $8.00 per Flexion Share in the aggregate (the &#8220;Milestone Payments&#8221;) upon the achievement of specified milestones pursuant to the terms of the Contingent Value Right Agreement in the form attached as Exhibit C to the Merger Agreement (the &#8220;CVR Agreement&#8221;) as further described below under the heading&#8212;CVR Agreement.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, on October 22, 2021, Purchaser commenced the Offer to acquire all of the outstanding Flexion Shares, at an offer price of (i) $8.50 per Flexion Share in cash, net of applicable withholding taxes and without interest, plus (ii) one CVR per Flexion Share, which will represent the right to receive one or more contingent payments up to $8.00 per Flexion Share in the aggregate upon the achievement of specified milestones on or prior to December 31, 2030. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertainty about the effect of the proposed Merger on our employees, partners, customers and other third parties may disrupt our sales and marketing or other key business activities and may have a material adverse effect on our business, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial condition, operating results and cash flows. Current and prospective employees may experience uncertainty about their roles following the Merger, and this may have an effect on our corporate culture. There can be no assurance we will be able to attract and retain key talent to the same extent that we have previously been able to attract and retain employees. Any loss or distraction of such employees could have a material adverse effect on our business, financial condition and operating results.[2] In addition, we have devoted, and will continue to devote, significant management and other internal resources towards the completion of the Merger and planning for integration, which could materially adversely affect our business, financial condition, operating results and cash flows.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to complete the Merger in a timely manner or at all could negatively impact the market price of our common stock as it currently reflects an assumption that the transaction will be completed. It could also adversely affect our business, financial condition, operating results and cash flows.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Completion of the Merger is subject to conditions beyond our control that may prevent, delay or otherwise adversely affect its completion in a material way, including, but not limited to, those described herein.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger cannot be completed until the conditions to closing are satisfied or (if permissible under applicable law) waived. These conditions are more fully described in the Tender Offer Statement on Schedule TO filed with the SEC on October 22, 2021 (together with any amendments and supplements thereto). We cannot guarantee that the closing conditions set forth in the Merger Agreement will be satisfied or, even if satisfied, that no event of termination will take place.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if the Merger is significantly delayed or not completed, we may suffer other consequences that could adversely affect our business, results of operations and stock price, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we would have incurred significant costs in connection with the Merger that we would be unable to recover;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be subject to negative publicity or be negatively perceived by the investment or business communities; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be subject to additional legal proceedings related to the Merger;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any disruptions to our business resulting from the announcement and pendency of the Merger, including any adverse changes in our relationships with our customers, suppliers, other business partners and employees, may continue or intensify in the event the Merger is not consummated; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to take advantage of alternative business opportunities or effectively respond to competitive pressures.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that our business, financial condition, operating results and cash flows will not be adversely affected, as compared to our condition prior to the announcement of the Merger, if the Merger is not consummated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will incur transaction fees and costs in connection with the Merger.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we have incurred $1.0 million of expenses and fees for professional services and other transaction costs in connection with the Merger and expect to continue to incur additional costs. A material portion of these expenses are payable by us whether or not the Merger is completed. While we have assumed that a certain amount of transaction expenses will be incurred, factors beyond our control could affect the total amount or the timing of these expenses. Many of the expenses that will be incurred, by their nature, are difficult to estimate accurately. These expenses may exceed the costs historically borne by us. These costs could adversely affect our business, financial condition, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The patents and the patent applications that we have covering our multivesicular liposome products are limited to specific injectable formulations, processes and uses of drugs encapsulated in our multivesicular liposome drug delivery technology and our market opportunity for our product candidates may be limited by the lack of patent protection for the active ingredient itself and other formulations and delivery technology and systems that may be developed by competitors.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The active ingredient in EXPAREL is bupivacaine. Patent protection for the bupivacaine molecules themselves has expired and generic immediate-release products are available. As a result, competitors who obtain the requisite regulatory approval can offer products with the same active ingredient as EXPAREL so long as the competitors do not infringe any process, use or formulation patents that we have developed for drugs encapsulated in our multivesicular liposome drug delivery technology.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we are aware of at least one FDA-approved long-acting instillable bupivacaine product on the market which utilizes an alternative delivery system to EXPAREL. Such a product is similar to EXPAREL in that it also extends the duration of effect of bupivacaine, but achieves this clinical outcome using a completely different drug delivery system as compared to our multivesicular liposome drug delivery technology.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of patents and patent applications covering products in the same field as EXPAREL indicates that competitors have sought to develop and may seek to market competing formulations that may not be covered by our patents and patent applications. The commercial opportunity for EXPAREL could be significantly harmed if competitors are able to develop and commercialize alternative formulations of bupivacaine that are long-acting but outside the scope of our patents.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, because EXPAREL has been approved by the FDA, one or more third parties may challenge the patents covering this product, which could result in the invalidation or unenforceability of some or all of the relevant patent claims. For example, if a third-party files an Abbreviated New Drug Application, or ANDA, for a generic drug product containing bupivacaine and relies in whole or in part on studies conducted by or for us, the third-party will be required to certify to the FDA that either: (i)&#160;there is no patent information listed in the FDA&#8217;s Orange Book with respect to our NDA for EXPAREL; (ii)&#160;the patents listed in the Orange Book have expired; (iii)&#160;the listed patents have not expired, but will expire on a particular date and approval is sought after patent expiration or (iv)&#160;the listed patents are invalid or will not be infringed by the manufacture, use or sale of the third-party&#8217;s generic drug product. A certification that the new product will not infringe the Orange Book-listed patents for EXPAREL, or that such patents are invalid, is called a paragraph&#160;IV certification. If the third-party submits a paragraph&#160;IV certification to the FDA, a notice of the paragraph&#160;IV certification must also be sent to us once the third-party&#8217;s ANDA is accepted for filing by the FDA. We may then initiate a lawsuit to defend the patents identified in the notice. The filing of a patent infringement lawsuit within 45&#160;days of receipt of the notice automatically prevents the FDA from approving the third-party&#8217;s ANDA until the earliest of 30&#160;months or the date on which the patent expires, the lawsuit is settled or the court reaches a decision in the infringement lawsuit in favor of the third-party. If we do not file&#160;a patent infringement lawsuit within the required 45-day period, the third-party&#8217;s ANDA will not be subject to the 30-month stay. Litigation or other proceedings to enforce or defend intellectual property rights are often very complex in nature, may be very expensive and time-consuming, may divert our management&#8217;s attention from our core business and may result in unfavorable results that could adversely impact our ability to prevent third parties from competing with our products.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, we received a Paragraph IV Certification Notice Letter advising that eVenus Pharmaceutical Laboratories, Inc., or eVenus, of Princeton, New Jersey, submitted an Abbreviated New Drug Application, or ANDA, to the FDA seeking authorization for the manufacturing and marketing of a generic version of EXPAREL in the U.S. In the Notice Letter, eVenus alleges that the claims of an FDA Orange Book-listed patent are invalid, unenforceable and/or will not be infringed by eVenus&#8217;s manufacture, use, or sale of the product described in eVenus&#8217;s ANDA submission.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA published rigorous criteria for proving bioequivalence to multivesicular liposomal bupivacaine in February 2018. Matching comparative characteristics must be conducted on at least three batches of an ANDA product with at least one batch manufactured at commercial scale and include liposome composition, internal aqueous environment of the liposome and in vitro drug release rates.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently assessing the Notice Letter and have 45 days from the date of receipt to commence a patent infringement lawsuit against eVenus. In the event that we bring a patent infringement lawsuit against eVenus, the FDA would enter a 30-month stay of final approval of eVenus&#8217;s ANDA. We intend to vigorously defend our intellectual property rights relating to EXPAREL.</span></div><div><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFAULTS UPON SENIOR SECURITIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Not applicable.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="icaeef1316917487cbff6510a43882f61_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="icaeef1316917487cbff6510a43882f61_133"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBITS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed below are filed or furnished as part of this report.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-9302021xex311.htm">31.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer and Chairman pursuant to Rule&#160;13a-14(a)&#160;and 15d-14(a), as amended.*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-9302021xex312.htm">31.2</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Rule&#160;13a-14(a)&#160;and 15d-14(a), as amended.*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pcrx-9302021xex321.htm">32.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer and Chairman and Chief Financial Officer pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc. for the quarter ended September 30, 2021, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders&#8217; Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Condensed Notes to Consolidated Financial Statements.*</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (Formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:8pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:8pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denotes management contract or compensatory plan or arrangement.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 49</span></div></div></div><div id="icaeef1316917487cbff6510a43882f61_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icaeef1316917487cbff6510a43882f61_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACIRA BIOSCIENCES,&#160;INC.<br/>(REGISTRANT)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DAVID STACK</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHARLES A. REINHART, III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pacira BioSciences, Inc.  |  Q3 2021 Form 10-Q  |  Page 50</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>pcrx-9302021xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i91e1a25a5913426aaf15375048161fe8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David Stack, certify that&#58;</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">I have reviewed this quarterly report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. (the &#8220;Registrant&#8221;)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the Registrant and have&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">disclosed in this report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the Registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DAVID STACK</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>pcrx-9302021xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i831efbf65bf044cd8ed6886bf5265e0f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Charles A. Reinhart, III, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">I have reviewed this quarterly report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. (the &#8220;Registrant&#8221;)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the Registrant and have&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">disclosed in this report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the Registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; CHARLES A. REINHART, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>pcrx-9302021xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if84540d749a5425d9040ec65066b86af_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. &#167;1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C.&#160;&#167;1350, the undersigned certifies that this Quarterly Report on Form&#160;10-Q of Pacira BioSciences,&#160;Inc. for the quarter ended September&#160;30, 2021, fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Pacira BioSciences,&#160;Inc.</font></div><div style="text-indent:27pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DAVID STACK</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Stack</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:4.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.827%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; CHARLES A. REINHART, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles A. Reinhart, III</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>pcrx-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:72021cac-ffd9-4fc5-b071-994f9d22f7d5,g:6c0c4d51-64cc-433e-9997-2f3b5b13ef74-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pcrx="http://www.pacira.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.pacira.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pcrx-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.pacira.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical">
        <link:definition>1406401 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSDetails" roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails">
        <link:definition>2402402 - Disclosure - DESCRIPTION OF BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails">
        <link:definition>2406403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails">
        <link:definition>2407404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.pacira.com/role/REVENUE">
        <link:definition>2108103 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.pacira.com/role/REVENUETables">
        <link:definition>2309302 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDetails" roleURI="http://www.pacira.com/role/REVENUEDetails">
        <link:definition>2410405 - Disclosure - REVENUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.pacira.com/role/INVENTORIES">
        <link:definition>2111104 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.pacira.com/role/INVENTORIESTables">
        <link:definition>2312303 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.pacira.com/role/INVENTORIESDetails">
        <link:definition>2413406 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETS" roleURI="http://www.pacira.com/role/FIXEDASSETS">
        <link:definition>2114105 - Disclosure - FIXED ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETSTables" roleURI="http://www.pacira.com/role/FIXEDASSETSTables">
        <link:definition>2315304 - Disclosure - FIXED ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FIXEDASSETSDetails" roleURI="http://www.pacira.com/role/FIXEDASSETSDetails">
        <link:definition>2416407 - Disclosure - FIXED ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.pacira.com/role/LEASES">
        <link:definition>2117106 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.pacira.com/role/LEASESTables">
        <link:definition>2318305 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.pacira.com/role/LEASESNarrativeDetails">
        <link:definition>2419408 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails">
        <link:definition>2420409 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails">
        <link:definition>2421410 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1">
        <link:definition>2421410 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails">
        <link:definition>2422411 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2123107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2324306 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
        <link:definition>2425412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails" roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails">
        <link:definition>2426413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets Acquired During Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.pacira.com/role/DEBT">
        <link:definition>2127108 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.pacira.com/role/DEBTTables">
        <link:definition>2328307 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://www.pacira.com/role/DEBTNarrativeDetails">
        <link:definition>2429414 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofDebtDetails" roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails">
        <link:definition>2430415 - Disclosure - DEBT - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofInterestExpenseDetails" roleURI="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails">
        <link:definition>2431416 - Disclosure - DEBT - Schedule of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2132109 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2333308 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails">
        <link:definition>2434417 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>2435418 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" roleURI="http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails">
        <link:definition>2436419 - Disclosure - FINANICIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails">
        <link:definition>2437420 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails">
        <link:definition>2438421 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available For Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANS" roleURI="http://www.pacira.com/role/STOCKPLANS">
        <link:definition>2139110 - Disclosure - STOCK PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSTables" roleURI="http://www.pacira.com/role/STOCKPLANSTables">
        <link:definition>2340309 - Disclosure - STOCK PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails">
        <link:definition>2441422 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofStockBasedCompensationActivityDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails">
        <link:definition>2442423 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSNarrativeDetails" roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails">
        <link:definition>2443424 - Disclosure - STOCK PLANS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKPLANSScheduleofValuationAssumptionsDetails" roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails">
        <link:definition>2444425 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2145111 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2346310 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDetails" roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails">
        <link:definition>2447426 - Disclosure - STOCKHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHARE" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARE">
        <link:definition>2148112 - Disclosure - NET INCOME (LOSS) PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHARETables" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables">
        <link:definition>2349311 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails">
        <link:definition>2450427 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails">
        <link:definition>2451428 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.pacira.com/role/INCOMETAXES">
        <link:definition>2152113 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.pacira.com/role/INCOMETAXESTables">
        <link:definition>2353312 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails">
        <link:definition>2454429 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.pacira.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>2455430 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMERCIALPARTNERS" roleURI="http://www.pacira.com/role/COMMERCIALPARTNERS">
        <link:definition>2156114 - Disclosure - COMMERCIAL PARTNERS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMERCIALPARTNERSDetails" roleURI="http://www.pacira.com/role/COMMERCIALPARTNERSDetails">
        <link:definition>2457431 - Disclosure - COMMERCIAL PARTNERS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2158115 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2459432 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.pacira.com/role/SUBSEQUENTEVENTS">
        <link:definition>2160116 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://www.pacira.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>2461433 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pcrx_CollaborativeLicensingAndMilestoneRevenueMember" abstract="true" name="CollaborativeLicensingAndMilestoneRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AccountsReceivablePaymentTerms" abstract="false" name="AccountsReceivablePaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_ConcentrationRiskNumberOfProducts" abstract="false" name="ConcentrationRiskNumberOfProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_DebtInstrumentConvertibleConversionPremiumShares" abstract="false" name="DebtInstrumentConvertibleConversionPremiumShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pcrx_ContingentConsideration" abstract="false" name="ContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_MajorCustomerThreeMember" abstract="true" name="MajorCustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" abstract="false" name="DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt" abstract="false" name="ProceedsFromConvertibleOptionComponentOfConvertibleDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LongTermInvestmentsMember" abstract="true" name="LongTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FortisMember" abstract="true" name="FortisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" abstract="false" name="AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_UponFirstCommercialSaleInMajorEUCountryMember" abstract="true" name="UponFirstCommercialSaleInMajorEUCountryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentMarketPrice" abstract="false" name="DebtInstrumentMarketPrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" abstract="true" name="UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" abstract="false" name="AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ClassOfWarrantOrRightNumberOfRightsIssued" abstract="false" name="ClassOfWarrantOrRightNumberOfRightsIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member" abstract="true" name="DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" abstract="false" name="AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_MeasurementInputExpectedMilestonePaymentMember" abstract="true" name="MeasurementInputExpectedMilestonePaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" abstract="false" name="DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_SkyePharmaHoldingIncMember" abstract="true" name="SkyePharmaHoldingIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" abstract="true" name="StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_TELABioMember" abstract="true" name="TELABioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_CommercialPartnersAndAgreementsTextBlock" abstract="false" name="CommercialPartnersAndAgreementsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" abstract="false" name="DebtInstrumentConversionObligationPremiumOnCommonStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDue2022Member" abstract="true" name="ConvertibleSeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_CollaborativeArrangementMilestonePaymentsReceived" abstract="false" name="CollaborativeArrangementMilestonePaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_SecondLargestCustomerMember" abstract="true" name="SecondLargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" abstract="false" name="AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtConversionAndRedemptionTermsAxis" abstract="true" name="DebtConversionAndRedemptionTermsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_DebtRedemptionTermsonorafterApril12020Member" abstract="true" name="DebtRedemptionTermsonorafterApril12020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" abstract="false" name="BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" abstract="false" name="DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_ConvertibleSeniorNotesDue2025Member" abstract="true" name="ConvertibleSeniorNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_DebtInstrumentConvertibleAssumedBorrowingRate" abstract="false" name="DebtInstrumentConvertibleAssumedBorrowingRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_AchievementofRegulatoryMilestoneMember" abstract="true" name="AchievementofRegulatoryMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" abstract="false" name="TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" abstract="false" name="BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="pcrx_ThirdLargestCustomerMember" abstract="true" name="ThirdLargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MyoscienceAcquisitionMember" abstract="true" name="MyoscienceAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_SettlementPeriodConvertibleDebtConversionRequest" abstract="false" name="SettlementPeriodConvertibleDebtConversionRequest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_MilestonePayment" abstract="false" name="MilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" abstract="true" name="EXPARELbupivacaineliposomeinjectablesuspensionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LargestCustomerMember" abstract="true" name="LargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones" abstract="false" name="PotentialAdditionalDebtInvestmentUponAchievingMilestones" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" abstract="false" name="DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" abstract="false" name="AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" abstract="false" name="CompensationExpenseFromEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" abstract="false" name="DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_AchievementOfMilestoneDomain" abstract="true" name="AchievementOfMilestoneDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ContingentConsiderationNoncurrent" abstract="false" name="ContingentConsiderationNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_A2022ConvertibleSeniorNotesMember" abstract="true" name="A2022ConvertibleSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ForeignPropertyPlantAndEquipmentNet" abstract="false" name="ForeignPropertyPlantAndEquipmentNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember" abstract="true" name="AchievementOfDevelopmentAndCommercialMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_SpineBioPharmaLLCMember" abstract="true" name="SpineBioPharmaLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_AchievementOfMilestoneAxis" abstract="true" name="AchievementOfMilestoneAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_Compensationexpensefromstockoptionsemployees" abstract="false" name="Compensationexpensefromstockoptionsemployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_EquityMethodInvestmentsAndOtherAssets" abstract="false" name="EquityMethodInvestmentsAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member" abstract="true" name="DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_CodaBioTherapeuticsIncMember" abstract="true" name="CodaBioTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_EurofarmaLabatoriesSAMember" abstract="true" name="EurofarmaLabatoriesSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ContingentConsiderationCurrent" abstract="false" name="ContingentConsiderationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" abstract="true" name="MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" abstract="false" name="ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" abstract="true" name="DebtRedemptionTermsOnOrAfterAugust12023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" abstract="false" name="ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_ThreeLargestCustomersMember" abstract="true" name="ThreeLargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_CollaborativeArrangementUpfrontPayment" abstract="false" name="CollaborativeArrangementUpfrontPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_MajorCustomerTwoMember" abstract="true" name="MajorCustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FlexionMember" abstract="true" name="FlexionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_GeneQuineBiotherapeuticsGmbHMember" abstract="true" name="GeneQuineBiotherapeuticsGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_NuanceBiotechCo.Ltd.Member" abstract="true" name="NuanceBiotechCo.Ltd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_MajorCustomerOneMember" abstract="true" name="MajorCustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes" abstract="false" name="RetirementOfEquityComponentOfConvertibleSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pcrx_IoveraMember" abstract="true" name="IoveraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pcrx_ContingentConsiderationPaymentTerm" abstract="false" name="ContingentConsiderationPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" abstract="false" name="BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_ScheduleOfInterestExpenseTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pcrx_DebtConversionAndRedemptionTermsDomain" abstract="true" name="DebtConversionAndRedemptionTermsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>pcrx-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:72021cac-ffd9-4fc5-b071-994f9d22f7d5,g:6c0c4d51-64cc-433e-9997-2f3b5b13ef74-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a52a3e92-ceca-49e7-8126-c248c09dd4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0818eae4-6fa4-49b9-b7ca-a45fce691b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a52a3e92-ceca-49e7-8126-c248c09dd4f9" xlink:to="loc_us-gaap_Liabilities_0818eae4-6fa4-49b9-b7ca-a45fce691b7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_93c1cedc-3a38-4c68-a925-23901bf8e8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a52a3e92-ceca-49e7-8126-c248c09dd4f9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_93c1cedc-3a38-4c68-a925-23901bf8e8d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_250c935e-f889-491d-8108-818c3c7a2731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a52a3e92-ceca-49e7-8126-c248c09dd4f9" xlink:to="loc_us-gaap_StockholdersEquity_250c935e-f889-491d-8108-818c3c7a2731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_40903982-48a9-4059-9983-41e452df5503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_62dc2a2a-01ee-452e-adb2-4ff1131cb84a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40903982-48a9-4059-9983-41e452df5503" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_62dc2a2a-01ee-452e-adb2-4ff1131cb84a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c82065d9-8d77-4dae-b2d3-b94513a7629d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40903982-48a9-4059-9983-41e452df5503" xlink:to="loc_us-gaap_ShortTermInvestments_c82065d9-8d77-4dae-b2d3-b94513a7629d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8198c95b-42a1-4749-bb82-1375ce3ea2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40903982-48a9-4059-9983-41e452df5503" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8198c95b-42a1-4749-bb82-1375ce3ea2ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bd2a9036-7f29-4cd3-b778-faa42fdbdf0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40903982-48a9-4059-9983-41e452df5503" xlink:to="loc_us-gaap_InventoryNet_bd2a9036-7f29-4cd3-b778-faa42fdbdf0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7cac1c75-29e7-4420-8191-d76e19122e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40903982-48a9-4059-9983-41e452df5503" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7cac1c75-29e7-4420-8191-d76e19122e1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9de31831-6f37-42a9-a319-4d811a79a7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_22eb4616-befb-46b1-89c7-6c3a388fa6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9de31831-6f37-42a9-a319-4d811a79a7f5" xlink:to="loc_us-gaap_AccountsPayableCurrent_22eb4616-befb-46b1-89c7-6c3a388fa6ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_13a74dc1-0805-4811-a8e6-29c75d7801a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9de31831-6f37-42a9-a319-4d811a79a7f5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_13a74dc1-0805-4811-a8e6-29c75d7801a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_de8f012c-5d03-4652-8568-60e5938a5a61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9de31831-6f37-42a9-a319-4d811a79a7f5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_de8f012c-5d03-4652-8568-60e5938a5a61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_b907690c-de49-4913-8e2e-561bf0ed6767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9de31831-6f37-42a9-a319-4d811a79a7f5" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_b907690c-de49-4913-8e2e-561bf0ed6767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent_734a6cba-db48-4b0a-95d5-61db3ba2c70b" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9de31831-6f37-42a9-a319-4d811a79a7f5" xlink:to="loc_pcrx_ContingentConsiderationCurrent_734a6cba-db48-4b0a-95d5-61db3ba2c70b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_bfce958c-05c4-4986-85b2-196a3ed959f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9de31831-6f37-42a9-a319-4d811a79a7f5" xlink:to="loc_us-gaap_TaxesPayableCurrent_bfce958c-05c4-4986-85b2-196a3ed959f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ca5e4039-c530-46bd-a2f4-c0b2ee19de3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:to="loc_us-gaap_AssetsCurrent_ca5e4039-c530-46bd-a2f4-c0b2ee19de3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_0ef0411b-62da-4d98-868a-dc1c4515d411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:to="loc_us-gaap_LongTermInvestments_0ef0411b-62da-4d98-868a-dc1c4515d411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d5cb640e-d4a1-4505-906b-1e5f7f9b47e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d5cb640e-d4a1-4505-906b-1e5f7f9b47e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8e2d1101-13f6-41e6-937f-f21599f5f4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8e2d1101-13f6-41e6-937f-f21599f5f4b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_562d0abc-b54c-43c5-a14d-f4d9797664c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:to="loc_us-gaap_Goodwill_562d0abc-b54c-43c5-a14d-f4d9797664c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67deba6c-885f-4943-b420-2202058492e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67deba6c-885f-4943-b420-2202058492e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_cc82fa70-5d4f-4500-8ec0-8496747677fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_cc82fa70-5d4f-4500-8ec0-8496747677fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_a84fcb67-c858-4359-8bf0-8a80c5308057" xlink:href="pcrx-20210930.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c1c0ba79-7d5a-4ae3-a163-00fcfb19a6b9" xlink:to="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_a84fcb67-c858-4359-8bf0-8a80c5308057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d298809a-8389-427b-9690-1374b88f181d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_34288817-a6b4-4db0-926f-f5de797eb7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d298809a-8389-427b-9690-1374b88f181d" xlink:to="loc_us-gaap_PreferredStockValue_34288817-a6b4-4db0-926f-f5de797eb7fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a5f06d68-133c-4e57-854e-d2ea75b9f127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d298809a-8389-427b-9690-1374b88f181d" xlink:to="loc_us-gaap_CommonStockValue_a5f06d68-133c-4e57-854e-d2ea75b9f127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e7ed5247-bdc6-4c4d-9231-aa1d9162a062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d298809a-8389-427b-9690-1374b88f181d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e7ed5247-bdc6-4c4d-9231-aa1d9162a062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9789d137-72e8-45e3-9352-a8b9be99d5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d298809a-8389-427b-9690-1374b88f181d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9789d137-72e8-45e3-9352-a8b9be99d5ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7a832f5f-cfce-421e-8694-656d3ee49ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d298809a-8389-427b-9690-1374b88f181d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7a832f5f-cfce-421e-8694-656d3ee49ecb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3f8a6397-c6e8-426a-813d-2640b901e1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d0099e10-406d-477c-ab65-df945159f239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f8a6397-c6e8-426a-813d-2640b901e1ba" xlink:to="loc_us-gaap_LiabilitiesCurrent_d0099e10-406d-477c-ab65-df945159f239" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_01ccbc05-917b-47a6-ac15-130107aeec2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f8a6397-c6e8-426a-813d-2640b901e1ba" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_01ccbc05-917b-47a6-ac15-130107aeec2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_760472f4-5ce5-4e4d-8385-3619486f7b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f8a6397-c6e8-426a-813d-2640b901e1ba" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_760472f4-5ce5-4e4d-8385-3619486f7b0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent_851b28ef-879a-499f-ab42-7d95314667be" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f8a6397-c6e8-426a-813d-2640b901e1ba" xlink:to="loc_pcrx_ContingentConsiderationNoncurrent_851b28ef-879a-499f-ab42-7d95314667be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2e7d153f-0c1c-4f61-bcbf-f5bf4a1fd906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f8a6397-c6e8-426a-813d-2640b901e1ba" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2e7d153f-0c1c-4f61-bcbf-f5bf4a1fd906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_262a972c-c3cb-403f-b718-0b7974b6575a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3f8a6397-c6e8-426a-813d-2640b901e1ba" xlink:to="loc_us-gaap_CommitmentsAndContingencies_262a972c-c3cb-403f-b718-0b7974b6575a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_08fbc158-dcd6-4033-a072-4b6389d0d041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_67ac171b-3870-41f4-b7cb-03d75f112612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_08fbc158-dcd6-4033-a072-4b6389d0d041" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_67ac171b-3870-41f4-b7cb-03d75f112612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5ef9ccc2-85d9-4f0b-bdf5-4f94c26a89d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_08fbc158-dcd6-4033-a072-4b6389d0d041" xlink:to="loc_us-gaap_CostsAndExpenses_5ef9ccc2-85d9-4f0b-bdf5-4f94c26a89d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86b98c3c-356b-46c9-8240-f97cd2301324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0d5e2551-c798-4ebb-8c95-678421630a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86b98c3c-356b-46c9-8240-f97cd2301324" xlink:to="loc_us-gaap_OperatingIncomeLoss_0d5e2551-c798-4ebb-8c95-678421630a3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a2fa5387-1583-4cae-8356-e42cd4747e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86b98c3c-356b-46c9-8240-f97cd2301324" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a2fa5387-1583-4cae-8356-e42cd4747e43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6aa90639-3bf5-4d3e-b8c3-c866ff3d4234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_82500282-f920-4616-8402-02a9375e55fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6aa90639-3bf5-4d3e-b8c3-c866ff3d4234" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_82500282-f920-4616-8402-02a9375e55fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_f240b623-d68e-4b1f-952e-5d3773a9dad0" xlink:href="pcrx-20210930.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6aa90639-3bf5-4d3e-b8c3-c866ff3d4234" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_f240b623-d68e-4b1f-952e-5d3773a9dad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_caa9d9d5-91f7-4690-a8a7-25c06ec343f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6aa90639-3bf5-4d3e-b8c3-c866ff3d4234" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_caa9d9d5-91f7-4690-a8a7-25c06ec343f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_acef526d-a8e6-41aa-8e5e-d0d28d7b99a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6aa90639-3bf5-4d3e-b8c3-c866ff3d4234" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_acef526d-a8e6-41aa-8e5e-d0d28d7b99a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_a2e7f8ba-0254-4b92-b4db-f38e3e1f5c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6aa90639-3bf5-4d3e-b8c3-c866ff3d4234" xlink:to="loc_us-gaap_CostOfRevenue_a2e7f8ba-0254-4b92-b4db-f38e3e1f5c5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8e66f499-7493-4144-8d8c-35591812f7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_959e0553-28fd-4d64-9ab5-082e8245c984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8e66f499-7493-4144-8d8c-35591812f7da" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_959e0553-28fd-4d64-9ab5-082e8245c984" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_822305d9-0656-4a79-a481-896623ae0700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8e66f499-7493-4144-8d8c-35591812f7da" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_822305d9-0656-4a79-a481-896623ae0700" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c61f6aa0-7a09-447a-8f28-73eab2365348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6867e4f4-cb1b-4601-a1e7-7aedbef9dc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c61f6aa0-7a09-447a-8f28-73eab2365348" xlink:to="loc_us-gaap_InterestExpense_6867e4f4-cb1b-4601-a1e7-7aedbef9dc1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_a1f1d7c1-23fb-4abc-9074-fc136245d6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c61f6aa0-7a09-447a-8f28-73eab2365348" xlink:to="loc_us-gaap_InvestmentIncomeInterest_a1f1d7c1-23fb-4abc-9074-fc136245d6e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ae43d8ac-bf83-462e-9864-a4d07481da45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c61f6aa0-7a09-447a-8f28-73eab2365348" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ae43d8ac-bf83-462e-9864-a4d07481da45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_af9d4cdb-d0eb-46a2-a686-6e0c43cb10f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c61f6aa0-7a09-447a-8f28-73eab2365348" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_af9d4cdb-d0eb-46a2-a686-6e0c43cb10f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_65847983-e3d6-46f7-8a60-33f8eaccf7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_97cca0f1-5f12-4878-896a-9f04a2b4eec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_65847983-e3d6-46f7-8a60-33f8eaccf7c1" xlink:to="loc_us-gaap_NetIncomeLoss_97cca0f1-5f12-4878-896a-9f04a2b4eec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_74e2cbba-243f-4f5a-9a44-5b452a1f993c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_65847983-e3d6-46f7-8a60-33f8eaccf7c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_74e2cbba-243f-4f5a-9a44-5b452a1f993c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6a405bcc-1159-4099-b56e-dfd04a9223b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_80c6b7a7-f3be-49eb-8f85-0f2fd1199f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6a405bcc-1159-4099-b56e-dfd04a9223b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_80c6b7a7-f3be-49eb-8f85-0f2fd1199f35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5b9e4cff-9934-46c4-a653-f7be82feef45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6a405bcc-1159-4099-b56e-dfd04a9223b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5b9e4cff-9934-46c4-a653-f7be82feef45" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09568547-dfb3-4a39-b9e7-72ba47ef15fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b3e969d1-9847-4d1e-923b-27beaea9c02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09568547-dfb3-4a39-b9e7-72ba47ef15fd" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b3e969d1-9847-4d1e-923b-27beaea9c02d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_f70a5628-dccc-4677-9227-da61e750e342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09568547-dfb3-4a39-b9e7-72ba47ef15fd" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_f70a5628-dccc-4677-9227-da61e750e342" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_b295a63b-8d94-4f21-8e05-1aca8de4a04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09568547-dfb3-4a39-b9e7-72ba47ef15fd" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_b295a63b-8d94-4f21-8e05-1aca8de4a04f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_17ae3065-dc06-4311-99bd-a9c749ba76ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09568547-dfb3-4a39-b9e7-72ba47ef15fd" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_17ae3065-dc06-4311-99bd-a9c749ba76ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_7de286bd-28da-45b8-94d1-603aafff7ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09568547-dfb3-4a39-b9e7-72ba47ef15fd" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_7de286bd-28da-45b8-94d1-603aafff7ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_8debaa88-7e55-49aa-929c-c8861c572a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_8debaa88-7e55-49aa-929c-c8861c572a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_04dfff71-8280-4e57-b603-acdf820e37e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_04dfff71-8280-4e57-b603-acdf820e37e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_16b4fea3-fa38-43a9-b358-1f510461c586" xlink:href="pcrx-20210930.xsd#pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:to="loc_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_16b4fea3-fa38-43a9-b358-1f510461c586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_25d4b178-4f7b-46d0-be97-32d52ff5fb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_25d4b178-4f7b-46d0-be97-32d52ff5fb4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_a499e642-0c3d-4a41-aef2-521f9568ba70" xlink:href="pcrx-20210930.xsd#pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:to="loc_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_a499e642-0c3d-4a41-aef2-521f9568ba70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_66551ba4-6345-4c6d-86b8-7ebb7cd8fb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_66551ba4-6345-4c6d-86b8-7ebb7cd8fb63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_5c6827af-3e38-4006-9434-5de6d8c7864d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_5c6827af-3e38-4006-9434-5de6d8c7864d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_f08c1943-f598-4ea3-bcfd-adaff8602e54" xlink:href="pcrx-20210930.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_489755b1-dc54-4ea2-8545-2b4a51093f31" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_f08c1943-f598-4ea3-bcfd-adaff8602e54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a394667-1d61-41d9-979b-3be314701d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a394667-1d61-41d9-979b-3be314701d1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_19f72606-f609-4da5-babc-4c8e04e4a3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_19f72606-f609-4da5-babc-4c8e04e4a3a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_21c05497-0233-420f-821d-b06229d23f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_21c05497-0233-420f-821d-b06229d23f51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ff17d28c-089a-4c26-83fe-180857efc4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ff17d28c-089a-4c26-83fe-180857efc4ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_c874a617-28b6-4aa3-920b-367a731ae65c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_c874a617-28b6-4aa3-920b-367a731ae65c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f4b1718f-1f96-45fa-a7bb-b2cc3b32c28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f4b1718f-1f96-45fa-a7bb-b2cc3b32c28f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_847de367-163c-47c7-be64-f1d96422ef54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_ShareBasedCompensation_847de367-163c-47c7-be64-f1d96422ef54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_8f91f262-37c3-4a47-b547-9cd4a420abc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_8f91f262-37c3-4a47-b547-9cd4a420abc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0def44ef-e67b-4ff6-93ad-b8b0053938ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0def44ef-e67b-4ff6-93ad-b8b0053938ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8b3deb88-9c0c-4396-8554-88a278d97564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_NetIncomeLoss_8b3deb88-9c0c-4396-8554-88a278d97564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_e16ae136-ac2f-4908-b242-2d6525bf1922" xlink:href="pcrx-20210930.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_e16ae136-ac2f-4908-b242-2d6525bf1922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_848810e1-45ec-4fc8-9e4d-9fdd08e60c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_848810e1-45ec-4fc8-9e4d-9fdd08e60c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_54873bf7-206d-4c4d-9543-722ac30bd919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_54873bf7-206d-4c4d-9543-722ac30bd919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f7e5f499-9791-4a51-a895-8f17b02fa623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f7e5f499-9791-4a51-a895-8f17b02fa623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_66d5ed37-1968-45cc-98e7-edb3552fb771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_66d5ed37-1968-45cc-98e7-edb3552fb771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2f09435c-1c60-449e-939f-37276f1ad2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2f09435c-1c60-449e-939f-37276f1ad2d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_49c115ec-0c86-4564-af96-d291fa4be239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6e61fc8-6fcc-4de8-951a-c016847b725c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_49c115ec-0c86-4564-af96-d291fa4be239" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_497d6991-4429-4464-8f6e-dd78653c13db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_876dcbf1-dcf0-4286-9e83-d313005d4112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_497d6991-4429-4464-8f6e-dd78653c13db" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_876dcbf1-dcf0-4286-9e83-d313005d4112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a019145e-62bf-4bea-8602-5ef3cc693e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_497d6991-4429-4464-8f6e-dd78653c13db" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a019145e-62bf-4bea-8602-5ef3cc693e8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ab3f5e00-5e1f-4544-9f8c-fea0bef0ddda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_497d6991-4429-4464-8f6e-dd78653c13db" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ab3f5e00-5e1f-4544-9f8c-fea0bef0ddda" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a2f2de95-647a-49f1-b0f5-1a7347d3bca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_78e22fe5-5da9-48ad-ad78-478b8834784f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a2f2de95-647a-49f1-b0f5-1a7347d3bca9" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_78e22fe5-5da9-48ad-ad78-478b8834784f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c7578607-77e6-43ac-83b6-7a798e8dd44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a2f2de95-647a-49f1-b0f5-1a7347d3bca9" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c7578607-77e6-43ac-83b6-7a798e8dd44f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1157121d-1156-4e35-b973-25aab44095bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a2f2de95-647a-49f1-b0f5-1a7347d3bca9" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1157121d-1156-4e35-b973-25aab44095bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FIXEDASSETSDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ee0c5ca8-986a-41a2-9531-1a8d290be2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0fc4a6a4-c991-4762-96ea-0d9f5401c505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ee0c5ca8-986a-41a2-9531-1a8d290be2a8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0fc4a6a4-c991-4762-96ea-0d9f5401c505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fd6d4eb9-f383-46e7-9d51-f70de26f1b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ee0c5ca8-986a-41a2-9531-1a8d290be2a8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fd6d4eb9-f383-46e7-9d51-f70de26f1b6e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_8cddcb2e-4cc8-4880-a2d6-e47b2cdf8979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_cd9cc065-715f-4c42-9b73-9b8f344b325a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_8cddcb2e-4cc8-4880-a2d6-e47b2cdf8979" xlink:to="loc_us-gaap_OperatingLeaseCost_cd9cc065-715f-4c42-9b73-9b8f344b325a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_f369eef5-05a8-4456-82f1-d6066d64542a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_8cddcb2e-4cc8-4880-a2d6-e47b2cdf8979" xlink:to="loc_us-gaap_VariableLeaseCost_f369eef5-05a8-4456-82f1-d6066d64542a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1b6fe638-78c0-484e-9ca6-8aafc0cdfcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1df60c72-f759-49ee-81f1-476cd3d99a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1b6fe638-78c0-484e-9ca6-8aafc0cdfcfa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1df60c72-f759-49ee-81f1-476cd3d99a38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5333236a-b2a2-4db9-bd77-d8cdb15c3f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1b6fe638-78c0-484e-9ca6-8aafc0cdfcfa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5333236a-b2a2-4db9-bd77-d8cdb15c3f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0357495a-0d75-484d-85fb-84e3097dbf47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1b6fe638-78c0-484e-9ca6-8aafc0cdfcfa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0357495a-0d75-484d-85fb-84e3097dbf47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4c6e0f73-3c9d-478c-adf2-af435670e213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1b6fe638-78c0-484e-9ca6-8aafc0cdfcfa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4c6e0f73-3c9d-478c-adf2-af435670e213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1026dbcf-f7dd-4fed-ba84-658edc3ed75a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1b6fe638-78c0-484e-9ca6-8aafc0cdfcfa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1026dbcf-f7dd-4fed-ba84-658edc3ed75a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_4ef869a4-875f-4b60-8237-b7f20261e153" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1b6fe638-78c0-484e-9ca6-8aafc0cdfcfa" xlink:to="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_4ef869a4-875f-4b60-8237-b7f20261e153" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0e7c934c-b028-456d-be5a-c2aca286f35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4d3ad82b-9c17-4e45-ab67-bc4fa5a48423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0e7c934c-b028-456d-be5a-c2aca286f35c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4d3ad82b-9c17-4e45-ab67-bc4fa5a48423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_be9110b1-92b1-4f95-b323-20460b5732bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0e7c934c-b028-456d-be5a-c2aca286f35c" xlink:to="loc_us-gaap_OperatingLeaseLiability_be9110b1-92b1-4f95-b323-20460b5732bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_4ea85a79-7793-4157-a627-34d4b35a9644" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_7b3fa999-2a74-40ff-907b-bc68c80f2c4c" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_4ea85a79-7793-4157-a627-34d4b35a9644" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_7b3fa999-2a74-40ff-907b-bc68c80f2c4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_33cdc6ae-72e9-49cc-95d6-1d4195ce5933" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_4ea85a79-7793-4157-a627-34d4b35a9644" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_33cdc6ae-72e9-49cc-95d6-1d4195ce5933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_142a78e5-f163-429b-9aa7-842536b12f8f" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_4ea85a79-7793-4157-a627-34d4b35a9644" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_142a78e5-f163-429b-9aa7-842536b12f8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_55c9d74b-e3dc-4a8c-9297-50fea3f12c18" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_4ea85a79-7793-4157-a627-34d4b35a9644" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_55c9d74b-e3dc-4a8c-9297-50fea3f12c18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_fa3d8a4e-d2a5-43bf-8fac-a31a93e1cbee" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_4ea85a79-7793-4157-a627-34d4b35a9644" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_fa3d8a4e-d2a5-43bf-8fac-a31a93e1cbee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_ca63f7d2-9d5c-4e3c-8c3c-d5df2723be02" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_4ea85a79-7793-4157-a627-34d4b35a9644" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_ca63f7d2-9d5c-4e3c-8c3c-d5df2723be02" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6ef3bd4f-518f-4300-853a-1014fa6b6ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_697082e3-6ce0-47c7-9040-13763ff0a9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6ef3bd4f-518f-4300-853a-1014fa6b6ceb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_697082e3-6ce0-47c7-9040-13763ff0a9ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_28d35978-9fc8-4f15-9b7e-ba1897df8ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6ef3bd4f-518f-4300-853a-1014fa6b6ceb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_28d35978-9fc8-4f15-9b7e-ba1897df8ca4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DEBTScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b9f3a8b7-7315-4c6d-9249-1121dd41ded3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_14e45823-9e73-4a97-a16b-4fdfae44464b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b9f3a8b7-7315-4c6d-9249-1121dd41ded3" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_14e45823-9e73-4a97-a16b-4fdfae44464b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_7187863c-a0fc-4870-a542-be2ddf300e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b9f3a8b7-7315-4c6d-9249-1121dd41ded3" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_7187863c-a0fc-4870-a542-be2ddf300e4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_686d6823-1b20-4856-8dcf-c7e4b69d2201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b9f3a8b7-7315-4c6d-9249-1121dd41ded3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_686d6823-1b20-4856-8dcf-c7e4b69d2201" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0247fd9-08d8-4b76-ac74-6954e165c406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8fc38e82-5a34-4bf9-8014-f571f5f1eec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0247fd9-08d8-4b76-ac74-6954e165c406" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8fc38e82-5a34-4bf9-8014-f571f5f1eec1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_89aece9a-bf4c-4a3f-be78-e8e09ad42949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0247fd9-08d8-4b76-ac74-6954e165c406" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_89aece9a-bf4c-4a3f-be78-e8e09ad42949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c8684fed-9c13-4726-93d7-3d3ffba98141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e0247fd9-08d8-4b76-ac74-6954e165c406" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c8684fed-9c13-4726-93d7-3d3ffba98141" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_94c1812b-0948-4add-89db-eaceef6d84da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_6778ff8d-1acf-4b40-84b7-860ba4806f45" xlink:href="pcrx-20210930.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_94c1812b-0948-4add-89db-eaceef6d84da" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_6778ff8d-1acf-4b40-84b7-860ba4806f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_7bd4ebce-2cb4-412c-82ed-9fdd19046c15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_94c1812b-0948-4add-89db-eaceef6d84da" xlink:to="loc_us-gaap_RestrictedStockExpense_7bd4ebce-2cb4-412c-82ed-9fdd19046c15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_d4725481-1ea0-49f3-ae53-25e81e424972" xlink:href="pcrx-20210930.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShareBasedCompensation_94c1812b-0948-4add-89db-eaceef6d84da" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_d4725481-1ea0-49f3-ae53-25e81e424972" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ffb3a23-530e-4c94-aca9-a818ec0b0024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c971983e-1cf2-49d6-af8a-4c30aecaf1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ffb3a23-530e-4c94-aca9-a818ec0b0024" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c971983e-1cf2-49d6-af8a-4c30aecaf1fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_e42647ad-d6c0-4851-ae3d-69a87aa8dcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ffb3a23-530e-4c94-aca9-a818ec0b0024" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_e42647ad-d6c0-4851-ae3d-69a87aa8dcc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0d1971a9-0493-4dba-83d9-7266f1b76f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ffb3a23-530e-4c94-aca9-a818ec0b0024" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0d1971a9-0493-4dba-83d9-7266f1b76f8d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7f574185-d350-4fc5-87e6-1abd963dec4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_214e5a14-54bb-4de4-b1d0-4e592387ddb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7f574185-d350-4fc5-87e6-1abd963dec4c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_214e5a14-54bb-4de4-b1d0-4e592387ddb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_39c1a5a9-9e18-4eff-9291-fb994c51d5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7f574185-d350-4fc5-87e6-1abd963dec4c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_39c1a5a9-9e18-4eff-9291-fb994c51d5b7" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>pcrx-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:72021cac-ffd9-4fc5-b071-994f9d22f7d5,g:6c0c4d51-64cc-433e-9997-2f3b5b13ef74-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i5577bf5498df4ebd9cd5f310a660dafa_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d0b72b9a-b2a5-40bf-b64c-af81baf78c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_RevenuesAbstract_d0b72b9a-b2a5-40bf-b64c-af81baf78c98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1913a50c-7a7e-405b-87a7-9eb83c4ad0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d0b72b9a-b2a5-40bf-b64c-af81baf78c98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1913a50c-7a7e-405b-87a7-9eb83c4ad0ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_539707dd-46d5-4564-81d1-b65898df5a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_CostOfRevenue_539707dd-46d5-4564-81d1-b65898df5a9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f4637a26-caed-49e8-bb82-dd1b165c2f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f4637a26-caed-49e8-bb82-dd1b165c2f63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9ed68b38-1a10-4678-b375-1708a0404b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9ed68b38-1a10-4678-b375-1708a0404b9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7c1e53a6-b3c8-4752-b8cb-edf89ea983b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7c1e53a6-b3c8-4752-b8cb-edf89ea983b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_6629b049-8704-4bd3-80b1-895afc26e707" xlink:href="pcrx-20210930.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_6629b049-8704-4bd3-80b1-895afc26e707" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d65027dc-67b3-4b7a-8d74-a5c523c45a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_CostsAndExpenses_d65027dc-67b3-4b7a-8d74-a5c523c45a5c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_782d74e9-f311-4553-85a3-3937888059a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_OperatingIncomeLoss_782d74e9-f311-4553-85a3-3937888059a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_960d621e-1ee7-4304-b35b-ae48bd127887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_InvestmentIncomeInterest_960d621e-1ee7-4304-b35b-ae48bd127887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8225ba5b-72ce-4cf1-947d-59a3c1da472f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_InterestExpense_8225ba5b-72ce-4cf1-947d-59a3c1da472f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_14045584-f33f-4472-90e9-6622f42da63c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_14045584-f33f-4472-90e9-6622f42da63c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_efe9213d-d02f-4553-929a-13ec5d05a72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_efe9213d-d02f-4553-929a-13ec5d05a72f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0d0a6942-1fd8-4bb6-a0db-402c5f700934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0d0a6942-1fd8-4bb6-a0db-402c5f700934" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f899b6a-f71b-41c7-b2a9-c600bd64a99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f899b6a-f71b-41c7-b2a9-c600bd64a99d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2bfdb8ba-d10f-4fa7-afbb-0b95cdd1eea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2bfdb8ba-d10f-4fa7-afbb-0b95cdd1eea7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bbb226c0-2ac0-4e8e-9bb3-b45edcf130a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_NetIncomeLoss_bbb226c0-2ac0-4e8e-9bb3-b45edcf130a1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1927e203-9bf4-456c-9a0c-89018cdaaaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_EarningsPerShareAbstract_1927e203-9bf4-456c-9a0c-89018cdaaaf3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_716e1bb8-da78-4fc9-92ad-979e1439e609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1927e203-9bf4-456c-9a0c-89018cdaaaf3" xlink:to="loc_us-gaap_EarningsPerShareBasic_716e1bb8-da78-4fc9-92ad-979e1439e609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e1370a4c-a79f-4833-9979-882be6b70f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1927e203-9bf4-456c-9a0c-89018cdaaaf3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e1370a4c-a79f-4833-9979-882be6b70f1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a881682f-5787-485a-a58c-a98a3327d272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a881682f-5787-485a-a58c-a98a3327d272" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf3964ef-51d5-4f5f-a155-b7fee3d1d30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a881682f-5787-485a-a58c-a98a3327d272" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf3964ef-51d5-4f5f-a155-b7fee3d1d30a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ea79642-1f41-4b27-8916-84d2f6d8f193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a881682f-5787-485a-a58c-a98a3327d272" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ea79642-1f41-4b27-8916-84d2f6d8f193" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e74e985b-0675-42ae-b2b7-564e38c06e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_StatementTable_e74e985b-0675-42ae-b2b7-564e38c06e1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4005ec58-8e17-4a10-91a9-b96968906372" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e74e985b-0675-42ae-b2b7-564e38c06e1f" xlink:to="loc_srt_ProductOrServiceAxis_4005ec58-8e17-4a10-91a9-b96968906372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4005ec58-8e17-4a10-91a9-b96968906372_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4005ec58-8e17-4a10-91a9-b96968906372" xlink:to="loc_srt_ProductsAndServicesDomain_4005ec58-8e17-4a10-91a9-b96968906372_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4005ec58-8e17-4a10-91a9-b96968906372" xlink:to="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_bb949b43-003d-4f49-b693-b2521c22c1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:to="loc_us-gaap_ProductMember_bb949b43-003d-4f49-b693-b2521c22c1ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_2f96e433-c47c-4d8d-ae9a-f1f3d96dfc04" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:to="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_2f96e433-c47c-4d8d-ae9a-f1f3d96dfc04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_0772652b-bc92-4ece-901a-12b0d74fcc78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:to="loc_us-gaap_RoyaltyMember_0772652b-bc92-4ece-901a-12b0d74fcc78" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="ia2e7a1b8393646d7b04bba7947d1ec92_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_76aa2865-520f-40ea-8f67-85c9aa20810b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76aa2865-520f-40ea-8f67-85c9aa20810b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_10c33910-ba35-4a71-adfb-3e1063046182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_SharesOutstanding_10c33910-ba35-4a71-adfb-3e1063046182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0ddbbdf2-f393-4923-8f7d-0fd9d36c86f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockholdersEquity_0ddbbdf2-f393-4923-8f7d-0fd9d36c86f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_34669045-4eb5-4cdf-8865-1e2e52c9530d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_34669045-4eb5-4cdf-8865-1e2e52c9530d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ba138ee7-4567-4624-a08a-9771f8f1d8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ba138ee7-4567-4624-a08a-9771f8f1d8fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_95ead457-7aef-4893-87e5-e1af755d8a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_95ead457-7aef-4893-87e5-e1af755d8a2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_cf4919d0-f2a5-450c-bed7-42be7243f289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_cf4919d0-f2a5-450c-bed7-42be7243f289" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_6b9f48bf-a0f1-4a4c-b15f-4f2731cbf8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_6b9f48bf-a0f1-4a4c-b15f-4f2731cbf8bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2e27a24e-f11c-44e8-b72a-74dc3ba8b492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2e27a24e-f11c-44e8-b72a-74dc3ba8b492" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9cef899d-f6d3-4a14-ba2b-e40d33ad1e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9cef899d-f6d3-4a14-ba2b-e40d33ad1e45" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_25841dad-4c5d-4a53-9965-b5d8d1db795e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_25841dad-4c5d-4a53-9965-b5d8d1db795e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a708e25f-0786-4863-9645-16dcfe0d295b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a708e25f-0786-4863-9645-16dcfe0d295b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_66f0b3b1-9bdb-4b75-b821-4ba063aad744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_NetIncomeLoss_66f0b3b1-9bdb-4b75-b821-4ba063aad744" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_388f10a5-fcec-4387-81c0-2df14fdbabf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f7915ed-ca18-4c21-9462-ee5c64bbe603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_76aa2865-520f-40ea-8f67-85c9aa20810b" xlink:to="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1e66166e-c600-47b7-a4b4-9aac3004fe1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:to="loc_us-gaap_DebtInstrumentAxis_1e66166e-c600-47b7-a4b4-9aac3004fe1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e66166e-c600-47b7-a4b4-9aac3004fe1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e66166e-c600-47b7-a4b4-9aac3004fe1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e66166e-c600-47b7-a4b4-9aac3004fe1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9d3937d0-5a3b-4a55-919f-248a95487e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e66166e-c600-47b7-a4b4-9aac3004fe1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9d3937d0-5a3b-4a55-919f-248a95487e34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_A2022ConvertibleSeniorNotesMember_4528dff3-c008-4b5f-aa7c-6a0cbac3385e" xlink:href="pcrx-20210930.xsd#pcrx_A2022ConvertibleSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d3937d0-5a3b-4a55-919f-248a95487e34" xlink:to="loc_pcrx_A2022ConvertibleSeniorNotesMember_4528dff3-c008-4b5f-aa7c-6a0cbac3385e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8e41b17e-b0c2-49b9-98d8-6c497ceb9a42" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d3937d0-5a3b-4a55-919f-248a95487e34" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8e41b17e-b0c2-49b9-98d8-6c497ceb9a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_34aa7341-7e58-4853-875b-c319aa1ca9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_34aa7341-7e58-4853-875b-c319aa1ca9fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34aa7341-7e58-4853-875b-c319aa1ca9fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34aa7341-7e58-4853-875b-c319aa1ca9fd" xlink:to="loc_us-gaap_EquityComponentDomain_34aa7341-7e58-4853-875b-c319aa1ca9fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34aa7341-7e58-4853-875b-c319aa1ca9fd" xlink:to="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3ef6d51c-8016-4460-ba98-749dd4222add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:to="loc_us-gaap_CommonStockMember_3ef6d51c-8016-4460-ba98-749dd4222add" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7def1ddb-bce2-4c7c-b6f1-6ec50b7bd3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7def1ddb-bce2-4c7c-b6f1-6ec50b7bd3f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b081bfd0-e0e1-4bba-8a58-5e37dc93af05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:to="loc_us-gaap_RetainedEarningsMember_b081bfd0-e0e1-4bba-8a58-5e37dc93af05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c6f86fd-f84a-4aea-a243-00f949824227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c6f86fd-f84a-4aea-a243-00f949824227" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i7331cdedae1545b5974d06d0f1342535_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a88cccc4-e3d1-4dc8-b703-de1691491951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:to="loc_us-gaap_NetIncomeLoss_a88cccc4-e3d1-4dc8-b703-de1691491951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_94319d69-ac86-4a72-b166-db684572967c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_94319d69-ac86-4a72-b166-db684572967c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ffa071f8-a752-4ddb-a0a3-b317055e2fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ffa071f8-a752-4ddb-a0a3-b317055e2fb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_bbb7077a-50f3-4ace-a063-bfb1622c49bf" xlink:href="pcrx-20210930.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_bbb7077a-50f3-4ace-a063-bfb1622c49bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_3b796db0-d50a-4293-89da-86d274ce3ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_3b796db0-d50a-4293-89da-86d274ce3ef0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e2487eb-7595-4e08-91f0-62b2c2452f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e2487eb-7595-4e08-91f0-62b2c2452f82" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_addde770-6964-4c14-b326-03049ff8772d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_addde770-6964-4c14-b326-03049ff8772d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b9fcb102-b82e-49f8-a169-e3890c16d202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_ShareBasedCompensation_b9fcb102-b82e-49f8-a169-e3890c16d202" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fe96d0e5-094a-4eb3-9070-2f7e9a9f0ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fe96d0e5-094a-4eb3-9070-2f7e9a9f0ca6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ad2e2073-0ce6-4ca5-8c17-dfda3539f009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ad2e2073-0ce6-4ca5-8c17-dfda3539f009" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_977058e1-49fe-4a5b-9907-c7d3e149b89d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_977058e1-49fe-4a5b-9907-c7d3e149b89d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_552e640f-7c11-497d-8249-13a4bb9349f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_552e640f-7c11-497d-8249-13a4bb9349f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b123e716-3abf-411f-a11c-a320517d216a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b123e716-3abf-411f-a11c-a320517d216a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c309efe4-6bc4-4488-bbc7-a776cd471ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c309efe4-6bc4-4488-bbc7-a776cd471ca1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b84c5316-6a36-4def-8ea4-7ab093385db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b84c5316-6a36-4def-8ea4-7ab093385db6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_14595343-45b0-4f03-8976-ad2fe1a29157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_14595343-45b0-4f03-8976-ad2fe1a29157" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_9a7da431-6ad4-4689-9013-057a3d31cfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_9a7da431-6ad4-4689-9013-057a3d31cfe9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cc16933f-06d8-4a0d-b073-f72b4306603b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cc16933f-06d8-4a0d-b073-f72b4306603b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f3a6408-4e33-4a39-a2f7-cbe0bb868f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f3a6408-4e33-4a39-a2f7-cbe0bb868f0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_820b6a25-119d-4e8e-87d1-1f77220eec8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_820b6a25-119d-4e8e-87d1-1f77220eec8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9ad8b579-6867-4a9b-8f4b-fe7c092e10a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9ad8b579-6867-4a9b-8f4b-fe7c092e10a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_45faf57f-a68b-45cb-ae34-884331026562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_45faf57f-a68b-45cb-ae34-884331026562" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_64ebc95f-4121-481d-a88f-7c5ebe48dc61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_64ebc95f-4121-481d-a88f-7c5ebe48dc61" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_582e58e5-9610-4403-a8ed-7044c4de8b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_582e58e5-9610-4403-a8ed-7044c4de8b7c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_04aaa674-9638-435e-829e-68fb3a3ebeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_04aaa674-9638-435e-829e-68fb3a3ebeb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_ab674b33-4258-41e4-875d-f956f57d4850" xlink:href="pcrx-20210930.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_ab674b33-4258-41e4-875d-f956f57d4850" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_bb6ef924-07a2-485c-a7e0-0b7f99035f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_bb6ef924-07a2-485c-a7e0-0b7f99035f4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_c3aec87b-1dd7-49e7-9789-07910551dbe8" xlink:href="pcrx-20210930.xsd#pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_c3aec87b-1dd7-49e7-9789-07910551dbe8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_8a1124f9-758f-4607-b44d-2a683d17ce85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_8a1124f9-758f-4607-b44d-2a683d17ce85" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_4e78a04e-951a-4389-942a-ec9525103113" xlink:href="pcrx-20210930.xsd#pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_4e78a04e-951a-4389-942a-ec9525103113" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_404acbd0-1311-4f29-b6f3-3790b7289bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_404acbd0-1311-4f29-b6f3-3790b7289bd3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_feadf42b-4ab4-47d0-937c-5aade24d9d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_feadf42b-4ab4-47d0-937c-5aade24d9d14" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b82e0fef-e020-4c7b-8aa5-3d094eb8aa08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b82e0fef-e020-4c7b-8aa5-3d094eb8aa08" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_edb8cc63-3c68-4b42-b5b9-da1495a45ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_edb8cc63-3c68-4b42-b5b9-da1495a45ee1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44978a3f-ed4f-4a51-bb66-7d2e5a4810b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44978a3f-ed4f-4a51-bb66-7d2e5a4810b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_776d1328-eacf-4744-8ed3-3830636314fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b18fa7e-3233-4cff-a813-5b242050a42c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b18fa7e-3233-4cff-a813-5b242050a42c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_356ec9ea-e25a-45f4-b449-1ace3897b1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b18fa7e-3233-4cff-a813-5b242050a42c" xlink:to="loc_us-gaap_InterestPaidNet_356ec9ea-e25a-45f4-b449-1ace3897b1dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_974e26af-c033-404e-98a5-5944e987b568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b18fa7e-3233-4cff-a813-5b242050a42c" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_974e26af-c033-404e-98a5-5944e987b568" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_465b22a9-2825-4a65-bf61-7d8a2c1ff99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_465b22a9-2825-4a65-bf61-7d8a2c1ff99f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0e78de16-4f4c-4ba3-a8cf-18c477b1249e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_465b22a9-2825-4a65-bf61-7d8a2c1ff99f" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0e78de16-4f4c-4ba3-a8cf-18c477b1249e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7791fa74-7e8a-4eb9-aa3c-1a0376599080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_StatementTable_7791fa74-7e8a-4eb9-aa3c-1a0376599080" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_efc3e9b6-9248-4f17-be9b-0f323229e053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7791fa74-7e8a-4eb9-aa3c-1a0376599080" xlink:to="loc_us-gaap_DebtInstrumentAxis_efc3e9b6-9248-4f17-be9b-0f323229e053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_efc3e9b6-9248-4f17-be9b-0f323229e053_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_efc3e9b6-9248-4f17-be9b-0f323229e053" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_efc3e9b6-9248-4f17-be9b-0f323229e053_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1fedc2cb-8b31-48a8-bd04-292fceff7adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_efc3e9b6-9248-4f17-be9b-0f323229e053" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1fedc2cb-8b31-48a8-bd04-292fceff7adc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_779a38d8-4fee-4574-90ea-d28c46e7bc73" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1fedc2cb-8b31-48a8-bd04-292fceff7adc" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_779a38d8-4fee-4574-90ea-d28c46e7bc73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_b0ab0efc-02c7-4951-89d8-fa1639bf6a7d" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1fedc2cb-8b31-48a8-bd04-292fceff7adc" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_b0ab0efc-02c7-4951-89d8-fa1639bf6a7d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended" id="ic447fd35d49e484dbf1979d9f9772924_DESCRIPTIONOFBUSINESSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_23b3e05f-6cd9-4527-a8f0-59dcccb40699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_23b3e05f-6cd9-4527-a8f0-59dcccb40699" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_b37e5073-d8f0-4aba-8867-f250283a1b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_b37e5073-d8f0-4aba-8867-f250283a1b8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_c2d29136-b60f-4b82-b9de-fb7c92fd87ad" xlink:href="pcrx-20210930.xsd#pcrx_ClassOfWarrantOrRightNumberOfRightsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_c2d29136-b60f-4b82-b9de-fb7c92fd87ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_aa19b039-ace8-41af-9792-e4c8453a0381" xlink:href="pcrx-20210930.xsd#pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_aa19b039-ace8-41af-9792-e4c8453a0381" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts_47d9f0eb-1386-4a58-b204-0e9e76fe3fbe" xlink:href="pcrx-20210930.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_pcrx_ConcentrationRiskNumberOfProducts_47d9f0eb-1386-4a58-b204-0e9e76fe3fbe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_dae0741d-b622-42a4-9dbc-30f9c8903f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_us-gaap_NumberOfReportableSegments_dae0741d-b622-42a4-9dbc-30f9c8903f05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_069830dc-3a52-4baf-8f0d-d6abaa0533e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_069830dc-3a52-4baf-8f0d-d6abaa0533e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_069830dc-3a52-4baf-8f0d-d6abaa0533e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_069830dc-3a52-4baf-8f0d-d6abaa0533e3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_069830dc-3a52-4baf-8f0d-d6abaa0533e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a84dfce0-f6b0-44dc-b0ac-8574179d8d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_069830dc-3a52-4baf-8f0d-d6abaa0533e3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a84dfce0-f6b0-44dc-b0ac-8574179d8d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b49ad480-ade1-4ece-b468-387ccfd082e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a84dfce0-f6b0-44dc-b0ac-8574179d8d7c" xlink:to="loc_us-gaap_SalesRevenueNetMember_b49ad480-ade1-4ece-b468-387ccfd082e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_718ad65a-72d3-4b80-a803-2d2b18834c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_718ad65a-72d3-4b80-a803-2d2b18834c41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_718ad65a-72d3-4b80-a803-2d2b18834c41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_718ad65a-72d3-4b80-a803-2d2b18834c41" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_718ad65a-72d3-4b80-a803-2d2b18834c41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_30d79e87-18f4-42f7-90cd-2a5d3d8a099a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_718ad65a-72d3-4b80-a803-2d2b18834c41" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_30d79e87-18f4-42f7-90cd-2a5d3d8a099a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_40461554-f8b6-417d-9a09-add369e8047b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_30d79e87-18f4-42f7-90cd-2a5d3d8a099a" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_40461554-f8b6-417d-9a09-add369e8047b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_93ed410d-208d-4c20-96f7-c6512c72d609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_93ed410d-208d-4c20-96f7-c6512c72d609" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93ed410d-208d-4c20-96f7-c6512c72d609_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_93ed410d-208d-4c20-96f7-c6512c72d609" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93ed410d-208d-4c20-96f7-c6512c72d609_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bcf1fc6c-6ff7-4ea1-98c3-6b78a4e7d0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_93ed410d-208d-4c20-96f7-c6512c72d609" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bcf1fc6c-6ff7-4ea1-98c3-6b78a4e7d0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionMember_cdab3b85-43ed-43eb-86f7-6c1ff5e90a76" xlink:href="pcrx-20210930.xsd#pcrx_FlexionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bcf1fc6c-6ff7-4ea1-98c3-6b78a4e7d0c1" xlink:to="loc_pcrx_FlexionMember_cdab3b85-43ed-43eb-86f7-6c1ff5e90a76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_151a5196-4efa-4e2a-8d0b-f57da1d6a523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_151a5196-4efa-4e2a-8d0b-f57da1d6a523" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_151a5196-4efa-4e2a-8d0b-f57da1d6a523_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_151a5196-4efa-4e2a-8d0b-f57da1d6a523" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_151a5196-4efa-4e2a-8d0b-f57da1d6a523_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a5eda112-9211-4728-95f0-072ead47747b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_151a5196-4efa-4e2a-8d0b-f57da1d6a523" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a5eda112-9211-4728-95f0-072ead47747b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_66aa38d3-255e-4a43-83f5-f96b4bd4c014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a5eda112-9211-4728-95f0-072ead47747b" xlink:to="loc_us-gaap_SubsequentEventMember_66aa38d3-255e-4a43-83f5-f96b4bd4c014" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="extended" id="ib253166898154629aa8a22de586caab4_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f35d3c18-153f-4b1e-ad98-637399911d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_359521e5-5a6f-452f-a30e-892218049b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f35d3c18-153f-4b1e-ad98-637399911d35" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_359521e5-5a6f-452f-a30e-892218049b94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f35d3c18-153f-4b1e-ad98-637399911d35" xlink:to="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ef8aa4c8-1bbf-4704-a246-89064dd40072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ef8aa4c8-1bbf-4704-a246-89064dd40072" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ef8aa4c8-1bbf-4704-a246-89064dd40072_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ef8aa4c8-1bbf-4704-a246-89064dd40072" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ef8aa4c8-1bbf-4704-a246-89064dd40072_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_dbc664c3-1bd0-48df-bcc4-3b094bdff4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ef8aa4c8-1bbf-4704-a246-89064dd40072" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_dbc664c3-1bd0-48df-bcc4-3b094bdff4d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_7cd8be85-ee6a-4ac1-a616-a65e00f6850d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_dbc664c3-1bd0-48df-bcc4-3b094bdff4d0" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_7cd8be85-ee6a-4ac1-a616-a65e00f6850d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e95a9166-c6b2-4048-9c38-943a238f710e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e95a9166-c6b2-4048-9c38-943a238f710e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e95a9166-c6b2-4048-9c38-943a238f710e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e95a9166-c6b2-4048-9c38-943a238f710e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e95a9166-c6b2-4048-9c38-943a238f710e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f12cb580-64ee-42d3-895d-528cf49233c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e95a9166-c6b2-4048-9c38-943a238f710e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f12cb580-64ee-42d3-895d-528cf49233c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_6750fd12-edba-4089-92c6-024d8c0b0373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f12cb580-64ee-42d3-895d-528cf49233c6" xlink:to="loc_us-gaap_SalesRevenueNetMember_6750fd12-edba-4089-92c6-024d8c0b0373" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3edc5a39-2f1c-419a-826b-55f61d842829" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:to="loc_srt_MajorCustomersAxis_3edc5a39-2f1c-419a-826b-55f61d842829" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3edc5a39-2f1c-419a-826b-55f61d842829_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_3edc5a39-2f1c-419a-826b-55f61d842829" xlink:to="loc_srt_NameOfMajorCustomerDomain_3edc5a39-2f1c-419a-826b-55f61d842829_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_3edc5a39-2f1c-419a-826b-55f61d842829" xlink:to="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember_f0da43ee-e9cd-4e44-9ae8-588cf02841b1" xlink:href="pcrx-20210930.xsd#pcrx_LargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:to="loc_pcrx_LargestCustomerMember_f0da43ee-e9cd-4e44-9ae8-588cf02841b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember_c361233f-0e1e-4e07-b88a-38d27fcfc886" xlink:href="pcrx-20210930.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:to="loc_pcrx_SecondLargestCustomerMember_c361233f-0e1e-4e07-b88a-38d27fcfc886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember_b5ec170c-0219-4a46-86f0-25d2916ab040" xlink:href="pcrx-20210930.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:to="loc_pcrx_ThirdLargestCustomerMember_b5ec170c-0219-4a46-86f0-25d2916ab040" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember_575e2745-44a7-4f1f-a633-fd5f35b28711" xlink:href="pcrx-20210930.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:to="loc_pcrx_ThreeLargestCustomersMember_575e2745-44a7-4f1f-a633-fd5f35b28711" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="extended" id="i36d5b0e413354029b95624f3545c0f45_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_84c7b68e-bff2-4761-a00d-f9036a795e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2720cc10-d1ef-443e-a788-000880355eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_84c7b68e-bff2-4761-a00d-f9036a795e94" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2720cc10-d1ef-443e-a788-000880355eae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_86cfd96f-35f4-486f-a1ca-234beaa7594d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_84c7b68e-bff2-4761-a00d-f9036a795e94" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_86cfd96f-35f4-486f-a1ca-234beaa7594d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_84c7b68e-bff2-4761-a00d-f9036a795e94" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e7773efb-20ec-433f-a861-7a300f953133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:to="loc_us-gaap_DebtInstrumentAxis_e7773efb-20ec-433f-a861-7a300f953133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e7773efb-20ec-433f-a861-7a300f953133_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e7773efb-20ec-433f-a861-7a300f953133" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e7773efb-20ec-433f-a861-7a300f953133_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_51d04b2b-b098-4e1d-b1ef-e0fa84d13442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e7773efb-20ec-433f-a861-7a300f953133" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_51d04b2b-b098-4e1d-b1ef-e0fa84d13442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_b312d911-4fdc-4289-a299-938f6ed1f6c1" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_51d04b2b-b098-4e1d-b1ef-e0fa84d13442" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_b312d911-4fdc-4289-a299-938f6ed1f6c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_1fdb9efc-655c-4c1e-852b-a0246e05a556" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_51d04b2b-b098-4e1d-b1ef-e0fa84d13442" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_1fdb9efc-655c-4c1e-852b-a0246e05a556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_23700202-566b-44b2-bad4-4af5d5a89468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_23700202-566b-44b2-bad4-4af5d5a89468" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_23700202-566b-44b2-bad4-4af5d5a89468_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_23700202-566b-44b2-bad4-4af5d5a89468" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_23700202-566b-44b2-bad4-4af5d5a89468_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e49bfca-ba5b-41f3-9cc6-41e6e115c6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_23700202-566b-44b2-bad4-4af5d5a89468" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e49bfca-ba5b-41f3-9cc6-41e6e115c6aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_568b72ff-b59d-4cf8-9c5d-6ad525af4aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1e49bfca-ba5b-41f3-9cc6-41e6e115c6aa" xlink:to="loc_us-gaap_UnsecuredDebtMember_568b72ff-b59d-4cf8-9c5d-6ad525af4aa4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUEDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#REVENUEDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/REVENUEDetails" xlink:type="extended" id="ib5e948be43ae4c259062ffd39e331623_REVENUEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8c8ecb58-1019-4369-98bf-077e22e26f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3e51e413-bcc3-452d-a9de-4b87022fd4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8c8ecb58-1019-4369-98bf-077e22e26f9f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3e51e413-bcc3-452d-a9de-4b87022fd4a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms_dd31bd59-0192-4d15-aac5-5ca152ed47f0" xlink:href="pcrx-20210930.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8c8ecb58-1019-4369-98bf-077e22e26f9f" xlink:to="loc_pcrx_AccountsReceivablePaymentTerms_dd31bd59-0192-4d15-aac5-5ca152ed47f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8c8ecb58-1019-4369-98bf-077e22e26f9f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a07ba8da-0164-460f-ba66-f2217d4e071a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:to="loc_srt_RangeAxis_a07ba8da-0164-460f-ba66-f2217d4e071a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a07ba8da-0164-460f-ba66-f2217d4e071a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a07ba8da-0164-460f-ba66-f2217d4e071a" xlink:to="loc_srt_RangeMember_a07ba8da-0164-460f-ba66-f2217d4e071a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f8a7634-13d9-4a8b-b6a9-e281a97a7e7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a07ba8da-0164-460f-ba66-f2217d4e071a" xlink:to="loc_srt_RangeMember_6f8a7634-13d9-4a8b-b6a9-e281a97a7e7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_281e7c31-7247-4ec3-9a53-5797709dc4ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f8a7634-13d9-4a8b-b6a9-e281a97a7e7f" xlink:to="loc_srt_MinimumMember_281e7c31-7247-4ec3-9a53-5797709dc4ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b9cbcfaa-afc6-4ae9-90bb-413bffe37098" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f8a7634-13d9-4a8b-b6a9-e281a97a7e7f" xlink:to="loc_srt_MaximumMember_b9cbcfaa-afc6-4ae9-90bb-413bffe37098" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0653384f-78fe-4bcb-8e71-dce6c7a268a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:to="loc_srt_StatementGeographicalAxis_0653384f-78fe-4bcb-8e71-dce6c7a268a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0653384f-78fe-4bcb-8e71-dce6c7a268a4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0653384f-78fe-4bcb-8e71-dce6c7a268a4" xlink:to="loc_srt_SegmentGeographicalDomain_0653384f-78fe-4bcb-8e71-dce6c7a268a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_79ef332e-0320-47a1-86f0-1bc47ecdc53d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0653384f-78fe-4bcb-8e71-dce6c7a268a4" xlink:to="loc_srt_SegmentGeographicalDomain_79ef332e-0320-47a1-86f0-1bc47ecdc53d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EuropeanUnionMember_3391d2bd-67a1-4003-a56a-57406304228b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EuropeanUnionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_79ef332e-0320-47a1-86f0-1bc47ecdc53d" xlink:to="loc_us-gaap_EuropeanUnionMember_3391d2bd-67a1-4003-a56a-57406304228b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_40501897-ec7c-40c5-a510-305f04d194a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:to="loc_srt_ProductOrServiceAxis_40501897-ec7c-40c5-a510-305f04d194a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_40501897-ec7c-40c5-a510-305f04d194a9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_40501897-ec7c-40c5-a510-305f04d194a9" xlink:to="loc_srt_ProductsAndServicesDomain_40501897-ec7c-40c5-a510-305f04d194a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_40501897-ec7c-40c5-a510-305f04d194a9" xlink:to="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_fbacbf44-1407-43b3-9244-4954e0611f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:to="loc_us-gaap_ProductMember_fbacbf44-1407-43b3-9244-4954e0611f9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_17bd3e8e-605e-4236-82de-87c4f662ae9f" xlink:href="pcrx-20210930.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:to="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_17bd3e8e-605e-4236-82de-87c4f662ae9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember_f4365581-597b-4144-b11c-d6d2d717db64" xlink:href="pcrx-20210930.xsd#pcrx_IoveraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:to="loc_pcrx_IoveraMember_f4365581-597b-4144-b11c-d6d2d717db64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c6b0cbfb-6b93-4d23-aaa8-504c5b41bd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FIXEDASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FIXEDASSETSDetails" xlink:type="extended" id="id443cb5f9f5245369bda2ac695fab978_FIXEDASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_22f9d9e8-25b9-4fac-b063-b030f1297370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_22f9d9e8-25b9-4fac-b063-b030f1297370" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_350f044b-41ae-4e42-b485-252d587423e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_350f044b-41ae-4e42-b485-252d587423e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2cb275ac-3e3f-42d0-8d9c-2a2699b9256d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2cb275ac-3e3f-42d0-8d9c-2a2699b9256d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f26fc594-6626-4895-a9b6-923ccc9fa32f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_Depreciation_f26fc594-6626-4895-a9b6-923ccc9fa32f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_0d996a0c-9f82-4f2c-9013-f29f82839ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_InterestCostsCapitalized_0d996a0c-9f82-4f2c-9013-f29f82839ccb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ForeignPropertyPlantAndEquipmentNet_326123b2-616f-46c4-9e04-a7a9193df3d0" xlink:href="pcrx-20210930.xsd#pcrx_ForeignPropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_pcrx_ForeignPropertyPlantAndEquipmentNet_326123b2-616f-46c4-9e04-a7a9193df3d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_e6088304-77ec-4587-8ce3-3b56a13f7372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_AssetRetirementObligation_e6088304-77ec-4587-8ce3-3b56a13f7372" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_115ecc27-c8c5-4d32-9194-4156df27b858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_115ecc27-c8c5-4d32-9194-4156df27b858" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e72321c-07a6-452e-9d60-7087cfd50aee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_115ecc27-c8c5-4d32-9194-4156df27b858" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e72321c-07a6-452e-9d60-7087cfd50aee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8e72321c-07a6-452e-9d60-7087cfd50aee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e72321c-07a6-452e-9d60-7087cfd50aee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8e72321c-07a6-452e-9d60-7087cfd50aee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e72321c-07a6-452e-9d60-7087cfd50aee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b99db3d5-6a1a-4929-a954-748967f911a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b99db3d5-6a1a-4929-a954-748967f911a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_954c160f-d624-4509-91de-d01f97c83c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_954c160f-d624-4509-91de-d01f97c83c94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember_0e195ee1-d850-4ef5-a472-dbf14403a602" xlink:href="pcrx-20210930.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_pcrx_ComputerEquipmentAndSoftwareMember_0e195ee1-d850-4ef5-a472-dbf14403a602" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_471b370e-0a9b-497d-a521-eb50dd389e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_471b370e-0a9b-497d-a521-eb50dd389e8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_6ea2add9-60af-49a1-a759-05a8c99ac469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_us-gaap_ConstructionInProgressMember_6ea2add9-60af-49a1-a759-05a8c99ac469" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended" id="icf1b88624f4f4de89857656751f0f36e_GOODWILLANDINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_8103cc5a-7ffa-4f8e-8364-0207fa1a47b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_8103cc5a-7ffa-4f8e-8364-0207fa1a47b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2a799342-af67-4548-83a8-1e9ea20e1a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_Goodwill_2a799342-af67-4548-83a8-1e9ea20e1a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_87557821-9627-4cfa-afc4-d7a7b7274f29" xlink:href="pcrx-20210930.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_87557821-9627-4cfa-afc4-d7a7b7274f29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_47a2d3ba-1c0d-40b8-82b3-dd337bd34a6f" xlink:href="pcrx-20210930.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_47a2d3ba-1c0d-40b8-82b3-dd337bd34a6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e838d79e-95d8-4e0c-9691-3cbeaa8fd697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e838d79e-95d8-4e0c-9691-3cbeaa8fd697" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_05f03ea5-41e3-4ded-b659-c35330fdb4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_05f03ea5-41e3-4ded-b659-c35330fdb4a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_a83e9fe3-37ba-4c31-8f6d-183e01658d91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_a83e9fe3-37ba-4c31-8f6d-183e01658d91" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_4bc02277-7343-4ec4-a2fb-1886e2ee61c4" xlink:href="pcrx-20210930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_4bc02277-7343-4ec4-a2fb-1886e2ee61c4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_22725047-43d2-41b7-9c3d-49a6f874e57b" xlink:href="pcrx-20210930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_22725047-43d2-41b7-9c3d-49a6f874e57b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45" xlink:href="pcrx-20210930.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:to="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45_default" xlink:href="pcrx-20210930.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_c814df76-095e-432f-b03d-5c93f1fda5b3" xlink:href="pcrx-20210930.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_c814df76-095e-432f-b03d-5c93f1fda5b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponFirstCommercialSaleInMajorEUCountryMember_5903d22c-c9da-48b8-9902-7a951c336e64" xlink:href="pcrx-20210930.xsd#pcrx_UponFirstCommercialSaleInMajorEUCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_c814df76-095e-432f-b03d-5c93f1fda5b3" xlink:to="loc_pcrx_UponFirstCommercialSaleInMajorEUCountryMember_5903d22c-c9da-48b8-9902-7a951c336e64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_19ec7464-d877-4a3a-9a9c-2bc84fc85e1d" xlink:href="pcrx-20210930.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_c814df76-095e-432f-b03d-5c93f1fda5b3" xlink:to="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_19ec7464-d877-4a3a-9a9c-2bc84fc85e1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_16034e79-37ad-4018-852b-120db674a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_16034e79-37ad-4018-852b-120db674a284" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16034e79-37ad-4018-852b-120db674a284_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16034e79-37ad-4018-852b-120db674a284" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16034e79-37ad-4018-852b-120db674a284_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86a6363d-5710-49c7-b099-90b737b7ad02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16034e79-37ad-4018-852b-120db674a284" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86a6363d-5710-49c7-b099-90b737b7ad02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember_ec4b1d99-f91c-4fde-bbff-4b3f669b1434" xlink:href="pcrx-20210930.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86a6363d-5710-49c7-b099-90b737b7ad02" xlink:to="loc_pcrx_SkyePharmaHoldingIncMember_ec4b1d99-f91c-4fde-bbff-4b3f669b1434" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_c4830834-dc8d-422a-a5c3-39a117307404" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86a6363d-5710-49c7-b099-90b737b7ad02" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_c4830834-dc8d-422a-a5c3-39a117307404" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails" xlink:type="extended" id="i7c22faabaf4c4e3e8be4ef7bd4967fd1_GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b0d969fc-2b36-4574-a028-7ed0767f7ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b0d969fc-2b36-4574-a028-7ed0767f7ec7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_141fb559-8526-48d1-81d3-8c5c7e8d4b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_141fb559-8526-48d1-81d3-8c5c7e8d4b7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_061e4816-05e1-4697-b231-c0401debfb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_061e4816-05e1-4697-b231-c0401debfb70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6368e12b-3dc0-4191-95e1-c65f8d114058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6368e12b-3dc0-4191-95e1-c65f8d114058" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7f15b652-331a-4741-a136-0cb47b2da87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7f15b652-331a-4741-a136-0cb47b2da87c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f15b652-331a-4741-a136-0cb47b2da87c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7f15b652-331a-4741-a136-0cb47b2da87c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f15b652-331a-4741-a136-0cb47b2da87c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd81fce5-e689-491f-97da-d95a07755a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7f15b652-331a-4741-a136-0cb47b2da87c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd81fce5-e689-491f-97da-d95a07755a43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_e8b83769-4e45-4bf1-9df3-606023a8f466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd81fce5-e689-491f-97da-d95a07755a43" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_e8b83769-4e45-4bf1-9df3-606023a8f466" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a5a57634-3440-43db-8e6f-00b86f1a9277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd81fce5-e689-491f-97da-d95a07755a43" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a5a57634-3440-43db-8e6f-00b86f1a9277" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_531547ec-7b28-443a-a16b-880ccb99b360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_531547ec-7b28-443a-a16b-880ccb99b360" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531547ec-7b28-443a-a16b-880ccb99b360_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_531547ec-7b28-443a-a16b-880ccb99b360" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531547ec-7b28-443a-a16b-880ccb99b360_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2cf4726c-da89-4778-bd4a-40e21b3a6c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_531547ec-7b28-443a-a16b-880ccb99b360" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2cf4726c-da89-4778-bd4a-40e21b3a6c42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_c3b0beba-bb5d-40ab-a72f-2aca9b047e91" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2cf4726c-da89-4778-bd4a-40e21b3a6c42" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_c3b0beba-bb5d-40ab-a72f-2aca9b047e91" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="extended" id="i947f2f486a974bc887a0fc01a0cc30ad_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_77bfe8be-933d-4993-97be-ae6803d58433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_77bfe8be-933d-4993-97be-ae6803d58433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_57c6a29c-8735-40ad-9135-15e1328e6686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_57c6a29c-8735-40ad-9135-15e1328e6686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_d558797d-ce5b-4b49-85c2-a3e390713e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_d558797d-ce5b-4b49-85c2-a3e390713e4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_0cd482b8-7557-48c1-9554-045b21597cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_0cd482b8-7557-48c1-9554-045b21597cd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f878078a-d3f6-4a13-afcd-47209ade3eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_RepaymentsOfDebt_f878078a-d3f6-4a13-afcd-47209ade3eef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f17fd609-8d7c-4560-8af8-a01fb1775476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f17fd609-8d7c-4560-8af8-a01fb1775476" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_108c8b10-6587-48bf-883f-42fd38ed16bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_108c8b10-6587-48bf-883f-42fd38ed16bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c29fec17-c8e7-44d7-863f-0154f1c5fe74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c29fec17-c8e7-44d7-863f-0154f1c5fe74" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock_e5d0bb7b-30b2-4d48-84c9-d5bcf2fcbeac" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock_e5d0bb7b-30b2-4d48-84c9-d5bcf2fcbeac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_9637b67f-0b17-41fb-9473-7ea40a15989f" xlink:href="pcrx-20210930.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_9637b67f-0b17-41fb-9473-7ea40a15989f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice_65e3c46e-2560-40bc-8f92-ed1c7a504dcd" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentMarketPrice_65e3c46e-2560-40bc-8f92-ed1c7a504dcd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_0840891d-2cb3-4f6c-bdd5-57d59e297103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_0840891d-2cb3-4f6c-bdd5-57d59e297103" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_87162a84-6909-478a-8d89-39600c1cd9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_87162a84-6909-478a-8d89-39600c1cd9d0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_8bcbfbc4-f590-4c17-a0a6-ce1f47052a99" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_8bcbfbc4-f590-4c17-a0a6-ce1f47052a99" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_d0b51958-7c59-4d45-b905-5edb309fff53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_SharePrice_d0b51958-7c59-4d45-b905-5edb309fff53" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_1460086e-9873-4bd3-90f4-6961009fe984" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_1460086e-9873-4bd3-90f4-6961009fe984" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent_f782feda-fcb8-4dda-a407-ee1a1f97203f" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent_f782feda-fcb8-4dda-a407-ee1a1f97203f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate_8071db4c-cc1d-498d-b1a2-07513b5f2e35" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleAssumedBorrowingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate_8071db4c-cc1d-498d-b1a2-07513b5f2e35" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_90a5dc5c-89e7-461d-a6a2-2b738897dc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_90a5dc5c-89e7-461d-a6a2-2b738897dc4f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6b32d031-2a5f-4236-942c-f72fd6161649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentTerm_6b32d031-2a5f-4236-942c-f72fd6161649" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt_f6be6842-5df7-47db-bb0d-968bb96e2bd7" xlink:href="pcrx-20210930.xsd#pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt_f6be6842-5df7-47db-bb0d-968bb96e2bd7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_e9c1460a-9181-4bdf-9fc4-13a3565b76e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_e9c1460a-9181-4bdf-9fc4-13a3565b76e8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt_48c21f0e-cd0f-414d-b429-fbe9d7418c57" xlink:href="pcrx-20210930.xsd#pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt_48c21f0e-cd0f-414d-b429-fbe9d7418c57" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt_765c2ec7-67f1-4e8e-a977-bbde9fc4cd02" xlink:href="pcrx-20210930.xsd#pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt_765c2ec7-67f1-4e8e-a977-bbde9fc4cd02" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06ed8b1f-b8f0-42cb-895e-114b6318ac88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06ed8b1f-b8f0-42cb-895e-114b6318ac88" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption_8fe86901-8ed9-457e-a762-aa6b67a95bba" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption_8fe86901-8ed9-457e-a762-aa6b67a95bba" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_98293eae-dae0-49ba-9568-ce213ed3e46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_98293eae-dae0-49ba-9568-ce213ed3e46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_4303f7ba-3d3a-4377-8d4e-916bd7426a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98293eae-dae0-49ba-9568-ce213ed3e46b" xlink:to="loc_us-gaap_UnsecuredDebtMember_4303f7ba-3d3a-4377-8d4e-916bd7426a27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c9fa277b-ee19-4dee-80e9-e0cc93c9a1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98293eae-dae0-49ba-9568-ce213ed3e46b" xlink:to="loc_us-gaap_ConvertibleDebtMember_c9fa277b-ee19-4dee-80e9-e0cc93c9a1fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_68328b39-171c-4362-b049-2c34652f7447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:to="loc_us-gaap_DebtInstrumentAxis_68328b39-171c-4362-b049-2c34652f7447" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_68328b39-171c-4362-b049-2c34652f7447_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_68328b39-171c-4362-b049-2c34652f7447" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_68328b39-171c-4362-b049-2c34652f7447_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_246298b8-a329-4c3c-9772-d56604ed9851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_68328b39-171c-4362-b049-2c34652f7447" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_246298b8-a329-4c3c-9772-d56604ed9851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_c4180e86-323e-4c24-bb4d-158b73628af6" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_246298b8-a329-4c3c-9772-d56604ed9851" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_c4180e86-323e-4c24-bb4d-158b73628af6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_badee7b1-f5c7-4288-b80f-b8c8c7a33f86" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_246298b8-a329-4c3c-9772-d56604ed9851" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_badee7b1-f5c7-4288-b80f-b8c8c7a33f86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis_e33f8b4b-2317-44e6-8290-163f6627e065" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsAxis_e33f8b4b-2317-44e6-8290-163f6627e065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_e33f8b4b-2317-44e6-8290-163f6627e065_default" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_e33f8b4b-2317-44e6-8290-163f6627e065" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_e33f8b4b-2317-44e6-8290-163f6627e065_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_e33f8b4b-2317-44e6-8290-163f6627e065" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member_f0e74b25-4533-4289-a738-c6c6a65c0a36" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:to="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member_f0e74b25-4533-4289-a738-c6c6a65c0a36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_36a331d1-7c0c-4ef1-b173-7909fcd7d0a4" xlink:href="pcrx-20210930.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:to="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_36a331d1-7c0c-4ef1-b173-7909fcd7d0a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member_391ecdd6-9183-4887-aeca-8863b5e91e0f" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:to="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member_391ecdd6-9183-4887-aeca-8863b5e91e0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsonorafterApril12020Member_8f4918b5-c516-40d1-8d28-f2bc2be298f5" xlink:href="pcrx-20210930.xsd#pcrx_DebtRedemptionTermsonorafterApril12020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:to="loc_pcrx_DebtRedemptionTermsonorafterApril12020Member_8f4918b5-c516-40d1-8d28-f2bc2be298f5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DEBTScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended" id="i01d3bce549eb49d4be42891888de4058_DEBTScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e11b2bb6-d89e-4337-a911-ad5678fbd4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e11b2bb6-d89e-4337-a911-ad5678fbd4a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3b5fd45d-a845-4e0d-9c5a-ddd39adf6877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3b5fd45d-a845-4e0d-9c5a-ddd39adf6877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_851e4cf1-000f-4366-bd3f-2aec667631d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_851e4cf1-000f-4366-bd3f-2aec667631d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b5b55d8c-d07a-4618-aafd-8169995a0dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b5b55d8c-d07a-4618-aafd-8169995a0dd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ef9fae72-a38e-4651-af7b-ec6174b8ef47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_LongTermDebt_ef9fae72-a38e-4651-af7b-ec6174b8ef47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c82b5f16-5a55-468a-af07-0836aaa09092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c82b5f16-5a55-468a-af07-0836aaa09092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c82b5f16-5a55-468a-af07-0836aaa09092_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c82b5f16-5a55-468a-af07-0836aaa09092" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c82b5f16-5a55-468a-af07-0836aaa09092_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e1536b24-8033-4716-96dc-89b43bce2cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c82b5f16-5a55-468a-af07-0836aaa09092" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e1536b24-8033-4716-96dc-89b43bce2cd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a4ae22be-7241-40a3-8a9b-6fe47f77df2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e1536b24-8033-4716-96dc-89b43bce2cd3" xlink:to="loc_us-gaap_UnsecuredDebtMember_a4ae22be-7241-40a3-8a9b-6fe47f77df2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eab339b7-695b-4ec3-82d3-88ddc54e8879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:to="loc_us-gaap_DebtInstrumentAxis_eab339b7-695b-4ec3-82d3-88ddc54e8879" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eab339b7-695b-4ec3-82d3-88ddc54e8879_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_eab339b7-695b-4ec3-82d3-88ddc54e8879" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eab339b7-695b-4ec3-82d3-88ddc54e8879_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2f9026b9-6e16-42fa-bb3f-130be7397d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_eab339b7-695b-4ec3-82d3-88ddc54e8879" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2f9026b9-6e16-42fa-bb3f-130be7397d17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_866cdaf2-8d7f-4c4b-b69d-c586eb99db54" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2f9026b9-6e16-42fa-bb3f-130be7397d17" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_866cdaf2-8d7f-4c4b-b69d-c586eb99db54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_70bb6818-793e-4dd8-a5b7-b106278c6a5e" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2f9026b9-6e16-42fa-bb3f-130be7397d17" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_70bb6818-793e-4dd8-a5b7-b106278c6a5e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended" id="i606d9c3139eb4d6c8f84f51b9214b432_FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_7f8687ed-dadd-4286-b0bd-b1e6c28b16d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_7f8687ed-dadd-4286-b0bd-b1e6c28b16d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_f0f14528-17ba-44d9-8bd1-221797693398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_7f8687ed-dadd-4286-b0bd-b1e6c28b16d2" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_f0f14528-17ba-44d9-8bd1-221797693398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_5d1a7f41-4136-4a6e-9c85-3071beb67f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_5d1a7f41-4136-4a6e-9c85-3071beb67f44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e696af4d-13e4-4e50-9fcc-381a30bd63c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_5d1a7f41-4136-4a6e-9c85-3071beb67f44" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e696af4d-13e4-4e50-9fcc-381a30bd63c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_7dba40a9-8400-47d4-8612-8e087d89f241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_DebtInstrumentFairValue_7dba40a9-8400-47d4-8612-8e087d89f241" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0c081fa3-6f48-4da8-8582-0c1d248c7007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0c081fa3-6f48-4da8-8582-0c1d248c7007" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_a05c91bd-2114-4e51-8a2e-fa1182ac04ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_SharePrice_a05c91bd-2114-4e51-8a2e-fa1182ac04ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_fab592cb-e6b2-4bd8-8bac-02ef12ce07de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_fab592cb-e6b2-4bd8-8bac-02ef12ce07de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_979211a0-3770-4371-907c-b074bca46ba6" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_979211a0-3770-4371-907c-b074bca46ba6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_f43a5afd-eebe-4e08-8530-ba538cd47bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_f43a5afd-eebe-4e08-8530-ba538cd47bcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f43a5afd-eebe-4e08-8530-ba538cd47bcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f43a5afd-eebe-4e08-8530-ba538cd47bcb" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f43a5afd-eebe-4e08-8530-ba538cd47bcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f43a5afd-eebe-4e08-8530-ba538cd47bcb" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_75da5ef9-fd6c-4329-96a2-10e6500e8ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_75da5ef9-fd6c-4329-96a2-10e6500e8ad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0564fff0-7dc8-40f4-b499-2a3394e66dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0564fff0-7dc8-40f4-b499-2a3394e66dee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18c70250-c970-43a3-b44a-a09cef818a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18c70250-c970-43a3-b44a-a09cef818a20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_064b33dc-385a-4cf9-876e-b1ecfc0378a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_064b33dc-385a-4cf9-876e-b1ecfc0378a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_064b33dc-385a-4cf9-876e-b1ecfc0378a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_064b33dc-385a-4cf9-876e-b1ecfc0378a2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_064b33dc-385a-4cf9-876e-b1ecfc0378a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_064b33dc-385a-4cf9-876e-b1ecfc0378a2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d1127124-f59e-4094-9013-b940d67119e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d1127124-f59e-4094-9013-b940d67119e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_28c187b3-fa2a-4bf6-a81c-e41621c03a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_28c187b3-fa2a-4bf6-a81c-e41621c03a6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_16a81cf5-a2f6-4929-80b6-2815beb81c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_16a81cf5-a2f6-4929-80b6-2815beb81c14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_DebtInstrumentAxis_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94ba4768-49a2-4c33-bb6c-8c2e322961a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94ba4768-49a2-4c33-bb6c-8c2e322961a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_af516d5a-7122-4daa-b5d1-0db8aebde25e" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94ba4768-49a2-4c33-bb6c-8c2e322961a5" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_af516d5a-7122-4daa-b5d1-0db8aebde25e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_ad5f703f-c6d3-4ac6-9597-c05faf2c4a79" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94ba4768-49a2-4c33-bb6c-8c2e322961a5" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_ad5f703f-c6d3-4ac6-9597-c05faf2c4a79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_26e50bf6-aa8e-440e-b54d-2a1ed33cb551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_26e50bf6-aa8e-440e-b54d-2a1ed33cb551" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_26e50bf6-aa8e-440e-b54d-2a1ed33cb551_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_26e50bf6-aa8e-440e-b54d-2a1ed33cb551" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_26e50bf6-aa8e-440e-b54d-2a1ed33cb551_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_046983a4-9a8a-41c4-ae2d-db1cccf26b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_26e50bf6-aa8e-440e-b54d-2a1ed33cb551" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_046983a4-9a8a-41c4-ae2d-db1cccf26b4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_36012309-c561-4414-82f4-7828384c8ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_046983a4-9a8a-41c4-ae2d-db1cccf26b4e" xlink:to="loc_us-gaap_UnsecuredDebtMember_36012309-c561-4414-82f4-7828384c8ebc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c6059bac-78c6-4a40-b0ab-b4b50b278c4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_srt_RangeAxis_c6059bac-78c6-4a40-b0ab-b4b50b278c4e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c6059bac-78c6-4a40-b0ab-b4b50b278c4e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c6059bac-78c6-4a40-b0ab-b4b50b278c4e" xlink:to="loc_srt_RangeMember_c6059bac-78c6-4a40-b0ab-b4b50b278c4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_08a8adcb-d659-4b34-9bf8-4b12ea14e958" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c6059bac-78c6-4a40-b0ab-b4b50b278c4e" xlink:to="loc_srt_RangeMember_08a8adcb-d659-4b34-9bf8-4b12ea14e958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_beb2600d-44e5-4615-a3bd-23dc64bc58b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_08a8adcb-d659-4b34-9bf8-4b12ea14e958" xlink:to="loc_srt_MaximumMember_beb2600d-44e5-4615-a3bd-23dc64bc58b3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended" id="ibd7858f7126d433ca8fe491d483d6b69_FINANCIALINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_0525e588-8cd4-4837-aa80-4de03f1c2279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_0525e588-8cd4-4837-aa80-4de03f1c2279" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_356e86e3-e85f-41b4-8246-900747e50ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_356e86e3-e85f-41b4-8246-900747e50ea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_796fbc31-7d25-4b84-80af-06ffe6f7f547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_796fbc31-7d25-4b84-80af-06ffe6f7f547" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_843e9bd8-8ded-4cc8-ae89-d115c063d661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_ConvertibleNotesPayable_843e9bd8-8ded-4cc8-ae89-d115c063d661" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_8ad381b6-d872-476f-ab74-c891e98d7496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_8ad381b6-d872-476f-ab74-c891e98d7496" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_4f872c0a-701d-487c-a7e9-9ee5a3d8f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_4f872c0a-701d-487c-a7e9-9ee5a3d8f0e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones_78f96426-c73a-456a-beeb-e1dc56ee97fe" xlink:href="pcrx-20210930.xsd#pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones_78f96426-c73a-456a-beeb-e1dc56ee97fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0f77d7da-1505-4cef-bb38-0f8807d5688a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0f77d7da-1505-4cef-bb38-0f8807d5688a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_3f4199d4-404a-4545-b630-5224886c9cfd" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_ContingentConsideration_3f4199d4-404a-4545-b630-5224886c9cfd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_93376318-d063-4eda-b8b9-8a7b37e90b96" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_93376318-d063-4eda-b8b9-8a7b37e90b96" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent_fefbe3ac-fc73-476a-b189-8e3eec5fdaf0" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_ContingentConsiderationCurrent_fefbe3ac-fc73-476a-b189-8e3eec5fdaf0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePayment_8cf7cdca-ade1-4233-8513-9e21aec4ff84" xlink:href="pcrx-20210930.xsd#pcrx_MilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_MilestonePayment_8cf7cdca-ade1-4233-8513-9e21aec4ff84" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_db3faaea-4c01-4cbf-86e0-c7bfa8e514ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_db3faaea-4c01-4cbf-86e0-c7bfa8e514ab" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7c0c807c-1534-4121-a679-55256dc05d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7c0c807c-1534-4121-a679-55256dc05d01" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1e48d61c-1bc5-4888-a527-50ade7f53e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1e48d61c-1bc5-4888-a527-50ade7f53e1a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d965a7f8-b047-4f13-98b6-8870a8da2892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d965a7f8-b047-4f13-98b6-8870a8da2892" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_a5d621a1-7c9c-4a01-8eeb-a3cdb269cc68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_InterestReceivable_a5d621a1-7c9c-4a01-8eeb-a3cdb269cc68" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_823a8f70-32e6-4fcc-b50c-0dd329aa4615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_823a8f70-32e6-4fcc-b50c-0dd329aa4615" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_54aeb6de-4fbe-43fc-8178-cc360aece657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_54aeb6de-4fbe-43fc-8178-cc360aece657" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_00886ffa-c933-4e9f-9b81-cfd702724e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_DebtInstrumentAxis_00886ffa-c933-4e9f-9b81-cfd702724e78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_00886ffa-c933-4e9f-9b81-cfd702724e78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_00886ffa-c933-4e9f-9b81-cfd702724e78" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_00886ffa-c933-4e9f-9b81-cfd702724e78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd3eb998-5866-4961-92d8-90f19a3064fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_00886ffa-c933-4e9f-9b81-cfd702724e78" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd3eb998-5866-4961-92d8-90f19a3064fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_82f98df2-83df-41c7-a0b1-9352d44ac290" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd3eb998-5866-4961-92d8-90f19a3064fe" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_82f98df2-83df-41c7-a0b1-9352d44ac290" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_281cd5dc-f60b-4d64-800a-17df483f4b54" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd3eb998-5866-4961-92d8-90f19a3064fe" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_281cd5dc-f60b-4d64-800a-17df483f4b54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_88844747-888c-4c76-b778-f92bf94e379d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_88844747-888c-4c76-b778-f92bf94e379d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_88844747-888c-4c76-b778-f92bf94e379d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_88844747-888c-4c76-b778-f92bf94e379d" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_88844747-888c-4c76-b778-f92bf94e379d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_88844747-888c-4c76-b778-f92bf94e379d" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TELABioMember_730f7ae9-3987-4b05-986f-788fc3ca5a3e" xlink:href="pcrx-20210930.xsd#pcrx_TELABioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:to="loc_pcrx_TELABioMember_730f7ae9-3987-4b05-986f-788fc3ca5a3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_GeneQuineBiotherapeuticsGmbHMember_5ae70030-c599-4cdc-b005-00b8d069e445" xlink:href="pcrx-20210930.xsd#pcrx_GeneQuineBiotherapeuticsGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:to="loc_pcrx_GeneQuineBiotherapeuticsGmbHMember_5ae70030-c599-4cdc-b005-00b8d069e445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SpineBioPharmaLLCMember_a092a372-9366-43ba-b363-0c20a77197eb" xlink:href="pcrx-20210930.xsd#pcrx_SpineBioPharmaLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:to="loc_pcrx_SpineBioPharmaLLCMember_a092a372-9366-43ba-b363-0c20a77197eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_061d9851-39f2-49e3-8d03-3f486d2a2943" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_061d9851-39f2-49e3-8d03-3f486d2a2943" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_061d9851-39f2-49e3-8d03-3f486d2a2943_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_061d9851-39f2-49e3-8d03-3f486d2a2943" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_061d9851-39f2-49e3-8d03-3f486d2a2943_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_10386c3a-b38c-4495-9b3d-829ff5d592f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_061d9851-39f2-49e3-8d03-3f486d2a2943" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_10386c3a-b38c-4495-9b3d-829ff5d592f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CodaBioTherapeuticsIncMember_df00941a-e605-4f62-b99e-aa912a36f42d" xlink:href="pcrx-20210930.xsd#pcrx_CodaBioTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_10386c3a-b38c-4495-9b3d-829ff5d592f6" xlink:to="loc_pcrx_CodaBioTherapeuticsIncMember_df00941a-e605-4f62-b99e-aa912a36f42d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_22dbfe49-eb2f-4df3-8f74-61e045a08eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_22dbfe49-eb2f-4df3-8f74-61e045a08eab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22dbfe49-eb2f-4df3-8f74-61e045a08eab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_22dbfe49-eb2f-4df3-8f74-61e045a08eab" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22dbfe49-eb2f-4df3-8f74-61e045a08eab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b7a8937-9c06-40b9-9eed-d3a4b13df774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_22dbfe49-eb2f-4df3-8f74-61e045a08eab" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b7a8937-9c06-40b9-9eed-d3a4b13df774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_0bd712f6-ca96-48e0-a57c-843327388822" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b7a8937-9c06-40b9-9eed-d3a4b13df774" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_0bd712f6-ca96-48e0-a57c-843327388822" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneAxis_38c0799e-a88d-45ae-aa36-9d56305fec31" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_pcrx_AchievementOfMilestoneAxis_38c0799e-a88d-45ae-aa36-9d56305fec31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneDomain_38c0799e-a88d-45ae-aa36-9d56305fec31_default" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pcrx_AchievementOfMilestoneAxis_38c0799e-a88d-45ae-aa36-9d56305fec31" xlink:to="loc_pcrx_AchievementOfMilestoneDomain_38c0799e-a88d-45ae-aa36-9d56305fec31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneDomain_f08ccd69-756a-4e22-a7e0-90354cfd1116" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pcrx_AchievementOfMilestoneAxis_38c0799e-a88d-45ae-aa36-9d56305fec31" xlink:to="loc_pcrx_AchievementOfMilestoneDomain_f08ccd69-756a-4e22-a7e0-90354cfd1116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementofRegulatoryMilestoneMember_5d3a5cde-0367-46ba-a626-5598584c498b" xlink:href="pcrx-20210930.xsd#pcrx_AchievementofRegulatoryMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_AchievementOfMilestoneDomain_f08ccd69-756a-4e22-a7e0-90354cfd1116" xlink:to="loc_pcrx_AchievementofRegulatoryMilestoneMember_5d3a5cde-0367-46ba-a626-5598584c498b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2adb57bd-88ce-4196-a459-9ce63913f59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2adb57bd-88ce-4196-a459-9ce63913f59f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2adb57bd-88ce-4196-a459-9ce63913f59f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2adb57bd-88ce-4196-a459-9ce63913f59f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2adb57bd-88ce-4196-a459-9ce63913f59f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_45a40b4a-4ecb-4907-9477-385c6c177f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2adb57bd-88ce-4196-a459-9ce63913f59f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_45a40b4a-4ecb-4907-9477-385c6c177f52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_b20dcaeb-5d99-464c-bc4f-d678aca85db8" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_45a40b4a-4ecb-4907-9477-385c6c177f52" xlink:to="loc_pcrx_ContingentConsiderationMember_b20dcaeb-5d99-464c-bc4f-d678aca85db8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ff8abc62-f8f3-491e-a962-d2eb20984856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ff8abc62-f8f3-491e-a962-d2eb20984856" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff8abc62-f8f3-491e-a962-d2eb20984856_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ff8abc62-f8f3-491e-a962-d2eb20984856" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff8abc62-f8f3-491e-a962-d2eb20984856_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfcaff3d-4183-4093-b1be-9c01ecd5236c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ff8abc62-f8f3-491e-a962-d2eb20984856" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfcaff3d-4183-4093-b1be-9c01ecd5236c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_c7eaf3d2-cf37-41f3-af29-2812c88d11ad" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfcaff3d-4183-4093-b1be-9c01ecd5236c" xlink:to="loc_pcrx_ContingentConsiderationMember_c7eaf3d2-cf37-41f3-af29-2812c88d11ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_ef5f6800-66ad-4513-8177-009d35c08654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_ef5f6800-66ad-4513-8177-009d35c08654" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ef5f6800-66ad-4513-8177-009d35c08654_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_ef5f6800-66ad-4513-8177-009d35c08654" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ef5f6800-66ad-4513-8177-009d35c08654_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_33495bf8-3b24-4a9f-9577-ac731d6ec0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_ef5f6800-66ad-4513-8177-009d35c08654" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_33495bf8-3b24-4a9f-9577-ac731d6ec0d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_9af156a5-36b4-477b-a379-197dc73ee8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33495bf8-3b24-4a9f-9577-ac731d6ec0d1" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_9af156a5-36b4-477b-a379-197dc73ee8ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_6b03424d-82cc-4b9d-aff2-2657b2b3411f" xlink:href="pcrx-20210930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33495bf8-3b24-4a9f-9577-ac731d6ec0d1" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_6b03424d-82cc-4b9d-aff2-2657b2b3411f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1261093b-8e06-425b-a3f0-eb577ce9abae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1261093b-8e06-425b-a3f0-eb577ce9abae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1261093b-8e06-425b-a3f0-eb577ce9abae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1261093b-8e06-425b-a3f0-eb577ce9abae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1261093b-8e06-425b-a3f0-eb577ce9abae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1faaefd1-5ac0-42c8-8af0-c69f9f7d5ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1261093b-8e06-425b-a3f0-eb577ce9abae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1faaefd1-5ac0-42c8-8af0-c69f9f7d5ffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b1e105ba-7554-4261-a003-eeca2c7d6d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1faaefd1-5ac0-42c8-8af0-c69f9f7d5ffb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b1e105ba-7554-4261-a003-eeca2c7d6d6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_98b12662-1e26-4bca-be7b-86112850e873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_98b12662-1e26-4bca-be7b-86112850e873" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_98b12662-1e26-4bca-be7b-86112850e873_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_98b12662-1e26-4bca-be7b-86112850e873" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_98b12662-1e26-4bca-be7b-86112850e873_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cd78eb6b-6537-4194-a33b-b7356adf33fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_98b12662-1e26-4bca-be7b-86112850e873" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cd78eb6b-6537-4194-a33b-b7356adf33fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_1eab9a76-131b-46b2-b115-0e66fc1ae240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cd78eb6b-6537-4194-a33b-b7356adf33fc" xlink:to="loc_us-gaap_AccountsReceivableMember_1eab9a76-131b-46b2-b115-0e66fc1ae240" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_435b29e2-05f0-41ca-8f4b-53a0214e76d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_435b29e2-05f0-41ca-8f4b-53a0214e76d5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_435b29e2-05f0-41ca-8f4b-53a0214e76d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_435b29e2-05f0-41ca-8f4b-53a0214e76d5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_435b29e2-05f0-41ca-8f4b-53a0214e76d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_355aeb17-10b0-4fbd-8fca-85419585e214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_435b29e2-05f0-41ca-8f4b-53a0214e76d5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_355aeb17-10b0-4fbd-8fca-85419585e214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_268234d0-09a9-4dbe-ba4a-6307b4112907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_355aeb17-10b0-4fbd-8fca-85419585e214" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_268234d0-09a9-4dbe-ba4a-6307b4112907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_919f4ec5-ca93-46ee-8822-7181a76eb1dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_srt_MajorCustomersAxis_919f4ec5-ca93-46ee-8822-7181a76eb1dc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_919f4ec5-ca93-46ee-8822-7181a76eb1dc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_919f4ec5-ca93-46ee-8822-7181a76eb1dc" xlink:to="loc_srt_NameOfMajorCustomerDomain_919f4ec5-ca93-46ee-8822-7181a76eb1dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_919f4ec5-ca93-46ee-8822-7181a76eb1dc" xlink:to="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember_849ae4aa-9784-40d1-867e-c5dbc372484e" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:to="loc_pcrx_MajorCustomerOneMember_849ae4aa-9784-40d1-867e-c5dbc372484e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember_037962bb-5875-46bb-bc7c-79fecac042cd" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:to="loc_pcrx_MajorCustomerTwoMember_037962bb-5875-46bb-bc7c-79fecac042cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember_6d69eda2-42b8-4156-9f6d-8224fcf35b8d" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:to="loc_pcrx_MajorCustomerThreeMember_6d69eda2-42b8-4156-9f6d-8224fcf35b8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1eb384c0-24aa-4742-a7e2-a121da71d141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1eb384c0-24aa-4742-a7e2-a121da71d141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_9a29f55f-a750-4bbd-9c70-82d617e40213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1eb384c0-24aa-4742-a7e2-a121da71d141" xlink:to="loc_us-gaap_NotesReceivableMember_9a29f55f-a750-4bbd-9c70-82d617e40213" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="extended" id="i86bddeb3f26248f5b2c756fef69f5965_FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b1cf93d9-f671-4ab8-b9f7-e1bfbd2c9b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_3e2af66b-625e-47f3-9b8f-8a335ff60e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b1cf93d9-f671-4ab8-b9f7-e1bfbd2c9b9c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_3e2af66b-625e-47f3-9b8f-8a335ff60e75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b1cf93d9-f671-4ab8-b9f7-e1bfbd2c9b9c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa3fd78-dbc2-473d-b9e7-f7de7cdbeeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa3fd78-dbc2-473d-b9e7-f7de7cdbeeb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e224ada4-8b00-469e-ab28-a67751072602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa3fd78-dbc2-473d-b9e7-f7de7cdbeeb9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e224ada4-8b00-469e-ab28-a67751072602" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_69a79834-badd-42a6-94c4-d0f2c8127f6e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_srt_RangeAxis_69a79834-badd-42a6-94c4-d0f2c8127f6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_69a79834-badd-42a6-94c4-d0f2c8127f6e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_69a79834-badd-42a6-94c4-d0f2c8127f6e" xlink:to="loc_srt_RangeMember_69a79834-badd-42a6-94c4-d0f2c8127f6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa0eaaac-11b9-4da4-a3fc-041c7d513bc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_69a79834-badd-42a6-94c4-d0f2c8127f6e" xlink:to="loc_srt_RangeMember_fa0eaaac-11b9-4da4-a3fc-041c7d513bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f4b39ffb-2d4e-4f92-8d56-b15a73ddcf45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fa0eaaac-11b9-4da4-a3fc-041c7d513bc9" xlink:to="loc_srt_MinimumMember_f4b39ffb-2d4e-4f92-8d56-b15a73ddcf45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_27c58634-2749-4a53-aa9f-5cfaf12eeb98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fa0eaaac-11b9-4da4-a3fc-041c7d513bc9" xlink:to="loc_srt_MaximumMember_27c58634-2749-4a53-aa9f-5cfaf12eeb98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_474ffa48-66e8-45df-b7ac-55b911bea50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_474ffa48-66e8-45df-b7ac-55b911bea50f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_474ffa48-66e8-45df-b7ac-55b911bea50f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_474ffa48-66e8-45df-b7ac-55b911bea50f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_474ffa48-66e8-45df-b7ac-55b911bea50f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1025a56d-98dd-4a8b-8afa-69301426e711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_474ffa48-66e8-45df-b7ac-55b911bea50f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1025a56d-98dd-4a8b-8afa-69301426e711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_230bd908-ea50-4f33-8316-ef9064c82db6" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1025a56d-98dd-4a8b-8afa-69301426e711" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_230bd908-ea50-4f33-8316-ef9064c82db6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8a27d922-03e6-4a27-aec5-6d6dc1786fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8a27d922-03e6-4a27-aec5-6d6dc1786fa9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a27d922-03e6-4a27-aec5-6d6dc1786fa9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8a27d922-03e6-4a27-aec5-6d6dc1786fa9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a27d922-03e6-4a27-aec5-6d6dc1786fa9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a7f7fed6-25bd-4329-a41d-cae46b12ac5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8a27d922-03e6-4a27-aec5-6d6dc1786fa9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a7f7fed6-25bd-4329-a41d-cae46b12ac5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_912ff03b-f94e-4964-b003-1eb2703f49b4" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a7f7fed6-25bd-4329-a41d-cae46b12ac5d" xlink:to="loc_pcrx_ContingentConsiderationMember_912ff03b-f94e-4964-b003-1eb2703f49b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_b34354be-f2f4-4696-93de-9fd963a11e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_b34354be-f2f4-4696-93de-9fd963a11e49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b34354be-f2f4-4696-93de-9fd963a11e49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b34354be-f2f4-4696-93de-9fd963a11e49" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b34354be-f2f4-4696-93de-9fd963a11e49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_4e4abaa2-d482-419a-a625-64e943520076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b34354be-f2f4-4696-93de-9fd963a11e49" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_4e4abaa2-d482-419a-a625-64e943520076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_00345a68-95a5-455e-874b-659c7543467a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4e4abaa2-d482-419a-a625-64e943520076" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_00345a68-95a5-455e-874b-659c7543467a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_80f70559-236c-4612-8a05-36d162a7441c" xlink:href="pcrx-20210930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4e4abaa2-d482-419a-a625-64e943520076" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_80f70559-236c-4612-8a05-36d162a7441c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="extended" id="i0e833597df744050aeca073d98778581_FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f96c384c-d369-459e-bc05-c86d90dbab3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f96c384c-d369-459e-bc05-c86d90dbab3a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_69e72a37-46f7-4652-a8f7-6b6ecbd26080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_69e72a37-46f7-4652-a8f7-6b6ecbd26080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b64d6ee8-00a6-41cc-b464-1b3ee0c2e8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b64d6ee8-00a6-41cc-b464-1b3ee0c2e8d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_45d86cc1-b043-4acb-bcc5-6547860e8232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_45d86cc1-b043-4acb-bcc5-6547860e8232" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims_b2f902bf-b9c7-4aa4-a6db-6c1a4e1df275" xlink:href="pcrx-20210930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims_b2f902bf-b9c7-4aa4-a6db-6c1a4e1df275" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7eb56d32-bf3c-4a4a-8909-ce3c0ce035a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e85bf44f-68dd-4d91-ae06-8b0f1cf941fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f96c384c-d369-459e-bc05-c86d90dbab3a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e85bf44f-68dd-4d91-ae06-8b0f1cf941fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_bfc49071-9882-4010-abd7-bfb2c1a75fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e85bf44f-68dd-4d91-ae06-8b0f1cf941fb" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_bfc49071-9882-4010-abd7-bfb2c1a75fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_bfc49071-9882-4010-abd7-bfb2c1a75fd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_bfc49071-9882-4010-abd7-bfb2c1a75fd4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_bfc49071-9882-4010-abd7-bfb2c1a75fd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ca019cc5-7fb6-4343-affe-7eacb2d51848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_bfc49071-9882-4010-abd7-bfb2c1a75fd4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ca019cc5-7fb6-4343-affe-7eacb2d51848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_032bfb68-027c-4272-aa39-027973d283a4" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ca019cc5-7fb6-4343-affe-7eacb2d51848" xlink:to="loc_pcrx_ContingentConsiderationMember_032bfb68-027c-4272-aa39-027973d283a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended" id="i0bd2e60eeebb4bea9f7f6ed94ce64483_FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_141fe59d-4676-4d5b-88e5-fe29210bbe46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_141fe59d-4676-4d5b-88e5-fe29210bbe46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d57bb4d9-4e70-43e2-86ad-bc0e5e3330d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d57bb4d9-4e70-43e2-86ad-bc0e5e3330d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c75e699e-7111-4f47-83a2-116cdc475433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c75e699e-7111-4f47-83a2-116cdc475433" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d28128fe-b18a-4367-82a4-01600ef41dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d28128fe-b18a-4367-82a4-01600ef41dd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_afafb961-a801-4f20-a5f5-f55c7aec545c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:to="loc_us-gaap_FinancialInstrumentAxis_afafb961-a801-4f20-a5f5-f55c7aec545c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_afafb961-a801-4f20-a5f5-f55c7aec545c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_afafb961-a801-4f20-a5f5-f55c7aec545c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_afafb961-a801-4f20-a5f5-f55c7aec545c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_afafb961-a801-4f20-a5f5-f55c7aec545c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_874974c9-4b3f-472c-a5ae-30f140d01472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_874974c9-4b3f-472c-a5ae-30f140d01472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0bdd3ab3-a31c-4bc8-948e-88208cc83a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:to="loc_us-gaap_CommercialPaperMember_0bdd3ab3-a31c-4bc8-948e-88208cc83a20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_c4618cd4-01be-4a53-abf4-1f3225b884f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_c4618cd4-01be-4a53-abf4-1f3225b884f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember_b7328c3d-7f1e-429f-be3c-b98f18a887a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:to="loc_us-gaap_USTreasuryBondSecuritiesMember_b7328c3d-7f1e-429f-be3c-b98f18a887a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:to="loc_us-gaap_InvestmentTypeAxis_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_879ba30f-851e-4959-bd9e-59249fb60518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_879ba30f-851e-4959-bd9e-59249fb60518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_5fd94322-543f-4a3a-b40f-a9870936db23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_879ba30f-851e-4959-bd9e-59249fb60518" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_5fd94322-543f-4a3a-b40f-a9870936db23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LongTermInvestmentsMember_0eff8fed-f6f1-403c-9462-51778286468d" xlink:href="pcrx-20210930.xsd#pcrx_LongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_879ba30f-851e-4959-bd9e-59249fb60518" xlink:to="loc_pcrx_LongTermInvestmentsMember_0eff8fed-f6f1-403c-9462-51778286468d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended" id="i155e47b185bd40fa80ba31b4ffd1a5db_STOCKPLANSScheduleofStockBasedCompensationExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0df9b7bb-ae9b-48a6-a86e-a60f518bbe70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f262d18c-a43f-4240-af4f-ab9bf432a612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0df9b7bb-ae9b-48a6-a86e-a60f518bbe70" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f262d18c-a43f-4240-af4f-ab9bf432a612" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0df9b7bb-ae9b-48a6-a86e-a60f518bbe70" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_80d2c2dd-ba19-49b3-a126-f632ac7cab2e" xlink:href="pcrx-20210930.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_80d2c2dd-ba19-49b3-a126-f632ac7cab2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_e3344ab3-2d81-428f-8906-c8b91411418e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:to="loc_us-gaap_RestrictedStockExpense_e3344ab3-2d81-428f-8906-c8b91411418e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_b3e8a7ea-cee8-4df5-8bbb-2b5cbf66324a" xlink:href="pcrx-20210930.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_b3e8a7ea-cee8-4df5-8bbb-2b5cbf66324a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_08b0b10d-21aa-4803-9dd0-c2d9fe6d65ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:to="loc_us-gaap_ShareBasedCompensation_08b0b10d-21aa-4803-9dd0-c2d9fe6d65ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fa502519-7b51-48d4-9d5e-239d4e42cfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0df9b7bb-ae9b-48a6-a86e-a60f518bbe70" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fa502519-7b51-48d4-9d5e-239d4e42cfe5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_45f9b481-7b66-4a88-95d9-6c0fc829845c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fa502519-7b51-48d4-9d5e-239d4e42cfe5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_45f9b481-7b66-4a88-95d9-6c0fc829845c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_45f9b481-7b66-4a88-95d9-6c0fc829845c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_45f9b481-7b66-4a88-95d9-6c0fc829845c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_45f9b481-7b66-4a88-95d9-6c0fc829845c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_45f9b481-7b66-4a88-95d9-6c0fc829845c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b9e1028b-6b70-4320-ba3c-52b0624092d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:to="loc_us-gaap_CostOfSalesMember_b9e1028b-6b70-4320-ba3c-52b0624092d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_dda9ef2f-88cc-459d-aabb-2389ec229275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_dda9ef2f-88cc-459d-aabb-2389ec229275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f952fe32-b2c3-4baa-88d8-b53558b56564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f952fe32-b2c3-4baa-88d8-b53558b56564" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSScheduleofStockBasedCompensationActivityDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="extended" id="i285c2680a02b460e8a81510655a6a00e_STOCKPLANSScheduleofStockBasedCompensationActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6048d486-7786-47f5-a479-991a53417be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6048d486-7786-47f5-a479-991a53417be7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ee18b80a-2d76-470a-bbe6-1f8afc81eef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ee18b80a-2d76-470a-bbe6-1f8afc81eef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9292aefe-530a-4d65-8ff5-6e1ccb143102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9292aefe-530a-4d65-8ff5-6e1ccb143102" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e7c6574-b86d-47ca-86a0-a598982719db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e7c6574-b86d-47ca-86a0-a598982719db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7c926722-4fde-4574-a651-f0bf72556f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7c926722-4fde-4574-a651-f0bf72556f16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_6c047c8c-425e-4a32-b68f-44d9d78d853f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_6c047c8c-425e-4a32-b68f-44d9d78d853f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e8b0bf49-8105-4e56-a5f2-e0efe180ceb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6048d486-7786-47f5-a479-991a53417be7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20de216e-f196-4e87-9e29-f382a49f503b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20de216e-f196-4e87-9e29-f382a49f503b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aeed59a9-0ed3-46fe-ac99-dab31b925141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aeed59a9-0ed3-46fe-ac99-dab31b925141" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_033aaa76-1cfc-4a7d-bab6-079855a515f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_033aaa76-1cfc-4a7d-bab6-079855a515f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7d7c2e7d-261b-40a7-99a6-4f6613734855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7d7c2e7d-261b-40a7-99a6-4f6613734855" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_cfd86033-959c-4fd6-b942-fbd0d5a1e972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_cfd86033-959c-4fd6-b942-fbd0d5a1e972" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_87595c5b-c707-4f56-b2d3-741b1b0966d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06cf797a-aa1a-46ba-a537-7ca6f56e79fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06cf797a-aa1a-46ba-a537-7ca6f56e79fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27ce9cc0-12d2-4914-ab86-1c8b6a88c95a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27ce9cc0-12d2-4914-ab86-1c8b6a88c95a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a98865a9-f7d5-4a0a-a1bd-6086f054b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a98865a9-f7d5-4a0a-a1bd-6086f054b6bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e6d05ce-345b-41ef-9466-7d9155727815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e6d05ce-345b-41ef-9466-7d9155727815" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ef6d8851-1a82-43a2-aa5a-678715100c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b08cf649-5eaa-41de-9ea8-04aa15d8e14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b08cf649-5eaa-41de-9ea8-04aa15d8e14d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72af06d1-959d-49a1-9f72-594e16a492e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72af06d1-959d-49a1-9f72-594e16a492e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89129e1c-0163-4d5d-a1c1-856aa1aeb01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89129e1c-0163-4d5d-a1c1-856aa1aeb01f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_cc42989b-7bc2-4bc3-a1ed-fc45c1ee7e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_cc42989b-7bc2-4bc3-a1ed-fc45c1ee7e20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2d37e907-4ae6-4e64-b665-a7de9a56c928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0219072d-387f-42d3-8d97-9843280dbef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6048d486-7786-47f5-a479-991a53417be7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0219072d-387f-42d3-8d97-9843280dbef1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f807d061-2588-4d03-af86-49b8aff50251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0219072d-387f-42d3-8d97-9843280dbef1" xlink:to="loc_us-gaap_AwardTypeAxis_f807d061-2588-4d03-af86-49b8aff50251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f807d061-2588-4d03-af86-49b8aff50251_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f807d061-2588-4d03-af86-49b8aff50251" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f807d061-2588-4d03-af86-49b8aff50251_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da0399cc-1a46-4916-911c-3cf14e1632f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f807d061-2588-4d03-af86-49b8aff50251" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da0399cc-1a46-4916-911c-3cf14e1632f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1dbf7e0a-20bb-42f7-9889-a6662173b21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da0399cc-1a46-4916-911c-3cf14e1632f5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1dbf7e0a-20bb-42f7-9889-a6662173b21e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="extended" id="ibe78f6bb550f48698ade16e353767acc_STOCKPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_a1058cbd-7c22-4da5-9657-f18c3c26d2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_a1058cbd-7c22-4da5-9657-f18c3c26d2a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_be510af1-4bbb-4ddb-a0c8-7e78ccf65549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_be510af1-4bbb-4ddb-a0c8-7e78ccf65549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_cf50da75-3750-4b2f-9097-583809ad37ac" xlink:href="pcrx-20210930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_cf50da75-3750-4b2f-9097-583809ad37ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_d34df12d-ac9b-46c6-96e0-427a0e1a4453" xlink:href="pcrx-20210930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_d34df12d-ac9b-46c6-96e0-427a0e1a4453" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4b8c5d57-5a59-41b7-b94d-1556af1f0a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4b8c5d57-5a59-41b7-b94d-1556af1f0a20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bd17b918-0455-4d42-a89b-7477eb61f159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bd17b918-0455-4d42-a89b-7477eb61f159" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c6e0ba68-ef5e-429e-8fd3-da9159f13245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c6e0ba68-ef5e-429e-8fd3-da9159f13245" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c6e0ba68-ef5e-429e-8fd3-da9159f13245" xlink:to="loc_us-gaap_AwardTypeAxis_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_765fea42-26f1-49cd-8c58-c43392908b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_765fea42-26f1-49cd-8c58-c43392908b58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b7ec4786-37e2-4e90-858f-09469aef86f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_765fea42-26f1-49cd-8c58-c43392908b58" xlink:to="loc_us-gaap_EmployeeStockMember_b7ec4786-37e2-4e90-858f-09469aef86f5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSScheduleofValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="extended" id="idb0f8adcd01b4129831384d5de2e3fcc_STOCKPLANSScheduleofValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a139bd8d-dbbb-4675-8044-ae6df5d963cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a139bd8d-dbbb-4675-8044-ae6df5d963cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f3e206b9-26cb-47fa-8f4b-c998ae50247b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f3e206b9-26cb-47fa-8f4b-c998ae50247b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0b9791e7-a15f-4870-a08a-b4203a05bb35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0b9791e7-a15f-4870-a08a-b4203a05bb35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_881580b2-7a02-4ec7-afab-40d63e9cf752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_881580b2-7a02-4ec7-afab-40d63e9cf752" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422956de-cbfc-4cce-aaa6-f0fd490fdac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422956de-cbfc-4cce-aaa6-f0fd490fdac1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_45de0e82-8df7-429c-801e-1ec29e604d69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422956de-cbfc-4cce-aaa6-f0fd490fdac1" xlink:to="loc_us-gaap_AwardTypeAxis_45de0e82-8df7-429c-801e-1ec29e604d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_45de0e82-8df7-429c-801e-1ec29e604d69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_45de0e82-8df7-429c-801e-1ec29e604d69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_45de0e82-8df7-429c-801e-1ec29e604d69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5071013-414d-4a43-be47-b0c53160ab22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_45de0e82-8df7-429c-801e-1ec29e604d69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5071013-414d-4a43-be47-b0c53160ab22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6713de92-144d-4493-ae1e-64605702a915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5071013-414d-4a43-be47-b0c53160ab22" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6713de92-144d-4493-ae1e-64605702a915" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKHOLDERSEQUITYDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="extended" id="ieb11037c489747f9827351a8cb366f86_STOCKHOLDERSEQUITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_459467e9-03c5-411e-a73b-be122fca8b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_459467e9-03c5-411e-a73b-be122fca8b2d" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a704eec2-2c9a-4500-b05d-01501e3da382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_StockholdersEquity_a704eec2-2c9a-4500-b05d-01501e3da382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9ff92b8b-6fb3-487d-9798-ba441617048f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9ff92b8b-6fb3-487d-9798-ba441617048f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6022bcdb-fa5a-4cd5-92b4-81a338e861b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6022bcdb-fa5a-4cd5-92b4-81a338e861b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_055e94d8-25f9-47d1-9237-c74a5fbd9118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_055e94d8-25f9-47d1-9237-c74a5fbd9118" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a3c31703-6f5d-4eb2-8fef-7dd5a1d384be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_875b57a1-2921-48b3-bd04-957d85517372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_459467e9-03c5-411e-a73b-be122fca8b2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_875b57a1-2921-48b3-bd04-957d85517372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f4f7001a-eb6a-4b5a-8d57-a4a6b9d9aace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_459467e9-03c5-411e-a73b-be122fca8b2d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f4f7001a-eb6a-4b5a-8d57-a4a6b9d9aace" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_df6916da-4544-4868-a9ea-2f8011c7f9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f4f7001a-eb6a-4b5a-8d57-a4a6b9d9aace" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_df6916da-4544-4868-a9ea-2f8011c7f9c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_df6916da-4544-4868-a9ea-2f8011c7f9c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_df6916da-4544-4868-a9ea-2f8011c7f9c7" xlink:to="loc_us-gaap_EquityComponentDomain_df6916da-4544-4868-a9ea-2f8011c7f9c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_038224af-ed95-469d-ad11-3e804bb702b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_df6916da-4544-4868-a9ea-2f8011c7f9c7" xlink:to="loc_us-gaap_EquityComponentDomain_038224af-ed95-469d-ad11-3e804bb702b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0e118d02-05b4-4d45-b221-c9872703790b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_038224af-ed95-469d-ad11-3e804bb702b1" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0e118d02-05b4-4d45-b221-c9872703790b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended" id="idf7f5272274040439e0a169a18df3939_NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_6420501c-9df9-4603-86db-f6f640c0d9db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_6420501c-9df9-4603-86db-f6f640c0d9db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4f865cef-a6d0-4fa5-b6ab-97f36ba5f5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_6420501c-9df9-4603-86db-f6f640c0d9db" xlink:to="loc_us-gaap_NetIncomeLoss_4f865cef-a6d0-4fa5-b6ab-97f36ba5f5a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_094cc4dd-6713-46f2-9d90-68f81a71145d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_094cc4dd-6713-46f2-9d90-68f81a71145d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b838fc0-a690-4d2a-be3c-db82114added" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_094cc4dd-6713-46f2-9d90-68f81a71145d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b838fc0-a690-4d2a-be3c-db82114added" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e008a1c-935d-406d-a58f-1c4f0e1562bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e008a1c-935d-406d-a58f-1c4f0e1562bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2a156809-1bef-4ba0-890d-a98e775880a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2a156809-1bef-4ba0-890d-a98e775880a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c4fa6307-8018-4a70-bf11-4443c2f1dd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c4fa6307-8018-4a70-bf11-4443c2f1dd3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_93b7e428-1032-4ca0-9fd2-25ab42fb4954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_93b7e428-1032-4ca0-9fd2-25ab42fb4954" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c80c47a7-7fb5-4874-8e98-2d7917f39cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_93b7e428-1032-4ca0-9fd2-25ab42fb4954" xlink:to="loc_us-gaap_EarningsPerShareBasic_c80c47a7-7fb5-4874-8e98-2d7917f39cd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_832bbb57-82b8-43e3-bd4c-5756766662eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_93b7e428-1032-4ca0-9fd2-25ab42fb4954" xlink:to="loc_us-gaap_EarningsPerShareDiluted_832bbb57-82b8-43e3-bd4c-5756766662eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cac72023-6c36-433f-8507-3d0a46c8a06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cac72023-6c36-433f-8507-3d0a46c8a06a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_27534751-c9ff-4903-9d7e-8aca4a0cd172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cac72023-6c36-433f-8507-3d0a46c8a06a" xlink:to="loc_us-gaap_AwardTypeAxis_27534751-c9ff-4903-9d7e-8aca4a0cd172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27534751-c9ff-4903-9d7e-8aca4a0cd172_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_27534751-c9ff-4903-9d7e-8aca4a0cd172" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27534751-c9ff-4903-9d7e-8aca4a0cd172_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_27534751-c9ff-4903-9d7e-8aca4a0cd172" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_daae9342-ad75-4710-8976-6f55297bc18c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_daae9342-ad75-4710-8976-6f55297bc18c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a7f7cc1f-90bc-40d8-81ef-0fbdd5b38456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a7f7cc1f-90bc-40d8-81ef-0fbdd5b38456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_1cd359ca-e595-4788-9ae5-552ffbb050fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:to="loc_us-gaap_EmployeeStockMember_1cd359ca-e595-4788-9ae5-552ffbb050fe" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="extended" id="i2e2fd5f1d32a46689a63d4c1919d467d_NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22370af2-bcf9-46cd-be53-629183f29f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ffe9b301-c34f-4301-86d6-747c383a5372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22370af2-bcf9-46cd-be53-629183f29f6a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ffe9b301-c34f-4301-86d6-747c383a5372" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_004f1157-ed16-46be-9507-e2597ce3f0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22370af2-bcf9-46cd-be53-629183f29f6a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_004f1157-ed16-46be-9507-e2597ce3f0e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_004f1157-ed16-46be-9507-e2597ce3f0e7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e7612e95-e70e-41e8-b097-cbbe4a6d1062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e7612e95-e70e-41e8-b097-cbbe4a6d1062" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4ab6588e-86fc-4131-8be8-e0e2011205c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4ab6588e-86fc-4131-8be8-e0e2011205c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_699cb5a5-3fa1-4ae0-81bc-3950dca66521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:to="loc_us-gaap_EmployeeStockMember_699cb5a5-3fa1-4ae0-81bc-3950dca66521" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMERCIALPARTNERSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#COMMERCIALPARTNERSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/COMMERCIALPARTNERSDetails" xlink:type="extended" id="ib394ec33287b47c08961cc1602c3757b_COMMERCIALPARTNERSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementUpfrontPayment_74ca62c9-6b76-47f6-8482-1803f37eeec1" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeArrangementUpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:to="loc_pcrx_CollaborativeArrangementUpfrontPayment_74ca62c9-6b76-47f6-8482-1803f37eeec1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsReceived_cf468c66-6b70-41f8-9d9a-29b3a7d63aa7" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeArrangementMilestonePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:to="loc_pcrx_CollaborativeArrangementMilestonePaymentsReceived_cf468c66-6b70-41f8-9d9a-29b3a7d63aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_1f1e6934-b0a4-4ff9-a327-87820e44cb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:to="loc_us-gaap_LitigationSettlementExpense_1f1e6934-b0a4-4ff9-a327-87820e44cb2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FreshStartAdjustmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:to="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_52e098e5-bd0f-4201-a5d9-60a447ec7ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:to="loc_us-gaap_TypeOfArrangementAxis_52e098e5-bd0f-4201-a5d9-60a447ec7ac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52e098e5-bd0f-4201-a5d9-60a447ec7ac0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_52e098e5-bd0f-4201-a5d9-60a447ec7ac0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52e098e5-bd0f-4201-a5d9-60a447ec7ac0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c7e8a204-37e3-44d3-9206-fd93f2a29b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_52e098e5-bd0f-4201-a5d9-60a447ec7ac0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c7e8a204-37e3-44d3-9206-fd93f2a29b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EurofarmaLabatoriesSAMember_7fc3102b-c95e-46ed-ab8f-c3e7b8540c11" xlink:href="pcrx-20210930.xsd#pcrx_EurofarmaLabatoriesSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c7e8a204-37e3-44d3-9206-fd93f2a29b36" xlink:to="loc_pcrx_EurofarmaLabatoriesSAMember_7fc3102b-c95e-46ed-ab8f-c3e7b8540c11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_30e62c9a-944e-43c0-a952-9bbc0809aeae" xlink:href="pcrx-20210930.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c7e8a204-37e3-44d3-9206-fd93f2a29b36" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_30e62c9a-944e-43c0-a952-9bbc0809aeae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneAxis_c735c166-7cf4-4032-9f43-08afc760d19f" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:to="loc_pcrx_AchievementOfMilestoneAxis_c735c166-7cf4-4032-9f43-08afc760d19f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneDomain_c735c166-7cf4-4032-9f43-08afc760d19f_default" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pcrx_AchievementOfMilestoneAxis_c735c166-7cf4-4032-9f43-08afc760d19f" xlink:to="loc_pcrx_AchievementOfMilestoneDomain_c735c166-7cf4-4032-9f43-08afc760d19f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneDomain_efdaa5f5-2ae5-47a4-bc1a-b037648b40b0" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pcrx_AchievementOfMilestoneAxis_c735c166-7cf4-4032-9f43-08afc760d19f" xlink:to="loc_pcrx_AchievementOfMilestoneDomain_efdaa5f5-2ae5-47a4-bc1a-b037648b40b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember_9be914d7-3346-46f3-b461-1a2932702ffb" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pcrx_AchievementOfMilestoneDomain_efdaa5f5-2ae5-47a4-bc1a-b037648b40b0" xlink:to="loc_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember_9be914d7-3346-46f3-b461-1a2932702ffb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ia8167ea3eb954bfd8684d3ea3145b6e1_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_d7358651-e476-4a8e-9cb6-0ff3fe635011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_d7358651-e476-4a8e-9cb6-0ff3fe635011" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_c601d18d-426a-46ca-9f35-6f787ee25d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_c601d18d-426a-46ca-9f35-6f787ee25d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ee8b5fc7-dc67-401d-9f8a-652bb3933c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:to="loc_us-gaap_RestructuringCharges_ee8b5fc7-dc67-401d-9f8a-652bb3933c4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:to="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b1a251ad-9da5-4df9-a5e5-1e817b38a261" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:to="loc_srt_CounterpartyNameAxis_b1a251ad-9da5-4df9-a5e5-1e817b38a261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b1a251ad-9da5-4df9-a5e5-1e817b38a261_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b1a251ad-9da5-4df9-a5e5-1e817b38a261" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b1a251ad-9da5-4df9-a5e5-1e817b38a261_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef2fac06-001a-4603-90d3-e023924c2ca0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b1a251ad-9da5-4df9-a5e5-1e817b38a261" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef2fac06-001a-4603-90d3-e023924c2ca0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember_f61a328e-6e18-44a9-8926-e0feba9c41d3" xlink:href="pcrx-20210930.xsd#pcrx_FortisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef2fac06-001a-4603-90d3-e023924c2ca0" xlink:to="loc_pcrx_FortisMember_f61a328e-6e18-44a9-8926-e0feba9c41d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_11d9c57a-856b-4861-a118-932d360e1984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_11d9c57a-856b-4861-a118-932d360e1984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_11d9c57a-856b-4861-a118-932d360e1984_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_11d9c57a-856b-4861-a118-932d360e1984" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_11d9c57a-856b-4861-a118-932d360e1984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5757c746-cc72-454a-bdc9-c780e6f245d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_11d9c57a-856b-4861-a118-932d360e1984" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5757c746-cc72-454a-bdc9-c780e6f245d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember_375f541c-7a24-49d9-93f9-336912faf737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_5757c746-cc72-454a-bdc9-c780e6f245d4" xlink:to="loc_us-gaap_OneTimeTerminationBenefitsMember_375f541c-7a24-49d9-93f9-336912faf737" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://www.pacira.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended" id="ic40ee4bb16464c31bb2e25b7d55cff9b_SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_48802a9e-7e20-44d1-8bc0-a955a0e344c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_48802a9e-7e20-44d1-8bc0-a955a0e344c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_c9abb45b-d532-46d3-a3a0-995eb11666a0" xlink:href="pcrx-20210930.xsd#pcrx_ClassOfWarrantOrRightNumberOfRightsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_c9abb45b-d532-46d3-a3a0-995eb11666a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_40c52924-229c-45f2-930c-6c3e1111fb42" xlink:href="pcrx-20210930.xsd#pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_40c52924-229c-45f2-930c-6c3e1111fb42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_ead70ebb-6b25-40dc-a356-d09e5cef34d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_ead70ebb-6b25-40dc-a356-d09e5cef34d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_402f194c-f37c-4838-a4b9-2aede36fd249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_402f194c-f37c-4838-a4b9-2aede36fd249" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage_61d7a2b9-2191-4592-b051-f9fbf308576a" xlink:href="pcrx-20210930.xsd#pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage_61d7a2b9-2191-4592-b051-f9fbf308576a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_76daa3e6-6633-4467-9a37-e2d45b44ba05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_76daa3e6-6633-4467-9a37-e2d45b44ba05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_76daa3e6-6633-4467-9a37-e2d45b44ba05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_76daa3e6-6633-4467-9a37-e2d45b44ba05" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_76daa3e6-6633-4467-9a37-e2d45b44ba05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cb3e2159-2422-418b-8181-82cffb983974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_76daa3e6-6633-4467-9a37-e2d45b44ba05" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cb3e2159-2422-418b-8181-82cffb983974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dcae1e35-0d1e-49be-a953-adcd2e1a3137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cb3e2159-2422-418b-8181-82cffb983974" xlink:to="loc_us-gaap_SubsequentEventMember_dcae1e35-0d1e-49be-a953-adcd2e1a3137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_476d6c0b-1265-4ccb-8900-e8df410a12a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_476d6c0b-1265-4ccb-8900-e8df410a12a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_476d6c0b-1265-4ccb-8900-e8df410a12a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_476d6c0b-1265-4ccb-8900-e8df410a12a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_476d6c0b-1265-4ccb-8900-e8df410a12a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab045dec-949c-40cc-ad40-fbedd37f8c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_476d6c0b-1265-4ccb-8900-e8df410a12a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab045dec-949c-40cc-ad40-fbedd37f8c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionMember_ad1abd1a-7484-4751-ba22-2bedb8c18db4" xlink:href="pcrx-20210930.xsd#pcrx_FlexionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab045dec-949c-40cc-ad40-fbedd37f8c48" xlink:to="loc_pcrx_FlexionMember_ad1abd1a-7484-4751-ba22-2bedb8c18db4" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>pcrx-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:72021cac-ffd9-4fc5-b071-994f9d22f7d5,g:6c0c4d51-64cc-433e-9997-2f3b5b13ef74-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_221c3422-d7d2-4097-a65c-ecab0f4364eb_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_49b125ca-cd30-4d9a-b1b2-6f2d231b03f9_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Major Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_17f8f989-b9f3-41d8-a6de-9c5be0ac1e16_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Unrealized Investment Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CodaBioTherapeuticsIncMember_b4481acf-8451-4699-aade-d9b0ee45a52b_terseLabel_en-US" xlink:label="lab_pcrx_CodaBioTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coda BioTherapeutics, Inc</link:label>
    <link:label id="lab_pcrx_CodaBioTherapeuticsIncMember_label_en-US" xlink:label="lab_pcrx_CodaBioTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coda BioTherapeutics, Inc [Member]</link:label>
    <link:label id="lab_pcrx_CodaBioTherapeuticsIncMember_documentation_en-US" xlink:label="lab_pcrx_CodaBioTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coda BioTherapeutics, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CodaBioTherapeuticsIncMember" xlink:href="pcrx-20210930.xsd#pcrx_CodaBioTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CodaBioTherapeuticsIncMember" xlink:to="lab_pcrx_CodaBioTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_3883afe9-6050-49d0-acb5-ee3830eb6d42_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8d90e21b-0415-40fa-91af-349a90bae815_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6bb40696-d9f9-41c9-8b14-9ffe68629d50_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1c25ae14-efe3-4eb9-be01-100628fb6d15_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_5f6dca54-846e-47b6-94af-99c923643526_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_98d3e874-d916-4c85-bd03-8aebdcc2d84d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_43b3f3f5-741a-4a63-a727-91c2a4107308_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_bec63405-348d-4151-b67a-6385c5c0303e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8f15cb3f-c14d-41d4-908a-18ca04d9f966_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_059b524a-b1cb-4f90-b837-0b43e61f66f8_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer two</link:label>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Two [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerTwoMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerTwoMember" xlink:to="lab_pcrx_MajorCustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_998f292b-d4ac-46b2-bf8b-7c18c2226867_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d1523455-0713-4e6c-b934-7b7220dfb55d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_59b145ec-8c7d-41bb-b0a2-eb682a4a78e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ab9d6c70-e0d0-4ad0-bd64-4d7f3e9b4f4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0dd557ce-2a77-4de3-ade1-6b70ed4cd516_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_64aa2e98-db7d-47a5-837f-dadcc872a3e7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsideration_8f43fa99-837d-4a35-a87f-fe695061dd1e_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsideration_label_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsideration_documentation_en-US" xlink:label="lab_pcrx_ContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the maximum amount of Contingent Consideration related to the acquisition of a business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsideration" xlink:to="lab_pcrx_ContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_0f0a0ee6-1fdc-4313-8a89-07e4df0c6fab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price of notes into common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_865777fa-f4c0-4dc2-b1e6-ba86ab611970_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_5dfc6242-29a3-418c-af34-29a59022e190_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_24536dd9-1ca0-44c6-b473-2c4c6d1348b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration to MyoScience, Inc. securityholders</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_cace2b0e-e5d4-4e2c-a2df-03c3d96d5750_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_78029c8f-0e88-42e8-8eff-188f92aa55fa_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OneTimeTerminationBenefitsMember_73944b6a-85e4-4453-9d84-6de17d193ef1_terseLabel_en-US" xlink:label="lab_us-gaap_OneTimeTerminationBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time Termination Benefits</link:label>
    <link:label id="lab_us-gaap_OneTimeTerminationBenefitsMember_label_en-US" xlink:label="lab_us-gaap_OneTimeTerminationBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time Termination Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OneTimeTerminationBenefitsMember" xlink:to="lab_us-gaap_OneTimeTerminationBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_e252673c-b3c1-4da6-8d3f-f884d08f405c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0ab9df76-2591-44f9-bc88-077b04f8a76e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a95e3296-a158-4dd3-add4-ca225a2b4914_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_ce255882-61a3-40ef-b0dc-cf4e4595e342_terseLabel_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment</link:label>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_label_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment [Member]</link:label>
    <link:label id="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember_documentation_en-US" xlink:label="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Milestone Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:href="pcrx-20210930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:to="lab_pcrx_MeasurementInputExpectedMilestonePaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f7dd773f-9ed0-414b-a3da-38e00d85bbe9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5c0ab351-af08-4621-bb07-287a9fabd0f5_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2c51fb9b-9129-4049-af11-7465ff877a39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_7d89df8d-355f-448e-981e-036eee9ea630_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6d6914d2-491d-4352-8d00-362938f2c00c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_5ce95202-7559-492d-879b-fdabc3fbf931_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f70abea7-f6e4-4cc6-82ba-f2bacaf3e97f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_b8b83616-0d31-4b8e-8060-828d1430b397_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8da1aa76-f03d-4566-a462-9f0996697a7b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4888c7c3-4c38-4f02-8912-ca8fccbfae0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration gains during period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b93ae47e-f21d-458f-bdd0-8996a0305ea7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments and accretion</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c3a599b1-da27-42fb-a243-27b492fa458f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_3266fe8e-fb2b-4110-a10b-e56bb613b09d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_260f1116-2b7e-4ade-97a2-d911a5d2add0_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated settlement fees</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_deb1d209-9254-474f-b362-ded41893ba4d_terseLabel_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_label_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense from stock options, employees</link:label>
    <link:label id="lab_pcrx_Compensationexpensefromstockoptionsemployees_documentation_en-US" xlink:label="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense from stock options (employee and board of director awards)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees" xlink:href="pcrx-20210930.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_Compensationexpensefromstockoptionsemployees" xlink:to="lab_pcrx_Compensationexpensefromstockoptionsemployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_de8ab0ea-8feb-44c1-ae91-71ef96d64e40_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_faf1bff7-b62b-402d-aac7-d9993521c312_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_27d497af-efcc-4757-ac84-82e5d33f245c_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_31484c7f-2e6f-463f-a956-2c6be16b261a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of conversion premium on the 2022 Notes (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_850ca472-1d1d-4789-bd8d-c7042f9494d5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_75d08529-733a-4aae-913f-a9ac3ae3027d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f20b02fd-8fb1-49ba-a42d-c963f1b91974_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c12e15dd-4ce6-430a-a037-acaae24561ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_1aea6ce5-3c1f-4239-9157-ea0bb41f7f4b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member_0f8b1f60-2352-4636-9d4e-f76e7fb8fc50_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion terms prior to close of business on business day immediately proceeding October 1, 2021</link:label>
    <link:label id="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member_label_en-US" xlink:label="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion Terms Business Day Immediately Preceding October 1, 2021 [Member]</link:label>
    <link:label id="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member_documentation_en-US" xlink:label="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion Terms Business Day Immediately Preceding October 1, 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member" xlink:to="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_626a52a4-424d-46f9-b492-2fa7d5c06b92_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_e4826726-940d-4e1b-809a-0f3dc5395d62_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_be6e8d55-3839-49e8-9593-105183c11b9b_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e43933b-abdc-496b-81d0-cea2291b663b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_8d31a155-5e52-4028-8e6c-4a1dda2e44af_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0e332af0-f573-4973-a530-2d952bef9fbc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized (loss) gain on investments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_74695c63-b536-4816-8f54-81612481259e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized (loss) gain on investments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_b6e0c96c-a92c-4418-b73e-72f08ae8973f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of carrying amount and fair value of the long-term debt</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_b1478b24-7e0b-464f-9a54-7858e810cd36_negatedTerseLabel_en-US" xlink:label="lab_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of equity component of the 2022 convertible senior notes</link:label>
    <link:label id="lab_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_label_en-US" xlink:label="lab_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of Equity Component of Convertible Senior Notes</link:label>
    <link:label id="lab_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_documentation_en-US" xlink:label="lab_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of Equity Component of Convertible Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes" xlink:href="pcrx-20210930.xsd#pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes" xlink:to="lab_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b79ef337-5b29-4149-a68b-7cdce9c0a229_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_ed20f05f-d44a-4010-a2fc-ccc2709347f5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_7d0ab0c9-b50a-439d-a88e-9d32695317c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of short-term investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_ae7e67c9-8518-4c2f-a418-997ff7723b0b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_98d95553-4d72-4b44-bee5-4a359ed56ef0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_fcfa0608-a60b-4ef1-8e57-58797c291e1f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_5011ad84-44ea-4541-a304-45cac5aeddb3_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue from customers to total revenue</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_e3738abf-4627-4cf9-b3da-8a9fe9eff2dc_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_b6f7bf0c-2b0b-490b-9003-1ca2a2acbd11_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationMember_4b3d9bfd-8cc8-4012-9dec-7978504989b0_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationMember_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationMember" xlink:to="lab_pcrx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2e636675-3d53-4329-9588-5a6e55dd78e5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_69eb45c6-cefd-4f96-816e-bc472133d7a3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_be6bf46a-6d4b-4afb-9cb6-e6a286a32158_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_4498d903-4439-4b7f-af6a-8feca4b85cc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_56d14aaa-fae1-47e1-8d65-535649ae03b4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of 2025 convertible senior notes issued, net of deferred taxes of $20,450 (Note 8)</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_aa81d4c9-2fbd-4e17-ad46-e7cedb78a26e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_3a6cbef5-04cc-47ea-bf2d-5bf27cdd895b_terseLabel_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative licensing and milestone revenue</link:label>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_label_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Licensing and Milestone Revenue [Member]</link:label>
    <link:label id="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_documentation_en-US" xlink:label="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Licensing and Milestone Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:to="lab_pcrx_CollaborativeLicensingAndMilestoneRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f67e6f01-73f2-4f65-8f62-e00aeca91a89_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_f981b0c1-1a5b-4904-9c26-b983608b3efb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_2f1fb313-765f-4f2c-a58b-daea703cd985_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_692342dc-b446-4ca5-b85f-1d6791fc001b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_d2e1dd98-600b-4b07-8f36-00d3006b860d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d8b73f49-cc06-4485-91a1-2e3d17cdd288_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_a0a63ebc-c1c7-4940-a5e0-8f37ce5cc264_terseLabel_en-US" xlink:label="lab_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent value right, per Flexion Share</link:label>
    <link:label id="lab_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_label_en-US" xlink:label="lab_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Rights Issued</link:label>
    <link:label id="lab_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_documentation_en-US" xlink:label="lab_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Rights Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued" xlink:href="pcrx-20210930.xsd#pcrx_ClassOfWarrantOrRightNumberOfRightsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued" xlink:to="lab_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b55734dc-2e8b-4a41-829d-5de790efe95a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_5ac48e9f-2e2a-431a-8812-035109471029_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input, contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3690cc89-5cd2-4d2d-b64f-c9082022b5ca_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_f93aac34-a1bd-49f6-9df7-310ec20fcd6f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_984d13d7-c419-41eb-bcf1-7a4be7557829_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_70540926-856f-4814-92eb-b71fc0264651_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets recorded in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_3f46764a-4fcb-4b54-aa5c-288f46c3d9ab_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FIXED ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b2cab54a-61df-4663-a009-d4d1368bcfb9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_89766050-da79-4e0d-95a4-9a54a4efc474_terseLabel_en-US" xlink:label="lab_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from equity component of the 2025 convertible senior notes</link:label>
    <link:label id="lab_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_label_en-US" xlink:label="lab_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Option Component of Convertible Debt</link:label>
    <link:label id="lab_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_documentation_en-US" xlink:label="lab_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Option Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt" xlink:href="pcrx-20210930.xsd#pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt" xlink:to="lab_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_41894491-8f95-408d-96b6-4338a1d3b97a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e6c20b2b-67dc-4135-aff3-d8848f275494_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_afc1a08d-0a4c-4b2f-a243-30d5c7a77460_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_62105c31-b3ce-40b4-b3b5-f8c3ac5fc0f0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per common share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_5763e33a-c836-491c-bb16-a41cf91eb6c3_terseLabel_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP purchasing period</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_label_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_documentation_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:href="pcrx-20210930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:to="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_03da9713-324b-46b0-ad07-933ba6af6215_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8a7f21d3-d481-49fb-8c5f-9981923eeb78_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_4beb7db8-5c6f-4c9d-9462-2998bc07ec2d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_fcd5c3cf-732e-4c51-9622-41a90af74319_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_87e75d51-d1c5-4b46-a72a-6e8a3424f3e2_verboseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, current</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Current</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationCurrent_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationCurrent" xlink:to="lab_pcrx_ContingentConsiderationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_817ec847-bbde-4928-8e23-0e248d54e721_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d813669c-ab88-4375-a67e-7f5556b54cbf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_804eaa3e-304f-4539-a30d-9166892b3013_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31, 2020</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0b2f900e-571c-49fa-afae-fbdcfbac98c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September 30, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8608b1bc-da0e-491a-a87f-cc4ba6fa2c9e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_c35f8978-2251-4ffd-b84c-4eab0d1f6be8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_b647847a-53fa-4cff-9279-db305bf7b536_terseLabel_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Shares Issued Under Employee Stock Purchase Plans</link:label>
    <link:label id="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_documentation_en-US" xlink:label="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from shares issued under Employee Stock Purchase Plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:href="pcrx-20210930.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:to="lab_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_2005f779-e060-40d3-a36d-45a0e34b3adc_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0097031c-38fa-492c-9b8f-75ef5658e233_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_d18c8cf7-e502-48a1-9517-cef247d489a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_76769b50-36d5-4497-ba30-261b1f652965_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_bc3447c8-93f0-412c-9884-0cbb5e7bb6f1_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_dec8c161-e370-43f7-9882-bef77806aaf9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_21817096-4efa-4b54-9cef-e9dbe29e7ac1_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_2505ddd3-7064-4cff-b783-dcb71b1ee79b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for operating lease liabilities, net of lease incentive</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_TELABioMember_424e308c-8c12-48d0-8341-40f170a4efc5_terseLabel_en-US" xlink:label="lab_pcrx_TELABioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TELA Bio</link:label>
    <link:label id="lab_pcrx_TELABioMember_label_en-US" xlink:label="lab_pcrx_TELABioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TELA Bio [Member]</link:label>
    <link:label id="lab_pcrx_TELABioMember_documentation_en-US" xlink:label="lab_pcrx_TELABioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TELA Bio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TELABioMember" xlink:href="pcrx-20210930.xsd#pcrx_TELABioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_TELABioMember" xlink:to="lab_pcrx_TELABioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_4fa9e552-4ed2-427c-b046-d4d6c4038ae3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_39f1af45-5de6-44c4-94e4-4c4b40178dbf_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt, net of debt discount and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_5d88fcd9-c9ab-4379-b249-e0b04dda307b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_31c0f10e-40a0-4f87-b21c-352b2cddc712_terseLabel_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of offering periods for ESPP</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_label_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</link:label>
    <link:label id="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_documentation_en-US" xlink:label="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:href="pcrx-20210930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:to="lab_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_91d2d26a-a1f1-42e8-b54b-b42541a90b3c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_80f735f2-35e9-482e-851c-3402a331b674_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on investment and other non-operating income, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_99daf769-0ca4-4ff9-abd0-ac29b7dbe62a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FortisMember_8939497a-7086-4f27-810b-b27b82ed198f_terseLabel_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis</link:label>
    <link:label id="lab_pcrx_FortisMember_label_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis [Member]</link:label>
    <link:label id="lab_pcrx_FortisMember_documentation_en-US" xlink:label="lab_pcrx_FortisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fortis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember" xlink:href="pcrx-20210930.xsd#pcrx_FortisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FortisMember" xlink:to="lab_pcrx_FortisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_79a5388f-d9f6-4880-8e4c-16f8982acc4d_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_94ac7826-6391-4fc1-9af1-518d69dfd9ab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_cb5ed6ee-d263-4c37-be5e-007621732999_verboseLabel_en-US" xlink:label="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contingent payment, share price</link:label>
    <link:label id="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_4c5b3e0e-4155-4b02-a56c-f95b8c44f550_terseLabel_en-US" xlink:label="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contingent payment, per Flexion Share, share price</link:label>
    <link:label id="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_label_en-US" xlink:label="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Maximum Additional Contingent Payment, If Circumstances Met, Share Price</link:label>
    <link:label id="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_documentation_en-US" xlink:label="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Maximum Additional Contingent Payment, If Circumstances Met, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" xlink:href="pcrx-20210930.xsd#pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" xlink:to="lab_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a79107e2-0f04-4654-8458-4623727b2dc6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_5d17445a-43d5-4d9f-a2d7-d20370c69b80_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in carrying value of goodwill during period</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_00b98426-13c4-4d62-ba72-84016ade5ce0_terseLabel_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments for EXPAREL agreed in connection with acquisition</link:label>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_label_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreed Milestone Payments for Sale of Product in Connection with Acquisition</link:label>
    <link:label id="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_documentation_en-US" xlink:label="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:href="pcrx-20210930.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:to="lab_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c1fc7e4e-01a6-4c0b-9d1f-f3a659d7c0fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CollaborativeArrangementUpfrontPayment_ff7d026b-8c52-4fda-9701-76ebc01a3726_terseLabel_en-US" xlink:label="lab_pcrx_CollaborativeArrangementUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment to be received</link:label>
    <link:label id="lab_pcrx_CollaborativeArrangementUpfrontPayment_label_en-US" xlink:label="lab_pcrx_CollaborativeArrangementUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Upfront Payment</link:label>
    <link:label id="lab_pcrx_CollaborativeArrangementUpfrontPayment_documentation_en-US" xlink:label="lab_pcrx_CollaborativeArrangementUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Upfront Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementUpfrontPayment" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeArrangementUpfrontPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CollaborativeArrangementUpfrontPayment" xlink:to="lab_pcrx_CollaborativeArrangementUpfrontPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_UponFirstCommercialSaleInMajorEUCountryMember_4718a078-734c-4948-9749-0ae7ad4a6d98_terseLabel_en-US" xlink:label="lab_pcrx_UponFirstCommercialSaleInMajorEUCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upon first commercial sale in a major EU country (United Kingdom, France, Germany, Italy and Spain)</link:label>
    <link:label id="lab_pcrx_UponFirstCommercialSaleInMajorEUCountryMember_label_en-US" xlink:label="lab_pcrx_UponFirstCommercialSaleInMajorEUCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upon First Commercial Sale in Major EU Country [Member]</link:label>
    <link:label id="lab_pcrx_UponFirstCommercialSaleInMajorEUCountryMember_documentation_en-US" xlink:label="lab_pcrx_UponFirstCommercialSaleInMajorEUCountryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the stage for milestone payments upon the first commercial sale in a major EU country (UK, France, Germany, Italy or Spain).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponFirstCommercialSaleInMajorEUCountryMember" xlink:href="pcrx-20210930.xsd#pcrx_UponFirstCommercialSaleInMajorEUCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_UponFirstCommercialSaleInMajorEUCountryMember" xlink:to="lab_pcrx_UponFirstCommercialSaleInMajorEUCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_5d50c3e8-0d8c-492f-8880-cb1bcb813012_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_dc4636b2-9441-4df7-a4ae-04a242acc675_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_10d121e9-aa11-47d9-b619-4de9d2ba8217_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Major Customers</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_448456ea-ba61-4935-98b8-f6f8669c22d4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_01bd5640-0e51-48fd-b1f0-e97fd1d4c3a9_terseLabel_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]</link:label>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_label_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]</link:label>
    <link:label id="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_documentation_en-US" xlink:label="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stages at which milestone payments for products are payable, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:href="pcrx-20210930.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:to="lab_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e8f90a56-d922-495a-8ae6-8fdf1d74e9af_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_42e81092-41ea-479a-9917-8765ef361856_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in valuation of investment due to changes in foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_a1f5eef2-a6ed-445e-90ea-2c0f15aae8a7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_76f14b47-c4b8-407e-9512-ac1aaa454fb3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_886cb377-0a4e-4653-9419-cda7daccb84a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_73b85dd2-b187-4ad5-9239-83d8bab73459_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_81577a45-fc05-4421-8c3b-013aeb7e376f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_6edf7a4a-79a4-4877-865d-f54b320ea3eb_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_d18e00da-9c27-4425-be6b-22147eb5a3dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, carrying amount of equity component</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_65672696-9469-4145-bece-8bd2455d7a07_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_d2a4bac7-c0ec-4cb4-a436-a61df8f18882_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment term</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Payment Term</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationPaymentTerm_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationPaymentTerm" xlink:to="lab_pcrx_ContingentConsiderationPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_81435469-d15f-41dc-8bb3-ecd78dcaccf5_terseLabel_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">When annual net sales collected reach $500.0 million</link:label>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_label_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upon Annual Net Sales Reaching Dollar 500.0 Million Threshold [Member]</link:label>
    <link:label id="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_documentation_en-US" xlink:label="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the stage for milestone payments when the annual net sales reach 500.0 million dollars.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:href="pcrx-20210930.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:to="lab_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_20a0c711-d10c-4e8b-aaf8-bd29f371ac7e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a0aa62e6-3e31-4868-a03d-3e091eaedf33_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_9b3a434a-25fc-4ff7-aa57-797f1190a1a3_terseLabel_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of operating lease not yet commenced, payments due</link:label>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_label_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Not Yet Commenced, Payments Due [Table Text Block]</link:label>
    <link:label id="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_documentation_en-US" xlink:label="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Not Yet Commenced, Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:href="pcrx-20210930.xsd#pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:to="lab_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_2f5a7952-1ac1-42cd-84b4-363f7d9ef6cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate of common stock per $1,000 of principal amount of Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_3ee2cd8a-26ff-4a35-9e58-6c37dbdd90c4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_ed7ea5f6-24a1-43d4-8bcd-f946fd6990eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_fa744e66-66a1-4eec-bb9a-1dc273cad094_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_509b07f9-958e-43d6-9021-8b3eaca03abf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_92b4b0fb-66a7-49bc-a92c-2d1dc4bb2859_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_a980c03b-73f0-4731-bf4d-8fc56ab51bb0_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (remaining three months)</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6442a6ab-cb6a-437c-9f57-0b3c4b372201_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_ceafc4f6-a3aa-42a4-b53e-1bb49caf5012_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ebe66a5-3847-4ef9-965c-bf9458217056_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_5d7542b8-0751-4e26-9fbf-b0d4ef7ef16c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_a5a2b0e4-371a-4085-94fa-3401613e8d68_terseLabel_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL / bupivacaine liposome injectable suspension</link:label>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_label_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL/bupivacaine liposome injectable suspension [Member]</link:label>
    <link:label id="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_documentation_en-US" xlink:label="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EXPAREL/bupivacaine liposome injectable suspension [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:href="pcrx-20210930.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:to="lab_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LargestCustomerMember_ed19185a-f2ca-4884-950b-45e6de79cd98_terseLabel_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest wholesaler</link:label>
    <link:label id="lab_pcrx_LargestCustomerMember_label_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_LargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember" xlink:href="pcrx-20210930.xsd#pcrx_LargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LargestCustomerMember" xlink:to="lab_pcrx_LargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_1ac857f1-f1e6-40ca-ae8a-a2229e8357e7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_681774de-9d71-4973-9e92-9fa473377350_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SpineBioPharmaLLCMember_ed5fcf23-3018-493f-85f5-1ea708ac70ff_terseLabel_en-US" xlink:label="lab_pcrx_SpineBioPharmaLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine BioPharma, LLC</link:label>
    <link:label id="lab_pcrx_SpineBioPharmaLLCMember_label_en-US" xlink:label="lab_pcrx_SpineBioPharmaLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine BioPharma, LLC [Member]</link:label>
    <link:label id="lab_pcrx_SpineBioPharmaLLCMember_documentation_en-US" xlink:label="lab_pcrx_SpineBioPharmaLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine BioPharma, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SpineBioPharmaLLCMember" xlink:href="pcrx-20210930.xsd#pcrx_SpineBioPharmaLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SpineBioPharmaLLCMember" xlink:to="lab_pcrx_SpineBioPharmaLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_d90041f7-a39e-4159-b8c3-65dfe06c3304_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_3802b86f-c154-48fa-b8bd-d0932af45f04_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_9f5d779b-8d87-41e3-8efe-b1684eeb2fb6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_9f4d09e3-33cc-4f5e-af95-c6420f5331a1_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_179878b1-56ba-46f4-868a-647782b2d47a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock_d3ea8cf1-dd0f-4d7f-8f14-4109610e3f5a_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of last sale price of common stock</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percentage of Last Reported Sale Price Of Common Stock</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percentage of Last Reported Sale Price Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" xlink:to="lab_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_7e13ea40-275c-47b2-9593-ca54a2d2cd19_terseLabel_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of products (in products)</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_label_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number Of Products</link:label>
    <link:label id="lab_pcrx_ConcentrationRiskNumberOfProducts_documentation_en-US" xlink:label="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number Of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts" xlink:href="pcrx-20210930.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConcentrationRiskNumberOfProducts" xlink:to="lab_pcrx_ConcentrationRiskNumberOfProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_28d4f6bc-c71b-4a6d-be1d-3e39866414ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_2357ad94-52b3-4c66-87da-3670243a51d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration to MyoScience, Inc. securityholders</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_15ccb105-8aeb-4139-89a3-77dcf432d3b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_b946fcff-6e7c-46b6-b039-6fc6d7e8e807_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2025Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_b950dcb0-3547-452d-84c4-ab13657afd08_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_da96a1ed-0277-40c2-b0aa-c21574dbd464_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesFairValueDisclosureAbstract_f454982a-3fac-44c6-ac88-4d4540aed909_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets:</link:label>
    <link:label id="lab_us-gaap_ReceivablesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_ReceivablesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_77de216d-f3f6-4e56-ab53-1f59a2031b5e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.001; 250,000,000 shares authorized; 44,523,410 shares issued and outstanding at September&#160;30, 2021; 43,636,929 shares issued and outstanding at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_2719fe86-400a-42b6-8b61-6ad0414f89b9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_4689ff0a-d098-4b43-961f-dff4105272ce_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FreshStartAdjustmentsTable_e354e876-2a87-4974-9ff9-5bf7f84123e2_terseLabel_en-US" xlink:label="lab_us-gaap_FreshStartAdjustmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fresh-Start Adjustments [Table]</link:label>
    <link:label id="lab_us-gaap_FreshStartAdjustmentsTable_label_en-US" xlink:label="lab_us-gaap_FreshStartAdjustmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganization, Chapter 11 [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FreshStartAdjustmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FreshStartAdjustmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FreshStartAdjustmentsTable" xlink:to="lab_us-gaap_FreshStartAdjustmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d65bfac8-5e6d-4050-ba9d-826f0b4b594f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_86266c9e-0dda-4500-86ab-36d83809fcc0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_b001edb2-c583-47e6-9ebe-02a5f88cd145_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk by major customer</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_5285f921-56b8-4639-bbdb-3c2b1c1becd4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_aa1013bc-8c39-4e56-8b7d-b2932464f79b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 15)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_4b115c8d-3f84-4b97-b944-3dbb7c6c4271_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_4fde6185-870c-4067-8899-706b61bd6475_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_01e66d86-8eaf-467a-a3db-68b565d08963_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ebcdcf00-ad8f-43a3-b3fb-52ba5a1f8a90_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_aa9adc0f-23ca-4e27-93c6-94c21df712b5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (remaining three months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e0061817-19b8-4a5a-a8cf-70edb961671c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based payment award, stock options, valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_07fb728d-89f5-4e85-81f8-ac929900c86b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issued in private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_61474004-5fce-471d-b586-d630dfa6b0b0_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_b419a656-c59b-4940-be54-1f1d434a0248_totalLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_fa13d09a-b5c2-40eb-b218-f29ac2de8657_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ca1d2bfc-aa46-413f-8aea-4110b0782054_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_925353ff-9ba9-42c8-b1c3-f2a16954a663_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share based compensation arrangements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryBondSecuritiesMember_3b539c45-abff-4e5b-9f55-e48a6b260e22_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Government bonds</link:label>
    <link:label id="lab_us-gaap_USTreasuryBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryBondSecuritiesMember" xlink:to="lab_us-gaap_USTreasuryBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_d0c309bc-ef29-43b0-b984-27991eb714f0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_5044ccd6-1431-4726-994f-7496cf1d8e26_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_77a26acf-6246-4f94-8a43-51c8bd7ec519_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_098a2df6-3210-4582-afaa-04fe388c6981_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion outstanding debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_9761b0ed-129f-413f-991c-d7120e65733b_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_60b104ca-fc38-445e-8879-87343df69eed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_94f84382-f3b7-407d-8957-d5960967285a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member_934cdb13-5894-4128-8860-02b68bcc4bfb_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion Terms Business Day Immediately Preceding February 3, 2020</link:label>
    <link:label id="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member_label_en-US" xlink:label="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion Terms Business Day Immediately Preceding February 3, 2020 [Member]</link:label>
    <link:label id="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member_documentation_en-US" xlink:label="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion Terms Business Day Immediately Preceding February 3, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member" xlink:to="lab_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions_5983e87b-e135-4a00-ab08-ba207562a112_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes related to equity</link:label>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions_label_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Effects Allocated Directly to Equity, Equity Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:to="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_9de832df-f0b3-4d0f-bee0-d68c4b17b99a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (loss) gain on investments, tax benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b9121d0c-1108-4e9b-b7ea-bd661562438d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_734a6138-4bec-4f05-b742-1bcf0c095a1d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_bf57fa0c-5d4b-4055-a008-034178577135_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_95387dce-736e-4c12-8178-5606ee0ad436_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6d77272-17f4-464d-ac25-a964727ef7a7_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ae483190-dd96-49f8-947f-7c343397cb57_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net product sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_99d81638-924c-477f-8685-8a12eeee19e4_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK PLANS</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans, Other than Share-based Compensation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f630b080-4b05-49c3-991a-941c1f770649_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_0beb919f-572c-43ee-bfb4-cbdd8a633a90_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_2e224a25-c33e-426d-aa53-daa768659fe0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e8715e62-ae38-4e4d-83bc-d6f86ea925c9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_25a24c74-12a0-429e-9b3f-0b6689f8227c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_03661747-5982-4a7e-b9dc-654567524ff1_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_94f585b3-b816-4f60-84c1-0ed6642a235a_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible note</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_a2c1001c-7df1-448c-9990-1d7ae2f732b0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_97188654-10cc-47cb-ba65-c49d154d9181_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, percentage of principal amount for computation of redemption price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_label_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percentage of Principal Amount for Computation of Redemption Price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:to="lab_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_bac7d67d-6daa-4028-9e38-4843397c35d5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReorganizationsAbstract_label_en-US" xlink:label="lab_us-gaap_ReorganizationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganizations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReorganizationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReorganizationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReorganizationsAbstract" xlink:to="lab_us-gaap_ReorganizationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_73bf716f-a03d-4dbf-ad86-3fc5a6e9cec2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_26b3568b-985d-4ca4-b4fc-6907a9401180_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a33e1b5d-6e51-4b40-82b0-e96afd958187_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_69a732f9-2c46-4121-b7c4-0f483adc54ef_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LongTermInvestmentsMember_db158de1-8d99-4c56-acec-fed928591466_verboseLabel_en-US" xlink:label="lab_pcrx_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term:</link:label>
    <link:label id="lab_pcrx_LongTermInvestmentsMember_label_en-US" xlink:label="lab_pcrx_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments [Member]</link:label>
    <link:label id="lab_pcrx_LongTermInvestmentsMember_documentation_en-US" xlink:label="lab_pcrx_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LongTermInvestmentsMember" xlink:href="pcrx-20210930.xsd#pcrx_LongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LongTermInvestmentsMember" xlink:to="lab_pcrx_LongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f9ea1669-7673-48e9-8df0-a09661c70f73_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_679fc930-8089-412b-8ff2-186c2b31797d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equity and debt investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d2278366-80d0-4d1b-9a5b-2bfffa3532b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2e72c4f5-7365-4ec5-8202-9e07cc5a8ef8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2d84d0d5-5274-453f-a371-e27dd0bc856c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_18d47147-63d0-4900-bbc4-57a8e222f52d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_97d6c63f-e404-41d7-a50e-2cd9a0dbb78e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8f46790b-4bd9-4b3f-8547-25a40d8bca6a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_aae48965-752a-432c-ab82-ef94faac8141_totalLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_70e8ace5-f55a-478c-9319-f92cc2da63a0_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_ee75b5d5-9977-49ad-9591-f33a0b3e430b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7802000c-62c6-4cf7-b1d5-d07f96445a01_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9ce62427-cc88-4220-9bcd-feef67e40ddf_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_8ffb64fe-fcf4-4f3e-a6e1-19c63348beb1_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ec45c57b-92a9-4172-b630-6b1d512e9946_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c1f49b95-689b-40e5-b7a8-9d492c35a0cb_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt_444a9bf5-fd45-47e1-800e-b3b3f0ffd2a4_terseLabel_en-US" xlink:label="lab_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period of transaction costs attributable to liability component of convertible debt</link:label>
    <link:label id="lab_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Period of Transaction Costs Attributable to Liability Component of Convertible Debt</link:label>
    <link:label id="lab_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt_documentation_en-US" xlink:label="lab_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Period of Transaction Costs Attributable to Liability Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" xlink:href="pcrx-20210930.xsd#pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" xlink:to="lab_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_5ca100ef-b626-4598-8dfc-c6115534e757_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_27c1f860-6029-4f19-8aaf-2310b98522ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d8f6ba5f-9cd6-440e-be8d-a4b86064ff37_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_eedd4eb2-a386-4515-9d22-063a78050e78_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b816396c-862c-44ec-a2b5-0c6295493241_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1f259f54-4f2e-457d-93ad-3e7b65aec3f1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of fixed assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AchievementOfMilestoneAxis_74620d40-4edd-45a5-8e9b-c40fe05d5035_terseLabel_en-US" xlink:label="lab_pcrx_AchievementOfMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Milestone [Axis]</link:label>
    <link:label id="lab_pcrx_AchievementOfMilestoneAxis_label_en-US" xlink:label="lab_pcrx_AchievementOfMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Milestone [Axis]</link:label>
    <link:label id="lab_pcrx_AchievementOfMilestoneAxis_documentation_en-US" xlink:label="lab_pcrx_AchievementOfMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information by categories of milestones achieved.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneAxis" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AchievementOfMilestoneAxis" xlink:to="lab_pcrx_AchievementOfMilestoneAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_468b01db-e251-49b2-994a-802d89d1192f_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_285a1cc4-d944-42ff-a551-09a25b68b4a5_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_931ac91c-5d30-4160-9e0a-3b2e0287ea91_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_00a0688e-efc7-476f-9746-6d639f2a3b0f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b677389e-1c8d-4f97-981d-a80e2c483d72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_ac10bb47-e5ad-405f-a07e-37349716bf80_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ecc61397-a96e-492d-a5b3-77eab2b6ec66_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_ccfd99a3-fe67-4389-b830-91e80cbf9b88_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c7d925bf-4f8a-4cf3-a9a5-a10340685982_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_65964199-d37a-4699-94d3-67de2348aa58_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_93af01ac-c836-4e6c-8aa9-8714b3a83d78_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c841c7a3-d2fe-40d3-bbe6-2652bb2c38cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_da4c8c93-4c84-4176-a83f-ba933e9604ac_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_6d332a71-c252-4dcb-ae89-461f30a87f61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5c73bc01-2a8e-4c86-866c-188f44b6705f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_bcac8eff-da4f-4e12-b611-5527e256c90a_terseLabel_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skye Pharma Holding Inc.</link:label>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_label_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skye Pharma Holding Inc. [Member]</link:label>
    <link:label id="lab_pcrx_SkyePharmaHoldingIncMember_documentation_en-US" xlink:label="lab_pcrx_SkyePharmaHoldingIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to SkyePharma Holding, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember" xlink:href="pcrx-20210930.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SkyePharmaHoldingIncMember" xlink:to="lab_pcrx_SkyePharmaHoldingIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_55633158-4610-43c4-9732-d03fd7eef521_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_7852733e-b0bd-41b7-93f7-a98076e971ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_1866251e-bd5b-45f3-959e-515a6d5a685f_terseLabel_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]</link:label>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_label_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]</link:label>
    <link:label id="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_documentation_en-US" xlink:label="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to milestone payments for products by the stage at which they are payable, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:href="pcrx-20210930.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:to="lab_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_1208a081-3bd0-4753-9556-da90e29117ee_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_ee08114c-e340-4465-98b7-ea5558d16ce3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest and other (Note 5)</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent_0423f7c5-fb1e-4a5c-9662-82b5d290244b_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, carrying amount of liability component</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Liability Component</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Liability Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" xlink:to="lab_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_a0302d90-ba6b-46ea-a847-53f42dc1362d_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offer price, per Flexion Share</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1ae48de8-578f-41d3-9c03-9e85bcdfa122_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e1b8abd5-56c0-4180-885d-d9cd6459536d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_3886567e-5549-4eeb-a975-93b1009ff844_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leases not yet commenced</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_230e7404-bec9-407e-8bf5-eec58164276a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_ad05fe92-2b81-447e-9438-408957e90e2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation from:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_522fba43-e026-46c4-a47c-7dd0bbceef4b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_68ef3a13-de0e-4a7c-820d-8b5549c6ec73_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_3b5ccba5-d65a-4427-bdf5-3fdd7680558b_terseLabel_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation [Policy Text Block]</link:label>
    <link:label id="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_documentation_en-US" xlink:label="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for basis of presentation and principles of consolidation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:href="pcrx-20210930.xsd#pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:to="lab_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_6fd9a994-18df-4ea9-99a3-53218261d0e3_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones_0ae468ee-a57b-4314-b339-3c0950a9671a_terseLabel_en-US" xlink:label="lab_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Predicated investment</link:label>
    <link:label id="lab_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones_label_en-US" xlink:label="lab_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Additional Debt Investment Upon Achieving Milestones</link:label>
    <link:label id="lab_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones_documentation_en-US" xlink:label="lab_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Additional Debt Investment Upon Achieving Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones" xlink:href="pcrx-20210930.xsd#pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones" xlink:to="lab_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_43b94f59-e5f1-4e56-8ac4-6280bd832b4b_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a041f786-3a49-4aff-a38f-b8a9eb6aee30_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MilestonePayment_7b99bc05-5656-4afe-9389-359b1bcc8919_terseLabel_en-US" xlink:label="lab_pcrx_MilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payment</link:label>
    <link:label id="lab_pcrx_MilestonePayment_label_en-US" xlink:label="lab_pcrx_MilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment</link:label>
    <link:label id="lab_pcrx_MilestonePayment_documentation_en-US" xlink:label="lab_pcrx_MilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePayment" xlink:href="pcrx-20210930.xsd#pcrx_MilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MilestonePayment" xlink:to="lab_pcrx_MilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_b54e2bd2-2973-443f-883d-e7cdc55aa407_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing sale price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1d2e4664-2c67-46de-a945-87fd29eee63a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_e6a679fd-b3c5-42c5-8050-fa9b0568f4ca_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligation_e7f8f388-fbd1-4d56-b8cb-8cd4f9b5e4c3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement obligation</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligation" xlink:to="lab_us-gaap_AssetRetirementObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_85958730-ad7e-4dcc-80a7-7ec633908be2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_GeneQuineBiotherapeuticsGmbHMember_f329ce64-406d-4523-a790-a605d967f27e_terseLabel_en-US" xlink:label="lab_pcrx_GeneQuineBiotherapeuticsGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GeneQuine</link:label>
    <link:label id="lab_pcrx_GeneQuineBiotherapeuticsGmbHMember_label_en-US" xlink:label="lab_pcrx_GeneQuineBiotherapeuticsGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GeneQuine Biotherapeutics GmbH [Member]</link:label>
    <link:label id="lab_pcrx_GeneQuineBiotherapeuticsGmbHMember_documentation_en-US" xlink:label="lab_pcrx_GeneQuineBiotherapeuticsGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GeneQuine Biotherapeutics GmbH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_GeneQuineBiotherapeuticsGmbHMember" xlink:href="pcrx-20210930.xsd#pcrx_GeneQuineBiotherapeuticsGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_GeneQuineBiotherapeuticsGmbHMember" xlink:to="lab_pcrx_GeneQuineBiotherapeuticsGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_4e464e35-ca11-4cd0-b640-061c84ceb107_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate_5abe522d-6a98-4cd8-8b1a-4daddcfdc03a_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed borrowing rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Assumed Borrowing Rate</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Assumed Borrowing Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleAssumedBorrowingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate" xlink:to="lab_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_4e2b5ad5-17e2-4bbf-b7e5-cf5f7cd73a1a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_24c0c036-eb2e-46df-8e49-0f9aef9cd8b3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0b7395cc-4a83-4b47-a4a9-90cc0dd07e48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_97d8025f-38f7-4ff8-88d1-b24920a9a926_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1113174d-a99b-40b0-bce6-c0f44c2e5eb3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_064fcf53-dd38-4fc8-b575-4b8d689f38fd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_5b33b29c-7019-46a7-b935-9cbb5ebaa533_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_75e35798-2fbb-4388-a012-c334f034b7c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_11b4d4f1-0265-4649-ba38-0adb7f470be5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_96707c5f-4214-4c95-bcd6-d2790450978b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of change in contingent consideration recorded at fair value using Level 3 measurements</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_b494c4f6-ec7d-4cef-8598-dc29da971fcd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercises of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_91b3ceca-03ab-4735-9015-217c8c21d8f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f8f99b67-8472-4170-b0c5-4b979751b383_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4b7df06c-bdc8-4aa3-9bc0-835453d83f8f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_10eb4593-ba0c-48a7-be43-7ae1213e0d24_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_083693a7-45ca-4dd9-b5f6-64582cc151ea_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (expense) benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_36eaefb6-d283-4187-b100-2d23ef8c5805_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_150f47ee-1f91-4880-92e9-812ac65528ea_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_104797bb-5693-41ef-ad5d-388c0d673a22_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_22f1afe2-8332-4aa5-bdaf-485614caa78c_terseLabel_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_label_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent</link:label>
    <link:label id="lab_pcrx_ContingentConsiderationNoncurrent_documentation_en-US" xlink:label="lab_pcrx_ContingentConsiderationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ContingentConsiderationNoncurrent" xlink:to="lab_pcrx_ContingentConsiderationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fad3bce6-70b8-4159-9165-5e5a225d3ce0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1f3a562a-278e-4715-b7fe-c0446112f523_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a1430fd6-ff3b-4c74-abcc-75525d853548_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_d82526b7-6ace-40d3-8520-58b6b200b99e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_769c0039-aae0-40e2-9d8b-e66a25145dad_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_7904f5ae-79d0-499c-ba4a-de23950f283d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_caec1252-0c3c-4f8a-b826-20969f257ce2_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ab45def4-5de8-48e4-9c34-898141104fef_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_f34b7d87-8cb5-4695-9513-97dd8fdf9d4d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2771ecb1-4411-4c96-84c7-8c5558a2d4a5_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_fb885666-0c57-4e3f-a2b1-36253217bf73_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_900231b0-eabc-4c89-a337-1a3eaf9669bd_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage_c73df4b6-6956-44e7-9e64-03dd8e20f703_terseLabel_en-US" xlink:label="lab_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tendered shares as a percent of Flexion Shares</link:label>
    <link:label id="lab_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage_label_en-US" xlink:label="lab_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Covenant Terms, Shares Tendered Combined With Other Shares Owned, Minimum, Percentage</link:label>
    <link:label id="lab_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage_documentation_en-US" xlink:label="lab_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Covenant Terms, Shares Tendered Combined With Other Shares Owned, Minimum, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" xlink:href="pcrx-20210930.xsd#pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" xlink:to="lab_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_125bc9df-2523-437f-af15-e7e1fb887088_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_380e5ce3-6603-41f2-bf23-59348f70c310_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_0180d508-4ba4-4b5d-bb53-3ddd7ebeee99_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ccc162fe-b3bd-4942-8be7-1ff0b91f293b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e8c0b08a-dac2-4094-90ff-32ecbe5bf5d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance of deferred tax assets released</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_6fc7a783-861c-4222-bb09-a18168386aca_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0417f9ec-8188-4543-be55-1a5ac549f089_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_65300cfb-0cdd-47af-ac7c-139262268970_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_7bf3b259-f75d-442a-ac21-be5f470af9e8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a43863a7-b0f4-4d10-8355-a0eb7cd7d381_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d949c3c5-24a5-4e94-aacd-fa5cc40ccc31_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_66f538c9-eb1a-4663-a77e-f4abcfd85d81_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_26f836c4-3654-4e44-9c8d-8fa1efff4167_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18f84b98-d5e6-442c-a571-9fec0908188a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_612d2c8a-5e38-4432-9717-9ddefd1f9725_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9d2582b0-5d12-45d2-a5f4-1790a92f9e41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_79c66c09-ebe0-4d92-9158-a6d339b56480_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_36a04954-ac0e-4b62-9166-086672e443a4_terseLabel_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition</link:label>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_label_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition [Member]</link:label>
    <link:label id="lab_pcrx_MyoscienceAcquisitionMember_documentation_en-US" xlink:label="lab_pcrx_MyoscienceAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Myoscience Acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MyoscienceAcquisitionMember" xlink:to="lab_pcrx_MyoscienceAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_843a5e8e-cd43-420e-adbe-0f82eb9ec451_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_798cacf7-87d0-484e-8994-5671012da02b_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_7c291a9d-015c-4524-a07e-1af587ff77a7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_be52fdc8-3a94-41ca-bfd7-73b880bb6d45_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_bb25b473-8f24-4d7e-af3c-8d9f14e9529e_terseLabel_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and other assets</link:label>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_label_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Other Assets</link:label>
    <link:label id="lab_pcrx_EquityMethodInvestmentsAndOtherAssets_documentation_en-US" xlink:label="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:href="pcrx-20210930.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:to="lab_pcrx_EquityMethodInvestmentsAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims_dee02ba8-1b01-4b10-a8a5-2c55d98d3a49_negatedTerseLabel_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offset indemnification claims</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims_label_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Offset Indemnification Claims</link:label>
    <link:label id="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims_documentation_en-US" xlink:label="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Offset Indemnification Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" xlink:href="pcrx-20210930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" xlink:to="lab_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EuropeanUnionMember_b50f3ec2-9603-4414-9748-e86b380cf2e0_terseLabel_en-US" xlink:label="lab_us-gaap_EuropeanUnionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Union or E.U.</link:label>
    <link:label id="lab_us-gaap_EuropeanUnionMember_label_en-US" xlink:label="lab_us-gaap_EuropeanUnionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Union [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EuropeanUnionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EuropeanUnionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EuropeanUnionMember" xlink:to="lab_us-gaap_EuropeanUnionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f4255383-0112-4a9f-9384-30ddb99cff6b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_63889ca6-376e-440d-a84a-cb3b63ee4847_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_e70cf0f4-a619-44fe-8d06-01dd04ebe050_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_6b736820-509f-43dd-95b6-8b14300bda45_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire Flexion Shares</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_513f6e28-0cb5-4945-91e9-9983a2d06968_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value (Level 2)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_eba802c6-7101-451b-b00c-37a4f6d8a915_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term:</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_90e6a0c9-180a-4747-8d01-3523c5c66bd1_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b47ffaaf-fc30-438e-b241-c9ca1bea5da7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_fa61c5a3-025e-41d4-b56f-dc7caebb8189_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c6f25298-1318-45f7-acef-5e8c7441025e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_de5c24fa-ed7a-4fd3-b2a6-6112999bffda_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, ESPP (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f6e1183d-69ae-4961-a48e-8fc90a7ef0e5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_71e5033d-5f67-4a48-aca3-16080711a2ce_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:to="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0f4543c2-15a7-452b-85ad-5cad76e96062_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1db6e0d5-1252-4371-9478-508ff7eecd50_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_eea61521-9b63-47e4-a54e-b2a5f17cd93e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_afc394e2-1f82-41c5-ab1c-4c7b4ffcae8f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0ed33ec5-6a65-442a-ba2c-4caa8289d1b3_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6aa7d353-0965-484b-bceb-9763a99ed579_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_9643c8a2-ce1c-4451-9d3c-1b7fcf900cc5_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_16ba0503-6582-4f00-88ae-d08b4fb7e363_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b7e38ea1-f954-4b93-b059-df6a90e55c56_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computation of basic and diluted loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_51e6e955-83f2-4b08-875f-5be53fcd62a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_3b84e59f-e0e3-471c-85fe-424e457121ca_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_d58c6107-268e-40a1-a4df-f9bbbca6e0ab_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_fd395885-f4f8-42dc-bebf-b6fd756479ea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_cef7119b-21fe-4908-ae04-72f3cd4fa9c7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cb63e37a-f410-447b-bce0-e6d8f3537ad0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_64587de4-912e-4ffd-9846-9fe2bfaffd9d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_22002071-e22d-4b89-94ec-2653b1960f55_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss (Note 11)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_5c4cd0d4-dd25-4b0e-87c1-42c7d4108a61_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of recognized stock-based compensation in consolidated statements of operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_95613a76-7dae-4b54-b019-82c7cd7dc941_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ForeignPropertyPlantAndEquipmentNet_37146b9e-e6e9-4b34-8393-a38a130ae537_terseLabel_en-US" xlink:label="lab_pcrx_ForeignPropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign property, plant and equipment, net</link:label>
    <link:label id="lab_pcrx_ForeignPropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_pcrx_ForeignPropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Property, Plant And Equipment, Net</link:label>
    <link:label id="lab_pcrx_ForeignPropertyPlantAndEquipmentNet_documentation_en-US" xlink:label="lab_pcrx_ForeignPropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to product goods and services and not intended for resale, located in a foreign country or territory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ForeignPropertyPlantAndEquipmentNet" xlink:href="pcrx-20210930.xsd#pcrx_ForeignPropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ForeignPropertyPlantAndEquipmentNet" xlink:to="lab_pcrx_ForeignPropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_ce9d956c-cc52-40e4-89c2-fd01cd4c9b3d_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7ea7ce94-229c-4661-9738-38c746255de4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_92563915-7971-4a60-9942-4e22d61960d6_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Major Customers</link:label>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:to="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_efcba563-fda3-4e8e-91d3-7ab4b2b1d7e5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_385bbe34-65a4-46d7-84b9-22a1b846a61e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of restructuring costs, once probable</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0820ef01-2244-4878-b992-b3137d8de74b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_4ad34579-b86e-425a-82ea-7ff2f949cc09_terseLabel_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third largest wholesaler</link:label>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_label_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_ThirdLargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_ThirdLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the third largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember" xlink:href="pcrx-20210930.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ThirdLargestCustomerMember" xlink:to="lab_pcrx_ThirdLargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_ec3f9b5c-ab5c-45a9-8871-9441adf3dab5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, realized loss</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_a79539d4-c165-443a-830d-a6758c7b1aff_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_9dd919ff-1a57-4cb3-b34f-0a1eab6a6ecd_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_8f59b3aa-2b3e-4434-91e3-41f2cd77b106_terseLabel_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers</link:label>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_label_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers [Member]</link:label>
    <link:label id="lab_pcrx_ThreeLargestCustomersMember_documentation_en-US" xlink:label="lab_pcrx_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember" xlink:href="pcrx-20210930.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ThreeLargestCustomersMember" xlink:to="lab_pcrx_ThreeLargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_92e555e0-1cab-477b-b0b1-4e3eca26e87a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_f87355ee-03a7-4cc1-8148-ddc9fd64f988_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_d5dfc206-41f2-4e99-946f-62333b5e4386_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_255f17c9-a9c9-4d1e-9eba-ac94b3491a33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_782893d7-7d8e-4318-9d75-9a4783010618_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5026839d-8129-41ee-a8a2-4321582c47d1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_f072224e-e3cc-473a-ace5-58ed4d04b9a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of composition of the Company's debt and financing obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_68335f8d-cf79-4027-a4fd-870a56507e62_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_6d6af417-ad37-4e1e-8cbc-b40dfbb97545_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_1b9bf634-a78e-4eb5-bfaf-12c943c20841_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of operating lease cost and other operating lease information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_aefecc8a-7483-408a-943f-5c7e9a689075_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_f2b54eb3-06c7-484a-9345-a51de3952cc5_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_0c712c82-b566-415f-8be2-3afbfea65ddb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_fe4b15fc-805e-4360-b3a0-82e0fdaa683f_terseLabel_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_label_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023 [Member]</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_documentation_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after August 1, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:href="pcrx-20210930.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:to="lab_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_f92adbe3-dfe0-4e3c-80c9-2edd4549b3fd_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e105cd77-b4f0-4adf-910b-35cdd3205cfd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_94c08089-4989-4882-90f8-fd1fbc36f640_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_898456e5-2c64-4464-974c-cb15b18da9fa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per common share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_8c82d538-e9a4-4150-b910-6f75a0f17d75_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of diluted securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtRedemptionTermsonorafterApril12020Member_3788370e-1e66-4b81-bcf6-e2a8adaf42a4_terseLabel_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsonorafterApril12020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after April 1, 2020</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsonorafterApril12020Member_label_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsonorafterApril12020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after April 1, 2020 [Member]</link:label>
    <link:label id="lab_pcrx_DebtRedemptionTermsonorafterApril12020Member_documentation_en-US" xlink:label="lab_pcrx_DebtRedemptionTermsonorafterApril12020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption Terms on or after April 1, 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsonorafterApril12020Member" xlink:href="pcrx-20210930.xsd#pcrx_DebtRedemptionTermsonorafterApril12020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtRedemptionTermsonorafterApril12020Member" xlink:to="lab_pcrx_DebtRedemptionTermsonorafterApril12020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_48466e71-41b8-414d-84c2-3ad4439a0261_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_058bf0e4-1f8c-4526-8e0e-0680736b5719_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_bdb4e2f1-2764-4eac-947e-8dd98cf16286_netLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales:</link:label>
    <link:label id="lab_us-gaap_ProductMember_9663d766-04a0-46cf-bf1c-4bddf8b0fcac_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net product sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_e44b7b37-d60b-4f89-9cdc-c08f6a22a85b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_a89db040-f577-4496-a1c0-106e0026c33c_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, convertible, conversion premium (in shares)</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Premium, Shares</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Premium, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:to="lab_pcrx_DebtInstrumentConvertibleConversionPremiumShares" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_2663043b-3f9b-4fee-a4cd-8bd736fe1e06_terseLabel_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual net sales threshold</link:label>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_label_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Net Sales Threshold for Determining Milestone Payments for Product in Connection with Acquisition</link:label>
    <link:label id="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_documentation_en-US" xlink:label="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:href="pcrx-20210930.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:to="lab_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_e7f5b67d-2048-4154-aa13-7d2dab18094f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_06dc7ae2-e499-4aa2-bf23-102c054b0693_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_de15dbb7-4ea8-480f-962d-031f527b0174_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b82b4b7e-1f41-46aa-8637-b78b684b9e30_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_bf429ee3-d8e1-4bec-a912-a817979934ab_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_f8147284-e309-45ff-912e-cca16909b17d_terseLabel_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_label_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022 [Member]</link:label>
    <link:label id="lab_pcrx_ConvertibleSeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:to="lab_pcrx_ConvertibleSeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc04a87b-de09-46b9-b3e7-0bfdc979af16_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AchievementofRegulatoryMilestoneMember_c3d7e81f-19d3-4e83-8ff6-7bc31322c015_terseLabel_en-US" xlink:label="lab_pcrx_AchievementofRegulatoryMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Regulatory Milestone</link:label>
    <link:label id="lab_pcrx_AchievementofRegulatoryMilestoneMember_label_en-US" xlink:label="lab_pcrx_AchievementofRegulatoryMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Regulatory Milestone [Member]</link:label>
    <link:label id="lab_pcrx_AchievementofRegulatoryMilestoneMember_documentation_en-US" xlink:label="lab_pcrx_AchievementofRegulatoryMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Regulatory Milestone [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementofRegulatoryMilestoneMember" xlink:href="pcrx-20210930.xsd#pcrx_AchievementofRegulatoryMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AchievementofRegulatoryMilestoneMember" xlink:to="lab_pcrx_AchievementofRegulatoryMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_03c507bd-4736-4d17-9cf6-1eafbdd92f7d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_314f755f-c78d-4d0c-9fdb-4c582a15e7d0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_7dcc242c-9adc-4b83-82ad-a4317eb0023f_terseLabel_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_label_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Assets and Unfavorable Lease Obligation</link:label>
    <link:label id="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_documentation_en-US" xlink:label="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:href="pcrx-20210930.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:to="lab_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_352f1209-9599-4f2c-b983-77bd749d0c70_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AchievementOfMilestoneDomain_431aab56-b8a9-44e1-8e64-29df5cd0701f_terseLabel_en-US" xlink:label="lab_pcrx_AchievementOfMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Milestone [Domain]</link:label>
    <link:label id="lab_pcrx_AchievementOfMilestoneDomain_label_en-US" xlink:label="lab_pcrx_AchievementOfMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Milestone [Domain]</link:label>
    <link:label id="lab_pcrx_AchievementOfMilestoneDomain_documentation_en-US" xlink:label="lab_pcrx_AchievementOfMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Different categories of achievement of milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneDomain" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AchievementOfMilestoneDomain" xlink:to="lab_pcrx_AchievementOfMilestoneDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_747dcca0-57bd-4cb9-9904-f353c6f702a7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_a25370f0-e358-4cd3-b253-074f6b2b383d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_bcf7984c-914f-4b94-adec-98b338b1f7c8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_4c04a46a-1576-4d48-970a-808c67a229e4_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of fixed assets and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_A2022ConvertibleSeniorNotesMember_f1a1b4e7-29a7-4ce2-8b7b-9820d645d142_terseLabel_en-US" xlink:label="lab_pcrx_A2022ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2022</link:label>
    <link:label id="lab_pcrx_A2022ConvertibleSeniorNotesMember_label_en-US" xlink:label="lab_pcrx_A2022ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Convertible Senior Notes [Member]</link:label>
    <link:label id="lab_pcrx_A2022ConvertibleSeniorNotesMember_documentation_en-US" xlink:label="lab_pcrx_A2022ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Convertible Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_A2022ConvertibleSeniorNotesMember" xlink:href="pcrx-20210930.xsd#pcrx_A2022ConvertibleSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_A2022ConvertibleSeniorNotesMember" xlink:to="lab_pcrx_A2022ConvertibleSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_17794213-8290-4128-9a10-33cf92bf099d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt component of the 2025 convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3ae77a9d-aeb2-4d3e-b520-17689443b627_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c08ac124-2bed-48ea-803a-b49d9740d15a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total transaction costs</link:label>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Related Commitment Fees and Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5b3c1313-6ebc-4b5b-8ea2-e65a8869b0c5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, remainder of fiscal year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_dd19363d-0cc2-4904-9104-5aaddbdc3357_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_caf8ff16-d6b4-4d4f-abc7-c8d0afa97517_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_e2603246-3938-4311-860a-79279e3f6ddd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7aff9062-b887-45e7-bf63-229c06537642_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FlexionMember_e933c019-8c9c-4c73-b550-00f030353474_terseLabel_en-US" xlink:label="lab_pcrx_FlexionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion</link:label>
    <link:label id="lab_pcrx_FlexionMember_label_en-US" xlink:label="lab_pcrx_FlexionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion [Member]</link:label>
    <link:label id="lab_pcrx_FlexionMember_documentation_en-US" xlink:label="lab_pcrx_FlexionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionMember" xlink:href="pcrx-20210930.xsd#pcrx_FlexionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FlexionMember" xlink:to="lab_pcrx_FlexionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_b58b5bf0-b6a1-4afd-97b1-b677f2428ee4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of equity investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_aa7c4b6d-d5a0-4a53-8c4a-86e7756239e3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_43e98de7-f3e6-4b92-af88-6be7cdbe47ff_terseLabel_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd.</link:label>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_label_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd. [Member]</link:label>
    <link:label id="lab_pcrx_NuanceBiotechCo.Ltd.Member_documentation_en-US" xlink:label="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuance Biotech Co. Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member" xlink:href="pcrx-20210930.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_NuanceBiotechCo.Ltd.Member" xlink:to="lab_pcrx_NuanceBiotechCo.Ltd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_bcff9749-3f0a-4ace-a9dd-82452185b31f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3ba61da9-db59-4b68-adc4-c3e2fef231d1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockExpense_5138fecd-9ce5-4989-b82b-a25e6054cd5b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockExpense_label_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock or Unit Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockExpense" xlink:to="lab_us-gaap_RestrictedStockExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_180a3f8b-7581-4785-a797-65fc1dfce03e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1d839ccf-2ccf-4013-b9dd-2bedfe8d44e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_11f4ad6d-c4e2-4683-9928-0c1320cee3e4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_046e1f0e-20ad-4858-8a67-943c28803ef6_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_f4fed18e-8200-46b7-b696-113fc9e57769_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of fixed assets summarized by major category</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0549988e-6f30-4a8c-aa78-2918fcb60650_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_5cc9e6d1-d078-47c9-8542-f89ddcfe9b3f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period of equity component of convertible debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_b755809e-223e-4b84-a7c4-29e458b65cc3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_077a4730-741d-4c6c-9571-5127394df007_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares of common stock authorized for issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_d37cfc26-d8ea-49ce-8e7a-2fb4d7b496d8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_47ef9012-c76e-4eff-b162-62e9b4ebde1c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_b6714107-bb6d-4026-a389-a2fdf5b362f9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_eca0aaf8-1c3d-43ba-94f6-ca18b3a4f68a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d7235674-3f95-4bd7-ac20-52f1c0dc4964_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_e1652f2e-27a7-4525-b4f6-b7434c58bce7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FIXED ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_2211e2e5-9c55-490b-bf36-887e2d99a6c7_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price of principal amount of notes</link:label>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_label_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Market Price</link:label>
    <link:label id="lab_pcrx_DebtInstrumentMarketPrice_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentMarketPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt market price, per $1,000 principal amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentMarketPrice" xlink:to="lab_pcrx_DebtInstrumentMarketPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_93fce7d7-8f80-4d25-bc3e-a80e2dec4ecd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d2fbafd1-4a86-4d64-b057-b477d2ee9a8e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_48757bf0-88f2-4d56-8802-64134a179f95_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT AND FINANCING OBLIGATIONS</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_22d56632-68cc-4e4b-92bf-1d11d83f30a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d2528350-d646-4234-8c34-777b9fdc8943_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_363f5a95-db1f-452f-9b69-43c77a205d2c_terseLabel_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, payment terms</link:label>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_label_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Payment Terms</link:label>
    <link:label id="lab_pcrx_AccountsReceivablePaymentTerms_documentation_en-US" xlink:label="lab_pcrx_AccountsReceivablePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms" xlink:href="pcrx-20210930.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AccountsReceivablePaymentTerms" xlink:to="lab_pcrx_AccountsReceivablePaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_3c2f3b4b-e49a-41ff-9828-ea99545c7c77_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Axis]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_label_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Axis]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsAxis_documentation_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information regarding the conversion and redemption terms of the debt instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:to="lab_pcrx_DebtConversionAndRedemptionTermsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_9d5821b1-e584-42c8-81de-869e2e68fb60_terseLabel_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement period - convertible debt conversion request</link:label>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_label_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Period - Convertible Debt Conversion Request</link:label>
    <link:label id="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest_documentation_en-US" xlink:label="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of trading days in a settlement period for convertible debt conversion requests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:href="pcrx-20210930.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:to="lab_pcrx_SettlementPeriodConvertibleDebtConversionRequest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_1d6b2c26-85e9-4722-815f-336b5ab7be53_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b1393e14-7439-4a85-a4e3-88b9cc3dfd1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_02fd00c6-63e9-4a67-ac91-3a27a5eca96c_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_IoveraMember_673b250a-631a-4dd8-8b9f-52968c7bb790_terseLabel_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176;</link:label>
    <link:label id="lab_pcrx_IoveraMember_label_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176; [Member]</link:label>
    <link:label id="lab_pcrx_IoveraMember_documentation_en-US" xlink:label="lab_pcrx_IoveraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">iovera&#176; [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember" xlink:href="pcrx-20210930.xsd#pcrx_IoveraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_IoveraMember" xlink:to="lab_pcrx_IoveraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_ffe266b6-40be-4d20-8842-c10778563002_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_05f559aa-ccf2-457f-b168-d908fed42554_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_88497065-bfe2-4c8c-9c04-2090a8947540_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7b61def9-80a9-41a9-8646-ebd19f97a6e7_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_6a3ccd08-6423-4928-b18f-7ecbf63ae953_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CommercialPartnersAndAgreementsTextBlock_89d8f18d-6cec-4f33-b23a-e0255f723602_verboseLabel_en-US" xlink:label="lab_pcrx_CommercialPartnersAndAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMERCIAL PARTNERS</link:label>
    <link:label id="lab_pcrx_CommercialPartnersAndAgreementsTextBlock_label_en-US" xlink:label="lab_pcrx_CommercialPartnersAndAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Partners and Agreements [Text Block]</link:label>
    <link:label id="lab_pcrx_CommercialPartnersAndAgreementsTextBlock_documentation_en-US" xlink:label="lab_pcrx_CommercialPartnersAndAgreementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the entire disclosure of commercial agreement and arrangement with third parties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CommercialPartnersAndAgreementsTextBlock" xlink:href="pcrx-20210930.xsd#pcrx_CommercialPartnersAndAgreementsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CommercialPartnersAndAgreementsTextBlock" xlink:to="lab_pcrx_CommercialPartnersAndAgreementsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_3d871d44-0d8f-475a-9650-6381051c3358_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_ec83205c-8ce2-43c3-842a-629d4694e3c6_terseLabel_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Domain]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_label_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion and Redemption Terms [Domain]</link:label>
    <link:label id="lab_pcrx_DebtConversionAndRedemptionTermsDomain_documentation_en-US" xlink:label="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identification of the conversion and redemption terms of the debt instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:to="lab_pcrx_DebtConversionAndRedemptionTermsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b7da2736-c693-4a40-8a5f-aa50f89ce301_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_361142b8-d889-4bdc-b9a9-a2226e261777_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91193aec-527c-4b25-a987-1983deb315d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_fd6908ed-a5c5-4018-8943-abf30ee77c9d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_c4cbdabc-c8e1-4e2f-b8cb-75814769e9d5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_62d54521-ee38-4f6e-ae0d-a1838bd44500_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_be8873c2-fd94-4cc0-89fa-a356c744d5d8_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b9e215b8-2f06-4c3f-a140-c51a5d492f13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income before income tax, domestic and foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_a124a82b-a51f-4ab6-b73e-8cd36b4873d7_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1370c59c-2d39-48f6-b331-2af8d266af38_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on disposal of fixed assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_8bc38ae9-624f-4912-8ef1-ba2b627ee14d_terseLabel_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second largest wholesaler</link:label>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_label_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Largest Customer [Member]</link:label>
    <link:label id="lab_pcrx_SecondLargestCustomerMember_documentation_en-US" xlink:label="lab_pcrx_SecondLargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the second largest customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember" xlink:href="pcrx-20210930.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_SecondLargestCustomerMember" xlink:to="lab_pcrx_SecondLargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e48bec36-3519-4a58-b639-513c149419f4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a652d6c4-86a7-4986-a45a-b1c8bfc7cf91_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d1d7ab4c-9503-4b68-9cd4-90757814943a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_21e55724-c8d8-42b6-9f30-8457f2b38265_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Flexion common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_d88d1281-7a2a-4e8d-a55a-9c28b22a1300_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_ce4f7adc-8002-4656-bd32-40c70016bfc5_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of percentage of revenue comprised by the three largest customers</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_77cb4bc9-ef7a-497e-9a2e-97279833e524_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_89b95990-0ad1-4e20-87fe-2fad82c783a9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_195bb6cc-3583-4624-b433-ed2dc501aa6a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt_51ed804f-e459-4765-8d66-a5f01c620bf5_terseLabel_en-US" xlink:label="lab_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs attributable to equity component of convertible debt</link:label>
    <link:label id="lab_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Costs Attributable to the Equity Component of Convertible Debt</link:label>
    <link:label id="lab_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt_documentation_en-US" xlink:label="lab_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Costs Attributable to the Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" xlink:href="pcrx-20210930.xsd#pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" xlink:to="lab_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_05b0d2de-8607-40f3-a054-40b1e4217e56_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_6d15bf59-8d91-445c-a209-4dcc2d36b65b_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_47521a68-2475-4886-beeb-4284e34dcbcd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_fc597514-6bdf-4998-a19a-7257a525f736_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_44eb46d2-9614-4388-ae20-b00f444c1e36_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61cbcdb2-cfc4-42e6-8cef-412984d502ec_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d70826d-209a-4ae3-905c-a825ea221f58_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ee21fed4-1349-42de-89c6-cf12f2c4d939_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9fa215fc-944d-48d4-a20d-47144174544b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e17d0e72-85d3-4310-97ec-23d0bcbadce5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_71f97366-971d-48ce-b261-1f2027b3a6a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_2e9633fd-cca9-4787-98bc-c04cc2912ec6_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer three</link:label>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer Three [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerThreeMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerThreeMember" xlink:to="lab_pcrx_MajorCustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_8a423a7b-d6f8-4eb9-90c0-342d52b57e79_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_b4d55ff8-5278-4d8b-8d22-1bf4cbe9807d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4abf7e2a-b348-47c8-b5b3-86cefd6ce8fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the company's stock option activity and restricted stock unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_34f3eda2-5407-4694-ba9f-504f338bc951_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_4d54a6f6-08b8-40f8-a32e-9cdd3e679902_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_ffb21e76-e99a-4fe8-926a-a266b74312b4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of equity component of 2022 convertible senior notes (Note 8)</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsReceived_c147afcc-b687-426b-bfc2-c2e6d60de6d3_terseLabel_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payment received</link:label>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsReceived_label_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments Received</link:label>
    <link:label id="lab_pcrx_CollaborativeArrangementMilestonePaymentsReceived_documentation_en-US" xlink:label="lab_pcrx_CollaborativeArrangementMilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Milestone Payments Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsReceived" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeArrangementMilestonePaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CollaborativeArrangementMilestonePaymentsReceived" xlink:to="lab_pcrx_CollaborativeArrangementMilestonePaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ccf9b6e4-22a1-4ddd-b995-8e2bffecc35e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_60d2306e-3f68-4ba8-96c1-73cbd37725fd_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c2198eb0-52e3-4204-b1e9-9ff597bf4fbc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_72d08849-454e-4877-9326-dd1ba978979a_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_e8a960c1-3ef5-4c24-8065-882aab228229_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional equity investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption_161b118d-bddf-49d0-9dea-ffaba965d34f_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion obligation, number of trading days prior to date of notice of redemption</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Conversion Obligation Number Of Trading Days Prior To Date On Which Entity Provides Notice Of Redemption</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of trading days prior to the date on which the entity provides notice of redemption during which the closing price of the entity's common stock must exceed the conversion price for the notes to be redeemed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" xlink:to="lab_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3ee471f-7507-4737-8970-c69843ee9ae0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_b2d751d7-d21d-49db-ab01-d1f2561c5a60_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, second period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:href="pcrx-20210930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_62bd90e0-6bc2-4545-bf80-df86da773487_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty revenue</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d0466841-8e8a-48d2-b72b-a4e5520c2608_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_97bca2d5-1f0e-452d-a422-f106e7ed8fc7_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d48903d5-834e-456b-8e1b-5b746b890ee5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_01c0572f-3185-468e-b789-ddbd457ca4d9_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_81b012d0-1218-491b-a9d1-7de1a32e2aa5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_1277d986-eb48-4aaf-8ae9-1f1d2846d8e0_terseLabel_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense, first period</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_label_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</link:label>
    <link:label id="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_documentation_en-US" xlink:label="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:href="pcrx-20210930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:to="lab_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3d6aba53-58e7-4c73-8e13-8df09e87cd10_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_8290d2d9-5751-4669-aa1b-577723d311fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate on convertible senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e9032e3a-ce9d-484f-96a6-6c2c936559e1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term of options (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0d3bd9d0-44ed-408b-b19b-94cbb6f8c5b9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_b133a6b3-ae14-4607-a880-ead1914b081e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_f569a740-5ce4-419f-ad78-13c6cc34e5bb_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_962cd467-1711-4888-a203-15675ac157e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance and financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Financing and Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_d5856323-b369-48e7-9aa0-fac410fd2ffb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_aedbf91d-2433-417b-aeb9-619251dead70_terseLabel_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of total interest expense recognized related to the Notes</link:label>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_label_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense [Table Text Block]</link:label>
    <link:label id="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock_documentation_en-US" xlink:label="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the amount of interest rate expenses related to convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:href="pcrx-20210930.xsd#pcrx_ScheduleOfInterestExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:to="lab_pcrx_ScheduleOfInterestExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_67ff65f8-5f09-4fa9-b7a9-9bf0d66a8ef9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite-lived intangible assets acquired as part of business combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7b57463a-4efe-4cca-a896-3d8164fc07b0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_d49f724a-94b7-4e65-8f6d-995d672059fa_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_efb58c3e-39f3-4a35-861d-706f5435d2e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_aa8b4901-fbea-406c-9254-95ed1e643d44_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_8649aeb2-1f0f-4ae0-af52-bbeefbe70f39_terseLabel_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, premium on common stock</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_label_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion Obligation Premium on Common Stock</link:label>
    <link:label id="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_documentation_en-US" xlink:label="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:to="lab_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_cfb4b464-0af6-4c76-a1c5-23fcdc385bab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_974b4319-033e-4010-bee1-2b379be90503_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f6a2a0a5-26f6-4869-896e-d9cb3335f979_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements/ Recent Accounting Pronouncements Not Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_MajorCustomerOneMember_c0184c8a-36c7-4cc0-8122-427bae948a71_terseLabel_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer one</link:label>
    <link:label id="lab_pcrx_MajorCustomerOneMember_label_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customer One [Member]</link:label>
    <link:label id="lab_pcrx_MajorCustomerOneMember_documentation_en-US" xlink:label="lab_pcrx_MajorCustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the major customer of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_MajorCustomerOneMember" xlink:to="lab_pcrx_MajorCustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_19c0f1f3-a0bf-4ab1-b46e-976764bd0e38_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_0d7ffa1d-54fe-48e9-bc6b-a5057d958e47_terseLabel_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_label_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</link:label>
    <link:label id="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_documentation_en-US" xlink:label="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:to="lab_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_8496d224-37ef-444a-a526-a12217e20747_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_0fee326b-dca0-4f45-aece-e76a00066f80_negatedLabel_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_label_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</link:label>
    <link:label id="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_documentation_en-US" xlink:label="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:href="pcrx-20210930.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:to="lab_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_72a2f120-a903-423f-a217-c0bd92d500c9_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_d2418089-1998-4a65-b732-90afae93d632_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_77d121b7-413a-4297-8993-e40fdf23cf3a_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_8aca648f-f88b-4eeb-a33a-ba6a783f7741_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_998186db-e885-4478-9ed3-1a933dbfdcf9_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill recorded in connection with the acquisition</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_EurofarmaLabatoriesSAMember_aa699e12-25ec-4f1f-be77-ab4bc8f7d2a4_terseLabel_en-US" xlink:label="lab_pcrx_EurofarmaLabatoriesSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurofarma Labatories S.A.</link:label>
    <link:label id="lab_pcrx_EurofarmaLabatoriesSAMember_label_en-US" xlink:label="lab_pcrx_EurofarmaLabatoriesSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurofarma Labatories S.A. [Member]</link:label>
    <link:label id="lab_pcrx_EurofarmaLabatoriesSAMember_documentation_en-US" xlink:label="lab_pcrx_EurofarmaLabatoriesSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurofarma Labatories S.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EurofarmaLabatoriesSAMember" xlink:href="pcrx-20210930.xsd#pcrx_EurofarmaLabatoriesSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_EurofarmaLabatoriesSAMember" xlink:to="lab_pcrx_EurofarmaLabatoriesSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_863c754e-5337-4bf4-8ffa-66d731f7677c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of key assumptions used in the valuation of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_56e7e050-02e1-4283-a583-30ce5992bb69_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt_9ae0dda2-8aba-40d8-a307-08a27056d196_terseLabel_en-US" xlink:label="lab_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax associated with equity component of convertible debt</link:label>
    <link:label id="lab_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Expense Associated to the Equity Component of Convertible Debt</link:label>
    <link:label id="lab_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt_documentation_en-US" xlink:label="lab_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Expense Associated to the Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" xlink:href="pcrx-20210930.xsd#pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" xlink:to="lab_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_90ef0548-dade-489b-a156-0994acf9e709_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_8a6e2627-4ab8-4380-ada2-6444bc017ae9_terseLabel_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense From Employee Stock Purchase Plan</link:label>
    <link:label id="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense From Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:href="pcrx-20210930.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:to="lab_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_5df34bfa-4005-4b73-93bf-3f07bd1c08b0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_97e92751-e428-44b9-94b8-f527dd86fc2d_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_cd68e467-bd31-45ec-8477-97ca02dff76c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_16fa19b2-e3cd-435c-8a4e-a0e6bceccc47_terseLabel_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_pcrx_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember" xlink:href="pcrx-20210930.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_ComputerEquipmentAndSoftwareMember" xlink:to="lab_pcrx_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_f7fc745d-a179-4caa-afa3-29f9119d97e2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_5b9c40eb-b7c0-440b-9dcb-3e72aa30b3f4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_c2a5b0e0-2849-48ad-94e3-039ab8016766_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember_0f6ff5ab-8f7d-4da3-8b7d-2f887a549a73_terseLabel_en-US" xlink:label="lab_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Development and Commercial Milestones</link:label>
    <link:label id="lab_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember_label_en-US" xlink:label="lab_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Development and Commercial Milestones [Member]</link:label>
    <link:label id="lab_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember_documentation_en-US" xlink:label="lab_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to the achievement of development and commercial events on the basis of which certain milestones are achieved.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember" xlink:to="lab_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a1074111-9c34-41cc-852b-88c8138da1f4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>pcrx-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:72021cac-ffd9-4fc5-b071-994f9d22f7d5,g:6c0c4d51-64cc-433e-9997-2f3b5b13ef74-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pacira.com/role/CoverPage" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1656a826-64b9-47ae-ba05-799119330b57" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_DocumentType_1656a826-64b9-47ae-ba05-799119330b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1578485f-834e-4c1a-b19e-d7531f517b37" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_DocumentQuarterlyReport_1578485f-834e-4c1a-b19e-d7531f517b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fb9a8453-8387-40f0-8e77-316b6c6ff550" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_DocumentPeriodEndDate_fb9a8453-8387-40f0-8e77-316b6c6ff550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b54e2029-e15d-4e20-907a-d385d3a3fe7e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_DocumentTransitionReport_b54e2029-e15d-4e20-907a-d385d3a3fe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5584b107-37a8-4791-8607-9daffaabd45c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityFileNumber_5584b107-37a8-4791-8607-9daffaabd45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c0d526c5-0476-43c9-87ef-27518f983323" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityRegistrantName_c0d526c5-0476-43c9-87ef-27518f983323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4aa8fdff-7875-4ebc-ae6a-af1a277556a4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4aa8fdff-7875-4ebc-ae6a-af1a277556a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_40d5825c-0ac9-4328-bbad-ee27a7518000" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityTaxIdentificationNumber_40d5825c-0ac9-4328-bbad-ee27a7518000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_80a3b93b-e471-41ac-aa00-9c1a0f498c82" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityAddressAddressLine1_80a3b93b-e471-41ac-aa00-9c1a0f498c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_08a65f20-0507-4582-9eb5-5ed391c6c5e0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityAddressCityOrTown_08a65f20-0507-4582-9eb5-5ed391c6c5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_66801ea5-4935-4ab1-b234-69823fe7676c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityAddressStateOrProvince_66801ea5-4935-4ab1-b234-69823fe7676c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2829df45-200a-48e9-bb7e-2cb31c9694f4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityAddressPostalZipCode_2829df45-200a-48e9-bb7e-2cb31c9694f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_33bf7011-e66b-4f81-888c-24337c7aef84" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_CityAreaCode_33bf7011-e66b-4f81-888c-24337c7aef84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_71a03d15-d586-436c-be32-f710fc47f2f8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_LocalPhoneNumber_71a03d15-d586-436c-be32-f710fc47f2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e21ad78b-aa69-4460-ad6e-61f48ccd2f5c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_Security12bTitle_e21ad78b-aa69-4460-ad6e-61f48ccd2f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1d8ec9d7-5720-4009-9376-1bc4c29466ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_TradingSymbol_1d8ec9d7-5720-4009-9376-1bc4c29466ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5dd0884c-f070-4254-ba22-66c64c13ef5b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_SecurityExchangeName_5dd0884c-f070-4254-ba22-66c64c13ef5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c3a0e5e6-80aa-47bc-ba8d-651635944dce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityCurrentReportingStatus_c3a0e5e6-80aa-47bc-ba8d-651635944dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e4381a9e-af76-4860-a999-3115da90f82a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityInteractiveDataCurrent_e4381a9e-af76-4860-a999-3115da90f82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_34f12474-ee6a-430c-a804-34fc0fa7cf70" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityFilerCategory_34f12474-ee6a-430c-a804-34fc0fa7cf70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9b507f48-86bb-429a-9097-9fc204936fd9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntitySmallBusiness_9b507f48-86bb-429a-9097-9fc204936fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_645aa652-c6ea-4899-94f2-4461d96ba3a7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityEmergingGrowthCompany_645aa652-c6ea-4899-94f2-4461d96ba3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_5ec9bfb3-c089-4784-ba2d-979e1ae92cd1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityShellCompany_5ec9bfb3-c089-4784-ba2d-979e1ae92cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ebfe094d-659a-4fb7-9913-acf5f66e0e7d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ebfe094d-659a-4fb7-9913-acf5f66e0e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a52d18fc-49b3-4f9d-b4fc-c35bd3cd7997" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_EntityCentralIndexKey_a52d18fc-49b3-4f9d-b4fc-c35bd3cd7997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6fa1c9ec-ca57-4c11-a804-97e8a91a99f3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_CurrentFiscalYearEndDate_6fa1c9ec-ca57-4c11-a804-97e8a91a99f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_49608270-86ca-4400-a90d-6ba5462a6857" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_DocumentFiscalYearFocus_49608270-86ca-4400-a90d-6ba5462a6857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_69629be8-975c-4892-b948-08eba53af168" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_69629be8-975c-4892-b948-08eba53af168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c14d71c5-783d-4798-8948-deef445f7ccf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5a2d9581-a8f3-47c7-9d6d-7265b251424b" xlink:to="loc_dei_AmendmentFlag_c14d71c5-783d-4798-8948-deef445f7ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3c8f949d-658b-499b-8fcf-5e5740035232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3c8f949d-658b-499b-8fcf-5e5740035232" xlink:to="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_94f8a132-0b0a-4e37-9e13-844a0d7b6dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_94f8a132-0b0a-4e37-9e13-844a0d7b6dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b6b368eb-fc7d-45d3-bbdf-8b266741be2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94f8a132-0b0a-4e37-9e13-844a0d7b6dcb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b6b368eb-fc7d-45d3-bbdf-8b266741be2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_02cdd40d-a06c-4e6a-b3d2-5a93a3069275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94f8a132-0b0a-4e37-9e13-844a0d7b6dcb" xlink:to="loc_us-gaap_ShortTermInvestments_02cdd40d-a06c-4e6a-b3d2-5a93a3069275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3a8bb32e-eb3c-47d2-86a6-bcf035549835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94f8a132-0b0a-4e37-9e13-844a0d7b6dcb" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3a8bb32e-eb3c-47d2-86a6-bcf035549835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_aa5ee2b3-8821-4cb2-ab34-181d330072a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94f8a132-0b0a-4e37-9e13-844a0d7b6dcb" xlink:to="loc_us-gaap_InventoryNet_aa5ee2b3-8821-4cb2-ab34-181d330072a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d1ecc871-69cf-46c9-a6cf-8ee3878d25b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94f8a132-0b0a-4e37-9e13-844a0d7b6dcb" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d1ecc871-69cf-46c9-a6cf-8ee3878d25b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_90f2c901-052c-45f9-b949-dfd3b90ac71f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94f8a132-0b0a-4e37-9e13-844a0d7b6dcb" xlink:to="loc_us-gaap_AssetsCurrent_90f2c901-052c-45f9-b949-dfd3b90ac71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_05ca24cf-af31-4883-88a9-ca2a70c81be9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_us-gaap_LongTermInvestments_05ca24cf-af31-4883-88a9-ca2a70c81be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c55c01d4-2de1-40ac-86d4-84e996bfa4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c55c01d4-2de1-40ac-86d4-84e996bfa4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a0c1313d-b7cd-4b95-970b-0fa0875cec99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a0c1313d-b7cd-4b95-970b-0fa0875cec99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f06680ed-781e-4190-a08c-295a2a7ad727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_us-gaap_Goodwill_f06680ed-781e-4190-a08c-295a2a7ad727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_044a5486-985e-4779-bb0a-512eed1e9861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_044a5486-985e-4779-bb0a-512eed1e9861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7f1bb9ad-d2b4-4ed5-bcfe-34e10faae97d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7f1bb9ad-d2b4-4ed5-bcfe-34e10faae97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_de2bbaeb-aea4-4cd8-b291-54db43049fb5" xlink:href="pcrx-20210930.xsd#pcrx_EquityMethodInvestmentsAndOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_pcrx_EquityMethodInvestmentsAndOtherAssets_de2bbaeb-aea4-4cd8-b291-54db43049fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_09312b59-a101-4fe3-93a3-61151f4e37d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d5ec9717-ac93-4469-b05a-a92f86c56ed6" xlink:to="loc_us-gaap_Assets_09312b59-a101-4fe3-93a3-61151f4e37d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3c8f949d-658b-499b-8fcf-5e5740035232" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_aa883d89-407a-430f-ac9f-648278f0d8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:to="loc_us-gaap_AccountsPayableCurrent_aa883d89-407a-430f-ac9f-648278f0d8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_13c5b130-c531-4adf-813d-05e6baa541a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_13c5b130-c531-4adf-813d-05e6baa541a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_46299847-45f7-43ba-b150-aa491eec13d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_46299847-45f7-43ba-b150-aa491eec13d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_0f475bb6-c67a-4e28-8c37-0ed699d46899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_0f475bb6-c67a-4e28-8c37-0ed699d46899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent_53d659d9-c375-4370-b07e-59058c1735ac" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:to="loc_pcrx_ContingentConsiderationCurrent_53d659d9-c375-4370-b07e-59058c1735ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_de48d417-ad92-4241-b663-61d836e888fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:to="loc_us-gaap_TaxesPayableCurrent_de48d417-ad92-4241-b663-61d836e888fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fcf21402-8403-4fcd-b262-eab3c7db65f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c2d648a-37b3-4866-a53a-b706b1e036c5" xlink:to="loc_us-gaap_LiabilitiesCurrent_fcf21402-8403-4fcd-b262-eab3c7db65f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_50a0685e-17dc-4a56-a237-9a6c5948047d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_50a0685e-17dc-4a56-a237-9a6c5948047d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2db3b25d-d99e-4005-9996-92b1f74ae123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2db3b25d-d99e-4005-9996-92b1f74ae123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationNoncurrent_1e6a6c4a-6a07-418c-8e6b-77f3ff1de035" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_pcrx_ContingentConsiderationNoncurrent_1e6a6c4a-6a07-418c-8e6b-77f3ff1de035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_58ac41b9-ac42-4c45-9eb7-1fb3ecb28123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_58ac41b9-ac42-4c45-9eb7-1fb3ecb28123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c341bb65-101d-46cb-a03c-aa72b6cb46e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_us-gaap_Liabilities_c341bb65-101d-46cb-a03c-aa72b6cb46e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b0fc19ee-8792-4834-aafc-08961ab24e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b0fc19ee-8792-4834-aafc-08961ab24e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_39585978-3f6e-4c92-bd63-1bac86c78e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_39585978-3f6e-4c92-bd63-1bac86c78e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_79b4ffa5-b4d2-4801-9dab-b7a02da8002e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39585978-3f6e-4c92-bd63-1bac86c78e2a" xlink:to="loc_us-gaap_PreferredStockValue_79b4ffa5-b4d2-4801-9dab-b7a02da8002e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2da05c0a-9953-4f39-b590-b8c65a5db9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39585978-3f6e-4c92-bd63-1bac86c78e2a" xlink:to="loc_us-gaap_CommonStockValue_2da05c0a-9953-4f39-b590-b8c65a5db9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_68a69d2f-798c-43ea-9640-bc70ad541a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39585978-3f6e-4c92-bd63-1bac86c78e2a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_68a69d2f-798c-43ea-9640-bc70ad541a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6fa7de99-b0c5-4275-b485-d2ffad525cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39585978-3f6e-4c92-bd63-1bac86c78e2a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6fa7de99-b0c5-4275-b485-d2ffad525cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_30a0f8e1-9902-4aba-b0cb-c334438c74a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39585978-3f6e-4c92-bd63-1bac86c78e2a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_30a0f8e1-9902-4aba-b0cb-c334438c74a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_40b48c1e-6049-4f05-a23b-9bfa39d6a709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_39585978-3f6e-4c92-bd63-1bac86c78e2a" xlink:to="loc_us-gaap_StockholdersEquity_40b48c1e-6049-4f05-a23b-9bfa39d6a709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d13218c6-6618-417d-9ba8-edac57916c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c29b7a21-a509-4065-a8fd-9c2176b72ce7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d13218c6-6618-417d-9ba8-edac57916c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_db92a1c5-1d5f-46c6-b8cb-b0131f5eab66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_db92a1c5-1d5f-46c6-b8cb-b0131f5eab66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_26e435e6-7d01-4f3d-adcb-2a44c6b005f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_26e435e6-7d01-4f3d-adcb-2a44c6b005f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_03b1c8ec-3460-414c-87a2-19cec202db4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:to="loc_us-gaap_PreferredStockSharesIssued_03b1c8ec-3460-414c-87a2-19cec202db4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1a36f8c2-b3ec-48b0-8030-21930d666f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1a36f8c2-b3ec-48b0-8030-21930d666f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c30bcba9-241c-41e8-b136-e851cc666cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c30bcba9-241c-41e8-b136-e851cc666cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_fef4e1d3-18a2-40e0-9b56-3687fb531008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_fef4e1d3-18a2-40e0-9b56-3687fb531008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3f373519-1dae-4f4e-8031-af5c3a266646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:to="loc_us-gaap_CommonStockSharesIssued_3f373519-1dae-4f4e-8031-af5c3a266646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9a05a7b2-7784-43db-b2e8-2e11dd9e7a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7ae4e08-a92a-4c53-8e15-f0629a81ce38" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9a05a7b2-7784-43db-b2e8-2e11dd9e7a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a7fa0888-60e0-49bf-90f9-8dbc90afd12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e74e985b-0675-42ae-b2b7-564e38c06e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a7fa0888-60e0-49bf-90f9-8dbc90afd12f" xlink:to="loc_us-gaap_StatementTable_e74e985b-0675-42ae-b2b7-564e38c06e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4005ec58-8e17-4a10-91a9-b96968906372" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e74e985b-0675-42ae-b2b7-564e38c06e1f" xlink:to="loc_srt_ProductOrServiceAxis_4005ec58-8e17-4a10-91a9-b96968906372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4005ec58-8e17-4a10-91a9-b96968906372" xlink:to="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_bb949b43-003d-4f49-b693-b2521c22c1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:to="loc_us-gaap_ProductMember_bb949b43-003d-4f49-b693-b2521c22c1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_2f96e433-c47c-4d8d-ae9a-f1f3d96dfc04" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeLicensingAndMilestoneRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:to="loc_pcrx_CollaborativeLicensingAndMilestoneRevenueMember_2f96e433-c47c-4d8d-ae9a-f1f3d96dfc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_0772652b-bc92-4ece-901a-12b0d74fcc78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8d05879d-6dd7-4c01-b346-9136d3d9b262" xlink:to="loc_us-gaap_RoyaltyMember_0772652b-bc92-4ece-901a-12b0d74fcc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e74e985b-0675-42ae-b2b7-564e38c06e1f" xlink:to="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d0b72b9a-b2a5-40bf-b64c-af81baf78c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_RevenuesAbstract_d0b72b9a-b2a5-40bf-b64c-af81baf78c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1913a50c-7a7e-405b-87a7-9eb83c4ad0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d0b72b9a-b2a5-40bf-b64c-af81baf78c98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1913a50c-7a7e-405b-87a7-9eb83c4ad0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_539707dd-46d5-4564-81d1-b65898df5a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_CostOfRevenue_539707dd-46d5-4564-81d1-b65898df5a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f4637a26-caed-49e8-bb82-dd1b165c2f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f4637a26-caed-49e8-bb82-dd1b165c2f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9ed68b38-1a10-4678-b375-1708a0404b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9ed68b38-1a10-4678-b375-1708a0404b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7c1e53a6-b3c8-4752-b8cb-edf89ea983b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7c1e53a6-b3c8-4752-b8cb-edf89ea983b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_6629b049-8704-4bd3-80b1-895afc26e707" xlink:href="pcrx-20210930.xsd#pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet_6629b049-8704-4bd3-80b1-895afc26e707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d65027dc-67b3-4b7a-8d74-a5c523c45a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_93706372-b7d8-4947-a612-deea69cdc586" xlink:to="loc_us-gaap_CostsAndExpenses_d65027dc-67b3-4b7a-8d74-a5c523c45a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_782d74e9-f311-4553-85a3-3937888059a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_OperatingIncomeLoss_782d74e9-f311-4553-85a3-3937888059a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_960d621e-1ee7-4304-b35b-ae48bd127887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_InvestmentIncomeInterest_960d621e-1ee7-4304-b35b-ae48bd127887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8225ba5b-72ce-4cf1-947d-59a3c1da472f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_InterestExpense_8225ba5b-72ce-4cf1-947d-59a3c1da472f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_14045584-f33f-4472-90e9-6622f42da63c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_14045584-f33f-4472-90e9-6622f42da63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_efe9213d-d02f-4553-929a-13ec5d05a72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_efe9213d-d02f-4553-929a-13ec5d05a72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0d0a6942-1fd8-4bb6-a0db-402c5f700934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f82eb1d0-b4da-4ccd-9ad3-38ebf92068ba" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0d0a6942-1fd8-4bb6-a0db-402c5f700934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f899b6a-f71b-41c7-b2a9-c600bd64a99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f899b6a-f71b-41c7-b2a9-c600bd64a99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2bfdb8ba-d10f-4fa7-afbb-0b95cdd1eea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2bfdb8ba-d10f-4fa7-afbb-0b95cdd1eea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bbb226c0-2ac0-4e8e-9bb3-b45edcf130a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_NetIncomeLoss_bbb226c0-2ac0-4e8e-9bb3-b45edcf130a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1927e203-9bf4-456c-9a0c-89018cdaaaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_EarningsPerShareAbstract_1927e203-9bf4-456c-9a0c-89018cdaaaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_716e1bb8-da78-4fc9-92ad-979e1439e609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1927e203-9bf4-456c-9a0c-89018cdaaaf3" xlink:to="loc_us-gaap_EarningsPerShareBasic_716e1bb8-da78-4fc9-92ad-979e1439e609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e1370a4c-a79f-4833-9979-882be6b70f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1927e203-9bf4-456c-9a0c-89018cdaaaf3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e1370a4c-a79f-4833-9979-882be6b70f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a881682f-5787-485a-a58c-a98a3327d272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ccd9864-03de-4109-817c-203a35924ad7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a881682f-5787-485a-a58c-a98a3327d272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf3964ef-51d5-4f5f-a155-b7fee3d1d30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a881682f-5787-485a-a58c-a98a3327d272" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf3964ef-51d5-4f5f-a155-b7fee3d1d30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ea79642-1f41-4b27-8916-84d2f6d8f193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a881682f-5787-485a-a58c-a98a3327d272" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ea79642-1f41-4b27-8916-84d2f6d8f193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f7fed4df-b5d7-4bf1-8ebe-8e4d0792b8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_093c2823-05d3-44b6-8f5a-a0d9e4067290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f7fed4df-b5d7-4bf1-8ebe-8e4d0792b8e7" xlink:to="loc_us-gaap_NetIncomeLoss_093c2823-05d3-44b6-8f5a-a0d9e4067290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d44f515-5c28-4c60-af1e-70e9b79cacab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f7fed4df-b5d7-4bf1-8ebe-8e4d0792b8e7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d44f515-5c28-4c60-af1e-70e9b79cacab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ab612d3c-da4b-4573-b8db-195ac1b136da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d44f515-5c28-4c60-af1e-70e9b79cacab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ab612d3c-da4b-4573-b8db-195ac1b136da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_07044e77-eb7d-49b2-9531-d780a00652e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d44f515-5c28-4c60-af1e-70e9b79cacab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_07044e77-eb7d-49b2-9531-d780a00652e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e2082d4e-48fd-425e-8a25-554a8f452cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d44f515-5c28-4c60-af1e-70e9b79cacab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e2082d4e-48fd-425e-8a25-554a8f452cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d1671ffb-aae6-45fb-9e46-0f17d13a28a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f7fed4df-b5d7-4bf1-8ebe-8e4d0792b8e7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d1671ffb-aae6-45fb-9e46-0f17d13a28a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_79db87f8-2e6d-40ec-bd73-09eab837845d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_79db87f8-2e6d-40ec-bd73-09eab837845d" xlink:to="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1e66166e-c600-47b7-a4b4-9aac3004fe1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:to="loc_us-gaap_DebtInstrumentAxis_1e66166e-c600-47b7-a4b4-9aac3004fe1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9d3937d0-5a3b-4a55-919f-248a95487e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e66166e-c600-47b7-a4b4-9aac3004fe1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9d3937d0-5a3b-4a55-919f-248a95487e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_A2022ConvertibleSeniorNotesMember_4528dff3-c008-4b5f-aa7c-6a0cbac3385e" xlink:href="pcrx-20210930.xsd#pcrx_A2022ConvertibleSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d3937d0-5a3b-4a55-919f-248a95487e34" xlink:to="loc_pcrx_A2022ConvertibleSeniorNotesMember_4528dff3-c008-4b5f-aa7c-6a0cbac3385e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8e41b17e-b0c2-49b9-98d8-6c497ceb9a42" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9d3937d0-5a3b-4a55-919f-248a95487e34" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_8e41b17e-b0c2-49b9-98d8-6c497ceb9a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_34aa7341-7e58-4853-875b-c319aa1ca9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_34aa7341-7e58-4853-875b-c319aa1ca9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_34aa7341-7e58-4853-875b-c319aa1ca9fd" xlink:to="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3ef6d51c-8016-4460-ba98-749dd4222add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:to="loc_us-gaap_CommonStockMember_3ef6d51c-8016-4460-ba98-749dd4222add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7def1ddb-bce2-4c7c-b6f1-6ec50b7bd3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7def1ddb-bce2-4c7c-b6f1-6ec50b7bd3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b081bfd0-e0e1-4bba-8a58-5e37dc93af05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:to="loc_us-gaap_RetainedEarningsMember_b081bfd0-e0e1-4bba-8a58-5e37dc93af05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c6f86fd-f84a-4aea-a243-00f949824227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3ed2762c-c061-45e0-8cb1-bfc1115b86dd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6c6f86fd-f84a-4aea-a243-00f949824227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_76aa2865-520f-40ea-8f67-85c9aa20810b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_432d69a4-44b0-4a08-84eb-ad88c40aa0ea" xlink:to="loc_us-gaap_StatementLineItems_76aa2865-520f-40ea-8f67-85c9aa20810b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76aa2865-520f-40ea-8f67-85c9aa20810b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_10c33910-ba35-4a71-adfb-3e1063046182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_SharesOutstanding_10c33910-ba35-4a71-adfb-3e1063046182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0ddbbdf2-f393-4923-8f7d-0fd9d36c86f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockholdersEquity_0ddbbdf2-f393-4923-8f7d-0fd9d36c86f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_34669045-4eb5-4cdf-8865-1e2e52c9530d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_34669045-4eb5-4cdf-8865-1e2e52c9530d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ba138ee7-4567-4624-a08a-9771f8f1d8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ba138ee7-4567-4624-a08a-9771f8f1d8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_95ead457-7aef-4893-87e5-e1af755d8a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_95ead457-7aef-4893-87e5-e1af755d8a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_cf4919d0-f2a5-450c-bed7-42be7243f289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_cf4919d0-f2a5-450c-bed7-42be7243f289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_6b9f48bf-a0f1-4a4c-b15f-4f2731cbf8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_6b9f48bf-a0f1-4a4c-b15f-4f2731cbf8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2e27a24e-f11c-44e8-b72a-74dc3ba8b492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2e27a24e-f11c-44e8-b72a-74dc3ba8b492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9cef899d-f6d3-4a14-ba2b-e40d33ad1e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9cef899d-f6d3-4a14-ba2b-e40d33ad1e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_25841dad-4c5d-4a53-9965-b5d8d1db795e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_25841dad-4c5d-4a53-9965-b5d8d1db795e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a708e25f-0786-4863-9645-16dcfe0d295b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a708e25f-0786-4863-9645-16dcfe0d295b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_66f0b3b1-9bdb-4b75-b821-4ba063aad744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_NetIncomeLoss_66f0b3b1-9bdb-4b75-b821-4ba063aad744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_388f10a5-fcec-4387-81c0-2df14fdbabf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_SharesOutstanding_388f10a5-fcec-4387-81c0-2df14fdbabf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f7915ed-ca18-4c21-9462-ee5c64bbe603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a45a012-e751-43bd-9b54-480cef1b2f23" xlink:to="loc_us-gaap_StockholdersEquity_8f7915ed-ca18-4c21-9462-ee5c64bbe603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4b60163-ae2c-417a-bc3c-5b7e1b4e4f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions_716fe184-8729-4104-bd55-bbf3ad976b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4b60163-ae2c-417a-bc3c-5b7e1b4e4f6e" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions_716fe184-8729-4104-bd55-bbf3ad976b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d2c18407-9802-4340-9532-3ef3c942f874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7791fa74-7e8a-4eb9-aa3c-1a0376599080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2c18407-9802-4340-9532-3ef3c942f874" xlink:to="loc_us-gaap_StatementTable_7791fa74-7e8a-4eb9-aa3c-1a0376599080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_efc3e9b6-9248-4f17-be9b-0f323229e053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7791fa74-7e8a-4eb9-aa3c-1a0376599080" xlink:to="loc_us-gaap_DebtInstrumentAxis_efc3e9b6-9248-4f17-be9b-0f323229e053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1fedc2cb-8b31-48a8-bd04-292fceff7adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_efc3e9b6-9248-4f17-be9b-0f323229e053" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1fedc2cb-8b31-48a8-bd04-292fceff7adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_779a38d8-4fee-4574-90ea-d28c46e7bc73" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1fedc2cb-8b31-48a8-bd04-292fceff7adc" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_779a38d8-4fee-4574-90ea-d28c46e7bc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_b0ab0efc-02c7-4951-89d8-fa1639bf6a7d" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1fedc2cb-8b31-48a8-bd04-292fceff7adc" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_b0ab0efc-02c7-4951-89d8-fa1639bf6a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7791fa74-7e8a-4eb9-aa3c-1a0376599080" xlink:to="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a88cccc4-e3d1-4dc8-b703-de1691491951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:to="loc_us-gaap_NetIncomeLoss_a88cccc4-e3d1-4dc8-b703-de1691491951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_94319d69-ac86-4a72-b166-db684572967c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_94319d69-ac86-4a72-b166-db684572967c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ffa071f8-a752-4ddb-a0a3-b317055e2fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ffa071f8-a752-4ddb-a0a3-b317055e2fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_bbb7077a-50f3-4ace-a063-bfb1622c49bf" xlink:href="pcrx-20210930.xsd#pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation_bbb7077a-50f3-4ace-a063-bfb1622c49bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_3b796db0-d50a-4293-89da-86d274ce3ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_3b796db0-d50a-4293-89da-86d274ce3ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e2487eb-7595-4e08-91f0-62b2c2452f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e2487eb-7595-4e08-91f0-62b2c2452f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_addde770-6964-4c14-b326-03049ff8772d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_addde770-6964-4c14-b326-03049ff8772d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b9fcb102-b82e-49f8-a169-e3890c16d202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_ShareBasedCompensation_b9fcb102-b82e-49f8-a169-e3890c16d202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fe96d0e5-094a-4eb3-9070-2f7e9a9f0ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_fe96d0e5-094a-4eb3-9070-2f7e9a9f0ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ad2e2073-0ce6-4ca5-8c17-dfda3539f009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_96b0be61-5bda-4480-b177-f2c2edbc92dd" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ad2e2073-0ce6-4ca5-8c17-dfda3539f009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_977058e1-49fe-4a5b-9907-c7d3e149b89d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_977058e1-49fe-4a5b-9907-c7d3e149b89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_552e640f-7c11-497d-8249-13a4bb9349f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_552e640f-7c11-497d-8249-13a4bb9349f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b123e716-3abf-411f-a11c-a320517d216a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b123e716-3abf-411f-a11c-a320517d216a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c309efe4-6bc4-4488-bbc7-a776cd471ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c309efe4-6bc4-4488-bbc7-a776cd471ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b84c5316-6a36-4def-8ea4-7ab093385db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b84c5316-6a36-4def-8ea4-7ab093385db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_14595343-45b0-4f03-8976-ad2fe1a29157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_14595343-45b0-4f03-8976-ad2fe1a29157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_9a7da431-6ad4-4689-9013-057a3d31cfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f5beee94-0f30-472c-a5b7-5cd24c6e8c28" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_9a7da431-6ad4-4689-9013-057a3d31cfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cc16933f-06d8-4a0d-b073-f72b4306603b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_2b812bdc-ee44-4c33-bb3e-0fff996e7076" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cc16933f-06d8-4a0d-b073-f72b4306603b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f3a6408-4e33-4a39-a2f7-cbe0bb868f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f3a6408-4e33-4a39-a2f7-cbe0bb868f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_820b6a25-119d-4e8e-87d1-1f77220eec8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_820b6a25-119d-4e8e-87d1-1f77220eec8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9ad8b579-6867-4a9b-8f4b-fe7c092e10a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9ad8b579-6867-4a9b-8f4b-fe7c092e10a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_45faf57f-a68b-45cb-ae34-884331026562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_45faf57f-a68b-45cb-ae34-884331026562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_64ebc95f-4121-481d-a88f-7c5ebe48dc61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_64ebc95f-4121-481d-a88f-7c5ebe48dc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_582e58e5-9610-4403-a8ed-7044c4de8b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bfeed96e-be56-4d74-9edd-2b9b60fc5232" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_582e58e5-9610-4403-a8ed-7044c4de8b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_04aaa674-9638-435e-829e-68fb3a3ebeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_04aaa674-9638-435e-829e-68fb3a3ebeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_ab674b33-4258-41e4-875d-f956f57d4850" xlink:href="pcrx-20210930.xsd#pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans_ab674b33-4258-41e4-875d-f956f57d4850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_bb6ef924-07a2-485c-a7e0-0b7f99035f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_bb6ef924-07a2-485c-a7e0-0b7f99035f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_c3aec87b-1dd7-49e7-9789-07910551dbe8" xlink:href="pcrx-20210930.xsd#pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt_c3aec87b-1dd7-49e7-9789-07910551dbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_8a1124f9-758f-4607-b44d-2a683d17ce85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_8a1124f9-758f-4607-b44d-2a683d17ce85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_4e78a04e-951a-4389-942a-ec9525103113" xlink:href="pcrx-20210930.xsd#pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes_4e78a04e-951a-4389-942a-ec9525103113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_404acbd0-1311-4f29-b6f3-3790b7289bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_404acbd0-1311-4f29-b6f3-3790b7289bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_feadf42b-4ab4-47d0-937c-5aade24d9d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_feadf42b-4ab4-47d0-937c-5aade24d9d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b82e0fef-e020-4c7b-8aa5-3d094eb8aa08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_10418187-2ec1-4175-8192-f284b0f2a357" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b82e0fef-e020-4c7b-8aa5-3d094eb8aa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_edb8cc63-3c68-4b42-b5b9-da1495a45ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_edb8cc63-3c68-4b42-b5b9-da1495a45ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44978a3f-ed4f-4a51-bb66-7d2e5a4810b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44978a3f-ed4f-4a51-bb66-7d2e5a4810b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_776d1328-eacf-4744-8ed3-3830636314fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_776d1328-eacf-4744-8ed3-3830636314fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b18fa7e-3233-4cff-a813-5b242050a42c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b18fa7e-3233-4cff-a813-5b242050a42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_356ec9ea-e25a-45f4-b449-1ace3897b1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b18fa7e-3233-4cff-a813-5b242050a42c" xlink:to="loc_us-gaap_InterestPaidNet_356ec9ea-e25a-45f4-b449-1ace3897b1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_974e26af-c033-404e-98a5-5944e987b568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b18fa7e-3233-4cff-a813-5b242050a42c" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_974e26af-c033-404e-98a5-5944e987b568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_465b22a9-2825-4a65-bf61-7d8a2c1ff99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab0985d3-69b4-4bdd-9f89-61e6304dda95" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_465b22a9-2825-4a65-bf61-7d8a2c1ff99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0e78de16-4f4c-4ba3-a8cf-18c477b1249e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_465b22a9-2825-4a65-bf61-7d8a2c1ff99f" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0e78de16-4f4c-4ba3-a8cf-18c477b1249e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_33725753-28c9-4811-8344-3b835aae9e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8a551cbe-69bd-47dc-b348-9f9e8c1a9fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_33725753-28c9-4811-8344-3b835aae9e7c" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8a551cbe-69bd-47dc-b348-9f9e8c1a9fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7a0dc5a2-3b55-4dea-9fb7-3e23ef1b8d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7a0dc5a2-3b55-4dea-9fb7-3e23ef1b8d68" xlink:to="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_069830dc-3a52-4baf-8f0d-d6abaa0533e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_069830dc-3a52-4baf-8f0d-d6abaa0533e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a84dfce0-f6b0-44dc-b0ac-8574179d8d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_069830dc-3a52-4baf-8f0d-d6abaa0533e3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a84dfce0-f6b0-44dc-b0ac-8574179d8d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b49ad480-ade1-4ece-b468-387ccfd082e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a84dfce0-f6b0-44dc-b0ac-8574179d8d7c" xlink:to="loc_us-gaap_SalesRevenueNetMember_b49ad480-ade1-4ece-b468-387ccfd082e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_718ad65a-72d3-4b80-a803-2d2b18834c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_718ad65a-72d3-4b80-a803-2d2b18834c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_30d79e87-18f4-42f7-90cd-2a5d3d8a099a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_718ad65a-72d3-4b80-a803-2d2b18834c41" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_30d79e87-18f4-42f7-90cd-2a5d3d8a099a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_40461554-f8b6-417d-9a09-add369e8047b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_30d79e87-18f4-42f7-90cd-2a5d3d8a099a" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_40461554-f8b6-417d-9a09-add369e8047b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_93ed410d-208d-4c20-96f7-c6512c72d609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_93ed410d-208d-4c20-96f7-c6512c72d609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bcf1fc6c-6ff7-4ea1-98c3-6b78a4e7d0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_93ed410d-208d-4c20-96f7-c6512c72d609" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bcf1fc6c-6ff7-4ea1-98c3-6b78a4e7d0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionMember_cdab3b85-43ed-43eb-86f7-6c1ff5e90a76" xlink:href="pcrx-20210930.xsd#pcrx_FlexionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bcf1fc6c-6ff7-4ea1-98c3-6b78a4e7d0c1" xlink:to="loc_pcrx_FlexionMember_cdab3b85-43ed-43eb-86f7-6c1ff5e90a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_151a5196-4efa-4e2a-8d0b-f57da1d6a523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_151a5196-4efa-4e2a-8d0b-f57da1d6a523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a5eda112-9211-4728-95f0-072ead47747b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_151a5196-4efa-4e2a-8d0b-f57da1d6a523" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a5eda112-9211-4728-95f0-072ead47747b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_66aa38d3-255e-4a43-83f5-f96b4bd4c014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a5eda112-9211-4728-95f0-072ead47747b" xlink:to="loc_us-gaap_SubsequentEventMember_66aa38d3-255e-4a43-83f5-f96b4bd4c014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_215dbe81-78c5-4ce1-a074-38ea2e78e4fd" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_23b3e05f-6cd9-4527-a8f0-59dcccb40699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_23b3e05f-6cd9-4527-a8f0-59dcccb40699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_b37e5073-d8f0-4aba-8867-f250283a1b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_b37e5073-d8f0-4aba-8867-f250283a1b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_c2d29136-b60f-4b82-b9de-fb7c92fd87ad" xlink:href="pcrx-20210930.xsd#pcrx_ClassOfWarrantOrRightNumberOfRightsIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_c2d29136-b60f-4b82-b9de-fb7c92fd87ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_aa19b039-ace8-41af-9792-e4c8453a0381" xlink:href="pcrx-20210930.xsd#pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_aa19b039-ace8-41af-9792-e4c8453a0381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConcentrationRiskNumberOfProducts_47d9f0eb-1386-4a58-b204-0e9e76fe3fbe" xlink:href="pcrx-20210930.xsd#pcrx_ConcentrationRiskNumberOfProducts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_pcrx_ConcentrationRiskNumberOfProducts_47d9f0eb-1386-4a58-b204-0e9e76fe3fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_dae0741d-b622-42a4-9dbc-30f9c8903f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_25a6c147-0e1a-48f8-9ae2-fa6b5666e30c" xlink:to="loc_us-gaap_NumberOfReportableSegments_dae0741d-b622-42a4-9dbc-30f9c8903f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_19759fe5-d017-42ac-8b3a-2b2041ddbd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_fef01072-2840-4189-99eb-c819cc81e7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_19759fe5-d017-42ac-8b3a-2b2041ddbd39" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_fef01072-2840-4189-99eb-c819cc81e7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0afa2310-1f77-4f28-a87e-3affd664d3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_38a7b6eb-be5f-415f-986a-bd70b50b1c90" xlink:href="pcrx-20210930.xsd#pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0afa2310-1f77-4f28-a87e-3affd664d3ce" xlink:to="loc_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_38a7b6eb-be5f-415f-986a-bd70b50b1c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_20cac7e2-2485-469a-8955-9af9867ee054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0afa2310-1f77-4f28-a87e-3affd664d3ce" xlink:to="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_20cac7e2-2485-469a-8955-9af9867ee054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c2d4c6b5-2ef5-46c0-9f9c-0fdcf16640d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0afa2310-1f77-4f28-a87e-3affd664d3ce" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c2d4c6b5-2ef5-46c0-9f9c-0fdcf16640d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aaca052f-5ab3-4b57-9492-7dfcc00cde00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_527175b4-537f-48ae-8799-a0285dd64751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aaca052f-5ab3-4b57-9492-7dfcc00cde00" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_527175b4-537f-48ae-8799-a0285dd64751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_35db05c7-ee10-4be0-95ae-79186674e010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_35db05c7-ee10-4be0-95ae-79186674e010" xlink:to="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ef8aa4c8-1bbf-4704-a246-89064dd40072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ef8aa4c8-1bbf-4704-a246-89064dd40072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_dbc664c3-1bd0-48df-bcc4-3b094bdff4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ef8aa4c8-1bbf-4704-a246-89064dd40072" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_dbc664c3-1bd0-48df-bcc4-3b094bdff4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_7cd8be85-ee6a-4ac1-a616-a65e00f6850d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_dbc664c3-1bd0-48df-bcc4-3b094bdff4d0" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_7cd8be85-ee6a-4ac1-a616-a65e00f6850d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e95a9166-c6b2-4048-9c38-943a238f710e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e95a9166-c6b2-4048-9c38-943a238f710e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f12cb580-64ee-42d3-895d-528cf49233c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e95a9166-c6b2-4048-9c38-943a238f710e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f12cb580-64ee-42d3-895d-528cf49233c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_6750fd12-edba-4089-92c6-024d8c0b0373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f12cb580-64ee-42d3-895d-528cf49233c6" xlink:to="loc_us-gaap_SalesRevenueNetMember_6750fd12-edba-4089-92c6-024d8c0b0373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3edc5a39-2f1c-419a-826b-55f61d842829" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:to="loc_srt_MajorCustomersAxis_3edc5a39-2f1c-419a-826b-55f61d842829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_3edc5a39-2f1c-419a-826b-55f61d842829" xlink:to="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LargestCustomerMember_f0da43ee-e9cd-4e44-9ae8-588cf02841b1" xlink:href="pcrx-20210930.xsd#pcrx_LargestCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:to="loc_pcrx_LargestCustomerMember_f0da43ee-e9cd-4e44-9ae8-588cf02841b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SecondLargestCustomerMember_c361233f-0e1e-4e07-b88a-38d27fcfc886" xlink:href="pcrx-20210930.xsd#pcrx_SecondLargestCustomerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:to="loc_pcrx_SecondLargestCustomerMember_c361233f-0e1e-4e07-b88a-38d27fcfc886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThirdLargestCustomerMember_b5ec170c-0219-4a46-86f0-25d2916ab040" xlink:href="pcrx-20210930.xsd#pcrx_ThirdLargestCustomerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:to="loc_pcrx_ThirdLargestCustomerMember_b5ec170c-0219-4a46-86f0-25d2916ab040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ThreeLargestCustomersMember_575e2745-44a7-4f1f-a633-fd5f35b28711" xlink:href="pcrx-20210930.xsd#pcrx_ThreeLargestCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_235c023c-f049-4684-8650-ad3c06a7a8ac" xlink:to="loc_pcrx_ThreeLargestCustomersMember_575e2745-44a7-4f1f-a633-fd5f35b28711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f35d3c18-153f-4b1e-ad98-637399911d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_4503dc22-830c-4cdd-9fda-9e9dfad108f1" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_f35d3c18-153f-4b1e-ad98-637399911d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_359521e5-5a6f-452f-a30e-892218049b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f35d3c18-153f-4b1e-ad98-637399911d35" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_359521e5-5a6f-452f-a30e-892218049b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_88e311ad-b1a7-4e85-a124-0665a660a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_88e311ad-b1a7-4e85-a124-0665a660a80a" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e7773efb-20ec-433f-a861-7a300f953133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:to="loc_us-gaap_DebtInstrumentAxis_e7773efb-20ec-433f-a861-7a300f953133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_51d04b2b-b098-4e1d-b1ef-e0fa84d13442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e7773efb-20ec-433f-a861-7a300f953133" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_51d04b2b-b098-4e1d-b1ef-e0fa84d13442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_b312d911-4fdc-4289-a299-938f6ed1f6c1" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_51d04b2b-b098-4e1d-b1ef-e0fa84d13442" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_b312d911-4fdc-4289-a299-938f6ed1f6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_1fdb9efc-655c-4c1e-852b-a0246e05a556" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_51d04b2b-b098-4e1d-b1ef-e0fa84d13442" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_1fdb9efc-655c-4c1e-852b-a0246e05a556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_23700202-566b-44b2-bad4-4af5d5a89468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_23700202-566b-44b2-bad4-4af5d5a89468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e49bfca-ba5b-41f3-9cc6-41e6e115c6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_23700202-566b-44b2-bad4-4af5d5a89468" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e49bfca-ba5b-41f3-9cc6-41e6e115c6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_568b72ff-b59d-4cf8-9c5d-6ad525af4aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1e49bfca-ba5b-41f3-9cc6-41e6e115c6aa" xlink:to="loc_us-gaap_UnsecuredDebtMember_568b72ff-b59d-4cf8-9c5d-6ad525af4aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_84c7b68e-bff2-4761-a00d-f9036a795e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_5fa666a6-6dc7-40bd-9927-2b3828cfbf4d" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_84c7b68e-bff2-4761-a00d-f9036a795e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2720cc10-d1ef-443e-a788-000880355eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_84c7b68e-bff2-4761-a00d-f9036a795e94" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2720cc10-d1ef-443e-a788-000880355eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_86cfd96f-35f4-486f-a1ca-234beaa7594d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_84c7b68e-bff2-4761-a00d-f9036a795e94" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_86cfd96f-35f4-486f-a1ca-234beaa7594d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUE" xlink:type="simple" xlink:href="pcrx-20210930.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7a20beed-cdc2-4c5b-9761-2a7750dc3660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f7dcc024-e598-440c-b193-589153955b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7a20beed-cdc2-4c5b-9761-2a7750dc3660" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f7dcc024-e598-440c-b193-589153955b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUETables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e1c33d43-b23d-4164-a519-20f80d28a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3679bd49-2d58-43b1-8e1b-fc69e2e935f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e1c33d43-b23d-4164-a519-20f80d28a061" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3679bd49-2d58-43b1-8e1b-fc69e2e935f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/REVENUEDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#REVENUEDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/REVENUEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4974138d-0904-4a77-892a-15cb8bbb0c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4974138d-0904-4a77-892a-15cb8bbb0c88" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a07ba8da-0164-460f-ba66-f2217d4e071a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:to="loc_srt_RangeAxis_a07ba8da-0164-460f-ba66-f2217d4e071a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f8a7634-13d9-4a8b-b6a9-e281a97a7e7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a07ba8da-0164-460f-ba66-f2217d4e071a" xlink:to="loc_srt_RangeMember_6f8a7634-13d9-4a8b-b6a9-e281a97a7e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_281e7c31-7247-4ec3-9a53-5797709dc4ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f8a7634-13d9-4a8b-b6a9-e281a97a7e7f" xlink:to="loc_srt_MinimumMember_281e7c31-7247-4ec3-9a53-5797709dc4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b9cbcfaa-afc6-4ae9-90bb-413bffe37098" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f8a7634-13d9-4a8b-b6a9-e281a97a7e7f" xlink:to="loc_srt_MaximumMember_b9cbcfaa-afc6-4ae9-90bb-413bffe37098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0653384f-78fe-4bcb-8e71-dce6c7a268a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:to="loc_srt_StatementGeographicalAxis_0653384f-78fe-4bcb-8e71-dce6c7a268a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_79ef332e-0320-47a1-86f0-1bc47ecdc53d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0653384f-78fe-4bcb-8e71-dce6c7a268a4" xlink:to="loc_srt_SegmentGeographicalDomain_79ef332e-0320-47a1-86f0-1bc47ecdc53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EuropeanUnionMember_3391d2bd-67a1-4003-a56a-57406304228b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EuropeanUnionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_79ef332e-0320-47a1-86f0-1bc47ecdc53d" xlink:to="loc_us-gaap_EuropeanUnionMember_3391d2bd-67a1-4003-a56a-57406304228b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_40501897-ec7c-40c5-a510-305f04d194a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:to="loc_srt_ProductOrServiceAxis_40501897-ec7c-40c5-a510-305f04d194a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_40501897-ec7c-40c5-a510-305f04d194a9" xlink:to="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_fbacbf44-1407-43b3-9244-4954e0611f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:to="loc_us-gaap_ProductMember_fbacbf44-1407-43b3-9244-4954e0611f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_17bd3e8e-605e-4236-82de-87c4f662ae9f" xlink:href="pcrx-20210930.xsd#pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:to="loc_pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember_17bd3e8e-605e-4236-82de-87c4f662ae9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_IoveraMember_f4365581-597b-4144-b11c-d6d2d717db64" xlink:href="pcrx-20210930.xsd#pcrx_IoveraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:to="loc_pcrx_IoveraMember_f4365581-597b-4144-b11c-d6d2d717db64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c6b0cbfb-6b93-4d23-aaa8-504c5b41bd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e78a2326-3d3e-4f1b-870d-10f7e1e1fc89" xlink:to="loc_us-gaap_ProductMember_c6b0cbfb-6b93-4d23-aaa8-504c5b41bd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8c8ecb58-1019-4369-98bf-077e22e26f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_90891e14-3768-4f4e-8c2f-61e3723cacb5" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8c8ecb58-1019-4369-98bf-077e22e26f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3e51e413-bcc3-452d-a9de-4b87022fd4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8c8ecb58-1019-4369-98bf-077e22e26f9f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3e51e413-bcc3-452d-a9de-4b87022fd4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AccountsReceivablePaymentTerms_dd31bd59-0192-4d15-aac5-5ca152ed47f0" xlink:href="pcrx-20210930.xsd#pcrx_AccountsReceivablePaymentTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8c8ecb58-1019-4369-98bf-077e22e26f9f" xlink:to="loc_pcrx_AccountsReceivablePaymentTerms_dd31bd59-0192-4d15-aac5-5ca152ed47f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIES" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_81b5ecb4-4245-4130-bc03-3cf6966096e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_fb7c7746-4cbb-42de-9f46-e858c6577483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_81b5ecb4-4245-4130-bc03-3cf6966096e2" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_fb7c7746-4cbb-42de-9f46-e858c6577483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_5ecceed3-ed4e-4b0f-bbf0-fc7f7b753c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_21e4f29b-12cf-4121-acaf-f6b110059339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5ecceed3-ed4e-4b0f-bbf0-fc7f7b753c49" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_21e4f29b-12cf-4121-acaf-f6b110059339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_fab52efe-5a9e-4ac7-b22c-24f9d0f3108f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d8450c31-98f3-4456-b636-8cf293ddbc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fab52efe-5a9e-4ac7-b22c-24f9d0f3108f" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d8450c31-98f3-4456-b636-8cf293ddbc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_024ca629-c341-4dc2-af7f-9189b7f8b193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fab52efe-5a9e-4ac7-b22c-24f9d0f3108f" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_024ca629-c341-4dc2-af7f-9189b7f8b193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d72ce1b5-a928-4512-bd00-c0d411864886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fab52efe-5a9e-4ac7-b22c-24f9d0f3108f" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d72ce1b5-a928-4512-bd00-c0d411864886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ee927a92-316a-4523-8641-4d82d3fa97e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fab52efe-5a9e-4ac7-b22c-24f9d0f3108f" xlink:to="loc_us-gaap_InventoryNet_ee927a92-316a-4523-8641-4d82d3fa97e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FIXEDASSETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_de3854ff-06cc-4488-8c53-c7fd58c1a16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_96220416-5b23-485e-960d-1ae3cff4ecc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_de3854ff-06cc-4488-8c53-c7fd58c1a16c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_96220416-5b23-485e-960d-1ae3cff4ecc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FIXEDASSETSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_79f830bf-592c-44e1-b1db-182fc78ce62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_2f435c19-e027-46ba-b678-9f92bad2671a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_79f830bf-592c-44e1-b1db-182fc78ce62d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_2f435c19-e027-46ba-b678-9f92bad2671a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FIXEDASSETSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FIXEDASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FIXEDASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fdb976fc-143d-4fc4-80ba-e754d25871bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_115ecc27-c8c5-4d32-9194-4156df27b858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fdb976fc-143d-4fc4-80ba-e754d25871bb" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_115ecc27-c8c5-4d32-9194-4156df27b858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e72321c-07a6-452e-9d60-7087cfd50aee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_115ecc27-c8c5-4d32-9194-4156df27b858" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e72321c-07a6-452e-9d60-7087cfd50aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e72321c-07a6-452e-9d60-7087cfd50aee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b99db3d5-6a1a-4929-a954-748967f911a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b99db3d5-6a1a-4929-a954-748967f911a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_954c160f-d624-4509-91de-d01f97c83c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_954c160f-d624-4509-91de-d01f97c83c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ComputerEquipmentAndSoftwareMember_0e195ee1-d850-4ef5-a472-dbf14403a602" xlink:href="pcrx-20210930.xsd#pcrx_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_pcrx_ComputerEquipmentAndSoftwareMember_0e195ee1-d850-4ef5-a472-dbf14403a602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_471b370e-0a9b-497d-a521-eb50dd389e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_471b370e-0a9b-497d-a521-eb50dd389e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_6ea2add9-60af-49a1-a759-05a8c99ac469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de56eaf2-7312-4827-b670-3e0e1a4dc810" xlink:to="loc_us-gaap_ConstructionInProgressMember_6ea2add9-60af-49a1-a759-05a8c99ac469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_115ecc27-c8c5-4d32-9194-4156df27b858" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_22f9d9e8-25b9-4fac-b063-b030f1297370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_22f9d9e8-25b9-4fac-b063-b030f1297370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_350f044b-41ae-4e42-b485-252d587423e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_350f044b-41ae-4e42-b485-252d587423e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2cb275ac-3e3f-42d0-8d9c-2a2699b9256d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2cb275ac-3e3f-42d0-8d9c-2a2699b9256d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f26fc594-6626-4895-a9b6-923ccc9fa32f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_Depreciation_f26fc594-6626-4895-a9b6-923ccc9fa32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_0d996a0c-9f82-4f2c-9013-f29f82839ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_InterestCostsCapitalized_0d996a0c-9f82-4f2c-9013-f29f82839ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ForeignPropertyPlantAndEquipmentNet_326123b2-616f-46c4-9e04-a7a9193df3d0" xlink:href="pcrx-20210930.xsd#pcrx_ForeignPropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_pcrx_ForeignPropertyPlantAndEquipmentNet_326123b2-616f-46c4-9e04-a7a9193df3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_e6088304-77ec-4587-8ce3-3b56a13f7372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7ed6cb26-d630-4b8f-afcd-b7a875f0a7f2" xlink:to="loc_us-gaap_AssetRetirementObligation_e6088304-77ec-4587-8ce3-3b56a13f7372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASES" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3e056883-6d7e-4431-8db8-5a2d843b141f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_f3fb0d23-abce-4ff0-9fc1-09bcb62e07e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e056883-6d7e-4431-8db8-5a2d843b141f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_f3fb0d23-abce-4ff0-9fc1-09bcb62e07e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5d8083fa-9de4-4dd4-a074-2899dd2cde01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_fba6f2bb-705c-4840-9528-62ee2b52a65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5d8083fa-9de4-4dd4-a074-2899dd2cde01" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_fba6f2bb-705c-4840-9528-62ee2b52a65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_79602695-19b9-4c80-b9da-5abfc0b0778e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5d8083fa-9de4-4dd4-a074-2899dd2cde01" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_79602695-19b9-4c80-b9da-5abfc0b0778e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_8ea9022b-8345-4a7d-b19f-9e5e3edc1867" xlink:href="pcrx-20210930.xsd#pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5d8083fa-9de4-4dd4-a074-2899dd2cde01" xlink:to="loc_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock_8ea9022b-8345-4a7d-b19f-9e5e3edc1867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4441355a-94f7-4ec8-a017-761e19712e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f48dd84e-725d-4afa-94ea-d44717ee19c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4441355a-94f7-4ec8-a017-761e19712e75" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f48dd84e-725d-4afa-94ea-d44717ee19c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_1ee6030e-bbb9-4ae0-8348-a55cb9c7573b" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4441355a-94f7-4ec8-a017-761e19712e75" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_1ee6030e-bbb9-4ae0-8348-a55cb9c7573b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_55100cf8-b918-4c24-8932-be8d94fd1a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_53b46956-7bcc-4d42-9393-9d78e4fcae9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55100cf8-b918-4c24-8932-be8d94fd1a28" xlink:to="loc_us-gaap_LeaseCostAbstract_53b46956-7bcc-4d42-9393-9d78e4fcae9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_61a683ab-dab1-4c20-8b5f-a3fd37bbcc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_53b46956-7bcc-4d42-9393-9d78e4fcae9b" xlink:to="loc_us-gaap_OperatingLeaseCost_61a683ab-dab1-4c20-8b5f-a3fd37bbcc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_b59acb6f-cb09-43e7-a766-db343bbde3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_53b46956-7bcc-4d42-9393-9d78e4fcae9b" xlink:to="loc_us-gaap_VariableLeaseCost_b59acb6f-cb09-43e7-a766-db343bbde3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_8c16744b-b01e-4905-9755-18eb1c35f7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_53b46956-7bcc-4d42-9393-9d78e4fcae9b" xlink:to="loc_us-gaap_LeaseCost_8c16744b-b01e-4905-9755-18eb1c35f7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_d13ea3d4-55d1-45a7-8c0c-78e05b283e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55100cf8-b918-4c24-8932-be8d94fd1a28" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_d13ea3d4-55d1-45a7-8c0c-78e05b283e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_684dabe6-042d-4c24-9b49-540859f8e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_d13ea3d4-55d1-45a7-8c0c-78e05b283e69" xlink:to="loc_us-gaap_OperatingLeasePayments_684dabe6-042d-4c24-9b49-540859f8e82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5e489167-63b3-4c12-95d7-922c2273cc03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_d13ea3d4-55d1-45a7-8c0c-78e05b283e69" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5e489167-63b3-4c12-95d7-922c2273cc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_dba2f0c0-dad4-4899-8a3b-75a8aaccd417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55100cf8-b918-4c24-8932-be8d94fd1a28" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_dba2f0c0-dad4-4899-8a3b-75a8aaccd417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f1ad4e00-4df6-42c4-a1ca-d97f4eb2304a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55100cf8-b918-4c24-8932-be8d94fd1a28" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f1ad4e00-4df6-42c4-a1ca-d97f4eb2304a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c2085046-e7de-4ca6-8a41-6c753d02634c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c2085046-e7de-4ca6-8a41-6c753d02634c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dc93ec22-33e2-4894-a669-82a6c1f87f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dc93ec22-33e2-4894-a669-82a6c1f87f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6edddd67-864c-4aac-bc17-0c8a36492f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6edddd67-864c-4aac-bc17-0c8a36492f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_35c34fe1-8ea8-4b8a-bd30-f0aeb6cca86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_35c34fe1-8ea8-4b8a-bd30-f0aeb6cca86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cda8edce-63c8-474e-b4ac-72801393a0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cda8edce-63c8-474e-b4ac-72801393a0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_2cc83da1-32db-44a9-a4f0-356aac0c235e" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_2cc83da1-32db-44a9-a4f0-356aac0c235e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_95085355-689f-4aa5-b77d-abcd8e4c79d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_95085355-689f-4aa5-b77d-abcd8e4c79d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9e013400-d161-4fd1-aea2-84d62130f857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9e013400-d161-4fd1-aea2-84d62130f857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b69051fd-fccc-4dbd-953d-3f9c6a42ffad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b6f0235a-e8dd-4b22-b55c-7c779cee4fae" xlink:to="loc_us-gaap_OperatingLeaseLiability_b69051fd-fccc-4dbd-953d-3f9c6a42ffad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_af892679-5ea7-4aee-ab45-1cc1b7ea5c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_3fb44d48-9965-43be-ad5e-ffe75b78cc0a" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af892679-5ea7-4aee-ab45-1cc1b7ea5c24" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear_3fb44d48-9965-43be-ad5e-ffe75b78cc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_f4dc6799-1734-4410-8289-674a0f3e604e" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af892679-5ea7-4aee-ab45-1cc1b7ea5c24" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne_f4dc6799-1734-4410-8289-674a0f3e604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_c1b16ca9-c6b7-4d06-be53-8b598d8f9ab2" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af892679-5ea7-4aee-ab45-1cc1b7ea5c24" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo_c1b16ca9-c6b7-4d06-be53-8b598d8f9ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_ab796a4f-77e6-4a13-aa26-c1e138642936" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af892679-5ea7-4aee-ab45-1cc1b7ea5c24" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree_ab796a4f-77e6-4a13-aa26-c1e138642936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_d3079fb8-7d4b-413b-8ef4-766e7d4a5645" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af892679-5ea7-4aee-ab45-1cc1b7ea5c24" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour_d3079fb8-7d4b-413b-8ef4-766e7d4a5645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_8207b52b-658d-4fe4-9d82-c5936c5cd337" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af892679-5ea7-4aee-ab45-1cc1b7ea5c24" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour_8207b52b-658d-4fe4-9d82-c5936c5cd337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_5609bf77-7ef1-4c68-823d-bde84f586bc3" xlink:href="pcrx-20210930.xsd#pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af892679-5ea7-4aee-ab45-1cc1b7ea5c24" xlink:to="loc_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability_5609bf77-7ef1-4c68-823d-bde84f586bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bc55fa05-b8a5-4fb2-84da-608c629ca066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b47dc337-c0d4-44f7-83e8-2cca6a3514cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bc55fa05-b8a5-4fb2-84da-608c629ca066" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b47dc337-c0d4-44f7-83e8-2cca6a3514cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1eeea2cf-c225-458b-8369-0b801bafcddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_7dd92e63-f14b-4b67-b0b6-0877c2ecc223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1eeea2cf-c225-458b-8369-0b801bafcddc" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_7dd92e63-f14b-4b67-b0b6-0877c2ecc223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ea669d19-50d3-4e6e-9b13-c0920a669e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ea669d19-50d3-4e6e-9b13-c0920a669e6b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45" xlink:href="pcrx-20210930.xsd#pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:to="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_c814df76-095e-432f-b03d-5c93f1fda5b3" xlink:href="pcrx-20210930.xsd#pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis_fd2e4ada-c3cd-49fa-9fee-9f31dc81eb45" xlink:to="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_c814df76-095e-432f-b03d-5c93f1fda5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponFirstCommercialSaleInMajorEUCountryMember_5903d22c-c9da-48b8-9902-7a951c336e64" xlink:href="pcrx-20210930.xsd#pcrx_UponFirstCommercialSaleInMajorEUCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_c814df76-095e-432f-b03d-5c93f1fda5b3" xlink:to="loc_pcrx_UponFirstCommercialSaleInMajorEUCountryMember_5903d22c-c9da-48b8-9902-7a951c336e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_19ec7464-d877-4a3a-9a9c-2bc84fc85e1d" xlink:href="pcrx-20210930.xsd#pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain_c814df76-095e-432f-b03d-5c93f1fda5b3" xlink:to="loc_pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember_19ec7464-d877-4a3a-9a9c-2bc84fc85e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_16034e79-37ad-4018-852b-120db674a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_16034e79-37ad-4018-852b-120db674a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86a6363d-5710-49c7-b099-90b737b7ad02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16034e79-37ad-4018-852b-120db674a284" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86a6363d-5710-49c7-b099-90b737b7ad02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SkyePharmaHoldingIncMember_ec4b1d99-f91c-4fde-bbff-4b3f669b1434" xlink:href="pcrx-20210930.xsd#pcrx_SkyePharmaHoldingIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86a6363d-5710-49c7-b099-90b737b7ad02" xlink:to="loc_pcrx_SkyePharmaHoldingIncMember_ec4b1d99-f91c-4fde-bbff-4b3f669b1434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_c4830834-dc8d-422a-a5c3-39a117307404" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_86a6363d-5710-49c7-b099-90b737b7ad02" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_c4830834-dc8d-422a-a5c3-39a117307404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_52f6172e-d49a-494a-8561-2d638619384d" xlink:to="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_8103cc5a-7ffa-4f8e-8364-0207fa1a47b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_8103cc5a-7ffa-4f8e-8364-0207fa1a47b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2a799342-af67-4548-83a8-1e9ea20e1a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_Goodwill_2a799342-af67-4548-83a8-1e9ea20e1a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_87557821-9627-4cfa-afc4-d7a7b7274f29" xlink:href="pcrx-20210930.xsd#pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition_87557821-9627-4cfa-afc4-d7a7b7274f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_47a2d3ba-1c0d-40b8-82b3-dd337bd34a6f" xlink:href="pcrx-20210930.xsd#pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition_47a2d3ba-1c0d-40b8-82b3-dd337bd34a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e838d79e-95d8-4e0c-9691-3cbeaa8fd697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e838d79e-95d8-4e0c-9691-3cbeaa8fd697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_05f03ea5-41e3-4ded-b659-c35330fdb4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_05f03ea5-41e3-4ded-b659-c35330fdb4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_a83e9fe3-37ba-4c31-8f6d-183e01658d91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_a83e9fe3-37ba-4c31-8f6d-183e01658d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_4bc02277-7343-4ec4-a2fb-1886e2ee61c4" xlink:href="pcrx-20210930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1_4bc02277-7343-4ec4-a2fb-1886e2ee61c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_22725047-43d2-41b7-9c3d-49a6f874e57b" xlink:href="pcrx-20210930.xsd#pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_68b6bf97-4aca-45ca-a959-9c551c240325" xlink:to="loc_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2_22725047-43d2-41b7-9c3d-49a6f874e57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21237745-2c18-4eee-84d8-290723d06500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21237745-2c18-4eee-84d8-290723d06500" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7f15b652-331a-4741-a136-0cb47b2da87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7f15b652-331a-4741-a136-0cb47b2da87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd81fce5-e689-491f-97da-d95a07755a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7f15b652-331a-4741-a136-0cb47b2da87c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd81fce5-e689-491f-97da-d95a07755a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_e8b83769-4e45-4bf1-9df3-606023a8f466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd81fce5-e689-491f-97da-d95a07755a43" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_e8b83769-4e45-4bf1-9df3-606023a8f466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a5a57634-3440-43db-8e6f-00b86f1a9277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd81fce5-e689-491f-97da-d95a07755a43" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a5a57634-3440-43db-8e6f-00b86f1a9277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_531547ec-7b28-443a-a16b-880ccb99b360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_531547ec-7b28-443a-a16b-880ccb99b360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2cf4726c-da89-4778-bd4a-40e21b3a6c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_531547ec-7b28-443a-a16b-880ccb99b360" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2cf4726c-da89-4778-bd4a-40e21b3a6c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_c3b0beba-bb5d-40ab-a72f-2aca9b047e91" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2cf4726c-da89-4778-bd4a-40e21b3a6c42" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_c3b0beba-bb5d-40ab-a72f-2aca9b047e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f7170292-7c62-4936-9448-1a8baad9b314" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b0d969fc-2b36-4574-a028-7ed0767f7ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b0d969fc-2b36-4574-a028-7ed0767f7ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_141fb559-8526-48d1-81d3-8c5c7e8d4b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_141fb559-8526-48d1-81d3-8c5c7e8d4b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_061e4816-05e1-4697-b231-c0401debfb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_061e4816-05e1-4697-b231-c0401debfb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6368e12b-3dc0-4191-95e1-c65f8d114058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_51801879-4209-4dc8-ae2c-c6cb0ec24e6a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6368e12b-3dc0-4191-95e1-c65f8d114058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBT" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_62db7702-56af-48e5-a9a1-40df883ef07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_8f688981-42a1-48d1-9810-b961ddfc68f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_62db7702-56af-48e5-a9a1-40df883ef07c" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_8f688981-42a1-48d1-9810-b961ddfc68f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_aa15aba9-a20c-46b5-85df-7b958c2f7c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_09b280e6-d317-482a-b5bd-f572a278068f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_aa15aba9-a20c-46b5-85df-7b958c2f7c1f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_09b280e6-d317-482a-b5bd-f572a278068f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock_0690f6d4-0e70-44be-b68c-82cd2c1ed9ea" xlink:href="pcrx-20210930.xsd#pcrx_ScheduleOfInterestExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_aa15aba9-a20c-46b5-85df-7b958c2f7c1f" xlink:to="loc_pcrx_ScheduleOfInterestExpenseTableTextBlock_0690f6d4-0e70-44be-b68c-82cd2c1ed9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_50888116-4ca9-4ef3-8f01-d366e9c106bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_50888116-4ca9-4ef3-8f01-d366e9c106bd" xlink:to="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_98293eae-dae0-49ba-9568-ce213ed3e46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5d575d8-09fa-4ea9-9fe0-5e868210d5a8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_98293eae-dae0-49ba-9568-ce213ed3e46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_4303f7ba-3d3a-4377-8d4e-916bd7426a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98293eae-dae0-49ba-9568-ce213ed3e46b" xlink:to="loc_us-gaap_UnsecuredDebtMember_4303f7ba-3d3a-4377-8d4e-916bd7426a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c9fa277b-ee19-4dee-80e9-e0cc93c9a1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98293eae-dae0-49ba-9568-ce213ed3e46b" xlink:to="loc_us-gaap_ConvertibleDebtMember_c9fa277b-ee19-4dee-80e9-e0cc93c9a1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_68328b39-171c-4362-b049-2c34652f7447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:to="loc_us-gaap_DebtInstrumentAxis_68328b39-171c-4362-b049-2c34652f7447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_246298b8-a329-4c3c-9772-d56604ed9851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_68328b39-171c-4362-b049-2c34652f7447" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_246298b8-a329-4c3c-9772-d56604ed9851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_c4180e86-323e-4c24-bb4d-158b73628af6" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_246298b8-a329-4c3c-9772-d56604ed9851" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_c4180e86-323e-4c24-bb4d-158b73628af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_badee7b1-f5c7-4288-b80f-b8c8c7a33f86" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_246298b8-a329-4c3c-9772-d56604ed9851" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_badee7b1-f5c7-4288-b80f-b8c8c7a33f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsAxis_e33f8b4b-2317-44e6-8290-163f6627e065" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionAndRedemptionTermsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsAxis_e33f8b4b-2317-44e6-8290-163f6627e065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionAndRedemptionTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsAxis_e33f8b4b-2317-44e6-8290-163f6627e065" xlink:to="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member_f0e74b25-4533-4289-a738-c6c6a65c0a36" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:to="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member_f0e74b25-4533-4289-a738-c6c6a65c0a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_36a331d1-7c0c-4ef1-b173-7909fcd7d0a4" xlink:href="pcrx-20210930.xsd#pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:to="loc_pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member_36a331d1-7c0c-4ef1-b173-7909fcd7d0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member_391ecdd6-9183-4887-aeca-8863b5e91e0f" xlink:href="pcrx-20210930.xsd#pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:to="loc_pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member_391ecdd6-9183-4887-aeca-8863b5e91e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtRedemptionTermsonorafterApril12020Member_8f4918b5-c516-40d1-8d28-f2bc2be298f5" xlink:href="pcrx-20210930.xsd#pcrx_DebtRedemptionTermsonorafterApril12020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_DebtConversionAndRedemptionTermsDomain_15fba408-d63f-4c8d-9181-aeb904277018" xlink:to="loc_pcrx_DebtRedemptionTermsonorafterApril12020Member_8f4918b5-c516-40d1-8d28-f2bc2be298f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_783a30b2-9657-4eea-afa5-d3334206b153" xlink:to="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_77bfe8be-933d-4993-97be-ae6803d58433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_77bfe8be-933d-4993-97be-ae6803d58433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_57c6a29c-8735-40ad-9135-15e1328e6686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_57c6a29c-8735-40ad-9135-15e1328e6686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_d558797d-ce5b-4b49-85c2-a3e390713e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_d558797d-ce5b-4b49-85c2-a3e390713e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_0cd482b8-7557-48c1-9554-045b21597cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_0cd482b8-7557-48c1-9554-045b21597cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f878078a-d3f6-4a13-afcd-47209ade3eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_RepaymentsOfDebt_f878078a-d3f6-4a13-afcd-47209ade3eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f17fd609-8d7c-4560-8af8-a01fb1775476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f17fd609-8d7c-4560-8af8-a01fb1775476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_108c8b10-6587-48bf-883f-42fd38ed16bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_108c8b10-6587-48bf-883f-42fd38ed16bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c29fec17-c8e7-44d7-863f-0154f1c5fe74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c29fec17-c8e7-44d7-863f-0154f1c5fe74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock_e5d0bb7b-30b2-4d48-84c9-d5bcf2fcbeac" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock_e5d0bb7b-30b2-4d48-84c9-d5bcf2fcbeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_9637b67f-0b17-41fb-9473-7ea40a15989f" xlink:href="pcrx-20210930.xsd#pcrx_SettlementPeriodConvertibleDebtConversionRequest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_SettlementPeriodConvertibleDebtConversionRequest_9637b67f-0b17-41fb-9473-7ea40a15989f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentMarketPrice_65e3c46e-2560-40bc-8f92-ed1c7a504dcd" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentMarketPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentMarketPrice_65e3c46e-2560-40bc-8f92-ed1c7a504dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_0840891d-2cb3-4f6c-bdd5-57d59e297103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_0840891d-2cb3-4f6c-bdd5-57d59e297103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_87162a84-6909-478a-8d89-39600c1cd9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_87162a84-6909-478a-8d89-39600c1cd9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_8bcbfbc4-f590-4c17-a0a6-ce1f47052a99" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock_8bcbfbc4-f590-4c17-a0a6-ce1f47052a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_d0b51958-7c59-4d45-b905-5edb309fff53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_SharePrice_d0b51958-7c59-4d45-b905-5edb309fff53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_1460086e-9873-4bd3-90f4-6961009fe984" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice_1460086e-9873-4bd3-90f4-6961009fe984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent_f782feda-fcb8-4dda-a407-ee1a1f97203f" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent_f782feda-fcb8-4dda-a407-ee1a1f97203f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate_8071db4c-cc1d-498d-b1a2-07513b5f2e35" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleAssumedBorrowingRate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate_8071db4c-cc1d-498d-b1a2-07513b5f2e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_90a5dc5c-89e7-461d-a6a2-2b738897dc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_90a5dc5c-89e7-461d-a6a2-2b738897dc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6b32d031-2a5f-4236-942c-f72fd6161649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtInstrumentTerm_6b32d031-2a5f-4236-942c-f72fd6161649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt_f6be6842-5df7-47db-bb0d-968bb96e2bd7" xlink:href="pcrx-20210930.xsd#pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt_f6be6842-5df7-47db-bb0d-968bb96e2bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_e9c1460a-9181-4bdf-9fc4-13a3565b76e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_e9c1460a-9181-4bdf-9fc4-13a3565b76e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt_48c21f0e-cd0f-414d-b429-fbe9d7418c57" xlink:href="pcrx-20210930.xsd#pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt_48c21f0e-cd0f-414d-b429-fbe9d7418c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt_765c2ec7-67f1-4e8e-a977-bbde9fc4cd02" xlink:href="pcrx-20210930.xsd#pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt_765c2ec7-67f1-4e8e-a977-bbde9fc4cd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06ed8b1f-b8f0-42cb-895e-114b6318ac88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06ed8b1f-b8f0-42cb-895e-114b6318ac88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption_8fe86901-8ed9-457e-a762-aa6b67a95bba" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_79f4860a-7744-4388-b718-400f292f362f" xlink:to="loc_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption_8fe86901-8ed9-457e-a762-aa6b67a95bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DEBTScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7a23a810-3df4-4e6e-b236-eb7c897c0d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7a23a810-3df4-4e6e-b236-eb7c897c0d21" xlink:to="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c82b5f16-5a55-468a-af07-0836aaa09092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c82b5f16-5a55-468a-af07-0836aaa09092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e1536b24-8033-4716-96dc-89b43bce2cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c82b5f16-5a55-468a-af07-0836aaa09092" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e1536b24-8033-4716-96dc-89b43bce2cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a4ae22be-7241-40a3-8a9b-6fe47f77df2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e1536b24-8033-4716-96dc-89b43bce2cd3" xlink:to="loc_us-gaap_UnsecuredDebtMember_a4ae22be-7241-40a3-8a9b-6fe47f77df2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eab339b7-695b-4ec3-82d3-88ddc54e8879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:to="loc_us-gaap_DebtInstrumentAxis_eab339b7-695b-4ec3-82d3-88ddc54e8879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2f9026b9-6e16-42fa-bb3f-130be7397d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_eab339b7-695b-4ec3-82d3-88ddc54e8879" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2f9026b9-6e16-42fa-bb3f-130be7397d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_866cdaf2-8d7f-4c4b-b69d-c586eb99db54" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2f9026b9-6e16-42fa-bb3f-130be7397d17" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_866cdaf2-8d7f-4c4b-b69d-c586eb99db54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_70bb6818-793e-4dd8-a5b7-b106278c6a5e" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2f9026b9-6e16-42fa-bb3f-130be7397d17" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_70bb6818-793e-4dd8-a5b7-b106278c6a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_02f3e406-f2f5-41e5-9f16-8f93cabbcbc7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e11b2bb6-d89e-4337-a911-ad5678fbd4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e11b2bb6-d89e-4337-a911-ad5678fbd4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3b5fd45d-a845-4e0d-9c5a-ddd39adf6877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3b5fd45d-a845-4e0d-9c5a-ddd39adf6877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_851e4cf1-000f-4366-bd3f-2aec667631d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_851e4cf1-000f-4366-bd3f-2aec667631d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b5b55d8c-d07a-4618-aafd-8169995a0dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b5b55d8c-d07a-4618-aafd-8169995a0dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ef9fae72-a38e-4651-af7b-ec6174b8ef47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b7749dd-e82d-4e72-9561-5610d503adc4" xlink:to="loc_us-gaap_LongTermDebt_ef9fae72-a38e-4651-af7b-ec6174b8ef47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#DEBTScheduleofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8550a2bb-0ef7-4433-8bf2-0b6cb486aaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b815e546-8232-4b18-be2a-66a2c329ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8550a2bb-0ef7-4433-8bf2-0b6cb486aaa0" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b815e546-8232-4b18-be2a-66a2c329ad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_55b68196-e1ff-4d63-b8da-5d7d72181f53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8550a2bb-0ef7-4433-8bf2-0b6cb486aaa0" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_55b68196-e1ff-4d63-b8da-5d7d72181f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_257dabf1-9e37-4cbf-9334-58ed212843fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8550a2bb-0ef7-4433-8bf2-0b6cb486aaa0" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_257dabf1-9e37-4cbf-9334-58ed212843fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_b7a798d6-8f90-49e0-ae46-de5263893956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8550a2bb-0ef7-4433-8bf2-0b6cb486aaa0" xlink:to="loc_us-gaap_InterestCostsCapitalized_b7a798d6-8f90-49e0-ae46-de5263893956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_691aa52e-ba65-4627-b893-41189d6e3b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8550a2bb-0ef7-4433-8bf2-0b6cb486aaa0" xlink:to="loc_us-gaap_InterestExpenseDebt_691aa52e-ba65-4627-b893-41189d6e3b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_f54888e3-ec47-4844-9b54-1e54cb812a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8550a2bb-0ef7-4433-8bf2-0b6cb486aaa0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_f54888e3-ec47-4844-9b54-1e54cb812a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_56b14a92-908d-40d2-9adf-c8b1cc19607b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_90da9651-7311-4e15-b640-aaee5744169e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_56b14a92-908d-40d2-9adf-c8b1cc19607b" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_90da9651-7311-4e15-b640-aaee5744169e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9ea6e5ba-a621-4df6-96e4-c1782e58d94c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_05afc07c-d895-44ef-bb37-51e4a5e698c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ea6e5ba-a621-4df6-96e4-c1782e58d94c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_05afc07c-d895-44ef-bb37-51e4a5e698c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1d8bf6de-db9a-466d-a829-c556eedc6900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ea6e5ba-a621-4df6-96e4-c1782e58d94c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1d8bf6de-db9a-466d-a829-c556eedc6900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_574c0a49-d659-47fb-9d9f-7c0e74decee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ea6e5ba-a621-4df6-96e4-c1782e58d94c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_574c0a49-d659-47fb-9d9f-7c0e74decee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_8eff8e22-06a5-4b17-9c61-988fef0540f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ea6e5ba-a621-4df6-96e4-c1782e58d94c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_8eff8e22-06a5-4b17-9c61-988fef0540f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5062d8d1-7042-4663-812c-eef2419135f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5062d8d1-7042-4663-812c-eef2419135f8" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_f43a5afd-eebe-4e08-8530-ba538cd47bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_f43a5afd-eebe-4e08-8530-ba538cd47bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f43a5afd-eebe-4e08-8530-ba538cd47bcb" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_75da5ef9-fd6c-4329-96a2-10e6500e8ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_75da5ef9-fd6c-4329-96a2-10e6500e8ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0564fff0-7dc8-40f4-b499-2a3394e66dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0564fff0-7dc8-40f4-b499-2a3394e66dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18c70250-c970-43a3-b44a-a09cef818a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f5a4ab4c-2982-4b1e-9ec5-8462290b2c0d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_18c70250-c970-43a3-b44a-a09cef818a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_064b33dc-385a-4cf9-876e-b1ecfc0378a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_064b33dc-385a-4cf9-876e-b1ecfc0378a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_064b33dc-385a-4cf9-876e-b1ecfc0378a2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d1127124-f59e-4094-9013-b940d67119e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d1127124-f59e-4094-9013-b940d67119e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_28c187b3-fa2a-4bf6-a81c-e41621c03a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_28c187b3-fa2a-4bf6-a81c-e41621c03a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_16a81cf5-a2f6-4929-80b6-2815beb81c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3564a65d-7cec-43f6-85b2-da6968e107d7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_16a81cf5-a2f6-4929-80b6-2815beb81c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_DebtInstrumentAxis_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94ba4768-49a2-4c33-bb6c-8c2e322961a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b0d473b0-f629-42f1-bfe1-1d6ecb8a1901" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94ba4768-49a2-4c33-bb6c-8c2e322961a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_af516d5a-7122-4daa-b5d1-0db8aebde25e" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94ba4768-49a2-4c33-bb6c-8c2e322961a5" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_af516d5a-7122-4daa-b5d1-0db8aebde25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_ad5f703f-c6d3-4ac6-9597-c05faf2c4a79" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94ba4768-49a2-4c33-bb6c-8c2e322961a5" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_ad5f703f-c6d3-4ac6-9597-c05faf2c4a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_26e50bf6-aa8e-440e-b54d-2a1ed33cb551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_26e50bf6-aa8e-440e-b54d-2a1ed33cb551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_046983a4-9a8a-41c4-ae2d-db1cccf26b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_26e50bf6-aa8e-440e-b54d-2a1ed33cb551" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_046983a4-9a8a-41c4-ae2d-db1cccf26b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_36012309-c561-4414-82f4-7828384c8ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_046983a4-9a8a-41c4-ae2d-db1cccf26b4e" xlink:to="loc_us-gaap_UnsecuredDebtMember_36012309-c561-4414-82f4-7828384c8ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c6059bac-78c6-4a40-b0ab-b4b50b278c4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_srt_RangeAxis_c6059bac-78c6-4a40-b0ab-b4b50b278c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_08a8adcb-d659-4b34-9bf8-4b12ea14e958" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c6059bac-78c6-4a40-b0ab-b4b50b278c4e" xlink:to="loc_srt_RangeMember_08a8adcb-d659-4b34-9bf8-4b12ea14e958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_beb2600d-44e5-4615-a3bd-23dc64bc58b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_08a8adcb-d659-4b34-9bf8-4b12ea14e958" xlink:to="loc_srt_MaximumMember_beb2600d-44e5-4615-a3bd-23dc64bc58b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bf0155f-1bbf-44a8-b4c2-fefc195e4c30" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_7f8687ed-dadd-4286-b0bd-b1e6c28b16d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_7f8687ed-dadd-4286-b0bd-b1e6c28b16d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_f0f14528-17ba-44d9-8bd1-221797693398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesFairValueDisclosureAbstract_7f8687ed-dadd-4286-b0bd-b1e6c28b16d2" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_f0f14528-17ba-44d9-8bd1-221797693398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_5d1a7f41-4136-4a6e-9c85-3071beb67f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_5d1a7f41-4136-4a6e-9c85-3071beb67f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e696af4d-13e4-4e50-9fcc-381a30bd63c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_5d1a7f41-4136-4a6e-9c85-3071beb67f44" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e696af4d-13e4-4e50-9fcc-381a30bd63c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_7dba40a9-8400-47d4-8612-8e087d89f241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_DebtInstrumentFairValue_7dba40a9-8400-47d4-8612-8e087d89f241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0c081fa3-6f48-4da8-8582-0c1d248c7007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0c081fa3-6f48-4da8-8582-0c1d248c7007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_a05c91bd-2114-4e51-8a2e-fa1182ac04ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_SharePrice_a05c91bd-2114-4e51-8a2e-fa1182ac04ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_fab592cb-e6b2-4bd8-8bac-02ef12ce07de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_fab592cb-e6b2-4bd8-8bac-02ef12ce07de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_979211a0-3770-4371-907c-b074bca46ba6" xlink:href="pcrx-20210930.xsd#pcrx_DebtInstrumentConvertibleConversionPremiumShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8b9d1e15-e612-41a2-84ca-012c8f31901c" xlink:to="loc_pcrx_DebtInstrumentConvertibleConversionPremiumShares_979211a0-3770-4371-907c-b074bca46ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b5efb80d-7e2e-47ea-a3f8-febd58937a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b5efb80d-7e2e-47ea-a3f8-febd58937a87" xlink:to="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_00886ffa-c933-4e9f-9b81-cfd702724e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_DebtInstrumentAxis_00886ffa-c933-4e9f-9b81-cfd702724e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd3eb998-5866-4961-92d8-90f19a3064fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_00886ffa-c933-4e9f-9b81-cfd702724e78" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd3eb998-5866-4961-92d8-90f19a3064fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2025Member_82f98df2-83df-41c7-a0b1-9352d44ac290" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd3eb998-5866-4961-92d8-90f19a3064fe" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2025Member_82f98df2-83df-41c7-a0b1-9352d44ac290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ConvertibleSeniorNotesDue2022Member_281cd5dc-f60b-4d64-800a-17df483f4b54" xlink:href="pcrx-20210930.xsd#pcrx_ConvertibleSeniorNotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd3eb998-5866-4961-92d8-90f19a3064fe" xlink:to="loc_pcrx_ConvertibleSeniorNotesDue2022Member_281cd5dc-f60b-4d64-800a-17df483f4b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_88844747-888c-4c76-b778-f92bf94e379d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_88844747-888c-4c76-b778-f92bf94e379d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_88844747-888c-4c76-b778-f92bf94e379d" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_TELABioMember_730f7ae9-3987-4b05-986f-788fc3ca5a3e" xlink:href="pcrx-20210930.xsd#pcrx_TELABioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:to="loc_pcrx_TELABioMember_730f7ae9-3987-4b05-986f-788fc3ca5a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_GeneQuineBiotherapeuticsGmbHMember_5ae70030-c599-4cdc-b005-00b8d069e445" xlink:href="pcrx-20210930.xsd#pcrx_GeneQuineBiotherapeuticsGmbHMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:to="loc_pcrx_GeneQuineBiotherapeuticsGmbHMember_5ae70030-c599-4cdc-b005-00b8d069e445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_SpineBioPharmaLLCMember_a092a372-9366-43ba-b363-0c20a77197eb" xlink:href="pcrx-20210930.xsd#pcrx_SpineBioPharmaLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_8d97fb32-d54f-4157-b256-a90cde6fce2e" xlink:to="loc_pcrx_SpineBioPharmaLLCMember_a092a372-9366-43ba-b363-0c20a77197eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_061d9851-39f2-49e3-8d03-3f486d2a2943" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_061d9851-39f2-49e3-8d03-3f486d2a2943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_10386c3a-b38c-4495-9b3d-829ff5d592f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_061d9851-39f2-49e3-8d03-3f486d2a2943" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_10386c3a-b38c-4495-9b3d-829ff5d592f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CodaBioTherapeuticsIncMember_df00941a-e605-4f62-b99e-aa912a36f42d" xlink:href="pcrx-20210930.xsd#pcrx_CodaBioTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_10386c3a-b38c-4495-9b3d-829ff5d592f6" xlink:to="loc_pcrx_CodaBioTherapeuticsIncMember_df00941a-e605-4f62-b99e-aa912a36f42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_22dbfe49-eb2f-4df3-8f74-61e045a08eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_22dbfe49-eb2f-4df3-8f74-61e045a08eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b7a8937-9c06-40b9-9eed-d3a4b13df774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_22dbfe49-eb2f-4df3-8f74-61e045a08eab" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b7a8937-9c06-40b9-9eed-d3a4b13df774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_0bd712f6-ca96-48e0-a57c-843327388822" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b7a8937-9c06-40b9-9eed-d3a4b13df774" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_0bd712f6-ca96-48e0-a57c-843327388822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneAxis_38c0799e-a88d-45ae-aa36-9d56305fec31" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_pcrx_AchievementOfMilestoneAxis_38c0799e-a88d-45ae-aa36-9d56305fec31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneDomain_f08ccd69-756a-4e22-a7e0-90354cfd1116" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_AchievementOfMilestoneAxis_38c0799e-a88d-45ae-aa36-9d56305fec31" xlink:to="loc_pcrx_AchievementOfMilestoneDomain_f08ccd69-756a-4e22-a7e0-90354cfd1116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementofRegulatoryMilestoneMember_5d3a5cde-0367-46ba-a626-5598584c498b" xlink:href="pcrx-20210930.xsd#pcrx_AchievementofRegulatoryMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_AchievementOfMilestoneDomain_f08ccd69-756a-4e22-a7e0-90354cfd1116" xlink:to="loc_pcrx_AchievementofRegulatoryMilestoneMember_5d3a5cde-0367-46ba-a626-5598584c498b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2adb57bd-88ce-4196-a459-9ce63913f59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2adb57bd-88ce-4196-a459-9ce63913f59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_45a40b4a-4ecb-4907-9477-385c6c177f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2adb57bd-88ce-4196-a459-9ce63913f59f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_45a40b4a-4ecb-4907-9477-385c6c177f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_b20dcaeb-5d99-464c-bc4f-d678aca85db8" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_45a40b4a-4ecb-4907-9477-385c6c177f52" xlink:to="loc_pcrx_ContingentConsiderationMember_b20dcaeb-5d99-464c-bc4f-d678aca85db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ff8abc62-f8f3-491e-a962-d2eb20984856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ff8abc62-f8f3-491e-a962-d2eb20984856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfcaff3d-4183-4093-b1be-9c01ecd5236c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ff8abc62-f8f3-491e-a962-d2eb20984856" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfcaff3d-4183-4093-b1be-9c01ecd5236c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_c7eaf3d2-cf37-41f3-af29-2812c88d11ad" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bfcaff3d-4183-4093-b1be-9c01ecd5236c" xlink:to="loc_pcrx_ContingentConsiderationMember_c7eaf3d2-cf37-41f3-af29-2812c88d11ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_ef5f6800-66ad-4513-8177-009d35c08654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_ef5f6800-66ad-4513-8177-009d35c08654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_33495bf8-3b24-4a9f-9577-ac731d6ec0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_ef5f6800-66ad-4513-8177-009d35c08654" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_33495bf8-3b24-4a9f-9577-ac731d6ec0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_9af156a5-36b4-477b-a379-197dc73ee8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33495bf8-3b24-4a9f-9577-ac731d6ec0d1" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_9af156a5-36b4-477b-a379-197dc73ee8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_6b03424d-82cc-4b9d-aff2-2657b2b3411f" xlink:href="pcrx-20210930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33495bf8-3b24-4a9f-9577-ac731d6ec0d1" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_6b03424d-82cc-4b9d-aff2-2657b2b3411f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1261093b-8e06-425b-a3f0-eb577ce9abae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1261093b-8e06-425b-a3f0-eb577ce9abae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1faaefd1-5ac0-42c8-8af0-c69f9f7d5ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1261093b-8e06-425b-a3f0-eb577ce9abae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1faaefd1-5ac0-42c8-8af0-c69f9f7d5ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b1e105ba-7554-4261-a003-eeca2c7d6d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1faaefd1-5ac0-42c8-8af0-c69f9f7d5ffb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b1e105ba-7554-4261-a003-eeca2c7d6d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_98b12662-1e26-4bca-be7b-86112850e873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_98b12662-1e26-4bca-be7b-86112850e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cd78eb6b-6537-4194-a33b-b7356adf33fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_98b12662-1e26-4bca-be7b-86112850e873" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cd78eb6b-6537-4194-a33b-b7356adf33fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_1eab9a76-131b-46b2-b115-0e66fc1ae240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cd78eb6b-6537-4194-a33b-b7356adf33fc" xlink:to="loc_us-gaap_AccountsReceivableMember_1eab9a76-131b-46b2-b115-0e66fc1ae240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_435b29e2-05f0-41ca-8f4b-53a0214e76d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_435b29e2-05f0-41ca-8f4b-53a0214e76d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_355aeb17-10b0-4fbd-8fca-85419585e214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_435b29e2-05f0-41ca-8f4b-53a0214e76d5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_355aeb17-10b0-4fbd-8fca-85419585e214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_268234d0-09a9-4dbe-ba4a-6307b4112907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_355aeb17-10b0-4fbd-8fca-85419585e214" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_268234d0-09a9-4dbe-ba4a-6307b4112907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_919f4ec5-ca93-46ee-8822-7181a76eb1dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_srt_MajorCustomersAxis_919f4ec5-ca93-46ee-8822-7181a76eb1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_919f4ec5-ca93-46ee-8822-7181a76eb1dc" xlink:to="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerOneMember_849ae4aa-9784-40d1-867e-c5dbc372484e" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:to="loc_pcrx_MajorCustomerOneMember_849ae4aa-9784-40d1-867e-c5dbc372484e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerTwoMember_037962bb-5875-46bb-bc7c-79fecac042cd" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:to="loc_pcrx_MajorCustomerTwoMember_037962bb-5875-46bb-bc7c-79fecac042cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MajorCustomerThreeMember_6d69eda2-42b8-4156-9f6d-8224fcf35b8d" xlink:href="pcrx-20210930.xsd#pcrx_MajorCustomerThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf05decc-7f95-4021-a8ef-8da5bb0be556" xlink:to="loc_pcrx_MajorCustomerThreeMember_6d69eda2-42b8-4156-9f6d-8224fcf35b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1eb384c0-24aa-4742-a7e2-a121da71d141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5d80aa5e-0fe9-45aa-ac12-87d9e1f663f9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1eb384c0-24aa-4742-a7e2-a121da71d141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_9a29f55f-a750-4bbd-9c70-82d617e40213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1eb384c0-24aa-4742-a7e2-a121da71d141" xlink:to="loc_us-gaap_NotesReceivableMember_9a29f55f-a750-4bbd-9c70-82d617e40213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_f861970f-5a49-4edd-9b88-83f9acb475a2" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_0525e588-8cd4-4837-aa80-4de03f1c2279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_0525e588-8cd4-4837-aa80-4de03f1c2279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_356e86e3-e85f-41b4-8246-900747e50ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_356e86e3-e85f-41b4-8246-900747e50ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_796fbc31-7d25-4b84-80af-06ffe6f7f547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_796fbc31-7d25-4b84-80af-06ffe6f7f547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_843e9bd8-8ded-4cc8-ae89-d115c063d661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_ConvertibleNotesPayable_843e9bd8-8ded-4cc8-ae89-d115c063d661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_8ad381b6-d872-476f-ab74-c891e98d7496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_8ad381b6-d872-476f-ab74-c891e98d7496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_4f872c0a-701d-487c-a7e9-9ee5a3d8f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_4f872c0a-701d-487c-a7e9-9ee5a3d8f0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones_78f96426-c73a-456a-beeb-e1dc56ee97fe" xlink:href="pcrx-20210930.xsd#pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones_78f96426-c73a-456a-beeb-e1dc56ee97fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0f77d7da-1505-4cef-bb38-0f8807d5688a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0f77d7da-1505-4cef-bb38-0f8807d5688a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsideration_3f4199d4-404a-4545-b630-5224886c9cfd" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsideration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_ContingentConsideration_3f4199d4-404a-4545-b630-5224886c9cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationPaymentTerm_93376318-d063-4eda-b8b9-8a7b37e90b96" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationPaymentTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_ContingentConsiderationPaymentTerm_93376318-d063-4eda-b8b9-8a7b37e90b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationCurrent_fefbe3ac-fc73-476a-b189-8e3eec5fdaf0" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_ContingentConsiderationCurrent_fefbe3ac-fc73-476a-b189-8e3eec5fdaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MilestonePayment_8cf7cdca-ade1-4233-8513-9e21aec4ff84" xlink:href="pcrx-20210930.xsd#pcrx_MilestonePayment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_pcrx_MilestonePayment_8cf7cdca-ade1-4233-8513-9e21aec4ff84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_db3faaea-4c01-4cbf-86e0-c7bfa8e514ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_db3faaea-4c01-4cbf-86e0-c7bfa8e514ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7c0c807c-1534-4121-a679-55256dc05d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7c0c807c-1534-4121-a679-55256dc05d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1e48d61c-1bc5-4888-a527-50ade7f53e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1e48d61c-1bc5-4888-a527-50ade7f53e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d965a7f8-b047-4f13-98b6-8870a8da2892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_d965a7f8-b047-4f13-98b6-8870a8da2892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_a5d621a1-7c9c-4a01-8eeb-a3cdb269cc68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_InterestReceivable_a5d621a1-7c9c-4a01-8eeb-a3cdb269cc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_823a8f70-32e6-4fcc-b50c-0dd329aa4615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_823a8f70-32e6-4fcc-b50c-0dd329aa4615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_54aeb6de-4fbe-43fc-8178-cc360aece657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_06375b51-9486-4e82-a87d-e54c04e3aa72" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_54aeb6de-4fbe-43fc-8178-cc360aece657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f1a2b8a7-1217-4a81-bb29-58569cf1ac7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f1a2b8a7-1217-4a81-bb29-58569cf1ac7b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa3fd78-dbc2-473d-b9e7-f7de7cdbeeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d6f89ac9-4293-4249-8ded-7c36e1ceb3e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa3fd78-dbc2-473d-b9e7-f7de7cdbeeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e224ada4-8b00-469e-ab28-a67751072602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa3fd78-dbc2-473d-b9e7-f7de7cdbeeb9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e224ada4-8b00-469e-ab28-a67751072602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_69a79834-badd-42a6-94c4-d0f2c8127f6e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_srt_RangeAxis_69a79834-badd-42a6-94c4-d0f2c8127f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa0eaaac-11b9-4da4-a3fc-041c7d513bc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_69a79834-badd-42a6-94c4-d0f2c8127f6e" xlink:to="loc_srt_RangeMember_fa0eaaac-11b9-4da4-a3fc-041c7d513bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f4b39ffb-2d4e-4f92-8d56-b15a73ddcf45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fa0eaaac-11b9-4da4-a3fc-041c7d513bc9" xlink:to="loc_srt_MinimumMember_f4b39ffb-2d4e-4f92-8d56-b15a73ddcf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_27c58634-2749-4a53-aa9f-5cfaf12eeb98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fa0eaaac-11b9-4da4-a3fc-041c7d513bc9" xlink:to="loc_srt_MaximumMember_27c58634-2749-4a53-aa9f-5cfaf12eeb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_474ffa48-66e8-45df-b7ac-55b911bea50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_474ffa48-66e8-45df-b7ac-55b911bea50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1025a56d-98dd-4a8b-8afa-69301426e711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_474ffa48-66e8-45df-b7ac-55b911bea50f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1025a56d-98dd-4a8b-8afa-69301426e711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MyoscienceAcquisitionMember_230bd908-ea50-4f33-8316-ef9064c82db6" xlink:href="pcrx-20210930.xsd#pcrx_MyoscienceAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1025a56d-98dd-4a8b-8afa-69301426e711" xlink:to="loc_pcrx_MyoscienceAcquisitionMember_230bd908-ea50-4f33-8316-ef9064c82db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8a27d922-03e6-4a27-aec5-6d6dc1786fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8a27d922-03e6-4a27-aec5-6d6dc1786fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a7f7fed6-25bd-4329-a41d-cae46b12ac5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8a27d922-03e6-4a27-aec5-6d6dc1786fa9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a7f7fed6-25bd-4329-a41d-cae46b12ac5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_912ff03b-f94e-4964-b003-1eb2703f49b4" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a7f7fed6-25bd-4329-a41d-cae46b12ac5d" xlink:to="loc_pcrx_ContingentConsiderationMember_912ff03b-f94e-4964-b003-1eb2703f49b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_b34354be-f2f4-4696-93de-9fd963a11e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_b34354be-f2f4-4696-93de-9fd963a11e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_4e4abaa2-d482-419a-a625-64e943520076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_b34354be-f2f4-4696-93de-9fd963a11e49" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_4e4abaa2-d482-419a-a625-64e943520076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_00345a68-95a5-455e-874b-659c7543467a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4e4abaa2-d482-419a-a625-64e943520076" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_00345a68-95a5-455e-874b-659c7543467a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_80f70559-236c-4612-8a05-36d162a7441c" xlink:href="pcrx-20210930.xsd#pcrx_MeasurementInputExpectedMilestonePaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4e4abaa2-d482-419a-a625-64e943520076" xlink:to="loc_pcrx_MeasurementInputExpectedMilestonePaymentMember_80f70559-236c-4612-8a05-36d162a7441c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b1cf93d9-f671-4ab8-b9f7-e1bfbd2c9b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_cdc963ec-25ca-4b72-ae5f-cb68cb38c23a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b1cf93d9-f671-4ab8-b9f7-e1bfbd2c9b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_3e2af66b-625e-47f3-9b8f-8a335ff60e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_b1cf93d9-f671-4ab8-b9f7-e1bfbd2c9b9c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_3e2af66b-625e-47f3-9b8f-8a335ff60e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9d8a2919-c650-4105-8122-3f5df4269948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e85bf44f-68dd-4d91-ae06-8b0f1cf941fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9d8a2919-c650-4105-8122-3f5df4269948" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e85bf44f-68dd-4d91-ae06-8b0f1cf941fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_bfc49071-9882-4010-abd7-bfb2c1a75fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e85bf44f-68dd-4d91-ae06-8b0f1cf941fb" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_bfc49071-9882-4010-abd7-bfb2c1a75fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ca019cc5-7fb6-4343-affe-7eacb2d51848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_bfc49071-9882-4010-abd7-bfb2c1a75fd4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ca019cc5-7fb6-4343-affe-7eacb2d51848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ContingentConsiderationMember_032bfb68-027c-4272-aa39-027973d283a4" xlink:href="pcrx-20210930.xsd#pcrx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ca019cc5-7fb6-4343-affe-7eacb2d51848" xlink:to="loc_pcrx_ContingentConsiderationMember_032bfb68-027c-4272-aa39-027973d283a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f96c384c-d369-459e-bc05-c86d90dbab3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e85bf44f-68dd-4d91-ae06-8b0f1cf941fb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f96c384c-d369-459e-bc05-c86d90dbab3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_f96c384c-d369-459e-bc05-c86d90dbab3a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_69e72a37-46f7-4652-a8f7-6b6ecbd26080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_69e72a37-46f7-4652-a8f7-6b6ecbd26080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b64d6ee8-00a6-41cc-b464-1b3ee0c2e8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b64d6ee8-00a6-41cc-b464-1b3ee0c2e8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_45d86cc1-b043-4acb-bcc5-6547860e8232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_45d86cc1-b043-4acb-bcc5-6547860e8232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims_b2f902bf-b9c7-4aa4-a6db-6c1a4e1df275" xlink:href="pcrx-20210930.xsd#pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims_b2f902bf-b9c7-4aa4-a6db-6c1a4e1df275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7eb56d32-bf3c-4a4a-8909-ce3c0ce035a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_10f14013-8523-41c1-a447-b9f800a8069a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7eb56d32-bf3c-4a4a-8909-ce3c0ce035a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4ebab26a-b543-4abb-8bda-ad1effa26a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4ebab26a-b543-4abb-8bda-ad1effa26a7d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_afafb961-a801-4f20-a5f5-f55c7aec545c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:to="loc_us-gaap_FinancialInstrumentAxis_afafb961-a801-4f20-a5f5-f55c7aec545c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_afafb961-a801-4f20-a5f5-f55c7aec545c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_874974c9-4b3f-472c-a5ae-30f140d01472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_874974c9-4b3f-472c-a5ae-30f140d01472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0bdd3ab3-a31c-4bc8-948e-88208cc83a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:to="loc_us-gaap_CommercialPaperMember_0bdd3ab3-a31c-4bc8-948e-88208cc83a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_c4618cd4-01be-4a53-abf4-1f3225b884f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_c4618cd4-01be-4a53-abf4-1f3225b884f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBondSecuritiesMember_b7328c3d-7f1e-429f-be3c-b98f18a887a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBondSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_690c0941-289b-4666-ab33-8472e420b77a" xlink:to="loc_us-gaap_USTreasuryBondSecuritiesMember_b7328c3d-7f1e-429f-be3c-b98f18a887a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:to="loc_us-gaap_InvestmentTypeAxis_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_879ba30f-851e-4959-bd9e-59249fb60518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_9c0e506f-6b5c-4a04-b7e4-1ead4aa2b2d3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_879ba30f-851e-4959-bd9e-59249fb60518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_5fd94322-543f-4a3a-b40f-a9870936db23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_879ba30f-851e-4959-bd9e-59249fb60518" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_5fd94322-543f-4a3a-b40f-a9870936db23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_LongTermInvestmentsMember_0eff8fed-f6f1-403c-9462-51778286468d" xlink:href="pcrx-20210930.xsd#pcrx_LongTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_879ba30f-851e-4959-bd9e-59249fb60518" xlink:to="loc_pcrx_LongTermInvestmentsMember_0eff8fed-f6f1-403c-9462-51778286468d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_ff5a3e59-73a7-4899-812a-8c5010eb0d89" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_141fe59d-4676-4d5b-88e5-fe29210bbe46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_141fe59d-4676-4d5b-88e5-fe29210bbe46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d57bb4d9-4e70-43e2-86ad-bc0e5e3330d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d57bb4d9-4e70-43e2-86ad-bc0e5e3330d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c75e699e-7111-4f47-83a2-116cdc475433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c75e699e-7111-4f47-83a2-116cdc475433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d28128fe-b18a-4367-82a4-01600ef41dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d085c87b-1c0f-4bd2-b6aa-67033511839e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d28128fe-b18a-4367-82a4-01600ef41dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_09b007be-a1c2-4707-bb5a-2a9a5116cde4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_3b6a0b82-50e4-4cfa-8952-82ab0be3e411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_09b007be-a1c2-4707-bb5a-2a9a5116cde4" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_3b6a0b82-50e4-4cfa-8952-82ab0be3e411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_bd5db2da-2f67-4770-9f42-61141ddcd82d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b910632c-f2f1-4bb9-ad2b-3313c6e2f16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_bd5db2da-2f67-4770-9f42-61141ddcd82d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b910632c-f2f1-4bb9-ad2b-3313c6e2f16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_850a8daa-e717-45a1-b368-55f172923ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_bd5db2da-2f67-4770-9f42-61141ddcd82d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_850a8daa-e717-45a1-b368-55f172923ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_b4c6b16f-f2bb-45ec-8299-765ac5549feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_bd5db2da-2f67-4770-9f42-61141ddcd82d" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_b4c6b16f-f2bb-45ec-8299-765ac5549feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7505f31b-57c0-4383-8d53-8f91f3eeb195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fa502519-7b51-48d4-9d5e-239d4e42cfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7505f31b-57c0-4383-8d53-8f91f3eeb195" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fa502519-7b51-48d4-9d5e-239d4e42cfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_45f9b481-7b66-4a88-95d9-6c0fc829845c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fa502519-7b51-48d4-9d5e-239d4e42cfe5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_45f9b481-7b66-4a88-95d9-6c0fc829845c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_45f9b481-7b66-4a88-95d9-6c0fc829845c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b9e1028b-6b70-4320-ba3c-52b0624092d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:to="loc_us-gaap_CostOfSalesMember_b9e1028b-6b70-4320-ba3c-52b0624092d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_dda9ef2f-88cc-459d-aabb-2389ec229275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_dda9ef2f-88cc-459d-aabb-2389ec229275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f952fe32-b2c3-4baa-88d8-b53558b56564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1e967217-cd32-493a-b0ed-d5e8e17834bb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f952fe32-b2c3-4baa-88d8-b53558b56564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0df9b7bb-ae9b-48a6-a86e-a60f518bbe70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fa502519-7b51-48d4-9d5e-239d4e42cfe5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0df9b7bb-ae9b-48a6-a86e-a60f518bbe70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f262d18c-a43f-4240-af4f-ab9bf432a612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0df9b7bb-ae9b-48a6-a86e-a60f518bbe70" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f262d18c-a43f-4240-af4f-ab9bf432a612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0df9b7bb-ae9b-48a6-a86e-a60f518bbe70" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_Compensationexpensefromstockoptionsemployees_80d2c2dd-ba19-49b3-a126-f632ac7cab2e" xlink:href="pcrx-20210930.xsd#pcrx_Compensationexpensefromstockoptionsemployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:to="loc_pcrx_Compensationexpensefromstockoptionsemployees_80d2c2dd-ba19-49b3-a126-f632ac7cab2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_e3344ab3-2d81-428f-8906-c8b91411418e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:to="loc_us-gaap_RestrictedStockExpense_e3344ab3-2d81-428f-8906-c8b91411418e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_b3e8a7ea-cee8-4df5-8bbb-2b5cbf66324a" xlink:href="pcrx-20210930.xsd#pcrx_CompensationExpenseFromEmployeeStockPurchasePlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:to="loc_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan_b3e8a7ea-cee8-4df5-8bbb-2b5cbf66324a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_08b0b10d-21aa-4803-9dd0-c2d9fe6d65ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_41d7fd02-3fd6-44f4-bf65-d52d66fd787e" xlink:to="loc_us-gaap_ShareBasedCompensation_08b0b10d-21aa-4803-9dd0-c2d9fe6d65ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSScheduleofStockBasedCompensationActivityDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_ebb3fb54-cca0-4843-9fc5-d8d6129ceb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0219072d-387f-42d3-8d97-9843280dbef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_ebb3fb54-cca0-4843-9fc5-d8d6129ceb48" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0219072d-387f-42d3-8d97-9843280dbef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f807d061-2588-4d03-af86-49b8aff50251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0219072d-387f-42d3-8d97-9843280dbef1" xlink:to="loc_us-gaap_AwardTypeAxis_f807d061-2588-4d03-af86-49b8aff50251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da0399cc-1a46-4916-911c-3cf14e1632f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f807d061-2588-4d03-af86-49b8aff50251" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da0399cc-1a46-4916-911c-3cf14e1632f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1dbf7e0a-20bb-42f7-9889-a6662173b21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da0399cc-1a46-4916-911c-3cf14e1632f5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1dbf7e0a-20bb-42f7-9889-a6662173b21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6048d486-7786-47f5-a479-991a53417be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0219072d-387f-42d3-8d97-9843280dbef1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6048d486-7786-47f5-a479-991a53417be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6048d486-7786-47f5-a479-991a53417be7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ee18b80a-2d76-470a-bbe6-1f8afc81eef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ee18b80a-2d76-470a-bbe6-1f8afc81eef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9292aefe-530a-4d65-8ff5-6e1ccb143102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9292aefe-530a-4d65-8ff5-6e1ccb143102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e7c6574-b86d-47ca-86a0-a598982719db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e7c6574-b86d-47ca-86a0-a598982719db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7c926722-4fde-4574-a651-f0bf72556f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7c926722-4fde-4574-a651-f0bf72556f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_6c047c8c-425e-4a32-b68f-44d9d78d853f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_6c047c8c-425e-4a32-b68f-44d9d78d853f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e8b0bf49-8105-4e56-a5f2-e0efe180ceb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f0d4affe-16c8-4729-bf07-6dded0851814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e8b0bf49-8105-4e56-a5f2-e0efe180ceb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6048d486-7786-47f5-a479-991a53417be7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20de216e-f196-4e87-9e29-f382a49f503b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20de216e-f196-4e87-9e29-f382a49f503b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aeed59a9-0ed3-46fe-ac99-dab31b925141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aeed59a9-0ed3-46fe-ac99-dab31b925141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_033aaa76-1cfc-4a7d-bab6-079855a515f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_033aaa76-1cfc-4a7d-bab6-079855a515f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7d7c2e7d-261b-40a7-99a6-4f6613734855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7d7c2e7d-261b-40a7-99a6-4f6613734855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_cfd86033-959c-4fd6-b942-fbd0d5a1e972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_cfd86033-959c-4fd6-b942-fbd0d5a1e972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_87595c5b-c707-4f56-b2d3-741b1b0966d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_87595c5b-c707-4f56-b2d3-741b1b0966d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06cf797a-aa1a-46ba-a537-7ca6f56e79fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_06cf797a-aa1a-46ba-a537-7ca6f56e79fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27ce9cc0-12d2-4914-ab86-1c8b6a88c95a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27ce9cc0-12d2-4914-ab86-1c8b6a88c95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a98865a9-f7d5-4a0a-a1bd-6086f054b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a98865a9-f7d5-4a0a-a1bd-6086f054b6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e6d05ce-345b-41ef-9466-7d9155727815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e6d05ce-345b-41ef-9466-7d9155727815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ef6d8851-1a82-43a2-aa5a-678715100c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0ecbc7bf-107f-477d-8710-e85b47d6a168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ef6d8851-1a82-43a2-aa5a-678715100c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_72ff3dd8-e3f4-49d0-b01d-12fd35422cf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b08cf649-5eaa-41de-9ea8-04aa15d8e14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b08cf649-5eaa-41de-9ea8-04aa15d8e14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72af06d1-959d-49a1-9f72-594e16a492e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72af06d1-959d-49a1-9f72-594e16a492e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89129e1c-0163-4d5d-a1c1-856aa1aeb01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89129e1c-0163-4d5d-a1c1-856aa1aeb01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_cc42989b-7bc2-4bc3-a1ed-fc45c1ee7e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_cc42989b-7bc2-4bc3-a1ed-fc45c1ee7e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2d37e907-4ae6-4e64-b665-a7de9a56c928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ecebd4d8-6a01-4606-a77a-df640d3e4960" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2d37e907-4ae6-4e64-b665-a7de9a56c928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9e7ba386-5c02-476c-911e-4218fbef3483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c6e0ba68-ef5e-429e-8fd3-da9159f13245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9e7ba386-5c02-476c-911e-4218fbef3483" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c6e0ba68-ef5e-429e-8fd3-da9159f13245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c6e0ba68-ef5e-429e-8fd3-da9159f13245" xlink:to="loc_us-gaap_AwardTypeAxis_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_765fea42-26f1-49cd-8c58-c43392908b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bedeeb96-aa07-4ac4-9a7f-2d0b9aa911b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_765fea42-26f1-49cd-8c58-c43392908b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b7ec4786-37e2-4e90-858f-09469aef86f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_765fea42-26f1-49cd-8c58-c43392908b58" xlink:to="loc_us-gaap_EmployeeStockMember_b7ec4786-37e2-4e90-858f-09469aef86f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c6e0ba68-ef5e-429e-8fd3-da9159f13245" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_a1058cbd-7c22-4da5-9657-f18c3c26d2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_a1058cbd-7c22-4da5-9657-f18c3c26d2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_be510af1-4bbb-4ddb-a0c8-7e78ccf65549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_be510af1-4bbb-4ddb-a0c8-7e78ccf65549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_cf50da75-3750-4b2f-9097-583809ad37ac" xlink:href="pcrx-20210930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_cf50da75-3750-4b2f-9097-583809ad37ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_d34df12d-ac9b-46c6-96e0-427a0e1a4453" xlink:href="pcrx-20210930.xsd#pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_d34df12d-ac9b-46c6-96e0-427a0e1a4453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4b8c5d57-5a59-41b7-b94d-1556af1f0a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4b8c5d57-5a59-41b7-b94d-1556af1f0a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bd17b918-0455-4d42-a89b-7477eb61f159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c38eac2-c56a-4d31-9f52-5867a703602f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bd17b918-0455-4d42-a89b-7477eb61f159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKPLANSScheduleofValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d61bd875-4732-422f-a8f3-a91f9fdde824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422956de-cbfc-4cce-aaa6-f0fd490fdac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d61bd875-4732-422f-a8f3-a91f9fdde824" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422956de-cbfc-4cce-aaa6-f0fd490fdac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_45de0e82-8df7-429c-801e-1ec29e604d69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422956de-cbfc-4cce-aaa6-f0fd490fdac1" xlink:to="loc_us-gaap_AwardTypeAxis_45de0e82-8df7-429c-801e-1ec29e604d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5071013-414d-4a43-be47-b0c53160ab22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_45de0e82-8df7-429c-801e-1ec29e604d69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5071013-414d-4a43-be47-b0c53160ab22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6713de92-144d-4493-ae1e-64605702a915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5071013-414d-4a43-be47-b0c53160ab22" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6713de92-144d-4493-ae1e-64605702a915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422956de-cbfc-4cce-aaa6-f0fd490fdac1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a139bd8d-dbbb-4675-8044-ae6df5d963cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a139bd8d-dbbb-4675-8044-ae6df5d963cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f3e206b9-26cb-47fa-8f4b-c998ae50247b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f3e206b9-26cb-47fa-8f4b-c998ae50247b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0b9791e7-a15f-4870-a08a-b4203a05bb35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0b9791e7-a15f-4870-a08a-b4203a05bb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_881580b2-7a02-4ec7-afab-40d63e9cf752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_df6b6e7c-6f76-403d-b426-f6cf37c31f60" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_881580b2-7a02-4ec7-afab-40d63e9cf752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c07b659b-23e5-41f0-a4c5-a517396178f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_170ed1fe-abab-46e9-8f52-148d539878db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c07b659b-23e5-41f0-a4c5-a517396178f3" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_170ed1fe-abab-46e9-8f52-148d539878db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_35245643-4bf5-4b6d-9943-13bed2875094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9550edff-a09a-47a2-b661-a2d1da70d95e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_35245643-4bf5-4b6d-9943-13bed2875094" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9550edff-a09a-47a2-b661-a2d1da70d95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#STOCKHOLDERSEQUITYDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5c7752bb-0904-410d-bf03-b0532df24bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f4f7001a-eb6a-4b5a-8d57-a4a6b9d9aace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5c7752bb-0904-410d-bf03-b0532df24bae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f4f7001a-eb6a-4b5a-8d57-a4a6b9d9aace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_df6916da-4544-4868-a9ea-2f8011c7f9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f4f7001a-eb6a-4b5a-8d57-a4a6b9d9aace" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_df6916da-4544-4868-a9ea-2f8011c7f9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_038224af-ed95-469d-ad11-3e804bb702b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_df6916da-4544-4868-a9ea-2f8011c7f9c7" xlink:to="loc_us-gaap_EquityComponentDomain_038224af-ed95-469d-ad11-3e804bb702b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0e118d02-05b4-4d45-b221-c9872703790b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_038224af-ed95-469d-ad11-3e804bb702b1" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0e118d02-05b4-4d45-b221-c9872703790b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_459467e9-03c5-411e-a73b-be122fca8b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f4f7001a-eb6a-4b5a-8d57-a4a6b9d9aace" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_459467e9-03c5-411e-a73b-be122fca8b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_459467e9-03c5-411e-a73b-be122fca8b2d" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a704eec2-2c9a-4500-b05d-01501e3da382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_StockholdersEquity_a704eec2-2c9a-4500-b05d-01501e3da382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9ff92b8b-6fb3-487d-9798-ba441617048f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9ff92b8b-6fb3-487d-9798-ba441617048f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6022bcdb-fa5a-4cd5-92b4-81a338e861b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6022bcdb-fa5a-4cd5-92b4-81a338e861b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_055e94d8-25f9-47d1-9237-c74a5fbd9118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_055e94d8-25f9-47d1-9237-c74a5fbd9118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a3c31703-6f5d-4eb2-8fef-7dd5a1d384be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c4bd5329-70f1-43f2-a90c-ddbe032d0552" xlink:to="loc_us-gaap_StockholdersEquity_a3c31703-6f5d-4eb2-8fef-7dd5a1d384be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_875b57a1-2921-48b3-bd04-957d85517372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_459467e9-03c5-411e-a73b-be122fca8b2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_875b57a1-2921-48b3-bd04-957d85517372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARE" xlink:type="simple" xlink:href="pcrx-20210930.xsd#NETINCOMELOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e5ad4a57-e7e3-4bea-b72b-3883a2604dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_19005c9d-63da-468d-b7b4-67eb71d4389c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e5ad4a57-e7e3-4bea-b72b-3883a2604dc7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_19005c9d-63da-468d-b7b4-67eb71d4389c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#NETINCOMELOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7c35dc3e-7b4e-403b-be5b-7ebf508b4c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a449334d-4280-418f-b540-bd47146d7c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c35dc3e-7b4e-403b-be5b-7ebf508b4c2c" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a449334d-4280-418f-b540-bd47146d7c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_26a43e5b-fe3f-4b30-be29-7c61cf22c161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c35dc3e-7b4e-403b-be5b-7ebf508b4c2c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_26a43e5b-fe3f-4b30-be29-7c61cf22c161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dd794091-64dd-494c-a045-f3271c17a30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cac72023-6c36-433f-8507-3d0a46c8a06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dd794091-64dd-494c-a045-f3271c17a30a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cac72023-6c36-433f-8507-3d0a46c8a06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_27534751-c9ff-4903-9d7e-8aca4a0cd172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cac72023-6c36-433f-8507-3d0a46c8a06a" xlink:to="loc_us-gaap_AwardTypeAxis_27534751-c9ff-4903-9d7e-8aca4a0cd172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_27534751-c9ff-4903-9d7e-8aca4a0cd172" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_daae9342-ad75-4710-8976-6f55297bc18c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_daae9342-ad75-4710-8976-6f55297bc18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a7f7cc1f-90bc-40d8-81ef-0fbdd5b38456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a7f7cc1f-90bc-40d8-81ef-0fbdd5b38456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_1cd359ca-e595-4788-9ae5-552ffbb050fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d207578-a4ab-4e19-b887-0b8e9af7868c" xlink:to="loc_us-gaap_EmployeeStockMember_1cd359ca-e595-4788-9ae5-552ffbb050fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cac72023-6c36-433f-8507-3d0a46c8a06a" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_6420501c-9df9-4603-86db-f6f640c0d9db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_6420501c-9df9-4603-86db-f6f640c0d9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4f865cef-a6d0-4fa5-b6ab-97f36ba5f5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_6420501c-9df9-4603-86db-f6f640c0d9db" xlink:to="loc_us-gaap_NetIncomeLoss_4f865cef-a6d0-4fa5-b6ab-97f36ba5f5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_094cc4dd-6713-46f2-9d90-68f81a71145d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_094cc4dd-6713-46f2-9d90-68f81a71145d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b838fc0-a690-4d2a-be3c-db82114added" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_094cc4dd-6713-46f2-9d90-68f81a71145d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b838fc0-a690-4d2a-be3c-db82114added" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e008a1c-935d-406d-a58f-1c4f0e1562bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e008a1c-935d-406d-a58f-1c4f0e1562bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2a156809-1bef-4ba0-890d-a98e775880a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2a156809-1bef-4ba0-890d-a98e775880a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c4fa6307-8018-4a70-bf11-4443c2f1dd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_bb2e6608-573f-4033-b210-60c0d1153146" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c4fa6307-8018-4a70-bf11-4443c2f1dd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_93b7e428-1032-4ca0-9fd2-25ab42fb4954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_c06c1689-5ea9-4123-b480-e55c8468f773" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_93b7e428-1032-4ca0-9fd2-25ab42fb4954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c80c47a7-7fb5-4874-8e98-2d7917f39cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_93b7e428-1032-4ca0-9fd2-25ab42fb4954" xlink:to="loc_us-gaap_EarningsPerShareBasic_c80c47a7-7fb5-4874-8e98-2d7917f39cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_832bbb57-82b8-43e3-bd4c-5756766662eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_93b7e428-1032-4ca0-9fd2-25ab42fb4954" xlink:to="loc_us-gaap_EarningsPerShareDiluted_832bbb57-82b8-43e3-bd4c-5756766662eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_23c1b6ca-d58c-4ca1-b86d-bec126c90987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_004f1157-ed16-46be-9507-e2597ce3f0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_23c1b6ca-d58c-4ca1-b86d-bec126c90987" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_004f1157-ed16-46be-9507-e2597ce3f0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_004f1157-ed16-46be-9507-e2597ce3f0e7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9fbf7c90-fbd0-4d39-ba9d-e27da9e0b280" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e7612e95-e70e-41e8-b097-cbbe4a6d1062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e7612e95-e70e-41e8-b097-cbbe4a6d1062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4ab6588e-86fc-4131-8be8-e0e2011205c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4ab6588e-86fc-4131-8be8-e0e2011205c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_699cb5a5-3fa1-4ae0-81bc-3950dca66521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ff84c36f-927c-4a2b-9f8c-323628c6a45b" xlink:to="loc_us-gaap_EmployeeStockMember_699cb5a5-3fa1-4ae0-81bc-3950dca66521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22370af2-bcf9-46cd-be53-629183f29f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_004f1157-ed16-46be-9507-e2597ce3f0e7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22370af2-bcf9-46cd-be53-629183f29f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ffe9b301-c34f-4301-86d6-747c383a5372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_22370af2-bcf9-46cd-be53-629183f29f6a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ffe9b301-c34f-4301-86d6-747c383a5372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXES" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_60d86099-bcf1-4c2c-b6bd-e805a264204a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b640b344-9b64-4ad1-b713-a4c1f0008e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_60d86099-bcf1-4c2c-b6bd-e805a264204a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b640b344-9b64-4ad1-b713-a4c1f0008e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_407314a5-09f6-4c91-a24d-8b124d59723f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_dc70b593-986a-4156-a181-6d579c7e7b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_407314a5-09f6-4c91-a24d-8b124d59723f" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_dc70b593-986a-4156-a181-6d579c7e7b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5cb709ec-85ab-451a-b9f2-9dc92f8b4eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1f567648-f737-4ea3-a44b-6517aa27df17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5cb709ec-85ab-451a-b9f2-9dc92f8b4eb6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1f567648-f737-4ea3-a44b-6517aa27df17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a6464825-6424-4445-96e1-90d52923a837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1f567648-f737-4ea3-a44b-6517aa27df17" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a6464825-6424-4445-96e1-90d52923a837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8e966c64-67df-4872-b70e-d304530b8471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1f567648-f737-4ea3-a44b-6517aa27df17" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8e966c64-67df-4872-b70e-d304530b8471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d50cfd0e-d9f7-42c2-af26-f8c90b643b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1f567648-f737-4ea3-a44b-6517aa27df17" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d50cfd0e-d9f7-42c2-af26-f8c90b643b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0acdb4c7-d6a2-4de2-b2a0-790c49ae56f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a79b61d5-48c8-43e6-b833-f2d83ac383f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0acdb4c7-d6a2-4de2-b2a0-790c49ae56f9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a79b61d5-48c8-43e6-b833-f2d83ac383f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_554fe493-5a62-49ee-a3d9-3f4affa4c9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0acdb4c7-d6a2-4de2-b2a0-790c49ae56f9" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_554fe493-5a62-49ee-a3d9-3f4affa4c9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMERCIALPARTNERS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#COMMERCIALPARTNERS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/COMMERCIALPARTNERS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReorganizationsAbstract_32605f6a-d683-4f32-9dea-d0a43a200f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReorganizationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CommercialPartnersAndAgreementsTextBlock_65dfa5b6-03ed-45fe-ba7b-2a5cea5ff5c9" xlink:href="pcrx-20210930.xsd#pcrx_CommercialPartnersAndAgreementsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReorganizationsAbstract_32605f6a-d683-4f32-9dea-d0a43a200f46" xlink:to="loc_pcrx_CommercialPartnersAndAgreementsTextBlock_65dfa5b6-03ed-45fe-ba7b-2a5cea5ff5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMERCIALPARTNERSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#COMMERCIALPARTNERSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/COMMERCIALPARTNERSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReorganizationsAbstract_518cdac2-5282-49cb-91ed-61671e1bd152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReorganizationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FreshStartAdjustmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReorganizationsAbstract_518cdac2-5282-49cb-91ed-61671e1bd152" xlink:to="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_52e098e5-bd0f-4201-a5d9-60a447ec7ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:to="loc_us-gaap_TypeOfArrangementAxis_52e098e5-bd0f-4201-a5d9-60a447ec7ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c7e8a204-37e3-44d3-9206-fd93f2a29b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_52e098e5-bd0f-4201-a5d9-60a447ec7ac0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c7e8a204-37e3-44d3-9206-fd93f2a29b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_EurofarmaLabatoriesSAMember_7fc3102b-c95e-46ed-ab8f-c3e7b8540c11" xlink:href="pcrx-20210930.xsd#pcrx_EurofarmaLabatoriesSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c7e8a204-37e3-44d3-9206-fd93f2a29b36" xlink:to="loc_pcrx_EurofarmaLabatoriesSAMember_7fc3102b-c95e-46ed-ab8f-c3e7b8540c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_NuanceBiotechCo.Ltd.Member_30e62c9a-944e-43c0-a952-9bbc0809aeae" xlink:href="pcrx-20210930.xsd#pcrx_NuanceBiotechCo.Ltd.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c7e8a204-37e3-44d3-9206-fd93f2a29b36" xlink:to="loc_pcrx_NuanceBiotechCo.Ltd.Member_30e62c9a-944e-43c0-a952-9bbc0809aeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneAxis_c735c166-7cf4-4032-9f43-08afc760d19f" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:to="loc_pcrx_AchievementOfMilestoneAxis_c735c166-7cf4-4032-9f43-08afc760d19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfMilestoneDomain_efdaa5f5-2ae5-47a4-bc1a-b037648b40b0" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_AchievementOfMilestoneAxis_c735c166-7cf4-4032-9f43-08afc760d19f" xlink:to="loc_pcrx_AchievementOfMilestoneDomain_efdaa5f5-2ae5-47a4-bc1a-b037648b40b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember_9be914d7-3346-46f3-b461-1a2932702ffb" xlink:href="pcrx-20210930.xsd#pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pcrx_AchievementOfMilestoneDomain_efdaa5f5-2ae5-47a4-bc1a-b037648b40b0" xlink:to="loc_pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember_9be914d7-3346-46f3-b461-1a2932702ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FreshStartAdjustmentsTable_be445eae-94cc-45c9-b3e7-fbbe43b14a46" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementUpfrontPayment_74ca62c9-6b76-47f6-8482-1803f37eeec1" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeArrangementUpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:to="loc_pcrx_CollaborativeArrangementUpfrontPayment_74ca62c9-6b76-47f6-8482-1803f37eeec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_CollaborativeArrangementMilestonePaymentsReceived_cf468c66-6b70-41f8-9d9a-29b3a7d63aa7" xlink:href="pcrx-20210930.xsd#pcrx_CollaborativeArrangementMilestonePaymentsReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:to="loc_pcrx_CollaborativeArrangementMilestonePaymentsReceived_cf468c66-6b70-41f8-9d9a-29b3a7d63aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_1f1e6934-b0a4-4ff9-a327-87820e44cb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_cfacf774-6638-4d05-91d0-983c55c70036" xlink:to="loc_us-gaap_LitigationSettlementExpense_1f1e6934-b0a4-4ff9-a327-87820e44cb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="pcrx-20210930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_efd8e56e-b25c-4267-942b-6326bce19558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_11d5d025-ad32-42e8-95a1-d0ee1a50cfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_efd8e56e-b25c-4267-942b-6326bce19558" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_11d5d025-ad32-42e8-95a1-d0ee1a50cfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fbc8d44d-c3ac-462b-93d9-886cad22850f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fbc8d44d-c3ac-462b-93d9-886cad22850f" xlink:to="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b1a251ad-9da5-4df9-a5e5-1e817b38a261" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:to="loc_srt_CounterpartyNameAxis_b1a251ad-9da5-4df9-a5e5-1e817b38a261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef2fac06-001a-4603-90d3-e023924c2ca0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b1a251ad-9da5-4df9-a5e5-1e817b38a261" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef2fac06-001a-4603-90d3-e023924c2ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FortisMember_f61a328e-6e18-44a9-8926-e0feba9c41d3" xlink:href="pcrx-20210930.xsd#pcrx_FortisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef2fac06-001a-4603-90d3-e023924c2ca0" xlink:to="loc_pcrx_FortisMember_f61a328e-6e18-44a9-8926-e0feba9c41d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_11d9c57a-856b-4861-a118-932d360e1984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_11d9c57a-856b-4861-a118-932d360e1984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5757c746-cc72-454a-bdc9-c780e6f245d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_11d9c57a-856b-4861-a118-932d360e1984" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5757c746-cc72-454a-bdc9-c780e6f245d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember_375f541c-7a24-49d9-93f9-336912faf737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_5757c746-cc72-454a-bdc9-c780e6f245d4" xlink:to="loc_us-gaap_OneTimeTerminationBenefitsMember_375f541c-7a24-49d9-93f9-336912faf737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_696f6772-da10-4b86-891c-d324702b97ac" xlink:to="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_d7358651-e476-4a8e-9cb6-0ff3fe635011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_d7358651-e476-4a8e-9cb6-0ff3fe635011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_c601d18d-426a-46ca-9f35-6f787ee25d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_c601d18d-426a-46ca-9f35-6f787ee25d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ee8b5fc7-dc67-401d-9f8a-652bb3933c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9c761c7-72c5-43dd-8e58-fea1681e3f1b" xlink:to="loc_us-gaap_RestructuringCharges_ee8b5fc7-dc67-401d-9f8a-652bb3933c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1ef8f7f8-ee19-43b3-86b9-138244694889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_ccc449ae-2232-483a-ad6f-4f9956078088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1ef8f7f8-ee19-43b3-86b9-138244694889" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_ccc449ae-2232-483a-ad6f-4f9956078088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.pacira.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="pcrx-20210930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://www.pacira.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_7867c731-986e-4b5d-bcb4-e2585597ecc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_7867c731-986e-4b5d-bcb4-e2585597ecc8" xlink:to="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_76daa3e6-6633-4467-9a37-e2d45b44ba05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_76daa3e6-6633-4467-9a37-e2d45b44ba05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cb3e2159-2422-418b-8181-82cffb983974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_76daa3e6-6633-4467-9a37-e2d45b44ba05" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cb3e2159-2422-418b-8181-82cffb983974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dcae1e35-0d1e-49be-a953-adcd2e1a3137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cb3e2159-2422-418b-8181-82cffb983974" xlink:to="loc_us-gaap_SubsequentEventMember_dcae1e35-0d1e-49be-a953-adcd2e1a3137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_476d6c0b-1265-4ccb-8900-e8df410a12a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_476d6c0b-1265-4ccb-8900-e8df410a12a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab045dec-949c-40cc-ad40-fbedd37f8c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_476d6c0b-1265-4ccb-8900-e8df410a12a5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab045dec-949c-40cc-ad40-fbedd37f8c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_FlexionMember_ad1abd1a-7484-4751-ba22-2bedb8c18db4" xlink:href="pcrx-20210930.xsd#pcrx_FlexionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab045dec-949c-40cc-ad40-fbedd37f8c48" xlink:to="loc_pcrx_FlexionMember_ad1abd1a-7484-4751-ba22-2bedb8c18db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_14c50591-552b-43f0-8ea5-2fb04ac287ac" xlink:to="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_48802a9e-7e20-44d1-8bc0-a955a0e344c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_48802a9e-7e20-44d1-8bc0-a955a0e344c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_c9abb45b-d532-46d3-a3a0-995eb11666a0" xlink:href="pcrx-20210930.xsd#pcrx_ClassOfWarrantOrRightNumberOfRightsIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued_c9abb45b-d532-46d3-a3a0-995eb11666a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_40c52924-229c-45f2-930c-6c3e1111fb42" xlink:href="pcrx-20210930.xsd#pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice_40c52924-229c-45f2-930c-6c3e1111fb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_ead70ebb-6b25-40dc-a356-d09e5cef34d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_ead70ebb-6b25-40dc-a356-d09e5cef34d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_402f194c-f37c-4838-a4b9-2aede36fd249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_402f194c-f37c-4838-a4b9-2aede36fd249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage_61d7a2b9-2191-4592-b051-f9fbf308576a" xlink:href="pcrx-20210930.xsd#pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_68f5f522-4e5d-46a0-afe4-de327b071903" xlink:to="loc_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage_61d7a2b9-2191-4592-b051-f9fbf308576a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>pcrx-20210930_g1.jpg
<DESCRIPTION>PACIRA BIOSCIENCES LOGO
<TEXT>
begin 644 pcrx-20210930_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !     %$2  0    !
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" #% ?0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ^P^&.GV8_>-/.?]IMH_2M6U\-V-G_J[6'\5W?SHYBCD;,9-:UG;R''[M_\
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MN7^1\RLXHK;#P^[_ (!_,GXJ_P""DW[<_@<-<ZWXR^+NCHO+->Z,UO&OUWP
M55\$_P#!?[]K+P3>+(/BI-JT0ZP:EH]A<(_U)A#C\&%?T[$9%> _M7?\$O\
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MMX=OI'@666TEMI(Y4P)(V210=RDX)&5ST)KT:O&O^">/P.A_9N_8;^%?@N*
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MH'_]EK^6FOZL/^"P%I]M_P""8?QO3^[X5NI/^^0&_I7\I]?LGAO+_8:J_O\
MZ(^VX7?^SS7G^B/V\_X-'-/\OX;_ !NNL?Z[4M)BS_N171_]GK]A*_)3_@TJ
MM-G[.OQ;N/\ GIXCM(\_[MMG_P!FK]:Z^!XQE?.*[\U_Z2CY[.W?&U/E^2"O
MB/\ X.)=*;4_^"2/Q*91DVEQI,_T U.U!_\ 0J^W*^0_^"\MI]M_X)*_&-/[
MMC8R?]\ZC:-_2O.R.5LRP[_OP_\ 2D<V7NV*IO\ O+\S^7NOWB_X-,=/\O\
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M,-T/<H>#['FG:^Q.VY]]33);0M)(RQQQ@LS,<*H'4DU_+G^W[\==8_X*M?\
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M5C1%R=N:]HK\BXBS)8_,*F)A\+=EZ)67W[_,^,S/%+$8F56.W3T6@445YO\
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M%OO^44_QH_[ T?\ Z505YV3_ ._T/\<?_2D<N!_WBG_B7YG\M5?T*?\ !JW
M(_\ @G+XB?O)X\OB?PLK 5_/77]#'_!K!_RC=US_ +'J_P#_ $DL:_8./_\
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M@XK[4_X+^_\ !$B$V.L?'CX/:*L+P*UYXQ\/6,.U'4<OJ-O&HX(&3,BC!&9
M 1(6_%JN3(\/DN/H+$X:A"_5.*;3[?Y/J8Y?3P.(IJK2IQ\U9:,^VO!/_!)[
M]L3_ (*":Q8^*M:T/Q+JT&L0)=P>(O&&N!8Y()0'1T,TC2M&RL&'EHPQTK[L
M_9 _X-3_  SX5O;35OC7XVF\4RQ,'?0?#P>TL7_V9+IL3.I_V%B/ ^:O+?\
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M?B)X-TVW6W\/B_\ [4T,1_ZK[!=J+B%8S_$L8D\K/K$:V?\ @CK^V5_PP_\
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M?$\:Y7]3S*4XKW:GO+U>Z^_7T:/"SW">PQ3:VEJOU_$*_EY_X+L?!Z;X,_\
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MJRODW_@NA<?9O^"3_P 9F]=+MD_[ZOK8?UKS<G_Y&%#_ !Q_]*1RX'_>*?\
MB7YG\N-?T,?\&L!S_P $WM<_['N__P#2.QK^>>OZ#O\ @U4O/._X)W>*(O\
MGCX\O0?QL; U^P<?_P#(I?\ BC^I]IQ%_N?S1^F3#<,'D'@@]Z_GQ_X. /\
M@C\/V0?'$WQ<^'6F;/ACXHO,:E86T?[OPO?2'A0H^[:RL3L_AC<^7\H,0/\
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M30+ZS6\\.^'[C_A)=;1TW1FULV60(X[K).8(C[2U_4J!@5^3_P#P:I?LJ_\
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MV2_C?X@^'_C73SI_B'PY<F"=02T4ZD;HYHF(&Z*1"KJV!E6' .0/[!J^!/\
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M_/!I5NX;![CSIPB@]"L$RGK7ZB7]_!I5C-=74T5O;6T;2S2RN$2)%&69B>
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M^33?Z?J?KYKG[;_P7\,V+7.H?%SX96=N@R7F\3V2#]9*^;_VA_\ @X:_9C^
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MJ\%\UOZ;UC8E<^X&:[JG4ISA+EFFGV>A4HN+M)6"BBFRRK#&SNRJB@LS,<
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M[V>[  &Z::5&DE<X&7=BWO7MFG:?;Z1I\%I:PQ6]K:QK##%$H5(D4855 X
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>pcrx-20210930_g2.jpg
<DESCRIPTION>PRODUCT PIPELINE
<TEXT>
begin 644 pcrx-20210930_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%D86T@1V]L
M9&)E<F<   60 P "    %   $*:0!  "    %   $+J2D0 "     S(V  "2
MD@ "     S(V  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M1*&4E>/4X_6D\+:KJ4UY<6&MS"6X$,=S$0@7Y&49& !T)Q5<ZT'S(Z:I(?\
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M,<C28/S0?,OR\%26(&"2!G!->DV-Q<3:;#/J-L+*X:,-- 90XB..5W#@X]:
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M6=IVA:;I-[?7=A;"*XU"7S;F0NS-(WXDX')P!@#TH T:*** "BBB@#4HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J5Y_KA_NU=JG=J3,,
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MS&VX) .<YQVQSU?V:?\ YXR?]\&C[-/_ ,\9/^^#2L@T(ZENO^13U'_>B_\
M0J3[-/\ \\9/^^#4MS;SGPOJ""&0NS1X7:<GYJ=]@.,HJQ]@O/\ GTG_ ._9
MH^P7G_/I/_W[-=%T:E>BK'V"\_Y])_\ OV:/L%Y_SZ3_ /?LT70%>BK'V"\_
MY])_^_9H^P7G_/I/_P!^S1= 5ZDA_P!?'_O#^=2?8+S_ )])_P#OV:?#87@F
M3-I/]X?\LSZT70'G_P 5O^2GZQ_O1_\ HI*Y"N[^)^D:E<_$G5IK;3[J:)FC
MVO' S*?W2="!7*?V#K'_ $"K[_P&?_"N^C)>SCKT1U4VN1&?16A_8.L?] J^
M_P# 9_\ "C^P=8_Z!5]_X#/_ (5KS+N7=&?16A_8.L?] J^_\!G_ ,*/[!UC
M_H%7W_@,_P#A1S+N%T9]%:']@ZQ_T"K[_P !G_PH_L'6/^@5??\ @,_^%',N
MX71ZM\"_^03KO_76'^35ZA7F_P %+"\LM*UM;RTGMR\D.T2QE=W#=,UZ3L;^
MZ?RKP,5K6D>97_B,2BEV-_=/Y4;&_NG\JYC$2BEV-_=/Y4;&_NG\J $HI=C?
MW3^5&QO[I_*@!**78W]T_E1L;^Z?RH 2BEV-_=/Y4;&_NG\J $HI=C?W3^5&
MQO[I_*@!**78W]T_E1L;^Z?RH 2BEV-_=/Y4;&_NG\J $HI=C?W3^5&QO[I_
M*@!**78W]T_E1L;^Z?RH 2BEV-_=/Y4;&_NG\J $HI=C?W3^5&QO[I_*@!**
M78W]T_E1L;^Z?RH 2BEV-_=/Y4;&_NG\J $HI=C?W3^5&QO[I_*@!**78W]T
M_E1L;^Z?RH 2BEV-_=/Y4;&_NG\J $HI=C?W3^5&QO[I_*@#SKXX:SJ>D_V'
M_96HW=EYOVCS/LT[1[\>7C.TC.,G\Z;\9?$VLZ!J6EQZ-J,UFLL3LXC(^8@C
M%5/V@/\ F7_^WG_VE57X^_\ (6T;_KA)_P"A"O4H1BU2NOYCMII/DOYG%?\
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M_9?SK,%.'2ERKL*R-,:[JG_/[+^=.77M4!S]LD_'%9HIPI<J[!9&B-<U,_\
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ML,US'=[B_P!H1F$FX]3NZYYZUG.@YVN[6VMW(E3<OD>M_!W3;G0_$7B?3[Y
M)[6-$<$<'!;!^A'/T-<9=_$#7-=TU?#VG6>G:9;7<@C-OIMOY(E+'&TY)ZDC
M.,9K 36]>CO)[N/4]22YN %FF6XD#R@# #-G)P/6J,/VFWGCFM_-BEC8.DB9
M5E8'(((Z$'O5*BN=SEJ]!JG[SDSV7QW<>%=%L]$\+ZW-K0.FVZ2H=,\H MC:
M&8OSN^4GC'WORC^)$%MK]CX6\7Z8KF*2:.&0LHW[2V5W8X&"&!]VKR*\GO\
M4;IKG4);FZG; :6=F=CCIDGFI5U+5UTY;!;R^%FK;EMA*_E@YSD+G&<\_6HC
MAW'E:>J_7<2I6L[GN_BGQS>>&_BII.F2S+_9%W;)YT;(/D=Y'7>&ZC&%SSC
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ME>^$-4\V#,MI*0+BV)X<>H]&'8UG4P$5&\'J3/#*WN[GTS]HE_O?H*/M$O\
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M:IKVGZ/)''>R2^;*K.L4%O).Y5<9;;&I(49')&.10!K_ &F7^_\ H*/M,O\
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MTD>XNEUB."0NJH?*%RPVH%S]T_2O;SI.G-/=3-86IEO%"7,AA7=.H& './F
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M\U[J-&TL074(TVS\J\<R7,?D+MG<]6<8^8GU-5HO"OAZ&SFM(=!TR.VG*M+
MEG&$D*_=++C!QVSTH \OO=2U[P9XA\3Z7;:[J.JF+0/[0BDOG$ABEWJI91C
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M% &I1110 4457L]0L]121M/NX+I8I#%(8)0X1QU4X/!&1QUH L4444 %%%%
M!1110 4444 %%%% !114$=_:2WTME%=0/=0J&E@60%XP>A9>H![9H GHHHH
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M<TNYE_\ ")>%O^A>TW_P"B_PH_X1+PM_T+VF_P#@%%_A6H:2CGEW#FEW,O\
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MH:CJ-KI5A)>7\AC@C(#,$+')(4 !02220  ,DFI;>=+JWCGC$BI(H8"2-HV
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MD$E\OG./.88P?O?+T'W<4Z+PEH<-U>7"6"^;>VJV=P6=F$D*KM"$$XQCCUH
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MI^H^,?$7C+Q19:?KT5G::3.T4,1LXW9R\9"#<1P%8;N<YZ'BLW0_B+K>M_\
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M*G[XR00>0&P>&YETG6--TF'PK<IK.S27LITN)9KYI(O/V0E49F8@$!7PO;D
M5Z)10!YOH,UUK5[X=AO-0U$0S6E_+*BW,D32%+A FX@AN ?8]NF06Z;J&IW'
MBH+=:I9VFHKJCK-:W&L2*[P!B%C6S*;.8]C*P))X;/)%>E44 <7X[OET^ZM+
MF744,443EM*34GLY[DDKAHS&0TC#!4(>#NZ@UF2QRV/C#7_$UG'(9+"\A6[A
M4?-+:M:P^8,=V3 <?[I'>O1Z* /+_".J:?I$GAN75KZVL8W\-A5>YF6,,?,4
MX!8CG%+%),=.M](L--N+BRU#5I;V&SA5$86,;J_"N5"HTA7 )&5;CKBO3Z*
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MHG_/7]*38G_/4?E3#24 /\M/^>H_*CRT_P">H_*HZ* )/+C_ .>H_*D\N/\
MYZC_ +YIAI* )/+C_P">P_[YH\N/_GL/^^:BHH D\J/_ )[#_OFCRH_^>P_[
MYJ*B@"PL:""0"4$$C)QTJ/RHO^>P_P"^:$_X]I?J*BH E\J+_GL/^^:/*B_Y
M[#_OFHJ* )?*B_Y[#_OFCRHO^>P_[YJ*B@"7RHO^>P_[YH\J+_GL/^^:BHH
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M1QVIO1:?:!J<+3<MM#_9Q\X7OD]O?BK][\/;P>)[S5/#_B6ZT:WU'R_MUI#
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M %&*** "BBB@ Q1110 48HHH **** #%%%!H 3%&*** %Q28HHH 7%)BBB@
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MDRQ)&0"<''S<<<@UJ^'OA]JFDZUX2O+BXLVCT73Y;6X$;L2[ONP4RHR.>^*
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M$[@$ )%N=\>B_.0* /7Z#10: $HHHH **** "BBB@ I#2TAH **** "BBB@
MI#2TAH **** "DI:2@!**** "@T4&@!**** "D-+2&@ HHHH #24II* "BBB
M@!**** $-%!HH *2EI* "D-+2&@!****  TE*:2@!****  TE*:2@!**** $
MHHHH D3_ (]I?J*BJ5/^/:7ZBHJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ I*6DH **** "BBB@ HHHH **** "BBB@ HHHH 3%&*,T9
MH ,48HS1F@ Q1BC-&: #%&#1FDR: #!HP?2C)HR: #!]*,'THR:,F@ P?2@@
M^E&302?6@!,'THP?2C)]:,GUH ,'THP?2C)]:,GUH 3!]#1M/I1D^IHR?4T
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M/*D_N-^5'FR?WV_.CS9/[[?G0 >5)_<;\J/*D_N-^5'FR?WV_.CS9/[[?G0
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M_C3O$>A7-U<?\]Y?^^S3#=W.?^/B7_OLU9.F7?\ SQ_\>'^-,.EWF?\ 4_\
MCP_QIWB&A6-Y<_\ /Q+_ -]FF&]NO^?F;_OX:LG2;W_GC_X^O^--.D7W_/#_
M ,?7_&G>([HK&]NO^?F;_OX:8;Z[_P"?J;_OX:LG1K__ )X?^/K_ (TTZ+J'
M_/O_ ./K_C3O$=T5#?WG_/W/_P!_#36U"\_Y^Y_^_AJT=#U'_GW_ /'U_P :
M:VA:C_S[_P#CZ_XT[P'>)3.H7O\ S]S_ /?UO\::VHWO_/Y<?]_6_P :MG0=
M2_Y]O_(B_P"-,/A_4S_R[?\ D1?\:=X>07B4SJ5]_P _MQ_W];_&F'4[_P#Y
M_;G_ +^M_C5T^'=4_P"?7_R(O^-,/AS5?^?7_P B+_C3O#R'>)1;5+__ )_K
MG_O\W^-,.JZA_P _]S_W^;_&KI\-ZL?^73_R(G^-,/AG5_\ GT_\BI_C3YH>
M0[Q*+:MJ/_/_ '7_ '^;_&HVU?4O^@A=?]_F_P :OGPOK!_Y<_\ R*G^-,;P
MKK)_Y<__ "*G^-/FI]T.\2@=7U+_ *"%U_W_ &_QJ-M8U/\ Z"-W_P!_V_QK
M0/A36O\ GR_\BI_C3#X2UL_\N7_D5/\ &GS4^Z"\3/.LZI_T$KS_ +_M_C43
M:UJN?^0G>?\ @0W^-:1\(:Y_SX_^1D_^*J-O!VND_P#'C_Y&3_XJJYJ?=#O
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M_P! W_R/'_\ %5&?A]XG/_,,_P#)B+_XJGS4NZ'S0\C);Q)KG_09U#_P*?\
MQJ)O$NN_]!K4?_ M_P#&M=OA[XH_Z!G_ ),1?_%5&WPZ\4GII?\ Y,1?_%4^
M:CW7X#YJ?D8K^)]>'36]2_\  N3_ !J%O%'B#'_(<U+_ ,"Y/\:VV^&_BL]-
M*_\ )B+_ .*J%OAIXM/32?\ R9B_^*JE.CW7X#YJ?=&(_BKQ".FO:G_X&2?X
MU _BSQ%G_D/ZI_X&2?XUN/\ #'Q>>FD?^3,/_P 743?"[Q@3_P @?_R:A_\
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M<*L2$&X(Y+':W&.@Y/3)=>*;'3(XEU<36UTT!GEMXH7N6@0<%F,2MM7.<,<
MX/H<1W6F:I9^))]6T5;2Y%Y D-Q;74S0X9"=KJZH_9F!7'H<]C5FTG7X=1NK
MVR&FSRZE:1PW*S2/&L,B;@&3"MO7#_=.W[O49P "[>^,-"T^9HKB])98%N6,
M,$DJK"V<2%D4@)P?FZ#C.,BE3Q?H<D%Y,MZ?*LH?M$KF&0 Q<_O$RO[Q/E.&
M3<#Z\BL>+P5<VECJ5G;7$3QSZ##I<#R$AMZ+(NYA@X!WCIGOQ3]9\)W^HVUQ
M'!-;J9="?31O9@/-)&&X'W>#SU]J +S^.O#T8DW7DV8T\QD%G,6\O!/FA=F3
M'P?W@^7ISR*MW_BG1]-E$=U=MDQ"9FAA>58XST=V12$4\_,Q X/H:J7&@74N
MK7MTLD(2?1UL5!8Y$@9SD\?=^8>_7BL23P/?1NC;(KY)M/@M;F$ZM<V:[HTV
MG_5*1(K ]& (_'  .I_X2/2_[6DTQ;AFNH@&E5(798@5W!G<#:H(Z$D \@<@
MU3?QCILEB]Q8R[PK0X-S%- KI+($5T)C.\$G@J"O(R0#FH[?PPZ_V]"[QPVV
MIP1P1"-B[1*L/EG.0,^WK5:?1=?U#PRFE7HTV$P-:;&AED;S/*E1V8Y0;,JG
M"X;D_>H V!XDTLZLNF_:'^T/(8D)@D\MI "2@EV["P .5!SP1VJ/P_K3:CX:
M&J:B88-KSB1ERJ*L<KKGDGLN3^-84GA76[CQ1;WUU<QRP6^I-=K(]_,<Q88)
M&+?;Y:E0P&X$DXSW-;6BZ/<:7X3?3KB.VNILW#>6S'RI-\CL%8E20"& /RGO
MP: *>I^,[>#3;*_LA*+::^B@D>ZLYHB4<$Y0,JECP,8!].:NKXGLK@6;63JZ
MW%Z;)EG66&1) C.5V%,AL+G#;1CG/0'&M/"FJI#;QR20P6]OJ4%S#9_;);E8
M(HUPP61U#<GHN HQP>:L-X7OFUXWGG0>3_;:ZB%W-GRQ:F$C&/O;L'TQW[4
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M (J*E^TOZ+^5'VE_1?RH BHJ7[2_HOY4?:7]%_*@"*BI?M+^B_E1]I?T7\J
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M44 %(:6D- !1110 &DI324 %%%% "4444 (:*#10 4E+24 %(:6D- "4444
M!I*4TE "4444 !I*4TE "4444 )1110!(G_'M+]1452I_P >TOU%14 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 :E%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24N:3(H **3<*-ZT +
M12>8M)YB>M #J*;YJ>M)YT?K^E #Z*9Y\?\ >_0TGVB+^]^AIV8$E%1_:8O[
MWZ&D^TP_WOT-%F!+0:A^UP_W_P!#0;R#^_\ H:+,"6BH?MMO_?\ T-)]NM_[
M_P"AHLQV9/14'V^V_O\ _CII/[0M?^>G_CI_PHLPLRQ15;^T;3_GI_XZ?\*/
M[2M/^>G_ (Z?\*.5]@LRS2&JW]J6?_/7_P =/^%-.JV7_/7_ ,=;_"CE?8+,
MMT53_M>Q_P">O_CK?X4?VQ8?\]O_ !UO\*?++L%F7**I?VSI_P#SV_\ '&_P
MI/[;T_\ Y[?^.-_A1RR[!9EZD-4?[=T[_GO_ ..-_A2'7M-'_+?_ ,<;_"CE
MEV"S+]%9_P#;^F#_ );_ /CC?X4G_"0Z6.MQ_P".-_A1R2[!RLT:2L[_ (2/
M2O\ GX_\AM_A2?\ "2:3_P _/_D-_P#"CDEV#E?8T:*S3XFT@?\ +S_Y#?\
MPI/^$GT?_GY_\AO_ (4<DNP<K[&G0:R_^$JT8?\ +U_Y#?\ PII\5Z*.MU_Y
M#?\ PI\DNP^678U:*R?^$MT0?\O7_D)_\*3_ (2_0A_R]_\ D)__ (FCDGV#
MEEV->D-9'_"8Z#_S]_\ D)__ (FFGQEH ZWG_D*3_P")H]G/L'++L;-%8O\
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M#S?_ !%'LJG\K^X.2?8Z>D-<N?BCX.'74_\ R7F_^(II^*G@P==4'_@/-_\
M$4_8U/Y7]P>SGV9U-%<J?BOX*'75/_):;_XBD_X6QX)_Z"G_ )+3?_$4>QJ_
MRO[@]G/LSJS25RO_  MCP3_T%/\ R6F_^(I/^%K^"?\ H*#_ ,!IO_B*/8U?
MY7]P>SGV9U5%<K_PM?P3_P!!,?\ @--_\11_PM?P3_T$Q_X#3?\ Q%'L:O\
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M110 4444 %%%% !1110 4&B@T )1110 4444 %%%% !2&EI#0 4444 %%%%
M!2&EI#0 4444 %)2TE "4444 %!HH- "4444 %(:6D- !1110 &DI324 %%%
M% "4444 (:*#10 4E+24 %(:6D- "4444 !I*4TE "4444 !I*4TE "4444
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MOFPS8P0,ZMCX$AM=)T*.+4+JQU#2+7[.MW9E/G# >8"LB,I4L,_=R,"NLHH
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M,>] "44N/>C'O0 E%+CWHQ[T )2&G8]Z3'O0 E%+CW%&!ZT )24['N*,#UH
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M>"?6NL\E/^>RT>2G_/9: .>M/"6E1Z%8Z9J5G;:HEFA6-KNW1PI/7:"#M'8
M=  .U7$T'1X[Z.]CTJQ2[B4+'.ML@D0!=H ;&0 ./IQ6KY*?\]EH\E/^>RT
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MA;YI,>WI3/&_CVXO+#Q-HVAZ#<:C:VFFNM[J"3*BV_FQ$J0A&7 !R<'(P>*
M/3Z*\L\,:Z;+5_#EBJW\S+X,@NA"EV! ^!T\HKC><8W[NF!CO5S0_BO<:SK,
MNDG0(4OVM)9[.*#5H9_/= 2(W*\1$X[].XH ]'HKR/P]\4->L_AS=>(/$VDM
M=16]R(TN5N(U,^Z4JR[%7Y=@[D?-^M:__"57LWCKPO'K6F:CHTUU'>$VHU!3
M#L6/<&E15^<X' R-I]: /1:*XSPKX\O_ !3>PR1>&+NVT:Z\S[+J;3*P?9G[
MR 90'! )/)I/$OCR]T;Q<GAW2?#LVL7LMB+R,1W*Q<;V4@[AP %SGG)(&.]
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MKXGLOB#<ZI?7_F:8X7%O]H8\9EVC?]Z79NZ. #YG'^K6O0* "BBB@ I*6DH
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MUIJFGW&J^([C4[?2;9[?3;:2W5!;ADV$D@_-QC&?0<\5Z#10!YU!\*9K#0-
MM]*\12V6JZ&9Q#J"6JL'65V9E:)F([XZ_P#UG-\)T;0S&=>NO[;.HC4O[7\H
M;O/ P/W><;<=L_CCBO0Z* .#O/AM-K']D'Q'KTFK/8W,LUP9[8!;A9%53&%5
M@(U 7MGJ:WO!WAV?PKH"Z3+J3:A##(WV9GBV-%$?NQDY.['//'TXK>HH ***
M* "BBB@ I*6DQ0 448HQ0 448HQ0 448HQ0 448HQ0 448HQ0 4&C%&* $HH
MP:,&@ HHP:,&@ HHP:,&@ I#2X-&#0 E%+M-&TT )12[31M- "4AIVTTA4T
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M4 145+]FE_N_J*/LTO\ =_44 (G_ ![2_45%5E8)!!(I7DD8YJ/[-+_<_44
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M7^Y^HH^S2_W/U% $5%2_9I?[GZBC[-+_ '/U% $5%2_9I?[GZBC[-+_<_44
M145+]FE_N?J*/LTO]S]10!%14OV:7^Y^HH^S2_W/U% $5%2_9I?[GZBC[-+_
M '/U% $5%2_9I?[GZBC[-+_<_44 <I\2M0O;#^S/L-W/;;_-W>3*R;L;,9P>
M>IJC\469;[3]I(_=OT/N*E^*O_,*_P"VW_LE0_%+_C^T_P#ZYO\ S%>_A$OW
M#_Q'R&/E)RQ:;V]F<)YC_P!]OSJ_?:3J>FVEO<WT+Q17(S$Q<'=QGH#D=>]9
MU=?KFA2#0_#[0WMW<RWRHJQ7$NY(RRK@*,<#G%>K4J<DHKO_ )'@T:+JTYR2
M=U;\[?,Y+S'_ +[?G1YC_P!]OSKM)?#'ARPU2WTC4+^^:_F"@O"%$:,W0'(S
MS_G%%EX%@DU75-+N[B47-O$);5T("R*0>2",\' /-9?7*-KOUVZ=S?\ L[$.
M7*K7O;?9VO9G%^8_]]OSH\Q_[[?G70Z5X=MKCPMJ>KZC+-%]FRD*K@ OCH<C
MU*CC'>KS^&-%TBUL1XCO+M+J\Y"6X4+$/5B1VSS5RQ--/EW>WZF<<%6E%2T2
MM?5^=E]_0Y#S'_OM^='F/_?;\Z["V\$PCQI)H][/*T'D&:.2(A6(S@9R"/7\
MJ@U30_#6GW4%L-9E,B2E+M@FX( I/  ZY '4XS[4EBJ3DHQN]+[%/ 5XQ<I6
M5G;5I:G+>8_]]OSK4T_P]K6JVC75A:2RPJ2-^\#./3)Y_"MJV\-Z%K6F7\NA
M75\)[--Q%T%VN,$\8'?!_P *30_%>G6.EV$5];W;7&G/(T'DN DF_/WLGW]_
MZ5$Z\I1?LHZK=->1=+"0C-?6)6BUHT]];/H]M?R.3+R*Q#,P(."">E)YC_WV
M_.I+JX:[O)KAP%::1I"!T!)S4-=BVU/.>^C'>8_]]OSH\Q_[[?G3:*8KL=YC
M_P!]OSIWF/\ WV_.HZ=2"[)!(_\ ?;\Z42/_ 'V_.F"E%(M-D@D?^^WYTX2/
M_>;\ZC%.%0RTV2"1_P"^WYTX2/\ WV_.HQ3A2+39()'_ +S?G2B1_P"\WYTP
M4X5):;'B1_[S?G3@[_WF_.HQ3A4LM-C_ #'_ +S?G3@[?WC^=,IPJ66FQX=O
M[S?G2[V_O-^=,6G5):;'AV_O'\Z4._\ >;\Z:*45)2;'AV_O'\Z<';^\?SI@
MI14EW) [?WC^=.#M_>/YU&*<*DM#][?WC^=*';^\?SIE.%25<>';^\?SIP=O
M[Q_.HQ3A2+0\.W]X_G3@[8^\?SI@I1TJ2D/#-_>/YTX,W]X_G3!UIPJ2T.#M
M_>/YT[>W]X_G3!2BD4/#M_>/YTX,WJ?SI@IPJ2AP9O[Q_.G;F]3^=,%.I%H<
M&;U/YTNYL=3^=-%+VJ2D/#'U/YTH9O4_G312BD4AVYO4_G3@S>I_.F4X5):'
M;F]3^=*&/J?SIM**10_<?4_G2ACZG\Z:*45)0\,?4_G1N/J?SI!12*0\,?4_
MG2[CZG\Z:*6D4.W'U/YT[<?4_G3:6I*'!CZG\Z7)]3313J0T+D^II0Q]33:4
M4BAX)]32ACZG\Z:*44BD.!/J:4$^IIHI12*' GU-.!/K3!3A2*%R?4TN3GK2
M4O>D,<"?6ER?6FBEI#%!/J:7)]32"BD4/!/K0"?6D%**0Q<GUIP)IM**10N3
MZTN3ZTG:EI#%!/K2Y--%.I#%R?6E!/K3:44BAP-&:04HI#%R:7)I*6@8N3BE
MS2=J6D,4&C-(*6D,,T9HHH ,T9HHH ,T9HHH ,T9HHH ,T9HHH ,T9HHH ,T
M9HHH ,T9HHH ,T9HHH ,T9HHH ,T9HHH ,T9HHH ,T9HHH ,T9HHH Y#XJ_\
MPK_MM_[)4/Q2_P"/[3_^N;_S%6?BC#+-_9?E1N^/.SM4G'W*E^(>C:CJEY9-
MI]I)<+'&P8H.AR*][#2C&-!M_P Q\CC(3G/%J*O_  _R/-*[O6=9LHM%\*R0
MW$4\EGY4DL4;@LNU5R".QXQS7._\(CK_ /T"Y_R%'_"(Z_\ ] N?\A7HU'1J
M2BW-:>:]#QZ"Q5&,HQIOWK='T=SJ=0L](U7Q3!KL6NV,=L3'++%)+B3*XX"^
MX ^E5/\ A+()?B1%J,3[+(@6Q=AC*'^(YZ#<<_05@_\ "(Z__P! N?\ (4?\
M(CK_ /T"Y_R%8QI4+6E4OI9:K8ZI5\4Y<T*33YN9Z/5_Y'2^.-3TZ'0X=,T>
MZBG6>X>>4PR*X&26P<>[<?[M:=SXBDU73[.?1/$-EID@3$\%V4!!]MP)XY^M
M</\ \(CK_P#T"Y_R%'_"(Z__ - N?\A4>PP_)%<ZNK[V>Y?UO&>TE)4FE))6
M5U:VUFCIM&U9%\?&;4];M[Q4M#']J(6),Y!VCH#U//>LK1;O2T^(-Q<:DT36
MS3RF.1^4#%CM;TQ[_2L[_A$=?_Z!<_Y"C_A$=?\ ^@7/^0K3V=#7WUJK=#%U
M<4^6])NTN;5-_F=_'K*1P:HFI>(-.N%EC?[-# Z@(N#QGN3D<<]*\GK9_P"$
M1U__ *!<_P"0H_X1'7_^@7/^0JL/&C0O::U]"<7/%8KE4J;TOW>_J8U%;/\
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M '#1Y$O]PT ,HI_D2_W#1Y$O]PT ,HI_D2_W#1Y$O]PT ,HI_D2_W#1Y$O\
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M(/\ ETTS_OU)_P#'*X)Z@?K5K#TOY2O90['H#?&_Q*/^7/3/^_4G_P <I/\
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MNZ_)P&8\G(ZD=-J.MWEOXDL]'T_3X[F2XMWN'EEN?*6-$9%/16)^^,8[^W(
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M:((%"\<#$:YSGOTJ.X\)6ER=15KN[2#4+B.YEMU*;5E0H=RDKN&?+7()(ZX
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M2Y0R@CK\H.: -"BN$\)^.KSQ5XXU:RM9=(;2+%FCB\J<M<RXV_O0 =IC.<9
MZD<UU-UXCT.RE>.]UG3[>1)!&Z2W2(5<C(4@G@X(./>@#2HK/O\ Q!HVE2QQ
M:IJUC922#*)<W*1EQZ@,1FJUQX@\CQ3;Z6T5M]FELVNC=-?1JRX/01'YBN.=
MXX% &S16?:^(-&O;M+6RU>QN+B1!(D,5RCNR$9W  Y(QSFM"@ HHHH ****
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M=D?\P_\ \C?_ &--/CYA_P P_P#\C_\ V-<FU1O3]C#L/V<3KC\0&'_,._\
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MA>_\G?\ [77C[]:;5?5*'\OYC]A3['L/_"_I/^A>_P#)W_[71_POZ3_H7O\
MR=_^UUX]11]3H?R_BP]A3['L/_"_9/\ H7__ "='_P ;H_X7[)_T+_\ Y.C_
M .-UX]11]3H?R_BP]A3['L/_  OV3_H7_P#R='_QNNY\'>/+7QA8-);'[/=1
M?ZZU9@63T(.!D>^*^9:N:3JUYH>IPW^FS&&>(Y!'0CN".X/I6=3!4W'W%9D3
MP\&O=T9]8?:)?[WZ"C[1+_>_05S'@WQE9>+]+\V'$5Y$ +BV)Y0^H]5/K71U
MXTHN#Y9;GGM.+LR3[3+_ 'OT%'VF7^]^@J*BI$6%GD,$C%N01CBH_M,O]_\
M04)_Q[2_45%0!+]IE_O_ *"C[3+_ '_T%<U=^(KI?$TFC:;I\5S-!;I<RB:Z
M\EWC9BN8EVG?C;SDJ 2HSS5Z77]-AM[R>2YQ'8SBWN&\MODD.W"].?\ 6+R,
MCGZT :_VF7^_^@H^TR_W_P!!7/R^,-#AOY+.2\82Q3K;RGR)"D4C8VJ[[=JY
MR,9(SVH'B_1#J/V(7C&87'V5C]GD\M9LX$;2;=H8D< GG(QG(H Z#[3+_?\
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M&4:C:M<^'=4_Y]?_ "(O^-,/AS5?^?7_ ,B+_C3YX]Q\R[F.U1FM@^&]6/\
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M8'S$G>,  YYH U?.7_GBGY4><O\ SQ3\JKQR"6))%#!74, RE3SZ@\@^QI]
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MID6)O/4Q*Q.075/7.,$CI6_K]K/-XFT26&"22.)+H2.J$A,Q #)[9/2NCHH
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M "_LR*V-FW.=S#^\*@\9?$&P\%W%K#?VES.;E&=3#MXP0.<D>M<1\?O^9?\
M^WG_ -I55^/?_(5T?_KA)_Z$*WC!/EOUN>/B,75I^UY?L\MOGN;G_"]]#_Z!
M>H?DG_Q5'_"]]#_Z!>H?DG_Q5>$UVR?"K7Y?"RZ[%+920-:_:EA61S*4V[L
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M?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\
M.HJ* )<V_P#=?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\ .HJ* )<V_P#=
M?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\
M.HJ* )<V_P#=?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\ .HJ* )<V_P#=
M?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\
M.HJ* )<V_P#=?\Z,V_\ =?\ .HJ* )<V_P#=?\Z,V_\ =?\ .HJ* /,/C]_S
M+_\ V\_^TJJ_'O\ Y"NC_P#7"3_T(5:^/W_,O_\ ;S_[2JK\>_\ D*Z/_P!<
M)/\ T(5U0^S\SYW&;XC_ +</):^A]+UA=)TCP%',5$%_:BTDW=/FB4K_ ./!
M1^-?/%=MXD\;6FJ>$O#>G::EU#>:0J[Y750NY54 J02>HSR!6DX\UD>?@ZZH
MJ<KZZ?FCK](T'_A7K>,M>D4(+,&VTXMGG?AE^OWHQGV:IOB5%'<>(O D5PBR
MQR2A71QD,"\0((/4&N<^(7Q-MO%WAVST[3[>YMV$@ENO-"A6(7@+@G(R2><=
M!57QK\0+/7KOP]=:1;W$4VD_,PN54!G!0C&&.1E/:LU&3:;.VI7H1IRI0>FE
MO/6[_ V]5T72X_C]8:?'IUHEDZH6ME@41G]V3]W&.HK6\+V=M8?'_7+:QMXK
M:!+/Y(HD"JN1"3@#@<FLBX^)/A&?Q1:>)FT?4FU6-%C=&9/*09PSCG+,%) S
M@'CIUJAIGQ%TJS^*VI^)I;:\-E=P>4D:HAD!Q&,D;L?P'O1:37R&JE"$TU)?
M'?Y6.L^'^J9C\:0?8;(?89I'\P0_/<;FF.)3GY@,8 XP":P_AM#IWBJ[\3WN
MIZ)I:GR(C'!%:J(X3M<$HISMSM!..]8GA#Q]I^A:QX@;4K2YEL-9+%O(V^8G
MS/C@D#HY[U-X3\:^'?"5]KRV=MJ3V-]#&EJ)!&T@*JP8O\P RS$\9XIN+UL3
M#$4W[+FDK+FO^-BP-*T[7_@8;^RL+:/5-)FQ/+#"J/(H/.YL9;Y'!/NM;]WX
M,T9[[PEX3ELK9+DPF[U&>)0DSA4^Z6 R0S;N_1>*XSX;^.;/PA)J$&KV]Q<V
M-Y&N4A 8AQD?=8@8()SSV%+J/Q&ED^*"^*;&)S!#B.*WF.TF+;@J<$C)RQ[X
M)'I3<97:1$:V']G&4MW9->2>K^:L>E0^$$U/6-0TO4_!.FZ?HNQEM+^W\L3Y
M!P&)5MW(Y' QC!S7-^!_#MA)X-OVTG3])UCQ#!<LDD6HJ'4*K8&T'ID=#TR>
M3QBN?U/7/AW?ZG<ZL^CZU)=7!:1[5I42 R'DG<#N'/IQ[5G^&-6\(:?:VDVK
MV>KQZI:S&07&GS*!*,\!@Q&/3Y?SI<KL6ZU+VBVZZW_^U^XZGP5I-M?_ !>U
M&VUGPW:V*K9ECITL:R1Q,/+&Y01CGDC']ZF:%H^B:3H/BOQ3J&F07YL+^2UM
M;69<Q)\R@?+TZR*/8"H;+XJ61^)EQXCU"RN$M#9&TABA"M(!N# MD@>O?CCK
M5#0/'^F6UOKVE:]83W&D:M<27 $!'FQLQ]"0.@4]>"O?/!:7Y"C4PZLKK>5F
MU]S8_P ,:GIGBSXAZ!%-X<TVSP95N8[>(>3<?NV*YC(P,8]_TK7\-:-I<_QR
MUBPGTZTDLXUE*6[P*8UP5QA2,#K7*Q^(O#V@>)-(U'PEI][ML69KA[Z0>9<!
MAC&%RJX&[D>OM75VGQ'\':?XOGU^RTG5&NK[Y;EY"F(AMY\M0W)+!<Y([X]"
M23Z+H31G3T]I)74KOTMZ%_P##';W/Q$A@18XHW9$11@* 9P !Z5S_@NTU*?P
M^#HO@:PU67S3YE]J&UE?_957*@8Z<&HO#GCW3=(N/%LMQ;W3_P!M.S6X15^3
M)D^_EN/OCIGO2Z1XRT"7P#;>&O$=KJ82UF,BO8.H\T%F;#;B.,L1CGH#UH:>
MOR*C4I-07-:RE^>G1V-[QGX;TRP\<^$G@TV&U&H7$:W5HB@Q<2)D;1Q_$0>Q
MQ4?Q+N_#NCF]T'3_  ];0WDR1R_;(XT7RCN4X48R 5!'!'7H<FLSQ%X]TK5]
M:\+W=E:74$&CRJ\L;A22H9#A3NYX3OBL/QSXAM?%'BF74K&*:*%HT15F #<#
M!X!(_6B,7I<*]:DHS]G;5K[K:EWX6_\ )2=+_P"VW_HEZK>._P#D?-7_ .OE
MJK^"];M_#OBZRU2]262"#?N6( L=R,O&2!U/K6UXBU/P7K-S?ZC NO+J%SN=
M%<0B(.1QG!)Q^M4[J=S"+C+#<EU>]_P.E\3:-IEMJ?@-+?3[6);J5!<!(5 F
M&Z'[W'S?>/7U-:%\^@Z=\2+?P_%X:TYX;O!FE>$%@S+\NP=% P,@#G)_'G[K
MQ;9>)?$'@NWLH;B-]/N8DE,RJ Q+Q#Y<$_W#UQ70^*M=\-:-\0$O=4L+V34K
M2)3&T!4QR9'!8$@Y&3TK+79GI*5-\TXM6O'\M2AI7@O2(?'FOK<Q>=8:2B31
MV['(.]-X!]0.1COQ1X;.D^/+/5;&XT+3].GAC\RWFLX=C*.<9(ZX./KGI6)H
M_P 1)+7Q;J.J:A:^;;:F L\$9Y50,+@GK@<=LY[58M_%_A_P[IM_'X1LK];N
M]&TRWK+B(<XV[2<XSQG\2<4VI&<*E#=6M>5UW[&KX-TFTNO YN-(T[3-3UD2
MGSHK\!MJY.  >F1C'0<GGC%0^'- LM2\5ZS>:QI*V46FHLATW.5#%?U'RDXZ
M<CM6%X<U7PQI\-G/J%KJ<>HVLA<RV<B[9><@,">!CCCTK5MOB3M\7WFHW%D6
ML+N)8'@4C>%7.#GN>3Q[^U#4KNP0G1Y8<]M/\MWIWW-'PZ=*\<V>J65QHEAI
M\T,>^WELXMC*.>I'7!Q]<]*32(-+LOA4NL76D6MY<0S,5,B#+$OM&X]2!GI[
M5FP>+=!\/Z;?1^%+.^6ZO1M,MXRXB'.-N"<XSQG\2<55C\4V8^&S>'C%/]K:
M3<'VCR\>8&ZYS^E%F4JD$M6G*S^_H=+J\VCV?A/3?$<?AZP:[N@(_*,>(5)!
M))0<'[IQ]:@\5>&["YUSP]]@MTLEU48E2$!54#:20,8!PQ_(5@:KXEM+_P "
MZ9HT44ZW-I(&D9E&PC##@YS_ !#M5S7O&4-^= FTR.:.?2QEO.  9ODX&"<C
MY3Z=:23'*K3DG>WV?^"=K_PCL<>MIIT?A6Q;1A'L:\8H9B=OWLYW=>/7OFO+
M]<L$TO7KVRB;='#,RH<YXSQ^.*Z+4==\(ZWJ U+4=/U-+M@/-BA=/+D(&.3G
M/;MBN2G>.2ZE>WB\F)G)2/=NV+G@9[X'>G%/J1B9PDK1[_A]R.[NO^2+6/\
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M,6E%)2BD,<*6D%+0,6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)H_X41H?_04U#\T_^)KU&BCVD^X?4,-_(>7?\*(T/_H*:A^:?_$T?\*(T/\
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M_A6B;B;_ )ZR?]]&FFXF_P">TG_?1H][N/ZM3[%'_A7VG?\ /W=?^._X4O\
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M&2 0&'8X(//8B@"UBW_O/^5&+?\ O/\ E45% $N+?^\_Y48M_P"\_P"5144
M2XM_[S_E1BW_ +S_ )5%10!+BW_O/^5&+?\ O/\ E45% $N+?^\_Y48M_P"\
M_P"5144 2XM_[S_E1BW_ +S_ )5%10!+BW_O/^5&+?\ O/\ E45% $N+?^\_
MY48M_P"\_P"5144 2XM_[S_E1BW_ +S_ )5%10!J4444 %>#:#X+T?6O#/C+
M7KIIK35;'5KTV^H0SNC1!%5QP#C&2<\9YZU[S7G[_!S1)9KOS=6UQK.\N6N9
M]/%Z%MY'8Y)**H]AG.>!S0!RMW\7]3TG0?#EN9-.CO;O3%N[B\U))F1OF9
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MFWDN[F[93T+P1!DX^I-<R_C6?PQ#XPOM*TJR$T/B!('!:0^?N)!9LN0&P.V
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MKT;;IC N9QZ/Q\WXT <KJ?B._P#^$@O].M=06&(ZA96:RJB,;82(6?&01N)
M W9P6'':LN"22WUZ_1KN/47_ .$EM(FN)88V)Q;H.@&%<8P2H!R#TZ5WB:!H
M\5C)91Z38I:R@"2!;9 C@'(!7&#@G-/AT;2[:-4M]-M(D1UD58X%4*RC"L !
MU X!["@#D-!UGQ-JNH6]ZD-X]J][+#<Q.+5;>&)69?EPWG;P57.X<_-P.*U/
M"M[J7VZYT[Q%<W3ZK'$LSQ.L/D%"S*'A,:AMI*])#N''%:[>']&?43J#Z38M
M>DY-R;9#(3C'WL9Z<5)I^D:;I".NE:=:6*R$%Q;0+&&(Z9V@9H NT444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &I1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1B@TAH 7%)@4E)3 =M%)
MM%--(:!C]BT;%J(TE $OEKZ?K1Y:>E0TE%@)_*3T_6D\E/3]:@IIIV L^3'Z
M?K1Y$?\ =_6JO:FT6 M_9X_[OZFC[/%_=_4U3---%F%B[]EB_N_J:3[)#_=_
M4U0---.S'8T/LD/]S]31]C@/\'ZFLTTAHL^X6-/[%!_<_P#'C2?8;?\ N?\
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M!_E#_GHOYT>4/^>BU'10!(8A_P ]%_.CRE_YZI^=1FDH D\E?^>J?G1Y*_\
M/5/SJ*B@"3R5_P">J?G1Y*_\]4_.HJ* +"Q 0./,4YQSZ5'Y*_\ /9/SH3_C
MVE^HJ*@"7R5_Y[)^='DK_P ]D_.HJ* )?)7_ )[)^='DK_SV3\ZBHH E\E?^
M>R?G1Y*_\]D_.HJ* )?)7_GLGYT>2O\ SV3\ZBHH E\E?^>R?G1Y*_\ /9/S
MJ*B@"7R5_P">R?G1Y*_\]D_.HJ* )?)7_GLGYT>2O_/9/SJ*B@"7R5_Y[)^=
M'DK_ ,]D_.HJ* )?)7_GLGYT>2O_ #V3\ZBHH E\E?\ GLGYT>2O_/9/SJ*B
M@"7R5_Y[)^='DK_SV3\ZBHH E\E?^>R?G1Y*_P#/9/SJ*B@"7R5_Y[)^='DK
M_P ]D_.HJ* )?)7_ )[)^='DK_SV3\ZBHH E\E?^>R?G1Y*_\]D_.HJ* )?)
M7_GLGYT>2O\ SV3\ZBHH E\E?^>R?G1Y*_\ /9/SJ*B@"7R5_P">R?G1Y*_\
M]D_.HJ* -2BBB@ KQ/P1XIU73OB!<OKNJW5QI&I7=[:Q?:9V=+>6%MXQDX4;
M3C _I7ME><ZE\(X=2\(W>C/JQ26;59-2BNA;<Q%^"FW=R,$C.1V..* .6\'^
M*]=NOB/<ZI?WMW+I]]I5SJ5MI[S,(TC65D0!>0#B/KCO7=VWQ"^T:?X4NO[,
MV_\ "12F/;]HS]GX)SG;\W3VJ6/X>VD/B>TU**Z*VMMHO]CK:"/DIDG=OSUP
M<8Q[YK&T?X4WNFW>BM<^*[B]M-$N3+9VKVBJJH<Y4D-DGD?,>@XQZ '%:7XF
M\0>&_!"2>'K;S?M/BB:*:7S(QU*;8L.#]_+?,/N[?>NLN_'%]I'B/6[JXTF^
M:]LM%AO)M-;5 UO'\ZAPH"$!@&)+@G.WH.M7S\+"/!\NC0ZVT4YU8ZI#=BU!
M\I\\*4+?-CZCZ5IZ?X$:'Q'>:MJVJG4GOM+73KE&MQ'YF,;GX..<?=QQGK0!
M6O/B?86U\JQ6CW%FNC?VO/<I)_JD/")MQRS$CN,9K-T'XQ6^J3745]I*VS16
M,M]"+6_BNS*D:EBK!/N/@?=-6/#OPEM='\/:SI>H:I+J/]JQ);F?RO+:&) 0
MBKRW0G/H>.*9X>^%MUH,UP1KUJRO:26T,EMHD%M/"67 D$R?,6'ZF@"C<?$:
M7Q#\,]>U633+K3([:*%XI+#5$\R0.^/ED53Y;C'*D9&?>M6[^(EY;WT6F:!X
M:O-<FM[&&ZO2EPJM"KJ" ,C]X^.<#&?Y4HOA"_\ 9.O07FO^?=ZS%'$]Q'I\
M<*($<,"8T(#,<=<BK]]\.+W^UQJ&@>*+K1Y9K.*TO/*MUD\]8U"@KD_(V!U&
M<=J )Y_B)Y.E^*KS^RB?^$>E$>PSX,^0#_=^3KTYKG['5WC^+6NZO':M,P\-
M17(MED +?=;;N.!^-7]9^%-SJ-[K)L?%-U8V&LA6NK3[,LF^15P&+DYQGD@8
MSTS5NZ^&,=Y>:E--JKA+_2(],*I!@ILV_/G=SG;]W'XT 5-"^+0U6[U.TO-(
MAM;FRT^2_C6#4XKI)53JI>,85O;D_P!=_P $>++WQAIS:A/H4NEV;QQO;2R3
MK)]HR#OP  0%(P">H(.!TKF-"^#IT>\N+F77(YY)]-ET\B'3([=0'& ^$/)'
M<G);UKN/"VA_\(UX7L-'^T?:?L<7E^=LV;^<YQDXZ^M 'D;ZM_8R>-[HO?+_
M ,5-&O\ H5W]G?ECQNVM\OJ,<^U==K'Q0OK#5M>L].\*SZC'H15[R=+M45(B
MF[?@KG/WOE&>%)S3M1^%8O[36X?[8,?]K:HFH[OLV?*VDG9]_GKUX^E81\#Z
M]KWCOQND6J7NA6%\T$;M]C#I?1&-@P5FQTZ94_Q$'K0!T-U\39;JZM;7PCX=
MN==N);%+^5//6 0Q,. 20<M[#\,U1NOC)!_9VC3Z7HLEU-JB2,89[M+81>6V
MUEW-PS9' XSQW.*O7?PRGMKZVN_"/B.XT&6.QCL)<6ZSB6-!@'#$8;W_ )56
MU#X2^;X:LM#TS7I+2RAB:.X2>S2Y\\LQ9I!N^X^2<,O(&/2@#1UCX@7UOK$>
MD^'O#-SK&H+9K>7,/VA8! C= 2P.6]JS_P#A;?VN+0AHGA^XU"YUJ.8Q6WVA
M8VCDB.&0DC&.&.[/ '3TLWGPVNXKZUO?#'B>ZT:YCT^+3YY#;K/Y\<8PI(8C
M#<=1^&*ETKX96FC:KX9N[&_DV:%'<*4DCW-<M,I#,6S\O+$XP>PH QK;XR7,
MMM!>W/A*[MM/6\%C>W3W28MYB<;57&7QW/RXZ5+KWQFM-%\0WMBFEK<6FGS"
M&ZN&OXHI W?RX6^:3'MZ5=N?A?\ :/"5[HAU?;]JU=M3\[[-]W+ [-N_GIUS
M^%4]:^$)OO$-_JFEZQ:6@OY?.FBO-%M[[#GJ5:3E0>N* .D\1^(M&N_#NLV-
MKJUC+>_V?.?LR7"&4?NB?N9W#CGI7$_#OQU=:;HOA;1=4T&>WL;]/L]IJ1G5
MA+(.WE@94<X!)_"O0;_PCHUU!>FWTRQM;V[MY(#>QVB>:N]"F=P )X/3-<MH
MOPKFTW4-%?4?$EQJ-AHGSVEDULL867'+;@<D9Y /3IGKD ;8_%9IO%UKHNH:
M+'9I=W#6\4J:G#-(K=M\2_,F3ZG\ZM:!\2AKNOWUF-(:WL;0S*UV;I&<>7UW
MPCYD![$\&L?1_@HND:QIUXFNK+'IUX+F)/[.C61ESDJ\H.YCTP3P.P]-:R^&
MDB>+1K6K:[)J"QI-'%%]D2-]LBE2))1\TF >-W2F!2\/_&"VUSQ!9V+Z8MM;
M:A(8[6=;^*60L.GF0K\T><=ZP/%/C6Z\6:?I$UOH-Q;Z,^NP"UU)YE(GV.0<
MIU7OCJ.".U=#X=^%+^'-<M;J#5[.>SM9"R02Z+;^<1SC-Q]_()Z^U11?":Z@
M@M;"/Q3<'2+&]6\M+%K52(R'W$%\Y;J?3&<XH&6?BX2-,\-X./\ BH;7^3TW
M5?B=<VESJDFF^&;G4-+T><V]]?+<*GENI^8*A&6Q_G KHO%WA<>*K;383=_9
M?L.H17N?+W[]@8;>HQG=UY^E<]J7PRNKJZU2*P\37-CI&KW#7-[8+;JY=VY;
M;(3E<X]/;FF!/>?$.=]8DL_#GAVZUJ.VMX;B[EBE5#$DJAD"J02[%3G YJIX
MB^*+>&]?EL[S1H_L<,JQO<'4HA*0<?,L'WB.?_U5;O/AY<)K<U]X<\176BQ7
M4$4%W#%"LGF+$H1-K$Y0A1C(R>OK6/KWP;76]5U.Z76U@CU";SRC:?'))&^>
MTI(;;_LC'XT :'ALG_A='C/_ *XV?_HH4GB[XE2^%-7FMI=&CGM8 A:9M2BC
MD<, <I"?F?&<<>A[<UT&F^&/[.\::SX@^U^9_:B0KY'EX\KRT"_>SSG&>@Q7
M*>)?A(OB#7=2OTUA;=-1"F2-[".9T95P"LA.Y1QR%QGIFF,NZO\ $2YM-:N=
M-TCP_+JKV]FE[O2Y6,>41EB<CC Q@#).:K:E\5K6VT[2)K#3UN+C4[<W(BN+
MV.V2)0<',C\$Y! '?%:]MX(%OK=YJ/\ :!;[5I2Z=Y?DXV[0!OSNYZ=,?C6%
M<?"6-])TB"#5HUO--A>#SY]/CN(Y49RW,3D@$%CSFF ^\^+$"Z1I%WIVE-<S
M:GYH$4MVD"QF,X8>8W!.>GKQZXIMQXN\2GXD6.G6ND,UA<6*3&W>>-20Q7=*
M21D%"2NS/.W/>K%]\.;R[\.6FE)KL, B61;CR]*A$4^]L@B(?*C <!ASWJR?
M <MMJ>B7FE:W-:-I=HMFX:!93<1 @D9/W2?7!]J .+\,^,;GPM;:W)+HTUUI
MG]O3">^$ZJ(2Y4 !3RQXR>@Y'K70^(/BI;Z+KMW8Q:<MS#8LJW,K7L<3@G&?
M+C;YI,9[58N/AL)_"6KZ)_:I7^TM2:_\[[/GR\E3LV[N?N]<CKTJ#6_AC_:&
MOW>J:=J=O:F\8/+'=:5#>#=C&5,G*CVIC&VGBS7[KXG/IL&G>;I36L<JCSXU
MV1LP_P!(Z;CUQLSFJF@^.7M_!^C"PL-0U74=2GFCM[>ZO0\C!"2Q:4J!@ CM
MP/IFNBD\(SIXOM=<L-6:T$=LEK<VRVRE9XU.< _P#IT'TQ63!\-)+'0M)MK#
M79+;4=)FEDM[Y+<$8D/S*8R2#Q@=?YTP.MTF]GU'2H;J\L9;"=P1);2G+1D,
M1U[CC(/<$5:-5=)LI]/TN&VO+Z6_G3<7N90 TA+$]!T'. .P JT:!C3333C3
M33&--+%(\4BO&<,/UI.O2M2QL?*Q+,/G[#^[_P#7I-I(3=D7(V9HE9UVL1R/
M2GT45B9A2&EI#0 4444 %)2TE "4444 %!HH- "4444 %(:6D- !1110 &DI
M324 %%%% "4444 (:*#10 4E+24 %(:6D- "4444 !I*4TE "4444 !I*4TE
M "4444 )1110!(G_ ![2_45%4J?\>TOU%14 <7XDUV]T37-:NK9_,6ST)+F.
M"1B8]_FR<E01R0 ,]>*BUO7M7T^WU.RU3[)++':0743VGG0[0TVQD)#[CC ^
M8%<]QVKI[_0-,U-[IKZV\TW=M]DF/F,N^+).W@\<L>1SSUHO] TW4YI9;ZV\
MUYH5@<^8PRBOO X/][G/6@#D+_4-:M'\<W$M_%-;6,>^*WV2H5_<*RA764%/
M?;@DY(VYQ5S6O&%UI5ZJ6SV\L4#VT<UN+2>5L2%02TX^2)L-D*VXD8.?F K?
MN_#6E7UQ>S7,$C-?P^1=*MQ(J2IC'*A@N<<;L9]ZBN_".BWUVUQ<VLC.[([J
MMS*J.R !&9 P4L HY(SP/2@#G(=<UG1K7Q;J5W=0WT5G?F*"W\F0%79(=N#O
M;"#?RH7).2#SBMSPWK6H:A?7EMJ$+O'$B2178TV>R1]V04V3$G<, Y!((8=,
M5>D\.:5-<7\LML7_ +139=1M*YCEX"Y,>=N["@;@,\=:FT[2;?2_,^S27C^9
MC=]IO9KC&,]/,9MO7MC/&>@H Y&VUG6M+B\4WMQ=6]\EOJ0M[>W>-TVNZP!/
MG+MMC'F<J%ZY.><5=O-<U_3IM2LI7TNYNK6Q%_#,(G@C9 Q#HP+MM.%.&W8Y
MY'!K:F\-:3<37\DUJ7_M%-EU&TKF.7@#)CSM#84#<!GCK4:^$]'6">)[>:87
M#(TSW%U+*\@0Y56=V+%0?X<[>3QR: .?@\57&J_V)J0C6.ROM1DCAA#NLJ1I
M#(3YFU]I8LA.T@A00#\PR+$?B76D\)CQ'/'I\EM=6ZRVUJ@='B:1U$:N^XAA
MA_F(5<$< YXWAX>TL7XO!:XF%R;L$2,%$I3RR^W.,E20>.>IYYJ"'PCH<$<\
M266Z&>-XF@DF=XT1SN941F*Q@D X4 <#T% '+^+=2U2/0]<T?67L[ASI?VJ*
M>TA:( ;]K*RL[=\$'///'%:>J>)-7BCUS4-/6Q6QT-]DL$Z,TMSM19)-KA@(
M_E<!<JW(R>N*U4\)Z,MG=6S6TLR7D8BG:>YEED=!T7>S%@HYX!QR?6GWGA?2
M+_4'O+JV9I9-GFJL\BQS;/N^9&&"28_V@> !T H YFZ\:ZC/XE;3=+N--C=;
M^&U6RF@>2X>-XU=IP!(N%4,>,'&TDGM6EIWBB^O=2LM+:* 7RW5S'J&U6VQQ
MP]&49R-_F0D9/1CUQ5:?POK)UN[GM+A(5N+U;A;N/4)HS&HV94VJKY4API7+
M'G.3Z5L:9H)L_%FM:U,L(>_\F./822$1,$MD#!)],\*M %?5M<O]/\36UM*T
M-EI<@C NIK22832,^#'O5@L)QMP7!!+<9QBL33=9U[3=%O[R[O+:^QKGV0!K
M>0; UT(V()D.%PWRK_#QR:ZV\T&PU"\2YO%N)61E81&ZE\DE3E28MVPD$ \K
MU /:HG\,:3)'?QO;R-%J#[[B/[1)L+YSN5=V$;(!RN#D T 9.I>)]0@UJ\TR
MTCMA)]KM;6WDE5B$\U"[,X##=@*< %<G'/>L>VN[ZR\0:D+UH9+B7Q!9PR/;
MM)$C VR8( ?/0#Y6++GUZUU*^#M#6WGA^R2-]HDCEEE>YE:5I$.4?S"V\,.S
M YI]MX4T:T'[BT8$W*W;,TTC,TRC <DL23CKGKU.30!@Z3XRU/4]4MF2S:2R
MN;N2 Q)IMP# BE@)#<']TW*C( &-W4XYU/"VM7^IR7$.M-#;W\2AGT\6DD3P
M LPSO9R)5RN Z *<&KL/AO3;>^>ZMA=0.[M(T<5[,D19OO'R@^S)R3TZ\]>:
MET[0['2YY)[59WGE4(TUS<R3OM!)"AI&8@9).!QS0!HT444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% &I1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1B@TA- "XI,49IN30 NVC8/2DW&D+
M&F [8/2CRQZ4PN?6DWMZT#'^6OI^M'E+Z?K4?F-ZTGF-Z_I1J!+Y2^GZTGDI
M_=_6H_-?U_2FF5_[WZ468$WDI_=_6CR(_P"[^M0><_\ >_2D\^3^]^E.S#4G
M^SQ_W?UH^S1_W?U-5S/)_>_04TW$O][]!19AJ6?LL7]S]32?9(O[GZFJIN9?
M[_Z"D-U-_?\ T%%F%F6_L</]S]32?8X?[GZFJ?VN;^_^@I#=S_W_ -!3LQV9
M=^Q0?\\__'C2?88/^>?_ (\:I&\G_O\ Z"FF]N/^>G_CHHLPLR_]@M_^>?\
MX\:3^S[?_GE_X\?\:SS?7/\ ST_\=%(;^Y_YZ?\ CHHY9!9FE'90QN'2/##H
M<DU/M-8JZC<*X+-N'<8'-:L,R3QAXSD?RI--;B:9+M-&TTE%2(7::0J:*0T
M+M/I1M/I244 +M/I1M/I24E "[#Z4;#Z4VEH 78?2@HWI24AH 78WI1L;TIM
M% #MC>E)L;TI*#0 OEMZ4>6WI3:* '&-O2D\MO3]:0TE #O+;T_6CRV]/UIM
M% "^4_I^M'E/Z?K3:* '&)_3]:/*?T_6FFDH ?Y3^GZTGDO_ '?UIM)F@!_D
MO_=_6D,+_P!W]:;FD)H ?Y,G]W]:/)D_N_K3** '&&3^[^M'D2?W?UIAI,T
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M-)2FDI@)24M)0 E--.IIIC$[4VG=J;3 0TTTXTTT ,---.---,8TTAI32&F
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MTM)2TAA2BDI10,6E%)2B@84M)2T@%%% HH&.HHHH 6BBBD,6@44"@8M HH%
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M_P"XWY5]!44?6O(?]E?W_P /^"?/XC?/W&_*GB-_[C?E7OM%+ZUY#_LO^_\
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M2"/SK5HH RO#_AC1O"UD]IH%A'9PNVYPI+%CTR68DG\36K110 4444 %%%%
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MMO\ QS_Z]:=)1SR"[,LZ/G_EO_XY_P#7I#HV?^6__CG_ ->M:DI\\@YF9/\
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M_P"2_P#]E33\-<_\Q;_R6_\ LJ[\ >@I,#TH]O4[A[2?<\^/PR_ZBW_DM_\
M9TP_"_/_ #%__);_ .SKT0@>E  ]!3^L5>X>UGW/.3\+<_\ ,8_\E?\ [.F'
MX4_]1G_R5_\ LZ])P/048'H*/K%7N/VL^YYF?A/G_F-?^2O_ -G33\),_P#,
M;_\ )3_[.O3MH]!^5)@>@I_6*O</;3[GEY^$.?\ F-_^2G_V=,/P>S_S'/\
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<]T?E1L7^Z/RH J45;V+_ '1^5&Q?[H_*@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>pcrx-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pcrx="http://www.pacira.com/20210930"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pcrx-20210930.xsd" xlink:type="simple"/>
    <context id="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd4be343c5c04ff3a57d3cb3f3dfe956_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i2b38381b6d0a45889401a583757402a5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i39c6077ecfb343b7b02e61046eb86e03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12dead7e93d941fa9ed3c4a6d9cdd283_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie63b52bbc6f8429686e59ef4517c7bf4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i45a4d517e9454a9a888918ce80188a4e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5b7287c7614e46d8ab1553c11a8c6b9d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie5a291ee19594ddfab77fce82e32a1c6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9842d334ede6470cba57f5223fd23c14_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i48ad93bee00549d8bdd6a51f78347c23_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2e97b7d115ac489bb255e8dbdd6a3227_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:CollaborativeLicensingAndMilestoneRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i117249baf38443f781c1edf946e8991e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if09bc71a12134a489569878485158a10_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5220037f26804a09aca54e93634fae07_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i343da0f70b794c348d0831e6aeaf9c59_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia213897e773040b6a9581d9de800ead9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7edff5520a404b2b83447444f9eb459f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i122a17173a484439aee4c4ca9b399085_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3b693b61cc3b4215a6ee287c335a9063_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i73d65492b3924412b7973c03af1fe9e6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8495ec90002a45e0bf0887939ab74508_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i948ca81132a24b4d8ef57d52788a5385_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21fe54e97dd84dc997ccfb0ebc078b9a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4f9c6243a10041a9a851d8813a74c05e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i077b7247a4a24b37a42640d85ace320b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifff9414f8ec14f648d23be05a58aa2b5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib557a2279d86475996731b3fc97be752_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i20e70406d1a045e4bd52905aacc53fa2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i55cda46fa2334de29508526999af243a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i014f2a1fc24b43b18ee6280f20cdf1ce_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0782a595bbfb44b29916dbcc9517713f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if774c56400c143a986cc56ea80547ef8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0697b721fc9e45f69f060f8f46d77072_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i07c52d1fdd134b989a3e678be437266e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0a8a218cb3b1417390af7c5813a511e9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i39a912dcf7aa45e69c293537f5fa8875_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5abf6e142c09447396ea931fa4051312_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:A2022ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i28f2bef137d34763a6e0945cc7109ba5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:A2022ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7254f3d070d24fedba65bee5b312cfb6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i255a01006e2448ef9f48b2f549fa8a87_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ide7713099e5342bc91935b76d0493eb3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i97143ff422764b1eb3afddc0d216dca4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie8d0686e48b449de8494030e085a5ba6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i41a7036c745f4bed845b3722cfd852b4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9e471ced5e9c4e899d18dd16de8c4d8e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ide22db36ba124396977f4e0de495a2cf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1c1289967bb1472eb59cfee843fc6864_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ae279ae07c24b808b12769dd2e5d56b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieaacf91e289d4f41a577e6a6fc15dd78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71ef8fa3f6ef4295b34719dd5bcd1ea2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i633a7f9223744608a36564a7e357408f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i948705b5248d4d66bb924c0499f8f0dd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib7fe3f4d4a2545b2bcf7893e525bd645_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i906da711ad9f492aa726ba7c1e3c3da3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4956ecea465b41aca59fcfcd35dcac46_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i46c78db21b3e43b48cc5600bf97beeb0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0a1a3131f4134e8897f0cf6d5e2ffd17_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa26d8ae002340a3ad3e4dd57c59814b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c6d0b8cddef42e7b5f9944be6d07888_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iffeb5e781f954b4e84f040966bddc6b8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i28039b2d361d4a4fab500d11195dad95_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:A2022ConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8e525b059b864af98aeec5d4a4a0628d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i53046ca604b24b22afbf86b490b8b1a7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i66f2b75905cb47d0a73cb049beed27cf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iecb17ba904c14ce8b2ecbe73f2cec747_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iddb7245efd2d449f81aae47fd4200c45_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i856232cea6c64e2ea98e0dc82a006dac_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c3443c6210e4129b77b12cacc1af29e_I20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-22</instant>
        </period>
    </context>
    <context id="i9252be06dfb84136b1c245c17afd18b9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i766f22ea0ac24a77a51e08e7ca35945f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i56f4b02fe95c4104bfdc2b5350e072e8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if28fae669275407da1afd4ccaffe03be_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i26b9a9fb65e1404983d517a01cb75626_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iacef49a3ede14eda8bd8c641ad091a60_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic5badbb37b7a4f1b94a0f02f00cf2590_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia74009bf8abb4b0b991b74490d2554f6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i844e9fe2488b4442bcf86bf11b9e76ed_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:SecondLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i205e1c4172cd4d2b809c620611b5e0b0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibb78eb77b14d47f892d26f89746691ff_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8688a00c06e54c5f8d4c92616c5ac6ea_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i30925928a2bd4e02a8ed2ea04199236d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThirdLargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i150082df5ab74269aac685d70ddd9809_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i44d32a7bfbd0444d949387c037771a01_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifed03345c8384bd697f0693a26aaf05a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i14236b4e4c5c46349502a9255c70ff12_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i72fedbc6decd4c5ab474fce89a1e607b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icb8afdaa87d44b849e4d16d61dab0781_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EuropeanUnionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iefd0f799d2934f3c879017bae1f70cac_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EuropeanUnionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i394d1f729acb4158a8f1b548947619fa_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i41b00db28bd24e8298f3daa38843e448_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib583d9b057b942b68b4eaeb985e512fd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie9363f54932e4fbba77650e2de1ba4de_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if1129d76aea6423ca3b15e9965559c8f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5accd35363b841d5bd616a756fec67a4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:EXPARELbupivacaineliposomeinjectablesuspensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3fde0359479247adb32995272e9e92e8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if5ff86ece96a40f6ba1006fbc2ee4fa1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i26bec4aae3774657b312c164cf9e6b95_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i29692bf80ec74a828827091f01d350e8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pcrx:IoveraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i99bdc6f6fda24e0fb4e3bc0f687562ff_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7ed0e5100a704244a6604a6ffdca5f84_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53f18cccc5ab4371abe468c2835247ca_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i898a223b5d1b4effbcd726f575d3e5e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibaa288b76e0a42ed96cf349f5192edb1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia34fa7325b3e40089d0092964f4fc930_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pcrx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic665add04b7e4b1e909cb5ea8efd8516_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2f9e89c1e0d94c15900cc25867cdaf15_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c2f20e3bb0c4ee4a9973bd9ac272cba_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie78554782b924c2e943917d448e44ec6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0379cda4d5d444419b2c756629bfe8be_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0e6245f12984622bb9ff0bf0fe46d7b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5263cd5b15ec419ea569ba7621aacc70_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89ff104d4b684eac9d78a0eec97980e2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie510ad82e9ae4ed9b7453890873a7867_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:SkyePharmaHoldingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis">pcrx:UponFirstCommercialSaleInMajorEUCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib955ef045d0147b4a41342834ab1923b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:SkyePharmaHoldingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis">pcrx:UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6d1f022a2e3f45c38d8813642eb0a4b7_D20190401-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="i89a81ffb612a403a924df2a487b03db8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if7501d0ecec348a18e56ac1ec8c99ddf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6cee35c07c974bff9beb7fa6c64d6aee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if16cf2053195434b94be734f2e6e754f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie965653fafce4fce912093bbf34f3347_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i01af4a06a1ff4be181f27dd6fc5dccd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic6a3944a915b4b7dacce440712764ef6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie438d7046d4b414a88a04918bfbd3568_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i77e86ff9a584425992768831eb59a2b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f322fb012d64653a2090e9d08a6fa7a_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i5ee5be00954e45748d8b246245010a0f_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i5a7be408192f4f12b6d240abce12cdf8_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ibb1bbaf7e7374ecb8bb7e29a54a2e98f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2987763b470247b1b64487558ed62361_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8676c39077d849cf9a97ed7b875cf79c_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="id3b1ed3537724b41a9d822235c8817fd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsOnOrAfterAugust12023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7110286438e148d29048a9c4ae47c6b4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ice3f2f561e0548b1b29b92f1b74cc3b5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic7de6bbd42d241129b6517fae46c1feb_D20170301-20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-01</startDate>
            <endDate>2017-03-31</endDate>
        </period>
    </context>
    <context id="i484fffcf3bfc42da8b6f439297ac33b8_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i76cecef789bf42e8a15eea314c8c854e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtRedemptionTermsonorafterApril12020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i1c1cb32c967149daac72034c56d3895d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:DebtConversionAndRedemptionTermsAxis">pcrx:DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i684590e84b124a17aead86fc30460d60_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2333c4061860489582acbe97375bee03_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i958bf8263a504b278937ce35716db65f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9c75da8d059b4e2596b5ff5b06924a84_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7181147be8bc4623ae8e9c54c8d545ad_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i02f839d9a53d4f3ca875382af344df93_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i583c220156b344feaaa6d77b90257b90_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iee07277d2a1a4c99b0127e42c9b1dd5f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i14c7c1373cd042e1a4d460c0d974dd24_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iae7f0c9606944edf9be67213b6c85881_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idec15b75fb0c42b2b08037d3e0496138_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if95fecb89ac048679a3ab7c3be07bf21_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i893cdc48adac4ec98ca312b73931a78d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i263034570486452a8b85ec7f5288179e_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i14f382f05018464aad3ae04a610ed007_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9d903a7704504ea2b8d765a75def60a0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pcrx:ConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a69013f0d0b4c429435e8c27ee9bb03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:TELABioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e0d7a6d98784688b9dd3fddc1b5a08c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:TELABioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib87f4d8c58fd4e109cfee6b9060ba4d0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:GeneQuineBiotherapeuticsGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0f39cd86209f4b77984b8ebe031d7b5a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:GeneQuineBiotherapeuticsGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i091d6864fe7b45dfae7464d8dfbc754e_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:GeneQuineBiotherapeuticsGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="iaddf1add92a940f384b1684b15e084d1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:GeneQuineBiotherapeuticsGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7a1ec36dd33e4facb2801b28ac07812b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7cfdc64ff7694ae3b4874240596655b1_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pcrx:CodaBioTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i2642fc1d446c40c890cec918384252cb_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">pcrx:SpineBioPharmaLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i3838cbd889d145a097da4753fd5b7d52_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:AchievementOfMilestoneAxis">pcrx:AchievementofRegulatoryMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if9c092d61fa44c89a1f992840f0cce80_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia60b65aa2ebd44c6a2368109e2845fd1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idcabd81228924ca98368c5d31fc89917_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibfac6863101f4d0cbbcb816ebbd63709_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie57c515402bb4f8eb1ac59b13452a7bb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4fba2629f05d45e2a951a1a3b00a7381_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9551ea61dd8e42de921cd6cb340713fa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i923a86d2b61a4ed5afa25b07cbdcf5a8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8336fab865c64a01a14d247bad7a374b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:MyoscienceAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">pcrx:MeasurementInputExpectedMilestonePaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iad8f7b4b2d424119bbbb3f917cb3b346_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia52993d557b44575b5efa778c644c50f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">pcrx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic4e113d16ac64bae9b930524840237b5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i22316fe6c9c9417c99464765f80e9ff2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic08f2b904bb04e27a90834e3f466dbd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia66d87b3e37142af9057b01f7429fa1a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic28d6c7359df4b11873f7e1849924a7e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icaaea71e25214e7182cb2fdf114dd014_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9cd891a11904cbca9a869e4c48499a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">pcrx:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaabd093cc73463987f26acf4772c0bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">pcrx:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51a59f89178947969b3cba1e3274e2dc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ied43576ff808456488d1b300724244f6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id114c1b120324ca1a1669aa5d23a5abb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4b036912429349368955de8ecae55a89_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7ed73dae03a470482270000763fd063_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1718ddd31a954033b183d8735f99a0a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pcrx:MajorCustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e0a781126c0441dacaff2fa6d34f7a5_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib22ffaf6dc27448ab2156941699b6b1a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c7ce8a3a5fc418d9801116dc3b6610c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5a5860adea844fa8b07fe21a35e0f561_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia516abbffb1e4c0ba991b35223d79126_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie261cb366710463b836156aa4c632d01_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a6a43537be9433b9fc3bf5d2c98e1a4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibfbabdf3eb7c47d9a56eb08fb08ae3f7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3a1ff59e16c64e2e9bc827316216d3ba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2bcecc3df2a2449395525e8d81ac6047_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7583ce2665944358a76869e7bdebea3a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i22815de90a2e44529cacea918876ba77_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f3f4a3e1d854d6688e4b30b04ac8976_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i033c3bf91fa74d9f8777d9d69a2050e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2748d7cb585c451096424351db231a1b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1d2ac06eaefc41a4919773d11bc58522_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5328ec671a74439b9a01511fe23d4b0c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i92cfc444422b4d0b8bace3222b587d3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e2148bdfe694503807898f469458f04_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i07396e9494fe4b07b8f774fda1e27972_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idc5902e825304da38fccdd9ed1ae795a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i467a1ba8b0124cfd8c7cc340c2972c7b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icc0600e264da44709593ccef5269505a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6dded111553f45dd92378a98c5010846_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i209c230b69834a4f9828d93ba9cc1546_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie6964e7e50494461b1d33b90b39ec59c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if1e6c6a626ee44d78fb558955fed8879_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4d5224e2aea7473884ab3ab568b5f742_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i801a1368563548fbb45290c7dfac40e5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ice17e0310ab24f19b2477b0ea0b3a5c0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia740c361205a40759e18df3c4efb99c0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i34dbb38f3ce9455eb1cb8977c02233dc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if70609b807c243d69cf4588104e93c8e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic0de685059e34723aae25d71c24a900e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3131d879dea24998a48d584e912182a8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i41071c327f3940bcaa6bb301df7449bb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i218c8db6e4454704b8551048521d1831_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8d011ec249be45c6b176c6e6198e14cb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i25c7e05a7fd8439d9f81fa9758796010_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9405e0168d3f418b965e10a3716b7c99_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8f66d871d84f43da953d2139367fb6c2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5d79527b591541b2b5cd79a11907b8f0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i80f1189a3be5472b8a2576c5439a28f3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia50e9b50fa274d2a877186bfca0244a2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i84c3ad13f8e54c46b927d50478630682_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:EurofarmaLabatoriesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2483978d600d43fb9c6740ff2f1e9576_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:EurofarmaLabatoriesSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pcrx:AchievementOfMilestoneAxis">pcrx:AchievementOfDevelopmentAndCommercialMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i90361c4a697b4f3e8ec723bc57e3d9f1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pcrx:NuanceBiotechCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id61de8fd8c9c45ff8bf796f260c5aa91_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pcrx:FortisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i8646cd5d4ebd458eab95c35c7d751c0e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib40c1bb9a8fc4a669685de4cfb5bf7b9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia161505b12724f2880a881bb1734845e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie0268792e6564110bccd672d24ff62fc_D20211022-20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-22</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <context id="i37b82df25f6144808d51c0943de2a4b1_I20211015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-15</instant>
        </period>
    </context>
    <context id="if6c3e67d137a4219a0590be4ad4df4ae_I20211118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396814</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pcrx:FlexionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-18</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="product">
        <measure>pcrx:product</measure>
    </unit>
    <unit id="segment">
        <measure>pcrx:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="offeringperiod">
        <measure>pcrx:offeringPeriod</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV8zLTEtMS0xLTA_ad4b05bd-618e-4291-b9c1-e65c48c17432">0001396814</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV80LTEtMS0xLTA_a573f5a0-0384-4e9a-ac68-eff927e8623b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV82LTEtMS0xLTA_2be70e96-6e24-403c-a21a-c71c1664ec28">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV83LTEtMS0xLTA_a239e709-8834-485b-a91d-a5311fe53f27">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80L2ZyYWc6YWYyMTM5ZjM0ZDQ5NGY3ZTgwZjE5MTE4ODY3ZGI0ZWIvdGFibGU6NzE2ZDMwYjYxZmVhNGExOTk1OGQzNWE3YmI3MzQwZTkvdGFibGVyYW5nZTo3MTZkMzBiNjFmZWE0YTE5OTU4ZDM1YTdiYjczNDBlOV84LTEtMS0xLTA_e618aa83-178f-43fb-89aa-f7c3546bdee0">false</dei:AmendmentFlag>
    <pcrx:AccountsReceivablePaymentTerms
      contextRef="i394d1f729acb4158a8f1b548947619fa_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMjYzOQ_a82865c6-0aeb-4bca-a017-866bd6d1661c">P0D</pcrx:AccountsReceivablePaymentTerms>
    <pcrx:DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption
      contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM0MjA_0a6e4989-0f64-4ad2-a49d-950959b333c7">P5D</pcrx:DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption>
    <pcrx:DebtInstrumentMarketPrice
      contextRef="i1c1cb32c967149daac72034c56d3895d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81OC9mcmFnOjU2YmY4YTc4MWRlMzRjN2Y4NjkyMGRhNzNlMDRkOTg5L3RleHRyZWdpb246NTZiZjhhNzgxZGUzNGM3Zjg2OTIwZGE3M2UwNGQ5ODlfMzE_855c56fc-1edc-4609-9b2c-010224a3cada"
      unitRef="number">1.038</pcrx:DebtInstrumentMarketPrice>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81OC9mcmFnOjU2YmY4YTc4MWRlMzRjN2Y4NjkyMGRhNzNlMDRkOTg5L3RleHRyZWdpb246NTZiZjhhNzgxZGUzNGM3Zjg2OTIwZGE3M2UwNGQ5ODlfNzc_34938b2a-19fb-4436-9bae-29e9e6fc5185"
      unitRef="number">0.0149491</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <pcrx:DebtInstrumentMarketPrice
      contextRef="i684590e84b124a17aead86fc30460d60_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81OC9mcmFnOjU2YmY4YTc4MWRlMzRjN2Y4NjkyMGRhNzNlMDRkOTg5L3RleHRyZWdpb246NTZiZjhhNzgxZGUzNGM3Zjg2OTIwZGE3M2UwNGQ5ODlfMTA5_c5cfad47-a33e-4024-8aaa-59319def4ef6"
      unitRef="number">1.086</pcrx:DebtInstrumentMarketPrice>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="iecb17ba904c14ce8b2ecbe73f2cec747_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81OC9mcmFnOjU2YmY4YTc4MWRlMzRjN2Y4NjkyMGRhNzNlMDRkOTg5L3RleHRyZWdpb246NTZiZjhhNzgxZGUzNGM3Zjg2OTIwZGE3M2UwNGQ5ODlfMTU0_45c8a4f6-6aca-4160-a354-ee7a8fdaf74a"
      unitRef="number">0.0139324</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDc0_6a25b9f0-9663-4a32-be37-45e1aae718d9">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6YjI1MDcyNmVhNzk2NDFhNThkYmUwNjZkNGZmNzc2MWUvdGFibGVyYW5nZTpiMjUwNzI2ZWE3OTY0MWE1OGRiZTA2NmQ0ZmY3NzYxZV8xLTAtMS0xLTA_f99b020a-295c-4068-a2e3-86cf30a4e1d4">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8xMjg_af30ca44-4ea4-49bc-af9e-40778f359fdb">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6NGY1ZmFiOGE1MDVjNDYwZmE5MGM0YzMzNjIzZjU1ZmQvdGFibGVyYW5nZTo0ZjVmYWI4YTUwNWM0NjBmYTkwYzRjMzM2MjNmNTVmZF8wLTAtMS0xLTA_02bcdeb8-8216-4572-92e8-c16723340620">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY4_9d9fedb5-1e63-4540-8f1e-77208799f51a">001-35060</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDc1_d9c413fd-7820-4b47-9ddc-8c144eac7b56">PACIRA BIOSCIENCES,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjViZTA0NmE0ZGU4NDEzOGJlOTJhMjA5ZmNhYWNjODYvdGFibGVyYW5nZToyNWJlMDQ2YTRkZTg0MTM4YmU5MmEyMDlmY2FhY2M4Nl8wLTAtMS0xLTA_0af50c56-f4eb-48dc-95e3-c4c4c4302f19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjViZTA0NmE0ZGU4NDEzOGJlOTJhMjA5ZmNhYWNjODYvdGFibGVyYW5nZToyNWJlMDQ2YTRkZTg0MTM4YmU5MmEyMDlmY2FhY2M4Nl8wLTItMS0xLTA_2d254be8-32c5-4d97-aadc-3c19fc5d6272">51-0619477</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY5_d530aec5-a783-4d62-9c9f-7210c95c6282">5401 West Kennedy Boulevard, Suite 890</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDcw_83d9765c-5813-4189-83b3-27878908649a">Tampa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8zMjk4NTM0ODg2MDM3_19bc991f-6760-4da9-884e-b35d70f552f4">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY1_b9f4543c-abf2-494a-9efb-322868f70e0b">33609</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY2_b4804586-ca0e-45af-a19c-204ed49f2565">813</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDcx_4dd58876-6600-4392-a2d2-458437f0f4af">553-6680</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjRjOWFiYjgzNzE5NDg5ZGFlZmNmYTBkYWMxOWEwNTQvdGFibGVyYW5nZToyNGM5YWJiODM3MTk0ODlkYWVmY2ZhMGRhYzE5YTA1NF8xLTAtMS0xLTA_f7433a1b-27b6-4384-bc59-1ea2a9ecccf2">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjRjOWFiYjgzNzE5NDg5ZGFlZmNmYTBkYWMxOWEwNTQvdGFibGVyYW5nZToyNGM5YWJiODM3MTk0ODlkYWVmY2ZhMGRhYzE5YTA1NF8xLTItMS0xLTA_723dfc84-ce5e-4941-a9b7-cab615c6ddf7">PCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6MjRjOWFiYjgzNzE5NDg5ZGFlZmNmYTBkYWMxOWEwNTQvdGFibGVyYW5nZToyNGM5YWJiODM3MTk0ODlkYWVmY2ZhMGRhYzE5YTA1NF8xLTQtMS0xLTA_44ce007b-13df-4f44-83ae-e7f27d125152">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDcy_c35c8a6a-328a-40da-bd2f-3a7575a86f9b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDY3_32420f2a-0241-43b3-9ada-327e6262f7df">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6ZjExNmY1ZjhiNTFiNGFkNjhlZjA1NmY1NWM0NjBlNjEvdGFibGVyYW5nZTpmMTE2ZjVmOGI1MWI0YWQ2OGVmMDU2ZjU1YzQ2MGU2MV8wLTEtMS0xLTA_d88883e5-1623-46c3-b00a-a4e884fc34c3">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6ZjExNmY1ZjhiNTFiNGFkNjhlZjA1NmY1NWM0NjBlNjEvdGFibGVyYW5nZTpmMTE2ZjVmOGI1MWI0YWQ2OGVmMDU2ZjU1YzQ2MGU2MV8xLTUtMS0xLTA_b6d93991-4081-4aa9-9139-b7a1014772f9">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGFibGU6ZjExNmY1ZjhiNTFiNGFkNjhlZjA1NmY1NWM0NjBlNjEvdGFibGVyYW5nZTpmMTE2ZjVmOGI1MWI0YWQ2OGVmMDU2ZjU1YzQ2MGU2MV8yLTUtMS0xLTA_2ac54e91-1ef2-428b-af3f-bdbfad6a1d60">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8yMDcz_30b5e166-e320-494f-9797-1358a4f02c45">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="icd4be343c5c04ff3a57d3cb3f3dfe956_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xL2ZyYWc6MTE3MjNiZTM0MDBjNDEwN2FlMGYxMjY5OWU3OGVhZTAvdGV4dHJlZ2lvbjoxMTcyM2JlMzQwMGM0MTA3YWUwZjEyNjk5ZTc4ZWFlMF8xOTc3_6e1491f1-52c1-41cf-943a-f7a8fa29de81"
      unitRef="shares">44544489</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMi0xLTEtMS0w_396d6d7b-f964-4428-bc20-808e550641f3"
      unitRef="usd">134036000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMi0zLTEtMS0w_45d3194d-5551-410a-853e-08ec35a32221"
      unitRef="usd">99957000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMy0xLTEtMS0w_1622f0db-ef80-4e2d-b46f-306d0ae99ee4"
      unitRef="usd">559822000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMy0zLTEtMS0w_dc329897-07b9-4315-b6ed-aee81d707c0c"
      unitRef="usd">421705000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNC0xLTEtMS0w_fcd43f57-4382-465a-8f91-ec19c457e5d7"
      unitRef="usd">49975000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNC0zLTEtMS0w_03189746-0eba-4ab1-875c-8c2def290ebd"
      unitRef="usd">53046000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNS0xLTEtMS0w_64e45025-bf5e-43ce-a555-13baa9ec4645"
      unitRef="usd">67209000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNS0zLTEtMS0w_fde8da7a-97e4-4626-959b-94c31a835293"
      unitRef="usd">64650000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNi0xLTEtMS0w_5c7f6ad4-d0f9-4a8c-96a8-612a3ba6b224"
      unitRef="usd">11310000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNi0zLTEtMS0w_b97d2ca8-5deb-4bc5-bac2-99f2528689fb"
      unitRef="usd">12265000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNy0xLTEtMS0w_77692b9b-cd22-4d0b-9aad-0b9bfa1c7856"
      unitRef="usd">822352000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNy0zLTEtMS0w_fd866435-9dd2-462a-83f6-2ce9ef3bbe72"
      unitRef="usd">651623000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfOC0xLTEtMS0w_4770c973-8611-49d7-9f43-d3bb8769116d"
      unitRef="usd">0</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfOC0zLTEtMS0w_5463037f-d813-4f03-a753-d0c76446c75b"
      unitRef="usd">95459000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfOS0xLTEtMS0w_1527b66f-787b-480c-9d9d-8bc873544a64"
      unitRef="usd">159235000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfOS0zLTEtMS0w_61fc36a0-a56a-4d20-809b-be1ff56ef809"
      unitRef="usd">136688000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTAtMS0xLTEtMA_666f5a18-2fcc-4180-960e-384600eacd13"
      unitRef="usd">69790000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTAtMy0xLTEtMA_bcc34eda-05a4-48c6-b9f4-b3ba76afbd97"
      unitRef="usd">74492000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTEtMS0xLTEtMA_31ca8da6-126c-40a3-bbcd-fb1ebf7ec7a6"
      unitRef="usd">99547000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTEtMy0xLTEtMA_530aeb86-6eee-48bc-9883-81f51376b21b"
      unitRef="usd">99547000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTItMS0xLTEtMA_6e963276-2058-4eb8-b179-3b9c2542b746"
      unitRef="usd">90621000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTItMy0xLTEtMA_b2d9c833-429c-42a8-8917-909af699c6e1"
      unitRef="usd">96521000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTMtMS0xLTEtMA_5b1184ed-1140-4953-aefb-6fed70ceb6b5"
      unitRef="usd">93265000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTMtMy0xLTEtMA_2dff5245-4d7e-4052-99d5-130dff2f599e"
      unitRef="usd">106164000</us-gaap:DeferredIncomeTaxAssetsNet>
    <pcrx:EquityMethodInvestmentsAndOtherAssets
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTQtMS0xLTEtMA_89ce524d-2513-4cba-8606-b33a782d998f"
      unitRef="usd">21192000</pcrx:EquityMethodInvestmentsAndOtherAssets>
    <pcrx:EquityMethodInvestmentsAndOtherAssets
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTQtMy0xLTEtMA_ba7950ba-008e-4baf-b29b-781c98d45431"
      unitRef="usd">14019000</pcrx:EquityMethodInvestmentsAndOtherAssets>
    <us-gaap:Assets
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTUtMS0xLTEtMA_afba31e2-e0ba-4eea-980f-5bba8e8c9ec5"
      unitRef="usd">1356002000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTUtMy0xLTEtMA_d0c44593-36a2-49c5-980b-886a3bde59f2"
      unitRef="usd">1274513000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTktMS0xLTEtMA_52f52a7e-9575-4f60-945f-4a0be98f3aaa"
      unitRef="usd">7895000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMTktMy0xLTEtMA_db2e0ea8-7580-495a-a995-c619fa5ff3b2"
      unitRef="usd">10431000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjAtMS0xLTEtMA_f7b610f8-a4d7-4052-9410-f98c37124cad"
      unitRef="usd">50798000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjAtMy0xLTEtMA_c25c5948-f53a-48f7-8876-3a00930d8920"
      unitRef="usd">70974000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjEtMS0xLTEtMA_98a0efbd-8035-410a-9f13-5e8f5cc11494"
      unitRef="usd">5879000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjEtMy0xLTEtMA_a025291c-1441-4f84-ab6c-ae2930bf7876"
      unitRef="usd">7425000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjMtMS0xLTEtMA_e1388514-260b-4f87-9c93-178bf7584523"
      unitRef="usd">155751000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjMtMS0xLTEtMA_e848207e-5035-4121-8232-b2bfa3db6ee3"
      unitRef="usd">155751000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjMtMy0xLTEtMA_6da82b5f-de7b-484d-8c18-db7424c41d04"
      unitRef="usd">149648000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjMtMy0xLTEtMA_c6574f28-1633-4d06-a180-2160ee28888d"
      unitRef="usd">149648000</us-gaap:ConvertibleDebtCurrent>
    <pcrx:ContingentConsiderationCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjQtMS0xLTEtMA_70881779-4905-42d0-b36e-5896140da512"
      unitRef="usd">5070000</pcrx:ContingentConsiderationCurrent>
    <pcrx:ContingentConsiderationCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjQtMy0xLTEtMA_a8dc62cf-2dd1-486c-a137-e1c8b39d6cb4"
      unitRef="usd">14736000</pcrx:ContingentConsiderationCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjUtMS0xLTEtMA_eb37fbb6-b2f7-475e-9ca1-616fa2a6b9c3"
      unitRef="usd">395000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjUtMy0xLTEtMA_8c0aaee0-bd6e-4bf3-94c7-235ffb802991"
      unitRef="usd">114000</us-gaap:TaxesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjYtMS0xLTEtMA_2f5a2cff-4bb4-4c39-b4c8-07a4c2ad5d96"
      unitRef="usd">225788000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjYtMy0xLTEtMA_f74c39fc-cd06-406d-9733-635855fe32b2"
      unitRef="usd">253328000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjctMS0xLTEtMA_7917ef9a-54cf-4237-9137-ec4aa26428ec"
      unitRef="usd">326146000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjctMy0xLTEtMA_cba764fb-148e-4565-be4e-5b3f54ea972a"
      unitRef="usd">313030000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjgtMS0xLTEtMA_7523791e-02e4-47ba-8143-2d40b21eb3b5"
      unitRef="usd">66784000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjgtMy0xLTEtMA_507eecac-25aa-4fbb-b231-7f187678a427"
      unitRef="usd">71025000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <pcrx:ContingentConsiderationNoncurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjktMS0xLTEtMA_3472dcf3-9673-41cb-a6d4-d5ff923caed9"
      unitRef="usd">11129000</pcrx:ContingentConsiderationNoncurrent>
    <pcrx:ContingentConsiderationNoncurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMjktMy0xLTEtMA_67700443-13ea-448e-b15e-d945cda0191c"
      unitRef="usd">13610000</pcrx:ContingentConsiderationNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzAtMS0xLTEtMA_eb374364-15c9-4573-8caf-c686dc454b14"
      unitRef="usd">7553000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzAtMy0xLTEtMA_114cbc2f-c5b6-487e-a7e7-094de6cba0cf"
      unitRef="usd">3832000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzEtMS0xLTEtMA_41147985-0d7f-4a30-a48c-ba9399c88a74"
      unitRef="usd">637400000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzEtMy0xLTEtMA_8290e64a-d67e-4554-b331-cbb0f4bef1bc"
      unitRef="usd">654825000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzItMS0xLTEtMA_eac524d8-b65b-4110-a1f4-0db4cabfb2e8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzItMy0xLTEtMA_5f388161-7a0e-4b85-a42b-b6e0566ae5b2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzM2_24c57c41-8100-4f73-a8d9-2b1f8222787c"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzM2_992387a1-a7bf-4f5d-add0-ded8403e854e"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzQw_6b24a46f-f761-4254-9c6d-ff0bc83398f8"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzQw_a642d279-3206-4cd8-b6f2-7c7fff3f5cf9"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzYy_192e3fdd-535e-4720-8e05-093f5209bebb"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzYy_289930ea-c2db-44bf-b9bb-d56a094a172a"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzYy_31f1cbdc-6be5-449d-ad0e-66e2bc12c8a3"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIzZDI5NjNjMWUyZTQ1NTY4YzA3YmJmNmRiZWQ5ZDE0XzYy_590bbb74-b2f1-43bc-a8ea-6e3105a161ba"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMS0xLTEtMA_634e3dec-7eae-4684-953a-be70112ff22b"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzQtMy0xLTEtMA_920e7b3b-0cda-46ba-a0f2-50bf2a624ff8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzMz_b35d9d07-0fd8-4ef1-aeae-e12ce32bd8b6"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzMz_e868c0e3-6cc3-482b-9619-6b9682fafc91"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzM3_50f65503-8c48-4c9a-820d-747d7f4b2ccb"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzM3_b90f085d-4155-4ec3-8811-05c6773c8e9e"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzU5_e5a7b401-3fc6-4176-8b0e-5d53bccf605b"
      unitRef="shares">44523410</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzU5_f731ca46-8a44-4c87-a1b5-935371fac329"
      unitRef="shares">44523410</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzEwNA_1d791dbc-24d4-43b3-ad2c-7066d73bdc6a"
      unitRef="shares">43636929</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRmNjcwYjg1ZjY0OTQxZGE4NmY3OTBkZjIxMWM1MzliXzEwNA_8ec2185b-365f-4fe2-9d1d-3ecda1d67fe4"
      unitRef="shares">43636929</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMS0xLTEtMA_fbaebeae-53d9-4416-b627-ed972e0d510e"
      unitRef="usd">45000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzUtMy0xLTEtMA_da436c60-86ab-4725-aa65-c02debb38802"
      unitRef="usd">44000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzYtMS0xLTEtMA_664c1203-11ac-4311-b22d-7db5174e2091"
      unitRef="usd">925169000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzYtMy0xLTEtMA_db1f299d-9c97-4981-9fa2-f48edbb05d5b"
      unitRef="usd">873201000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzctMS0xLTEtMA_c0e93d25-b679-4115-ba06-0c6e05627c84"
      unitRef="usd">-206765000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzctMy0xLTEtMA_726b1ebf-a013-4331-a57d-84f31516e6c8"
      unitRef="usd">-253875000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzgtMS0xLTEtMA_8945dd41-7fe3-487d-8317-89f6e918e0c3"
      unitRef="usd">153000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzgtMy0xLTEtMA_3f52af71-8636-43cf-bad2-cedee20a7f7b"
      unitRef="usd">318000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzktMS0xLTEtMA_c3846076-4156-4060-b2a4-e7c81a2563de"
      unitRef="usd">718602000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfMzktMy0xLTEtMA_ee3ef371-e12b-4def-8d60-62399e752064"
      unitRef="usd">619688000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNDAtMS0xLTEtMA_ebcb3352-147f-4db2-ac4d-f7ebd06c945c"
      unitRef="usd">1356002000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xNi9mcmFnOmQwNTNiNWUzN2Y1ODQwODg4MzRmODc5YTAxOWQwOTU5L3RhYmxlOmI2MzRjN2E2MTJlYjRlMzY4MGZiMDZmZDI2NzIxMmFlL3RhYmxlcmFuZ2U6YjYzNGM3YTYxMmViNGUzNjgwZmIwNmZkMjY3MjEyYWVfNDAtMy0xLTEtMA_e9f9495f-be52-43ef-8d01-c056d8bc7f37"
      unitRef="usd">1274513000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12dead7e93d941fa9ed3c4a6d9cdd283_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMy0xLTEtMS0w_14e60ce8-fa4b-4a4b-a650-03a2925cb8d7"
      unitRef="usd">126791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie63b52bbc6f8429686e59ef4517c7bf4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMy0zLTEtMS0w_84bdc1b7-a5ee-4e44-9fa8-f0bf58002a6f"
      unitRef="usd">116889000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45a4d517e9454a9a888918ce80188a4e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMy01LTEtMS0w_a9fe4218-b68f-4421-89dc-19dd7ac9297f"
      unitRef="usd">380392000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b7287c7614e46d8ab1553c11a8c6b9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMy03LTEtMS0w_e84b7b68-b299-489a-95d2-6cf8f34a343c"
      unitRef="usd">296850000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5a291ee19594ddfab77fce82e32a1c6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNC0xLTEtMS0w_8b108dfc-a3d6-457d-8729-2d5e564c3af6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9842d334ede6470cba57f5223fd23c14_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNC0zLTEtMS0w_1a5c417c-3b3d-4b0f-9279-16877ff2f5c4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48ad93bee00549d8bdd6a51f78347c23_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNC01LTEtMS0w_7668dff2-716c-49a0-b2c7-f8fa9ea7b005"
      unitRef="usd">125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e97b7d115ac489bb255e8dbdd6a3227_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNC03LTEtMS0w_ed3860a9-f00a-48e6-9d68-28c46b592a36"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i117249baf38443f781c1edf946e8991e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNS0xLTEtMS0w_398a199e-a0d3-4855-b0ed-2617608922b0"
      unitRef="usd">931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if09bc71a12134a489569878485158a10_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNS0zLTEtMS0w_e5db469a-d525-4191-8892-ec8f9cbf6cde"
      unitRef="usd">595000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5220037f26804a09aca54e93634fae07_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNS01LTEtMS0w_faee1660-d8b5-41b2-b12f-2124c1b3c767"
      unitRef="usd">1822000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i343da0f70b794c348d0831e6aeaf9c59_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNS03LTEtMS0w_a0dee5cc-ac3f-4d0b-bf5e-6e41fbadd70f"
      unitRef="usd">1823000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNi0xLTEtMS0w_3b4b8551-73d8-49d3-8100-63b7841875f0"
      unitRef="usd">127722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNi0zLTEtMS0w_461a2fc4-1d93-4e68-b692-c5ab1b790a74"
      unitRef="usd">117484000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNi01LTEtMS0w_bdd67180-e7f0-4bc7-b489-29453cb785ab"
      unitRef="usd">382339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfNi03LTEtMS0w_8b65cf81-2b27-4b3d-ace3-2c155ebc88b6"
      unitRef="usd">298673000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOC0xLTEtMS0w_9ede31c5-e629-41ea-aeb8-06c14d246cf9"
      unitRef="usd">34651000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOC0zLTEtMS0w_4780e8c3-2f89-4f69-9cdb-77b1b8712045"
      unitRef="usd">29993000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOC01LTEtMS0w_c6d6ba27-47f4-4a8f-a94d-03b2fbc7f950"
      unitRef="usd">101248000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOC03LTEtMS0w_6579ec60-5fe3-4dd3-bfa1-3e05cf1e144b"
      unitRef="usd">82031000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOS0xLTEtMS0w_71bd8a68-782c-44da-8a31-b92dcaba2248"
      unitRef="usd">11578000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOS0zLTEtMS0w_17f09cea-65b3-4e5f-b98c-6dbe3d581b42"
      unitRef="usd">14651000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOS01LTEtMS0w_24cfeb8d-f7b9-44c8-b618-67be0c946d07"
      unitRef="usd">40031000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfOS03LTEtMS0w_aa6e7e76-439c-4bfb-877d-0ff1f27bf5e7"
      unitRef="usd">44090000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTAtMS0xLTEtMA_99fee23f-d273-42bc-9b90-6a931c1976a4"
      unitRef="usd">48807000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTAtMy0xLTEtMA_2bb48d8e-dd67-423d-b541-875f5331ef85"
      unitRef="usd">52561000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTAtNS0xLTEtMA_8ac63c83-2736-43b6-b177-3f79fe4f9046"
      unitRef="usd">148142000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTAtNy0xLTEtMA_065a9ecc-a82b-40bb-94d6-84bf337afee8"
      unitRef="usd">140683000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTEtMS0xLTEtMA_cf2062cb-18c7-480b-9040-e8c8e06e80a7"
      unitRef="usd">1967000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTEtMy0xLTEtMA_3f5efae2-3592-4c1e-abb4-a57eab377034"
      unitRef="usd">1967000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTEtNS0xLTEtMA_2e3c9d83-fb56-403e-b384-858776aeb34e"
      unitRef="usd">5900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTEtNy0xLTEtMA_c3bec40b-8c9a-41f0-8ba6-07f9ef881069"
      unitRef="usd">5900000</us-gaap:AmortizationOfIntangibleAssets>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTItMS0xLTEtMA_2115a3e5-53e4-49ed-b4c0-fbd29adaa5ec"
      unitRef="usd">714000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTItMy0xLTEtMA_024a2269-4457-4c14-9b3b-017cb2bc1313"
      unitRef="usd">-692000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTItNS0xLTEtMA_a386e627-c09c-4a23-a104-ef51a9c25089"
      unitRef="usd">-1305000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTItNy0xLTEtMA_020152e8-ee7b-464a-851c-119d541912c6"
      unitRef="usd">1599000</pcrx:AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet>
    <us-gaap:CostsAndExpenses
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTMtMS0xLTEtMA_2a7739b3-b4fb-41ea-940d-fe2bde297689"
      unitRef="usd">96289000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTMtMy0xLTEtMA_b200522e-5cef-4f87-8474-ae03a02bcc93"
      unitRef="usd">99864000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTMtNS0xLTEtMA_d18e74e0-a20a-48ca-8e45-ad5ce46c06a5"
      unitRef="usd">296626000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTMtNy0xLTEtMA_e5ae3daf-9022-48da-95c0-e78c397db9cc"
      unitRef="usd">271105000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTQtMS0xLTEtMA_c123d32f-ec6c-4c6f-b96f-5948c54e60f2"
      unitRef="usd">31433000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTQtMy0xLTEtMA_2c45e4d0-60fd-48a7-a2f0-09b2c61527b4"
      unitRef="usd">17620000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTQtNS0xLTEtMA_44c5b158-3c47-4616-9a43-1167fca7e183"
      unitRef="usd">85713000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTQtNy0xLTEtMA_6c709ef7-8b58-4d07-a663-b6049b76969e"
      unitRef="usd">27568000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTYtMS0xLTEtMA_860de14f-eca8-4d9e-8c40-03bc50ee1b4d"
      unitRef="usd">177000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTYtMy0xLTEtMA_de911d32-2395-4e3e-92b2-27cedc34dbee"
      unitRef="usd">1025000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTYtNS0xLTEtMA_a0f37fed-eb84-44d8-bc3d-fc6879c92e41"
      unitRef="usd">816000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTYtNy0xLTEtMA_e569f78a-38e7-432d-bc49-bce4cea2744b"
      unitRef="usd">3936000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTctMS0xLTEtMA_ee3abcc4-6976-4dd6-8ce3-f96b6c2b8a7d"
      unitRef="usd">7333000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTctMy0xLTEtMA_82daab82-a093-4247-a005-6efbc2efff5a"
      unitRef="usd">7132000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTctNS0xLTEtMA_406c883f-44c5-4037-af16-0f7eba7977d9"
      unitRef="usd">21327000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTctNy0xLTEtMA_fbd208f8-2785-4093-92a2-af973ae7ba68"
      unitRef="usd">18609000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTgtMS0xLTEtMA_201f4e11-e22c-4e9c-bbf7-624c4eaadb5e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTgtMy0xLTEtMA_409b4125-eb92-4755-8107-3d666af1c708"
      unitRef="usd">-8071000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTgtNS0xLTEtMA_0c835931-bdb7-4911-a94d-f04b3fc8087b"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTgtNy0xLTEtMA_4a40ba80-58b8-43a5-b570-ca9fc846cccf"
      unitRef="usd">-8071000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTktMS0xLTEtMA_ef4f8772-10d4-4cb8-97d9-bf2650868669"
      unitRef="usd">-46000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTktMy0xLTEtMA_dcbaca48-8a0c-4bcf-8148-66badf757141"
      unitRef="usd">2708000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTktNS0xLTEtMA_5002502c-cf04-4ff0-921c-e2e15b1bd3bb"
      unitRef="usd">-2600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMTktNy0xLTEtMA_a1f5dfd1-60e2-4ef8-9bdc-feefb911f7f4"
      unitRef="usd">2571000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjAtMS0xLTEtMA_0c513061-f0d0-4163-9305-c3caae360645"
      unitRef="usd">-7202000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjAtMy0xLTEtMA_664af1ca-8421-4146-bcfb-01b4b0c786e8"
      unitRef="usd">-11470000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjAtNS0xLTEtMA_a0b94c11-c064-497b-9265-9cb28cb0e074"
      unitRef="usd">-23111000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjAtNy0xLTEtMA_51e126de-a270-409a-a217-5b097263fcb2"
      unitRef="usd">-20173000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjEtMS0xLTEtMA_824f040a-cee4-4923-80a2-802fdef954ee"
      unitRef="usd">24231000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjEtMy0xLTEtMA_5ea2eba7-ec60-4bda-ab7e-9ea57a69f311"
      unitRef="usd">6150000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjEtNS0xLTEtMA_e4342f6c-1145-4c9a-a167-e1af0ad5ad66"
      unitRef="usd">62602000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjEtNy0xLTEtMA_adc31784-7d39-456e-8a47-7350e577b4fe"
      unitRef="usd">7395000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjItMS0xLTEtMA_de224121-d912-4e5b-9045-f8766950a1fa"
      unitRef="usd">6571000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjItMy0xLTEtMA_686fe9a9-42ac-4148-b10f-e2f1e789802d"
      unitRef="usd">-123969000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjItNS0xLTEtMA_2d2c9838-ea53-4790-acd6-12cd40db1a4b"
      unitRef="usd">15492000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjItNy0xLTEtMA_203fce1a-9e41-4871-8570-e9833114c7c7"
      unitRef="usd">-123613000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjMtMS0xLTEtMA_4ab62241-6dda-4fd0-9d50-68ffa62feddb"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjMtMy0xLTEtMA_7a4bfe7a-1f7e-4658-b0bd-132433e94fe8"
      unitRef="usd">130119000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjMtNS0xLTEtMA_b5743bed-9a3f-4a03-ab39-90a89e4fd4f5"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjMtNy0xLTEtMA_182ccef9-51b7-4ce2-bb13-3aa8f8e02992"
      unitRef="usd">131008000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjYtMS0xLTEtMA_ee4742ac-212c-419c-8340-addb182ff7aa"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjYtMy0xLTEtMA_30862dc6-8d2c-4ce5-b2a2-9afdc7ae9b57"
      unitRef="usdPerShare">3.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjYtNS0xLTEtMA_108d76af-d711-4741-9e8b-d9e1e1232583"
      unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjYtNy0xLTEtMA_6e7f198b-cd8d-4bed-a1c7-7dc3f462d93a"
      unitRef="usdPerShare">3.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjctMS0xLTEtMA_cfc3509c-8412-46aa-9136-639c0e7f556b"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjctMy0xLTEtMA_07a87063-3ea5-4078-9fed-904b9eb76f08"
      unitRef="usdPerShare">2.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjctNS0xLTEtMA_657e2594-d48b-4a12-a59a-9951db4b4360"
      unitRef="usdPerShare">1.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjctNy0xLTEtMA_9324cfb3-ad26-4b41-a353-15f1a2c1437b"
      unitRef="usdPerShare">3.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjktMS0xLTEtMA_3c70a029-a3bc-46af-8a25-859bf67b71a2"
      unitRef="shares">44476000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjktMy0xLTEtMA_22daa683-8eb2-43ed-b660-3763115282a6"
      unitRef="shares">42928000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjktNS0xLTEtMA_2c7cffdc-f675-42ec-84c2-7b0f482eb625"
      unitRef="shares">44151000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMjktNy0xLTEtMA_3741a53d-1ac5-4eb6-b55e-6c90731ca14c"
      unitRef="shares">42393000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMzAtMS0xLTEtMA_ec5aa6ce-5a5b-4426-86fa-f83fc17418f0"
      unitRef="shares">45463000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMzAtMy0xLTEtMA_ed5e9e0f-fc5b-424d-a660-6d57a2030955"
      unitRef="shares">44275000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMzAtNS0xLTEtMA_8e9b4e1d-59ba-4329-bdf4-6a00688633f4"
      unitRef="shares">45674000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xOS9mcmFnOmJiNTVmY2U2Nzg1NjQ1MTRiMTgzNDdlNGZhMDc5ODJmL3RhYmxlOjcyMjQ3NmRhN2E3ZTQ0OThhNzlkZjA2N2Q5ODdlY2E0L3RhYmxlcmFuZ2U6NzIyNDc2ZGE3YTdlNDQ5OGE3OWRmMDY3ZDk4N2VjYTRfMzAtNy0xLTEtMA_e29f9562-ec33-4f66-9e79-30107a4d8264"
      unitRef="shares">43333000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfMi0xLTEtMS0w_4ab62241-6dda-4fd0-9d50-68ffa62feddb"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfMi0zLTEtMS0w_f0406d8d-a5bd-4f5d-897c-252f69e5a064"
      unitRef="usd">130119000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfMi01LTEtMS0w_b5743bed-9a3f-4a03-ab39-90a89e4fd4f5"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfMi03LTEtMS0w_3a9652dc-c393-40f6-9dde-b1fc5d90e432"
      unitRef="usd">131008000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNC0xLTEtMS0w_334a0a02-9792-47ac-a1bf-b65e1a81db5d"
      unitRef="usd">-30000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNC0zLTEtMS0w_284bf4ee-4cf6-44c4-b371-9474e1102ab2"
      unitRef="usd">-643000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNC01LTEtMS0w_4f61c47c-cf52-41ce-8dfa-a22936cc6191"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNC03LTEtMS0w_26ae7f06-eea1-487b-bcef-859507588dab"
      unitRef="usd">525000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNS0xLTEtMS0w_33fe86b7-17e6-447c-ba9a-29829e609b8c"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNS0zLTEtMS0w_32337398-693b-4d75-9a8a-5bc1884cb3a9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNS01LTEtMS0w_1ef809c4-5f50-4ea6-889e-0955012cff43"
      unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNS03LTEtMS0w_36cde35d-719d-43fc-be47-00f66b549e66"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNi0xLTEtMS0w_d5444c97-134f-49f4-a63c-61b2dd6ef981"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNi0zLTEtMS0w_489c4461-7f48-4d02-9b9c-40de5405892a"
      unitRef="usd">-643000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNi01LTEtMS0w_4667d9ab-0cca-4ad3-87fe-e8bd7a0636d2"
      unitRef="usd">-165000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNi03LTEtMS0w_823f21a4-2f5d-41e9-a346-d022fca7a89b"
      unitRef="usd">525000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNy0xLTEtMS0w_d21956dd-3c9e-4346-988d-30457b7bb5bd"
      unitRef="usd">17632000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNy0zLTEtMS0w_55edd411-e822-444d-b403-3b6fb0dfc240"
      unitRef="usd">129476000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNy01LTEtMS0w_5279bef2-7950-4a8c-9edf-a2974cddc541"
      unitRef="usd">46945000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yMi9mcmFnOjA1NDUzNDQzNTVhYzQ2MDJiZjdlMTg1Zjg3NmY0ZGFlL3RhYmxlOmFlYzNjN2FjMjM2MDRmMmM5ZDM4YzBhMWU5ZWVhYjUyL3RhYmxlcmFuZ2U6YWVjM2M3YWMyMzYwNGYyYzlkMzhjMGExZTllZWFiNTJfNy03LTEtMS0w_32939c6e-25a8-486b-abe2-f064fe9a5443"
      unitRef="usd">131533000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i7edff5520a404b2b83447444f9eb459f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi0xLTEtMS0w_3bcbb578-ac41-4997-ba50-7408e01a5aaa"
      unitRef="shares">44437000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7edff5520a404b2b83447444f9eb459f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi0zLTEtMS0w_f47efabd-7518-4fb4-af8d-81188632324b"
      unitRef="usd">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i122a17173a484439aee4c4ca9b399085_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi01LTEtMS0w_8a36058e-4dcc-4e43-a276-a7c9b2817554"
      unitRef="usd">911368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3b693b61cc3b4215a6ee287c335a9063_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi03LTEtMS0w_b6639925-6b23-4887-b28b-5d25ff500d14"
      unitRef="usd">-224425000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73d65492b3924412b7973c03af1fe9e6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi05LTEtMS0w_acc090d9-21f9-45ab-a83a-3d2445f406a3"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8495ec90002a45e0bf0887939ab74508_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMi0xMS0xLTEtMA_e991661e-62bc-4be1-9d0a-51997508c41d"
      unitRef="usd">687168000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i948ca81132a24b4d8ef57d52788a5385_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNS0xLTEtMS0w_18a9f5a5-62c5-4468-92a2-3d3e12526a3e"
      unitRef="shares">74000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i948ca81132a24b4d8ef57d52788a5385_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNS0zLTEtMS0w_1367cc8e-9a75-4387-b3fa-c5bb16e71ef7"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i21fe54e97dd84dc997ccfb0ebc078b9a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNS01LTEtMS0w_df8d7054-81b5-4110-9591-9653b53bd595"
      unitRef="usd">3017000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNS0xMS0xLTEtMA_80cf0e21-0510-4625-a01b-2e38a3e98131"
      unitRef="usd">3018000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i948ca81132a24b4d8ef57d52788a5385_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfNi0xLTEtMS0w_d5aa3577-c40c-47b9-84c0-273e5977889a"
      unitRef="shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i21fe54e97dd84dc997ccfb0ebc078b9a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfOC01LTEtMS0w_f2089068-e4a8-4180-be4a-0ae19981d8a5"
      unitRef="usd">10784000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfOC0xMS0xLTEtMA_2a28f717-5591-42ad-bdb2-a7c1c6d30810"
      unitRef="usd">10784000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4f9c6243a10041a9a851d8813a74c05e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTItOS0xLTEtMA_7aca3d65-fde9-4064-855d-5ecc94768c18"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTItMTEtMS0xLTA_a08023a5-6e7d-4efb-9fe8-0ecda38ba746"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i077b7247a4a24b37a42640d85ace320b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTMtNy0xLTEtMA_3d420ba3-b816-471d-872a-4c6f0aa2662c"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTMtMTEtMS0xLTA_bccd110d-8381-4799-9019-6d0a55454efa"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ifff9414f8ec14f648d23be05a58aa2b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtMS0xLTEtMA_f3fc7c24-5966-4b5a-ad87-9efa05373ec6"
      unitRef="shares">44523000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifff9414f8ec14f648d23be05a58aa2b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtMy0xLTEtMA_2fe356e1-0f32-44c2-bd20-cbd79ce4eb9b"
      unitRef="usd">45000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib557a2279d86475996731b3fc97be752_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtNS0xLTEtMA_05aedec6-efc2-4a51-aee0-4558b17e3a76"
      unitRef="usd">925169000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20e70406d1a045e4bd52905aacc53fa2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtNy0xLTEtMA_6b06daaa-b610-40ef-8cb1-0d22d795521f"
      unitRef="usd">-206765000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55cda46fa2334de29508526999af243a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtOS0xLTEtMA_6813695b-9c7c-481f-9d9b-2fc03ece8a28"
      unitRef="usd">153000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmNkNDNiN2NjZWNjMjQyYWU5MTE5ZGE3N2YxMWRhZTFiL3RhYmxlcmFuZ2U6Y2Q0M2I3Y2NlY2MyNDJhZTkxMTlkYTc3ZjExZGFlMWJfMTQtMTEtMS0xLTA_4a92c188-21af-454d-9bed-5de40538abe4"
      unitRef="usd">718602000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i014f2a1fc24b43b18ee6280f20cdf1ce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi0xLTEtMS0w_54fefd52-5df8-4c8d-8ff7-aaff2b5d2540"
      unitRef="shares">42608000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i014f2a1fc24b43b18ee6280f20cdf1ce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi0zLTEtMS0w_1fa1f790-08db-454d-85b9-f51b43abb205"
      unitRef="usd">43000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0782a595bbfb44b29916dbcc9517713f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi01LTEtMS0w_5e6c2373-66d4-4442-ae55-7803484d9f6b"
      unitRef="usd">785124000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if774c56400c143a986cc56ea80547ef8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi03LTEtMS0w_03cef44d-197e-426e-a4cf-9271ec2f4fda"
      unitRef="usd">-398509000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0697b721fc9e45f69f060f8f46d77072_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi05LTEtMS0w_f9ffd4a4-66a5-4ff0-b0f6-a1519f02fd79"
      unitRef="usd">1490000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07c52d1fdd134b989a3e678be437266e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMi0xMS0xLTEtMA_4efc2d97-5513-427f-a29e-2c977e0dbaf7"
      unitRef="usd">388148000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0a8a218cb3b1417390af7c5813a511e9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNS0xLTEtMS0w_70bc413f-e139-4d02-9b32-8d604df9c711"
      unitRef="shares">703000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0a8a218cb3b1417390af7c5813a511e9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNS0zLTEtMS0w_5de522ac-7405-4b1d-b839-92c9eb0bc86b"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i39a912dcf7aa45e69c293537f5fa8875_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNS01LTEtMS0w_60270453-e6b0-4073-b177-49bd8d15f464"
      unitRef="usd">24582000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNS0xMS0xLTEtMA_407c6787-dc02-44e7-9500-a988bf0b10da"
      unitRef="usd">24582000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0a8a218cb3b1417390af7c5813a511e9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfNi0xLTEtMS0w_e7b5c031-e84a-4826-846f-9d3eadea1730"
      unitRef="shares">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i39a912dcf7aa45e69c293537f5fa8875_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfOC01LTEtMS0w_bfc1a923-1cfe-4453-b073-cb3546b91c20"
      unitRef="usd">10954000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfOC0xMS0xLTEtMA_67cf0e4b-e84a-4ce4-b5dd-7730a7068ba2"
      unitRef="usd">10954000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i5abf6e142c09447396ea931fa4051312_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTAtNS0xLTEtMA_d714b983-5615-4e86-aaa0-cd59504a638b"
      unitRef="usd">-33089000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i28f2bef137d34763a6e0945cc7109ba5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTAtMTEtMS0xLTA_7ad79baa-bd52-4106-89fa-71d2eccb4857"
      unitRef="usd">-33089000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjdjMDAwZDYyNTYyYjRhOWRiZjIwMzEyYjZiYzk2NTU4XzEwOTk1MTE2Mjc4ODY_fa9c458b-1615-4c10-bf7e-fe39a081c1d1"
      unitRef="usd">20450000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i7254f3d070d24fedba65bee5b312cfb6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTEtNS0xLTEtMA_cbe7277c-a1ca-48db-8bdf-9e7f44263f61"
      unitRef="usd">64619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i7254f3d070d24fedba65bee5b312cfb6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTEtMTEtMS0xLTA_dd040558-a1e2-46db-b51c-232398f51804"
      unitRef="usd">64619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i255a01006e2448ef9f48b2f549fa8a87_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTItOS0xLTEtMA_ce44c9ab-67a4-4095-b52a-15f07c133ba6"
      unitRef="usd">-643000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTItMTEtMS0xLTA_780d6bb2-3da2-49a8-8dc4-5d077f19724f"
      unitRef="usd">-643000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="ide7713099e5342bc91935b76d0493eb3_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTMtNy0xLTEtMA_c4fdea23-ef7d-489a-bdd8-9a7d526c6686"
      unitRef="usd">130119000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTMtMTEtMS0xLTA_f20cc229-ef9a-4095-a205-daf98d50f4c6"
      unitRef="usd">130119000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i97143ff422764b1eb3afddc0d216dca4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtMS0xLTEtMA_71b5da7f-955c-4369-8344-c565b3aed8b5"
      unitRef="shares">43313000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i97143ff422764b1eb3afddc0d216dca4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtMy0xLTEtMA_cd0e84c5-258d-41d6-9f6e-7b6b70ed5f82"
      unitRef="usd">43000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8d0686e48b449de8494030e085a5ba6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtNS0xLTEtMA_f5f675db-2220-482f-9911-6fa9e8e3fc1b"
      unitRef="usd">852190000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41a7036c745f4bed845b3722cfd852b4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtNy0xLTEtMA_f0d0ae7e-7d96-4ae7-9529-6a6b2e17d0f7"
      unitRef="usd">-268390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e471ced5e9c4e899d18dd16de8c4d8e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtOS0xLTEtMA_2e93ce41-05d2-47f1-942c-1b4421e49f6e"
      unitRef="usd">847000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOmRjYTdmNWQxMTJiYjRjYTNhZjQ3MzJhZWU3ZmVjZDk5L3RhYmxlcmFuZ2U6ZGNhN2Y1ZDExMmJiNGNhM2FmNDczMmFlZTdmZWNkOTlfMTQtMTEtMS0xLTA_f7eea33a-0c14-4f25-ac65-1e7c1fc34452"
      unitRef="usd">584690000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i1c1289967bb1472eb59cfee843fc6864_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi0xLTEtMS0w_992cf4d5-0611-421f-a0d5-197ccef47091"
      unitRef="shares">43637000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1c1289967bb1472eb59cfee843fc6864_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi0zLTEtMS0w_cf6f3af1-ff07-4f23-acff-022c8dad8992"
      unitRef="usd">44000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4ae279ae07c24b808b12769dd2e5d56b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi01LTEtMS0w_38c7ac1f-a2ff-4a92-b6f5-d7d6afc09732"
      unitRef="usd">873201000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieaacf91e289d4f41a577e6a6fc15dd78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi03LTEtMS0w_3dd2284c-1398-4929-a315-308b500af375"
      unitRef="usd">-253875000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i71ef8fa3f6ef4295b34719dd5bcd1ea2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi05LTEtMS0w_f7d231b7-27f4-4f71-bfe9-5cb580f0e70f"
      unitRef="usd">318000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMi0xMS0xLTEtMA_b4811360-64fd-4107-8b2b-a3786eb2a179"
      unitRef="usd">619688000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i633a7f9223744608a36564a7e357408f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNS0xLTEtMS0w_c3ab2d77-4a5c-4d29-9e7c-ac609c7fff01"
      unitRef="shares">553000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i633a7f9223744608a36564a7e357408f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNS0zLTEtMS0w_492a5976-78fa-40ee-8ebf-503d7c02ca2f"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i948705b5248d4d66bb924c0499f8f0dd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNS01LTEtMS0w_6df9bed9-97fc-47fe-b91a-1d406bd65b17"
      unitRef="usd">19038000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNS0xMS0xLTEtMA_0f5c5d0a-cc16-40c4-b5f0-744ef4887d6f"
      unitRef="usd">19039000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i633a7f9223744608a36564a7e357408f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNi0xLTEtMS0w_afcd9edb-6e3b-49a8-9e93-5dc762a5bdfc"
      unitRef="shares">302000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i633a7f9223744608a36564a7e357408f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNy0xLTEtMS0w_c9b20552-b394-461a-97e6-8dfb5cc5c659"
      unitRef="shares">31000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i948705b5248d4d66bb924c0499f8f0dd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNy01LTEtMS0w_29361bb7-b155-4c35-aeb2-242e36c115c6"
      unitRef="usd">1574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfNy0xMS0xLTEtMA_b37e1e48-689a-41b7-a6fe-c89ea14787e6"
      unitRef="usd">1574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i948705b5248d4d66bb924c0499f8f0dd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfOC01LTEtMS0w_21a092a8-feed-4865-bb51-ad9ad7e934b9"
      unitRef="usd">31356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfOC0xMS0xLTEtMA_38a5b95e-c76f-411d-9c4a-9c15146693df"
      unitRef="usd">31356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib7fe3f4d4a2545b2bcf7893e525bd645_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTItOS0xLTEtMA_68691caa-2135-433a-86fb-85a8c6a72ccd"
      unitRef="usd">-165000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTItMTEtMS0xLTA_ab31e4f1-7bab-42c7-985e-512199dece52"
      unitRef="usd">-165000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i906da711ad9f492aa726ba7c1e3c3da3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTMtNy0xLTEtMA_ae3d83cb-b89b-4cb8-978d-00fab4332837"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTMtMTEtMS0xLTA_2558379e-70c7-4ffc-956c-f1b2b7bd7645"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ifff9414f8ec14f648d23be05a58aa2b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtMS0xLTEtMA_d4f142c7-2ad5-4a7b-b766-c6dd30e46003"
      unitRef="shares">44523000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifff9414f8ec14f648d23be05a58aa2b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtMy0xLTEtMA_708e3c27-befa-4c9e-9569-9a462089780e"
      unitRef="usd">45000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib557a2279d86475996731b3fc97be752_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtNS0xLTEtMA_2293f4fd-82c0-4e7a-a609-f145ccb3dfda"
      unitRef="usd">925169000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20e70406d1a045e4bd52905aacc53fa2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtNy0xLTEtMA_9b25d112-d0ae-48b4-897d-564d69e88caa"
      unitRef="usd">-206765000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55cda46fa2334de29508526999af243a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtOS0xLTEtMA_37aa1730-6d7b-4e14-b094-4d8ddd051ac4"
      unitRef="usd">153000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjE3N2U4OTA4NTM2MDQ3NGVhZWYzZjNmNzhjZGI4YmMwL3RhYmxlcmFuZ2U6MTc3ZTg5MDg1MzYwNDc0ZWFlZjNmM2Y3OGNkYjhiYzBfMTQtMTEtMS0xLTA_788ba7ae-0cbf-4513-8a87-5768332ae2b0"
      unitRef="usd">718602000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i4956ecea465b41aca59fcfcd35dcac46_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi0xLTEtMS0w_28242e6c-071e-4248-b82a-c3215dea6bc1"
      unitRef="shares">41908000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i4956ecea465b41aca59fcfcd35dcac46_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi0zLTEtMS0w_e1c8a00a-d773-4dc3-b089-624218fc8cc4"
      unitRef="usd">42000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46c78db21b3e43b48cc5600bf97beeb0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi01LTEtMS0w_f275c70f-4421-4a58-8202-84df346fbaec"
      unitRef="usd">753978000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0a1a3131f4134e8897f0cf6d5e2ffd17_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi03LTEtMS0w_8738e9e8-6600-40f8-b17f-6103c331d714"
      unitRef="usd">-399398000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa26d8ae002340a3ad3e4dd57c59814b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi05LTEtMS0w_499f8337-7158-4260-bd8b-4b941dda0f68"
      unitRef="usd">322000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c6d0b8cddef42e7b5f9944be6d07888_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMi0xMS0xLTEtMA_4049b863-591e-481a-93bb-af0d3643c4a6"
      unitRef="usd">354944000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNS0xLTEtMS0w_c697e1a8-6d89-47f4-92f7-ec381d50b8af"
      unitRef="shares">1130000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNS0zLTEtMS0w_97e1e303-bb7b-4258-9889-8eb1c4fc063e"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iffeb5e781f954b4e84f040966bddc6b8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNS01LTEtMS0w_b1cf2cae-dec2-40fc-b2fd-1c4367ddd9e9"
      unitRef="usd">36237000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNS0xMS0xLTEtMA_92903430-9012-4df2-a043-5854864c7ed5"
      unitRef="usd">36238000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNi0xLTEtMS0w_93c28544-565a-497c-8eb4-d63b748a3274"
      unitRef="shares">238000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i4e40614cb475485b84f5720583e83dfb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNy0xLTEtMS0w_21e0d85a-e72a-44cd-a854-6f3fd73c2256"
      unitRef="shares">37000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iffeb5e781f954b4e84f040966bddc6b8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNy01LTEtMS0w_0b5625c7-b11f-4135-8e55-c56fc38e9573"
      unitRef="usd">1421000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfNy0xMS0xLTEtMA_44349d04-5ad0-4660-8aef-aa2c72c74908"
      unitRef="usd">1421000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iffeb5e781f954b4e84f040966bddc6b8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfOC01LTEtMS0w_c766d557-7dbd-4c8e-88f7-cc2eab04dae5"
      unitRef="usd">29024000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfOC0xMS0xLTEtMA_75e5fbf9-f160-426e-8eb3-84a8c6342e4e"
      unitRef="usd">29024000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i28039b2d361d4a4fab500d11195dad95_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTAtNS0xLTEtMA_476593d2-dfab-4f8e-8c56-c54d723032cf"
      unitRef="usd">-33089000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i28039b2d361d4a4fab500d11195dad95_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTAtMTEtMS0xLTA_86b00722-6b92-415f-acf0-b06d1f29cf41"
      unitRef="usd">-33089000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjcxYmIzMDQ4MjVlMTQxNzg5MjI1N2RmMDdlOGZkMzBmXzEwOTk1MTE2Mjc4ODY_637da24b-7beb-4649-a87c-77599b2a2b19"
      unitRef="usd">20450000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i8e525b059b864af98aeec5d4a4a0628d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTEtNS0xLTEtMA_51709403-f858-40f8-ab2c-08c3397042e1"
      unitRef="usd">64619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="i8e525b059b864af98aeec5d4a4a0628d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTEtMTEtMS0xLTA_56026835-aa50-45e8-9765-9d7f5edb6944"
      unitRef="usd">64619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i53046ca604b24b22afbf86b490b8b1a7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTItOS0xLTEtMA_f6e83962-0513-4c8c-8990-73c15dae4abd"
      unitRef="usd">525000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTItMTEtMS0xLTA_a3358bbf-e905-4f09-a62d-4d2eff24c5fb"
      unitRef="usd">525000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i66f2b75905cb47d0a73cb049beed27cf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTMtNy0xLTEtMA_ab6c54cb-8b4a-4c9c-9a4f-0be8de43515b"
      unitRef="usd">131008000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTMtMTEtMS0xLTA_f2c31e8a-4482-4a03-97cf-55cc8637c43e"
      unitRef="usd">131008000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i97143ff422764b1eb3afddc0d216dca4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtMS0xLTEtMA_cf4ed0ec-4126-4fb6-ac4d-f9215dab377a"
      unitRef="shares">43313000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i97143ff422764b1eb3afddc0d216dca4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtMy0xLTEtMA_366bf888-e46f-4a75-bce2-a4337279f7b8"
      unitRef="usd">43000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8d0686e48b449de8494030e085a5ba6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtNS0xLTEtMA_683c0d6f-e7d1-4cc5-acf4-8a74a7bb44d8"
      unitRef="usd">852190000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41a7036c745f4bed845b3722cfd852b4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtNy0xLTEtMA_f4d21743-18f5-4d9b-b17a-252c77ad850d"
      unitRef="usd">-268390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e471ced5e9c4e899d18dd16de8c4d8e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtOS0xLTEtMA_d39d0544-f1dc-40f2-b29e-d18ced8741ca"
      unitRef="usd">847000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yNS9mcmFnOmMwY2YwOTQ4NDczMzRlNzZiYmVlYzQ4NzU2M2I5M2M5L3RhYmxlOjY3NmZhMzZjY2RjODQ0NDNiNzg2ZDI3OTFkY2JlNGVkL3RhYmxlcmFuZ2U6Njc2ZmEzNmNjZGM4NDQ0M2I3ODZkMjc5MWRjYmU0ZWRfMTQtMTEtMS0xLTA_36c1b800-c5cf-4aab-a221-a4c673929e93"
      unitRef="usd">584690000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMy0xLTEtMS0w_555082e2-2f86-47aa-a58c-2d346f9708bd"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMy0zLTEtMS0w_3617fdab-96d1-4fb3-aeb0-7c6c0e0f2c84"
      unitRef="usd">131008000</us-gaap:NetIncomeLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNS0xLTEtMS0w_24586e39-1724-41aa-bda1-46b531bd097b"
      unitRef="usd">12953000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNS0zLTEtMS0w_7cbf1f9d-d38f-441b-91e3-9ea6ec090343"
      unitRef="usd">-124572000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNi0xLTEtMS0w_ede15c72-d9b1-4995-ac88-d0ea8d814dbd"
      unitRef="usd">15478000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNi0zLTEtMS0w_ea1c91ff-84fe-4eed-ad1d-4e81eea77451"
      unitRef="usd">14847000</us-gaap:DepreciationDepletionAndAmortization>
    <pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNy0xLTEtMS0w_41619a10-d2b2-4be1-bc1e-0529b5865c91"
      unitRef="usd">1976000</pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation>
    <pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNy0zLTEtMS0w_7c91c824-c36a-4f63-9722-21ef17faff11"
      unitRef="usd">1512000</pcrx:AmortizationOfOtherAssetsAndUnfavorableLeaseObligation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfOC0xLTEtMS0w_71311266-f833-490e-8ce1-dfcf42f06531"
      unitRef="usd">17245000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfOC0zLTEtMS0w_9301deb3-44b8-493b-b6a1-932cc1a458c5"
      unitRef="usd">12684000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfOS0xLTEtMS0w_0d68f974-be9e-4616-b47f-7bbe864724a1"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfOS0zLTEtMS0w_18d350e7-d540-483d-89be-41b5b81aa617"
      unitRef="usd">-8071000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTAtMS0xLTEtMA_4ff75281-6ab7-40ab-abd9-55a9c136cb79"
      unitRef="usd">10000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTAtMy0xLTEtMA_6c362a41-8008-4388-8631-d8c6b8189ae3"
      unitRef="usd">-22000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ShareBasedCompensation
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTEtMS0xLTEtMA_6c0444dc-2541-40d8-b35f-8c03b791af15"
      unitRef="usd">31356000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTEtMy0xLTEtMA_c5850be3-f846-4253-a9d7-8d150e27f875"
      unitRef="usd">29024000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTItMS0xLTEtMA_1f459908-b179-413d-bf60-fd2c2b938e06"
      unitRef="usd">-2147000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTItMy0xLTEtMA_ba546ad3-9dc1-43da-8ce1-4c82307a1924"
      unitRef="usd">-1560000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTMtMS0xLTEtMA_6427c6b1-5ec3-4b2b-856a-444c3cc25eac"
      unitRef="usd">2641000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTMtMy0xLTEtMA_71596853-7de1-409b-b274-a4a55fb75ff3"
      unitRef="usd">-2779000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTUtMS0xLTEtMA_d5a8930b-b8cf-44c1-ad78-594b5d75def3"
      unitRef="usd">-3070000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTUtMy0xLTEtMA_b096dde4-1a53-42cf-a247-b23fa44a3bb7"
      unitRef="usd">-1386000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTYtMS0xLTEtMA_e5aaa235-ebfe-4bf4-aee4-d51a4136267d"
      unitRef="usd">2560000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTYtMy0xLTEtMA_7e2f84ca-3c64-4e29-96ef-b364c8d8e305"
      unitRef="usd">10246000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTctMS0xLTEtMA_bff4cd0e-1dbf-4207-8e35-c8c7506c2495"
      unitRef="usd">-907000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTctMy0xLTEtMA_af71f057-e12b-4c15-a965-cbbeb769b228"
      unitRef="usd">382000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTgtMS0xLTEtMA_54552b6f-b9c6-4a1f-9bc7-e24507cc69c0"
      unitRef="usd">-825000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTgtMy0xLTEtMA_27ec93b9-73cd-4652-96b4-d3217e1270e5"
      unitRef="usd">-1117000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTktMS0xLTEtMA_3d582c00-d3a2-4325-afba-8dd8fb440f78"
      unitRef="usd">-17034000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMTktMy0xLTEtMA_ad47eb9e-2d3c-423b-913e-38143b539793"
      unitRef="usd">-16454000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjAtMS0xLTEtMA_4e653e67-580c-4269-b2fc-4166026ea398"
      unitRef="usd">-1996000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjAtMy0xLTEtMA_ae5c54ee-14ec-410f-931d-6c1ca330fc26"
      unitRef="usd">-1670000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjEtMS0xLTEtMA_e515f9ee-e44f-4647-b1c0-6215babfd708"
      unitRef="usd">5662000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjEtMy0xLTEtMA_ed479a88-84e3-4414-bdfc-1b2869179348"
      unitRef="usd">9409000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjItMS0xLTEtMA_0d0a5b2c-97a8-4202-a3df-a3e545175af1"
      unitRef="usd">102502000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjItMy0xLTEtMA_d296d769-a425-4f52-8bd9-7368cfe51d3a"
      unitRef="usd">30365000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjUtMS0xLTEtMA_98bf8eee-9afd-439d-93b9-73bafc6d271b"
      unitRef="usd">36700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjUtMy0xLTEtMA_b080988f-3eda-4f7c-a5a8-2e605909c6b7"
      unitRef="usd">23393000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjYtMS0xLTEtMA_551c994e-61ca-440f-954c-0cf9d00f586e"
      unitRef="usd">513492000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjYtMy0xLTEtMA_2d54f9a1-15eb-4e5a-bf60-8cddc667f0d3"
      unitRef="usd">326664000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjctMS0xLTEtMA_dfb21f43-cf87-4bdb-b6a7-7031e93c384c"
      unitRef="usd">470614000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjctMy0xLTEtMA_9c8d5a28-9508-4415-b98d-cd000e74b48f"
      unitRef="usd">154767000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjktMS0xLTEtMA_b7456bb5-4812-4e4d-9150-322348bf7b79"
      unitRef="usd">17187000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMjktMy0xLTEtMA_1799d944-5587-41fd-a1dc-43987b6a5240"
      unitRef="usd">0</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzAtMS0xLTEtMA_74f186f5-b745-4dfb-838f-b17c5eebc1af"
      unitRef="usd">9057000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzAtMy0xLTEtMA_437c9ee3-1523-4902-88ff-b0ca48553e5a"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzItMS0xLTEtMA_66e15c6f-30e0-40d3-b89d-65840a52e436"
      unitRef="usd">-87708000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzItMy0xLTEtMA_5312821a-70b1-4f9e-a513-c0d0addbd830"
      unitRef="usd">-195290000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzQtMS0xLTEtMA_d7847031-5f51-4cea-828b-a224782a7a27"
      unitRef="usd">19049000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzQtMy0xLTEtMA_c6872e34-f1ca-407a-a70a-3b69d95f6341"
      unitRef="usd">35980000</us-gaap:ProceedsFromStockOptionsExercised>
    <pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzUtMS0xLTEtMA_e50dfde2-36cb-4e57-b462-edf70136713b"
      unitRef="usd">1574000</pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans>
    <pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzUtMy0xLTEtMA_6a5c80fa-5639-41d7-88fb-40302e29c60c"
      unitRef="usd">1421000</pcrx:ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="iecb17ba904c14ce8b2ecbe73f2cec747_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzYtMS0xLTEtMA_412eae34-06bf-4068-9c23-7f78a230dcfc"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="iddb7245efd2d449f81aae47fd4200c45_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzYtMy0xLTEtMA_cd65f1f3-a3d3-4551-b20e-1fa1e7d07904"
      unitRef="usd">314708000</us-gaap:ProceedsFromConvertibleDebt>
    <pcrx:ProceedsFromConvertibleOptionComponentOfConvertibleDebt
      contextRef="iecb17ba904c14ce8b2ecbe73f2cec747_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzctMS0xLTEtMA_81d824da-2989-4c85-aa64-6eb92b7224e0"
      unitRef="usd">0</pcrx:ProceedsFromConvertibleOptionComponentOfConvertibleDebt>
    <pcrx:ProceedsFromConvertibleOptionComponentOfConvertibleDebt
      contextRef="iddb7245efd2d449f81aae47fd4200c45_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzctMy0xLTEtMA_5acb7527-4feb-446c-8d53-e82b3624a95f"
      unitRef="usd">87792000</pcrx:ProceedsFromConvertibleOptionComponentOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzktMS0xLTEtMA_06f09faa-cbd9-4613-90ff-b10d9c8abfb2"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i856232cea6c64e2ea98e0dc82a006dac_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfMzktMy0xLTEtMA_b11e0147-49c9-4c56-9b8c-737cf375d19a"
      unitRef="usd">176793000</us-gaap:RepaymentsOfConvertibleDebt>
    <pcrx:RetirementOfEquityComponentOfConvertibleSeniorNotes
      contextRef="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDAtMS0xLTEtMA_1edb09fd-ea6f-4180-a03f-b1b9bc056b2f"
      unitRef="usd">0</pcrx:RetirementOfEquityComponentOfConvertibleSeniorNotes>
    <pcrx:RetirementOfEquityComponentOfConvertibleSeniorNotes
      contextRef="i856232cea6c64e2ea98e0dc82a006dac_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDAtMy0xLTEtMA_c8c00dda-85e8-4d61-a7b0-9e2f4ee421e7"
      unitRef="usd">33089000</pcrx:RetirementOfEquityComponentOfConvertibleSeniorNotes>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDItMS0xLTEtMA_c7dddde4-ba80-4472-9c7e-b5ef785a022d"
      unitRef="usd">0</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDItMy0xLTEtMA_307ff22b-8a8c-43ce-b40c-664b6681c29a"
      unitRef="usd">12487000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDMtMS0xLTEtMA_0d83c715-6506-41e1-b784-6a51f4fddaff"
      unitRef="usd">1338000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDMtMy0xLTEtMA_71eea57f-44b2-4523-b4b7-d5d34294a2ef"
      unitRef="usd">5591000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDQtMS0xLTEtMA_881872c9-ce21-4aa6-9003-610859692b1b"
      unitRef="usd">19285000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDQtMy0xLTEtMA_347288c9-f30d-4238-9c1c-f5739fc6787d"
      unitRef="usd">211941000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDUtMS0xLTEtMA_20634e05-99c1-4c1a-ac48-c52d5e498591"
      unitRef="usd">34079000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDUtMy0xLTEtMA_f9d0cb34-5eab-4707-a0d5-0c07c589a969"
      unitRef="usd">47016000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDYtMS0xLTEtMA_800a4839-9ac5-4917-9b84-b44e2b67e8fb"
      unitRef="usd">99957000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0c6d0b8cddef42e7b5f9944be6d07888_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDYtMy0xLTEtMA_ee31bb7c-0729-4c78-9a80-8a3770c211bf"
      unitRef="usd">78228000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDctMS0xLTEtMA_1d8b8f4f-fea2-4ee6-b9f2-3c983b8bfa16"
      unitRef="usd">134036000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNDctMy0xLTEtMA_392851f6-6039-4ccc-aa18-3876f85bbbbf"
      unitRef="usd">125244000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNTMtMS0xLTEtMA_82b52db3-d2f6-46a2-a19a-67ab05442bb4"
      unitRef="usd">5096000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNTMtMy0xLTEtMA_7b96c388-e579-400f-826e-cc294781ce80"
      unitRef="usd">5305000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNTQtMS0xLTEtMA_c6aed491-5982-4570-abf8-80f069e148ee"
      unitRef="usd">2259000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNTQtMy0xLTEtMA_82acc9a1-320d-4b56-909b-42b1413cf72a"
      unitRef="usd">2329000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNjAtMS0xLTEtMA_21bf8d0c-4a0b-4a1d-95c7-080779e1b285"
      unitRef="usd">4719000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8yOC9mcmFnOjZkYzEyMGI5NTY5MzQ1YWI5YzM5MGU3MjljOTMxNjQyL3RhYmxlOjljM2E4YzA3NTYzNDRlMjc4MGE5NmQ0NjA3MmI0MjI0L3RhYmxlcmFuZ2U6OWMzYThjMDc1NjM0NGUyNzgwYTk2ZDQ2MDcyYjQyMjRfNjAtMy0xLTEtMA_36310ac7-fbbb-4d74-8ec1-8729014d20dd"
      unitRef="usd">9442000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMzQ5Mw_e9d576ce-0318-4f63-83a6-8999ae79ba9f">DESCRIPTION OF BUSINESS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#x201c;Company&#x201d; or &#x201c;Pacira&#x201d;) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients&#x2019; journeys along the neural pain pathway. The Company&#x2019;s long-acting, local analgesic, EXPAREL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012 and approved by the European Commission in November 2020. EXPAREL utilizes the Company&#x2019;s unique and proprietary multivesicular liposome delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, the Company added iovera&#xb0;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience. The iovera&#xb0; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to only targeted nerves.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, Pacira entered the Merger Agreement (as defined below) with Oyster Acquisition Company Inc., a Delaware corporation and wholly owned subsidiary of Pacira (&#x201c;Merger Sub&#x201d;), and Flexion Therapeutics, Inc., a Delaware corporation, or Flexion. Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, on October 22, 2021, Merger Sub commenced a cash tender offer (the &#x201c;Offer&#x201d;), to acquire all of the outstanding shares of common stock of Flexion, $0.001 par value per share (the &#x201c;Flexion Shares&#x201d;), at an offer price of (i) $8.50 per Flexion Share in cash, net of applicable withholding taxes and without interest, plus (ii) one contingent value right per Flexion Share, which will represent the right to receive one or more contingent payments up to $8.00 per Flexion Share in the aggregate upon the achievement of specified milestones on or prior to December 31, 2030. Refer to Note 16, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from two products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as one reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Novel Coronavirus (COVID-19) Pandemic&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company&#x2019;s net product sales were negatively impacted by the global pandemic caused by a novel strain of coronavirus (COVID-19), which mandated significant postponement or suspension in the scheduling of elective surgical procedures resulting from public health guidance and government directives. Elective surgical restrictions began to lift on a state-by-state basis in April 2020, allowing net product sales to return to year-over-year growth in June 2020. However, while many restrictions have since eased with COVID-19 vaccines now widely available, the elective surgery market faced additional pandemic-related challenges in August and September 2021 due to regional surges in COVID-19 delta variant cases, staffing shortages and surgical fatigue from care teams addressing significant procedure backlogs. While these challenges began to subside in October 2021, it is unknown how long it will take the elective surgical market to normalize, or if restrictions on elective surgical procedures will recur due to COVID-19 variant strains or otherwise. The Company&#x2019;s manufacturing sites are operational and have safety protocols and guidelines as recommended by federal, state and local governments. To date, there have been no material impacts to the Company&#x2019;s supply chain. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise from the COVID-19 pandemic that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMzI5ODUzNDg5MzU2NQ_17efb88b-1771-4074-99eb-41557202f29c"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMzI5ODUzNDg5MzUzOQ_70021f6b-7583-4754-b2ef-1ba360b777fe"
      unitRef="usdPerShare">8.5</us-gaap:BusinessAcquisitionSharePrice>
    <pcrx:ClassOfWarrantOrRightNumberOfRightsIssued
      contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMzI5ODUzNDg5MzYzMg_5a03e181-4494-442d-a930-fcc6e69e3624"
      unitRef="shares">1</pcrx:ClassOfWarrantOrRightNumberOfRightsIssued>
    <pcrx:BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice
      contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfODc5NjA5MzAzMjQxMg_bbed6002-0d61-41b0-a037-3ca4d0031e34"
      unitRef="usdPerShare">8.00</pcrx:BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice>
    <pcrx:ConcentrationRiskNumberOfProducts
      contextRef="i9252be06dfb84136b1c245c17afd18b9_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMTE0Nw_41af17f2-e3ab-494a-a195-89b010767894"
      unitRef="product">2</pcrx:ConcentrationRiskNumberOfProducts>
    <us-gaap:NumberOfReportableSegments
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNC9mcmFnOmQyMzhjMzk5ZDczNTQwZWY4ODBmMGNjMmE1M2NkMzA2L3RleHRyZWdpb246ZDIzOGMzOTlkNzM1NDBlZjg4MGYwY2MyYTUzY2QzMDZfMTk0NA_88b94782-27a1-48a5-bd7d-9d3a5f9cb0b4"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA2Mg_6ee15b97-eecc-4437-acf9-5564b6e66ca7">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Annual Report on Form&#160;10-K for the year ended December 31, 2020&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements at September&#160;30, 2021, and for the three and nine month periods ended September&#160;30, 2021 and 2020, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2020 is derived from the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2020. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee and sells iovera&#xb0; directly to end users. The table below includes the percentage of revenues comprised by the Company&#x2019;s three largest wholesalers in each period presented:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Second largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Third largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amended the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The standard allows for certain exceptions, including the exception to the use of the incremental approach for intra-period tax allocations, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also required franchise or similar taxes partially based on income to be reported as income tax and to reflect the effects of enacted changes in tax laws or rates in the annual effective tax rate computation from the date of enactment. Lastly, in future acquisitions, the Company will be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The standard became effective for the Company beginning January 1, 2021 and there were no material impacts to the consolidated financial statements upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative, and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The other separation models would be eliminated, including the model for convertible debt that can be settled in cash &lt;/span&gt;&lt;/div&gt;or shares. As a result, these convertible debt instruments will be accounted for as a single liability instrument. In addition, the new guidance requires diluted earnings per share calculations to be prepared using the if-converted method, instead of the treasury stock method. The guidance must be applied in fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company plans to adopt the new guidance using a modified retrospective method of transition, which would be applied to transactions outstanding at the time of adoption. At September&#160;30, 2021, the Company has recognized debt discounts of $68.7&#160;million for its 0.750% convertible senior notes due 2025 and $3.8&#160;million for its 2.375% convertible senior notes due 2022. Upon adoption on January 1, 2022, these debt discounts would be eliminated along with any related future amortization. Further deferred financing costs previously allocated to the conversion features will be re-allocated to the outstanding debt, slightly increasing future annual amortization of deferred financing costs. The Company expects the impact of this standard to be material to its consolidated financial statements and related disclosures.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA4Mg_21b2d40d-d5ec-4560-80d8-7153d837ee4b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Annual Report on Form&#160;10-K for the year ended December 31, 2020&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements at September&#160;30, 2021, and for the three and nine month periods ended September&#160;30, 2021 and 2020, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2020 is derived from the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2020. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.&lt;/span&gt;&lt;/div&gt;</pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA1Nw_03c151ac-0251-4dd4-b870-df3591a77785">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee and sells iovera&#xb0; directly to end users.</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA4NQ_3cb7f33e-93bb-4121-818f-a3433d119757">The table below includes the percentage of revenues comprised by the Company&#x2019;s three largest wholesalers in each period presented:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Second largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Third largest wholesaler&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i766f22ea0ac24a77a51e08e7ca35945f_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMi0xLTEtMS0w_24615aeb-519b-4451-91e0-1cc9b964b5b8"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i56f4b02fe95c4104bfdc2b5350e072e8_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMi0zLTEtMS0w_f86678e4-c927-4e29-9581-232f799f5e8a"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if28fae669275407da1afd4ccaffe03be_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMi01LTEtMS0w_6647076e-48f5-43cd-819d-d7f20e8b47a8"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i26b9a9fb65e1404983d517a01cb75626_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMi03LTEtMS0w_eafb37aa-291d-4cec-9fce-f1ac69f2e023"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iacef49a3ede14eda8bd8c641ad091a60_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMy0xLTEtMS0w_9aeafd52-59d9-4593-ad65-1c5d225cf337"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic5badbb37b7a4f1b94a0f02f00cf2590_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMy0zLTEtMS0w_ba4fec7b-9692-4c65-a1b0-205a4d13bbfd"
      unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia74009bf8abb4b0b991b74490d2554f6_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMy01LTEtMS0w_706cbdc6-193d-48dd-b659-d758eb8c7f6d"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i844e9fe2488b4442bcf86bf11b9e76ed_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfMy03LTEtMS0w_0324f861-867f-4c4e-85eb-3156512b3989"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i205e1c4172cd4d2b809c620611b5e0b0_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNC0xLTEtMS0w_6b8050ca-a109-419f-93cc-8932eb34c4ba"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibb78eb77b14d47f892d26f89746691ff_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNC0zLTEtMS0w_5e8c8b20-1689-471a-8993-7f87f82fdcf5"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8688a00c06e54c5f8d4c92616c5ac6ea_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNC01LTEtMS0w_7565fd21-315f-42c6-bc0b-99b797f4bb8c"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i30925928a2bd4e02a8ed2ea04199236d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNC03LTEtMS0w_cf9b82e1-647e-4fa6-b482-1d98c45f3326"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i150082df5ab74269aac685d70ddd9809_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNS0xLTEtMS0w_c80231c7-fea8-4813-a10d-f66f419ee1d2"
      unitRef="number">0.85</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i44d32a7bfbd0444d949387c037771a01_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNS0zLTEtMS0w_8bf1786a-2f0f-4d5e-9a97-ae934239da71"
      unitRef="number">0.86</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifed03345c8384bd697f0693a26aaf05a_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNS01LTEtMS0w_3b163855-7778-43fc-b31b-68edd3fac1ff"
      unitRef="number">0.85</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i14236b4e4c5c46349502a9255c70ff12_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RhYmxlOjU5MjFhNzhkODg0MTQwYjM5OGI2MjAwNDlmZWFhNmRlL3RhYmxlcmFuZ2U6NTkyMWE3OGQ4ODQxNDBiMzk4YjYyMDA0OWZlYWE2ZGVfNS03LTEtMS0w_555d157d-201d-43cb-9054-99cd46892b46"
      unitRef="number">0.87</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNjA3Mw_906f5d88-d116-4121-88fd-a17fc4c02b39">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amended the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The standard allows for certain exceptions, including the exception to the use of the incremental approach for intra-period tax allocations, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also required franchise or similar taxes partially based on income to be reported as income tax and to reflect the effects of enacted changes in tax laws or rates in the annual effective tax rate computation from the date of enactment. Lastly, in future acquisitions, the Company will be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The standard became effective for the Company beginning January 1, 2021 and there were no material impacts to the consolidated financial statements upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative, and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The other separation models would be eliminated, including the model for convertible debt that can be settled in cash &lt;/span&gt;&lt;/div&gt;or shares. As a result, these convertible debt instruments will be accounted for as a single liability instrument. In addition, the new guidance requires diluted earnings per share calculations to be prepared using the if-converted method, instead of the treasury stock method. The guidance must be applied in fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company plans to adopt the new guidance using a modified retrospective method of transition, which would be applied to transactions outstanding at the time of adoption. At September&#160;30, 2021, the Company has recognized debt discounts of $68.7&#160;million for its 0.750% convertible senior notes due 2025 and $3.8&#160;million for its 2.375% convertible senior notes due 2022. Upon adoption on January 1, 2022, these debt discounts would be eliminated along with any related future amortization. Further deferred financing costs previously allocated to the conversion features will be re-allocated to the outstanding debt, slightly increasing future annual amortization of deferred financing costs. The Company expects the impact of this standard to be material to its consolidated financial statements and related disclosures.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNTUxMQ_d9d76b60-3851-4c25-8809-5c57c8d6112e"
      unitRef="usd">68700000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNTUyMg_b52e931a-6218-4f13-a5ae-be82d2733b6e"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNTU2Mw_36c2d24a-08ff-4ce3-b788-7e4c7a05e22a"
      unitRef="usd">3800000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8zNy9mcmFnOmUyNzI2ZGFkMTVmYzRmYzhhYWViODRmZTk0MWU4ZDEyL3RleHRyZWdpb246ZTI3MjZkYWQxNWZjNGZjOGFhZWI4NGZlOTQxZThkMTJfNTU3NA_893ad27a-9f3a-4c58-92ff-9dd08e6f2060"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfNDMxNg_3d28296e-44e1-4f35-ac8d-0d0dee5cb491">REVENUE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s sources of revenue include (i) sales of EXPAREL in the United States, or U.S.; (ii) sales of iovera&#xb0; in the U.S.; (iii) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use in the U.S. and (iv) license fees and milestone payments. To date, there has been no revenue from sales of EXPAREL or iovera&#xb0; in the European Union, or E.U. The Company does not consider revenue from sources other than sales of EXPAREL to be material to its consolidated revenue, which could change in the future. As such, the following disclosure only relates to revenue associated with net EXPAREL product sales.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Product Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL revenue is recorded at the time the product is delivered to the end-user.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, wholesaler service fees, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers and doctors. Payment terms generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMjYzOQ_a82865c6-0aeb-4bca-a017-866bd6d1661c"&gt;zero&lt;/span&gt; to 37 days from the date of the transaction, and accordingly, there is no significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#x2019;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#x2019;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL to &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregated net product sales in the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;EXPAREL / bupivacaine liposome injectable suspension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;iovera&#xb0;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb8afdaa87d44b849e4d16d61dab0781_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMzI5ODUzNDg4NzY0NQ_54d0bdf6-cef1-42ea-8d11-105c5d37a74f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefd0f799d2934f3c879017bae1f70cac_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMzI5ODUzNDg4NzY0NQ_eac253ab-b73d-46a8-a773-faf95fa6d5c4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <pcrx:AccountsReceivablePaymentTerms
      contextRef="i41b00db28bd24e8298f3daa38843e448_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMjY0NQ_fdab0230-2139-4d5e-a074-9c192495ba23">P37D</pcrx:AccountsReceivablePaymentTerms>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfNDMxNA_091d01b7-8a36-423e-a81d-b6b16e5f10f3">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregated net product sales in the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;EXPAREL / bupivacaine liposome injectable suspension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;iovera&#xb0;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib583d9b057b942b68b4eaeb985e512fd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfMy0yLTEtMS0w_08fd6e05-7cd3-4dc6-80d2-ef07431244c8"
      unitRef="usd">122609000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9363f54932e4fbba77650e2de1ba4de_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfMy00LTEtMS0w_5de12d59-99cc-4a16-a561-3b513db66c20"
      unitRef="usd">114163000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1129d76aea6423ca3b15e9965559c8f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfMy02LTEtMS0w_2bfe469c-12ab-4e02-9e1c-0b89490fbf23"
      unitRef="usd">369128000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5accd35363b841d5bd616a756fec67a4_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfMy04LTEtMS0w_c4f9abc1-c14e-463e-a2e2-b10625634418"
      unitRef="usd">290459000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fde0359479247adb32995272e9e92e8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNC0yLTEtMS0w_5be81e02-8e07-4653-aed0-3104c6dcb1a8"
      unitRef="usd">4182000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5ff86ece96a40f6ba1006fbc2ee4fa1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNC00LTEtMS0w_b5c98e18-9163-4296-9f3e-f2fb14c8562d"
      unitRef="usd">2726000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26bec4aae3774657b312c164cf9e6b95_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNC02LTEtMS0w_e39de4f3-56fe-4110-a2c7-6832ed7529a1"
      unitRef="usd">11264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29692bf80ec74a828827091f01d350e8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNC04LTEtMS0w_a6f4af37-240d-49cc-8fef-6650436463dc"
      unitRef="usd">6391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12dead7e93d941fa9ed3c4a6d9cdd283_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNS0yLTEtMS0w_6a179f98-f966-4f36-a1d7-855b65c284a3"
      unitRef="usd">126791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie63b52bbc6f8429686e59ef4517c7bf4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNS00LTEtMS0w_60fc97c4-a291-45cd-ad8b-f8ba2b7572cf"
      unitRef="usd">116889000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45a4d517e9454a9a888918ce80188a4e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNS02LTEtMS0w_66865552-d7bc-4bba-a3ed-e635ba768c66"
      unitRef="usd">380392000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b7287c7614e46d8ab1553c11a8c6b9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RhYmxlOmFhOWI1ZTYwMmQxMTRlMDJhYzM2N2UxOTYzNjg4ZTU3L3RhYmxlcmFuZ2U6YWE5YjVlNjAyZDExNGUwMmFjMzY3ZTE5NjM2ODhlNTdfNS04LTEtMS0w_78aa6794-a8f4-41d2-9f54-bc7d2cfd13d3"
      unitRef="usd">296850000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RleHRyZWdpb246YTI4MjE3ZTkwODNjNGE4NjlmZDIxNTczYjliYjVjOTRfOTU_7ec539fb-acb2-4352-84f3-a47c5d932e16">INVENTORIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of inventories, net are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RleHRyZWdpb246YTI4MjE3ZTkwODNjNGE4NjlmZDIxNTczYjliYjVjOTRfOTM_1c7dd047-8cba-47b9-826e-e2d3df8bd141">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of inventories, net are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfMi0xLTEtMS0w_ebb6644d-524c-491f-ada4-021b87a5f620"
      unitRef="usd">35434000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfMi0zLTEtMS0w_0be50f03-8d00-46a9-a1aa-baf483efa78f"
      unitRef="usd">26886000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfMy0xLTEtMS0w_369bfcf1-a678-4e30-885f-36613e718ee0"
      unitRef="usd">17222000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfMy0zLTEtMS0w_aeb36a87-e646-45c6-b1b1-a95c02d82442"
      unitRef="usd">16266000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfNC0xLTEtMS0w_cd78adc5-8c1c-433e-833f-9a2feddd47e9"
      unitRef="usd">14553000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfNC0zLTEtMS0w_ac67852a-e256-4030-88d6-4f331c601141"
      unitRef="usd">21498000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfNS0xLTEtMS0w_f9401242-4f88-489c-909f-240ec07327b5"
      unitRef="usd">67209000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80My9mcmFnOmEyODIxN2U5MDgzYzRhODY5ZmQyMTU3M2I5YmI1Yzk0L3RhYmxlOjk5ZmFlOWZkNTg2YjQyNWRiMGMyN2M1NTczMmI5OWUzL3RhYmxlcmFuZ2U6OTlmYWU5ZmQ1ODZiNDI1ZGIwYzI3YzU1NzMyYjk5ZTNfNS0zLTEtMS0w_f6ec7306-6b59-4c2d-b810-8dea880a70c1"
      unitRef="usd">64650000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTA1OQ_71deb4ba-7108-47c0-97d6-0a4c400c64ac">FIXED ASSETS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed assets, net, summarized by major category, consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2021 and 2020, depreciation expense was $3.8 million and $3.1 million, respectively. For the three months ended September&#160;30, 2021 and 2020, there was $0.9 million and $0.7 million of capitalized interest on the construction of manufacturing sites, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September&#160;30, 2021 and 2020, depreciation expense was $9.6&#160;million and $8.9&#160;million, respectively. For the nine months ended September&#160;30, 2021 and 2020, there was $3.0&#160;million and $1.5&#160;million of capitalized interest on the construction of manufacturing sites, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021 and December&#160;31, 2020, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $66.9 million and $67.5 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021 and December&#160;31, 2020, the Company had asset retirement obligations of $2.1&#160;million and $2.0&#160;million, respectively, which are included in accrued expenses and other liabilities on its condensed consolidated balance &lt;/span&gt;&lt;/div&gt;sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTA1Ng_9ee5de93-50ad-470b-b13e-e6127c0c9379">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed assets, net, summarized by major category, consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i99bdc6f6fda24e0fb4e3bc0f687562ff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfMi0xLTEtMS0w_681378bf-5729-427e-9e2e-b3e365c71215"
      unitRef="usd">111819000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7ed0e5100a704244a6604a6ffdca5f84_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfMi0zLTEtMS0w_2bd1431a-95a4-4038-a075-8b4eda385910"
      unitRef="usd">74966000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i53f18cccc5ab4371abe468c2835247ca_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfMy0xLTEtMS0w_e60e9d12-7363-47c1-a44d-0d514757955d"
      unitRef="usd">60426000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i898a223b5d1b4effbcd726f575d3e5e0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfMy0zLTEtMS0w_34fbd828-2fbf-4a63-b98b-bbdc271e69ca"
      unitRef="usd">54434000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibaa288b76e0a42ed96cf349f5192edb1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNC0xLTEtMS0w_2877b98f-d77f-41c1-a854-27148df39f15"
      unitRef="usd">12744000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia34fa7325b3e40089d0092964f4fc930_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNC0zLTEtMS0w_a0e3b315-7964-4634-91f8-c53a8ba27d5b"
      unitRef="usd">12170000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic665add04b7e4b1e909cb5ea8efd8516_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNS0xLTEtMS0w_589af54b-dd95-4298-997c-562fb6fe088d"
      unitRef="usd">2477000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2f9e89c1e0d94c15900cc25867cdaf15_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNS0zLTEtMS0w_21621889-73f1-4801-931c-045e9faa5a29"
      unitRef="usd">2387000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1c2f20e3bb0c4ee4a9973bd9ac272cba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNi0xLTEtMS0w_85f52a6b-39db-4587-95f3-57261c8e5bcd"
      unitRef="usd">59579000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie78554782b924c2e943917d448e44ec6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNi0zLTEtMS0w_9cf91b69-bd94-4c62-8ccb-370e553bbb54"
      unitRef="usd">71091000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNy0xLTEtMS0w_0ab144a4-67ce-4a4f-8789-591a9c586dab"
      unitRef="usd">247045000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfNy0zLTEtMS0w_f5954f90-190f-4ef1-89af-3b005e6929e7"
      unitRef="usd">215048000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfOC0xLTEtMS0w_b0552289-7b97-481f-95e1-758397a431f7"
      unitRef="usd">87810000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfOC0zLTEtMS0w_2d951912-d9d8-4cdd-8ce7-ca4d05d2bc08"
      unitRef="usd">78360000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfOS0xLTEtMS0w_76321fe2-8d12-4fe2-b7f2-775278a4dbb0"
      unitRef="usd">159235000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RhYmxlOjhhMjg4MzQ0NmM3MDQ5NjI5ZmVmZTUwMWMxZjUxN2ZlL3RhYmxlcmFuZ2U6OGEyODgzNDQ2YzcwNDk2MjlmZWZlNTAxYzFmNTE3ZmVfOS0zLTEtMS0w_1fa83c94-b71f-4dc1-8df0-0f2337d6b6be"
      unitRef="usd">136688000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTgy_76b5ca91-f539-4068-9dac-39cc05d767ec"
      unitRef="usd">3800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTg5_e5dc8719-7825-4a6a-a584-33a1675407bd"
      unitRef="usd">3100000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="i0379cda4d5d444419b2c756629bfe8be_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMjU1_fd6e5a08-fd73-436c-be2c-034d6d9cdc85"
      unitRef="usd">900000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ia0e6245f12984622bb9ff0bf0fe46d7b_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMjYy_df08fd78-d273-4002-b988-f360565c4994"
      unitRef="usd">700000</us-gaap:InterestCostsCapitalized>
    <us-gaap:Depreciation
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNDEw_b3642677-6c7a-493c-b3b8-7d46837e4adf"
      unitRef="usd">9600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNDE3_533f9ae1-8385-4d3c-88b1-49ee7647775b"
      unitRef="usd">8900000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="i5263cd5b15ec419ea569ba7621aacc70_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNDgx_67916564-d06a-49f6-afbc-8aa96c38d0b8"
      unitRef="usd">3000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i89ff104d4b684eac9d78a0eec97980e2_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNDg4_abb591e6-2182-4558-ba65-3fd9bf5d994b"
      unitRef="usd">1500000</us-gaap:InterestCostsCapitalized>
    <pcrx:ForeignPropertyPlantAndEquipmentNet
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNzE1_2fcd4bae-98b9-42f4-9b66-e1144786b44f"
      unitRef="usd">66900000</pcrx:ForeignPropertyPlantAndEquipmentNet>
    <pcrx:ForeignPropertyPlantAndEquipmentNet
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfNzIy_d0e2f7d3-be3b-4ae2-a9c5-fc6963871348"
      unitRef="usd">67500000</pcrx:ForeignPropertyPlantAndEquipmentNet>
    <us-gaap:AssetRetirementObligation
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfODEy_d144eab5-3ab0-4715-b34c-f7b754cc88cf"
      unitRef="usd">2100000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80Ni9mcmFnOjZiYmY3NTE1MDk2YTQzNDk4ZDM5NTU0NjVjNDUxMTA4L3RleHRyZWdpb246NmJiZjc1MTUwOTZhNDM0OThkMzk1NTQ2NWM0NTExMDhfMTA5OTUxMTYyODkwOQ_56636a3d-5ba1-42aa-928e-088fe96f62f2"
      unitRef="usd">2000000</us-gaap:AssetRetirementObligation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTc0Nw_c970f41c-f7ab-45c7-83af-92a9fe194c4a">LEASES&lt;div style="margin-bottom:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases all of its facilities, including its EXPAREL manufacturing facility in San Diego, California and its iovera&#xb0; manufacturing facility in Fremont, California. These leases have remaining terms up to 8.9 years, some of which provide renewal options at the then-current market value. The Company also has an embedded lease with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England. A portion of the associated monthly base fees have been allocated to the lease component based on a relative fair value basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. Total operating lease costs are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for operating lease liabilities, net of lease incentive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets recorded in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to net the amortization of the right-of-use asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. The weighted average remaining lease term and the weighted average discount rate are summarized as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.46 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.39 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the Company&#x2019;s operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMjM2_52693a95-39a0-4b56-8442-5872b16bc72c">P8Y10M24D</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTc0Mg_bb2da7de-6fa4-41e3-a5b3-e914fa3e61d1">Total operating lease costs are as follows (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for operating lease liabilities, net of lease incentive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets recorded in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The weighted average remaining lease term and the weighted average discount rate are summarized as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.46 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.39 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfMy0yLTEtMS0w_8db5a6c6-63f9-4857-aac8-7b0edb34269c"
      unitRef="usd">2919000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfMy00LTEtMS0w_ef15b899-3c4b-4902-8b51-858441b4b631"
      unitRef="usd">3099000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfMy02LTEtMS0w_37e1feaa-d348-4de2-9127-6180f2fa11c8"
      unitRef="usd">8762000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfMy04LTEtMS0w_d1382d43-8a1e-4820-809f-79bc8c700e79"
      unitRef="usd">7085000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNC0yLTEtMS0w_4ced101f-96c6-46ef-a0b6-d1478ebd37f3"
      unitRef="usd">416000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNC00LTEtMS0w_54058af2-3874-4805-849f-dba4c71bdf0a"
      unitRef="usd">611000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNC02LTEtMS0w_63d6c1de-bcd7-41de-a5c9-71c4b770e915"
      unitRef="usd">1318000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNC04LTEtMS0w_549c1738-3bbd-4c87-8bae-dc8a8326acec"
      unitRef="usd">1661000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNS0yLTEtMS0w_876ddaf8-3dd6-47d0-ba9c-3b5fc238886c"
      unitRef="usd">3335000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNS00LTEtMS0w_a3c72043-9fe8-44f6-8158-47d6607de4fd"
      unitRef="usd">3710000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNS02LTEtMS0w_a341fcf1-726c-421f-b724-f16297507745"
      unitRef="usd">10080000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjZmN2E4OTM3MWUyYTRkYTE5MmE5MmZjYTYxNjI4MTY2L3RhYmxlcmFuZ2U6NmY3YTg5MzcxZTJhNGRhMTkyYTkyZmNhNjE2MjgxNjZfNS04LTEtMS0w_7f5a4856-e69d-4b7e-9f48-552e3f3b4a03"
      unitRef="usd">8746000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmNlMDk2MzIzZmYwZDRhNzBhODFlOTFlZjMwOTc1MGU0L3RhYmxlcmFuZ2U6Y2UwOTYzMjNmZjBkNGE3MGE4MWU5MWVmMzA5NzUwZTRfMy0yLTEtMS0w_85a54233-9af3-41bb-8b1e-529298bd99dc"
      unitRef="usd">9868000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmNlMDk2MzIzZmYwZDRhNzBhODFlOTFlZjMwOTc1MGU0L3RhYmxlcmFuZ2U6Y2UwOTYzMjNmZjBkNGE3MGE4MWU5MWVmMzA5NzUwZTRfMy00LTEtMS0w_1e227880-9bf6-47b4-bb53-76d59de4154b"
      unitRef="usd">11251000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmNlMDk2MzIzZmYwZDRhNzBhODFlOTFlZjMwOTc1MGU0L3RhYmxlcmFuZ2U6Y2UwOTYzMjNmZjBkNGE3MGE4MWU5MWVmMzA5NzUwZTRfNC0yLTEtMS0w_08f4be0e-96b3-4210-834b-5ec6bc40beef"
      unitRef="usd">212000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmNlMDk2MzIzZmYwZDRhNzBhODFlOTFlZjMwOTc1MGU0L3RhYmxlcmFuZ2U6Y2UwOTYzMjNmZjBkNGE3MGE4MWU5MWVmMzA5NzUwZTRfNC00LTEtMS0w_27d43cc6-6613-473d-80e2-69f4defb498e"
      unitRef="usd">42101000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjhiMDIxMGUzZTcyOTRkMWVhNjE4MDE3MjliN2RjZWRjL3RhYmxlcmFuZ2U6OGIwMjEwZTNlNzI5NGQxZWE2MTgwMTcyOWI3ZGNlZGNfMi0yLTEtMS0w_0b5a3b07-8508-44fe-bec7-cc7286f9d71d">P8Y5M15D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjhiMDIxMGUzZTcyOTRkMWVhNjE4MDE3MjliN2RjZWRjL3RhYmxlcmFuZ2U6OGIwMjEwZTNlNzI5NGQxZWE2MTgwMTcyOWI3ZGNlZGNfMi00LTEtMS0w_95f569fb-b234-49c4-937b-05d43edc55fd">P9Y4M20D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjhiMDIxMGUzZTcyOTRkMWVhNjE4MDE3MjliN2RjZWRjL3RhYmxlcmFuZ2U6OGIwMjEwZTNlNzI5NGQxZWE2MTgwMTcyOWI3ZGNlZGNfMy0yLTEtMS0w_c89be1fd-aec3-4df8-ac3e-fe1eee9026b2"
      unitRef="number">0.0688</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ide22db36ba124396977f4e0de495a2cf_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjhiMDIxMGUzZTcyOTRkMWVhNjE4MDE3MjliN2RjZWRjL3RhYmxlcmFuZ2U6OGIwMjEwZTNlNzI5NGQxZWE2MTgwMTcyOWI3ZGNlZGNfMy00LTEtMS0w_6f851b04-1d97-4ebd-9937-73b4577a860e"
      unitRef="number">0.0688</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTc0NQ_363d681e-7d94-41b9-a3f8-53ebc8f8195c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the Company&#x2019;s operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfMS0yLTEtMS0w_22bbe26a-8e1b-4e3a-8572-fe75aa438723"
      unitRef="usd">2659000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfMi0yLTEtMS0w_2c3945e4-3d99-412e-b85e-15642c50cc30"
      unitRef="usd">10645000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfMy0yLTEtMS0w_ce2b38c7-7c3a-4fb4-9577-ab32707e599f"
      unitRef="usd">10697000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfNC0yLTEtMS0w_bdb88b03-46ac-412a-96ec-093de1882c23"
      unitRef="usd">10980000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfNS0yLTEtMS0w_3b762944-40d3-473c-a68c-d0ba5e8b3cd9"
      unitRef="usd">11271000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfNi0yLTEtMS0w_12e5d0c6-1c31-4260-b2ff-204aa3cafc1e"
      unitRef="usd">50802000</pcrx:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfNy0yLTEtMS0w_05abd65c-9971-4213-81c9-baf51ddb4e57"
      unitRef="usd">97054000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfOS0yLTEtMS0w_52a6107a-afe2-4361-ae14-6b4fac23fc82"
      unitRef="usd">24391000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOmQ1Njg0Yzk1ZmI0ZjRiOWE4MjgyYWY5MjFhMzM5ZDNmL3RhYmxlcmFuZ2U6ZDU2ODRjOTVmYjRmNGI5YTgyODJhZjkyMWEzMzlkM2ZfMTAtMi0xLTEtMA_433a3ac4-e1ce-41cf-ba0f-4834093ce1e1"
      unitRef="usd">72663000</us-gaap:OperatingLeaseLiability>
    <pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTc1MA_6302d36d-ad88-471a-85df-7a5250159c88">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into one lease agreement (not included in the table above) for which there are future obligations but the lease has not yet commenced as of September&#160;30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Minimum Payments Due&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RleHRyZWdpb246MmNmNjI5YTQ2ZTg1NGUyZjhiZWQ2ZmU4ZjdkZjUwMjFfMTA5OTUxMTYzMDU0MQ_b41fa372-b637-4ec1-a610-e9d6d89bbebb"
      unitRef="segment">1</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfMS0yLTEtMS0yMjUzNQ_736415c8-ed76-44ac-af38-b8d395fa64fc"
      unitRef="usd">0</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfMi0yLTEtMS0yMjUzNQ_115d0864-14fe-4fd2-b3ef-64c41bd6a9fd"
      unitRef="usd">439000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfMy0yLTEtMS0yMjUzNQ_b489dba0-c401-4048-8063-3ff3b82d47cb"
      unitRef="usd">453000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfNC0yLTEtMS0yMjUzNQ_4b82735c-5288-49ae-b486-a4b1a28aea61"
      unitRef="usd">466000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfNS0yLTEtMS0yMjUzNQ_2988169b-042a-40a8-baba-219d1f12452d"
      unitRef="usd">480000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfNi0yLTEtMS0yMjUzNQ_c40c1cd2-579e-421d-a2ff-b3470fa8db58"
      unitRef="usd">495000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour>
    <pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80OS9mcmFnOjJjZjYyOWE0NmU4NTRlMmY4YmVkNmZlOGY3ZGY1MDIxL3RhYmxlOjg1NzRiNWEwZmM5NDQ4Mzg5MmVmYmI1NmQzNmRkZjMwL3RhYmxlcmFuZ2U6ODU3NGI1YTBmYzk0NDgzODkyZWZiYjU2ZDM2ZGRmMzBfNy0yLTEtMS0yMjg1MA_dc4be845-4d10-44e8-a667-8b649024173c"
      unitRef="usd">2333000</pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMjA1OA_0b780355-5dae-41a1-9252-45e358044ad2">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#x2019;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#x201c;Skyepharma Acquisition&#x201d;), and the acquisition of MyoScience, Inc. (the &#x201c;MyoScience Acquisition&#x201d;) in April 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no change in the carrying value of the Company&#x2019;s goodwill during the three and nine months ended September&#160;30, 2021. The balance at both September&#160;30, 2021 and December&#160;31, 2020 was $99.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. As of September&#160;30, 2021, the remaining milestone payments include: $4.0&#160;million upon the first commercial sale in the United Kingdom, France, Germany, Italy or Spain (the &#x201c;Applicable Countries&#x201d;); and $32.0&#160;million when annual net sales collected reach $500.0&#160;million (measured on a rolling quarterly basis). Any remaining milestone payments will be treated as additional costs of the Skyepharma Acquisition and, therefore, recorded as goodwill if and when each contingency is resolved.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the MyoScience Acquisition, the Company recorded goodwill totaling $37.5&#160;million. The Company made a tax election that allows the acquired goodwill and intangible assets associated with the MyoScience Acquisition to be tax deductible.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net, consist of the developed technology and customer relationships that were acquired in the MyoScience Acquisition and are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense on intangible assets was consistent for the three and nine months periods ended September&#160;30, 2021 and 2020. Amortization expense was $2.0 million and $5.9 million for the three and nine month periods, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assuming no changes in the gross carrying amount of these intangible assets, amortization expense will be $2.0 million for the remaining three months of 2021, $7.9 million annually through 2032 and $2.2 million in 2033.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMzk5_4adf4cdd-4b54-4760-aa7c-5b6009e2a522"
      unitRef="usd">0</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMzk5_8a9e1bca-6cf4-473e-ab6c-4ec6fd1d1e41"
      unitRef="usd">0</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfNTIy_287326e5-7782-49dd-86ce-3afdd17519a9"
      unitRef="usd">99500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfNTIy_f25ca003-59d8-48d5-9f6c-c61c7cdef2d6"
      unitRef="usd">99500000</us-gaap:Goodwill>
    <pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition
      contextRef="ie510ad82e9ae4ed9b7453890873a7867_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfODc5_29c851d6-7568-4a00-b947-13cff5d7cea5"
      unitRef="usd">4000000</pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition>
    <pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition
      contextRef="ib955ef045d0147b4a41342834ab1923b_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfOTcz_e55621d7-75b6-42a6-b2bd-a84454b0753b"
      unitRef="usd">32000000</pcrx:AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition>
    <pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition
      contextRef="ib955ef045d0147b4a41342834ab1923b_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTAxNA_4728b212-b0ef-445a-a086-d7cafad55b3f"
      unitRef="usd">500000000</pcrx:AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6d1f022a2e3f45c38d8813642eb0a4b7_D20190401-20190430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTMyMw_1f0a8702-d680-4eee-b6e0-1b17699d7257"
      unitRef="usd">37500000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMjA2MQ_c8d34ca5-bce2-4cbc-b894-0fd1c3bebeec">Intangible assets, net, consist of the developed technology and customer relationships that were acquired in the MyoScience Acquisition and are summarized as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i89a81ffb612a403a924df2a487b03db8_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMi0yLTEtMS0w_460e6fbb-c9c7-46e1-a1b2-8507fb5f17ea">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if7501d0ecec348a18e56ac1ec8c99ddf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMi00LTEtMS0w_ec0445b9-dbae-45bc-8583-4696080f8975"
      unitRef="usd">110000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6cee35c07c974bff9beb7fa6c64d6aee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMi02LTEtMS0w_9d9cccf3-f0ca-43c6-9e23-ee1839a6c4bd"
      unitRef="usd">110000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if16cf2053195434b94be734f2e6e754f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMy0yLTEtMS0w_e60b9730-0d63-4f65-8555-f8ec2ead3ddf">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie965653fafce4fce912093bbf34f3347_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMy00LTEtMS0w_247d3b3d-78e4-4d30-9bc7-9595c64fd08f"
      unitRef="usd">90000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i01af4a06a1ff4be181f27dd6fc5dccd4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfMy02LTEtMS0w_2dc74f77-7307-4fd7-b4c3-408b801c84fe"
      unitRef="usd">90000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNC00LTEtMS0w_6a9a788e-639c-41b5-9096-9e2b059171df"
      unitRef="usd">110090000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic6a3944a915b4b7dacce440712764ef6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNC02LTEtMS0w_af6a0cb8-e7d1-4504-afb1-5203ed27ee2f"
      unitRef="usd">110090000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNS00LTEtMS0w_d07a9015-0170-434a-85b1-c9edd86eb657"
      unitRef="usd">19469000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic6a3944a915b4b7dacce440712764ef6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNS02LTEtMS0w_24ee3e45-6a99-43f3-af3d-2ef4708ee158"
      unitRef="usd">13569000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNi00LTEtMS0w_36202394-16f1-4341-986e-385f919ab864"
      unitRef="usd">90621000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic6a3944a915b4b7dacce440712764ef6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RhYmxlOjBiZmMwYTdmOWIxMzRiMDRiODBmZWIyMzU2ZWY5Y2QxL3RhYmxlcmFuZ2U6MGJmYzBhN2Y5YjEzNGIwNGI4MGZlYjIzNTZlZjljZDFfNi02LTEtMS0w_2b068d7e-9604-49cb-9be1-3138469c9b15"
      unitRef="usd">96521000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTgxMA_2e172bc9-edd3-481e-ab59-f16a75467f6c"
      unitRef="usd">2000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTgxMA_4c83f2eb-aa31-40a9-852e-0465a45bddd5"
      unitRef="usd">2000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTgxNw_34b0f824-767a-4e2d-9a36-6b49cbe3bbe6"
      unitRef="usd">5900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTgxNw_e6a668ff-dbf0-4884-b96c-515e7897056d"
      unitRef="usd">5900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMTk3OA_a02d7d07-8ec6-432c-b4d1-3c398ea1c19f"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMjAxOA_ab8ca44a-2324-4464-b983-d4c5a9e61f3b"
      unitRef="usd">7900000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1>
    <pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81Mi9mcmFnOmM1MzZiMTc5Yjg2MjRkYzdiOGY3ZDVlMGY1NTE3MDI0L3RleHRyZWdpb246YzUzNmIxNzliODYyNGRjN2I4ZjdkNWUwZjU1MTcwMjRfMjA0Nw_b4c1096a-b410-451a-a5cc-6daaa142958f"
      unitRef="usd">2200000</pcrx:FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3Nzg_cd284748-d209-4219-924d-f0e1eeb90b85">DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes Due 2025&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company completed a private placement of $402.5&#160;million in aggregate principal amount of its 0.750% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per year, payable semiannually in arrears on February 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and August 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of each year. The 2025 Notes mature on August 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2025 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% convertible senior notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds from the issuance of the 2025 Notes were approximately $390.0&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $185.0&#160;million in aggregate principal amount of its outstanding 2.375% convertible senior notes due 2022 in privately-negotiated transactions for a total of $211.1&#160;million of cash (including accrued interest).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert the 2025 Notes at any time prior to the close of business on the business day immediately preceding February 3, 2025, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i) during any calendar quarter (and only during such calendar quarter), if the last reported sale price of the Company&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii) during the five business day period immediately after any five consecutive trading day period (the &#x201c;measurement period&#x201d;) in which the trading price (as defined in the 2025 Indenture) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company&#x2019;s common stock and the conversion rate on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(iii) upon the occurrence of specified corporate events, including a merger or a sale of all or substantially all of the Company&#x2019;s assets; or&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(iv) if the Company calls the 2025 Notes for redemption, until the close of business on the business day immediately preceding the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended&#160;September&#160;30, 2021, none of these conditions for conversion were met.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the 40 consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#x2019;s common stock or a combination of cash and shares of the Company&#x2019;s common stock, at the Company&#x2019;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $71.78 per share of the Company&#x2019;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately 32.5% to the closing sale price of $54.17 per share of the Company&#x2019;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the 2025 Notes had a market price o&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $1,086&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; pe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the $402.5&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#x2019;s option).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; scheduled trading day immediately before the maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for (i) each of at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) 100% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#x201c;make-whole fundamental change&#x201d; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company undergoes a fundamental change, as defined in the 2025 Indenture, subject to certain conditions, holders of the 2025 Notes may require the Company to repurchase for cash all or part of their 2025 Notes at a repurchase price equal to 100% of the principal amount of the 2025 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a &#x201c;make-whole fundamental change&#x201d; (as defined in the 2025 Indenture) occurs prior to August 1, 2025, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its notes in connection with the make-whole fundamental change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 Notes are the Company&#x2019;s general unsecured obligations that rank senior in right of payment to all of its indebtedness that is expressly subordinated in right of payment to the 2025 Notes, and equal in right of payment to the Company&#x2019;s unsecured indebtedness. The 2025 Notes are also effectively junior in right of payment to any of the Company&#x2019;s secured indebtedness to the extent of the value of the assets securing such indebtedness, and are structurally subordinated to any debt or other liabilities (including trade payables) of the Company&#x2019;s subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the 2025 Notes are currently classified on the Company&#x2019;s consolidated balance sheet at September&#160;30, 2021 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#x2019;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 470-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an entity must separately account for the liability and equity components of convertible debt instruments (such as the 2025 Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer&#x2019;s economic interest cost. The liability component of the instrument is valued in a manner that reflects the market interest rate for a similar nonconvertible instrument at the date of issuance. The initial carrying value of the liability component of $314.7&#160;million was calculated using a 5.78% assumed borrowing rate. The equity component of $87.8&#160;million, representing the conversion option, was determined by deducting the fair value of the liability component from the par value of the 2025 Notes and is recorded in additional paid-in capital on the consolidated &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;balance sheet at the issuance date. The equity component is treated as a discount on the liability component of the 2025 Notes, which is amortized over the five-year term of the 2025 Notes using the effective interest rate method. The equity component is not re-measured as long as it continues to meet the conditions for equity classification. A deferred tax liability was recognized in the amount of $20.5&#160;million, with the offsetting amount recorded in additional paid-in capital.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocated the total transaction costs of approximately $12.5&#160;million related to the issuance of the 2025 Notes to the liability and equity components of the 2025 Notes based on their relative values. Transaction costs attributable to the liability component are amortized to interest expense over the five-year term of the 2025 Notes, and transaction costs attributable to the equity component totaling $2.7&#160;million are netted with the equity component in stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company. The 2025 Indenture contains customary events of default with respect to the 2025 Notes, including that upon certain events of default, 100% of the principal and accrued and unpaid interest on the 2025 Notes will automatically become due and payable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Senior Notes Due 2022&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2017, the Company completed a private placement of $345.0 million in aggregate principal amount of 2.375% convertible senior notes due 2022, or 2022 Notes, and entered into an indenture, or 2022 Indenture, with respect to the 2022 Notes. The 2022 Notes accrue interest at a fixed rate of 2.375% per year, payable semiannually in arrears on April&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and October&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of each year. The 2022 Notes mature on April 1, 2022. As discussed above, in July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $185.0&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $211.1&#160;million in cash (including accrued interest). The partial repurchase of the 2022 Notes resulted in an $8.1&#160;million loss on early extinguishment of debt.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2022 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% convertible senior notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 1, 2021 and until the close of business on the second scheduled trading day immediately preceding April 1, 2022, holders may convert their 2022 Notes at any time. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion, holders will receive the principal amount of their 2022 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the 40 consecutive trading days during the observation period (as more fully described in the 2022 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#x2019;s common stock or a combination of cash and shares of the Company&#x2019;s common stock, at the Company&#x2019;s option. The initial conversion rate for the 2022 Notes is 14.9491 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $66.89 per share of the Company&#x2019;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2022 Notes represents a premium of approximately 37.5% to the closing sale price of $48.65 per share of the Company&#x2019;s common stock on the Nasdaq Global Select Market on March 7, 2017, the date that the Company priced the private offering of the 2022 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the 2022 Notes had a market price of $1,038 pe&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2022 Notes will be paid pursuant to the terms of the 2022 Indenture. In the event that all of the 2022 Notes are settled, the Company would &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;be required to repay the remaining $160.0 million in principal value a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nd any conversion premium in any combination of cash and shares of its common stock (at the Company&#x2019;s option).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April 1, 2020, the Company may redeem for cash, shares of the Company&#x2019;s common stock or a combination of cash and shares of the Company&#x2019;s common stock, at the Company&#x2019;s option, all or part of the 2022 Notes if the last reported sale price (as defined in the 2022 Indenture) of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period ending within &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM0MjA_0a6e4989-0f64-4ad2-a49d-950959b333c7"&gt;five&lt;/span&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;trading days prior to the date on which the Company provides notice of redemption. This condition was not met during the quarter ended September&#160;30, 2021. The redemption price will equal the sum of (i)&#160;100% of the principal amount of the 2022 Notes being redeemed, plus (ii)&#160;accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2022 Notes for redemption will constitute a &#x201c;make-whole fundamental change&#x201d; (as defined in the 2022 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2022 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest and other (Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate on convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ASU 2020-06 will require the Company to eliminate debt discounts along with any related future amortization. Further deferred financing costs previously allocated to the conversion features will be re-allocated to the outstanding debt, slightly increasing future annual amortization of deferred financing costs. This new accounting pronouncement has not been adopted as of September&#160;30, 2021. For additional information regarding ASU 2020-06, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie438d7046d4b414a88a04918bfbd3568_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTEz_d998aec5-8b2f-4018-9b86-abff6f9307c6"
      unitRef="usd">402500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie438d7046d4b414a88a04918bfbd3568_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTUz_1e0e5b24-0911-42cf-ab21-1a76d32968d4"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie438d7046d4b414a88a04918bfbd3568_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMzM4_653ff413-696c-44a4-94d4-659d633bd517"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3ODQ_21e2a3c2-1a6d-41c4-999e-d3d3c62fd45a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2025 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750% convertible senior notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total debt composition of the 2022 Notes is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% convertible senior notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMi0wLTEtMS0wL3RleHRyZWdpb246MmQ0NzgyNjU1NWVhNDBiMDkzOGEzMzJhYjRiYjJhNzdfNA_b2d90ead-154a-4d0b-ad15-daa6dc46c828"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMi0xLTEtMS0w_66fd2f63-f89c-4d49-9fc4-bf39c619a9d1"
      unitRef="usd">402500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i77e86ff9a584425992768831eb59a2b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMi0zLTEtMS0w_eb4ffaed-ff5e-462e-a56d-b1db8a8155bf"
      unitRef="usd">402500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMy0xLTEtMS0w_b360374c-3d93-4344-9829-c93791a5eb4b"
      unitRef="usd">7610000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i77e86ff9a584425992768831eb59a2b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfMy0zLTEtMS0w_d3d02c16-2307-46c1-912d-947c027a54a7"
      unitRef="usd">8940000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfNC0xLTEtMS0w_2e741ffc-7292-4790-bd28-2d8b11ed19c9"
      unitRef="usd">68744000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i77e86ff9a584425992768831eb59a2b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfNC0zLTEtMS0w_cf8008cd-c53e-46b2-aa4b-50f5e9c7e71f"
      unitRef="usd">80530000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfNS0xLTEtMS0w_30b6f4b2-5285-448b-b159-dc04ad053a3e"
      unitRef="usd">326146000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i77e86ff9a584425992768831eb59a2b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjdlY2EzMWYwZDA1MDQyODdhZmI2OGE0NTYxZThhMDc5L3RhYmxlcmFuZ2U6N2VjYTMxZjBkMDUwNDI4N2FmYjY4YTQ1NjFlOGEwNzlfNS0zLTEtMS0w_c8c38729-12e6-4b5f-a6df-35d1f29a7c82"
      unitRef="usd">313030000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i1f322fb012d64653a2090e9d08a6fa7a_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNjE5_c8df715f-d1b0-4cd3-9c30-77539b7bc81c"
      unitRef="usd">390000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i5ee5be00954e45748d8b246245010a0f_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNzg3_526d6081-0519-4c11-bbc4-0d5d32afa508"
      unitRef="usd">185000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ee5be00954e45748d8b246245010a0f_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODM5_ab6e7be1-6b46-450f-a2d6-9f8fa4bb6e31"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i5a7be408192f4f12b6d240abce12cdf8_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfOTI4_c0e63a85-88f5-4d80-900d-18f298709c4e"
      unitRef="usd">211100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ibb1bbaf7e7374ecb8bb7e29a54a2e98f_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTI5Nw_131e73d9-49ad-41bd-9343-74bebd6a5647"
      unitRef="segment">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ibb1bbaf7e7374ecb8bb7e29a54a2e98f_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM2MQ_71efe645-db55-4889-a499-5d1fb78cbb1f"
      unitRef="segment">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ibb1bbaf7e7374ecb8bb7e29a54a2e98f_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ5NA_5a0974af-9545-49b1-a3a8-7349c90eb90b"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <pcrx:DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock
      contextRef="i2987763b470247b1b64487558ed62361_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTgzNg_aabc4e07-7878-4fb4-9a33-575a710642b2"
      unitRef="number">0.98</pcrx:DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock>
    <pcrx:SettlementPeriodConvertibleDebtConversionRequest
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMjcxNA_ccdead21-e793-47dd-984d-381314f43604">P40D</pcrx:SettlementPeriodConvertibleDebtConversionRequest>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i8676c39077d849cf9a97ed7b875cf79c_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMzE4Mw_2acbd0bb-7d97-4a60-a8ed-41555249712b"
      unitRef="usdPerShare">71.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock
      contextRef="i8676c39077d849cf9a97ed7b875cf79c_I20200731"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMzQzOQ_d62cf898-360b-457d-8cdc-e31c9a11b541"
      unitRef="number">0.325</pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock>
    <us-gaap:SharePrice
      contextRef="i8676c39077d849cf9a97ed7b875cf79c_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMzQ3MQ_d39638a8-51d3-43ba-b514-1b5c3d692e3b"
      unitRef="usdPerShare">54.17</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="id3b1ed3537724b41a9d822235c8817fd_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNDEwOA_8a30432e-f72a-4144-8df1-e0964e1781e8"
      unitRef="usd">402500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNDY4MQ_5da2bc63-6f00-4e02-ab20-0402db41af57"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNDc0OA_0a0be323-738d-4279-9e50-e0a64862e373"
      unitRef="segment">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNDgwNA_e89bf394-b110-4653-8613-dcca054bc04e"
      unitRef="segment">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice
      contextRef="i8bc04244cd6f4923bc24c8f88d8a26e6_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNTA4NA_3a2a65c0-ad49-46df-ab3d-8e89e090e518"
      unitRef="number">1</pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice>
    <pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice
      contextRef="i2987763b470247b1b64487558ed62361_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfNTg1OA_de91be52-beaf-436f-86d6-f6636d58deb5"
      unitRef="number">1</pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice>
    <pcrx:DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent
      contextRef="i7110286438e148d29048a9c4ae47c6b4_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODAxNg_97626dba-d004-4dec-a1b9-ecbdf57caa76"
      unitRef="usd">314700000</pcrx:DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent>
    <pcrx:DebtInstrumentConvertibleAssumedBorrowingRate
      contextRef="i7110286438e148d29048a9c4ae47c6b4_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODA0Mg_6683196b-5936-4aa8-b952-b6edb59266cb"
      unitRef="number">0.0578</pcrx:DebtInstrumentConvertibleAssumedBorrowingRate>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i7110286438e148d29048a9c4ae47c6b4_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODA5Mw_6af2b224-bcdc-4f62-a207-074a82041ccd"
      unitRef="usd">87800000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentTerm
      contextRef="ice3f2f561e0548b1b29b92f1b74cc3b5_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3NzY_fcd4190a-6583-4dc3-88de-2d1547cfa9c6">P5Y</us-gaap:DebtInstrumentTerm>
    <pcrx:DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODcwNg_6e63e6d1-48d7-4f4a-8a76-86d67abcb5c9"
      unitRef="usd">20500000</pcrx:DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="ice3f2f561e0548b1b29b92f1b74cc3b5_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfODg0NQ_ded632f4-5f56-4a90-9632-3d7aa136778c"
      unitRef="usd">12500000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <pcrx:AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3ODE_287db1ee-3468-4cfa-9521-31d77fb20ad0">P5Y</pcrx:AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt>
    <pcrx:TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfOTE4MA_42c6a8ae-7db9-434b-9572-ca63e1731b61"
      unitRef="usd">2700000</pcrx:TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ic7de6bbd42d241129b6517fae46c1feb_D20170301-20170331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfOTgwMA_6f0aa09e-2dd6-43a1-82b1-abdcf0a4b17f"
      unitRef="usd">345000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i484fffcf3bfc42da8b6f439297ac33b8_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfOTgzNg_bcf486f0-fd1f-4d93-a359-10c47b17c14b"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i484fffcf3bfc42da8b6f439297ac33b8_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTAwMjE_1a5b18ae-f34c-4171-a057-5273c3153dde"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i5ee5be00954e45748d8b246245010a0f_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTAyNzU_f05193f0-2fb4-4da1-90dc-6f7294bb5eef"
      unitRef="usd">185000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:RepaymentsOfDebt
      contextRef="i5a7be408192f4f12b6d240abce12cdf8_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTAzODA_a5669a30-8a6f-4417-b85a-b13738414c2f"
      unitRef="usd">211100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5a7be408192f4f12b6d240abce12cdf8_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTA0Nzc_abbd1bb3-ff2d-4948-9888-add0b7e5993f"
      unitRef="usd">-8100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMi0wLTEtMS0wL3RleHRyZWdpb246ZTg1OTA2ZDIzYTA3NDcxNzk3YzlkOTUzYWM2OWNhNGNfNA_b8f798be-c7a9-46b0-a469-054d18d054ff"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMi0xLTEtMS0w_27dac8da-e5e8-4e87-86cf-08251803b452"
      unitRef="usd">160000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i76cecef789bf42e8a15eea314c8c854e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMi0zLTEtMS0w_76fec104-5111-4584-8f2c-ad7dcaa45f26"
      unitRef="usd">160000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMy0xLTEtMS0w_fd36d9f0-3b66-404e-80b3-1ed00b29f0b1"
      unitRef="usd">443000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i76cecef789bf42e8a15eea314c8c854e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfMy0zLTEtMS0w_17bcfede-2a26-48bf-827d-9c9763bda6e7"
      unitRef="usd">1089000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfNC0xLTEtMS0w_2df846aa-5aae-420f-a211-8d1f97690b2c"
      unitRef="usd">3806000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i76cecef789bf42e8a15eea314c8c854e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfNC0zLTEtMS0w_a22c2ce1-f9b6-426a-8761-718ce443a269"
      unitRef="usd">9263000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfNS0xLTEtMS0w_81fac68d-f107-4edf-a9c1-6b1b9a8c0922"
      unitRef="usd">155751000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i76cecef789bf42e8a15eea314c8c854e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOjlhMDU0YThmZjkzZjQ0NDRhMTgyYzAzOTAyNDU5MjA3L3RhYmxlcmFuZ2U6OWEwNTRhOGZmOTNmNDQ0NGExODJjMDM5MDI0NTkyMDdfNS0zLTEtMS0w_7b6ec27d-8bce-4616-9a81-3af0c99192ce"
      unitRef="usd">149648000</us-gaap:LongTermDebt>
    <pcrx:SettlementPeriodConvertibleDebtConversionRequest
      contextRef="i7b5c22e9f3b54e87ab480944cefdf787_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTE0MDM_93c56cf5-1c91-4ebb-95f1-bc707105db52">P40D</pcrx:SettlementPeriodConvertibleDebtConversionRequest>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTE4NzI_a9ea8b82-fa6f-4161-a75c-365fe3221e0f"
      unitRef="usdPerShare">66.89</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock
      contextRef="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTIxMjg_81cd30ac-7462-44e4-bb3c-311a5298d438"
      unitRef="number">0.375</pcrx:DebtInstrumentConversionObligationPremiumOnCommonStock>
    <us-gaap:SharePrice
      contextRef="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTIxNjA_fbc8e313-9c24-4151-a7b3-69c6d1f2d9b0"
      unitRef="usdPerShare">48.65</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5ee5be00954e45748d8b246245010a0f_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTI3OTg_ad3ce176-2667-4982-889d-2f620549b5cb"
      unitRef="usd">160000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTMyNjE_bc1b6988-4ef7-4609-bb96-ec9cd5665112"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTMzMTY_d8e8635f-961e-4e7a-9d47-9fb79faf4ae4"
      unitRef="segment">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTMzNzI_bc43e95a-6103-4b6c-9262-3c1218aaae38"
      unitRef="segment">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice
      contextRef="ic97811d8ba074906a5ecdbd997d2fc5e_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM2MDk_bfc07e8b-8586-4742-99f0-0584acd92b48"
      unitRef="number">1</pcrx:DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice>
    <pcrx:ScheduleOfInterestExpenseTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTQ3NzU_e46608e7-7893-4a65-8572-b5d1ec2f44f5">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest and other (Note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rate on convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pcrx:ScheduleOfInterestExpenseTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMi0xLTEtMS0w_6e0b11b1-6319-4692-bc8d-821162a3b7e9"
      unitRef="usd">1704000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMi0zLTEtMS0w_2fca26a0-c4a0-45b6-af25-3fc113a2cb31"
      unitRef="usd">1764000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMi01LTEtMS0w_33d217b9-e727-4d74-a94b-206820e8b08c"
      unitRef="usd">5122000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMi03LTEtMS0w_2fe541ea-fcf2-4419-9d10-c2a6046ef9d2"
      unitRef="usd">5861000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMy0xLTEtMS0w_32af772a-7c9d-4044-af89-68dd0d775214"
      unitRef="usd">666000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMy0zLTEtMS0w_a1ceb50d-75c9-4a46-9d5a-fd8b1864a307"
      unitRef="usd">629000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMy01LTEtMS0w_473f2038-408d-413e-a225-f4bfa3b88d40"
      unitRef="usd">1976000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfMy03LTEtMS0w_5fccb4ce-e758-48da-88d7-051fe3f43a3c"
      unitRef="usd">1512000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNC0xLTEtMS0w_50b3b472-150d-4385-a7ef-59dd5e76467e"
      unitRef="usd">5844000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNC0zLTEtMS0w_d55414f5-1cf5-4048-af3a-ff3ee7a553dc"
      unitRef="usd">5430000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNC01LTEtMS0w_7cbdc0a8-5b67-4715-8aa2-e977b310b97a"
      unitRef="usd">17245000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNC03LTEtMS0w_470cd2da-85c8-43f8-9ddf-6470a494d57a"
      unitRef="usd">12684000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestCostsCapitalized
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNS0xLTEtMS0w_809233d1-10e2-4808-98f8-1b7e05fa012e"
      unitRef="usd">881000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNS0zLTEtMS0w_13a73859-bdee-469b-9daa-826cf64e459c"
      unitRef="usd">691000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNS01LTEtMS0w_4a3a0521-1889-438f-877d-03e1770ad05c"
      unitRef="usd">3016000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNS03LTEtMS0w_c1825cd0-6fff-4e4f-862a-8dacd99ee676"
      unitRef="usd">1448000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestExpenseDebt
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNi0xLTEtMS0w_d97b41d0-a362-4e3a-ab27-d67efcb20a7b"
      unitRef="usd">7333000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNi0zLTEtMS0w_0d916b96-9194-4e9d-be2c-3aa253b86915"
      unitRef="usd">7132000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNi01LTEtMS0w_6ffe3871-9d6f-4796-a30e-2fb2ad51eed5"
      unitRef="usd">21327000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfNi03LTEtMS0w_144e9416-27f5-4179-b974-41a69fc269ad"
      unitRef="usd">18609000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfOC0xLTEtMS0w_afd86071-1a93-4081-8deb-725967a1a10c"
      unitRef="number">0.0670</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfOC0zLTEtMS0w_5eef6ee8-63fe-4d09-924f-f4de234b3ef2"
      unitRef="number">0.0678</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfOC01LTEtMS0w_75166f24-d2d2-4c13-ad29-994d4fce322e"
      unitRef="number">0.0670</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RhYmxlOmVhY2E5MDg1ZTRiZTQ4ZTFiNTAyMzk3MTA1Nzg2ZmU5L3RhYmxlcmFuZ2U6ZWFjYTkwODVlNGJlNDhlMWI1MDIzOTcxMDU3ODZmZTlfOC03LTEtMS0w_9d715deb-f633-4d30-838e-1ef6945164c2"
      unitRef="number">0.0735</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2ODQ_541ec515-5f3b-4430-b9a6-8d726f13ece3">FINANCIAL INSTRUMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:40.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:40.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:40.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#x2019;s equity investment with a readily determinable fair value was calculated utilizing market quotations from a major American stock exchange (Level 1). The fair value of the Company&#x2019;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#x2019;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amount of the investments without a readily determinable fair value have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions. Certain assets and liabilities are measured at fair value on a non-recurring basis, including assets and liabilities acquired in a business combination, equity instruments measured at cost and long-lived assets, which would be recognized at fair value if deemed impaired or if reclassified as assets held for sale. The fair value in these instances would be determined using Level 3 inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Acquisition-related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Liabilities Measured at Amortized Cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;2.375% convertible senior notes due 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;0.750% convertible senior notes due 2025 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The closing price of the Company&#x2019;s common stock as reported on the Nasdaq Global Select Market was&#160;$56.00&#160;per share on September&#160;30, 2021, compared to a conversion price of&#160;$66.89&#160;per share for the 2022 Notes and $71.78 per share for the 2025 Notes. The maximum conversion premium that could have been due on the 2022 Notes and 2025 Notes at September&#160;30, 2021 was&#160;approximately 2.4 million&#160;and 5.6&#160;million shares of the Company&#x2019;s common stock, respectively. These figures assume no increases in the conversion rate for certain corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity and Debt Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the Company held an equity investment in TELA Bio, Inc., or TELA Bio, in its condensed consolidated balance sheets in the amount of $11.6&#160;million. During the nine months ended September&#160;30, 2021, the Company sold its investment in TELA Bio for net cash proceeds of $9.1&#160;million. During the nine months ended September&#160;30, 2021, the Company recognized a realized loss of $2.6&#160;million, which has been recorded in other, net in the condensed consolidated statements of operations. The fair value of TELA Bio was based on a Level 1 input. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021 and December&#160;31, 2020, the Company held an equity investment of $4.1&#160;million and $1.2&#160;million, respectively, in GeneQuine Biotherapeutics GmbH, or GeneQuine, a privately held biopharmaceutical company headquartered in Hamburg, Germany. This investment has no readily determinable fair value and is recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments. During 2021, the Company purchased a convertible note from GeneQuine in the amount of $1.2&#160;million and invested an additional $3.0&#160;million in equity investments. During the nine months ended September&#160;30, 2021, the valuation of the convertible note was reduced by less than $0.1&#160;million due to changes in foreign currency exchange rates. The Company has the right to make additional investments in debt securities of $1.7&#160;million predicated upon GeneQuine achieving certain prespecified near-term milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company purchased privately-held preferred shares in Coda BioTherapeutics, Inc., a preclinical stage biopharmaceutical company that is developing a gene-therapy platform to treat neurological disorders and diseases for a purchase price of $10.0&#160;million. There were no adjustments to this investment during the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company purchased a convertible note in the amount of $3.0&#160;million from Spine BioPharma, LLC, a preclinical stage biopharmaceutical company. There were no adjustments to this investment during the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-related Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $100.0 million upon the achievement of certain regulatory and commercial milestones. The Company&#x2019;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As of September&#160;30, 2021, the maximum potential remaining milestone payments to be paid are $48.0&#160;million. The Company made a $7.0 million milestone payment during the nine months ended September&#160;30, 2021 for the achievement of one regulatory milestone. Another regulatory milestone in the amount of $5.0&#160;million was met in the three months ended September&#160;30, 2021 and is expected to be paid in November 2021. During the nine months ended September&#160;30, 2020, the Company made $15.0 million in cash payments for the achievement of two regulatory milestones. As of September&#160;30, 2021 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and December 31, 2020, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $16.2&#160;million and $28.3&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. For the three and nine months ended September&#160;30, 2021, the Company recognized $1.2&#160;million and $2.1 million gains, respectively, related to contingent consideration. For the three and nine months ended September 30, 2020, the Company recognized $0.8&#160;million of charges and $1.6&#160;million of gains, respectively, related to contingent consideration. These amounts have been included in acquisition-related (gains) charges in the condensed consolidated statements of operations. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rate used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. At September&#160;30, 2021, the weighted average discount rate was 3.65% and the weighted average probability of success for the regulatory milestone that has not yet been met was 2.0%. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the key assumptions used in the valuation of the Company&#x2019;s contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Ranges Utilized as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.49% to 3.81%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probabilities of payment for regulatory milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2% to 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected years of payment for regulatory and commercial milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 to 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the Company&#x2019;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Fair value adjustments and accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Offset indemnification claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,000)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available-for-Sale Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate and government bonds with maturities greater than three months, but less than one year. Long-term investments consist of government bonds with maturities greater than one year but less than three years. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#x2019;s short-term and long-term investments are reported in other comprehensive income (loss). At September&#160;30, 2021 and December 31, 2020, all of the Company&#x2019;s short-term and long-term investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term and long-term investments had an &#x201c;A&#x201d; or better rating by Standard&#160;&amp;amp; Poor&#x2019;s.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the Company&#x2019;s investments at September&#160;30, 2021 and December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021 Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;U.S. Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020 Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;U.S. Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;U.S. Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, there were no investments available for sale that were materially less than their amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elects to recognize its interest receivable separate from its available-for-sale investments. At September&#160;30, 2021 and December&#160;31, 2020, the interest receivable recognized in prepaid expenses and other current assets was $0.4&#160;million and $1.6&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term and long-term investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;As of September&#160;30, 2021, three wholesalers each accounted for over 10% of the Company&#x2019;s accounts receivable, at 31%, 27% and 26%. At December&#160;31, 2020, three wholesalers each accounted for over 10% of the Company&#x2019;s accounts receivable, at 36%, 28% and 23%. For additional information regarding the Company&#x2019;s wholesalers, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. EXPAREL revenues are primarily derived from major wholesalers that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the Company&#x2019;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of September&#160;30, 2021 and December&#160;31, 2020, the Company did not deem any allowances for credit losses on its accounts receivable necessary.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2ODE_0867299e-019b-4f6b-9ff1-c2b61fa0db2e">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Acquisition-related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Financial Liabilities Measured at Amortized Cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;2.375% convertible senior notes due 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;0.750% convertible senior notes due 2025 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) The closing price of the Company&#x2019;s common stock as reported on the Nasdaq Global Select Market was&#160;$56.00&#160;per share on September&#160;30, 2021, compared to a conversion price of&#160;$66.89&#160;per share for the 2022 Notes and $71.78 per share for the 2025 Notes. The maximum conversion premium that could have been due on the 2022 Notes and 2025 Notes at September&#160;30, 2021 was&#160;approximately 2.4 million&#160;and 5.6&#160;million shares of the Company&#x2019;s common stock, respectively. These figures assume no increases in the conversion rate for certain corporate events.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i2333c4061860489582acbe97375bee03_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNC0yLTEtMS0w_b2d7213b-19ca-47ae-8192-b928d55abcf3"
      unitRef="usd">4164000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i958bf8263a504b278937ce35716db65f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNC00LTEtMS0w_71a39c8b-63c0-499e-be08-0ef7e9cede66"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i9c75da8d059b4e2596b5ff5b06924a84_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNC02LTEtMS0w_c3324fce-2fd5-415f-995e-36f1501ad591"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i7181147be8bc4623ae8e9c54c8d545ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNC04LTEtMS0w_c4d383cf-56f4-49fc-aaf8-c00a801716b8"
      unitRef="usd">4164000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2333c4061860489582acbe97375bee03_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNi0yLTEtMS0w_da96cf82-c5ce-46aa-8463-068b9f16b8b7"
      unitRef="usd">16199000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i958bf8263a504b278937ce35716db65f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNi00LTEtMS0w_682cd091-8d1f-4913-b79e-230ab76eb869"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9c75da8d059b4e2596b5ff5b06924a84_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNi02LTEtMS0w_b31f83fc-4e58-4c62-be2b-e0b55e892701"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7181147be8bc4623ae8e9c54c8d545ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfNi04LTEtMS0w_c384789f-ab6b-4a9b-8647-b05f68ac0258"
      unitRef="usd">16199000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i72fedbc6decd4c5ab474fce89a1e607b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS0wLTEtMS0wL3RleHRyZWdpb246YmZlOTg4NzBlYTM0NGM3NWFhZTRjNWNmZmQ0MzY1MTJfNw_dd895c0b-de60-41ed-901b-4d44778bb7a7"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i02f839d9a53d4f3ca875382af344df93_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS0yLTEtMS0w_93ca297e-372b-4474-95c5-0c7de3e1c868"
      unitRef="usd">155751000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i583c220156b344feaaa6d77b90257b90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS00LTEtMS0w_a6e83aaf-44af-4d70-aece-005e59c4dc4e"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iee07277d2a1a4c99b0127e42c9b1dd5f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS02LTEtMS0w_8cb36b36-685f-44f3-82a9-f26b79dfe7ea"
      unitRef="usd">166000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i14c7c1373cd042e1a4d460c0d974dd24_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfOS04LTEtMS0w_35b76ac6-ce8f-4e18-8f3f-888cc3b1c23a"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic42c474800e04fb4a3a3b9d2f8401c54_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjhmMTMwMzE0NjEzZjQ3MmI4NDM4Yjg1ZjViYjQ2ZGRhXzc_1a4755ea-7025-4496-8a53-4bfbbc85205a"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iae7f0c9606944edf9be67213b6c85881_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtMi0xLTEtMA_9583ba9b-91cc-4b53-b883-5ec42cbeb94d"
      unitRef="usd">326146000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idec15b75fb0c42b2b08037d3e0496138_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtNC0xLTEtMA_9e5883e0-e8c2-4cbf-8fba-26697da0fc89"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if95fecb89ac048679a3ab7c3be07bf21_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtNi0xLTEtMA_b3df5a08-e44d-4849-b259-8f153a0b05a2"
      unitRef="usd">437216000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i893cdc48adac4ec98ca312b73931a78d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjNhZGE0MjFlMDA3ODRhZDU5YmViNWE5MDg2ODRiMDY0L3RhYmxlcmFuZ2U6M2FkYTQyMWUwMDc4NGFkNTliZWI1YTkwODY4NGIwNjRfMTAtOC0xLTEtMA_082b2fca-0610-4f42-893c-c077ba911782"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SharePrice
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjUzMQ_54bdd5b8-15fd-473d-be12-314682128ee2"
      unitRef="usdPerShare">56.00</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i4871ff6619af4e72a1eb0fed3ef25d91_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjU4NQ_cd21702f-6d51-4165-97c8-0b4d83a73957"
      unitRef="usdPerShare">66.89</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i263034570486452a8b85ec7f5288179e_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjYyMQ_8add76e6-72af-45fb-b285-0f33b31612e1"
      unitRef="usdPerShare">71.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <pcrx:DebtInstrumentConvertibleConversionPremiumShares
      contextRef="i14f382f05018464aad3ae04a610ed007_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjc2Nw_ff5e77ab-d955-4458-ab2b-c8e65d3a4350"
      unitRef="shares">2400000</pcrx:DebtInstrumentConvertibleConversionPremiumShares>
    <pcrx:DebtInstrumentConvertibleConversionPremiumShares
      contextRef="i9d903a7704504ea2b8d765a75def60a0_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMjc3NA_7b08c916-d725-4963-83bc-fe56b2e9c78c"
      unitRef="shares">5600000</pcrx:DebtInstrumentConvertibleConversionPremiumShares>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i8a69013f0d0b4c429435e8c27ee9bb03_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzA4NQ_6b1f0783-e3b4-4aa3-b4aa-f94e9b9e6e32"
      unitRef="usd">11600000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i6e0d7a6d98784688b9dd3fddc1b5a08c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzE5MA_56b7db6f-0de9-410a-8226-bf9e18233b86"
      unitRef="usd">9100000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiRealizedLoss
      contextRef="i6e0d7a6d98784688b9dd3fddc1b5a08c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzI3Mg_b703f9d4-11bb-4967-965e-06cf81777319"
      unitRef="usd">2600000</us-gaap:EquitySecuritiesFvNiRealizedLoss>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib87f4d8c58fd4e109cfee6b9060ba4d0_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA5OTUxMTYzOTY0Nw_dd1bc304-e331-412e-8391-f60824edbc22"
      unitRef="usd">4100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0f39cd86209f4b77984b8ebe031d7b5a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzQ5MA_8b9cf3f7-6979-4a6b-a01e-dc3449a8fe38"
      unitRef="usd">1200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i091d6864fe7b45dfae7464d8dfbc754e_I20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzg5MQ_b0fe8d7d-aa9b-424b-af1e-cba278d919fe"
      unitRef="usd">1200000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="iaddf1add92a940f384b1684b15e084d1_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMzg0ODI5MDcxMDExMw_0a29ba65-b4aa-4cd9-88f9-5ec7b63e97e0"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="i7a1ec36dd33e4facb2801b28ac07812b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA5OTUxMTY0MDA2Mg_648297cd-f4d4-40ce-8c1f-1612f41be28f"
      unitRef="usd">100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <pcrx:PotentialAdditionalDebtInvestmentUponAchievingMilestones
      contextRef="i091d6864fe7b45dfae7464d8dfbc754e_I20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNDA4OA_b70d27c9-443b-4d8d-92c3-d24a594c467d"
      unitRef="usd">1700000</pcrx:PotentialAdditionalDebtInvestmentUponAchievingMilestones>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i7cfdc64ff7694ae3b4874240596655b1_D20210401-20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNDU1Mg_694e2425-8747-4771-9baa-9986ac1d473e"
      unitRef="usd">10000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i2642fc1d446c40c890cec918384252cb_I20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNDcwOQ_ab77b9a2-b098-45f5-bc55-3c52c9992522"
      unitRef="usd">3000000</us-gaap:ConvertibleNotesPayable>
    <pcrx:ContingentConsideration
      contextRef="i6d1f022a2e3f45c38d8813642eb0a4b7_D20190401-20190430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTEwOA_08741fff-7eb0-4960-a7c8-51c63bcf3d06"
      unitRef="usd">100000000</pcrx:ContingentConsideration>
    <pcrx:ContingentConsiderationPaymentTerm
      contextRef="i6d1f022a2e3f45c38d8813642eb0a4b7_D20190401-20190430"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTMyNg_79b1c013-63c6-4d24-aae0-2bfc09406b05">P60D</pcrx:ContingentConsiderationPaymentTerm>
    <pcrx:ContingentConsiderationCurrent
      contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTQ0OA_df8cd9c4-e429-4776-aec1-c9e8671f2395"
      unitRef="usd">48000000</pcrx:ContingentConsiderationCurrent>
    <pcrx:MilestonePayment
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTQ3MQ_0fd48246-3037-49df-9abd-76e4a72e7117"
      unitRef="usd">7000000</pcrx:MilestonePayment>
    <pcrx:MilestonePayment
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA5OTUxMTY0MDA5Mg_46e18621-e214-4ebd-b226-6623ee649d0b"
      unitRef="usd">5000000</pcrx:MilestonePayment>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i3838cbd889d145a097da4753fd5b7d52_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTYxNw_88943773-260a-4417-bad3-1889ce0d46c7"
      unitRef="usd">15000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTgyMw_011bb9be-69fb-4d81-b692-a5bdb32d883a"
      unitRef="usd">16200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic6a3944a915b4b7dacce440712764ef6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNTgzMA_94bf071a-a5d3-4df3-928c-dad813639ebc"
      unitRef="usd">28300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="if9c092d61fa44c89a1f992840f0cce80_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNjA4OQ_5d806299-4520-4e42-9478-de569b0c1bc3"
      unitRef="usd">1200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNjEwNQ_513b1c9f-9d72-4d60-b1c4-8b3fd77c0963"
      unitRef="usd">2100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ia60b65aa2ebd44c6a2368109e2845fd1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNjIyNw_d9a520c4-5e4c-43c8-9d9d-ec50bdb28922"
      unitRef="usd">-800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="idcabd81228924ca98368c5d31fc89917_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNjI0NQ_cca54605-9098-475d-b5f6-15de2208c1cb"
      unitRef="usd">1600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ibfac6863101f4d0cbbcb816ebbd63709_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNzE3Ng_54ce5df6-0b6d-4c25-848b-f77338e6215c"
      unitRef="number">0.0365</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ie57c515402bb4f8eb1ac59b13452a7bb_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfNzI4NA_f26643ee-ba27-47f9-8b11-55ab9afb0a25"
      unitRef="number">0.020</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2ODk_9cb78ad4-d32c-46ac-93ad-b0a7697a8764">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the key assumptions used in the valuation of the Company&#x2019;s contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Ranges Utilized as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.49% to 3.81%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probabilities of payment for regulatory milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2% to 100%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected years of payment for regulatory and commercial milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 to 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i4fba2629f05d45e2a951a1a3b00a7381_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIwOTQ4Y2IwZmVmYjQxZmM4OTc4NTcyOTI5NTg2ZmIxL3RhYmxlcmFuZ2U6MjA5NDhjYjBmZWZiNDFmYzg5Nzg1NzI5Mjk1ODZmYjFfMS0yLTEtMS0wL3RleHRyZWdpb246ZjE4MjdjNGZhNmJhNDk3NWI5ZjU3NjBlMDJiM2E3MjdfNA_2ebe4772-f90c-4c88-b131-a90eacef153a"
      unitRef="number">0.0349</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i9551ea61dd8e42de921cd6cb340713fa_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIwOTQ4Y2IwZmVmYjQxZmM4OTc4NTcyOTI5NTg2ZmIxL3RhYmxlcmFuZ2U6MjA5NDhjYjBmZWZiNDFmYzg5Nzg1NzI5Mjk1ODZmYjFfMS0yLTEtMS0wL3RleHRyZWdpb246ZjE4MjdjNGZhNmJhNDk3NWI5ZjU3NjBlMDJiM2E3MjdfMTA_185deb17-67ef-4aa8-83a2-6e2b9b76e367"
      unitRef="number">0.0381</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i923a86d2b61a4ed5afa25b07cbdcf5a8_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIwOTQ4Y2IwZmVmYjQxZmM4OTc4NTcyOTI5NTg2ZmIxL3RhYmxlcmFuZ2U6MjA5NDhjYjBmZWZiNDFmYzg5Nzg1NzI5Mjk1ODZmYjFfMi0yLTEtMS0wL3RleHRyZWdpb246ODRlZDg3YTM3NDRiNGNmNjgwYTI4YmNkNTRiNjkxOTNfNA_a85f0659-77c2-43e0-8931-e4389ed427f5"
      unitRef="number">0.02</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i8336fab865c64a01a14d247bad7a374b_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIwOTQ4Y2IwZmVmYjQxZmM4OTc4NTcyOTI5NTg2ZmIxL3RhYmxlcmFuZ2U6MjA5NDhjYjBmZWZiNDFmYzg5Nzg1NzI5Mjk1ODZmYjFfMi0yLTEtMS0wL3RleHRyZWdpb246ODRlZDg3YTM3NDRiNGNmNjgwYTI4YmNkNTRiNjkxOTNfMTA_0aa5c21f-d18c-4618-a6d3-34b708d1d8e4"
      unitRef="number">1</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2NzA_bd306a9d-7fab-4049-a62c-6cf0babd1296">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the Company&#x2019;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Fair value adjustments and accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Offset indemnification claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,000)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iad8f7b4b2d424119bbbb3f917cb3b346_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfMS0yLTEtMS0w_08281b66-4e79-4ce4-b1db-f01472696960"
      unitRef="usd">28346000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfMy0yLTEtMS0w_8236322e-1a7f-4afd-9dee-dea373d234c6"
      unitRef="usd">2147000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfNC0yLTEtMS0w_8e65d71a-82ae-4bfd-bfb2-fff2be72b28d"
      unitRef="usd">7000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims
      contextRef="ic3736a862fac49b58a14b1afef758cc4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfNS0yLTEtMS0w_ef855c4b-0086-4139-832b-2c8af03eb9d5"
      unitRef="usd">3000000</pcrx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia52993d557b44575b5efa778c644c50f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjUxMjhmNTgzNmRjNzRmZDBiZmYzMDMzN2QyZWEyNDkyL3RhYmxlcmFuZ2U6NTEyOGY1ODM2ZGM3NGZkMGJmZjMwMzM3ZDJlYTI0OTJfNi0yLTEtMS0w_53efb043-5c42-4860-8f6a-4111bb6f5f2d"
      unitRef="usd">16199000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA2NjM_17dacfe9-096f-4bd1-90f4-16211ed42836">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the Company&#x2019;s investments at September&#160;30, 2021 and December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021 Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;U.S. Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020 Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;U.S. Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;U.S. Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic4e113d16ac64bae9b930524840237b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMi0yLTEtMS0w_806f72f6-ecc8-47c5-bfe9-77502b7c9fe4"
      unitRef="usd">17615000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic4e113d16ac64bae9b930524840237b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMi00LTEtMS0w_b9d7633e-0cd7-464a-afd8-566659489b15"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic4e113d16ac64bae9b930524840237b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMi02LTEtMS0w_ac07aff7-446b-4823-8d0a-319c0fc2cf6a"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic4e113d16ac64bae9b930524840237b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMi04LTEtMS0w_6584c1d5-5fc6-4ef8-bb74-5a5809a45654"
      unitRef="usd">17616000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i22316fe6c9c9417c99464765f80e9ff2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMy0yLTEtMS0w_ca3a59bb-59e4-449a-904d-cd24dd1fa254"
      unitRef="usd">423302000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i22316fe6c9c9417c99464765f80e9ff2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMy00LTEtMS0w_6c24d0a3-f234-4a4a-8741-db65aa8c3844"
      unitRef="usd">82000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i22316fe6c9c9417c99464765f80e9ff2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMy02LTEtMS0w_1042017b-6dc2-4ec5-9ad6-f2cbe154992d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i22316fe6c9c9417c99464765f80e9ff2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMy04LTEtMS0w_e1fdeeac-a337-4f29-b336-a2e3b268f2ff"
      unitRef="usd">423384000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNC0yLTEtMS0w_cb90cde6-7dc6-459f-a2af-c6593a56a01f"
      unitRef="usd">32612000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNC00LTEtMS0w_ef3c7cb1-8117-418f-b326-99e3e1998329"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNC02LTEtMS0w_ceb9b670-a07e-4769-9696-c8dd4f3f6098"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6352f0a61dd348c095b2daf6a1b0a5d3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNC04LTEtMS0w_c9957bd8-10dc-4cef-89f4-376785a02e9b"
      unitRef="usd">32605000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNS0yLTEtMS0w_8bf31b69-7d22-4672-a0e2-0c26ad7e86e7"
      unitRef="usd">86194000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNS00LTEtMS0w_fda1494d-c0ac-4d11-83f6-0e5aaa01fefa"
      unitRef="usd">24000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNS02LTEtMS0w_96820009-a665-49d7-9047-c1e88cc98ca4"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie517fecce2504cbe8f63439f4c2cc6a0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfNS04LTEtMS0w_b2335061-8ca4-4dc1-b1a0-f0756307e536"
      unitRef="usd">86217000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMTItMi0xLTEtMA_a3aab917-ced2-4833-81d6-33a8fe4d4824"
      unitRef="usd">559723000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMTItNC0xLTEtMA_791ad2ea-b7c2-4983-ae9b-da1660a6634a"
      unitRef="usd">109000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMTItNi0xLTEtMA_d15ab037-1650-4f6d-ae08-d8bf5bba6c6d"
      unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjQ0MzUxZWFhMWE3ZjRjN2NiMmIwNzNlYTg2OGJhOWIwL3RhYmxlcmFuZ2U6NDQzNTFlYWExYTdmNGM3Y2IyYjA3M2VhODY4YmE5YjBfMTItOC0xLTEtMA_54027237-3e91-42ed-a8db-d843a8fcd366"
      unitRef="usd">559822000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic08f2b904bb04e27a90834e3f466dbd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMi0yLTEtMS0w_2edc9bc5-778b-4dcf-a5b2-0bc3cad291b2"
      unitRef="usd">34918000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic08f2b904bb04e27a90834e3f466dbd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMi00LTEtMS0w_f7003b28-cbce-46a6-9cdd-672849b638da"
      unitRef="usd">98000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic08f2b904bb04e27a90834e3f466dbd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMi02LTEtMS0w_5ce86878-8658-4293-be53-0f85ea3ecf67"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic08f2b904bb04e27a90834e3f466dbd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMi04LTEtMS0w_b29ac6f5-8581-446f-bce1-687d04f284ef"
      unitRef="usd">35016000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia66d87b3e37142af9057b01f7429fa1a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMy0yLTEtMS0w_b69f036d-4144-4ce1-8235-4cee882305af"
      unitRef="usd">221494000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia66d87b3e37142af9057b01f7429fa1a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMy00LTEtMS0w_9372fc50-dfc5-4381-8c28-20a9c5bbf22a"
      unitRef="usd">36000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia66d87b3e37142af9057b01f7429fa1a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMy02LTEtMS0w_8524c1e3-172e-4021-b1ee-320638147fbb"
      unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia66d87b3e37142af9057b01f7429fa1a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMy04LTEtMS0w_41ca6825-5e4d-439d-8973-41b4afbf0ba6"
      unitRef="usd">221512000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic28d6c7359df4b11873f7e1849924a7e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNC0yLTEtMS0w_d39b90a7-d8dd-45f9-83f1-fc66a014441d"
      unitRef="usd">120375000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic28d6c7359df4b11873f7e1849924a7e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNC00LTEtMS0w_fde3e519-7014-4d39-aa17-fbee78d0b21c"
      unitRef="usd">179000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic28d6c7359df4b11873f7e1849924a7e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNC02LTEtMS0w_974aefc7-4702-4247-a99e-7a98c94298ea"
      unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic28d6c7359df4b11873f7e1849924a7e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNC04LTEtMS0w_ed1825a4-f260-42f4-a467-2c00f9323a75"
      unitRef="usd">120543000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icaaea71e25214e7182cb2fdf114dd014_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNS0yLTEtMS0w_1ff09ef4-a1b1-4d8c-bb7b-6c501894bf61"
      unitRef="usd">44629000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icaaea71e25214e7182cb2fdf114dd014_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNS00LTEtMS0w_b360bcdb-7c0e-4e6c-a31e-eb8bfc6cff65"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icaaea71e25214e7182cb2fdf114dd014_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNS02LTEtMS0w_b74a8b21-966e-488d-ac10-024461829add"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icaaea71e25214e7182cb2fdf114dd014_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNS04LTEtMS0w_f5e972d8-15c7-4b8a-9ff5-90bed5908105"
      unitRef="usd">44634000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNi0yLTEtMS0w_187ae289-709f-44bd-b7ef-4b22e042ae4b"
      unitRef="usd">421416000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNi00LTEtMS0w_0fa5d6c6-46f7-4527-8a32-9d31dd72bef2"
      unitRef="usd">320000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNi02LTEtMS0w_1f7df29a-af8c-4639-ac8e-cc70c1c396ce"
      unitRef="usd">31000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f13e0669f2244e4bf52dfa27a3e5584_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfNi04LTEtMS0w_641dab4a-5646-4538-9c73-78e7e7754971"
      unitRef="usd">421705000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie9cd891a11904cbca9a869e4c48499a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTAtMi0xLTEtMA_1d271480-c337-49b1-a810-fc3e7ae0fccf"
      unitRef="usd">95429000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie9cd891a11904cbca9a869e4c48499a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTAtNC0xLTEtMA_29abf50c-3fcd-4a31-b6d7-3282a24092ec"
      unitRef="usd">30000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie9cd891a11904cbca9a869e4c48499a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTAtNi0xLTEtMA_e8aedf0c-f6fc-4ddc-a405-a4340c46abd0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie9cd891a11904cbca9a869e4c48499a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTAtOC0xLTEtMA_6067fe13-b011-4ced-aab9-37617de9da92"
      unitRef="usd">95459000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idaabd093cc73463987f26acf4772c0bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTEtMi0xLTEtMA_26ebc5be-ef36-44a7-a891-9c27db98c71c"
      unitRef="usd">95429000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idaabd093cc73463987f26acf4772c0bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTEtNC0xLTEtMA_a9710d89-4ac7-407f-8982-18e6baa0f3ff"
      unitRef="usd">30000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idaabd093cc73463987f26acf4772c0bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTEtNi0xLTEtMA_7adc9a71-15df-4ff6-8048-1c8ff5371a77"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idaabd093cc73463987f26acf4772c0bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTEtOC0xLTEtMA_dcf7aec9-98b6-4703-ad8f-a80c635ee51a"
      unitRef="usd">95459000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTItMi0xLTEtMA_2ff8db11-d247-4dfa-a351-e8c3f503e467"
      unitRef="usd">516845000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTItNC0xLTEtMA_01047381-aec7-4a3d-9a8c-22de2250177e"
      unitRef="usd">350000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTItNi0xLTEtMA_e7ce11ae-4583-473a-bd6b-98c17e83b285"
      unitRef="usd">31000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RhYmxlOjIyMGExNTY3MGIyNTQ3MDdhYjY5MjEzMjFiZDRmN2MyL3RhYmxlcmFuZ2U6MjIwYTE1NjcwYjI1NDcwN2FiNjkyMTMyMWJkNGY3YzJfMTItOC0xLTEtMA_48cef763-f810-4c21-a7e1-3c046a3f8167"
      unitRef="usd">517164000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InterestReceivable
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTM2Mw_2d8686b5-0bbf-47cd-a57a-66a907da89c3"
      unitRef="usd">400000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTM3MA_4fd8c1ca-b701-4694-9704-62c3925566c4"
      unitRef="usd">1600000</us-gaap:InterestReceivable>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i51a59f89178947969b3cba1e3274e2dc_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTg1Mg_7631f30d-e4de-4434-b1a4-f3cb725d09a8"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ied43576ff808456488d1b300724244f6_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTg1Ng_869a1bb0-462f-459d-8d91-a8d81aefd5ef"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id114c1b120324ca1a1669aa5d23a5abb_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTg2Mw_97ded7d0-8ebd-45e8-ab96-55149e32c409"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4b036912429349368955de8ecae55a89_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTk1OA_9062348f-3461-4f6c-a21c-e80772abfc80"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie7ed73dae03a470482270000763fd063_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTk2Mg_f89ab6df-ffff-4d66-bf28-b563d73d6dd2"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1718ddd31a954033b183d8735f99a0a4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfOTk2OQ_632afa2a-4899-4f1b-8321-3af69c754581"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA1ODI_03677550-a685-4c50-9fb1-25fc146a8261"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82MS9mcmFnOjdjMmYxNzk3ODJiMTRjYWZiOWNhYTBhYWRkZGMxYWJlL3RleHRyZWdpb246N2MyZjE3OTc4MmIxNGNhZmI5Y2FhMGFhZGRkYzFhYmVfMTA1ODI_eba118b2-15c0-4e34-afc5-0f4fdf21f3df"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTQwNA_f4b1e258-647c-4cd0-8c89-849cc62f7593">STOCK PLANS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company&#x2019;s stockholders approved the Amended and Restated 2011 Stock Incentive Plan, or 2011 Plan. The 2011 Plan was amended to increase the number of shares of common stock authorized for issuance as equity awards under the plan by 1,500,000 shares.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Awards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables contain information about the Company&#x2019;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Exercise Price (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,235,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(238,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,170,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Grant Date Fair Value (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of stock options granted during the nine months ended September&#160;30, 2021 wa&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$27.36&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;per share. The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Black-Scholes Weighted Average Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.82%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.26%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2014 Employee Stock Purchase Plan, or ESPP, features two six-month offering periods per year, running from January 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at 85% of the closing fair market value of the Company&#x2019;s common stock on either the offering date or the purchase date, whichever is less. During the nine months ended September&#160;30, 2021, 31,230 shares were purchased and issued through the ESPP.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i7e0a781126c0441dacaff2fa6d34f7a5_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMjk5_091eba59-cd1b-460b-91ff-5ec51eb6e325"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTM4Mg_7eb71d0c-9cf4-4ddb-a2d6-7bc983dd0499">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib22ffaf6dc27448ab2156941699b6b1a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMi0yLTEtMS0w_b489a9f9-91fa-44a1-8a7b-43ddf96e90a0"
      unitRef="usd">1512000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7c7ce8a3a5fc418d9801116dc3b6610c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMi00LTEtMS0w_01610997-fc9c-448d-afe2-f26b61b00f2d"
      unitRef="usd">1546000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5a5860adea844fa8b07fe21a35e0f561_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMi02LTEtMS0w_3c369342-0ff3-430d-9526-9c4c3c776222"
      unitRef="usd">4429000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia516abbffb1e4c0ba991b35223d79126_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMi04LTEtMS0w_f864a29b-7363-4e6b-be0c-41982d477d6c"
      unitRef="usd">4050000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie261cb366710463b836156aa4c632d01_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMy0yLTEtMS0w_78f197d5-1ba7-4761-bcdf-a7c0a32b2475"
      unitRef="usd">1156000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8a6a43537be9433b9fc3bf5d2c98e1a4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMy00LTEtMS0w_39110223-81b8-4988-8372-23ca77c446c9"
      unitRef="usd">1401000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibfbabdf3eb7c47d9a56eb08fb08ae3f7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMy02LTEtMS0w_302e9f63-b56c-4eec-b2c9-1a71801dc337"
      unitRef="usd">3591000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3a1ff59e16c64e2e9bc827316216d3ba_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMy04LTEtMS0w_98ced716-21db-41d0-a4c4-c671d8113be0"
      unitRef="usd">3944000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2bcecc3df2a2449395525e8d81ac6047_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNC0yLTEtMS0w_613e3212-5e90-4ba4-802c-b4ce97e6eb80"
      unitRef="usd">8116000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7583ce2665944358a76869e7bdebea3a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNC00LTEtMS0w_e2922ebc-10ae-444d-8bf4-cc0c180b7fb1"
      unitRef="usd">8007000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i22815de90a2e44529cacea918876ba77_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNC02LTEtMS0w_a0c005c4-a19a-4fbe-b041-68e2284b7c8b"
      unitRef="usd">23336000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0f3f4a3e1d854d6688e4b30b04ac8976_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNC04LTEtMS0w_3774acd6-62f2-46da-ab09-8c25de55e044"
      unitRef="usd">21030000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNS0yLTEtMS0w_b5535696-89f6-4c34-bc32-7209b77b3141"
      unitRef="usd">10784000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNS00LTEtMS0w_0d048841-5e31-4703-994e-c6d97932d02b"
      unitRef="usd">10954000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNS02LTEtMS0w_fc031ba6-6118-4ea0-ac5b-94b24ef2d33e"
      unitRef="usd">31356000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfNS04LTEtMS0w_c2ba232a-2af6-416f-8976-d3e5785d6176"
      unitRef="usd">29024000</us-gaap:AllocatedShareBasedCompensationExpense>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOC0yLTEtMS0w_e1ba8a38-eb8a-407d-bfd7-565bd82b04fe"
      unitRef="usd">6458000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOC00LTEtMS0w_457b491c-5e3b-4a92-8014-787692f7fe55"
      unitRef="usd">7181000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOC02LTEtMS0w_b0ef177c-2758-416b-a3cc-8ba45ddf314b"
      unitRef="usd">19507000</pcrx:Compensationexpensefromstockoptionsemployees>
    <pcrx:Compensationexpensefromstockoptionsemployees
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOC04LTEtMS0w_cbca9aea-5f94-49a0-b92e-64220b03b562"
      unitRef="usd">19795000</pcrx:Compensationexpensefromstockoptionsemployees>
    <us-gaap:RestrictedStockExpense
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOS0yLTEtMS0w_d56ab2ef-285b-4600-8b7b-cc69e1bb3b2a"
      unitRef="usd">4126000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOS00LTEtMS0w_4e0f506a-5c71-433c-83fc-4c2a6cdc036e"
      unitRef="usd">3552000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOS02LTEtMS0w_cc4dd142-96f5-4d0d-98bf-170055a69817"
      unitRef="usd">11164000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfOS04LTEtMS0w_957c06c8-c4d8-4eb7-99c9-c0161ab35d91"
      unitRef="usd">8589000</us-gaap:RestrictedStockExpense>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTAtMi0xLTEtMA_6fe2a665-0f5f-4111-bf61-01d40df7fbfa"
      unitRef="usd">200000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTAtNC0xLTEtMA_40f3d357-64df-42a5-90cf-dbed8caee3ca"
      unitRef="usd">221000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTAtNi0xLTEtMA_588ea266-6739-4ede-84a8-8dceb80db6c6"
      unitRef="usd">685000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <pcrx:CompensationExpenseFromEmployeeStockPurchasePlan
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTAtOC0xLTEtMA_a51020fe-edef-40dd-8cf9-8bf35ad74ecc"
      unitRef="usd">640000</pcrx:CompensationExpenseFromEmployeeStockPurchasePlan>
    <us-gaap:ShareBasedCompensation
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTEtMi0xLTEtMA_0a4c4257-da1c-4bd1-a014-ddb8fb7ea151"
      unitRef="usd">10784000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTEtNC0xLTEtMA_799e58ae-3aeb-41d3-83d6-60f1d9d2ba74"
      unitRef="usd">10954000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTEtNi0xLTEtMA_dfa146db-dbc2-4cdd-b845-e0ad41689bd6"
      unitRef="usd">31356000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjIyMmYwMDYwYTE1OTRlOTQ5NzVlMGE4YjE2Y2ZiZWY5L3RhYmxlcmFuZ2U6MjIyZjAwNjBhMTU5NGU5NDk3NWUwYThiMTZjZmJlZjlfMTEtOC0xLTEtMA_e6c2f79c-4df8-496d-ad8a-331376974c1f"
      unitRef="usd">29024000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTM5MA_498952ba-b7f3-4824-8408-525fd8557e43">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables contain information about the Company&#x2019;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Exercise Price (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,235,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(238,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,170,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Weighted Average Grant Date Fair Value (Per Share)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMS0yLTEtMS0w_36ce232c-a619-4699-a770-1679b8a16825"
      unitRef="shares">6235118</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i39c6077ecfb343b7b02e61046eb86e03_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMS00LTEtMS0w_943a61b9-a337-45d4-ac34-d0b6da113429"
      unitRef="usdPerShare">45.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMi0yLTEtMS0w_e1422e65-0609-46a8-9528-8dd50355aae2"
      unitRef="shares">769352</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMi00LTEtMS0w_64c1751e-f45f-4e4f-bec5-08d9b2f3126e"
      unitRef="usdPerShare">61.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMy0yLTEtMS0w_c57ba8a7-8301-43be-9067-fb1c8aa7d477"
      unitRef="shares">553023</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfMy00LTEtMS0w_78c07c55-bbc3-4942-93bc-3c19d3aa863a"
      unitRef="usdPerShare">34.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNC0yLTEtMS0w_1918c61e-c089-49af-a8c9-78dfce16fa74"
      unitRef="shares">238865</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNC00LTEtMS0w_65778aff-c7d6-4f9b-9374-a7b8e57baa8c"
      unitRef="usdPerShare">46.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNS0yLTEtMS0w_c0161003-1f24-4e34-bae7-ed2b4f9ff9b1"
      unitRef="shares">42416</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNS00LTEtMS0w_ae89a51e-be0a-4d87-bce6-0ab963c97415"
      unitRef="usdPerShare">76.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNi0yLTEtMS0w_1d126ab2-0d8a-4e3d-999b-7acd6994b65b"
      unitRef="shares">6170166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2b38381b6d0a45889401a583757402a5_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOjI3MDdmN2NjZDJjMjRjYzY4ODUzNTE3NzhkNGM5ZjJiL3RhYmxlcmFuZ2U6MjcwN2Y3Y2NkMmMyNGNjNjg4NTM1MTc3OGQ0YzlmMmJfNi00LTEtMS0w_5a3b2656-2fa3-44dc-9c1a-174a3e1c70ee"
      unitRef="usdPerShare">48.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i033c3bf91fa74d9f8777d9d69a2050e5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMS0yLTEtMS0w_4a75081c-634e-43a9-b73c-d7476934d7ef"
      unitRef="shares">957453</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i033c3bf91fa74d9f8777d9d69a2050e5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMS00LTEtMS0w_0ef74d09-9396-4d29-84b6-20bfe10d05bc"
      unitRef="usdPerShare">46.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMi0yLTEtMS0w_f8ad2b12-18dc-436e-a3f9-06cb0239d350"
      unitRef="shares">401845</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMi00LTEtMS0w_c298fb7f-fc17-43ea-938a-329651292334"
      unitRef="usdPerShare">61.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMy0yLTEtMS0w_bf985f67-3e72-4e81-a10a-df3a89ed6483"
      unitRef="shares">302228</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfMy00LTEtMS0w_c63682a8-9c26-4081-8596-2ab0122c04a7"
      unitRef="usdPerShare">44.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfNC0yLTEtMS0w_8dd48aca-8e01-4b34-a935-097fda5127b8"
      unitRef="shares">114562</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfNC00LTEtMS0w_59a83f13-872c-4cd7-b6fb-4b5b086c7175"
      unitRef="usdPerShare">49.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1d2ac06eaefc41a4919773d11bc58522_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfNS0yLTEtMS0w_9e196f97-5492-4701-817e-d5741e0399e5"
      unitRef="shares">942508</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1d2ac06eaefc41a4919773d11bc58522_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmFjNGY2YWMxYzJhMjQ3ZWFhNWU0NGZlZTY2ZjE2YzY2L3RhYmxlcmFuZ2U6YWM0ZjZhYzFjMmEyNDdlYWE1ZTQ0ZmVlNjZmMTZjNjZfNS00LTEtMS0w_ac71247c-251c-44b3-8b8d-c46c7e921532"
      unitRef="usdPerShare">52.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfNzA2_55843e81-d06a-4409-bedf-ee650ef78df4"
      unitRef="usdPerShare">27.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTQwMw_d129d326-e736-4b3e-ab27-cebe26e13c60">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Black-Scholes Weighted Average Assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.82%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.26%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmZkYjliZGIwNjMwYjQ5MDU5NDVhZDVjYjYxYzJkZTVjL3RhYmxlcmFuZ2U6ZmRiOWJkYjA2MzBiNDkwNTk0NWFkNWNiNjFjMmRlNWNfMS0yLTEtMS0w_3073827d-ddd2-443e-929b-53af63510c76"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmZkYjliZGIwNjMwYjQ5MDU5NDVhZDVjYjYxYzJkZTVjL3RhYmxlcmFuZ2U6ZmRiOWJkYjA2MzBiNDkwNTk0NWFkNWNiNjFjMmRlNWNfMi0yLTEtMS0w_00d48dcf-529d-4fa0-b1da-440595c4b043"
      unitRef="number">0.0082</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmZkYjliZGIwNjMwYjQ5MDU5NDVhZDVjYjYxYzJkZTVjL3RhYmxlcmFuZ2U6ZmRiOWJkYjA2MzBiNDkwNTk0NWFkNWNiNjFjMmRlNWNfMy0yLTEtMS0w_9c40084f-2ef8-4ac9-b98b-084838ea9b81"
      unitRef="number">0.4926</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RhYmxlOmZkYjliZGIwNjMwYjQ5MDU5NDVhZDVjYjYxYzJkZTVjL3RhYmxlcmFuZ2U6ZmRiOWJkYjA2MzBiNDkwNTk0NWFkNWNiNjFjMmRlNWNfNC0yLTEtMS0w_4033480c-e416-4afb-8515-bc551ac4cad4">P5Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods
      contextRef="i5328ec671a74439b9a01511fe23d4b0c_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfOTcx_4f0add70-5cf4-46b0-add1-0fafd4d710a0"
      unitRef="offeringperiod">2</pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods>
    <pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod
      contextRef="i5328ec671a74439b9a01511fe23d4b0c_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTM5Mw_dcdc4989-5484-475c-aec7-6371ca944144">P6M</pcrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTE2Mg_94659988-85da-4e22-aed8-4062145a6cf3"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82NC9mcmFnOmJkNzI4MjNjNGE2ZDQ1ZWM5ZTBjMjA2MmIxZmRkMTc5L3RleHRyZWdpb246YmQ3MjgyM2M0YTZkNDVlYzllMGMyMDYyYjFmZGQxNzlfMTMyOA_6954d853-b38d-4e16-9461-5085ca6d6f1b"
      unitRef="shares">31230</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RleHRyZWdpb246MWFmZGUwMThmM2VkNGI1Zjk4MWU5MzdmYzhlNGI1OGJfMzky_ebd2dc5e-6951-402a-9bee-034ebdc51941">STOCKHOLDERS&#x2019; EQUITY&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Income &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the changes in the balances of the Company&#x2019;s accumulated other comprehensive income  for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Net unrealized (loss) gain on investments, net of tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Net of a $54&#160;thousand tax benefit for the nine months ended September 30, 2021. There was no tax benefit for the nine months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RleHRyZWdpb246MWFmZGUwMThmM2VkNGI1Zjk4MWU5MzdmYzhlNGI1OGJfMzg5_eeedde40-1c50-4282-9d6c-65c8772c0012">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the changes in the balances of the Company&#x2019;s accumulated other comprehensive income  for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Net unrealized (loss) gain on investments, net of tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Net of a $54&#160;thousand tax benefit for the nine months ended September 30, 2021. There was no tax benefit for the nine months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i92cfc444422b4d0b8bace3222b587d3c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfMi0yLTEtMS0w_fdd44975-a285-4834-bf2e-dc6b70645328"
      unitRef="usd">318000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e2148bdfe694503807898f469458f04_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfMi00LTEtMS0w_876f0ff7-37f8-4839-88dd-e2ac5cead45a"
      unitRef="usd">322000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i07396e9494fe4b07b8f774fda1e27972_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfMy0yLTEtMS0w_c3b1ab68-ec90-48d1-882d-a2c7dbc3ea48"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="idc5902e825304da38fccdd9ed1ae795a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfMy00LTEtMS0w_b3ec3857-42d3-4f9c-9140-7addc4a78095"
      unitRef="usd">525000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i07396e9494fe4b07b8f774fda1e27972_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNC0yLTEtMS0w_51bb897b-f671-4849-8e5c-402a5d69d2e6"
      unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="idc5902e825304da38fccdd9ed1ae795a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNC00LTEtMS0w_bc29ec47-248d-4a7a-b3c3-3546715aa62a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i07396e9494fe4b07b8f774fda1e27972_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNS0yLTEtMS0w_e88ed860-e100-4c75-9fff-be2166e3c2fc"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="idc5902e825304da38fccdd9ed1ae795a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNS00LTEtMS0w_b23a2664-2696-4ad5-a5cf-46cecda90ab7"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i467a1ba8b0124cfd8c7cc340c2972c7b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNi0yLTEtMS0w_27166b6f-67ad-4a87-9f1a-bd58a096a234"
      unitRef="usd">153000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc0600e264da44709593ccef5269505a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RhYmxlOjM5MzIyYTQ1OThmZDQ3NDI4NDA5NzU2MjJkOTRmYjlkL3RhYmxlcmFuZ2U6MzkzMjJhNDU5OGZkNDc0Mjg0MDk3NTYyMmQ5NGZiOWRfNi00LTEtMS0w_5fd6f04c-255d-4cb2-a9cc-fbf9578af0b5"
      unitRef="usd">847000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RleHRyZWdpb246MWFmZGUwMThmM2VkNGI1Zjk4MWU5MzdmYzhlNGI1OGJfMjYz_623891ef-8877-483e-9397-7b8f4c4c3af6"
      unitRef="usd">54000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV82Ny9mcmFnOjFhZmRlMDE4ZjNlZDRiNWY5ODFlOTM3ZmM4ZTRiNThiL3RleHRyZWdpb246MWFmZGUwMThmM2VkNGI1Zjk4MWU5MzdmYzhlNGI1OGJfMzI4_9abb2985-506f-4445-92fc-61edbb739892"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RleHRyZWdpb246YWM0NjM4MTZiNTc4NGI1MWFmZjk3ZGJjNGMwNjQyZGFfMjA4NA_4d70c8e1-9424-45df-8f51-6ba30df8b961">NET INCOME (LOSS) PER SHARE&lt;div style="margin-bottom:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs, the purchase of shares from the ESPP (using the treasury stock method) and the conversion of the excess conversion value on the 2022 Notes and 2025 Notes, if applicable. As discussed in Note 8, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company has the option to pay cash for the aggregate principal amount due upon the conversion of its 2022 Notes and 2025 Notes. Since it is the Company&#x2019;s intent to settle the principal amount of its 2022 Notes and 2025 Notes in cash, the potentially dilutive effect of such notes on net income (loss) per share is computed under the treasury stock method. ASU 2020-06 will require the Company to use the if-converted method upon adoption; this new accounting pronouncement has not been adopted as of September&#160;30, 2021. For additional information regarding ASU 2020-06, see Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per common share for the three and nine mon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ths ended September&#160;30, 2021 and 2020 (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computation of diluted securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of conversion premium on the 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following outstanding stock options, RSUs and ESPP purchase options are antidilutive in the periods presented (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RleHRyZWdpb246YWM0NjM4MTZiNTc4NGI1MWFmZjk3ZGJjNGMwNjQyZGFfMjA4MQ_67f6f2fa-5669-4dc5-8995-81f643d6b5c6">&lt;div style="margin-bottom:10pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per common share for the three and nine mon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ths ended September&#160;30, 2021 and 2020 (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computation of diluted securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of conversion premium on the 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dilutive effect of ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMy0xLTEtMS0w_4ab62241-6dda-4fd0-9d50-68ffa62feddb"
      unitRef="usd">17660000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMy0zLTEtMS0w_2f857d73-314b-4696-822c-a5f4b7ca689d"
      unitRef="usd">130119000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMy01LTEtMS0w_b5743bed-9a3f-4a03-ab39-90a89e4fd4f5"
      unitRef="usd">47110000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMy03LTEtMS0w_ee7e38f3-417a-47ad-b7e5-27eb4806c74d"
      unitRef="usd">131008000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTItMS0xLTEtMA_949a351e-25d4-417c-9ce6-4328034ec4c8"
      unitRef="shares">44476000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTItMy0xLTEtMA_b802a402-43f9-4866-97d6-fb95e1eb966b"
      unitRef="shares">42928000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTItNS0xLTEtMA_60d0e619-a60b-4267-8c9e-aa6d79708096"
      unitRef="shares">44151000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTItNy0xLTEtMA_f8ed2592-70b7-4d3b-8b2f-a57d715680b7"
      unitRef="shares">42393000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6dded111553f45dd92378a98c5010846_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTQtMS0xLTEtMA_14f5fe2d-51f1-4814-9311-20cf400d813a"
      unitRef="shares">827000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i209c230b69834a4f9828d93ba9cc1546_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTQtMy0xLTEtMA_c8211827-5a70-4bb7-865e-ee1b5232de1e"
      unitRef="shares">1086000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i75398ebadfcb4945bb8dcf6b88262927_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTQtNS0xLTEtMA_996f9823-9bf0-4a9a-85f1-6f60fd975c62"
      unitRef="shares">1132000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie6964e7e50494461b1d33b90b39ec59c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTQtNy0xLTEtMA_b6e3c530-5ee5-46cd-a732-4a598abb710f"
      unitRef="shares">740000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if1e6c6a626ee44d78fb558955fed8879_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTUtMS0xLTEtMA_5ca410b2-99f1-4f21-8aaf-b6f965033e3d"
      unitRef="shares">160000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4d5224e2aea7473884ab3ab568b5f742_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTUtMy0xLTEtMA_dee2295d-efc5-44e8-af58-43620b7e4948"
      unitRef="shares">261000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2748d7cb585c451096424351db231a1b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTUtNS0xLTEtMA_8a68c555-3853-433e-8a90-e94d6bdb8437"
      unitRef="shares">337000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i801a1368563548fbb45290c7dfac40e5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTUtNy0xLTEtMA_d71328f0-cfb1-41cf-b34f-1119698d46af"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTYtMS0xLTEtMA_b813eb79-65cc-4c4d-85da-cb28758a2162"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTYtMy0xLTEtMA_8b1b1dde-0ed2-411b-bad1-f50b6598a0c3"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTYtNS0xLTEtMA_5748173e-a315-4317-9191-360b7db6b6bc"
      unitRef="shares">51000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTYtNy0xLTEtMA_8a4fbfd8-f467-4ae7-8976-9db066699a71"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ice17e0310ab24f19b2477b0ea0b3a5c0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTctMS0xLTEtMA_e0bdecd6-26bb-4e39-969a-f65b22e93b7f"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia740c361205a40759e18df3c4efb99c0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTctMy0xLTEtMA_c781254f-5083-4824-82ff-9ee2addcc575"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5328ec671a74439b9a01511fe23d4b0c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTctNS0xLTEtMA_4713a001-66a8-4f96-a35d-0f724e529e3b"
      unitRef="shares">3000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i34dbb38f3ce9455eb1cb8977c02233dc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTctNy0xLTEtMA_b647fdc9-249e-4718-8b7c-494251e1f843"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTktMS0xLTEtMA_b5d5565a-4e23-457a-9686-e6fd60321439"
      unitRef="shares">45463000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTktMy0xLTEtMA_982514ad-41d9-4207-aff6-6f01f2ffea67"
      unitRef="shares">44275000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTktNS0xLTEtMA_e13cf0c0-4907-48cd-9ac9-7226a1bf6918"
      unitRef="shares">45674000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMTktNy0xLTEtMA_b8da081a-68eb-4e0c-995f-c94a0b97e0df"
      unitRef="shares">43333000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjEtMS0xLTEtMA_2ede25ed-c1b2-4e0d-8eda-2a8881d3cddc"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjEtMy0xLTEtMA_c50f1440-c5c9-4783-94ad-e043b1d2ecd9"
      unitRef="usdPerShare">3.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjEtNS0xLTEtMA_d11a8db3-25cb-4d59-ac2b-789aa334dfcd"
      unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjEtNy0xLTEtMA_c883b450-ebad-4aa4-a71a-4d66c3257748"
      unitRef="usdPerShare">3.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjItMS0xLTEtMA_bbb8470e-8d59-485c-84b3-3ebe81043587"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjItMy0xLTEtMA_e9728798-183f-4ba1-9766-f9c9f413c4e3"
      unitRef="usdPerShare">2.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjItNS0xLTEtMA_ff306559-70f3-4358-814f-652b485eba5d"
      unitRef="usdPerShare">1.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOjk3ODNkZjI0ZDVhMjRjMWU5NDc5ZGRjNDlmZjAwZGM1L3RhYmxlcmFuZ2U6OTc4M2RmMjRkNWEyNGMxZTk0NzlkZGM0OWZmMDBkYzVfMjItNy0xLTEtMA_29596a1d-25b6-4f0c-99ed-421cc548c51b"
      unitRef="usdPerShare">3.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RleHRyZWdpb246YWM0NjM4MTZiNTc4NGI1MWFmZjk3ZGJjNGMwNjQyZGFfMjA4Mw_82f8d8bb-8eb4-4085-8e74-e94baaf8f9fb">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following outstanding stock options, RSUs and ESPP purchase options are antidilutive in the periods presented (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average ESPP purchase options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if70609b807c243d69cf4588104e93c8e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMi0xLTEtMS0w_3f90e4c1-7e62-4ee9-8878-f734c99a9dd0"
      unitRef="shares">2707000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic0de685059e34723aae25d71c24a900e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMi0zLTEtMS0w_d3c1bb5c-5151-46e4-90cd-7fc71d3dd3ef"
      unitRef="shares">3585000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3131d879dea24998a48d584e912182a8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMi01LTEtMS0w_9eb18cb1-822c-4e4b-892d-7045df6073eb"
      unitRef="shares">1895000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i41071c327f3940bcaa6bb301df7449bb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMi03LTEtMS0w_2380e60e-4bf7-4157-bf44-d3fe98872600"
      unitRef="shares">4746000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i218c8db6e4454704b8551048521d1831_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMy0xLTEtMS0w_84e8834d-26dc-4e36-b4cf-d281463b593d"
      unitRef="shares">369000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8d011ec249be45c6b176c6e6198e14cb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMy0zLTEtMS0w_57017dae-cedc-4ff7-b43a-8a3b458967ab"
      unitRef="shares">5000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i25c7e05a7fd8439d9f81fa9758796010_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMy01LTEtMS0w_17e5342d-f5d0-4a49-8a32-e32a15a1d86a"
      unitRef="shares">132000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9405e0168d3f418b965e10a3716b7c99_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfMy03LTEtMS0w_13d77024-6312-48c3-a21d-c0e397b916b6"
      unitRef="shares">126000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8f66d871d84f43da953d2139367fb6c2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNS0xLTEtMS0w_9513b250-041d-49cb-aae9-8ca502a14413"
      unitRef="shares">26000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5d79527b591541b2b5cd79a11907b8f0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNS0zLTEtMS0w_8aad258b-6940-4950-8463-b11e777107ad"
      unitRef="shares">25000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i80f1189a3be5472b8a2576c5439a28f3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNS01LTEtMS0w_d62ef8dd-f208-4712-8519-ad64cb265ac9"
      unitRef="shares">9000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia50e9b50fa274d2a877186bfca0244a2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNS03LTEtMS0w_1e048644-856e-4ca0-bbd9-8b6084bb23ea"
      unitRef="shares">22000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNy0xLTEtMS0w_44db0509-fa15-4184-93cc-b3ef6f1f8eb4"
      unitRef="shares">3102000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNy0zLTEtMS0w_6da13914-99b5-447e-9795-f215363dc13f"
      unitRef="shares">3615000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNy01LTEtMS0w_f6851c59-cd4a-4e83-89c1-28ae63cfd556"
      unitRef="shares">2036000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83MC9mcmFnOmFjNDYzODE2YjU3ODRiNTFhZmY5N2RiYzRjMDY0MmRhL3RhYmxlOmQyNzhiOWYwZDUxYjQwNDJiZjJmZDZjMzY5NWQwYThhL3RhYmxlcmFuZ2U6ZDI3OGI5ZjBkNTFiNDA0MmJmMmZkNmMzNjk1ZDBhOGFfNy03LTEtMS0w_793087b7-231d-4a10-90bc-439591309658"
      unitRef="shares">4894000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTMxNQ_cd04503c-4eea-415a-8bbc-c8b18c8d5067">INCOME TAXES&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2021 and 2020, the Company had income tax expense of $6.6 million and an income tax benefit of $124.0 million, respectively. For the nine months ended September&#160;30, 2021 and 2020, the Company recorded income tax expense of $15.5&#160;million and an income tax benefit of $123.6&#160;million, respectively. The income tax expense for the three and nine months ended September&#160;30, 2021 represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items including equity compensation and non-deductible capital losses. The income tax benefit for the three and nine months ended September&#160;30, 2020 represents the full release of a $124.6&#160;million valuation allowance on the Company&#x2019;s net domestic deferred assets as the Company determined that there was sufficient positive evidence to conclude that it was more likely than not that domestic deferred taxes were realizable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the nine months ended September 30, 2021, the Company recorded a valuation allowance against U.S. capital loss carryforwards since it is more likely than not the tax benefit related to the losses are not realizable. The Company continues to maintain a full valuation allowance on its foreign net deferred tax balances.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTMyNA_44fb44c1-e802-4e52-a059-3c58fd647a08">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfMy0xLTEtMS0w_0ffbd4f4-771b-4a9a-b234-2460a1bd7c13"
      unitRef="usd">25167000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfMy0zLTEtMS0w_a828102b-6cbe-458e-9917-132aa9b4251e"
      unitRef="usd">8175000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfMy01LTEtMS0w_c0d779c2-4565-46fe-a662-d6415dcf0580"
      unitRef="usd">66962000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfMy03LTEtMS0w_9b6539a4-06e1-434f-a8e2-ae5156a01b76"
      unitRef="usd">10154000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNC0xLTEtMS0w_fbefa9df-6232-49a1-9720-d23c31983142"
      unitRef="usd">-936000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNC0zLTEtMS0w_05da2bf3-35ee-4283-94b4-46aa3620c502"
      unitRef="usd">-2025000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNC01LTEtMS0w_19bbfc30-c4c1-426c-a71c-1efff2f2ad59"
      unitRef="usd">-4360000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNC03LTEtMS0w_9765cac5-bebc-4ead-9437-ddd663783dd1"
      unitRef="usd">-2759000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNS0xLTEtMS0w_387a064e-760c-4ce5-bb71-7dcd109ba1be"
      unitRef="usd">24231000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNS0zLTEtMS0w_0cb629e0-96e9-4b81-9939-fe3e8bb0de96"
      unitRef="usd">6150000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNS01LTEtMS0w_4f801855-b5b2-4a9c-a830-2ad459c0efb8"
      unitRef="usd">62602000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RhYmxlOmE4NGY0YTdjMjlhNjQ0NzE4NDM4MTQwYzg2MDA3ODlmL3RhYmxlcmFuZ2U6YTg0ZjRhN2MyOWE2NDQ3MTg0MzgxNDBjODYwMDc4OWZfNS03LTEtMS0w_65a7a4b0-6f06-47ce-8956-329a32a594f2"
      unitRef="usd">7395000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9ad8b62d837c467891400496ee94d66b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTcw_9c06645d-69e7-406e-baed-4427d105d72f"
      unitRef="usd">6600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMjEy_4aac36dc-16a9-40ca-acb0-9f340802c127"
      unitRef="usd">-124000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMzA5_d2e2812a-1b0e-47ad-a9ca-1faa684072e6"
      unitRef="usd">15500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMzE2_8cd32c17-93bb-48a7-af1a-7d46f3c0a4ae"
      unitRef="usd">-123600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ia213897e773040b6a9581d9de800ead9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTA5OTUxMTYzMDE5MQ_2c7c746c-581a-4500-9b3e-755923f0ae41"
      unitRef="usd">-124600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83My9mcmFnOjlhOTEzNDFiYTVjZDQ3NWJhMjEwNjM4ZjNlMGIwNmI3L3RleHRyZWdpb246OWE5MTM0MWJhNWNkNDc1YmEyMTA2MzhmM2UwYjA2YjdfMTA5OTUxMTYzMDE5MQ_c6722980-87fa-4cf6-a125-44cd6bac0847"
      unitRef="usd">-124600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <pcrx:CommercialPartnersAndAgreementsTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83Ni9mcmFnOmM1OGQwNTlhMjFkOTQyNDdiMGVhNjQwYmE4YjM1MTNmL3RleHRyZWdpb246YzU4ZDA1OWEyMWQ5NDI0N2IwZWE2NDBiYThiMzUxM2ZfMTkzNg_2c39ca00-5bf5-4228-acdb-0cf541a70ef2">COMMERCIAL PARTNERS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eurofarma Laboratories S.A.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company entered into a distribution agreement with Eurofarma Laboratories S.A., or Eurofarma, for the development and commercialization of EXPAREL in Latin America. Under the terms of the agreement, Eurofarma obtained the exclusive right to market and distribute EXPAREL in 19 countries in Latin America, including Argentina, Brazil, Colombia, and Mexico. In addition, Eurofarma is responsible for regulatory filings for EXPAREL in these countries. The Company received a $0.3&#160;million upfront payment that is partially refundable upon certain circumstances and will receive royalties based on Eurofarma&#x2019;s future commercialization of the product and is also eligible to receive milestone payments that are triggered by the achievement of certain regulatory and commercial events. The Company recognized $0.1&#160;million of collaborative licensing and milestone revenue in its condensed consolidated statements of operations during the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nuance Biotech Co. Ltd.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#x2019;s intellectual property against the risk of a generic product. Dissolution costs of $3.0&#160;million were included in other operating expenses in the condensed consolidated statements of operations for the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Verve Medical Products, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company entered into a licensing agreement with Verve Medical Products, Inc. for the distribution of iovera&#xb0; in Canada.&lt;/span&gt;&lt;/div&gt;</pcrx:CommercialPartnersAndAgreementsTextBlock>
    <pcrx:CollaborativeArrangementUpfrontPayment
      contextRef="i84c3ad13f8e54c46b927d50478630682_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83Ni9mcmFnOmM1OGQwNTlhMjFkOTQyNDdiMGVhNjQwYmE4YjM1MTNmL3RleHRyZWdpb246YzU4ZDA1OWEyMWQ5NDI0N2IwZWE2NDBiYThiMzUxM2ZfNTU5_5ac94896-f2f2-4681-b669-140d75384b9a"
      unitRef="usd">300000</pcrx:CollaborativeArrangementUpfrontPayment>
    <pcrx:CollaborativeArrangementMilestonePaymentsReceived
      contextRef="i2483978d600d43fb9c6740ff2f1e9576_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83Ni9mcmFnOmM1OGQwNTlhMjFkOTQyNDdiMGVhNjQwYmE4YjM1MTNmL3RleHRyZWdpb246YzU4ZDA1OWEyMWQ5NDI0N2IwZWE2NDBiYThiMzUxM2ZfODc5_72042f57-9668-49cf-98af-663e83b901bc"
      unitRef="usd">100000</pcrx:CollaborativeArrangementMilestonePaymentsReceived>
    <us-gaap:LitigationSettlementExpense
      contextRef="i90361c4a697b4f3e8ec723bc57e3d9f1_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83Ni9mcmFnOmM1OGQwNTlhMjFkOTQyNDdiMGVhNjQwYmE4YjM1MTNmL3RleHRyZWdpb246YzU4ZDA1OWEyMWQ5NDI0N2IwZWE2NDBiYThiMzUxM2ZfMTY0MA_a690446b-7156-4001-ba3b-4d5d42cc797c"
      unitRef="usd">3000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfNDAyMw_9f5242bf-fa02-4413-be27-211ba7ddae0a">COMMITMENTS AND CONTINGENCIES&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MyoScience Milestone Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#x201c;Pacira CryoTech&#x201d;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#x201c;Fortis&#x201d;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#x201c;Merger Agreement&#x201d;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $30.0&#160;million, plus attorneys&#x2019; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pediatric Trial Commitments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Food and Drug Administration, or FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the United Kingdom&#x2019;s withdrawal from the E.U., the agreed pediatric plan will be applicable in the United Kingdom , or UK, as well. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#x201c;PLAY&#x201d;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and UK to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency (MHRA) are still reviewing the Type II variations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;One-Time Termination Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has communicated to a select number of employees a commitment to provide one-time termination benefits in the event that a facility closure occurs. The Company is recognizing these expenses ratably over the remaining service period required. The Company currently estimates the total cost of these one-time benefits to be approximately $1.1&#160;million. In the three and nine months ended September&#160;30, 2021, the Company has recognized $0.4&#160;million in one-time termination charges, which are included in acquisition-related (gains) charges, product discontinuation and other in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="id61de8fd8c9c45ff8bf796f260c5aa91_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfMTc0MA_7f57260f-4699-42ab-89d9-4c2caa954d71"
      unitRef="usd">30000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i8646cd5d4ebd458eab95c35c7d751c0e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfNDAxNA_60130dea-51ad-490e-9f81-5033ae3d9b84"
      unitRef="usd">1100000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="ib40c1bb9a8fc4a669685de4cfb5bf7b9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfMTY0OTI2NzQ0NjUyNg_2abf9eba-7b17-486e-a3bc-a72a231775a9"
      unitRef="usd">400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia161505b12724f2880a881bb1734845e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV83OS9mcmFnOmUzMjFhNDRlNzBjYjQ5NTdhYTc0NDNkYThmZmI4MDI2L3RleHRyZWdpb246ZTMyMWE0NGU3MGNiNDk1N2FhNzQ0M2RhOGZmYjgwMjZfMTY0OTI2NzQ0NjUyNg_a2258fe6-87e7-4898-a54c-ccdc0aff3eda"
      unitRef="usd">400000</us-gaap:RestructuringCharges>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i3614c786a0bb4b519909ca9e28898780_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zMjk4NTM0OTEyNTA2_bdd98c1f-8f9e-403c-80c9-2b41f875d8b5">SUBSEQUENT EVENTS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 11, 2021, the Company entered into an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;), with Merger Sub and Flexion. Flexion is a biopharmaceutical company focused on the discovery, development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, or OA, the most common form of arthritis. Flexion has an approved product, ZILRETTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(triamcinolone acetonide extended-release injectable suspension), which it markets in the U.S. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of OA knee pain. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, on October 22, 2021, Merger Sub commenced the Offer to acquire all of the outstanding Flexion Shares at an offer price of (i) $8.50 per Flexion Share in cash, net of applicable withholding taxes and without interest, plus (ii) one contingent value right per Flexion Share, or CVR, which will represent the right to receive one or more contingent payments up to $8.00 per Flexion Share in the aggregate upon the achievement of specified milestones on or prior to December 31, 2030. The Company estimates the initial cash payment to acquire all of the Flexion Shares will be approximately $450.0&#160;million, which excludes merger transaction fees. In addition, the Company will assume Flexion&#x2019;s cash and outstanding debt at the closing of the merger. As of September 30, 2021, Flexion&#x2019;s outstanding debt and termination fees less cash was estimated to be approximately $144.0&#160;million. The total consideration payable pursuant to the Merger Agreement will be dependent upon, among other things, the total number of Flexion Shares outstanding at the expiration of the Offer and at the closing of the merger as well as the closing price of the Flexion Shares on the trading day immediately prior to the closing of the merger. The Company anticipates funding such cash requirements from its available cash and cash equivalents and short-term investments and expects to explore debt financing to supplement its cash position. The fair value of the CVRs will be estimated and recognized at the closing of the merger and will be paid if and when milestones are met.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The obligation of the Company to purchase Flexion Shares tendered in the Offer is subject to the conditions set forth in the Merger Agreement, including but not limited to, that (i) the number of Flexion Shares tendered together with other Flexion shares owned by the Merger Sub would represent more than 50% of the total Flexion Shares at the time of the expiration of the Offer, and (ii) the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired or been terminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The foregoing description of the Merger Agreement and the transactions contemplated thereby do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the Merger Agreement, a copy of which is attached as &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;&lt;a href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;Exhibit 2.1 to &lt;/a&gt;&lt;a href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;the Company&lt;/a&gt;&lt;a href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;&#x2019;s Current Report on Form 8-K dated October 11, 2021&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg0NjE5_96543a97-dfa1-45e1-b617-f69b4d3b80db"
      unitRef="usdPerShare">8.50</us-gaap:BusinessAcquisitionSharePrice>
    <pcrx:ClassOfWarrantOrRightNumberOfRightsIssued
      contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg2Njc3_2f338db5-1136-48a8-bae9-b811036f9cdb"
      unitRef="shares">1</pcrx:ClassOfWarrantOrRightNumberOfRightsIssued>
    <pcrx:BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice
      contextRef="i8c3443c6210e4129b77b12cacc1af29e_I20211022"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg0NjUw_7ec87829-ab34-49e4-b413-61c6a2a59590"
      unitRef="usdPerShare">8.00</pcrx:BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ie0268792e6564110bccd672d24ff62fc_D20211022-20211022"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg2NDcx_4c956216-20bb-4957-905c-1ef4947a88bb"
      unitRef="usd">450000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i37b82df25f6144808d51c0943de2a4b1_I20211015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV8zODQ4MjkwNzg2NDU1_dc10d8f3-0b18-41fc-acef-ecb523521f94"
      unitRef="usd">144000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <pcrx:BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage
      contextRef="if6c3e67d137a4219a0590be4ad4df4ae_I20211118"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV8xMzM0L2ZyYWc6ZDgwNDBiY2Q4YjJjNGMxOWE1NzY1N2I0YzUwODVlYTEvdGV4dHJlZ2lvbjpkODA0MGJjZDhiMmM0YzE5YTU3NjU3YjRjNTA4NWVhMV80OTQ3ODAyNDE4MjM4_e6502baf-b5a5-420c-947f-723be18c4da2"
      unitRef="number">0.50</pcrx:BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760759345064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PACIRA BIOSCIENCES,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0619477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5401 West Kennedy Boulevard, Suite 890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tampa<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">553-6680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PCRX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,544,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001396814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682827576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 134,036<span></span>
</td>
<td class="nump">$ 99,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term available-for-sale investments</a></td>
<td class="nump">559,822<span></span>
</td>
<td class="nump">421,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">49,975<span></span>
</td>
<td class="nump">53,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">67,209<span></span>
</td>
<td class="nump">64,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">11,310<span></span>
</td>
<td class="nump">12,265<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">822,352<span></span>
</td>
<td class="nump">651,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term available-for-sale investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">95,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">159,235<span></span>
</td>
<td class="nump">136,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">69,790<span></span>
</td>
<td class="nump">74,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">99,547<span></span>
</td>
<td class="nump">99,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">90,621<span></span>
</td>
<td class="nump">96,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">93,265<span></span>
</td>
<td class="nump">106,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_EquityMethodInvestmentsAndOtherAssets', window );">Investments and other assets</a></td>
<td class="nump">21,192<span></span>
</td>
<td class="nump">14,019<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,356,002<span></span>
</td>
<td class="nump">1,274,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,895<span></span>
</td>
<td class="nump">10,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">50,798<span></span>
</td>
<td class="nump">70,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">5,879<span></span>
</td>
<td class="nump">7,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible senior notes</a></td>
<td class="nump">155,751<span></span>
</td>
<td class="nump">149,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationCurrent', window );">Contingent consideration</a></td>
<td class="nump">5,070<span></span>
</td>
<td class="nump">14,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">225,788<span></span>
</td>
<td class="nump">253,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible senior notes</a></td>
<td class="nump">326,146<span></span>
</td>
<td class="nump">313,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="nump">66,784<span></span>
</td>
<td class="nump">71,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">11,129<span></span>
</td>
<td class="nump">13,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">7,553<span></span>
</td>
<td class="nump">3,832<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">637,400<span></span>
</td>
<td class="nump">654,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 15)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001; 250,000,000 shares authorized; 44,523,410 shares issued and outstanding at September&#160;30, 2021; 43,636,929 shares issued and outstanding at December&#160;31, 2020</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">925,169<span></span>
</td>
<td class="nump">873,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(206,765)<span></span>
</td>
<td class="num">(253,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">718,602<span></span>
</td>
<td class="nump">619,688<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,356,002<span></span>
</td>
<td class="nump">$ 1,274,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_EquityMethodInvestmentsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments and Other Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_EquityMethodInvestmentsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760759857128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">44,523,410<span></span>
</td>
<td class="nump">43,636,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">44,523,410<span></span>
</td>
<td class="nump">43,636,929<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682260200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 127,722<span></span>
</td>
<td class="nump">$ 117,484<span></span>
</td>
<td class="nump">$ 382,339<span></span>
</td>
<td class="nump">$ 298,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of goods sold</a></td>
<td class="nump">34,651<span></span>
</td>
<td class="nump">29,993<span></span>
</td>
<td class="nump">101,248<span></span>
</td>
<td class="nump">82,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">11,578<span></span>
</td>
<td class="nump">14,651<span></span>
</td>
<td class="nump">40,031<span></span>
</td>
<td class="nump">44,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">48,807<span></span>
</td>
<td class="nump">52,561<span></span>
</td>
<td class="nump">148,142<span></span>
</td>
<td class="nump">140,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">1,967<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet', window );">Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</a></td>
<td class="num">(714)<span></span>
</td>
<td class="nump">692<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
<td class="num">(1,599)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">96,289<span></span>
</td>
<td class="nump">99,864<span></span>
</td>
<td class="nump">296,626<span></span>
</td>
<td class="nump">271,105<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">31,433<span></span>
</td>
<td class="nump">17,620<span></span>
</td>
<td class="nump">85,713<span></span>
</td>
<td class="nump">27,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">1,025<span></span>
</td>
<td class="nump">816<span></span>
</td>
<td class="nump">3,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(7,333)<span></span>
</td>
<td class="num">(7,132)<span></span>
</td>
<td class="num">(21,327)<span></span>
</td>
<td class="num">(18,609)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,071)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,071)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">2,708<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
<td class="nump">2,571<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(7,202)<span></span>
</td>
<td class="num">(11,470)<span></span>
</td>
<td class="num">(23,111)<span></span>
</td>
<td class="num">(20,173)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">24,231<span></span>
</td>
<td class="nump">6,150<span></span>
</td>
<td class="nump">62,602<span></span>
</td>
<td class="nump">7,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">(6,571)<span></span>
</td>
<td class="nump">123,969<span></span>
</td>
<td class="num">(15,492)<span></span>
</td>
<td class="nump">123,613<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 17,660<span></span>
</td>
<td class="nump">$ 130,119<span></span>
</td>
<td class="nump">$ 47,110<span></span>
</td>
<td class="nump">$ 131,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in USD per share)</a></td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in USD per share)</a></td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="nump">$ 2.94<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">44,476<span></span>
</td>
<td class="nump">42,928<span></span>
</td>
<td class="nump">44,151<span></span>
</td>
<td class="nump">42,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">45,463<span></span>
</td>
<td class="nump">44,275<span></span>
</td>
<td class="nump">45,674<span></span>
</td>
<td class="nump">43,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 126,791<span></span>
</td>
<td class="nump">$ 116,889<span></span>
</td>
<td class="nump">$ 380,392<span></span>
</td>
<td class="nump">$ 296,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember', window );">Collaborative licensing and milestone revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 931<span></span>
</td>
<td class="nump">$ 595<span></span>
</td>
<td class="nump">$ 1,822<span></span>
</td>
<td class="nump">$ 1,823<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_CollaborativeLicensingAndMilestoneRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681242328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 17,660<span></span>
</td>
<td class="nump">$ 130,119<span></span>
</td>
<td class="nump">$ 47,110<span></span>
</td>
<td class="nump">$ 131,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized (loss) gain on investments, net of tax</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(643)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive (loss) income</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(643)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 17,632<span></span>
</td>
<td class="nump">$ 129,476<span></span>
</td>
<td class="nump">$ 46,945<span></span>
</td>
<td class="nump">$ 131,533<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760673836136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Convertible Senior Notes Due 2022</div></th>
<th class="th">
<div>Convertible Senior Notes Due 2022 </div>
<div>Additional Paid-In Capital</div>
</th>
<th class="th">
<div>Convertible Senior Notes Due 2025 </div>
<div>Additional Paid-In Capital</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,908,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 354,944<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 753,978<span></span>
</td>
<td class="num">$ (399,398)<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">36,238<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">36,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">1,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">29,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Retirement of equity component of 2022 convertible senior notes (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (33,089)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Equity component of 2025 convertible senior notes issued, net of deferred taxes of $20,450 (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss (Note 11)</a></td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">131,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="nump">584,690<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">852,190<span></span>
</td>
<td class="num">(268,390)<span></span>
</td>
<td class="nump">847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,608,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Jun. 30, 2020</a></td>
<td class="nump">388,148<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">785,124<span></span>
</td>
<td class="num">(398,509)<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">703,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">24,582<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">24,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">10,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Retirement of equity component of 2022 convertible senior notes (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (33,089)<span></span>
</td>
<td class="num">$ (33,089)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Equity component of 2025 convertible senior notes issued, net of deferred taxes of $20,450 (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss (Note 11)</a></td>
<td class="num">(643)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(643)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">130,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="nump">584,690<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">852,190<span></span>
</td>
<td class="num">(268,390)<span></span>
</td>
<td class="nump">847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,637,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 619,688<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">873,201<span></span>
</td>
<td class="num">(253,875)<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">553,023<span></span>
</td>
<td class="nump">553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 19,039<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">19,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">31,230<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">$ 1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">31,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss (Note 11)</a></td>
<td class="num">(165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">47,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">718,602<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">925,169<span></span>
</td>
<td class="num">(206,765)<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Jun. 30, 2021</a></td>
<td class="nump">687,168<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">911,368<span></span>
</td>
<td class="num">(224,425)<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">3,018<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">10,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss (Note 11)</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">17,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">$ 718,602<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 925,169<span></span>
</td>
<td class="num">$ (206,765)<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682255368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 47,110<span></span>
</td>
<td class="nump">$ 131,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="nump">12,953<span></span>
</td>
<td class="num">(124,572)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation of fixed assets and amortization of intangible assets</a></td>
<td class="nump">15,478<span></span>
</td>
<td class="nump">14,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation', window );">Amortization of debt issuance costs</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">17,245<span></span>
</td>
<td class="nump">12,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">(Gain) loss on disposal of fixed assets</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">31,356<span></span>
</td>
<td class="nump">29,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Changes in contingent consideration</a></td>
<td class="num">(2,147)<span></span>
</td>
<td class="num">(1,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Loss (gain) on investment and other non-operating income, net</a></td>
<td class="nump">2,641<span></span>
</td>
<td class="num">(2,779)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">3,070<span></span>
</td>
<td class="nump">1,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(2,560)<span></span>
</td>
<td class="num">(10,246)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">907<span></span>
</td>
<td class="num">(382)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(825)<span></span>
</td>
<td class="num">(1,117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and income taxes payable</a></td>
<td class="num">(17,034)<span></span>
</td>
<td class="num">(16,454)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(1,996)<span></span>
</td>
<td class="num">(1,670)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment of contingent consideration to MyoScience, Inc. securityholders</a></td>
<td class="num">(5,662)<span></span>
</td>
<td class="num">(9,409)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">102,502<span></span>
</td>
<td class="nump">30,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of fixed assets</a></td>
<td class="num">(36,700)<span></span>
</td>
<td class="num">(23,393)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of available-for-sale investments</a></td>
<td class="num">(513,492)<span></span>
</td>
<td class="num">(326,664)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Sales of available-for-sale investments</a></td>
<td class="nump">470,614<span></span>
</td>
<td class="nump">154,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchases of equity and debt investments</a></td>
<td class="num">(17,187)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLongtermInvestments', window );">Sale of equity investment</a></td>
<td class="nump">9,057<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) investing activities</a></td>
<td class="num">(87,708)<span></span>
</td>
<td class="num">(195,290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercises of stock options</a></td>
<td class="nump">19,049<span></span>
</td>
<td class="nump">35,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans', window );">Proceeds from shares issued under employee stock purchase plan</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">1,421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Payment of debt issuance and financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration to MyoScience, Inc. securityholders</a></td>
<td class="num">(1,338)<span></span>
</td>
<td class="num">(5,591)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">19,285<span></span>
</td>
<td class="nump">211,941<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">34,079<span></span>
</td>
<td class="nump">47,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">99,957<span></span>
</td>
<td class="nump">78,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">134,036<span></span>
</td>
<td class="nump">125,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">5,096<span></span>
</td>
<td class="nump">5,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">2,259<span></span>
</td>
<td class="nump">2,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Fixed assets included in accounts payable and accrued liabilities</a></td>
<td class="nump">4,719<span></span>
</td>
<td class="nump">9,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from debt component of the 2025 convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">314,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt', window );">Proceeds from equity component of the 2025 convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">87,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(176,793)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes', window );">Retirement of equity component of the 2022 convertible senior notes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (33,089)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Convertible Option Component of Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from shares issued under Employee Stock Purchase Plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Retirement of Equity Component of Convertible Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentOfFinancingAndStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681525112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions', window );">Deferred taxes related to equity</a></td>
<td class="nump">$ 20,450<span></span>
</td>
<td class="nump">$ 20,450<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax effect of an increase or decrease in contributed capital (for example, deductible expenditures reported as a reduction of the proceeds from issuing capital stock) during the period charged or credited directly to shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675173784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira BioSciences,&#160;Inc. and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Pacira&#8221;) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients&#8217; journeys along the neural pain pathway. The Company&#8217;s long-acting, local analgesic, EXPAREL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012 and approved by the European Commission in November 2020. EXPAREL utilizes the Company&#8217;s unique and proprietary multivesicular liposome delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, the Company added iovera&#176;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to its commercial offering with the acquisition of MyoScience, Inc., or MyoScience. The iovera&#176; system is a handheld cryoanalgesia device used to deliver a precise, controlled application of cold temperature to only targeted nerves.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Pacira entered the Merger Agreement (as defined below) with Oyster Acquisition Company Inc., a Delaware corporation and wholly owned subsidiary of Pacira (&#8220;Merger Sub&#8221;), and Flexion Therapeutics, Inc., a Delaware corporation, or Flexion. Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, on October 22, 2021, Merger Sub commenced a cash tender offer (the &#8220;Offer&#8221;), to acquire all of the outstanding shares of common stock of Flexion, $0.001 par value per share (the &#8220;Flexion Shares&#8221;), at an offer price of (i) $8.50 per Flexion Share in cash, net of applicable withholding taxes and without interest, plus (ii) one contingent value right per Flexion Share, which will represent the right to receive one or more contingent payments up to $8.00 per Flexion Share in the aggregate upon the achievement of specified milestones on or prior to December 31, 2030. Refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacira is subject to risks common to companies in similar industries and stages, including, but not limited to, competition from larger companies, reliance on revenue from two products, reliance on a limited number of wholesalers, reliance on a limited number of manufacturing sites, new technological innovations, dependence on key personnel, reliance on third-party service providers and sole source suppliers, protection of proprietary technology, compliance with government regulations and risks related to cybersecurity.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is managed and operated as a single business focused on the development, manufacture, marketing, distribution and sale of non-opioid pain management and regenerative health solutions. The Company is managed by a single management team, and consistent with its organizational structure, the Chief Executive Officer and Chairman manages and allocates resources at a consolidated level. Accordingly, the Company views its business as one reportable segment to evaluate performance, allocate resources, set operational targets and forecast its future financial results.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Novel Coronavirus (COVID-19) Pandemic</span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company&#8217;s net product sales were negatively impacted by the global pandemic caused by a novel strain of coronavirus (COVID-19), which mandated significant postponement or suspension in the scheduling of elective surgical procedures resulting from public health guidance and government directives. Elective surgical restrictions began to lift on a state-by-state basis in April 2020, allowing net product sales to return to year-over-year growth in June 2020. However, while many restrictions have since eased with COVID-19 vaccines now widely available, the elective surgery market faced additional pandemic-related challenges in August and September 2021 due to regional surges in COVID-19 delta variant cases, staffing shortages and surgical fatigue from care teams addressing significant procedure backlogs. While these challenges began to subside in October 2021, it is unknown how long it will take the elective surgical market to normalize, or if restrictions on elective surgical procedures will recur due to COVID-19 variant strains or otherwise. The Company&#8217;s manufacturing sites are operational and have safety protocols and guidelines as recommended by federal, state and local governments. To date, there have been no material impacts to the Company&#8217;s supply chain. The situation remains dynamic and subject to rapid and possibly material changes. Additional negative impacts may also arise from the COVID-19 pandemic that the Company is unable to foresee. The nature and extent of such impacts will depend on future developments, which are highly uncertain and cannot be predicted.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676493704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Report on Form&#160;10-K for the year ended December 31, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at September&#160;30, 2021, and for the three and nine month periods ended September&#160;30, 2021 and 2020, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2020 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2020. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee and sells iovera&#176; directly to end users. The table below includes the percentage of revenues comprised by the Company&#8217;s three largest wholesalers in each period presented:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amended the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The standard allows for certain exceptions, including the exception to the use of the incremental approach for intra-period tax allocations, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also required franchise or similar taxes partially based on income to be reported as income tax and to reflect the effects of enacted changes in tax laws or rates in the annual effective tax rate computation from the date of enactment. Lastly, in future acquisitions, the Company will be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The standard became effective for the Company beginning January 1, 2021 and there were no material impacts to the consolidated financial statements upon adoption.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2021</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative, and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The other separation models would be eliminated, including the model for convertible debt that can be settled in cash </span></div>or shares. As a result, these convertible debt instruments will be accounted for as a single liability instrument. In addition, the new guidance requires diluted earnings per share calculations to be prepared using the if-converted method, instead of the treasury stock method. The guidance must be applied in fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company plans to adopt the new guidance using a modified retrospective method of transition, which would be applied to transactions outstanding at the time of adoption. At September&#160;30, 2021, the Company has recognized debt discounts of $68.7&#160;million for its 0.750% convertible senior notes due 2025 and $3.8&#160;million for its 2.375% convertible senior notes due 2022. Upon adoption on January 1, 2022, these debt discounts would be eliminated along with any related future amortization. Further deferred financing costs previously allocated to the conversion features will be re-allocated to the outstanding debt, slightly increasing future annual amortization of deferred financing costs. The Company expects the impact of this standard to be material to its consolidated financial statements and related disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675116808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text">REVENUE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sources of revenue include (i) sales of EXPAREL in the United States, or U.S.; (ii) sales of iovera&#176; in the U.S.; (iii) sales of, and royalties on, its bupivacaine liposome injectable suspension for veterinary use in the U.S. and (iv) license fees and milestone payments. To date, there has been no revenue from sales of EXPAREL or iovera&#176; in the European Union, or E.U. The Company does not consider revenue from sources other than sales of EXPAREL to be material to its consolidated revenue, which could change in the future. As such, the following disclosure only relates to revenue associated with net EXPAREL product sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Product Sales</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers based on orders of the product placed by end-users, namely hospitals, ambulatory surgery centers and healthcare provider offices. EXPAREL is delivered directly to the end-user without the wholesaler ever taking physical possession of the product. Product revenue is recognized when control of the promised goods are transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods. EXPAREL revenue is recorded at the time the product is delivered to the end-user.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of returns allowances, prompt payment discounts, wholesaler service fees, volume rebates and chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale, using the most likely amount method, except for returns, which is based on the expected value method. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a quarterly basis.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of accounts receivable arise from product sales and represent amounts due from wholesalers, hospitals, ambulatory surgery centers and doctors. Payment terms generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV80MC9mcmFnOjQ3OTEwMTBiNTkxMzQyNWZhNjNkZTg2ZWExMGE4MTZjL3RleHRyZWdpb246NDc5MTAxMGI1OTEzNDI1ZmE2M2RlODZlYTEwYTgxNmNfMjYzOQ_a82865c6-0aeb-4bca-a017-866bd6d1661c">zero</span> to 37 days from the date of the transaction, and accordingly, there is no significant financing component.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in Accounting Standards Codification, or ASC, 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good that is distinct. When identifying individual performance obligations, the Company considers all goods promised in the contract regardless of whether explicitly stated in the customer contract or implied by customary business practices. The Company&#8217;s contracts with customers require it to transfer an individual distinct product, which represents a single performance obligation. The Company&#8217;s performance obligation with respect to its product sales is satisfied at a point in time, which transfers control upon delivery of EXPAREL to </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its customers. The Company considers control to have transferred upon delivery because the customer has legal title to the asset, physical possession of the asset has been transferred, the customer has significant risks and rewards of ownership of the asset, and the Company has a present right to payment at that time.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL / bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,791&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,392&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,850&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676522952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,209&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,650&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675145576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">FIXED ASSETS</a></td>
<td class="text">FIXED ASSETS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,045&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,688&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021 and 2020, depreciation expense was $3.8 million and $3.1 million, respectively. For the three months ended September&#160;30, 2021 and 2020, there was $0.9 million and $0.7 million of capitalized interest on the construction of manufacturing sites, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2021 and 2020, depreciation expense was $9.6&#160;million and $8.9&#160;million, respectively. For the nine months ended September&#160;30, 2021 and 2020, there was $3.0&#160;million and $1.5&#160;million of capitalized interest on the construction of manufacturing sites, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021 and December&#160;31, 2020, total fixed assets, net includes leasehold improvements and manufacturing process equipment located in Europe in the amount of $66.9 million and $67.5 million, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the Company had asset retirement obligations of $2.1&#160;million and $2.0&#160;million, respectively, which are included in accrued expenses and other liabilities on its condensed consolidated balance </span></div>sheet, for costs associated with returning leased spaces to their original condition upon the termination of certain lease agreements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676525752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all of its facilities, including its EXPAREL manufacturing facility in San Diego, California and its iovera&#176; manufacturing facility in Fremont, California. These leases have remaining terms up to 8.9 years, some of which provide renewal options at the then-current market value. The Company also has an embedded lease with Thermo Fisher Scientific Pharma Services for the use of their manufacturing facility in Swindon, England. A portion of the associated monthly base fees have been allocated to the lease component based on a relative fair value basis.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease costs for the facilities include lease and non-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. Total operating lease costs are as follows (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,085&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,710&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to net the amortization of the right-of-use asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statement of cash flows.</span></div><div style="margin-bottom:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. The weighted average remaining lease term and the weighted average discount rate are summarized as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.46 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.39 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,663&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675191000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill results from the acquisition of Pacira Pharmaceuticals, Inc. (the Company&#8217;s California operating subsidiary) from SkyePharma Holding, Inc., or Skyepharma, (now a subsidiary of Vectura Group plc) in March 2007 (the &#8220;Skyepharma Acquisition&#8221;), and the acquisition of MyoScience, Inc. (the &#8220;MyoScience Acquisition&#8221;) in April 2019.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in the carrying value of the Company&#8217;s goodwill during the three and nine months ended September&#160;30, 2021. The balance at both September&#160;30, 2021 and December&#160;31, 2020 was $99.5&#160;million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Skyepharma Acquisition occurred in March 2007, prior to the requirements to record contingent consideration at fair value under ASC 805-30. In connection with the Skyepharma Acquisition, the Company agreed to certain milestone payments for DepoBupivacaine products, including EXPAREL. As of September&#160;30, 2021, the remaining milestone payments include: $4.0&#160;million upon the first commercial sale in the United Kingdom, France, Germany, Italy or Spain (the &#8220;Applicable Countries&#8221;); and $32.0&#160;million when annual net sales collected reach $500.0&#160;million (measured on a rolling quarterly basis). Any remaining milestone payments will be treated as additional costs of the Skyepharma Acquisition and, therefore, recorded as goodwill if and when each contingency is resolved.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the MyoScience Acquisition, the Company recorded goodwill totaling $37.5&#160;million. The Company made a tax election that allows the acquired goodwill and intangible assets associated with the MyoScience Acquisition to be tax deductible.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Intangible Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net, consist of the developed technology and customer relationships that were acquired in the MyoScience Acquisition and are summarized as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:58.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.248%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,521&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense on intangible assets was consistent for the three and nine months periods ended September&#160;30, 2021 and 2020. Amortization expense was $2.0 million and $5.9 million for the three and nine month periods, respectively.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming no changes in the gross carrying amount of these intangible assets, amortization expense will be $2.0 million for the remaining three months of 2021, $7.9 million annually through 2032 and $2.2 million in 2033.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676492264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2025</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company completed a private placement of $402.5&#160;million in aggregate principal amount of its 0.750% convertible senior notes due 2025, or 2025 Notes, and entered into an indenture, or 2025 Indenture, with respect to the 2025 Notes. The 2025 Notes accrue interest at a fixed rate of 0.750% per year, payable semiannually in arrears on February 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and August 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. The 2025 Notes mature on August 1, 2025.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% convertible senior notes due 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,610)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,146&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,030&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the issuance of the 2025 Notes were approximately $390.0&#160;million, after deducting commissions and the offering expenses paid by the Company. A portion of the net proceeds from the 2025 Notes was used by the Company to repurchase $185.0&#160;million in aggregate principal amount of its outstanding 2.375% convertible senior notes due 2022 in privately-negotiated transactions for a total of $211.1&#160;million of cash (including accrued interest).</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert the 2025 Notes at any time prior to the close of business on the business day immediately preceding February 3, 2025, only under the following circumstances:</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) during any calendar quarter (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) during the five business day period immediately after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the trading price (as defined in the 2025 Indenture) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company&#8217;s common stock and the conversion rate on each such trading day;</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) upon the occurrence of specified corporate events, including a merger or a sale of all or substantially all of the Company&#8217;s assets; or</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) if the Company calls the 2025 Notes for redemption, until the close of business on the business day immediately preceding the redemption date.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended&#160;September&#160;30, 2021, none of these conditions for conversion were met.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February 3, 2025, until the close of business on the second scheduled trading day immediately preceding August 1, 2025, holders may convert their 2025 Notes at any time.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, holders will receive the principal amount of their 2025 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the 40 consecutive trading days during the observation period (as more fully described in the 2025 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option. The initial conversion rate for the 2025 Notes is 13.9324 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $71.78 per share of the Company&#8217;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2025 Notes represents a premium of approximately 32.5% to the closing sale price of $54.17 per share of the Company&#8217;s common stock on the Nasdaq Global Select Market on July 7, 2020, the date that the Company priced the private offering of the 2025 Notes.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the 2025 Notes had a market price o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1,086</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2025 Notes will be paid pursuant to the terms of the 2025 Indenture. In the event that all of the 2025 Notes are converted, the Company would be required to repay the $402.5&#160;million in principal value and any conversion premium in any combination of cash and shares of its common stock (at the Company&#8217;s option).</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to August 1, 2023, the Company may not redeem the 2025 Notes. On or after August 1, 2023 (but, in the case of a redemption of less than all of the outstanding 2025 Notes, no later than the 40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> scheduled trading day immediately before the maturity date), the Company may redeem for cash all or part of the 2025 Notes if the last reported sale price (as defined in the 2025 Indenture) of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for (i) each of at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related notice of redemption and (ii) the trading day immediately before the date the Company sends such notice. The redemption price will equal the sum of (i) 100% of the principal amount of the 2025 Notes being redeemed, plus (ii) accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2025 Notes for redemption will constitute a &#8220;make-whole fundamental change&#8221; (as defined in the 2025 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2025 Notes.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a fundamental change, as defined in the 2025 Indenture, subject to certain conditions, holders of the 2025 Notes may require the Company to repurchase for cash all or part of their 2025 Notes at a repurchase price equal to 100% of the principal amount of the 2025 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a &#8220;make-whole fundamental change&#8221; (as defined in the 2025 Indenture) occurs prior to August 1, 2025, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its notes in connection with the make-whole fundamental change.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are the Company&#8217;s general unsecured obligations that rank senior in right of payment to all of its indebtedness that is expressly subordinated in right of payment to the 2025 Notes, and equal in right of payment to the Company&#8217;s unsecured indebtedness. The 2025 Notes are also effectively junior in right of payment to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness, and are structurally subordinated to any debt or other liabilities (including trade payables) of the Company&#8217;s subsidiaries.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the 2025 Notes are currently classified on the Company&#8217;s consolidated balance sheet at September&#160;30, 2021 as long-term debt, the future convertibility and resulting balance sheet classification of this liability is monitored at each quarterly reporting date and is analyzed dependent upon market prices of the Company&#8217;s common stock during the prescribed measurement periods. In the event that the holders of the 2025 Notes have the election to convert the 2025 Notes at any time during the prescribed measurement period, the 2025 Notes would then be considered a current obligation and classified as such.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an entity must separately account for the liability and equity components of convertible debt instruments (such as the 2025 Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer&#8217;s economic interest cost. The liability component of the instrument is valued in a manner that reflects the market interest rate for a similar nonconvertible instrument at the date of issuance. The initial carrying value of the liability component of $314.7&#160;million was calculated using a 5.78% assumed borrowing rate. The equity component of $87.8&#160;million, representing the conversion option, was determined by deducting the fair value of the liability component from the par value of the 2025 Notes and is recorded in additional paid-in capital on the consolidated </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balance sheet at the issuance date. The equity component is treated as a discount on the liability component of the 2025 Notes, which is amortized over the five-year term of the 2025 Notes using the effective interest rate method. The equity component is not re-measured as long as it continues to meet the conditions for equity classification. A deferred tax liability was recognized in the amount of $20.5&#160;million, with the offsetting amount recorded in additional paid-in capital.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated the total transaction costs of approximately $12.5&#160;million related to the issuance of the 2025 Notes to the liability and equity components of the 2025 Notes based on their relative values. Transaction costs attributable to the liability component are amortized to interest expense over the five-year term of the 2025 Notes, and transaction costs attributable to the equity component totaling $2.7&#160;million are netted with the equity component in stockholders&#8217; equity.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company. The 2025 Indenture contains customary events of default with respect to the 2025 Notes, including that upon certain events of default, 100% of the principal and accrued and unpaid interest on the 2025 Notes will automatically become due and payable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes Due 2022</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company completed a private placement of $345.0 million in aggregate principal amount of 2.375% convertible senior notes due 2022, or 2022 Notes, and entered into an indenture, or 2022 Indenture, with respect to the 2022 Notes. The 2022 Notes accrue interest at a fixed rate of 2.375% per year, payable semiannually in arrears on April&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and October&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. The 2022 Notes mature on April 1, 2022. As discussed above, in July 2020, the Company used part of the net proceeds from the issuance of the 2025 Notes to repurchase $185.0&#160;million aggregate principal amount of the 2022 Notes in privately-negotiated transactions for an aggregate of $211.1&#160;million in cash (including accrued interest). The partial repurchase of the 2022 Notes resulted in an $8.1&#160;million loss on early extinguishment of debt.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% convertible senior notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,751&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 1, 2021 and until the close of business on the second scheduled trading day immediately preceding April 1, 2022, holders may convert their 2022 Notes at any time. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, holders will receive the principal amount of their 2022 Notes and any excess conversion value, calculated based on the per share volume-weighted average price for each of the 40 consecutive trading days during the observation period (as more fully described in the 2022 Indenture). For both the principal and excess conversion value, holders may receive cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option. The initial conversion rate for the 2022 Notes is 14.9491 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of $66.89 per share of the Company&#8217;s common stock. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2022 Notes represents a premium of approximately 37.5% to the closing sale price of $48.65 per share of the Company&#8217;s common stock on the Nasdaq Global Select Market on March 7, 2017, the date that the Company priced the private offering of the 2022 Notes.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the 2022 Notes had a market price of $1,038 pe</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1,000 principal amount. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest and the possibility of stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2022 Notes will be paid pursuant to the terms of the 2022 Indenture. In the event that all of the 2022 Notes are settled, the Company would </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be required to repay the remaining $160.0 million in principal value a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd any conversion premium in any combination of cash and shares of its common stock (at the Company&#8217;s option).</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2020, the Company may redeem for cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s option, all or part of the 2022 Notes if the last reported sale price (as defined in the 2022 Indenture) of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period ending within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhZWVmMTMxNjkxNzQ4N2NiZmY2NTEwYTQzODgyZjYxL3NlYzpjYWVlZjEzMTY5MTc0ODdjYmZmNjUxMGE0Mzg4MmY2MV81NS9mcmFnOjJkYjFkYWYyYTdiMjRmMjhiODQzODg0YjQ4MjFjMjc2L3RleHRyZWdpb246MmRiMWRhZjJhN2IyNGYyOGI4NDM4ODRiNDgyMWMyNzZfMTM0MjA_0a6e4989-0f64-4ad2-a49d-950959b333c7">five</span> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trading days prior to the date on which the Company provides notice of redemption. This condition was not met during the quarter ended September&#160;30, 2021. The redemption price will equal the sum of (i)&#160;100% of the principal amount of the 2022 Notes being redeemed, plus (ii)&#160;accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date. In addition, calling the 2022 Notes for redemption will constitute a &#8220;make-whole fundamental change&#8221; (as defined in the 2022 Indenture) and will, in certain circumstances, increase the conversion rate applicable to the conversion of such notes if it is converted in connection with the redemption. No sinking fund is provided for the 2022 Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,016)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU 2020-06 will require the Company to eliminate debt discounts along with any related future amortization. Further deferred financing costs previously allocated to the conversion features will be re-allocated to the outstanding debt, slightly increasing future annual amortization of deferred financing costs. This new accounting pronouncement has not been adopted as of September&#160;30, 2021. For additional information regarding ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676428008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in the principal or most advantageous market in an orderly transaction. To increase consistency and comparability in fair value measurements, the FASB established a three-level hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of fair value measurements are:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="padding-left:40.5pt"><span><br/></span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</span></div><div style="padding-left:40.5pt"><span><br/></span></div><div style="padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these items. The fair value of the Company&#8217;s equity investment with a readily determinable fair value was calculated utilizing market quotations from a major American stock exchange (Level 1). The fair value of the Company&#8217;s convertible senior notes are calculated utilizing market quotations from an over-the-counter trading market for these notes (Level 2). The fair value of the Company&#8217;s acquisition-related contingent consideration is reported at fair value on a recurring basis (Level 3). The carrying amount of the investments without a readily determinable fair value have not been adjusted for either an impairment or upward or downward adjustments based on observable transactions. Certain assets and liabilities are measured at fair value on a non-recurring basis, including assets and liabilities acquired in a business combination, equity instruments measured at cost and long-lived assets, which would be recognized at fair value if deemed impaired or if reclassified as assets held for sale. The fair value in these instances would be determined using Level 3 inputs. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Notes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;2.375% convertible senior notes due 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;0.750% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was&#160;$56.00&#160;per share on September&#160;30, 2021, compared to a conversion price of&#160;$66.89&#160;per share for the 2022 Notes and $71.78 per share for the 2025 Notes. The maximum conversion premium that could have been due on the 2022 Notes and 2025 Notes at September&#160;30, 2021 was&#160;approximately 2.4 million&#160;and 5.6&#160;million shares of the Company&#8217;s common stock, respectively. These figures assume no increases in the conversion rate for certain corporate events.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity and Debt Investments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company held an equity investment in TELA Bio, Inc., or TELA Bio, in its condensed consolidated balance sheets in the amount of $11.6&#160;million. During the nine months ended September&#160;30, 2021, the Company sold its investment in TELA Bio for net cash proceeds of $9.1&#160;million. During the nine months ended September&#160;30, 2021, the Company recognized a realized loss of $2.6&#160;million, which has been recorded in other, net in the condensed consolidated statements of operations. The fair value of TELA Bio was based on a Level 1 input. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021 and December&#160;31, 2020, the Company held an equity investment of $4.1&#160;million and $1.2&#160;million, respectively, in GeneQuine Biotherapeutics GmbH, or GeneQuine, a privately held biopharmaceutical company headquartered in Hamburg, Germany. This investment has no readily determinable fair value and is recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments. During 2021, the Company purchased a convertible note from GeneQuine in the amount of $1.2&#160;million and invested an additional $3.0&#160;million in equity investments. During the nine months ended September&#160;30, 2021, the valuation of the convertible note was reduced by less than $0.1&#160;million due to changes in foreign currency exchange rates. The Company has the right to make additional investments in debt securities of $1.7&#160;million predicated upon GeneQuine achieving certain prespecified near-term milestones.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company purchased privately-held preferred shares in Coda BioTherapeutics, Inc., a preclinical stage biopharmaceutical company that is developing a gene-therapy platform to treat neurological disorders and diseases for a purchase price of $10.0&#160;million. There were no adjustments to this investment during the three and nine months ended September&#160;30, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company purchased a convertible note in the amount of $3.0&#160;million from Spine BioPharma, LLC, a preclinical stage biopharmaceutical company. There were no adjustments to this investment during the three and nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related Contingent Consideration</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Company completed the MyoScience Acquisition pursuant to the terms of an Agreement and Plan of Merger, which provided for contingent milestone payments of up to an aggregate of $100.0 million upon the achievement of certain regulatory and commercial milestones. The Company&#8217;s obligation to make milestone payments is limited to those milestones achieved through December 31, 2023, and are to be paid within 60 days of the end of the fiscal quarter of achievement. As of September&#160;30, 2021, the maximum potential remaining milestone payments to be paid are $48.0&#160;million. The Company made a $7.0 million milestone payment during the nine months ended September&#160;30, 2021 for the achievement of one regulatory milestone. Another regulatory milestone in the amount of $5.0&#160;million was met in the three months ended September&#160;30, 2021 and is expected to be paid in November 2021. During the nine months ended September&#160;30, 2020, the Company made $15.0 million in cash payments for the achievement of two regulatory milestones. As of September&#160;30, 2021 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and December 31, 2020, a contingent consideration liability related to the MyoScience Acquisition has been recognized in the amounts of $16.2&#160;million and $28.3&#160;million, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contingent consideration obligations are recorded at their estimated fair values and are revalued each reporting period if and until the related contingencies are resolved. For the three and nine months ended September&#160;30, 2021, the Company recognized $1.2&#160;million and $2.1 million gains, respectively, related to contingent consideration. For the three and nine months ended September 30, 2020, the Company recognized $0.8&#160;million of charges and $1.6&#160;million of gains, respectively, related to contingent consideration. These amounts have been included in acquisition-related (gains) charges in the condensed consolidated statements of operations. The Company has measured the fair value of its contingent consideration using a probability-weighted discounted cash flow approach that is based on unobservable inputs and a Monte Carlo simulation. These inputs include, as applicable, estimated probabilities and the timing of achieving specified commercial and regulatory milestones, estimated forecasts of revenue and costs and the discount rate used to calculate the present value of estimated future payments. Significant changes may increase or decrease the probabilities of achieving the related commercial and regulatory events, shorten or lengthen the time required to achieve such events, or increase or decrease estimated forecasts. At September&#160;30, 2021, the weighted average discount rate was 3.65% and the weighted average probability of success for the regulatory milestone that has not yet been met was 2.0%. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ranges Utilized as of September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.49% to 3.81%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2% to 100%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2023</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Offset indemnification claims</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,000)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available-for-Sale Investments</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate and government bonds with maturities greater than three months, but less than one year. Long-term investments consist of government bonds with maturities greater than one year but less than three years. Net unrealized gains and losses (excluding credit losses, if any) from the Company&#8217;s short-term and long-term investments are reported in other comprehensive income (loss). At September&#160;30, 2021 and December 31, 2020, all of the Company&#8217;s short-term and long-term investments are classified as available-for-sale investments and are determined to be Level 2 instruments, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. At the time of purchase, all short-term and long-term investments had an &#8220;A&#8221; or better rating by Standard&#160;&amp; Poor&#8217;s.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s investments at September&#160;30, 2021 and December&#160;31, 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021 Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,723&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,822&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020 Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,416&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,705&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, there were no investments available for sale that were materially less than their amortized cost.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elects to recognize its interest receivable separate from its available-for-sale investments. At September&#160;30, 2021 and December&#160;31, 2020, the interest receivable recognized in prepaid expenses and other current assets was $0.4&#160;million and $1.6&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term and long-term investments and accounts receivable. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. Such amounts may exceed federally-insured limits.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As of September&#160;30, 2021, three wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at 31%, 27% and 26%. At December&#160;31, 2020, three wholesalers each accounted for over 10% of the Company&#8217;s accounts receivable, at 36%, 28% and 23%. For additional information regarding the Company&#8217;s wholesalers, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EXPAREL revenues are primarily derived from major wholesalers that generally have significant cash resources. The Company performs ongoing credit evaluations of its customers as warranted and generally does not require collateral. Allowances for credit losses on the Company&#8217;s accounts receivable are maintained based on historical payment patterns, current and estimated future economic conditions, aging of accounts receivable and its write-off history. As of September&#160;30, 2021 and December&#160;31, 2020, the Company did not deem any allowances for credit losses on its accounts receivable necessary.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760674937256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock', window );">STOCK PLANS</a></td>
<td class="text">STOCK PLANS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Incentive Plans</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s stockholders approved the Amended and Restated 2011 Stock Incentive Plan, or 2011 Plan. The 2011 Plan was amended to increase the number of shares of common stock authorized for issuance as equity awards under the plan by 1,500,000 shares.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,954&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,356&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,024&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,954&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,356&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,024&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,235,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238,865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,416)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,170,166&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of stock options granted during the nine months ended September&#160;30, 2021 wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$27.36</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share. The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:80.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.26%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42 years</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2014 Employee Stock Purchase Plan, or ESPP, features two six-month offering periods per year, running from January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to June 30 and July 1 to December 31. Under the ESPP, employees may elect to contribute after-tax earnings to purchase shares at 85% of the closing fair market value of the Company&#8217;s common stock on either the offering date or the purchase date, whichever is less. During the nine months ended September&#160;30, 2021, 31,230 shares were purchased and issued through the ESPP.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676730520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the changes in the balances of the Company&#8217;s accumulated other comprehensive income  for the periods presented (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net unrealized (loss) gain on investments, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net of a $54&#160;thousand tax benefit for the nine months ended September 30, 2021. There was no tax benefit for the nine months ended September 30, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760674937256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME (LOSS) PER SHARE</a></td>
<td class="text">NET INCOME (LOSS) PER SHARE<div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing the net income (loss) attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period. </span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs, the purchase of shares from the ESPP (using the treasury stock method) and the conversion of the excess conversion value on the 2022 Notes and 2025 Notes, if applicable. As discussed in Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company has the option to pay cash for the aggregate principal amount due upon the conversion of its 2022 Notes and 2025 Notes. Since it is the Company&#8217;s intent to settle the principal amount of its 2022 Notes and 2025 Notes in cash, the potentially dilutive effect of such notes on net income (loss) per share is computed under the treasury stock method. ASU 2020-06 will require the Company to use the if-converted method upon adoption; this new accounting pronouncement has not been adopted as of September&#160;30, 2021. For additional information regarding ASU 2020-06, see Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential common shares are excluded from the diluted net income (loss) per share computation to the extent they would be antidilutive.</span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per common share for the three and nine mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended September&#160;30, 2021 and 2020 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,333&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following outstanding stock options, RSUs and ESPP purchase options are antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average ESPP purchase options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,894&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675274360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,395&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021 and 2020, the Company had income tax expense of $6.6 million and an income tax benefit of $124.0 million, respectively. For the nine months ended September&#160;30, 2021 and 2020, the Company recorded income tax expense of $15.5&#160;million and an income tax benefit of $123.6&#160;million, respectively. The income tax expense for the three and nine months ended September&#160;30, 2021 represents the estimated annual effective tax rate applied to the year-to-date domestic operating results adjusted for certain discrete tax items including equity compensation and non-deductible capital losses. The income tax benefit for the three and nine months ended September&#160;30, 2020 represents the full release of a $124.6&#160;million valuation allowance on the Company&#8217;s net domestic deferred assets as the Company determined that there was sufficient positive evidence to conclude that it was more likely than not that domestic deferred taxes were realizable.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the nine months ended September 30, 2021, the Company recorded a valuation allowance against U.S. capital loss carryforwards since it is more likely than not the tax benefit related to the losses are not realizable. The Company continues to maintain a full valuation allowance on its foreign net deferred tax balances.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760674937256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMERCIAL PARTNERS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReorganizationsAbstract', window );"><strong>Reorganizations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_CommercialPartnersAndAgreementsTextBlock', window );">COMMERCIAL PARTNERS</a></td>
<td class="text">COMMERCIAL PARTNERS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eurofarma Laboratories S.A.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company entered into a distribution agreement with Eurofarma Laboratories S.A., or Eurofarma, for the development and commercialization of EXPAREL in Latin America. Under the terms of the agreement, Eurofarma obtained the exclusive right to market and distribute EXPAREL in 19 countries in Latin America, including Argentina, Brazil, Colombia, and Mexico. In addition, Eurofarma is responsible for regulatory filings for EXPAREL in these countries. The Company received a $0.3&#160;million upfront payment that is partially refundable upon certain circumstances and will receive royalties based on Eurofarma&#8217;s future commercialization of the product and is also eligible to receive milestone payments that are triggered by the achievement of certain regulatory and commercial events. The Company recognized $0.1&#160;million of collaborative licensing and milestone revenue in its condensed consolidated statements of operations during the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nuance Biotech Co. Ltd.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company entered an agreement with Nuance Biotech Co. Ltd., or Nuance, a China-based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL in China. Under the terms of the agreement, the Company had granted Nuance the exclusive rights to develop and commercialize EXPAREL. In April 2021, the Company and Nuance agreed to a mutual termination of the agreement due to the lack of a viable regulatory pathway that adequately safeguards the Company&#8217;s intellectual property against the risk of a generic product. Dissolution costs of $3.0&#160;million were included in other operating expenses in the condensed consolidated statements of operations for the nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verve Medical Products, Inc.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company entered into a licensing agreement with Verve Medical Products, Inc. for the distribution of iovera&#176; in Canada.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_CommercialPartnersAndAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the entire disclosure of commercial agreement and arrangement with third parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_CommercialPartnersAndAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReorganizationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReorganizationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760677156024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the ordinary course of its business, including those related to patents, product liability and government investigations. Except as described below, the Company is not presently a party to any legal proceedings that it believes to be material, and is not aware of any pending or threatened litigation against the Company which it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MyoScience Milestone Litigation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company and its subsidiary, Pacira CryoTech, Inc. (&#8220;Pacira CryoTech&#8221;), filed a lawsuit in the Court of Chancery of the State of Delaware against Fortis Advisors LLC (&#8220;Fortis&#8221;), solely in its capacity as representative for the former securityholders of MyoScience, and certain other defendants, seeking declaratory judgment with respect to certain terms of the merger agreement for the MyoScience Acquisition (the &#8220;Merger Agreement&#8221;), specifically related to the achievement of certain milestone payments under the Merger Agreement. In addition, the Company and Pacira CryoTech sought general, special and compensatory damages against the other defendants related to breach of fiduciary duties in connection with the purported achievement of milestone payments under the Merger Agreement, and breach of the Merger Agreement and certain other agreements with the defendants. In October 2020, Fortis filed an answer and counterclaim against the Company and Pacira CryoTech seeking to recover certain milestone payments under the Merger Agreement. The total remaining value of these milestones is $30.0&#160;million, plus attorneys&#8217; fees. The Company believes that the counterclaim from Fortis is without merit and intends to vigorously defend against all claims. The Company is unable to predict the outcome of this action at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric Trial Commitments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Food and Drug Administration, or FDA, as a condition of EXPAREL approval, has required the Company to study EXPAREL in pediatric patients, as well as the administration of EXPAREL as a nerve block in the pediatric setting. The Company was granted a deferral for the required pediatric trials until after the indications were approved in adults. Similarly, in Europe, the Company agreed with the European Medicines Agency, or EMA, on a Pediatric Investigation Plan as a prerequisite </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for submitting a Marketing Authorization Application (MAA) in the E.U. Despite the United Kingdom&#8217;s withdrawal from the E.U., the agreed pediatric plan will be applicable in the United Kingdom , or UK, as well. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company announced positive results for its extended pharmacokinetic and safety study (&#8220;PLAY&#8221;) for local analgesia in children aged six to 17 undergoing cardiovascular or spine surgeries. Those positive results were the basis for the submission of a supplemental New Drug Application, or sNDA, in the U.S. and Type II variations in the E.U. and UK to expand the EXPAREL label to include use in patients six years of age and older for single-dose infiltration to produce postsurgical local analgesia. In March 2021, the Company announced that the FDA approved the submission of the sNDA in the U.S. The EMA and the Medicines and Healthcare Products Regulatory Agency (MHRA) are still reviewing the Type II variations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is working with the FDA, MAA and MHRA to finalize the regulatory pathway for its remaining pediatric commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One-Time Termination Benefits</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has communicated to a select number of employees a commitment to provide one-time termination benefits in the event that a facility closure occurs. The Company is recognizing these expenses ratably over the remaining service period required. The Company currently estimates the total cost of these one-time benefits to be approximately $1.1&#160;million. In the three and nine months ended September&#160;30, 2021, the Company has recognized $0.4&#160;million in one-time termination charges, which are included in acquisition-related (gains) charges, product discontinuation and other in the condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760674937256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2021, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), with Merger Sub and Flexion. Flexion is a biopharmaceutical company focused on the discovery, development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, or OA, the most common form of arthritis. Flexion has an approved product, ZILRETTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(triamcinolone acetonide extended-release injectable suspension), which it markets in the U.S. ZILRETTA is the first and only extended-release, intra-articular (meaning in the joint) injection indicated for the management of OA knee pain. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, on October 22, 2021, Merger Sub commenced the Offer to acquire all of the outstanding Flexion Shares at an offer price of (i) $8.50 per Flexion Share in cash, net of applicable withholding taxes and without interest, plus (ii) one contingent value right per Flexion Share, or CVR, which will represent the right to receive one or more contingent payments up to $8.00 per Flexion Share in the aggregate upon the achievement of specified milestones on or prior to December 31, 2030. The Company estimates the initial cash payment to acquire all of the Flexion Shares will be approximately $450.0&#160;million, which excludes merger transaction fees. In addition, the Company will assume Flexion&#8217;s cash and outstanding debt at the closing of the merger. As of September 30, 2021, Flexion&#8217;s outstanding debt and termination fees less cash was estimated to be approximately $144.0&#160;million. The total consideration payable pursuant to the Merger Agreement will be dependent upon, among other things, the total number of Flexion Shares outstanding at the expiration of the Offer and at the closing of the merger as well as the closing price of the Flexion Shares on the trading day immediately prior to the closing of the merger. The Company anticipates funding such cash requirements from its available cash and cash equivalents and short-term investments and expects to explore debt financing to supplement its cash position. The fair value of the CVRs will be estimated and recognized at the closing of the merger and will be paid if and when milestones are met.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligation of the Company to purchase Flexion Shares tendered in the Offer is subject to the conditions set forth in the Merger Agreement, including but not limited to, that (i) the number of Flexion Shares tendered together with other Flexion shares owned by the Merger Sub would represent more than 50% of the total Flexion Shares at the time of the expiration of the Offer, and (ii) the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired or been terminated.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing description of the Merger Agreement and the transactions contemplated thereby do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the Merger Agreement, a copy of which is attached as </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit 2.1 to </a><a href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">the Company</a><a href="http://www.sec.gov/Archives/edgar/data/1396814/000110465921124889/tm2129703d1_ex2-1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#8217;s Current Report on Form 8-K dated October 11, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675167800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and in accordance with the rules&#160;and regulations of the United </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States Securities and Exchange Commission (SEC), for interim reporting. Pursuant to these rules&#160;and regulations, certain information and footnote disclosures normally included in complete annual financial statements have been condensed or omitted. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes thereto included in the Company&#8217;s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1396814/000139681421000014/pcrx-20201231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Report on Form&#160;10-K for the year ended December 31, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements at September&#160;30, 2021, and for the three and nine month periods ended September&#160;30, 2021 and 2020, are unaudited, but include all adjustments (consisting of only normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial information set forth herein in accordance with GAAP. The condensed consolidated balance sheet at December&#160;31, 2020 is derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2020. The condensed consolidated financial statements as presented reflect certain reclassifications from previously issued financial statements to conform to the current year presentation. The accounts of wholly-owned subsidiaries are included in the condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for these interim periods are not necessarily indicative of results that may be expected for any other interim periods or for the full year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Concentration of Major Customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>&#160;&#160;&#160;&#160;The Company sells EXPAREL through a drop-ship program under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual doctors. The Company also sells EXPAREL directly to ambulatory surgery centers and physicians. The Company sells its bupivacaine liposome injectable suspension for veterinary use to a third-party licensee and sells iovera&#176; directly to end users.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements/ Recent Accounting Pronouncements Not Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amended the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The standard allows for certain exceptions, including the exception to the use of the incremental approach for intra-period tax allocations, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also required franchise or similar taxes partially based on income to be reported as income tax and to reflect the effects of enacted changes in tax laws or rates in the annual effective tax rate computation from the date of enactment. Lastly, in future acquisitions, the Company will be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The standard became effective for the Company beginning January 1, 2021 and there were no material impacts to the consolidated financial statements upon adoption.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2021</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative, and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The other separation models would be eliminated, including the model for convertible debt that can be settled in cash </span></div>or shares. As a result, these convertible debt instruments will be accounted for as a single liability instrument. In addition, the new guidance requires diluted earnings per share calculations to be prepared using the if-converted method, instead of the treasury stock method. The guidance must be applied in fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company plans to adopt the new guidance using a modified retrospective method of transition, which would be applied to transactions outstanding at the time of adoption. At September&#160;30, 2021, the Company has recognized debt discounts of $68.7&#160;million for its 0.750% convertible senior notes due 2025 and $3.8&#160;million for its 2.375% convertible senior notes due 2022. Upon adoption on January 1, 2022, these debt discounts would be eliminated along with any related future amortization. Further deferred financing costs previously allocated to the conversion features will be re-allocated to the outstanding debt, slightly increasing future annual amortization of deferred financing costs. The Company expects the impact of this standard to be material to its consolidated financial statements and related disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of presentation and principles of consolidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676492984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of percentage of revenue comprised by the three largest customers</a></td>
<td class="text">The table below includes the percentage of revenues comprised by the Company&#8217;s three largest wholesalers in each period presented:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Second largest wholesaler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Third largest wholesaler</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676713224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregated revenue</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregated net product sales in the periods presented as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;EXPAREL / bupivacaine liposome injectable suspension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;iovera&#176;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total net product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,791&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,392&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,850&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676714344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of components of inventories</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of inventories, net are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,209&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,650&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675191000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of fixed assets summarized by major category</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets, net, summarized by major category, consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,045&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,688&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760683072216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of operating lease cost and other operating lease information</a></td>
<td class="text">Total operating lease costs are as follows (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,085&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,710&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities, net of lease incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets recorded in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The weighted average remaining lease term and the weighted average discount rate are summarized as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.46 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.39 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of maturities of operating lease liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,663&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock', window );">Schedule of operating lease not yet commenced, payments due</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into one lease agreement (not included in the table above) for which there are future obligations but the lease has not yet commenced as of September&#160;30, 2021 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Minimum Payments Due</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total future lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Operating Lease Not Yet Commenced, Payments Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675161112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of finite-lived intangible assets acquired as part of business combination</a></td>
<td class="text">Intangible assets, net, consist of the developed technology and customer relationships that were acquired in the MyoScience Acquisition and are summarized as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:58.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.248%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,521&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760674923096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of composition of the Company's debt and financing obligations</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2025 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750% convertible senior notes due 2025</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,610)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,146&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,030&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total debt composition of the 2022 Notes is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% convertible senior notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total debt, net of debt discount and deferred financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,751&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ScheduleOfInterestExpenseTableTextBlock', window );">Schedule of total interest expense recognized related to the Notes</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total interest expense recognized in the periods presented (dollar amounts in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest and other (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,016)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rate on convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ScheduleOfInterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of interest rate expenses related to convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ScheduleOfInterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682750312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of carrying amount and fair value of the long-term debt</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Notes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financial Liabilities Measured at Amortized Cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;2.375% convertible senior notes due 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;0.750% convertible senior notes due 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) The closing price of the Company&#8217;s common stock as reported on the Nasdaq Global Select Market was&#160;$56.00&#160;per share on September&#160;30, 2021, compared to a conversion price of&#160;$66.89&#160;per share for the 2022 Notes and $71.78 per share for the 2025 Notes. The maximum conversion premium that could have been due on the 2022 Notes and 2025 Notes at September&#160;30, 2021 was&#160;approximately 2.4 million&#160;and 5.6&#160;million shares of the Company&#8217;s common stock, respectively. These figures assume no increases in the conversion rate for certain corporate events.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of key assumptions used in the valuation of contingent consideration</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the key assumptions used in the valuation of the Company&#8217;s contingent consideration:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assumption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ranges Utilized as of September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.49% to 3.81%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probabilities of payment for regulatory milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2% to 100%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected years of payment for regulatory and commercial milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2023</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of change in contingent consideration recorded at fair value using Level 3 measurements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the Company&#8217;s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Fair value adjustments and accretion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Offset indemnification claims</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,000)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of short-term investments</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company&#8217;s investments at September&#160;30, 2021 and December&#160;31, 2020 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021 Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,723&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,822&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020 Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>(Level 2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,416&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,705&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;U.S. Government bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681365560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of recognized stock-based compensation in consolidated statements of operations</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense in the periods presented as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,954&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,356&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,024&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,954&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,356&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,024&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of the company's stock option activity and restricted stock unit activity</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables contain information about the Company&#8217;s stock option and restricted stock unit, or RSU, activity for the nine months ended September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Exercise Price (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,235,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238,865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,416)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,170,166&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Weighted Average Grant Date Fair Value (Per Share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of share-based payment award, stock options, valuation assumptions</a></td>
<td class="text">The fair values of stock options granted were estimated using the Black-Scholes option valuation model with the following weighted average assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:80.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Black-Scholes Weighted Average Assumption</span></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.26%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term of options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42 years</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675230136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the changes in the balances of the Company&#8217;s accumulated other comprehensive income  for the periods presented (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net unrealized (loss) gain on investments, net of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net of a $54&#160;thousand tax benefit for the nine months ended September 30, 2021. There was no tax benefit for the nine months ended September 30, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676621128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computation of basic and diluted loss per share</a></td>
<td class="text"><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per common share for the three and nine mon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths ended September&#160;30, 2021 and 2020 (in thousands, except per share amounts):</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computation of diluted securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of conversion premium on the 2022 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dilutive effect of ESPP purchase options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,333&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Basic net income per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following outstanding stock options, RSUs and ESPP purchase options are antidilutive in the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average ESPP purchase options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,894&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760675142968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of income before income tax, domestic and foreign</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,395&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760683077880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>product </div>
<div>segment </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 22, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Flexion common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionMember', window );">Flexion | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Flexion common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Offer price, per Flexion Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued', window );">Contingent value right, per Flexion Share | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice', window );">Additional contingent payment, share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue, Net | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ConcentrationRiskNumberOfProducts', window );">Concentration of products (in products) | product</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Maximum Additional Contingent Payment, If Circumstances Met, Share Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Number Of Rights Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ClassOfWarrantOrRightNumberOfRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ConcentrationRiskNumberOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Number Of Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ConcentrationRiskNumberOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682826536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details) - Concentration risk by major customer - Sales Revenue, Net<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Second largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Third largest wholesaler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Three Largest Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration of Major Customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue from customers to total revenue</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">87.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_LargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_LargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_SecondLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_SecondLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_ThirdLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_ThirdLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_ThreeLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_ThreeLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760768264376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details) - Unsecured Debt - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt instrument, unamortized discount</a></td>
<td class="nump">$ 68,744<span></span>
</td>
<td class="nump">$ 80,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt instrument, unamortized discount</a></td>
<td class="nump">$ 3,806<span></span>
</td>
<td class="nump">$ 9,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682982872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 127,722<span></span>
</td>
<td class="nump">$ 117,484<span></span>
</td>
<td class="nump">$ 382,339<span></span>
</td>
<td class="nump">$ 298,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember', window );">EXPAREL / bupivacaine liposome injectable suspension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">122,609<span></span>
</td>
<td class="nump">114,163<span></span>
</td>
<td class="nump">369,128<span></span>
</td>
<td class="nump">290,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pcrx_IoveraMember', window );">iovera&#176;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">4,182<span></span>
</td>
<td class="nump">2,726<span></span>
</td>
<td class="nump">11,264<span></span>
</td>
<td class="nump">6,391<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="nump">$ 126,791<span></span>
</td>
<td class="nump">$ 116,889<span></span>
</td>
<td class="nump">380,392<span></span>
</td>
<td class="nump">$ 296,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EuropeanUnionMember', window );">European Union or E.U. | EXPAREL / bupivacaine liposome injectable suspension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EuropeanUnionMember', window );">European Union or E.U. | iovera&#176;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AccountsReceivablePaymentTerms', window );">Accounts receivable, payment terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AccountsReceivablePaymentTerms', window );">Accounts receivable, payment terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">37 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AccountsReceivablePaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AccountsReceivablePaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pcrx_IoveraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pcrx_IoveraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EuropeanUnionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EuropeanUnionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681813624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 35,434<span></span>
</td>
<td class="nump">$ 26,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">17,222<span></span>
</td>
<td class="nump">16,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">14,553<span></span>
</td>
<td class="nump">21,498<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 67,209<span></span>
</td>
<td class="nump">$ 64,650<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760683454248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FIXED ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">$ 247,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 247,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(87,810)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87,810)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,360)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">159,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">3,800<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
<td class="nump">$ 8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">881<span></span>
</td>
<td class="nump">691<span></span>
</td>
<td class="nump">3,016<span></span>
</td>
<td class="nump">1,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ForeignPropertyPlantAndEquipmentNet', window );">Foreign property, plant and equipment, net</a></td>
<td class="nump">66,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligation</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">111,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">60,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,434<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">12,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">2,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>FIXED ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment, gross</a></td>
<td class="nump">59,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ForeignPropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to product goods and services and not intended for resale, located in a foreign country or territory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ForeignPropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=pcrx_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760676431800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts', window );">Number of leases not yet commenced</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760759975448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Summary of operating lease cost and other operating lease information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Fixed lease costs</a></td>
<td class="nump">$ 2,919<span></span>
</td>
<td class="nump">$ 3,099<span></span>
</td>
<td class="nump">$ 8,762<span></span>
</td>
<td class="nump">$ 7,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">416<span></span>
</td>
<td class="nump">611<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total</a></td>
<td class="nump">$ 3,335<span></span>
</td>
<td class="nump">$ 3,710<span></span>
</td>
<td class="nump">10,080<span></span>
</td>
<td class="nump">8,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash Flow, Operating Activities, Lessee [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for operating lease liabilities, net of lease incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,868<span></span>
</td>
<td class="nump">11,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets recorded in exchange for lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
<td class="nump">$ 42,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">8 years 5 months 15 days<span></span>
</td>
<td class="text">9 years 4 months 20 days<span></span>
</td>
<td class="text">8 years 5 months 15 days<span></span>
</td>
<td class="text">9 years 4 months 20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">6.88%<span></span>
</td>
<td class="nump">6.88%<span></span>
</td>
<td class="nump">6.88%<span></span>
</td>
<td class="nump">6.88%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682900456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of maturities of operating lease liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021 (remaining three months)</a></td>
<td class="nump">$ 2,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">10,645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">10,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">10,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">11,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">2026 and thereafter</a></td>
<td class="nump">50,802<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">97,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(24,391)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 72,663<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682625528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear', window );">2021 (remaining three months)</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne', window );">2022</a></td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo', window );">2023</a></td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree', window );">2024</a></td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour', window );">2025</a></td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour', window );">2026</a></td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability', window );">Total future lease payments</a></td>
<td class="nump">$ 2,333<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760759475320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Change in carrying value of goodwill during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill recorded in connection with the acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,547,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,547,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,547,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,967,000<span></span>
</td>
<td class="nump">$ 1,967,000<span></span>
</td>
<td class="nump">5,900,000<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Amortization expense, remainder of fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1', window );">Amortization expense, first period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2', window );">Amortization expense, second period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during period</a></td>
<td class="nump">$ 37,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponFirstCommercialSaleInMajorEUCountryMember', window );">Upon first commercial sale in a major EU country (United Kingdom, France, Germany, Italy and Spain) | Skye Pharma Holding Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition', window );">Milestone payments for EXPAREL agreed in connection with acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember', window );">When annual net sales collected reach $500.0 million | Skye Pharma Holding Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition', window );">Milestone payments for EXPAREL agreed in connection with acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition', window );">Annual net sales threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponFirstCommercialSaleInMajorEUCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponFirstCommercialSaleInMajorEUCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_SkyePharmaHoldingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_SkyePharmaHoldingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis=pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760766345816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets Acquired During Period (Details) - Myoscience Acquisition - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">$ 110,090<span></span>
</td>
<td class="nump">$ 110,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(19,469)<span></span>
</td>
<td class="num">(13,569)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">90,621<span></span>
</td>
<td class="nump">96,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760678786552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>segment</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>segment </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_SettlementPeriodConvertibleDebtConversionRequest', window );">Settlement period - convertible debt conversion request</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt', window );">Deferred tax associated with equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt', window );">Amortization period of transaction costs attributable to liability component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt', window );">Transaction costs attributable to equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,071,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,071,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock', window );">Percentage of last sale price of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentMarketPrice', window );">Market price of principal amount of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of common stock per $1,000 of principal amount of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0139324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock', window );">Convertible debt, premium on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice', window );">Debt instrument, percentage of principal amount for computation of redemption price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Debt Conversion Terms Business Day Immediately Preceding February 3, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Debt Redemption Terms on or after August 1, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice', window );">Debt instrument, percentage of principal amount for computation of redemption price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_SettlementPeriodConvertibleDebtConversionRequest', window );">Settlement period - convertible debt conversion request</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of common stock per $1,000 of principal amount of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0149491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock', window );">Convertible debt, premium on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022 | Conversion terms prior to close of business on business day immediately proceeding October 1, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentMarketPrice', window );">Market price of principal amount of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022 | Debt Redemption Terms on or after April 1, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | segment</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | segment</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage stock price trigger</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice', window );">Debt instrument, percentage of principal amount for computation of redemption price</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption', window );">Conversion obligation, number of trading days prior to date of notice of redemption</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 402,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Debt issued in private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 390,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 402,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Debt issued in private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>DEBT AND FINANCING OBLIGATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent', window );">Convertible debt, carrying amount of liability component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 314,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 314,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate', window );">Assumed borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Convertible debt, carrying amount of equity component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Amortization period of equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Total transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Period of Transaction Costs Attributable to Liability Component of Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of trading days prior to the date on which the entity provides notice of redemption during which the closing price of the entity's common stock must exceed the conversion price for the notes to be redeemed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConvertibleAssumedBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Assumed Borrowing Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConvertibleAssumedBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Carrying Amount of Liability Component</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentMarketPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt market price, per $1,000 principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentMarketPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Percentage of Last Reported Sale Price Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Expense Associated to the Equity Component of Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_SettlementPeriodConvertibleDebtConversionRequest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of trading days in a settlement period for convertible debt conversion requests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_SettlementPeriodConvertibleDebtConversionRequest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transaction Costs Attributable to the Equity Component of Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsonorafterApril12020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtConversionAndRedemptionTermsAxis=pcrx_DebtRedemptionTermsonorafterApril12020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760677710616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Schedule of Debt (Details) - Unsecured Debt - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible senior notes</a></td>
<td class="nump">$ 402,500<span></span>
</td>
<td class="nump">$ 402,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(7,610)<span></span>
</td>
<td class="num">(8,940)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="num">(68,744)<span></span>
</td>
<td class="num">(80,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">$ 326,146<span></span>
</td>
<td class="nump">313,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible senior notes</a></td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(443)<span></span>
</td>
<td class="num">(1,089)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="num">(3,806)<span></span>
</td>
<td class="num">(9,263)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net of debt discount and deferred financing costs</a></td>
<td class="nump">$ 155,751<span></span>
</td>
<td class="nump">$ 149,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681489160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Schedule of Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="nump">$ 1,704<span></span>
</td>
<td class="nump">$ 1,764<span></span>
</td>
<td class="nump">$ 5,122<span></span>
</td>
<td class="nump">$ 5,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">666<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">5,844<span></span>
</td>
<td class="nump">5,430<span></span>
</td>
<td class="nump">17,245<span></span>
</td>
<td class="nump">12,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest and other (Note 5)</a></td>
<td class="num">(881)<span></span>
</td>
<td class="num">(691)<span></span>
</td>
<td class="num">(3,016)<span></span>
</td>
<td class="num">(1,448)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total</a></td>
<td class="nump">$ 7,333<span></span>
</td>
<td class="nump">$ 7,132<span></span>
</td>
<td class="nump">$ 21,327<span></span>
</td>
<td class="nump">$ 18,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate on convertible senior notes</a></td>
<td class="nump">6.70%<span></span>
</td>
<td class="nump">6.78%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
<td class="nump">7.35%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681139320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details) - USD ($)<br> $ / shares in Units, $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes receivable</a></td>
<td class="nump">$ 4,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">16,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">155,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">326,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">437,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesFairValueDisclosureAbstract', window );"><strong>Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes receivable</a></td>
<td class="nump">4,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">16,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible senior notes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share)</a></td>
<td class="nump">$ 56.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConvertibleConversionPremiumShares', window );">Debt instrument, convertible, conversion premium (in shares)</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member', window );">Convertible Senior Notes Due 2022 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing sale price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price of notes into common stock (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
<td class="nump">$ 71.78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_DebtInstrumentConvertibleConversionPremiumShares', window );">Debt instrument, convertible, conversion premium (in shares)</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member', window );">Convertible Senior Notes Due 2025 | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_DebtInstrumentConvertibleConversionPremiumShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Conversion Premium, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_DebtInstrumentConvertibleConversionPremiumShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pcrx_ConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760670321752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationCurrent', window );">Contingent consideration, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,070,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,070,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,736,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_MilestonePayment', window );">Milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,338,000<span></span>
</td>
<td class="nump">$ 5,591,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Amount of allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Reduction in valuation of investment due to changes in foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Concentration risk by major customer | Major customer three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember', window );">Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Contingent consideration gains during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="num">$ (800,000)<span></span>
</td>
<td class="nump">$ 2,147,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsideration', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationPaymentTerm', window );">Payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ContingentConsiderationCurrent', window );">Contingent consideration, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Acquisition-related contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition | Contingent Consideration | Measurement Input, Discount Rate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition | Contingent Consideration | Measurement Input, Expected Milestone Payment | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember', window );">Myoscience Acquisition | Achievement of Regulatory Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pcrx_CodaBioTherapeuticsIncMember', window );">Coda BioTherapeutics, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Payments to acquire investments</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_TELABioMember', window );">TELA Bio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedLoss', window );">Equity securities, realized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_GeneQuineBiotherapeuticsGmbHMember', window );">GeneQuine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Additional equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones', window );">Predicated investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_SpineBioPharmaLLCMember', window );">Spine BioPharma, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible note</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of Contingent Consideration related to the acquisition of a business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ContingentConsiderationPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Payment Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ContingentConsiderationPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_MilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_MilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Additional Debt Investment Upon Achieving Milestones</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pcrx_MajorCustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pcrx_MajorCustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AchievementOfMilestoneAxis=pcrx_AchievementofRegulatoryMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AchievementOfMilestoneAxis=pcrx_AchievementofRegulatoryMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pcrx_CodaBioTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pcrx_CodaBioTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_TELABioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_TELABioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_GeneQuineBiotherapeuticsGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_GeneQuineBiotherapeuticsGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_SpineBioPharmaLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=pcrx_SpineBioPharmaLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682365320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANICIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details) - Fair Value, Inputs, Level 3 - Myoscience Acquisition - Contingent Consideration<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.0365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.0349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Minimum | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Maximum | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">0.0381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Maximum | Measurement Input, Expected Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input, contingent consideration</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_MyoscienceAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=pcrx_MeasurementInputExpectedMilestonePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681963528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details) - Contingent Consideration - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments and accretion</a></td>
<td class="num">$ (1,200)<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="num">(2,147)<span></span>
</td>
<td class="num">$ (1,600)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims', window );">Offset indemnification claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at September 30, 2021</a></td>
<td class="nump">$ 16,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Offset Indemnification Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=pcrx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682843656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Schedule of Available For Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 559,723<span></span>
</td>
<td class="nump">$ 516,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">559,822<span></span>
</td>
<td class="nump">517,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=pcrx_LongTermInvestmentsMember', window );">Long-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">17,615<span></span>
</td>
<td class="nump">34,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">17,616<span></span>
</td>
<td class="nump">35,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">423,302<span></span>
</td>
<td class="nump">221,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">423,384<span></span>
</td>
<td class="nump">221,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds | Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">32,612<span></span>
</td>
<td class="nump">120,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">32,605<span></span>
</td>
<td class="nump">120,543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember', window );">U.S. Government bonds | Short-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">86,194<span></span>
</td>
<td class="nump">44,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="nump">$ 86,217<span></span>
</td>
<td class="nump">44,634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember', window );">U.S. Government bonds | Long-term:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,459<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=pcrx_LongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=pcrx_LongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760683113576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 10,784<span></span>
</td>
<td class="nump">$ 10,954<span></span>
</td>
<td class="nump">$ 31,356<span></span>
</td>
<td class="nump">$ 29,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Stock-based compensation from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_Compensationexpensefromstockoptionsemployees', window );">Stock options</a></td>
<td class="nump">6,458<span></span>
</td>
<td class="nump">7,181<span></span>
</td>
<td class="nump">19,507<span></span>
</td>
<td class="nump">19,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Restricted stock units</a></td>
<td class="nump">4,126<span></span>
</td>
<td class="nump">3,552<span></span>
</td>
<td class="nump">11,164<span></span>
</td>
<td class="nump">8,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="nump">685<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">10,784<span></span>
</td>
<td class="nump">10,954<span></span>
</td>
<td class="nump">31,356<span></span>
</td>
<td class="nump">29,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">1,546<span></span>
</td>
<td class="nump">4,429<span></span>
</td>
<td class="nump">4,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,156<span></span>
</td>
<td class="nump">1,401<span></span>
</td>
<td class="nump">3,591<span></span>
</td>
<td class="nump">3,944<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 8,116<span></span>
</td>
<td class="nump">$ 8,007<span></span>
</td>
<td class="nump">$ 23,336<span></span>
</td>
<td class="nump">$ 21,030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_CompensationExpenseFromEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation Expense From Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_CompensationExpenseFromEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_Compensationexpensefromstockoptionsemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation expense from stock options (employee and board of director awards)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_Compensationexpensefromstockoptionsemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681088280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning of period (in shares) | shares</a></td>
<td class="nump">6,235,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">769,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(553,023)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(238,865)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares) | shares</a></td>
<td class="num">(42,416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding end of period (in shares) | shares</a></td>
<td class="nump">6,170,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 45.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">61.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">34.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">46.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in dollars per share) | $ / shares</a></td>
<td class="nump">76.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 48.71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of period (shares) | shares</a></td>
<td class="nump">957,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">401,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares) | shares</a></td>
<td class="num">(302,228)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(114,562)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of period (shares) | shares</a></td>
<td class="nump">942,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 46.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">61.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">44.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">49.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 52.85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760769355976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>offeringPeriod </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares of common stock authorized for issuance</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, ESPP (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods', window );">Number of offering periods for ESPP | offeringPeriod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod', window );">ESPP purchasing period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682400520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK PLANS - Schedule of Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Incentive Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="nump">0.82%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">49.26%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of options (in years)</a></td>
<td class="text">5 years 5 months 1 day<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760683253144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="nump">$ 687,168<span></span>
</td>
<td class="nump">$ 388,148<span></span>
</td>
<td class="nump">$ 619,688<span></span>
</td>
<td class="nump">$ 354,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized (loss) gain on investments, net of tax</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(643)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="nump">718,602<span></span>
</td>
<td class="nump">584,690<span></span>
</td>
<td class="nump">718,602<span></span>
</td>
<td class="nump">584,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized (loss) gain on investments, tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Accumulated Net Unrealized Investment Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized (loss) gain on investments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 847<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 847<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682667384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 17,660<span></span>
</td>
<td class="nump">$ 130,119<span></span>
</td>
<td class="nump">$ 47,110<span></span>
</td>
<td class="nump">$ 131,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">44,476<span></span>
</td>
<td class="nump">42,928<span></span>
</td>
<td class="nump">44,151<span></span>
</td>
<td class="nump">42,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive effect of conversion premium on the 2022 Notes (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">45,463<span></span>
</td>
<td class="nump">44,275<span></span>
</td>
<td class="nump">45,674<span></span>
</td>
<td class="nump">43,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in USD per share)</a></td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in USD per share)</a></td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="nump">$ 2.94<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">827<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">1,132<span></span>
</td>
<td class="nump">740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Computation of diluted securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share based compensation arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681221960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">3,102<span></span>
</td>
<td class="nump">3,615<span></span>
</td>
<td class="nump">2,036<span></span>
</td>
<td class="nump">4,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">2,707<span></span>
</td>
<td class="nump">3,585<span></span>
</td>
<td class="nump">1,895<span></span>
</td>
<td class="nump">4,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760674948632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income (loss) before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 25,167<span></span>
</td>
<td class="nump">$ 8,175<span></span>
</td>
<td class="nump">$ 66,962<span></span>
</td>
<td class="nump">$ 10,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(936)<span></span>
</td>
<td class="num">(2,025)<span></span>
</td>
<td class="num">(4,360)<span></span>
</td>
<td class="num">(2,759)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">$ 24,231<span></span>
</td>
<td class="nump">$ 6,150<span></span>
</td>
<td class="nump">$ 62,602<span></span>
</td>
<td class="nump">$ 7,395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682091304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">$ (6,571)<span></span>
</td>
<td class="nump">$ 123,969<span></span>
</td>
<td class="num">$ (15,492)<span></span>
</td>
<td class="nump">$ 123,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance of deferred tax assets released</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760682379512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMERCIAL PARTNERS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=pcrx_EurofarmaLabatoriesSAMember', window );">Eurofarma Labatories S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_CollaborativeArrangementUpfrontPayment', window );">Upfront payment to be received</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=pcrx_EurofarmaLabatoriesSAMember', window );">Eurofarma Labatories S.A. | Achievement of Development and Commercial Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_CollaborativeArrangementMilestonePaymentsReceived', window );">Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member', window );">Nuance Biotech Co. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Estimated settlement fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_CollaborativeArrangementMilestonePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Milestone Payments Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_CollaborativeArrangementMilestonePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_CollaborativeArrangementUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Upfront Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_CollaborativeArrangementUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=pcrx_EurofarmaLabatoriesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=pcrx_EurofarmaLabatoriesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_AchievementOfMilestoneAxis=pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_AchievementOfMilestoneAxis=pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=pcrx_NuanceBiotechCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760769717448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember', window );">One-time Termination Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Estimate of restructuring costs, once probable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pcrx_FortisMember', window );">Fortis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought</a></td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pcrx_FortisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pcrx_FortisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139760681945176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent Event - Flexion<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 22, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Nov. 18, 2021</div></th>
<th class="th">
<div>Oct. 15, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Offer price, per Flexion Share | $ / shares</a></td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued', window );">Contingent value right, per Flexion Share | shares</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice', window );">Additional contingent payment, per Flexion Share, share price | $ / shares</a></td>
<td class="nump">$ 8.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Payments to acquire Flexion Shares | $</a></td>
<td class="nump">$ 450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Flexion outstanding debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage', window );">Tendered shares as a percent of Flexion Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Maximum Additional Contingent Payment, If Circumstances Met, Share Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Covenant Terms, Shares Tendered Combined With Other Shares Owned, Minimum, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pcrx_ClassOfWarrantOrRightNumberOfRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Number Of Rights Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pcrx_ClassOfWarrantOrRightNumberOfRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pcrx_FlexionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pcrx_FlexionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>82
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MY#MJO>KQ8F/R(S?^E9)0K"'4NKR"3TT5>WW%B99)OEVVDEK+*#_<"NX+91Z
M^VLI]>G$_$"YXSK^#U!+ P04    " !F?6-3*A82D-D&  "('   &    'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;*V9:U/;.!2&_XHF[73:&2"Z6+YPFZ%
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MIM;+]?@D=#A$;5E,48R)VV2V,9D%35Z+^O&_SJW,<C2,JZW(:$0SMV4$.Q3
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M3-LW OW\06BPKF_,QZC-Q\?3?P%02P,$%     @ 9GUC4ZYP[O#H @  Q0D
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M< BMT)S,RAI@A;MMP5=(&&L=S0QL;:RW5D.8>8P3)?0NT7ZJVW\<#8:CR7"
M]&CR^' _Z#WKR4WOH3?J#]'D;CA\GJ"+,1; 5 **1)A>HL_H$W*13/2J;+M*
M<YAH;E3DO,ES!GMR3B"KH-"[0H$7^#O<^X?=!Q!I=]^Z>YONKE9?EB H2Q#8
M>.$^'(45Z,Y4B,_0+6&81013-.:2V$[[T9M*)72__3R0+"R3A399=4^RL>Y2
M$ )BI!]M]'*%,BS0$M,%H O"4,PIQ4*B#$1>WLM=Y<U3-&P*\YXNNU[%\W0I
ME^M5/&:UP5\M^:OG\>=-@/!")5R0/WK#Z,A7=\+G\6MK6#7/?K;PC]MM"*B5
M FH?$D"D7!R'K[V#VL8^9+$!7"^!ZQ\"UO_)4F$6$S8_1ET_2GW(8H.Z45(W
M#E+W>9KJ=^<_FKQQ4I,?L]J ;Y;PS3/@S^[PYKMB!D7K;I?]%,L-!:U20>M\
M!:>U>.L=4[5:"\*JOPV_PS"LA_56T-K-[GO_SB3O?/HS^KT(?X*&79:[1;AK
M9ZRYX'S!8DZ81!1FVM6K-'0,D=\9\HGBF3UVIUSI0]P.$WW/ F$,]/Z,<_4V
M,2=Y>7/K_@502P,$%     @ 9GUC4^;\#25-!P  BA\  !@   !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6RM65U3VS@4_2N:S#ZT,T LR9\,, .)N\M,6QA"
MM\\F41)/;2NU%*#[ZU>R39Q(UR*SW1<2FZ,KG2OEGB/IXH77/\2:,8E>RZ(2
MEZ.UE)OS\5C,UZS,Q!G?L$K]9\GK,I/JL5Z-Q:9FV:)I5!9CXGGAN,SR:G1U
MT;R[KZ\N^%86><7N:R2V99G5OVY8P5\N1WCT]N(A7ZVE?C&^NMAD*S9C\MOF
MOE9/XUV415ZR2N2\0C5;7HZN\7E*0]V@0?R=LQ>Q]QUI*D^<_] /MXO+D:='
MQ HVESI$ICZ>V805A8ZDQO&S"SK:]:D;[G]_B_ZI(:_(/&6"37CQ/5_(]>4H
M'J$%6V;;0C[PE[]81RC0\>:\$,U?]-)AO1&:;X7D9==8C:#,J_8S>^T2L==
MQ8$;D*X!,1OX PUHUX >VX/?-?"/[2'H&C34QRWW)G'33&97%S5_0;5&JVCZ
M2Y/]IK7*5U[IA3*3M?IOKMK)J\G=UVGZ=99.D?HVN_M\.[U^5 ^S1_7Q)?WZ
M.$-WG]#=??IP_7BK .@4?9M-T8<_/B*QSFHF4%ZAQS7?BJQ:B!/TQ\'SQ5BJ
M(>J.QO-N.#?M<,C <"CZPBNY%BBM%FP!M)^ZVR>.]F.5FEU^R%M^;H@SX(QM
MSA#U3A#Q" ;&,SF^N0?1^;W>T__<^T$RZ&ZQT"8>'8CWP)Y9M67BW!'+W\7R
MFUC^0*Q'+K-"E9HV(K12VO9ATU[7N^<K3**(D(OQ\_X$ # <^;%_")O:,!H3
M2I-#6&K#2!*'$=W!#L@&.[*!,W%W&U9G,J]6B+VJ$B_<*0QW44-G"B=<2,27
M:,7Y0B#!"^@'<]/&"/:)^V& C2S:*)(D"362:*.PAXD?&TFT83'Q*(9S&.W8
M1DZV#TRPK)ZOD:HL2@J>E<9ME&))B'-DCQ,'D3',"8"R,S.U4;ZW3Z:E#*!\
M+_%@RO&.<NRD/%/ZJ1;-"5JQ2BV@HJ&>+90,Y$+J!?7,(/:Q/98X]B*#O8T*
M2!":[&T4]F/L&S_"%()Y83SPLTEV_!,G_^N2US+_)VLLA5KHV?SG-J_90HF,
MS*I5_E0PE G!)%@_$GM,26AFX1C0U 8%B><9*7@'=)  [/7R[+E3H"F+7&?@
MM&9%)A7[/Y7_0Q\^<R$^GJ#[FB^V<XFFN9@KZ<NK;9LN71R4(.L5<R?7K#Y!
M7QGX6^D&L#_PTP@;Y7,"H,+$6 53 (2I%QB)@CK$09(,I&K/R> C%(5;I18D
MC:TQ)"&)$Y,U %-R8&H+ "-)&)+09 [@(HSW,G1(G?34B9/Z;37G)4/+FI=O
M"> 53)S8<H!]2DWB-@Q'(?%,XC8L#B),3=XVC$1!& _0[NT(=ON19F&C#]U$
M?U1E0:?!):VXMR?8[4]N*\F4OY5=4#"7/I DL\! ((\$9B)M5(RMY6.#:$+#
M@2SVW@0'QS'M\@A2#8 B0>UE \$PM>H$ ",*%IF$ 1R.0V^H5/3&";N=DZZ=
M2!5)92B*7XJWKA>JS*ZUG]!"LV!/<*VTG8UGIL"&G"KQ-77U_4CINY$.R?<^
M"KN-5"<'U8 <V$[FU ]-DC:(1%YL<@1"D= 23BA8,$BS]T[8;9XZ.6A*1+>R
MATG;_N4T4ILFDS8 P]B/K+((X C%V#2-(,[#0[L-W/LF[#9.G1X\L26O65?!
MD,Q>!\30MB[$)Z;%G0"P$ <6=P"E)MTTC  LHLF $)+>+A&W7;K=4=V3A2?E
MGI<Y./$$\")A8/Y:)P ,$YJ$AE^80N%PX)M&*87CA7A@XDGO@8C; RF/YQ"L
MKO'!7CD*0[.$03#J86RQM7&^MC,F62@<]KP!^2>]ZR'$*?\]6:0\3WL@Y1)_
MTAL+0IUIO,E$/M?%8C^^^E(JS6BZ01^4!=<G8;N./X();[N)]ZO\F6FM 1 ]
M\\RM-X#"9^:F+H5C#>@EZ<T0<9NA:5YL]<[C?\B(#V3$/(69 "AREIBV&T!A
M*W$I@%(I(0,IZ5T3<1_I?&^.H%5.LF?EMU?L(!G*7&RE4'O4A3(6SB796Q;B
MMBSMDM1);GN LVM;!M_W(U.^(1A)B*G?8#1L'I"D8#2:#-6RWJ<0MT]Y6W3O
M<0:.7@(_-*TI!//5+L3D#$4+(]_D#,#HOA\^Y-R;%N(V+;JD;;H=O<@*4Z\/
MH_9V@"2_?6Y+>XVE;HU]_^2V"W!X=!M&B2FK$ Z'L;D-GP(X&GO4DE4 I_;A
M<3!P"D-[6:5N69WPHLB>>'ODAHI\KF_*JE5SNE+F:IHDK]A;2EQ)[K6-NK7M
MJ"G;.[=WZ]D14T;?W=F\#YD"$&SN=5-GG$."O4!1MT ]\%]9(7\=,P5]A:?N
M"G_4%/3UF[KK]Q%3$%JK-[%,.  *$K.( 2 <FQ<G*8PR2]AX[VZQ9/6JN=05
M2NVVE6QOCG9O=Q?'U\UUJ?'^!I]/,/!^BL_3]EJX#]_>4G_)ZE5>"52PI>K*
M.XO4?-7MQ6_[(/FFN=E\XE+RLOFZ9MF"U1J@_K_D7+X]Z YVU^]7_P)02P,$
M%     @ 9GUC4_!,4'=X P    L  !@   !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6RE5EV/VC@4_2M6U(=6:B?? 4: -$-2%6F'&0VT?:CVP4,,29O8U#8P
MW5^_UTXF"XE)1]T7B)US[O4YU['O^,CX#Y$1(M%S65 QL3(I=]>V+=89*;&X
M8CM"X<V&\1)+&/*M+7:<X%23RL+V'">R2YQ3:SK6<P]\.F9[6>24/' D]F6)
M^:];4K#CQ'*MEXG'?)M)-6%/QSN\)4LB/^\>.(SL)DJ:EX2*G%'$R69BW;C7
MR4CA->!+3H[BY!DI)4^,_5"#>3JQ'+4@4I"U5!$P_!W(C!2%"@3+^%G'M)J4
MBGCZ_!+]H]8.6IZP(#-6?,U3F4VLH852LL'[0CZRXR=2ZPE5O#4KA/Y%QQKK
M6&B]%Y*5-1E64.:T^L?/M0\G!(AC)G@UP6L3@@L$OR;XK\T0U(3@M1G"FJ"E
MVY5V;5R,)9Z..3LBKM 033UH]S4;_,JIVB=+R>%M#CPYG=TOXF2Q3&($3\O[
MO^;QS0H&RQ7\W26+U1+=?X17=P^/R2? S;\D:+Z <8(^H,_+&+U]\PZ]03E%
MJXSM!::I&-L2UJ6BV^MZ#;?5&KP+:_#1':,R$RBA*4D-_+B?/^KAV^!'8XKW
M8LJMUQMP2797R'?>(\_Q7,-Z9J^G.R8Y_R][\L?9S\SPFQWBZWC^I7@22P(G
M@T1L@V:LA.,H4^?$@: Y7;.2H&\W3T)R^.3_[DD7-.D"G2ZXD&X!9V.NXYHV
M4L6--%<=@8>I.X@BD'DX+8\!Y3NN.SJ'Q5U8,'#=5K#$%,QUG&$#.Y,9-C+#
M7E?O948X6I_96<E&;PLFQ+OK'B^C)DGT6R_W%*Z/(O^'I'5@M(7; \$9G=,#
M$5)55KQ'E.CZ2OQLLKU*$YYX\,%OFV[ 1('?LMP <J-AR_$N*/1"L]V#QHE!
MKQ-PJ<"50>%$Y9S0]2\$^Y6* E>75?I]7QMA$C_H+,=K2>\B6N;$743+F:0O
MQIGD82-YV"MYQ20N$#/LLWH?7/[*AMTJ>:TBS0R8;KD-(#<*6\J[H(OE'C7:
M1[W:9X;ORB1T9#I._'9Y#2AO% RBEM@N+(A&05NM(9COAK[?$FR?7.DEX5O=
M2PDHY)[*ZNQN9IMV[49W*:WY6_=ZYAKF8VCOJF[LO_!5;WB'^3:G A5D ZF<
MJP&4AE?]5C60;*<;BB<FH3W1CQFTJ(0K +S?,"9?!BI!T_1._P502P,$%
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MJBX1RW^/8B+2M*XD=?S1%AWLSUDG'G[^L_IETWC9F+NX%),\_7>RK%;G@W"
MEN(^WJ;5Y_SI@V@;Q.MZBSPMF[_HJ8WU!FBQ+:M\W29+!>LDV_V/O[4=<9"
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M<FMS:&5E=',O<VAE970W+GAM;+5:6V_;N!+^*X2Q#UV@KL6+)*M( J1)<S9
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M8<L,#SDV0:NZI&#R3%W_^^[\T_6_8/OLU?.WZG#9M>9!YY!*JC:M"ZYAV_^
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M+,MD7U@G/H['5WUVZ9F=:+5K2!4).+5H2G:1M3Q5/559XW302?[D+BND62C
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MS.^CN[+,^(3!V';PIG"81W G0R5WHD&P \J@:"R!HO)("SC+@-IJ;K/1D\[
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M-O1KR%F?#FF$8)['4;[U?*YDX.\3K*\=G[,2S$"?=N C?<%0N':JY!"GL.?
ML9^F:#K2Q6>(OV[G8!F/<PQ7XCZ2SBUO\1W%B]:U2DF?@4\[7,Z%NU;0]8Q4
M;6CXUL6&['D 4,H#]IR..8%H$(F)&:;23159, (?1]CTF## Z$4S-Z=?+74^
MH-.)Y$$UEEBD]00[F5O97&&$6[:ENC[9/&Y7+!FY_K'YC$\&FI]12$,HT[E(
M^D(\]Y%SJ_,YN:(A?\)S) ,5ORROGJZ^RX_CY^BU>/RH?XX1"NB)4LVQ=+BY
M]Z8G7/Q0'F^0L?QQ>F8#SC5\62B) )$ WM-'K_:&-EC]M>+H_U!+ P04
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M<-_Z#PV/_NXUZHV_PS@DHK3[T>^E^VO297<[.!SO[ECW3&^X=#DN295Z>!R
M[NXMW<:JQM\5ULK2S<,O*[KJH78'Z'NIE'W>. /[R^/R7U!+ P04    " !F
M?6-36@<._=$%  !A#0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6R5
M5VUOVS80_BL'MRM:P+$E^3U- B1I@@UHAJ#>V@W#/M#2V2)*D1I)Q79__>XH
MR;&3QMT^)*)$WO&YY^X>TF=K8[^Z'-'#IE#:G7=R[\O3?M^E.1;"]4R)FF:6
MQA;"TZM=]5UI463!J%#])(K&_4)(W;DX"]_N[<69J;R2&N\MN*HHA-U>H3+K
M\T[<:3]\DJO<\X?^Q5DI5CA'_WMY;^FMO_.2R0*UDT:#Q>5YYS(^O1KR^K#@
ML\2UVQL#1[(PYBN__)*==R(&A I3SQX$/1[P&I5B1P3CG\9G9[<E&^Z/6^^W
M(7:*92$<7AOU168^/^],.Y#A4E3*?S+KG[&)9\3^4J-<^ _K>FU,B]/*>5,T
MQH2@D+I^BDW#PY[!-'K!(&D,DH"[WBB@_""\N#BS9@V65Y,W'H10@S6!DYJ3
M,O>69B79^8N/-Y?SF_E9WY,O_M)/&[NKVBYYP6X&=T;[W,&-SC [M.\3AAV0
MI 5RE1QU.,>R!X.H"TF4Q$?\#7:!#8*_P4N!(>7*P5^7"^<MY?[O(SZ'.Y_#
MX'/XO\DZ:L>-=>I*D>)YASK'H7W 3N,,?LL1KDU1"KT%56,62H%9@O0.EB*5
M2GJ)K@M2IZK*I%Z%F9L_[B\_W7RD6M 5K?*5Y9EF_986PUQH^"!Q9;IP+92D
M!M92@-!9L)?F :UX\RJ>C-\?<7)KL:!$[[OH,6:'+=I</""U)PL &WNTA8.J
M!&]@VIO!%H4E\,X4R$&M<YGF4%KS(#,VT[@6%&W)+4J1>_#$!_WID[2R-.T)
MF_U*XO0@5(6] [J$<H:V)S,-6"PPHTJL45$3^9S7VL+ K:3VL#!/);F32YG"
M?2ZHH6%.B9 IA4!QA7TK%S#24-ICQ*ZESHSN4NVO%/'9@TLHC0TJ4YN#<,ZD
M4G@"Q/3E:ANT Y;8,K9 U)QIDX95Q!;;U>A3"M!H#IZ-,F#U(JZ48 4C*(0N
MT,'3TM6DD$Q;FB>HK0_G'R-[K*.FC-JMN!RTT2=/-N:,590H(I>^%0R )!\X
MR1ZUT&EM:3PSVZQX1( ;.C,<UZQ0AMY#-G"#:>6-W3;06O]2N\KN/-(N"M!Y
M(@6\V"!'9WPHD>_%1ZC8Q](0D6L';RD[/C>5(U?NW2D18Q$/E I^I=X\_$+*
MX[E\;)"?PS<6(_X7[8UNY6979S6*UY!T9_&,GH-N-./GM#L9)_2<=*/I"#X+
M*\5"X8'1,![#.(XA[@[B*?T?C^,F5'8S&(S"<Q)'](PC\A/5?H=CF%=EJ9".
M1EZ="I?#DL(G)NM#NCXO55M73Y@CQMTQSGY$T",1U[QS*606RNQI@A2%O-,N
M31U,K5'/4 5R)U(IOX99=SJ><H1Q-QG%$"X%)V9YPJU(381$E,746,9!0'&3
MYD*O,.Q8>S,+)5>BU@]*1,RT#Y-N',4'8L$Z$>X"-2D,*#1JP8W[3>PWKWT&
M(I1FF,*L2O?7'L:Z)66CZ&1)>2&T=7OL$0&!:ZX (E9S:]/(&26SD*Q0]IQ6
M]K[+J^L]"Z2@72N+M9(?(9X%E<71>5F$'3+I4E/1!I8;C&9K/9:>@%0J@X6Q
M?"8&P:&K!=>0)>'_1J9!:X!/C8:)?<4/^4!!KIZ@J;&OP^6(G @^=%;[UC7F
MX*,E^=GJ)ZBIY^L[9,#U6,JG+U;JE_^T_[1'O17.*YCU!LW1]=SV$,VX-YW"
M3^WC3O!Y$:AO"J1)VYM7TR2>O/]!MHZKV9^$!RY7*XLKWOF. BBJ N[%EFO&
MP0<Z$4+,;_>2$Q0PG$'N71"J\6C&JQ(6E?%PQ.-!&,\F/![R>#8-@C<*;3D)
M)([;])!"+XDN&$7=:90TDE7'4K9(9J1[HR%\1$=)D459^="^9$:E"&^387<P
MB]^]H.S[C)""$N+Q +YW>^OO77L+M*MPN><#BY)3WX!W7W>_'R[K:_/C\OK'
MQYVP*SJ(",&23*/>9-2I9:!]\:8,E^B%\70E#\.<?@.AY04TOS3&MR^\P>Y7
MU<6_4$L#!!0    ( &9]8U.%-=Q1&P8  )L.   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;*U7;6_;-A#^*X07# F@V;(=)W&:!'!>F@9+VZ!.NP'#
M/M#4V2)*D2I)Q7%__>Y(659:._NP 4%,D<>[Y^Z>.Y)G2V._NAS L^=":7?>
MR;TO3WL])W(HN.N:$C2NS(TMN,=/N^BYT@+/PJ9"]09I>M0KN-2=B[,P]V O
MSDSEE=3P8)FKBH+;U24HLSSO]#OKB4]RD7N:Z%V<E7P!4_"?RP>+7[U&2R8+
MT$X:S2S,SSN3_NGE(<D'@2\2EJXU9N3)S)BO]'&7G7=2 @0*A"<-''^>X J4
M(D4(XUNML].8I(WM\5K[V^ [^C+C#JZ,^D-F/C_OG'18!G->*?_)+-]![<^(
M] FC7/C/EE%V-.PP43EOBGHS(BBDCK_\N8Y#:\-)NF/#H-XP"+BCH8#RFGM^
M<6;-DEF21FTT"*Z&W0A.:DK*U%M<E;C/7]Q^_'C]Q]W]/9M\N&9W'QXG'V[O
M+N]OV&0ZO7F<GO4\VB#)GJCU749]@QWZQNR]T3YW[$9GD+W<WT-L#<#!&N#E
MX%6%4RB[;)@F;) .^J_H&S8.#X.^X2Z'C<F64BG&=<;NM.=Z(6<*V,0Y\(Y=
M2R>4<94%]M=DYKQ%VOS]BMG#QNQA,'OXO\7YO^ACC9>/.; K4Y1<KW[]Y630
M/W[CV&*]:,$A>1V;6U,PCY)<?*NDDZ%>S)P]<"$M9P\Y1_X+J+P47+D$PR:Z
M;-]O47W%E<1.H25GV#<L]U(OL.!G3F82:_X@FII^74%4RMX9E:%,U)DP8\-B
M&183MJ\QRKRE@%!]P8*N$-:M-57)2B4.F-3L/;<B1Y*DQQ$901JD;S;:V&3C
M7%CLOSE( @NV>/Y^9:9"@A;0]K;6N5G<II/ 3$HK%8+IC[N4 233DCNF#1,Y
M\@U(A/0);NV*(O3$505D=UM,FW1EE25ADO&Y!0C@-1*#%;'F@&J.8<5X*&9@
MF[()(+!Y*4Z8N6<SX_,M<D'A-8AZMA]FTX!];SSNCK !*86N1GW;0\N,$)6U
MB.-%4A*&(<'L>A/P6\ -%K"[(_UPSH(P-F,"_4 7<9:&F/- (6K>GLVYM'6@
M*O33(M6OV$DZ^FV8=C%'M$'7K7XIT3V_$V+2#C/C"PQE1B $6(_'&'D)V'@Q
MKB5?18C(:0Q,:2ZK4CYQP2GHI359)3S6@]1"541C=O/GP^33S7T7VPFE\^<0
M)[7[=%[2ABVVHC8X97N'W70=<E:5)I)F+JVC\!0%6"&Y8HZKAE&?M?3HS.^H
M.C-%PMY:'CA\"Q@#O4(R>ZY6H<Q*<K5-ZTE9*BQP:H97IM+>2G!K4K\)U-@;
M#EJ(ECE@8K2N$(/&ZP/A< A,T8F+(/".@,G?&Z5I:]-^ 9RZ:\8HJ\RB-(7A
M6\6M!XO0\(B5[@ #B*EY-4RA)&98"FB'S"%)>9:%!",@89QWZXK:P51T*:0#
M[P'&8I B":.JINCD/+@>G T.-1P5*R8=]5"CGB#;R<'MW>(E!QO+C5EO,%'D
M^=[P^,?"6^\J>(;5S#Q_9LTMQ^=8*ESA7<MM^IIM:R9OY.;<X_'<PQ^#;*)
M_@MRJA0*.UI%Q%@ I*:[Y2B]^]%(0C1)8F4CA>OD9/"$5\.22A!$KHTRBU4
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MAKIL&LFXU!04_['6F=H+M+FW5X&@!-#*NM:>KQ5V@5)A3:93WVW)^&#'C2'
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M)UO9T.'@HCMLSV+;K7DOQHV92V\PS"*EFPX^<6&ZV:2JK#8W_"!61O.4BCH
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M7%$7WX-4GT4?OO(,428O[9'V=<@TXMCH\HA$-^Q>](_4[;;*5*D4\:C5,-2
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MF^O4/34>C[L'VT>N%F5#9LV1-/!'R0"4>P2YB9$K^_"828//&#M<XKM1*#J
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MQ\,>*?\Z]!LC&_<B6TB#]YU;%GA0<V4)\'TI46?KC16P?:)?_ -02P,$%
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M](UV2>0<^Z;JC)'XK99^!>0JNRC\)G#:Z"-RIR9><X60BDIRFG)EH/LA0)O
MOBM \?<!RFNE:$VA:(Y5-(GUG(2/0M5KJGP#")V2G&YGRL\_'2?]R2\.-#WH
MVX#1,X76<N#)"Q_ND'9V910D2X\+Q[T0GO>H%I<DY>H\EZDDAE 9)\-9X:/,
MD"W3&:4F!!0;' 6"0257LI(/E%&\KBFFOA'XD5!3Z4NV1SV%DO\*BGJ7+J0W
M5\R>0A$O!DLL*#&<AZ_=^^[.V=+$VA4=XU+8C/R6+$W^R+WN["8 G5K(['7>
M-ND"@I LW79MUF)+X:,TKDF2<-Q"A;P532+L.6SI^0%H+MAPR*U04H.B6,YU
M7WK8>JTVH42[",T0>6YJ[9N.8;NZ[;<NFC;C6;QIUFZ%75 @06%.T+@[&77
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MVV'5$H6Q;7D3>M](HNC8N,A9 1T3.HMZ6/<[^_?7O?JFS!_ 2B7>?H/+Z:1
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M;HSIL< 5G;U,P/>50^UW+[)!?^D_^AM02P,$%     @ 9GUC4Z"WX-LK"0
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;+58:V_;.A+]*X076*2
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M?[Y#O_)GI[,LF<&1$C]X:K->T D@Q14KA;U3FV^X/<^IPTN4,/X/F\KW_#2
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M0]#P_&+H@6YUVSI658U6ULJ2\AJSH*<.M0N@\XU2=N^X!/WC.?L+4$L#!!0
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M'NAQ9HT;J[IA3NR4I:DSB V->=1.@>YKI>S[QCF8?ASK_P!02P,$%     @
M9GUC4W>X+U6)!   80L  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL
MM5;;;MLX$/V5@?:"!%!MW2VECH$D3;$+-(N@SK98+/:!EL8644E422I._GZ'
ME'Q+''=?]L6D),Z9,S-GQIRNA?RF2D0-3W75J$NGU+J]&(]57F+-U$BTV-"7
MI9 UT_0H5V/52F2%-:JK<>!YR;AFO'%F4_ON7LZFHM,5;_!>@NKJFLGG:ZS$
M^M+QG<V+SWQ5:O-B/)NV;(5SU'^V]Y*>QEN4@M?8*"X:D+B\=*[\B^O$G+<'
MOG!<J[T]F$@60GPS#[\7EXYG"&&%N38(C)9'O,&J,D!$X_N Z6Q=&L/]_0;]
MHXV=8EDPA3>B^LH+75XZJ0,%+EE7Z<]B_1L.\<0&+Q>5LK^P[L]./ ?R3FE1
M#\;$H.9-O[*G(0][!NE;!L%@$%C>O2/+\@/3;#:58@W2G"8TL[&A6FLBQQM3
ME+F6])63G9Y]NKV:W\[A[($M*E3GT[$F4/-IG \ USU \ 9 !G>BT:6"VZ;
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M'Q4,+ATI.^)VQ2C)X/)84X\/+N 6]<H_,PSX+'1W\7 ZO&1NNPO\FWCW#/K
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M(W)IFP%*3A4U"L)^Z 5L$K3MA)N:1)#=EHV% G T(U"Q$SL%FVC*B]GWP7S
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M.^Y;,L-A$"^&-/%,DLNUG?9RF3BY^]#I!]G(-A- G"3LN+^^NP(3Y\[VI%]
M0OOR[&J?E3A?2_6DET(8>"Z+2E\,EL;49\.AGBU%R;4K:U'ARERJDAN<JL50
MUTKPS"J5Q9!Y7CPL>5X-QN?VVYT:G\O&%'DE[A3HIBRYVER)0JXO!OY@^^$^
M7RP-?1B.SVN^$!-A'NL[A;-A;R7+2U'I7%:@Q/QB<.F?7<4D;P4^YV*M=\9
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M]:KV0MQ.C*SM)70J#5YI[7")_Q!"D0"NSR5>QKH).>C_2L;_ 5!+ P04
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M<VAE970S."YX;6RU5EMOVC 4_BM6M(=-JL@%:.D$2"VT&M+:(K++P[0'DQS
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M<H-#(DAS +^OA-#[C3%0C9WC7U!+ P04    " !F?6-38]I']D(#   2#@
M&0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6R]5VMOVC 4_2M6I$F;U)$G
MCU: 1$.Z(16*2+MI'TUR(5F3F-FFM/]^M@D!.A(H4RLA\.N<XWM]A'W;*T(?
M603 T7.:9*RC19POKG2=!1&DF-7( C(Q,R,TQ5QTZ5QG"PHX5* TT2W#:.@I
MCC.MVU9C8]IMDR5/X@S&%+%EFF+Z<@T)674T4]L,3.)YQ.6 WFTO\!Q\X ^+
M,14]O6 )XQ0R%I,,49AUM)YYY9F.!*@5/V)8L9TVDJ%,"7F4G4'8T0RY(T@@
MX)("BY\G<"%)))/8QY^<5"LT)7"WO6&_4<&+8*:8@4N2GW'(HX[6TE (,[Q,
M^(2LOD,>4%WR!21AZANM\K6&AH(EXR3-P6(':9RM?_%SGH@=@. Y#+!R@/4:
MX)0 [!Q@GZK@Y #G5(5Z#E"AZ^O85>+ZF.-NFY(5HG*U8),-E7V%%OF*,VD4
MGU,Q&PL<[_H/PV%O\@O=W2!_\&TTN!FXO=$]ZKGNW</H?C#ZAL9WMP-WX/GH
M*_*%3<-E HC,D$NR #).L3KO2<P>Y>@0_R84N6K?0!GZW >.XX1]$>A]!)6(
MZ8N(12*"'"%%< (,3> )LB5<H!'PMLY%I'*_>I!'=;V.RBJ)RD9#DO&((2\+
M(3R [U?C+ROPNLAPD69KD^9KJY+0AT4-V<8%L@S+/+ ?]W2X<2B<_U/WSE;?
M2X9=>,Y6?$X)WRVF<V <K2(BCEH<-ZT@=0I21Y':):3[[OK7BA42]4*B7KGO
M,5 I(?X_)3]=.Q3-*$D+_S+$B?APG&SF#YFW6L8V:X;QZ9!)SL3US\1Y;\?M
MY;51Y+512>1#0+(0)6^Q1;/@;KZ7+5J%1.MC;%$M8[7*;%&-LXTR6YRIYQW1
M.V:+RR*OEY5$]U%,W^@*T]A>>\9[^<+<N5O-CW'&$1VK46:-8\!ZF3?.5?3.
M4-S/KK7-KG7$'Q0 ;2Z3DTYN>T.9]KO98WMCF<X'V:-:IU5VRNXQ8-DI]\]5
M](X!FV7VT'?>N"(Q<U5<,!209<;73X]BM"A@>NK9_FK\VKQRS0/C?5GPJ#?U
MEGY=+0V%Q>*,H01F0LJH-<6]2-<%R+K#R4*]L*>$BU-3S4@4;4#E C$_(X1O
M.E*@* .[?P%02P,$%     @ 9GUC4ZC-=%LE P  NPD  !D   !X;"]W;W)K
M<VAE971S+W-H965T-# N>&ULS59=;]LX$/PK"Z$')$ :R9*_4M@&7-EI532.
M$2=W* [W0$MKFRA%JB1EM_WU)6E%<"ZVD-ZA0%\DDMJ9G25') <[(3^K#:*&
MKSGC:NAMM"[>^+Y*-Y@3=2D*Y.;+2LB<:-.5:U\5$DGF0#GSPR#H^CFAW!L-
MW-A<C@:BU(QRG$M099X3^>TM,K$;>BWO<>".KC?:#OBC04'6N$#]4,REZ?DU
M2T9SY(H*#A)70V_<>C.]LO$NX$^*.W70!EO)4HC/MI-D0R^P@I!AJBT#,:\M
MQLB8)3(ROE2<7IW2 @_;C^S7KG93RY(HC 7[BV9Z,_3Z'F2X(B73=V+W'JMZ
M.I8O%4RY)^RJV,"#M%1:Y!78*,@IW[_)UVH>#@"M]@E 6 '"EP*B"A"]%-"N
M .V7 CH5P)7N[VMW$S<AFHP&4NQ VFC#9AMN]AW:S!?EUB<++<U7:G!ZM'BX
MN1G??8+;:U@D[V;)=1*/9_<PCN/;A]E],GL'\]N/29Q,%_ :9F;=QVDJ2JXI
M7\-<"F[:*1K?: 5G$]2$,G5N(A^XPK24F,$$E]H.+"9P]NH<7@'E<+\1I2(\
M4P-?FQJL$C^M]+[=ZPU/Z<7B$J+@ L(@;!V!Q\WP":8&WG+PX A\T@S_4+)&
M^+09?D/D([S5>PKWS;K5BQ?6BQ<ZOO8)OECP+4I-EPQA@9P*"3.A4<&D1"NQ
MTY CJG-$+D=T(L<=;I&7> $)IYH2!N.B8#0E[C>?HZ0B@[C,2T;L'P_3U<IL
M 7 OB=E*7,S?'PTC)!IS]4^#GG:MI]U8L_,3Y4K+TMKN DI.<F$FX;LQ6T:5
M<^<Q7^UINX[6[I[;4;??:[<'_O;0/L^C^D$G"NJH)YH[M>9.H^:%)MJHHURC
M1*5!FBZ<$04$"I2I*>/\F.)FTN"RU_GCF(5_&O:DIFY=4_=_>2]LR-&K<_1^
M"^_U:SW]7^.]_C-71?V@^R_K/0^Z"KO1<>==U8JO?H7SFDG#R^B$]?XC;OKS
MN/UL^ <'G[W6F UV;=8'&*X,D[6Z!W)_5=AWM"C<6;@4VIRLKKDQMRN4-L!\
M7PGCX:ICC]?ZOC;Z 5!+ P04    " !F?6-3#\_]Z H$  !8$0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T,2YX;6RU6%V/HS84_2M6NJIVI6W AO Q32+-
M)%1=::<:93;;2E4?'' 2=P&SMDEFI/[X&L- 0@@[VDU>$C#WGNM[#CY@QGO&
MOX@M(1(\)7$J)H.ME-F-88AP2Q(LABPCJ;JR9CS!4IWRC2$R3G"DDY+80*;I
M& FFZ6 ZUF,/?#IFN8QI2AXX$'F28/Y\1V*VGPS@X&5@03=;60P8TW&&-^21
MR&7VP-694:-$-"&IH"P%G*PG@UMX$Z!1D: C/E.R%P?'H&AEQ=B7XN1#-!F8
MQ8Q(3$)90&#UMR,S$L<%DIK'UPIT4-<L$@^/7]!_T\VK9E98D!F+_Z21W$X&
MW@!$9(WS6"[8_G=2-:0G&+)8Z%^P+V-=%1SF0K*D2E8S2&A:_N.GBHB#!(73
MG8"J!-1.L,\D6%6"]=H*=I5@O[;"J$K0K1ME[YJX.99X.N9L#W@1K="* \V^
MSE9\T;2X41XE5U>IRI/31? Y^&,9@+=S(C&-Q3OP"U@^SL';-^_ &T!3\&G+
M<H'32(P-J>H564988=^5V.@,M@7N62JW @1I1**._'E_OM^3;Z@^ZV;12[-W
MJ!?PD61#8)GO 3(1[)C/[/7I9E<[/U8]^.[J1V18M?*6QK/.X,VIP)L-)QNL
M5RQ;@P79D30GX.^/*A1\D"01__04LNM"MBYDGRGTB4D<@U297L99E(<2"!R3
MSONI!'(T4&%QNRE$KHO0V-@=RM01!EW;LX_#YJ=AEH<LRS\."T[#D.\YKE6'
M'74]JKL>]78=_/5PNP@^ @.L\HSN<(@+4F.:,<$2HE;6O\HJ\2HFRJ-%5CIO
M#]E.7=:YKJIN7<B]E*HET.A(5>28+1UF'6'0AH[54O4TS')\B+R6JJ=AR#?M
MD=^MJE=W[?5V3=F.</SS3]!U?NTAT:_A_.NJ!<W&Y\U+Z54A'7)G0Z^]"#NB
MD(N<EEH=41 BI[54@XXPQ_)AMUCPX.$&?[SI8VS48*,K:]<X-;0NIIW58:&.
M>T!EI5Y'''0\SV_K9YTN-\^T?-06\!0/^8XW,L](V#P\8/_3(\BY>BO&*5BF
MFF8.@N%R"/X#%S98V!@['%U9^,;,H7,AX><5TJ%0Y[AO+![V>_Q9[E]I@["Q
M5>A=F=/&<J%_,4[]DYOZ#*>H\6'4[\/W-*5)GO2]S3;VAN!U64.-VR'4.^W;
M,&1Y*H7:'(9$K3:UKMZ###^K/:,$DO"DD\!O@)H@PL]];HP:BT3]%GF/G[Y%
M:V,YR+XRK8V7H/ZWQ.^DM1_4<L_R:ASL%!/"-WJ++H">1+EUJ$?KSP"W>O/;
M&K^#-S/8,3Z'-T&YR6_@RV\.]YAO:"I 3-:JE#ET51.\W,:7)Y)E>I^Z8E+M
M>O7AEN"(\") 75\S)E].B@+UQY3I_U!+ P04    " !F?6-3QUMOKG "   H
M!@  &0   'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6R-5<MNXC 4_14KZJ*5
MIDWB/*!50&JAU7313@5]+$:S,,D%K#IVQC;0_OW83AI1"&@VQ->^Y]QS_+AD
M&R'?U1) HX^2<37PEEI75[ZO\B641%V("KA9F0M9$FU"N?!5)8$4#E0R'P=!
MZI>$<F^8N;DG.<S$2C/*X4DBM2I+(C]O@(G-P N]KXD)72RUG?"'6446, 7]
M4CU)$_DM2T%+X(H*CB3,!]YU>#5*;;Y+>*6P45MC9)W,A'BWP7TQ\ (K"!CD
MVC(0\UG#"!BS1$;&WX;3:TM:X/;XB_W.>3=>9D3!2+ W6NCEP.M[J( Y63$]
M$9N?T/A)+%\NF'*_:%/GQCT/Y2NE1=F C8*2\OI+/II]V *$\0$ ;@#X?P%1
M XB<T5J9LS4FF@PS*39(VFS#9@=N;QS:N*'<GN)42[-*#4X/[Q]?;Q^??TWN
M;Z?H= R:4*;.T#EZF8[1Z<D9.D&4H^>E6"G""Y7YVM2T2#]O^&]J?GR ?PK5
M!8J"'P@'..R CX[#QY ;>.C@P7>X;YRV=G%K%SN^Z)!=O@:NA?Q$8ZIR)M1*
M OI]/5-:F@OUYTB%J*T0N0KQ@0H3LC'GHT%2PCKWJX:G#F[?V'H8)7$49_YZ
M>UOVLW#:[Z=MUC=M<:LM/JKMS;RH<\K/*RER4)WJ:H)DJV[8PQCOJ.O(2G%Z
M0%W2JDN.JKNCG)J+7*"%$-U7+=DO&R=)M"-N/PN'\66_6US:BDN/BGL6FK N
M3>G>0:4]'%SN:.K(BM,DV-'D;[UCVT,?B%Q0KA"#N<$%%SUC2M9]J0ZTJ-S3
MG@EM&H4;+DTK!VD3S/I<"/T5V&[1_CD,_P%02P,$%     @ 9GUC4ZG(T66V
M!   LA0  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULM5C;;MLX%/P5
MPNA#"Z212-T#QT!B1]@"#3:HV]U]96S:)BJ)*DG%2;]^J4LD6Z((H4U?;(F>
M<XZ&0\VA.3\R_ET<")'@.4TR<3T[2)E?69;8'$B*Q27+2:9^V3&>8JEN^=X2
M.2=X6P6EB85LV[=23+/98EZ-/?#%G!4RH1EYX$ 4:8KYRRU)V/%Z!F>O U_H
M_B#+ 6LQS_&>K(G\EC]P=6>U6;8T)9F@+ .<[*YG-_ J1GX94"'^H>0H3JY!
M2>61L>_ES:?M]<PNGX@D9"/+%%A]/9$E29(RDWJ.'TW265NS##R]?LT>5^05
MF4<LR)(E_]*M/%S/PAG8DATN$OF%'?\B#2&OS+=AB:@^P;'&N@J\*81D:1.L
MGB"E6?V-GYN). E0>?0!J E _0!W),!I IRI%=PFP)U:P6L"O*D!?A-0B6G5
MDU7-] I+O)AS=@2\1*MLY44E5Q6M)IAFY<I:2ZY^I2I.+N)/_]VMP,UZ??=U
M#=ZOB,0T$1_ 1_!MO0+OWWT [P#-P-<#*P3.MF)N256T#+4V38';N@ :*>"
M>Y;)@P!WV99L-?$K<WQDB+<4V98Q>F5\BXP)UR2_!(Y] 9"-H.9YEM/#;1V=
MWZM^]WO58W/XBFQ4.-2%G\VETZX>I\KG3%@]AG1NF\ZMTKDCZ1ZX<DPN7RY
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M'U,]A8(P!OI\Q;EZ61@']5P[_@-02P,$%     @ 9GUC4R8C)4^'"   @RX
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M>M%@;&^_0/"W=J\WS>TVT5O9\-\H&^TJ.7 Z,8'#=B*!%9K@2$(36*$)VFX
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M(Z V3!ICD8+;5&AU:@Z:[<^;;*=8NC;[;L!2Q+$I"34=:9.@#7,4E<E<%LG
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MBV]1BAV=;?.O,^XRK;,DW]QP9A:Z=H#Y_3XS4U[NV!-47P3-_@502P,$%
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M<P6[K8*3*SAM%7JY0J^M0C]7Z+=5&.0*@[8*PUQAF$Z'#+\4_ EBZ/J2DE=
MA32W)KZD,RC5YIC[D9CL3XSRIS[78]>SQ</H8;P8W8'%P]/S\LO]].'Y"7P&
M#XA2).8A^#3!#/E!_,MEE_$!A5K7S8W?9,9AC7$3W).(;6(PC3SL*?0G>GVK
M27^FUQ\VZ<\;_(<: UV>Z4.ZX7NZ;Z#6XFA+SX%EG %H0//+TP1\^DF5UW%K
M*^:PWLI$;^4);]OX,FUOQ:BW,OL07VX_Q)>YWLH$N]R*V61EH;?R*XH.5M01
ME2:0=5BO5FK6JC$[)I&+(R;6)B\52S_^"OZ\XS)@P7 8_Z49P3Z,8*<CV/4C
M,#]:\T& 2WA1\W VV!FG(TKY;=5,RTSV4I.BONZN':-O\+_+[JXX"UK*S:MR
MIMVW>D7!4G#.(3A'&]R]'V#.J3Q?6[0/:X+)3#@E)PU%,%6Y_I%<R<?>P<>>
MUL?'S#/ .QF!@!(,U0KK5=PQ+6M0<?NV5\7 &9JU;O</;O>U;B\BABE/+F^!
M7.SOT$N 5<GM5[RT5;EM)S:OBID]#02#0RP#;2RCD"0\Y60%4,#;0<377 J'
M1Y(7MDH"WJ.Y0B)613BH^'0<7*/$?%#!J":BX2&BH3:B!\)P#)8UT)1,FH;L
M'8P3D9%9Z$],K>-+["597^Q'8(>")!N,0^-'.S[=TJ7B)1@P MP-XFLE%I(<
M+=[G1CEGN7N W[*G@'N+5;C-<D=*I*.92R:4(4#];,HG2V%E@']!.7E4).]E
MSUN[O\6R3QL_3+G8??D&IRY=6F49,4]51TQ92,S&2G(<X2<4 P2VF(H'RCZA
MP:9EGAO&S\I6KD&Q5U4LQR5KB*DO(A^))WLE.I]DS3![I\)3$KRI9_@?PU-O
M$_9K\6Q0'#3A*<G>;&#[C\1S0[%VA4K"-H<G0A1* H?&QR/:8!,J%EK>=C<H
M6@V(0EDTH+YH%'K8<7W;5#8NZ1S"4P$CZ1E:/]2$@S7RHYC7.\J?"I1\HMQ7
MY^9+C1%4-%#37+!8]#X/5 V90A#RGKS:7JJ&UO5D4-83J*?P^SV)71^+9FSD
M?DO\V&_"5%(Z=$Z%J:1HJ._KZS!5[O^K37K6B]2G4=(XU#/G^_Z"M^NA<FR]
M>L\ 'MK'NI1(YH5ZYOVAO2:LML_V0+E!:R-9]ERR,]3WTX4)^)GB@/>4WO=L
MUB:Y^1+ /=4*G;66G"LDX<#2A&O)0F'IN5F]]+(JJ61:41DQBA.*T[FVB+8)
M.P,3/TY++5CRA'&1.[S# ;!TYR*2\RWS1$O8DM1OZ3OY8DA^%M+W@)Y;-ZWB
MON[<L'K.$>8M!,L1%(Z/](7E@X"<OFVQ*^:\/%!YIY56J$K.M^Q3H2K)WVHX
M%/J?J&;6Q5ZY"!8\QK1)K.R]+"N6OJS4(CIR-SY'(@V+;Y>7>)UPGB)T+T'3
MI4_6$ZM_*HADH;#TA>('S\1NK>I!BGE\F%=V258 2U\!QL1#X,8GSQL^_A8G
MS'?C,[X^7-T9K"1<^U1'*[9D3%O?)>=)C<71"1)3A^+"H8KJC.3&KCLCJ<NG
M+;G5UG/K\_1N)/*I"TW2G'VR8_+".;F^'9WRC+%](6.J/4]NH]0-:]MA6]*6
MK:>M1TI<C+T8K"@)08SXKI4O<]S"JUENN0CC4'?694LVLO5LE"<EQKR!XT2$
M^9*@& 7^/[Q6!"16'KS9U9-KJ$V1I"9;WZO>X@C_EOA:HK,E"=F#4TTJR2JV
MGE7:3*J)76WT;%/5.^:"3I/@7&'Q>+]8_KU%$IG3>,2PPY3YXE E(DSUF\ B
M-]%^=$EQCI[B1IZ7ED,4M%L83I7?+!V].9+>'#V]/5+L^6ZZ3]"ZL,CME)+1
MU[D@2='1]WY/6S%9.<4^;A -T1FXNQMK)JTCF= Y59/F%'ZXT[-=BWETXU1I
M38U>M_#"1(CI.GW;)@;IWB3[I?1P]_!&SRA]C^7H_HUY,385]R?FQ51U?V9>
MW&;O\<AAL]>*[A%=BZ.= *^X"\9YG\="LS=UL@M&MNEK'"^$,1*F7S<8\>9'
M"/#G*\*SDE^( 0[O2UW_!U!+ P04    " !F?6-3C3%&I ,#  "U#   &0
M 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6S%5]MNXC 0_14K3[L2)7&X%"I
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M!XZ#*=(00F['-8LT8% [8&Q=!VK2! 8^]&J_1@8S3/HP-"<7[759[=@YON]
M3?#46R.#2=^F4',)M7/IA,:CC'1 YOK/NL'&<D*09AUJ;]Z.[3R0H7=3>^W7
M)1K;-]MO+-+81)]A,TF8F$4T!BNZ8N+X$Z1)B?RN3Y#&(&K'H/4$-9E'$,9N
M8^>;=DCU+GU+1X<T(%$[($\X0TU$A@V931MLVWK-4-3.T%,.4;/%JS?O!I,+
M&XJPIB]N;P&//46XV0#F^QV2^J#6M%/[[4%D$:I1CC]#N5AQ024#4ZY&[:./
M$=94QIT/OWO3[Q?'WR88,?)AO3P-9A"Y.+#TGUA#%'<U >,F'^L5:C"!@:43
MP1J@N+,9&!L&W* NTC0H6P8)K!&,NQF#L:%51;Y;;SP,9FJ_/8(M.C7.<3O.
M7R\GE^ 'WS"1YL5]ZEG2=,9=S\A88Q5_:4H>X28@0Q_V&X0R3-/$M\TK1).4
M=#1,CXB!D765!IO HE CE'0U;H^(8=R&=8D&&POFB88PZ60B'Y5A_(/-5B-Y
M7:-A<"<^MG0?1/.<M//<=HZ.FN?)WO]/=CW/$\U5\K5YGIPTSQ.-2-+5/$^.
MG^>))A_I;)XG1\_S1 .1=#//EV'\P^PWYGEG[T5(_A;J@8HWE4T0LX7R<R\#
M)5[L7NSL;B1?%>]&IEQ*GA272T;G3.0&ZOL%Y_+C)G_=4KU>&_X/4$L#!!0
M   ( &9]8U-%RBA;$P0  .X/   9    >&PO=V]R:W-H965T<R]S:&5E=#4X
M+GAM;*U7;7.C-A#^*QKF/MS-7 ("9$/&]DR,W6FGO383Y]K/BI$-$T!4DN/<
MOZ\D"#A")IFKO]B\//M(S^ZRJYT=*7OB&2$"O)1%Q>=.)D1]X[I\FY$2\VM:
MDTJ^V5%68B%OV=[E-2,XU49EX?J>-W%+G%?.8J:?W;'%C!Y$D5?DC@%^*$O,
M?BQ)08]S!SJO#^[S?2;4 W<QJ_&>;(CX7M\Q>>=V+&E>DHKGM *,[.;.+;Q9
MPT@9:,3?.3GRDVN@I#Q2^J1N?DOGCJ=V1 JR%8H"R[]GDI"B4$QR'_^VI$ZW
MIC(\O7YE_T6+EV(>,2<)+?[)4Y'-G<@!*=GA0R'NZ?%7T@I"BF]+"ZY_P;'%
M>@[8'KB@96LL=U#F5?./7UI'G!A('KN!WQKXID%XQB!H#8*/KA"V!N%'5T"M
M@9;N-MJUXU98X,6,T2-@"BW9U(7VOK:6_LHKE2@;P>3;7-J)Q>;AK^1W</?'
M[9\;< 4V,@_30T$ W8&-H-LGL)1!2$%"2YF9'.O8KE_4->'@\XH(G!?\B[3\
MOEF!SY^^@$\@K\!#1@\<5RF?N4+N4:WD;MO]+)O]^&?V$X!OM!(9!^LJ):G%
M?C5N'X_8N](WG8/\5P<M_5'"#:FO0>!]!;[G0\M^DH^;>S8Y_V_U]4^O_L89
M09<M@>8+SO%EF)&K84Z,4(<==:BIPW/4*MVN'C7U]C3=2)-NME1J&">:457$
MYP7TIE$X<Y]/ V1#Q<A K8:H  9H\A:U'J+\V/-[KC?242<=C7OUG/0=H^7-
MB&\GW0*3]WT+:*U(K=]D8XY.9$U"%!E^'(*F,(*&&X<@&"-O:KC1AIK&R.[&
M::=R.JKRGG#!\JV07N1:\*'*A57N=+!\"'TCU,D0%"#D&W*'( CAQ,BM]1 5
MH2BVJXTZM=&HVG59%_0'(:W6^L"VF<P@4!>XLFF.!GN09PE#L@7CFP$>8B81
M,O1:,*%GEQMW<N-1N0]4X,*F*QY&P%(#;*AA#1BB;#5@B!JI =#K&[$WJC"A
M7*B^NZ<TY8#38JQ[P9/^#B]=LJ'?D_L7+]HMY9M8(&A\6(D5%1JA6%E08>C'
M1L!L* ^=24C8]T(8O%=O")9?'9 G'7DV?9:'[EH>H<689_MN",.+AZWO-Q!=
M/FS(4NK,;R.QH4+/K"$65(!B:(;-@HK#<]]9WPOA.\U0#B5YM?\*]J0B#!<Z
M?#B59^M<]@^LYI8Q)_?="$XO'L&^^,/QZO]3$8P&AY=(-BLS@A:49S;PE07E
M!T%@EDH;#'J!^>FY)_-+2=A>#XY<"CM4HCF<=D^[X?16CV3&\R6\2:#E^4H-
MLWI>ZNF;2?@;9ON\XJ @.[F4=SV5Z<::X;*Y$;36T],C%7(6TY>9',@)4P#Y
M?D>I>+U1"W0C_N(_4$L#!!0    ( &9]8U/R$T#C800  %82   9    >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;*68[V^;.!B _Q4KN@^== -L?D]II+;;
M[DYW6ZMF[3Z[P4FL L[93M))]\?/A@33 A[)?4F X->/7_P^)I[N&7\6:T(D
M>"GR4EQ.UE)N/KBN6*Q)@87#-J14ORP9+[!4IWSEB@TG.*L:%;F+/"]R"TS+
MR6Q:7;OCLRG;RIR6Y(X#L2T*S']<DYSM+R=P<KQP3U=KJ2^XL^D&K\B<R(?-
M'5=G;A,EHP4I!64EX&1Y.;F"'ZY1JAM4=SQ2LA>M8Z"'\L38LS[Y*[N<>)J(
MY&0A=0BLOG;DAN2YCJ0X_CT$G31]ZH;MXV/TS]7@U6">L" W+/].,[F^G"03
MD)$EWN;RGNW_)(<!A3K>@N6B^@3[^M[8FX#%5DA6'!HK@H*6]3=^.22BU< ?
M:H .#5#%77=447[$$L^FG.T!UW>K:/J@&FK56L'14C^5N>3J5ZK:R=G\V^W-
MW^#NGZNO<_ >S-5#S[8Y 6P)YI(MGL&U&G$&;EBAIH' 52*O="*I_ $N/A*)
M:2[>35VI4'1 =W'H]KKN%@UTFX(OK)1K 3Z5&<E>MW?5$)IQH.,XKI$UX)QL
M'.![OP/D(?@;<(%88TY$_6F)[S=Y\JOX_D#\K]OBB7"=E]N-SH(M9M#$#*J8
MP4#,VZT4$I<9+5?@B:QH6>HCU<6&<,HR<$'+PS#>@?] WU#JS-2]A%4ON@IW
MLPCY(83)U-WUX(4-7FC%^X/C4I+Q&&$'(XY2/T3]%%%#$5DI/KT0OJ#B!(ZH
MP_$^#'T/^?T@<0,26T&4!):$GI*0N N"_"2)PGZ0I %)?I&1#>4G8"1=C  %
M,.JG2!N*=/3D)65VQK1-N],6QAZ,!L"@9Y3F66OU>Z5BE:&K'>%J:0''.03N
M.%T02^7"EC;A_Z[=C.4YYD)?JM.@\V'<U&O-NM>DE90@=-*!2H;(X*+1M7P.
M5AT=!J\>EN,/E!0T5H7^"=5]#IG?)?,#)Q@B,VZ&=CF_+O=SR((N61 Y,!T@
M,UJ&=B^WZ_\<KK#+%4=.-.!I:$0-[:9NEP26/5(X!S;JUD/BQ'" U;@<VF5^
M3X14+M"/MW[/>2BI%.#B?O[P]G7F=0]&TC 9^<)0A;;%-,J%=N<^E#O%K9A5
M>GNE,T:[L.O=-(R#<*!BD-$N\L8Y9@S%(5:;(O!@$@RLC<B(&=G%_%AG:!P$
M["Z-ZD4!H0'?(N-;9/=MRQZC0% 7!,(@'"I*9 2+[()M3YDW%3D*S.].E@"%
MWE""C%Y1<-H:7<T>H/[#$/ 94PX><;ZU+=7(^!+9??G+JMF*[!0G';I+7GO=
M#P928OR)[/YLZN=4GJAW<1XL:"-)9)?DL91.Y8E[%K[ 2>(!'J-49'_Q;175
MJ4A)#U+JI$.V,49&XXW\IKQ.14P[LRI$3O*6T&W]U2\(7U4;&@(LV+:4];_^
MYFJS:7)5;Q68V^L=ER^8JV(0("=+U=1S8C6O>;V)49](MJDV#IZ8E*RH#M<$
M9X3K&]3O2\;D\41WT&PES7X"4$L#!!0    ( &9]8U.[?)7?+0,  !$)   9
M    >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;*U6VX[3,!#]E5$$$DC0W'I;
MU%;:+2!NNT1;+L_>9-)8Z]C!=EI ?#RVDZ8%TL #?4AMQ^?,F1E[)HN]D/>J
M0-3PM61<+;U"Z^J9[ZNTP)*HD:B0FS>YD"719BJWOJHDDLR!2N9'03#U2T*Y
MMUJXM42N%J+6C'),)*BZ+(G\=H5,[)=>Z!T6;NFVT';!7RTJLL4-ZH]5(LW,
M[U@R6B)75'"0F"^]R_#9.G0 M^,3Q;TZ&8-UY4Z(>SMYG2V]P"I"AJFV%,3\
M[7"-C%DFH^-+2^IU-BWP='Q@?^F<-\[<$85KP3[33!=+;^Y!ACFIF;X5^U?8
M.C2Q?*E@RCUAW^R=FLUIK;0H6[!14%+>_).O;2!. %%P!A"U@.@WP'A\!A"W
M@-@YVBAS;CTGFJP64NQ!VMV&S0Y<;!S:>$.Y3>-&2_.6&IQ>;3Z\7[^%Y-WE
MS0:>P@V1DMBXPJ/GJ EEZO'"U\:,W>RG+>550QF=H0SA6G!=*'C!,\QZ\.MA
M_,4 WC?N=3Y&!Q^OHD'"-S4?01P\@2B(0E40B:I/U3#)!JLCB<ASE)1O$_,4
MV0/PH:'M(_]%<MRE)7;6XG/6M$COX35/D;MT)(SP(=YQQSMVO.,SO#=U>8<2
M1 XDRZB]2(2UVNUB*LK2W"WEK)-:%T+2[YB!*1= E:J)$=1W(!JC$V?4%H[=
M*IP$]K?P=SUJ)YW:R:#:S^X2&OMDA](4%<@)E; CK#8'E'+(!&-$*JB,2\Z)
MQ_ #CMGH2W)C<'ZB-)J-XFF_SFFG<SJH,ZEE6IA: I6D*?X>R"?P8I,D\(@H
M(%:JS6G?M5H/&YE/1D'P<. ,S#JULT&B39-NFT\3VMI<,@E85DQ\0VQ37W4.
MF7/G0MU$M%?V[(_DQV$4GTG]O!,Y'Q1I0S;@ZT5'<_%?[U$8'.MF\(\WZ5 ,
M;&Y--5#NMKB4_X!?"T5O+0S^"%_4'[KPI*:'?PW>(8='8;W6AXFF4+I2W!<Q
M_Z3IE"BWKA<K<_)KKIO^TZUV_?[2=3G_N+WY6+@F<DNY H:Y@0:CF8F&;/IO
M,]&B<BWL3FC3$-VP,-\L*.T&\SX70A\FUD#W%;3Z"5!+ P04    " !F?6-3
MZK*A+Y$"   5!P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6RME6UO
MVC 0Q[_**=*D3MI(" ^%"I"@[;2JZXK*UKUVXPNQ\$-F.Z5\^]D.9$PJ$2_V
M)O'#W>_^/MOGR5;IC2D0+;P)+LTT*JPMK^+89 4*8CJJ1.EF<J4%L:ZKU[$I
M-1(:G 2/TR09QH(P&<TF86RI9Q-56<XD+C682@BB=POD:CN-NM%AX(FM"^L'
MXMFD)&M<H?U9+K7KQ0V%,H'2,"5!8SZ-YMVKQ=C;!X-GAEMSU :_DA>E-KYS
M1Z=1X@4AQ\QZ G&_5[Q&SCW(R?B]9T9-2.]XW#[0OX2UN[6\$(/7BO]BU!;3
M:!0!Q9Q4W#ZI[5?<KV?@>9GB)GQA6]L.G'%6&:O$WMDI$$S6?_*VS\.10]H[
MX9#N'=*@NPX45-X02V83K;:@O;6C^498:O!VXICTF[*RVLTRYV=GJQ^/U_>P
M_#;_OH+/L')[3BN.H')X)KPB(7-SX[:L]$T#%S=H">/FXR2V+KR'Q-D^U*(.
ME9X(-88')6UAX%92I/_ZQTYVHST]:%^DK< 5EAWH)9\@3=)N"Z_7Y*(7>+U3
M/*NR#=S)#*4_*K#D1)H6;K_A]@.W?X)[^U:Z,X@4*'ME%"6%'4-.X8(8(%"B
M]@'?36@[-^DDR8<6?8-&WZ!=GRBYVB%"G8#'L-4MW&'#'?[7?%XVW,M6O4_,
M;"#73C"3%C4:"YI8/".?[=RD,TK;\CEJ](W.V^]7Q=T-XLSNSM#6SNR/.^FP
M3=RX$3<^3YS+G/#W7!UN-I.P0Z+?O]KMT$'M"0,0]17O B6[]]3&1Z5*H%Z'
M@FP@4Y6T==5J1IN:/Z]+W5_S^L%X('K-G'".N7--.I?NE.NZ"-<=J\I0^%Z4
M=64T- OW;J'V!FX^5\H>.CY \Q+._@!02P,$%     @ 9GUC4W?^Z6X%!
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MH> ;(C0:O>F%J;YA8[URIL_)3 E\FB-/C>^_3KX]3,GSS<_IC'PB,SR'Z;H
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MM7DRLFA)Q42+W%7UM="F1[AA:MHX2GO ["?"W$DYL0:J/P:#/U!+ P04
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MA4VF16/XC)NRS[7$MPQQ>AC>3:>3Q70\6\S)]6Q$PKO98C+[/)Z%D_&<'(]
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MV_8W&%X0-=M^G8N)A*YH,JZ[<CZMFHYNZ*SU 81]Y+8Z[ C&,9@= 0S+@SG
M.(:%Y?F?QM-'QV,PS%O?BO113A_E&)8-&5<?+(^=$^O#/M(X#L,HPF9T/+8Z
M&&/S%D7PM:MAWH"!Y8%,+YMK?+7Q"CE<!]B:'JH0;*1X)6(CQ><:$/N\ 2..
M[:N-Y0$&M@I8[4!^>QZH*3LG#&%5,6_8'8PC<8PA4(OV&HTB9'8B^-C7![M+
MPC".[0A@=@=AB"%P-^((Y@ \8$@85N_!O?>1MWE/>=O?:T=_ %!+ P04
M" !F?6-3EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M#4#:)X'DB?Z8T=" = !(YX20K4BZ *1[2DC;@/0 2.^4D(X!^0F _'1*2->
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MIS'A7_W8S*H6E.0MY"3_C)?XWUI)PX(RO84^?IC-:-ST@;D?)Z%^LB8:.&A
M'S7,9BQI^F23TG0)E+#PFNH>VXX?I  +60%\<<5U1]"0I%9X*WU8D TL9!N
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MY"P"  #V*   &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=I+3N-
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M_RGKO7/K/XX?GV5GF_XMGXW_$5R\ %!+ 0(4 Q0    ( &9]8U,'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ 9GUC4_6Q1ISO    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ 9GUC4YE<G",0!@  G"<  !,
M         ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !F
M?6-3)7BUZE(%  !]%0  &               @($."   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ 9GUC4RH6$I#9!@  B!P  !@
M         ("!E@T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( &9]8U.N<.[PZ (  ,4)   8              " @:44  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !F?6-3YOP-)4T'  "*'P
M&               @('#%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ 9GUC4_!,4'=X P    L  !@              ("!1A\  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( &9]8U.;EM^L2P@
M *XL   8              " @?0B  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " !F?6-3(#R1490(  #:)   &               @(%U
M*P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ 9GUC4\XR
MA#%K @  >04  !@              ("!/S0  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( &9]8U/1?WPF6@H  %T7   8
M  " @> V  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !F
M?6-3!LA6&10*  "Y&   &0              @(%P00  >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( &9]8U/67]TQR@@  -85   9
M          " @;M+  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#
M%     @ 9GUC4X8N2C^$ @  ,04  !D              ("!O%0  'AL+W=O
M<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !F?6-3(MNK138$  !(
M"@  &0              @(%W5P  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM
M;%!+ 0(4 Q0    ( &9]8U-:!P[]T04  &$-   9              " @>1;
M  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ 9GUC4X4U
MW%$;!@  FPX  !D              ("![&$  'AL+W=O<FMS:&5E=',O<VAE
M970Q-2YX;6Q02P$"% ,4    " !F?6-3?3":HAL2  #A00  &0
M    @($^:   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M &9]8U-10A=#D1(  #XX   9              " @9!Z  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ 9GUC4UPK+K^ !@  E0X  !D
M             ("!6(T  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " !F?6-3%LF#J"X#   !!P  &0              @($/E   >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( &9]8U.]L8"C^P4
M *X/   9              " @727  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ 9GUC4X&19[16!   D0H  !D              ("!
MIIT  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !F?6-3
MCZI;9 4%    #   &0              @($SH@  >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( &9]8U.@M^#;*PD  "@5   9
M      " @6^G  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ 9GUC4UA.;XQ%!P  T1   !D              ("!T;   'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !F?6-3/R"5U:\(  !U%@
M&0              @(%-N   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( &9]8U/*9&2BL0(  .D%   9              " @3/!  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 9GUC4YWH19C8
M @  ZP4  !D              ("!&\0  'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " !F?6-3-3T!\)("  !(!0  &0
M@($JQP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( &9]
M8U. K9=/' ,  $0&   9              " @?/)  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ 9GUC4W>X+U6)!   80L  !D
M         ("!1LT  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " !F?6-3XSD'SQ<#  "#!@  &0              @($&T@  >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( &9]8U/8VAQU% 0  .L)
M   9              " @535  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ 9GUC4Q2#Q\6]!@  JA$  !D              ("!G]D
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !F?6-3C">2
M:W0%  "A#   &0              @(&3X   >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    ( &9]8U/K:SY/,0,  .T&   9
M  " @3[F  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
M9GUC4TG@#\M)!   I H  !D              ("!IND  'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " !F?6-3^;'+0:,"  "V!0  &0
M            @($F[@  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( &9]8U,1'+=M7P,  ((*   9              " @0#Q  !X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ 9GUC4V/:1_9" P
M$@X  !D              ("!EO0  'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " !F?6-3J,UT6R4#  "["0  &0              @($/
M^   >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( &9]8U,/
MS_WH"@0  %@1   9              " @6O[  !X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ 9GUC4\=;;ZYP @  * 8  !D
M     ("!K/\  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &9]8U,&IV3-A (  *0&   9              "
M@:<0 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ 9GUC
M4[6PEL^0!   'Q$  !D              ("!8A,! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " !F?6-3=8.0$6H#  #C"@  &0
M        @($I& $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( &9]8U,F(R5/AP@  (,N   9              " @<H; 0!X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ 9GUC4_YS-U.3 P  4PT
M !D              ("!B"0! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    " !F?6-3:A[PE8H#  "]"P  &0              @(%2* $
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( &9]8U-FH-%J
M/P8  !TD   9              " @1,L 0!X;"]W;W)K<VAE971S+W-H965T
M-3,N>&UL4$L! A0#%     @ 9GUC4ZW?O69"!P  .R4  !D
M ("!B3(! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " !F
M?6-3C3%&I ,#  "U#   &0              @($".@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( &9]8U.8K U550,  ' )   9
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M970V,"YX;6Q02P$"% ,4    " !F?6-3ZK*A+Y$"   5!P  &0
M    @(& 4@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    (
M &9]8U-W_NEN!00  $ .   9              " @4A5 0!X;"]W;W)K<VAE
M971S+W-H965T-C(N>&UL4$L! A0#%     @ 9GUC4[8_Y3>S!   R1(  !D
M             ("!A%D! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"
M% ,4    " !F?6-3%O8G9"\#   V"P  &0              @(%N7@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( &9]8U/W>Z/KZ (
M )0(   9              " @=1A 0!X;"]W;W)K<VAE971S+W-H965T-C4N
M>&UL4$L! A0#%     @ 9GUC4_YBSS.S @  90<  !D              ("!
M\V0! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    " !F?6-3
M*_S9;.$"   D"   &0              @('=9P$ >&PO=V]R:W-H965T<R]S
M:&5E=#8W+GAM;%!+ 0(4 Q0    ( &9]8U,VUQ'RW (  #0(   9
M      " @?5J 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%
M  @ 9GUC4P5@P>7J @  ] <  !D              ("!"&X! 'AL+W=O<FMS
M:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " !F?6-325Y?QTP#  "\%0
M#0              @ $I<0$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &9]
M8U.7BKL<P    !,"   +              "  :!T 0!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( &9]8U-[YMC3-04   TM   /              "  8EU 0!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !F?6-3EW=RY"P"  #V*   &@
M            @ 'K>@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " !F?6-3UD@C+O<!   K*   $P              @ %/?0$ 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     30!- !(5  !W?P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>257</ContextCount>
  <ElementCount>405</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>81</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1406401 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - FIXED ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETS</Role>
      <ShortName>FIXED ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2117106 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2127108 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2132109 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2139110 - Disclosure - STOCK PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANS</Role>
      <ShortName>STOCK PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2145111 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2148112 - Disclosure - NET INCOME (LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHARE</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2152113 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2156114 - Disclosure - COMMERCIAL PARTNERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/COMMERCIALPARTNERS</Role>
      <ShortName>COMMERCIAL PARTNERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2158115 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2160116 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/REVENUE</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INVENTORIES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2315304 - Disclosure - FIXED ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETSTables</Role>
      <ShortName>FIXED ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FIXEDASSETS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2318305 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/LEASES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2324306 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2328307 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/DEBT</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2333308 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2340309 - Disclosure - STOCK PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSTables</Role>
      <ShortName>STOCK PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKPLANS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2346310 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2349311 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARE</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2353312 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INCOMETAXES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2402402 - Disclosure - DESCRIPTION OF BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/DESCRIPTIONOFBUSINESS</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - REVENUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/REVENUEDetails</Role>
      <ShortName>REVENUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/REVENUETables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/INVENTORIESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - FIXED ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FIXEDASSETSDetails</Role>
      <ShortName>FIXED ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/FIXEDASSETSTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2419408 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails</Role>
      <ShortName>LEASES - Summary of operating lease cost and other operating lease information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails</Role>
      <ShortName>LEASES - Schedule of maturities of operating lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails</Role>
      <ShortName>LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets Acquired During Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets Acquired During Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - DEBT - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTScheduleofDebtDetails</Role>
      <ShortName>DEBT - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - DEBT - Schedule of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails</Role>
      <ShortName>DEBT - Schedule of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2435418 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2436419 - Disclosure - FINANICIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails</Role>
      <ShortName>FINANICIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2437420 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2438421 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available For Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Schedule of Available For Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2441422 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2442423 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2443424 - Disclosure - STOCK PLANS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSNarrativeDetails</Role>
      <ShortName>STOCK PLANS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2444425 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails</Role>
      <ShortName>STOCK PLANS - Schedule of Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2447426 - Disclosure - STOCKHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2450427 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2451428 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/NETINCOMELOSSPERSHARETables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2454429 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2455430 - Disclosure - INCOME TAXES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2457431 - Disclosure - COMMERCIAL PARTNERS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/COMMERCIALPARTNERSDetails</Role>
      <ShortName>COMMERCIAL PARTNERS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/COMMERCIALPARTNERS</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2459432 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="pcrx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2461433 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacira.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.pacira.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="pcrx-20210930.htm">pcrx-20210930.htm</File>
    <File>pcrx-20210930.xsd</File>
    <File>pcrx-20210930_cal.xml</File>
    <File>pcrx-20210930_def.xml</File>
    <File>pcrx-20210930_lab.xml</File>
    <File>pcrx-20210930_pre.xml</File>
    <File>pcrx-9302021xex311.htm</File>
    <File>pcrx-9302021xex312.htm</File>
    <File>pcrx-9302021xex321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pcrx-20210930_g1.jpg</File>
    <File>pcrx-20210930_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>88
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pcrx-20210930.htm": {
   "axisCustom": 3,
   "axisStandard": 28,
   "contextCount": 257,
   "dts": {
    "calculationLink": {
     "local": [
      "pcrx-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pcrx-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pcrx-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pcrx-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pcrx-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pcrx-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 574,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://www.pacira.com/20210930": 4,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 11
   },
   "keyCustom": 54,
   "keyStandard": 351,
   "memberCustom": 35,
   "memberStandard": 42,
   "nsprefix": "pcrx",
   "nsuri": "http://www.pacira.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.pacira.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - REVENUE",
     "role": "http://www.pacira.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - INVENTORIES",
     "role": "http://www.pacira.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - FIXED ASSETS",
     "role": "http://www.pacira.com/role/FIXEDASSETS",
     "shortName": "FIXED ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117106 - Disclosure - LEASES",
     "role": "http://www.pacira.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127108 - Disclosure - DEBT",
     "role": "http://www.pacira.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132109 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139110 - Disclosure - STOCK PLANS",
     "role": "http://www.pacira.com/role/STOCKPLANS",
     "shortName": "STOCK PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145111 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148112 - Disclosure - NET INCOME (LOSS) PER SHARE",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHARE",
     "shortName": "NET INCOME (LOSS) PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152113 - Disclosure - INCOME TAXES",
     "role": "http://www.pacira.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:CommercialPartnersAndAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156114 - Disclosure - COMMERCIAL PARTNERS",
     "role": "http://www.pacira.com/role/COMMERCIALPARTNERS",
     "shortName": "COMMERCIAL PARTNERS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:CommercialPartnersAndAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158115 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160116 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.pacira.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - REVENUE (Tables)",
     "role": "http://www.pacira.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.pacira.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315304 - Disclosure - FIXED ASSETS (Tables)",
     "role": "http://www.pacira.com/role/FIXEDASSETSTables",
     "shortName": "FIXED ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318305 - Disclosure - LEASES (Tables)",
     "role": "http://www.pacira.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324306 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328307 - Disclosure - DEBT (Tables)",
     "role": "http://www.pacira.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333308 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340309 - Disclosure - STOCK PLANS (Tables)",
     "role": "http://www.pacira.com/role/STOCKPLANSTables",
     "shortName": "STOCK PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346310 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349311 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables",
     "shortName": "NET INCOME (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353312 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.pacira.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402402 - Disclosure - DESCRIPTION OF BUSINESS (Details)",
     "role": "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
     "shortName": "DESCRIPTION OF BUSINESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i766f22ea0ac24a77a51e08e7ca35945f_D20210701-20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk of Major Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i766f22ea0ac24a77a51e08e7ca35945f_D20210701-20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "ic42c474800e04fb4a3a3b9d2f8401c54_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)",
     "role": "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - REVENUE (Details)",
     "role": "http://www.pacira.com/role/REVENUEDetails",
     "shortName": "REVENUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "ib583d9b057b942b68b4eaeb985e512fd_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - INVENTORIES (Details)",
     "role": "http://www.pacira.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - FIXED ASSETS (Details)",
     "role": "http://www.pacira.com/role/FIXEDASSETSDetails",
     "shortName": "FIXED ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i39c6077ecfb343b7b02e61046eb86e03_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419408 - Disclosure - LEASES - Narrative (Details)",
     "role": "http://www.pacira.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - LEASES - Summary of operating lease cost and other operating lease information (Details)",
     "role": "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails",
     "shortName": "LEASES - Summary of operating lease cost and other operating lease information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - LEASES - Schedule of maturities of operating lease liabilities (Details)",
     "role": "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails",
     "shortName": "LEASES - Schedule of maturities of operating lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)",
     "role": "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails",
     "shortName": "LEASES -Schedule of maturities of operating lease liabilities (lease not yet commenced) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets Acquired During Period (Details)",
     "role": "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets Acquired During Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i1b7eaae33ec24855a33a6d8666ef2cf6_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:SettlementPeriodConvertibleDebtConversionRequest",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - DEBT - Narrative (Details)",
     "role": "http://www.pacira.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pcrx:SettlementPeriodConvertibleDebtConversionRequest",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "ic42c474800e04fb4a3a3b9d2f8401c54_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - DEBT - Schedule of Debt (Details)",
     "role": "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
     "shortName": "DEBT - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "ic42c474800e04fb4a3a3b9d2f8401c54_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - DEBT - Schedule of Interest Expense (Details)",
     "role": "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails",
     "shortName": "DEBT - Schedule of Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pcrx:ScheduleOfInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2333c4061860489582acbe97375bee03_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NotesReceivableFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Fair Value of Liabilities Measured on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2333c4061860489582acbe97375bee03_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NotesReceivableFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:ContingentConsiderationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435418 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pcrx:MilestonePayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "ibfac6863101f4d0cbbcb816ebbd63709_I20210930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436419 - Disclosure - FINANICIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)",
     "role": "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
     "shortName": "FINANICIAL INSTRUMENTS - Fair Value Measurement Inputs and Valuation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i4fba2629f05d45e2a951a1a3b00a7381_I20210930",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "iad8f7b4b2d424119bbbb3f917cb3b346_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437420 - Disclosure - FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Fair Value of Contingent Consideration Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "iad8f7b4b2d424119bbbb3f917cb3b346_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438421 - Disclosure - FINANCIAL INSTRUMENTS - Schedule of Available For Sale Securities (Details)",
     "role": "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Schedule of Available For Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i2b38381b6d0a45889401a583757402a5_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441422 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails",
     "shortName": "STOCK PLANS - Schedule of Stock Based Compensation Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i39c6077ecfb343b7b02e61046eb86e03_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442423 - Disclosure - STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
     "shortName": "STOCK PLANS - Schedule of Stock Based Compensation Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i39c6077ecfb343b7b02e61046eb86e03_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i4956ecea465b41aca59fcfcd35dcac46_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i4956ecea465b41aca59fcfcd35dcac46_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i7e0a781126c0441dacaff2fa6d34f7a5_D20210601-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443424 - Disclosure - STOCK PLANS - Narrative (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
     "shortName": "STOCK PLANS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i7e0a781126c0441dacaff2fa6d34f7a5_D20210601-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444425 - Disclosure - STOCK PLANS - Schedule of Valuation Assumptions (Details)",
     "role": "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails",
     "shortName": "STOCK PLANS - Schedule of Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i8495ec90002a45e0bf0887939ab74508_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447426 - Disclosure - STOCKHOLDERS' EQUITY (Details)",
     "role": "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450427 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
     "shortName": "NET INCOME (LOSS) PER SHARE - Schedule of Computation of EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451428 - Disclosure - NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)",
     "role": "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
     "shortName": "NET INCOME (LOSS) PER SHARE - Schedule of Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454429 - Disclosure - INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)",
     "role": "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Schedule of Federal, State and Local, and Foreign Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i9ad8b62d837c467891400496ee94d66b_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455430 - Disclosure - INCOME TAXES - Narrative (Details)",
     "role": "http://www.pacira.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i84c3ad13f8e54c46b927d50478630682_D20210601-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:CollaborativeArrangementUpfrontPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457431 - Disclosure - COMMERCIAL PARTNERS (Details)",
     "role": "http://www.pacira.com/role/COMMERCIALPARTNERSDetails",
     "shortName": "COMMERCIAL PARTNERS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i84c3ad13f8e54c46b927d50478630682_D20210601-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "pcrx:CollaborativeArrangementUpfrontPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i8646cd5d4ebd458eab95c35c7d751c0e_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459432 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "ib40c1bb9a8fc4a669685de4cfb5bf7b9_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i8c3443c6210e4129b77b12cacc1af29e_I20211022",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionSharePrice",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461433 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "ie0268792e6564110bccd672d24ff62fc_D20211022-20211022",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930",
      "decimals": "-4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1406401 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "role": "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "if2bcdbc90e5b467e9932a815219ab0c7_D20200701-20200930",
      "decimals": "-4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://www.pacira.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pcrx-20210930.htm",
      "contextRef": "i3614c786a0bb4b519909ca9e28898780_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 81,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.pacira.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pcrx_A2022ConvertibleSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Convertible Senior Notes",
        "label": "2022 Convertible Senior Notes [Member]",
        "terseLabel": "Convertible Senior Notes Due 2022"
       }
      }
     },
     "localname": "A2022ConvertibleSeniorNotesMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_AccountsReceivablePaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Payment Terms",
        "label": "Accounts Receivable, Payment Terms",
        "terseLabel": "Accounts receivable, payment terms"
       }
      }
     },
     "localname": "AccountsReceivablePaymentTerms",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_AchievementOfDevelopmentAndCommercialMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the achievement of development and commercial events on the basis of which certain milestones are achieved.",
        "label": "Achievement of Development and Commercial Milestones [Member]",
        "terseLabel": "Achievement of Development and Commercial Milestones"
       }
      }
     },
     "localname": "AchievementOfDevelopmentAndCommercialMilestonesMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_AchievementOfMilestoneAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by categories of milestones achieved.",
        "label": "Achievement of Milestone [Axis]",
        "terseLabel": "Achievement of Milestone [Axis]"
       }
      }
     },
     "localname": "AchievementOfMilestoneAxis",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_AchievementOfMilestoneDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different categories of achievement of milestones.",
        "label": "Achievement of Milestone [Domain]",
        "terseLabel": "Achievement of Milestone [Domain]"
       }
      }
     },
     "localname": "AchievementOfMilestoneDomain",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_AchievementofRegulatoryMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Achievement of Regulatory Milestone [Member]",
        "label": "Achievement of Regulatory Milestone [Member]",
        "terseLabel": "Achievement of Regulatory Milestone"
       }
      }
     },
     "localname": "AchievementofRegulatoryMilestoneMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net",
        "label": "Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net",
        "negatedLabel": "Acquisition-related Gain (Loss), Product Discontinuation Costs, and Other, Net"
       }
      }
     },
     "localname": "AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition.",
        "label": "Agreed Milestone Payments for Sale of Product in Connection with Acquisition",
        "terseLabel": "Milestone payments for EXPAREL agreed in connection with acquisition"
       }
      }
     },
     "localname": "AgreedMilestonePaymentsForSaleOfProductInConnectionWithAcquisition",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AmortizationOfOtherAssetsAndUnfavorableLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amortization of deferred financing costs and unfavorable lease obligations. Deferred financing costs are amortized over the term of the associated financing arrangement. Unfavorable lease obligations are determined based on the fair value of a lease compared to the acquired lease terms in connection with a business combination, which are amortized over the remaining lease term.",
        "label": "Amortization of Other Assets and Unfavorable Lease Obligation",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfOtherAssetsAndUnfavorableLeaseObligation",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Period of Transaction Costs Attributable to Liability Component of Convertible Debt",
        "label": "Amortization Period of Transaction Costs Attributable to Liability Component of Convertible Debt",
        "terseLabel": "Amortization period of transaction costs attributable to liability component of convertible debt"
       }
      }
     },
     "localname": "AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition.",
        "label": "Annual Net Sales Threshold for Determining Milestone Payments for Product in Connection with Acquisition",
        "terseLabel": "Annual net sales threshold"
       }
      }
     },
     "localname": "AnnualNetSalesThresholdForDeterminingMilestonePaymentsForProductInConnectionWithAcquisition",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of presentation and principles of consolidation.",
        "label": "Basis of Presentation and Principles of Consolidation [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Maximum Additional Contingent Payment, If Circumstances Met, Share Price",
        "label": "Business Acquisition, Maximum Additional Contingent Payment, If Circumstances Met, Share Price",
        "terseLabel": "Additional contingent payment, per Flexion Share, share price",
        "verboseLabel": "Additional contingent payment, share price"
       }
      }
     },
     "localname": "BusinessAcquisitionMaximumAdditionalContingentPaymentIfCircumstancesMetSharePrice",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pcrx_BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Covenant Terms, Shares Tendered Combined With Other Shares Owned, Minimum, Percentage",
        "label": "Business Combination, Covenant Terms, Shares Tendered Combined With Other Shares Owned, Minimum, Percentage",
        "terseLabel": "Tendered shares as a percent of Flexion Shares"
       }
      }
     },
     "localname": "BusinessCombinationCovenantTermsSharesTenderedCombinedWithOtherSharesOwnedMinimumPercentage",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pcrx_ClassOfWarrantOrRightNumberOfRightsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Number Of Rights Issued",
        "label": "Class Of Warrant Or Right, Number Of Rights Issued",
        "terseLabel": "Contingent value right, per Flexion Share"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfRightsIssued",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pcrx_CodaBioTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coda BioTherapeutics, Inc",
        "label": "Coda BioTherapeutics, Inc [Member]",
        "terseLabel": "Coda BioTherapeutics, Inc"
       }
      }
     },
     "localname": "CodaBioTherapeuticsIncMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_CollaborativeArrangementMilestonePaymentsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Milestone Payments Received",
        "label": "Collaborative Arrangement, Milestone Payments Received",
        "terseLabel": "Milestone payment received"
       }
      }
     },
     "localname": "CollaborativeArrangementMilestonePaymentsReceived",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_CollaborativeArrangementUpfrontPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Upfront Payment",
        "label": "Collaborative Arrangement, Upfront Payment",
        "terseLabel": "Upfront payment to be received"
       }
      }
     },
     "localname": "CollaborativeArrangementUpfrontPayment",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_CollaborativeLicensingAndMilestoneRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Licensing and Milestone Revenue",
        "label": "Collaborative Licensing and Milestone Revenue [Member]",
        "terseLabel": "Collaborative licensing and milestone revenue"
       }
      }
     },
     "localname": "CollaborativeLicensingAndMilestoneRevenueMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_CommercialPartnersAndAgreementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the entire disclosure of commercial agreement and arrangement with third parties.",
        "label": "Commercial Partners and Agreements [Text Block]",
        "verboseLabel": "COMMERCIAL PARTNERS"
       }
      }
     },
     "localname": "CommercialPartnersAndAgreementsTextBlock",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_CompensationExpenseFromEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Expense From Employee Stock Purchase Plan",
        "label": "Compensation Expense From Employee Stock Purchase Plan",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "CompensationExpenseFromEmployeeStockPurchasePlan",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_Compensationexpensefromstockoptionsemployees": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation expense from stock options (employee and board of director awards)",
        "label": "Compensation expense from stock options, employees",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "Compensationexpensefromstockoptionsemployees",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConcentrationRiskNumberOfProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number Of Products",
        "label": "Concentration Risk, Number Of Products",
        "terseLabel": "Concentration of products (in products)"
       }
      }
     },
     "localname": "ConcentrationRiskNumberOfProducts",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_ContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum amount of Contingent Consideration related to the acquisition of a business.",
        "label": "Contingent Consideration",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsideration",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Current",
        "label": "Contingent Consideration, Current",
        "terseLabel": "Contingent consideration",
        "verboseLabel": "Contingent consideration, current"
       }
      }
     },
     "localname": "ContingentConsiderationCurrent",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ContingentConsiderationNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Noncurrent",
        "label": "Contingent Consideration, Noncurrent",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationNoncurrent",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ContingentConsiderationPaymentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Payment Term",
        "label": "Contingent Consideration, Payment Term",
        "terseLabel": "Payment term"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentTerm",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_ConvertibleSeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2022 [Member]",
        "label": "Convertible Senior Notes Due 2022 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2022"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2022Member",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ConvertibleSeniorNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2025",
        "label": "Convertible Senior Notes Due 2025 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2025"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2025Member",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtConversionAndRedemptionTermsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information regarding the conversion and redemption terms of the debt instruments.",
        "label": "Debt Conversion and Redemption Terms [Axis]",
        "terseLabel": "Debt Conversion and Redemption Terms [Axis]"
       }
      }
     },
     "localname": "DebtConversionAndRedemptionTermsAxis",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_DebtConversionAndRedemptionTermsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the conversion and redemption terms of the debt instruments.",
        "label": "Debt Conversion and Redemption Terms [Domain]",
        "terseLabel": "Debt Conversion and Redemption Terms [Domain]"
       }
      }
     },
     "localname": "DebtConversionAndRedemptionTermsDomain",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion Terms Business Day Immediately Preceding February 3, 2020",
        "label": "Debt Conversion Terms Business Day Immediately Preceding February 3, 2020 [Member]",
        "terseLabel": "Debt Conversion Terms Business Day Immediately Preceding February 3, 2020"
       }
      }
     },
     "localname": "DebtConversionTermsBusinessDayImmediatelyPrecedingFebruary32020Member",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion Terms Business Day Immediately Preceding October 1, 2021 [Member]",
        "label": "Debt Conversion Terms Business Day Immediately Preceding October 1, 2021 [Member]",
        "terseLabel": "Conversion terms prior to close of business on business day immediately proceeding October 1, 2021"
       }
      }
     },
     "localname": "DebtConversionTermsBusinessDayImmediatelyPrecedingOctober12021Member",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of trading days prior to the date on which the entity provides notice of redemption during which the closing price of the entity's common stock must exceed the conversion price for the notes to be redeemed.",
        "label": "Debt Instrument Conversion Obligation Number Of Trading Days Prior To Date On Which Entity Provides Notice Of Redemption",
        "terseLabel": "Conversion obligation, number of trading days prior to date of notice of redemption"
       }
      }
     },
     "localname": "DebtInstrumentConversionObligationNumberOfTradingDaysPriorToDateOnWhichEntityProvidesNoticeOfRedemption",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_DebtInstrumentConversionObligationPremiumOnCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument.",
        "label": "Debt Instrument, Conversion Obligation Premium on Common Stock",
        "terseLabel": "Convertible debt, premium on common stock"
       }
      }
     },
     "localname": "DebtInstrumentConversionObligationPremiumOnCommonStock",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentConvertibleAssumedBorrowingRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Assumed Borrowing Rate",
        "label": "Debt Instrument, Convertible, Assumed Borrowing Rate",
        "terseLabel": "Assumed borrowing rate"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleAssumedBorrowingRate",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Carrying Amount of Liability Component",
        "label": "Debt Instrument, Convertible, Carrying Amount of Liability Component",
        "terseLabel": "Convertible debt, carrying amount of liability component"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfLiabilityComponent",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_DebtInstrumentConvertibleConversionPremiumShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Conversion Premium, Shares",
        "label": "Debt Instrument, Convertible, Conversion Premium, Shares",
        "terseLabel": "Debt instrument, convertible, conversion premium (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPremiumShares",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pcrx_DebtInstrumentMarketPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt market price, per $1,000 principal amount.",
        "label": "Debt Instrument, Market Price",
        "terseLabel": "Market price of principal amount of notes"
       }
      }
     },
     "localname": "DebtInstrumentMarketPrice",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pcrx_DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Percentage of Last Reported Sale Price Of Common Stock",
        "label": "Debt Instrument, Percentage of Last Reported Sale Price Of Common Stock",
        "terseLabel": "Percentage of last sale price of common stock"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfLastReportedSalePriceOfCommonStock",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of principal amount used in computation of the redemption price to be paid on conversion of convertible notes.",
        "label": "Debt Instrument, Percentage of Principal Amount for Computation of Redemption Price",
        "terseLabel": "Debt instrument, percentage of principal amount for computation of redemption price"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfPrincipalAmountForComputationOfRedemptionPrice",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pcrx_DebtRedemptionTermsOnOrAfterAugust12023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption Terms on or after August 1, 2023",
        "label": "Debt Redemption Terms on or after August 1, 2023 [Member]",
        "terseLabel": "Debt Redemption Terms on or after August 1, 2023"
       }
      }
     },
     "localname": "DebtRedemptionTermsOnOrAfterAugust12023Member",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DebtRedemptionTermsonorafterApril12020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption Terms on or after April 1, 2020 [Member]",
        "label": "Debt Redemption Terms on or after April 1, 2020 [Member]",
        "terseLabel": "Debt Redemption Terms on or after April 1, 2020"
       }
      }
     },
     "localname": "DebtRedemptionTermsonorafterApril12020Member",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Expense Associated to the Equity Component of Convertible Debt",
        "label": "Deferred Tax Expense Associated to the Equity Component of Convertible Debt",
        "terseLabel": "Deferred tax associated with equity component of convertible debt"
       }
      }
     },
     "localname": "DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_EXPARELbupivacaineliposomeinjectablesuspensionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EXPAREL/bupivacaine liposome injectable suspension [Member]",
        "label": "EXPAREL/bupivacaine liposome injectable suspension [Member]",
        "terseLabel": "EXPAREL / bupivacaine liposome injectable suspension"
       }
      }
     },
     "localname": "EXPARELbupivacaineliposomeinjectablesuspensionMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_EquityMethodInvestmentsAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments and Other Assets",
        "label": "Equity Method Investments and Other Assets",
        "terseLabel": "Investments and other assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndOtherAssets",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_EurofarmaLabatoriesSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eurofarma Labatories S.A.",
        "label": "Eurofarma Labatories S.A. [Member]",
        "terseLabel": "Eurofarma Labatories S.A."
       }
      }
     },
     "localname": "EurofarmaLabatoriesSAMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Offset Indemnification Claims",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Offset Indemnification Claims",
        "negatedTerseLabel": "Offset indemnification claims"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOffsetIndemnificationClaims",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1",
        "terseLabel": "Amortization expense, first period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2",
        "terseLabel": "Amortization expense, second period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FlexionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Flexion",
        "label": "Flexion [Member]",
        "terseLabel": "Flexion"
       }
      }
     },
     "localname": "FlexionMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ForeignPropertyPlantAndEquipmentNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to product goods and services and not intended for resale, located in a foreign country or territory.",
        "label": "Foreign Property, Plant And Equipment, Net",
        "terseLabel": "Foreign property, plant and equipment, net"
       }
      }
     },
     "localname": "ForeignPropertyPlantAndEquipmentNet",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_FortisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fortis",
        "label": "Fortis [Member]",
        "terseLabel": "Fortis"
       }
      }
     },
     "localname": "FortisMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_GeneQuineBiotherapeuticsGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GeneQuine Biotherapeutics GmbH",
        "label": "GeneQuine Biotherapeutics GmbH [Member]",
        "terseLabel": "GeneQuine"
       }
      }
     },
     "localname": "GeneQuineBiotherapeuticsGmbHMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_IoveraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "iovera\u00b0 [Member]",
        "label": "iovera\u00b0 [Member]",
        "terseLabel": "iovera\u00b0"
       }
      }
     },
     "localname": "IoveraMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_LargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the largest customer of the entity.",
        "label": "Largest Customer [Member]",
        "terseLabel": "Largest wholesaler"
       }
      }
     },
     "localname": "LargestCustomerMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiability",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 5.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due After Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 6.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 2.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 4.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 3.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Due Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails": {
       "order": 1.0,
       "parentTag": "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability, Remainder Of Fiscal Year",
        "terseLabel": "2021 (remaining three months)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesleasenotyetcommencedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Number Of Contracts",
        "terseLabel": "Number of leases not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_LongTermInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Investments [Member]",
        "label": "Long-Term Investments [Member]",
        "verboseLabel": "Long-term:"
       }
      }
     },
     "localname": "LongTermInvestmentsMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer One [Member]",
        "terseLabel": "Major customer one"
       }
      }
     },
     "localname": "MajorCustomerOneMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer Three [Member]",
        "terseLabel": "Major customer three"
       }
      }
     },
     "localname": "MajorCustomerThreeMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MajorCustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the major customer of the entity.",
        "label": "Major Customer Two [Member]",
        "terseLabel": "Major customer two"
       }
      }
     },
     "localname": "MajorCustomerTwoMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MeasurementInputExpectedMilestonePaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Expected Milestone Payment [Member]",
        "label": "Measurement Input, Expected Milestone Payment [Member]",
        "terseLabel": "Measurement Input, Expected Milestone Payment"
       }
      }
     },
     "localname": "MeasurementInputExpectedMilestonePaymentMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_MilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment",
        "label": "Milestone Payment",
        "terseLabel": "Milestone payment"
       }
      }
     },
     "localname": "MilestonePayment",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to milestone payments for products by the stage at which they are payable, in connection with the acquisition.",
        "label": "Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]",
        "terseLabel": "Milestone Payments for Product in Connection with Acquisition by Stage at which they are Payable [Axis]"
       }
      }
     },
     "localname": "MilestonePaymentsForProductInConnectionWithAcquisitionByStageAtWhichTheyArePayableAxis",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pcrx_MyoscienceAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Myoscience Acquisition [Member]",
        "label": "Myoscience Acquisition [Member]",
        "terseLabel": "Myoscience Acquisition"
       }
      }
     },
     "localname": "MyoscienceAcquisitionMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_NuanceBiotechCo.Ltd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nuance Biotech Co. Ltd. [Member]",
        "label": "Nuance Biotech Co. Ltd. [Member]",
        "terseLabel": "Nuance Biotech Co. Ltd."
       }
      }
     },
     "localname": "NuanceBiotechCo.Ltd.Member",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_PotentialAdditionalDebtInvestmentUponAchievingMilestones": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Additional Debt Investment Upon Achieving Milestones",
        "label": "Potential Additional Debt Investment Upon Achieving Milestones",
        "terseLabel": "Predicated investment"
       }
      }
     },
     "localname": "PotentialAdditionalDebtInvestmentUponAchievingMilestones",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ProceedsFromConvertibleOptionComponentOfConvertibleDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Convertible Option Component of Convertible Debt",
        "label": "Proceeds from Convertible Option Component of Convertible Debt",
        "terseLabel": "Proceeds from equity component of the 2025 convertible senior notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleOptionComponentOfConvertibleDebt",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from shares issued under Employee Stock Purchase Plans.",
        "label": "Proceeds From Shares Issued Under Employee Stock Purchase Plans",
        "terseLabel": "Proceeds from shares issued under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_RetirementOfEquityComponentOfConvertibleSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement of Equity Component of Convertible Senior Notes",
        "label": "Retirement of Equity Component of Convertible Senior Notes",
        "negatedTerseLabel": "Retirement of equity component of the 2022 convertible senior notes"
       }
      }
     },
     "localname": "RetirementOfEquityComponentOfConvertibleSeniorNotes",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_ScheduleOfInterestExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of interest rate expenses related to convertible notes.",
        "label": "Schedule of Interest Expense [Table Text Block]",
        "terseLabel": "Schedule of total interest expense recognized related to the Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseTableTextBlock",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Operating Lease Not Yet Commenced, Payments Due",
        "label": "Schedule of Operating Lease Not Yet Commenced, Payments Due [Table Text Block]",
        "terseLabel": "Schedule of operating lease not yet commenced, payments due"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeaseNotYetCommencedPaymentsDueTableTextBlock",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pcrx_SecondLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the second largest customer of the entity.",
        "label": "Second Largest Customer [Member]",
        "terseLabel": "Second largest wholesaler"
       }
      }
     },
     "localname": "SecondLargestCustomerMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_SettlementPeriodConvertibleDebtConversionRequest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of trading days in a settlement period for convertible debt conversion requests.",
        "label": "Settlement Period - Convertible Debt Conversion Request",
        "terseLabel": "Settlement period - convertible debt conversion request"
       }
      }
     },
     "localname": "SettlementPeriodConvertibleDebtConversionRequest",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods",
        "terseLabel": "Number of offering periods for ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period",
        "terseLabel": "ESPP purchasing period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pcrx_SkyePharmaHoldingIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to SkyePharma Holding, Inc.",
        "label": "Skye Pharma Holding Inc. [Member]",
        "terseLabel": "Skye Pharma Holding Inc."
       }
      }
     },
     "localname": "SkyePharmaHoldingIncMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_SpineBioPharmaLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spine BioPharma, LLC",
        "label": "Spine BioPharma, LLC [Member]",
        "terseLabel": "Spine BioPharma, LLC"
       }
      }
     },
     "localname": "SpineBioPharmaLLCMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stages at which milestone payments for products are payable, in connection with the acquisition.",
        "label": "Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]",
        "terseLabel": "Stage at which Milestone Payments for Product are Payable in Connection with Acquisition [Domain]"
       }
      }
     },
     "localname": "StageAtWhichMilestonePaymentsForProductArePayableInConnectionWithAcquisitionDomain",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_TELABioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TELA Bio",
        "label": "TELA Bio [Member]",
        "terseLabel": "TELA Bio"
       }
      }
     },
     "localname": "TELABioMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ThirdLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the third largest customer of the entity.",
        "label": "Third Largest Customer [Member]",
        "terseLabel": "Third largest wholesaler"
       }
      }
     },
     "localname": "ThirdLargestCustomerMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_ThreeLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest Customers",
        "label": "Three Largest Customers [Member]",
        "terseLabel": "Three Largest Customers"
       }
      }
     },
     "localname": "ThreeLargestCustomersMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction Costs Attributable to the Equity Component of Convertible Debt",
        "label": "Transaction Costs Attributable to the Equity Component of Convertible Debt",
        "terseLabel": "Transaction costs attributable to equity component of convertible debt"
       }
      }
     },
     "localname": "TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pcrx_UponAnnualNetSalesReachingDollar500.0MillionThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the stage for milestone payments when the annual net sales reach 500.0 million dollars.",
        "label": "Upon Annual Net Sales Reaching Dollar 500.0 Million Threshold [Member]",
        "terseLabel": "When annual net sales collected reach $500.0 million"
       }
      }
     },
     "localname": "UponAnnualNetSalesReachingDollar500.0MillionThresholdMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pcrx_UponFirstCommercialSaleInMajorEUCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the stage for milestone payments upon the first commercial sale in a major EU country (UK, France, Germany, Italy or Spain).",
        "label": "Upon First Commercial Sale in Major EU Country [Member]",
        "terseLabel": "Upon first commercial sale in a major EU country (United Kingdom, France, Germany, Italy and Spain)"
       }
      }
     },
     "localname": "UponFirstCommercialSaleInMajorEUCountryMember",
     "nsuri": "http://www.pacira.com/20210930",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r53",
      "r55",
      "r122",
      "r123",
      "r289",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r186",
      "r358",
      "r362",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Major Customers [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r288",
      "r327",
      "r381",
      "r383",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r553",
      "r595",
      "r599",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r288",
      "r327",
      "r381",
      "r383",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r553",
      "r595",
      "r599",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r186",
      "r358",
      "r362",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Name of Major Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r183",
      "r358",
      "r360",
      "r555",
      "r594",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r183",
      "r358",
      "r360",
      "r555",
      "r594",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r288",
      "r327",
      "r371",
      "r381",
      "r383",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r553",
      "r595",
      "r599",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r288",
      "r327",
      "r371",
      "r381",
      "r383",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r553",
      "r595",
      "r599",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r54",
      "r55",
      "r122",
      "r123",
      "r289",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r184",
      "r185",
      "r358",
      "r361",
      "r597",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r358",
      "r361",
      "r597",
      "r623",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r38",
      "r519"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r17",
      "r187",
      "r188"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r36",
      "r241"
     ],
     "calculation": {
      "http://www.pacira.com/role/FIXEDASSETSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r57",
      "r58",
      "r59",
      "r64",
      "r71",
      "r72",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Accumulated Net Unrealized Investment Gain (Loss)"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r20",
      "r61",
      "r63",
      "r64",
      "r584",
      "r604",
      "r605"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r71",
      "r72",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r60",
      "r64",
      "r71",
      "r72",
      "r73",
      "r126",
      "r127",
      "r128",
      "r460",
      "r600",
      "r601",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r18",
      "r416",
      "r519"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r413",
      "r414",
      "r415",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "auth_ref": [
      "r341",
      "r347",
      "r430"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.",
        "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature",
        "terseLabel": "Equity component of 2025 convertible senior notes issued, net of deferred taxes of $20,450 (Note 8)"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Retirement of equity component of 2022 convertible senior notes (Note 8)"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r385",
      "r387",
      "r419",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r387",
      "r410",
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r24",
      "r189",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Amount of allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r86",
      "r105",
      "r308",
      "r497"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r80",
      "r105",
      "r308",
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r105",
      "r230",
      "r236"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r198",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetRetirementObligation": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligation",
        "terseLabel": "Asset retirement obligation"
       }
      }
     },
     "localname": "AssetRetirementObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r117",
      "r172",
      "r175",
      "r181",
      "r209",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r457",
      "r461",
      "r485",
      "r517",
      "r519",
      "r560",
      "r581"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r52",
      "r117",
      "r209",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r457",
      "r461",
      "r485",
      "r517",
      "r519"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r194"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r192",
      "r217"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r191",
      "r193",
      "r217",
      "r566"
     ],
     "calculation": {
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value (Level 2)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r388",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r380",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r380",
      "r382",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "verboseLabel": "Offer price, per Flexion Share"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r104",
      "r453"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Changes in contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r450",
      "r451",
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Acquisition-related contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Measurement input, contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r109",
      "r110",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Fixed assets included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r33",
      "r107"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r101",
      "r107",
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r101",
      "r486"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Cash Flow, Operating Activities, Lessee [Abstract]"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r258",
      "r567",
      "r588"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 15)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r267",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)",
        "verboseLabel": "Flexion common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16",
      "r519"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, par value $0.001; 250,000,000 shares authorized; 44,523,410 shares issued and outstanding at September\u00a030, 2021; 43,636,929 shares issued and outstanding at December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock": {
     "auth_ref": [
      "r369",
      "r370",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans, Other than Share-based Compensation [Text Block]",
        "terseLabel": "STOCK PLANS"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r67",
      "r69",
      "r70",
      "r78",
      "r570",
      "r590"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r162",
      "r163",
      "r186",
      "r482",
      "r483",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r162",
      "r163",
      "r186",
      "r482",
      "r483",
      "r606",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r162",
      "r163",
      "r186",
      "r482",
      "r483",
      "r606",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]",
        "verboseLabel": "Concentration of Major Customers"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r162",
      "r163",
      "r186",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)",
        "verboseLabel": "Percentage of revenue from customers to total revenue"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r159",
      "r162",
      "r163",
      "r164",
      "r482",
      "r484",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r162",
      "r163",
      "r186",
      "r482",
      "r483",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible Debt, Current",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r283",
      "r285",
      "r286",
      "r288",
      "r298",
      "r299",
      "r300",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r318",
      "r319",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r14",
      "r562",
      "r582",
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "terseLabel": "Convertible note"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r82",
      "r117",
      "r209",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r485"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r160",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "verboseLabel": "Concentration risk by major customer"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r302",
      "r309",
      "r310",
      "r312",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r11",
      "r13",
      "r14",
      "r116",
      "r124",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r318",
      "r319",
      "r320",
      "r321",
      "r500",
      "r561",
      "r562",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r14",
      "r314",
      "r562",
      "r579"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Convertible debt, carrying amount of equity component"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r287",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price of notes into common stock (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r44",
      "r287",
      "r342",
      "r343",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate of common stock per $1,000 of principal amount of Notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r285",
      "r318",
      "r319",
      "r498",
      "r500",
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r300",
      "r318",
      "r319",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r43",
      "r305",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate on convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r43",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "verboseLabel": "DEBT AND FINANCING OBLIGATIONS"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r116",
      "r124",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r318",
      "r319",
      "r320",
      "r321",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r116",
      "r124",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r311",
      "r318",
      "r319",
      "r320",
      "r321",
      "r342",
      "r344",
      "r345",
      "r346",
      "r497",
      "r498",
      "r500",
      "r501",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Amortization period of equity component of convertible debt"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r298",
      "r497",
      "r501"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discount on debt",
        "terseLabel": "Debt instrument, unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "terseLabel": "Flexion outstanding debt"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses.",
        "label": "Debt Related Commitment Fees and Debt Issuance Costs",
        "terseLabel": "Total transaction costs"
       }
      }
     },
     "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r37",
      "r298",
      "r499"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r422",
      "r423"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r118",
      "r429",
      "r435",
      "r436",
      "r437"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r105",
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r105",
      "r170"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation of fixed assets and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r358",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregated revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r79",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r139",
      "r141",
      "r149",
      "r150",
      "r151",
      "r155",
      "r156",
      "r466",
      "r467",
      "r571",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income per common share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r79",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r141",
      "r149",
      "r150",
      "r151",
      "r155",
      "r156",
      "r466",
      "r467",
      "r571",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income per common share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r71",
      "r72",
      "r73",
      "r126",
      "r127",
      "r128",
      "r130",
      "r136",
      "r138",
      "r158",
      "r210",
      "r341",
      "r347",
      "r413",
      "r414",
      "r415",
      "r431",
      "r432",
      "r465",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r600",
      "r601",
      "r602",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r1",
      "r117",
      "r209",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r1",
      "r117",
      "r209",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedLoss": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Loss",
        "terseLabel": "Equity securities, realized loss"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r300",
      "r318",
      "r319",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EuropeanUnionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Economic and political union of member states, located primarily in Europe.",
        "label": "European Union [Member]",
        "terseLabel": "European Union or E.U."
       }
      }
     },
     "localname": "EuropeanUnionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of key assumptions used in the valuation of contingent consideration"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r468",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r468",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r300",
      "r318",
      "r319",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r469",
      "r526",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r300",
      "r318",
      "r319",
      "r468",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r300",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r300",
      "r372",
      "r373",
      "r378",
      "r379",
      "r469",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r300",
      "r318",
      "r319",
      "r372",
      "r373",
      "r378",
      "r379",
      "r469",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r300",
      "r318",
      "r319",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r469",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r468",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of carrying amount and fair value of the long-term debt"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r472",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r472",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of change in contingent consideration recorded at fair value using Level 3 measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)",
        "terseLabel": "Reduction in valuation of investment due to changes in foreign currency exchange rates"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Fair value adjustments and accretion",
        "terseLabel": "Contingent consideration gains during period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments made"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance at September 30, 2021",
        "periodStartLabel": "Balance at December 31, 2020"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofContingentConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r300",
      "r318",
      "r319",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r526",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r204",
      "r205",
      "r206",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r219",
      "r220",
      "r221",
      "r311",
      "r339",
      "r464",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial Liabilities:"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Less: accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Amortization expense, remainder of fiscal year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r231",
      "r232",
      "r235",
      "r237",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r235",
      "r557"
     ],
     "calculation": {
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Total intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r231",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r235",
      "r556"
     ],
     "calculation": {
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FreshStartAdjustmentsTable": {
     "auth_ref": [
      "r516",
      "r517",
      "r518",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about reorganization under Chapter 11 of Bankruptcy Code.",
        "label": "Reorganization, Chapter 11 [Table]",
        "terseLabel": "Fresh-Start Adjustments [Table]"
       }
      }
     },
     "localname": "FreshStartAdjustmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Office furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "(Gain) loss on disposal of fixed assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r105",
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt",
        "terseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r224",
      "r225",
      "r519",
      "r559"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill recorded in connection with the acquisition"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Change in carrying value of goodwill during period"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r119",
      "r438"
     ],
     "calculation": {
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r76",
      "r172",
      "r174",
      "r177",
      "r180",
      "r182",
      "r558",
      "r568",
      "r573",
      "r592"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r119",
      "r438"
     ],
     "calculation": {
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income (loss) before income taxes:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESScheduleofFederalStateandLocalandForeignIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r243",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r425",
      "r426",
      "r428",
      "r433",
      "r439",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions": {
     "auth_ref": [
      "r440",
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tax effect of an increase or decrease in contributed capital (for example, deductible expenditures reported as a reduction of the proceeds from issuing capital stock) during the period charged or credited directly to shareholders' equity.",
        "label": "Income Tax Effects Allocated Directly to Equity, Equity Transactions",
        "terseLabel": "Deferred taxes related to equity"
       }
      }
     },
     "localname": "IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r137",
      "r138",
      "r171",
      "r424",
      "r434",
      "r441",
      "r593"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax (expense) benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r146",
      "r147",
      "r151"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Dilutive effect of conversion premium on the 2022 Notes (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r151"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of share based compensation arrangements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r229",
      "r233"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "negatedTerseLabel": "Capitalized interest and other (Note 5)",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails",
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r75",
      "r169",
      "r495",
      "r499",
      "r572"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r86",
      "r306",
      "r317",
      "r320",
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r88",
      "r307",
      "r320",
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r99",
      "r102",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r25",
      "r222"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r50",
      "r519"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r222"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r26",
      "r222"
     ],
     "calculation": {
      "http://www.pacira.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r84",
      "r168"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Equity investment"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r512",
      "r514"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease, Cost [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of operating lease cost and other operating lease information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of maturities of operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2021 (remaining three months)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40",
      "r117",
      "r176",
      "r209",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r458",
      "r461",
      "r462",
      "r485",
      "r517",
      "r518"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r23",
      "r117",
      "r209",
      "r485",
      "r519",
      "r563",
      "r586"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r117",
      "r209",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r458",
      "r461",
      "r462",
      "r485",
      "r517",
      "r518",
      "r519"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Estimated settlement fees"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r14",
      "r299",
      "r315",
      "r318",
      "r319",
      "r562",
      "r583"
     ],
     "calculation": {
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total debt, net of debt discount and deferred financing costs"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Long-term available-for-sale investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r266",
      "r268",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r258",
      "r261",
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss contingency, damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r159",
      "r162",
      "r163",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Major Customers"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r101",
      "r103",
      "r106"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r65",
      "r68",
      "r73",
      "r77",
      "r106",
      "r117",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r137",
      "r138",
      "r148",
      "r172",
      "r174",
      "r177",
      "r180",
      "r182",
      "r209",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r467",
      "r485",
      "r569",
      "r589"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements/ Recent Accounting Pronouncements Not Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other (expense) income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesReceivableFairValueDisclosure": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.",
        "label": "Notes Receivable, Fair Value Disclosure",
        "terseLabel": "Notes receivable"
       }
      }
     },
     "localname": "NotesReceivableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Notes Receivable"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OneTimeTerminationBenefitsMember": {
     "auth_ref": [
      "r247",
      "r248",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A lump sum payment to an involuntarily terminated employee in conjunction with exit or disposal activities.",
        "label": "One-time Termination Benefits [Member]",
        "terseLabel": "One-time Termination Benefits"
       }
      }
     },
     "localname": "OneTimeTerminationBenefitsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r172",
      "r174",
      "r177",
      "r180",
      "r182"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r506",
      "r514"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Fixed lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESScheduleofmaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r504",
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for operating lease liabilities, net of lease incentive"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r502"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r511",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r510",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r455",
      "r456",
      "r459"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r66",
      "r69",
      "r455",
      "r456",
      "r459"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss (Note 11)",
        "totalLabel": "Total other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r57",
      "r61"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net unrealized (loss) gain on investments, net of tax",
        "verboseLabel": "Net unrealized (loss) gain on investments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r58",
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Unrealized (loss) gain on investments, tax benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Loss (gain) on investment and other non-operating income, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of contingent consideration to MyoScience, Inc. securityholders",
        "terseLabel": "Payment for contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "negatedTerseLabel": "Payment of contingent consideration to MyoScience, Inc. securityholders"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.",
        "label": "Payment of Financing and Stock Issuance Costs",
        "negatedTerseLabel": "Payment of debt issuance and financing costs"
       }
      }
     },
     "localname": "PaymentOfFinancingAndStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Additional equity investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "terseLabel": "Payments to acquire investments",
        "verboseLabel": "Payments to acquire Flexion Shares"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLongtermInvestments": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.",
        "label": "Payments to Acquire Long-term Investments",
        "negatedTerseLabel": "Purchases of equity and debt investments"
       }
      }
     },
     "localname": "PaymentsToAcquireLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedLabel": "Purchases of available-for-sale investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r15",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r15",
      "r519"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at September\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r31",
      "r32"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from debt component of the 2025 convertible senior notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Debt issued in private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from sale of equity investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfLongtermInvestments": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.",
        "label": "Proceeds from Sale of Long-term Investments",
        "terseLabel": "Sale of equity investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-term Investments",
        "terseLabel": "Sales of available-for-sale investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r94",
      "r412"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercises of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "netLabel": "Net product sales:",
        "terseLabel": "Net product sales",
        "verboseLabel": "Total net product sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r36",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r244",
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "FIXED ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r35",
      "r240"
     ],
     "calculation": {
      "http://www.pacira.com/role/FIXEDASSETSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant, and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "FIXED ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r9",
      "r10",
      "r242",
      "r519",
      "r577",
      "r587"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.pacira.com/role/FIXEDASSETSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Fixed assets, net",
        "totalLabel": "Fixed assets, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r9",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of fixed assets summarized by major category"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r9",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables, Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial Assets:"
       }
      }
     },
     "localname": "ReceivablesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r64",
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReorganizationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reorganizations [Abstract]"
       }
      }
     },
     "localname": "ReorganizationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedTerseLabel": "Repayments of convertible senior notes"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r421",
      "r554",
      "r640"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockExpense": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShareBasedCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.",
        "label": "Restricted Stock or Unit Expense",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r247",
      "r250",
      "r252",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Estimate of restructuring costs, once probable"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r105",
      "r246",
      "r251",
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r247",
      "r248",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r19",
      "r347",
      "r416",
      "r519",
      "r585",
      "r603",
      "r605"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r126",
      "r127",
      "r128",
      "r130",
      "r136",
      "r138",
      "r210",
      "r413",
      "r414",
      "r415",
      "r431",
      "r432",
      "r465",
      "r600",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r166",
      "r167",
      "r173",
      "r178",
      "r179",
      "r183",
      "r184",
      "r186",
      "r357",
      "r358",
      "r555"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total net product sales",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r359",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r509",
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets recorded in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalty revenue"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r162",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskofMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r64",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsAcquiredDuringPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of potential dilutive effect of the securities excluded from the calculation of diluted loss per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of short-term investments"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of composition of the Company's debt and financing obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computation of basic and diluted loss per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r141",
      "r145",
      "r149",
      "r151",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r387",
      "r409",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r387",
      "r409",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of recognized stock-based compensation in consolidated statements of operations"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of finite-lived intangible assets acquired as part of business combination"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r227",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of income before income tax, domestic and foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r8",
      "r28",
      "r29",
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of components of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r36",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FIXEDASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r388",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r390",
      "r400",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of the company's stock option activity and restricted stock unit activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of share-based payment award, stock options, valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r159",
      "r162",
      "r163",
      "r164",
      "r482",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of percentage of revenue comprised by the three largest customers"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Stock-based compensation from:"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of period (shares)",
        "periodStartLabel": "Unvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of period (usd per share)",
        "periodStartLabel": "Unvested at beginning of period (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (shares)",
        "terseLabel": "Vested restricted stock units (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Stock Incentive Plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares of common stock authorized for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r392",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding end of period (in shares)",
        "periodStartLabel": "Outstanding beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "periodStartLabel": "Outstanding beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r386",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails",
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "verboseLabel": "Closing sale price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r404",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term of options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSScheduleofValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock, ESPP (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balances (in shares)",
        "periodStartLabel": "Balances (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r12",
      "r564",
      "r565",
      "r580"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term available-for-sale investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r619",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term:"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r113",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r48",
      "r71",
      "r72",
      "r73",
      "r126",
      "r127",
      "r128",
      "r130",
      "r136",
      "r138",
      "r158",
      "r210",
      "r341",
      "r347",
      "r413",
      "r414",
      "r415",
      "r431",
      "r432",
      "r465",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r600",
      "r601",
      "r602",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "verboseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r158",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r15",
      "r16",
      "r341",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r341",
      "r347",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKPLANSScheduleofStockBasedCompensationActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r15",
      "r16",
      "r341",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Shares issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r48",
      "r341",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r21",
      "r22",
      "r117",
      "r190",
      "r209",
      "r485",
      "r519"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.pacira.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r326",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r340",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r494",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r494",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r494",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r494",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.pacira.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r520",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r204",
      "r205",
      "r206",
      "r311",
      "r339",
      "r464",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.pacira.com/role/FINANICIALINSTRUMENTSFairValueMeasurementInputsandValuationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMERCIALPARTNERSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r247",
      "r248",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryBondSecuritiesMember": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities greater than ten and as long as thirty years, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Bond Securities [Member]",
        "terseLabel": "U.S. Government bonds"
       }
      }
     },
     "localname": "USTreasuryBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/DEBTNarrativeDetails",
      "http://www.pacira.com/role/DEBTScheduleofDebtDetails",
      "http://www.pacira.com/role/FINANCIALINSTRUMENTSFairValueofLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.pacira.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Valuation allowance of deferred tax assets released"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r507",
      "r514"
     ],
     "calculation": {
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/LEASESSummaryofoperatingleasecostandotheroperatingleaseinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Computation of diluted securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r140",
      "r151"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r139",
      "r151"
     ],
     "calculation": {
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.pacira.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.pacira.com/role/NETINCOMELOSSPERSHAREScheduleofComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e34017-109320"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r641": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r642": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r643": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r644": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r645": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r646": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r647": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r648": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r649": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r650": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r651": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r652": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r653": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>89
<FILENAME>0001396814-21-000063-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001396814-21-000063-xbrl.zip
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MRL!JKR.ET@5AK/=,2C"Q0IDSIFOM7!<*WKGX7DHU$]:[Q(T0')66!@HQ6:'
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M@"<1A6,20U+F0]+&<I!,^JB$7$)PYSXQ.Q\M)BHZ3:F+-@G+G-,,(R<=*/#
MHZM#,K6%HSSS1Q5#704!G%#2(WL-3MH44HA<QN""J&;_J%T"?O1 $2"ULXL
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MF9:"Z.B0W481@DL)"/=UJ"F^DN1%D^3Y%(!5WCJ;O)) !1'6\"B15A,:O,8
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M.4<''< XC!=3$&CAK2&44D27>Z4H"37*K[)@<,XEJ8ITTBCB(C@C1'+&$YV
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MZWXQ&N[MOZ[)EE"FA8DZ>&ED$!*-J1(,_2N-'I%PM$[;CN:-S_S-*8W,!:+
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ML703U. \#Y"\U,IXPR+2K6U-%\YHJTAM+U)7Z]JM,%X6C&?STZ1)2EO@.BI
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M?I\7L$4-VA(/Z'S*AG_^-;.N#4D)14N:,.MF^[]%O0@KG%N8#' 7<Z$">ZG
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M&U1JCB%QTJ5T8>=/9;G*<NO-<JOUD%666X3E9OQB3BCD+@8PMO26L82#==R
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MC7KC^"H._^SY.'$OO8Q^\+;?W*5QK%=WTQSNIJ-G,Q'GQ(@V1&J(6/J:4$W
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M6]N*ZJXDRZI._O L6H_!;_B5=0&LT9556 ]^917!AE]9%\"&7UD7P(9?61?
MAE]9%\"&7UD7P(9?61? AE]9%\"&7UD7P(9?61? AE]9%\"&7UD7P(9?61?
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MN:3KHC7.M!7."#"_E4Q@C9. C.<6?A!!N)2&A;2$\K4KP/'$[^PVP!._L]L
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M03O$G>$D!(N3U(!>M+-!._AZXO"%O0S8:1]"3)Q&Y40RAG,7X6.EM>YLT*7
MML66;AQSX[1D2)@<(M#$(L.<0S;AP"1GGEL)Z"9X#PCY4!"N:_?TQ._L-L 3
MO_.I]?O:_!Q'OA[':IC@U2 @J^%Q1NBKLY8>9].%:^8S1(YS%4K'E>!:.,V3
M4!0+S:)F(;E2@A+/2E#BVSCRLS4>3V/8F(Y@89L&M4V^0[FXV]!L1LS0*3;7
M4&Q.RVYDH\U+HR*Q&H$Y;1!7B2-#DT+1,TV" "75II55TB/LQC4JN\8JR\+C
MEP3%;L[@W\7#I;-TQ\*WP,+ST']FX,@P0\[E0]%4:&0T,+..CGB>/)8,Q#WI
MV/?QLF]*T8FH-$E&<,<CL"_FV$CI0O#2Z3N1SQUOWQ9OSV/?P,&)>ALS*6B.
M"'GD: H(&)M)%4(PT:RL,MFC3'4,_L 8O.LZV9&I(]-]1 \I81K4)J48B$DG
MK1%@[)@0-<;1!M.)RP<E+A?=](8:S#C#R& " C,DBBSF# D-=HWD7L4@6H%Y
MXURQ6V3QI]92\-]Q/(FA&L$_H]KG7QMG7&;:'W/%/<)6,#_+%7?),:(7%G G
M'[2-@[$M/4Y'(SLXB$=Q,'EQ,K_EE3W)'ZU]LJ/0Q!2W!D#":?YP7([L[A_:
M00MH#9&W!@W>=:AV'51;/)UDF*< 7QP)*2SB1OELVW,4)'.*:\NHXBNKMP!H
M71>H!Z%:=F3JR-21J2-31Z:.3(^83$\M-:&);U=U\12 %1#BJ(I'Q_WA28R-
M>52*WQQ/1_X0=/'JN&\'7=;"G9I*7TM,V&Q)56YZU1+I%=#HL731O"/+YV2Q
M+@.).&@P>J*B8/EP'Y %2PC)Q%)08!91D9,NN]#'0V/DSJ?^(,CT($/05P)Q
MA\/7P^%Y&!H[(:GP"CE"$N*$":2C$,@+F7P^LR@4RUEBG'9I)C_ XT=U"/WX
M=*#X=+X=F3HR/5F)N3Q1Z$YBWI;ELGA@C#-N N9(V( 1EQ(C;6-"UE*OX'_<
M8+U\,O.I!:++ED<NQS9AOO/XYQ.+0=^[LZ_SR79D>C1D6EJS>2V\GXXG)5EC
M?S@OW)]K]F\-VFK]Q9OISN>#O(G_F=;C>A+WXNAC[6.C/;R)?G@P*$\IBD2G
M+UQ#7]A=7["PO9(R"*&0"BX@[G5$6B>%O*?1.LR#C6)EE9H>IK=UNKS#@PZV
M.S)U9'IH9%I:$[N3KLLE71>M<26B2"X9E("Y<W&JF',H&=+<:B\9IY'')92O
M77V.)W[G4TN">1,G]:BDG><*';&DF!?'#*S)8%(28.!S &N:D;Z,O#3*C(-Z
M.*H&PPD,Y9<=^*?25W>&ZB($3SM"T)&I(]-M5ERF&C/C:&"2!&YYLDY@' @A
M1@30,L5WJ)D_4GKY>_3-YI#.^@Q =]/Z'#4WHIMT.N5U2@+NKTUV%B(\2@K#
M D4!*(YXRCX;+R3R@@=%&6;4IY55QGI8FQM4:^Y8OT/HCDP=F1YH1D0G2#M!
M>ID@W6Y"'R!,U_[1TF&L*$72&8HX$0E9GS!R6 :2J/&)D_N6I#\E3^*[;?%0
M?YP]NWT$RO<_)Z38]/=53?.<?5XUMKE8M,U/J0-36-9YG'$?- =P>M4@EOF$
MF.)H%$,UL9\7FALO\6Q@T/]UATYR?BVL;7IW[]O/FRE%/QFO]?M#G[M^;]0C
M^+M_LC]L=E7S<W\$"]',H3M'<SV(!7A=;VV5=8/?_9]#[(_^/;!_F^GN>__Y
M[='6E^V-UWS[_;_[V_NO88T.Q/;[+;)#WQQM;X3^[A_PS"\OCO[/ETV8WP<"
MSZ/P#KZ[\?8?R52PE#ND7 3#1W*#K%8>*24,B&]+'3$KJQ3WN+A8-?2B>ZZP
MTA,)7G4QQHY,'9GN(12LHZ#"89&;.'";C+8Q>I&M#(LEU>'N0\'G#(B_Z\EA
M\]$8[GT9[60ZZD*^UQ5Y"^XY010V'#.4=.Y'E+NI64<]PMHS9A3F-()1(7E/
MDHM&1<?YR\WY'4!W9.K(U,G13H[^)--QP3LG)*92,X&L%1AQ$34R2@ID@DHB
M!B<-YTLH2)]:ZDPIOUA\<:-X& ?C^F.LZN)M:4UN0NXA)>8!BI^G> 2](U-'
MIHY,'9DZ,BVASBT8YM);B;FC\#]JDTM:.FZPTXY8=>U"9D556%_4%)JPS)_#
M\7@G3G;3OOW\:C@JA: GDU'MIA,+ZO7^\)4=@2[>:=/7TJ:W)KMSKU2243,C
M*<*"L'S0SR-M#$:*>2*"C=RZL+(*-M82%07H&'KYSB5U#'V?#+UH'EO&A'8N
MH6BP0#QA@ZRD ?% P92EW(ODEHVCGUJ9#^"!UA;N"GMT#MB.3!V9.C(]7C)=
M0Q.3,E&G!$CN7"8Z8 MZN,/<N!@#53[=;C@#Q-!<+^N4KFLI7=N3T]+0H',Y
MZ07W#FG'+5A1QB-C>4+811TB9X((T+D((SV,N[8X#XU_.YA]$&1:VD(<'<S>
M!&87;=M$/2-1Y]K[FB)N,4,&I"(2PGLMF?*\]!9?.IR]I=CODMBTZE+V>V'[
M=N!C92?57CR>Q",71Q7#O7P" ]\DT.N&HQ!'J)G<<P8D",-IKK(PFU-[PV1X
M_#P3:#SLU^'TXF,"LDO;BAA%.$N)4ZHD=R0Z9E,('@=*9/"6_[-U&^5ZRYMW
MIY/QQ [R>G8P=BT8>SU9*/[C$X\!1X\XH1+QY"2RG@>4#,T^=\>4LBNKG/48
M8;?DI+L]'KIGI_T]@\72>1+_Z_YVPC5VP%*AZ$5U\,<A])*BYH?#/JS?N#DO
MUL'D=6%R;E0S*5W26J/(90)E3PGD?*3(<L84528IIS-,=A#9060'D3\9(J,.
M6&H9N7:<9T.9Y[,L.&(MK'!6WHZ6V>'G3?%SX<"1U Q$&$!G5($@[KW(50PX
MTE8!F#J@8P#\U(+VB+EX+K8#T0Y$.Q"]Y8(RG%B%F?2*B\1=#)H+L/8H]2D
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MCY&D1#CK4E 8E!O1DW))HM6=TV4)E9N.TY>5T^=:3@Q<&9M+-_.8^U@1CEP
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MG/:Z/V+6A2J7Y>K:="P1[>%_PCK.%+$N<JD]U4Q0KKRM"-F*@=1L&DN4.)I
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M$^(Q$93]G(@YC$64AIJH<KDP ?K_X'IA3Z7_K\%A\D_L]]_4K/?#SK!M!S&
M;IWV0'F*]/57YC;Y8]7HRL9T739GE@5^;L?\ R#81J<+$WA1_/U*=*N [0[
MMC,; ^*P$)1F5Z\S"G%-$C(B$J1@J8VRG)$$P*9579/EX^,_*^?*2U#U)V$F
ME:K_'E6?.=4)1A!#* HF:,1]"$C[J)"W/& 1J/-8K[U5NL[DBJAZY8)9_G>I
MLDE5"[6JY_?"G5>K5-_O6<#^;$".DHR2%"G2.8&(YY^<2A0I):C2@/W.Y18X
MPM0I>V37554<M0+3"DQ7S!-8@>F=P73*H4FRFGG# 4+!4N;!$X#5A!%.E#$5
MI),N I@R69?ZD?V JUTM]<;:J"M7(;#;*RK]#8YZ,=8Z\/VC?BW"P$)M4@&M
M7"^&Z[7,;HKP[:R9]3D?8BW^/(TG_5@[L_W:?]ZE1(X-VDD:@$5Y+I4V!$;*
MC8S1\""E&]6Q5'-U+&?P0-P)#V:-[HG^R^>I_P\H<WEX#H3("6\-04DP@SB6
M&IE@/0)8]F '*PG(O/:6K2_K;PWDL)U7-4O"798Z@7$=G#<X"@=+'8UAU&HB
M*#'68:^*I<;CI<;54C_*4HN#*(+7BABD-!4YY=8BL%HX8LP2J03'RH6\U,MQ
M)^.EKM=ZL7\:X8\_8OM\O?8@V( +>W?'"<R4\0&(N@@<_D>,HUX)*:EQ*6H7
M'Q<GMG/AO=@?O.OV!_UW]K0U@!WA(H;7*TC'7\E!"C(*BS5*03'$F?3(1>H1
M9@#5 9;':['V%J\O1R'>&S,LCI)RD0@UFDM*G3,I89=PBEP&Y1X7,ZIE7UKV
MO?,#H'8:5ERC0/.R8TQSRCY( 9-82.&Y,3PO^W(8_&39NZGFI]-9:XWFN=8]
M*7#$SP9TPW>!UPP3W&/8R\6'^ZU!["]"T-VYU7/C9"?PR6^A9/<J+5[MTP_1
ML^;FUMF!8Y)3J1227EG$#0-X94XC%;@$>ARY#6GMK5F_JKC-O3&6$J:-BDHQ
MS+&3U@A-@@E18QQM,".,)14O>\SU9@>"L61L!..9:>!E =9;:T=@Y6-4DBNE
M<M*ROF0[G5OOJ\C9??#C?MQ,4,E\$(Z(Z(&912ND<59)2JSU7CTR8%2;])(P
M'?X\D,H0*21' <L,'DDBFQQ(E+5&>J8#=CJ3_*O2W^\+'AKX&,$\<"<UC]:;
MW!P6Q^B-,AI'^KC@4:W]\MKS ^N<,"1*1(FFB NAD;-2()8"6$<B #_+U0_6
MKSK8^&4L[>62M(W!M6@Z+IL_^HC4Q_B:4P=J:?'T&J;:MX<!AM>^M*!C<<_Y
MZ88/?>SW9VHUM;N^".UKG=2VAMGO76N5ZV8[W>%)T=3C+HI]S\/.V^GSJ>_]
M? ,;%4SIU4$NLS[Z5Z?7%UOD@"8/N&HC,MKE"M2)(^.D1)$0SH&@.\Z!$$KY
MF ;W/8]EJF5_I&7?!GL;MLVD D,N,H>XC13E] J4O#22:448U[F/YR5X?I7#
M[@4#<3\#V[VP&* QE[RS)^>U(SO"8YBW0:M7H&ZMZ]JMP\).Z:\4>$Z""?.
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M_UJ;NW!TXHFGEUC7[[:'@ZLO62HM\^A%9&Y5&'#M[4?K6SU;^[O5_>);&2,
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M@;D>_J37V;']WA#D3!3RUKW?+W):G^M,#ZRN0D&O527@NB9L-9M=^_UEU0@
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M[)(36=(1_*!$,%21&G4@SR)1O/_3^ 9Z==Y7D635W#;K5DD/7(G>]',9$G\
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MUUF\E2,U916_EE6$31KV<+BB;+V9%AR!U&=V8X\[WP8GO5#1!Q^[7ROJ,(I
M*6#,=C2*QQW8C^'S(]NM:,401@6,H&,[O:YUW5[W.).)\7T![HY@UX;O' YR
M-8?P%38\NQ^!T'1@*_P"]X.+X=[EW!!X2+E?1:J!40S&O*1PG5%W=!S[_K04
MA?"9B T;3TS3*1XV!&6M#.75QOL_  LR4^V.#O+4X<_#&%$O?HV]SD$W#NW0
M'YQVOAUT_<&8\8WRR. F^0DPUT/['1C?CXH(GL"88!\?.'@C7S,!AC$<G63V
M!X,#7GCNRI/^^6N_'0 1JD9;F-=D"IE-Q6J(G3+$0I(63+%CA_&WI620R7N3
MP$LTI3:%JN[Q'&=5^;TY<D3T/0Y=4RI_7R4V^?N9]2*\@I:_BC"3WSKW21_?
MG@PRK2^@,NK\<M*WX?,)*&[XM:AZ=0Q>Z?ZH AV;K0W8"T>C<@H.?\EJTY#P
M3LA65LJ60(:@4<:3,=H 6:Z4I:$<4W7>AX=5('< 0\SG[C"NP;!6Z'J]:FU<
MOXIP/EO*J&VE^M:DFOYVGT+=V9EB=RW9$]%UL#V%',I1@WJV</]3*<%@5N#7
M.N[D&/:NX7#@!L-BF[O3\4X(4FY;(5QE(63W*X0?YE"(B1B>9"DLA )0\1@N
M*)%$3=G*U,]^M=U>_OY2H-D;?)N/F6PA9CXL9U]> V^'P]-,OZIUR#QK;*C#
M+">6>J:B5=<]^,;HH"*A^9?,%>&K%=FL?5^CFD"7-Y6OG/S]R)Y6?SPZ&@Z
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M):L&P"W7-3CO##G;3?6J78<N=/?^).__Q4[_XN4_%W)R-N+D*3O[MW]L[+G
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MQC>/"V^!].)9MEAZU05:;3A==;._/4Z_)33=F9)3 :\+#'F%6#0$<1H!374
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M:8B4"DQ@D7,SUSF?Y*UAM8;5EP*K-SD8_=BX6D=,[X2K,TECRD=";$1<:(8
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MD]*]@7:5A F0T:LB@:]*5,M7P9CLPHREV.MGS/ROJ[FR6EK=*@D\X/J;#+?
MZ__UN[W">EX@I1<ITB_8RI7LXPQ;"5([P97UC#H ?ZI)E#[7(%%4"# -"\A6
M4&D:BEGS,9^$COOU(S[[O1A&[;B9)B[$Y]C_WO+Q$HL(#J,O_[:9/IWDB'Z
MH?7*T_*#E^M5-'A.9HA.D8 ],C[Q7&[:(4N#1,IYHUD(N!3VTU["0K+5V9#M
M3#)PR0)1%?_T,W(Q20W.V<(EZ2LE8I SAP>QBMKF$$,.-PR*?Y87]48POC#X
M[=4%MGI894%/C&N9IU_&=0\'\=7D+W],^ONTNN7XRQ_],4ZC'UOD;$G.Y.B7
M4UQ]/34R*[@R-.,R,N,GC[]>*;\Z<^Z@^HZ+%6STI5_C%7++[P K;_7+7PV6
MD!5)3#W8>K"2BFO=]HK22C?H57?EI>;<I1<<\ZLXR,,<9S-71?YPA9,Y:Z4!
MU^T-BHWL5)<F_&0OIF!X^1JUEY[K]#3ADYO,S@,*W,QAUQL<!%OLZ<XL[SJ5
MOJ[SPB]MXO \U/29SDTM5',1JI?0 R)[@3F\L-O+_!]6+]Q'IX?[K=6Z<)-Z
M_6H"-W[_9U,LP%&:DDTR>*HXU]91(J3A1!KCI"-V' Q1E^2 W[1J0!4(B>'B
M.,E&Y0XO3,V 6X9#IC4#.MM'C?7M\OS_YM:G]N;61]'\^7<;GL.W]S?H-MUI
M[7S=%A?4#( QKQTU]U_O-;:^B.8[^-_Z 6M^_0+WVFLUMG;V=SI_PGNT4Z.%
MCT^ZTSNNC37)Y-T"F[M:$*2M<HBS$)*1T6"+RWT#0I]*G=H:^FKHNQ_H4U[Y
MJ"VS(GE.=# :$T( "9F3DF _3G\>0Q^NH6\!H0^?0!\FL&;&*)2\\0!].B";
M(D6)2B>)PSC14$(?O^R\=@U]-?2]$.@35FB);8A6<YZL=EB!KA#+1,1)2'+%
MR;\:^A8 ^N@)]#'/I&&<(IP2 ZZ' S*"2F0\]\PK)2FE2ZO\(5J9U=!70]]B
M0Y\51%KG4G(D<H^=-88X)BAE01E"Y9E#;S7T+2#T\1/H2UIR2XU#BDF OB@=
M<A$#_R-&T\"5"M)GZ,-WK^9<-V:9G[Y^BH-H^[XJ&A/B]]CN'>;DT/OHMW*M
M9E4OHYDWE<0[)J7*!Y*8TTP2(:WE7C(:,*EC?8L.?<<SL3ZE$S$J"$2<58@K
M29#S(2&K/+:,.LI5F2,,2[Q #;UKI9ZS4FLK+6>"*1<-9\R9Y)E+(E!O="0G
MA_CK*-8"*_4TBL4,(1BX*-+$:<2-UD@S11%EWBKE.9?>9*7F^'QEIUJIGXU2
MN^2L"XE%!VNN@K%"1H=U@O_9R)*JXS.+K]0S\1E,HTG@GS@AP36)T2,'\(R(
M541C$CQC:FF5+0M3*_4S5FIF24K"1"*]Y!%$PGE-%2.2$AF8LW7D8?&5>AIY
M,-K'H(A$E 2'. D8@2/%D0?O*FA"F,L';MBRX?,JS?\HP84GF$OU.;;AP]WE
M2;F;JJ)MZ+2ZK4%9G.I[O(_DJFL!W073^?R CCH?O6<A44LY-\P(044L*UAZ
MB;FJXPP+#G3--S-Q!DE89)10)*+!B#O+D<84* SWT:B8"]L T.EE0N:UL;Y
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M10I:"!4Y2'8$HW\(LSWLC[)(PWI.Y+ T!JUNB-WA*TI7JG*T#\RC2K'<VHO
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M6V! X&B<P,E2Q0.U&@!=2Y>\!6>>6UK'89Z"5L_$82+F6G(.NBPCXK",R+D
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MR/D7S*)2S>NT#IM;KFY<Y29.EKXK%PV"F28*'B;O],+CN%"<X,+$-;>4F.^
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M_%@]A<"$F+!B2>:Z2:H *'5[SUK+?L+R?ZN]:]4P9_EFN%3@M9<M05%U^1A
M@V-9<E@K)!P@\OIF=?6E]NJJY3?W&-_W[:QR*41FD$%FB,..R_ES9:;MCCD5
M?B8"X8A"4SSL=8DY(N)AXX;K!-,BU<#FB/K1KJ1![H19%,OC=F2\&^ZZZ_G*
MQ"NJ3-QSP5UXJXU;"R+ 4?4[+/=!S9,9N@>A3B1C*S9[#N64<+;>GZFR_+S!
M@NZX2.@(/%K,A3:TJ@?CDDZ)65-'U<81WJMC-4Z^O6+2D3Q\R= W:AAEG)V3
M19AU$T6_11&AZ%]1[5CFD^8;6!^P]%**J8>["#'="1E-B^V'(G2V77TQ9W1F
MDVD2(HHTCD-,_VB.FZS/E3Y;J9@5[\3=6P8-Y$V/LP1OKI"$)BHO*"1ZH2S5
M0_@:RH34="=?=.B*,ZHGLNBQ9UTL"UTNV ?7;9ATW\O,<2R9TSDPINQ';QJ^
MW:7M936QDYWJH*R.ZU+ I32KW(^-P]JWH3&,0J&#'K @(\4E]1[G:$D+QR+&
MA/=%#=XVRKIX%DJ.M<1=_WJJDY2*FZET5^[W6<I'#B6RKV2\(<7GEJYS-*Z?
M^WYJ,60L#0])Y4;)KZ34[Y=SO)%*_7($B@AR-0SESC>F4N;3F-GC8 .WN'=!
M&0V$)%@:MU5N+%?:1@@8PTMS(@V:SEAAN\H]8W'HHY"#"(P1PTC9W(-C"H'Y
MR$&2C&-NGK=4>ZE("16<<\4[# 0SUIR?5-.NF*V+5%2$AX#%Y:E&!:-C=S23
M>JHHUC(G=%$9T%8:CDU](S(R+*)]<A43&(%HN:R<W ,LX@$KW#<U94^^^V&L
M%P$<$UF\[F<9J$9MGW71^A=X >H]KML:7OS\^4N>O0^Q/6C"_$3"K]V&$0Q,
MXEQKO:5P?B3413(YF"ML9T[CL 53EA#V#A8?JT 0:,+<8D3(^-U&7R(X#'IE
MUN-*]6I=XBT1@<^G!9'5K->N\'QER<,IS9G@#$!<8!I"8<:-#]),>,7$@PEP
M?8$\YWB^< -T>,H-MIC,>PV)O)J>.*NDI.,2+Z^YX"MJB@?U#R7^]*^E.JV\
MS3*MPV]?TCKXBL5'XF9B2B3?<R4M5 EP5?HA=V%7C:!%SE!'6XEX]!CUB.8+
M0\U%O!2J=##AX"*,#+8.Z$1")PYGL"DI\N\N]#YFZ#SB#F"A?I4S7&ILU$Y[
M%?<B7I/M4!2V*?$I$71&5TLJ>B6F5&([#M2E(E ;@Z"JH BV[0I=[+"%,5I#
M#!5F=O',8RN6&V23*<DMQO4S,@0:$8TJC &>'3FL/LN*H%VC=PAJ=&3D5,PE
M]"[X/P)Q&IHR+/*&AAL)E0[Y@]^,T")*MV%?+VP>%48U;HM'"0N-C<-*2<R4
MQ"R9%-QA=*\:-(<(><JKE/@+I\2;54I\-\92I<17F _+^7'VW"AZ&4JJ#Y^O
M"O13%<5413%544P=-L74GJO)ZS$EH1.P&Z>**Q91Y"39:>+Y!)3(*\=*[A'C
M:W#+H"L./H!0577L*(4$]J7FUG0F4AE^_NNLAG\N%$5Q)[RAJA-3.'X.A1@P
M7$0;<)Z30Q>,/,ZS\G>,,>O"77ADW?@)E:2B(2F0'<>@"S%P06HNV_UK:%]5
M/:]+L%B3$L!I3A,G1-B+<%MJ[:6 Z#31F7I&:D/4(UT#E6^LM"TFB<;H[988
MF#.EG27<^+ B5D1R/+0;,PGSAK\<ARL4&&:_%AJ_[AK-;J_ 8$N+ ?93,;JW
M>'0J2'A0KJA35Y96;]]WT1=UYN'QKBE4EA6%D RNE/U,UBECCM6*%(18K.!@
MZ<R:0;Q9DVRD.T\U8O4KKA&>&ZO-TO-.*FRCA_06GC];8NB9NC!OB; CN*-C
M_:@*AO@.DS":CCWJ:^N#BQ")2:FI]\G'C^?Q*ZX%7-@8QDF[9]S$QJ!GX&5O
M#?)JLB;<IM&HMP?&_SOH_(B_<U60E((8F'<^.;MX1=>T:HUZI_O_O34NL7RC
MWL "E<?@KZE$:B.1FF RC$MCOGN3=%(JMSFIUN8EUT8H\')V\J(OQVO2X$71
MYU[OQX4X9Z;L56ME['*BZM[Q-GB &AD!J9C!$5HV; :#<A9KV2%9"<CS"\C/
M&.X%33YG.-$1D"?VP?0=J0M=U7[2D8B!0Q,O,]4>8?UVSN A)Q_IU\B&%$N(
M';+0!S>VTH7>";60X7[E1>>#7 VRG_3TKAGQT'G?%1&4$AT.Q252[.GJ4:9^
ME"4I":029^&3)5&>S(7@*H@LZYY#,JQFR51'FV_>BZ&6I")RUO(F=I\%?T,/
M_O/2C#Q&3_9\5V19)$$-\% VAB$3JV2"3P*>V_(,GB"2Q;S@9H7DJO1M <&@
M$U>X\:PV&YCDP,'L>$XJ_.PD(1J\+-^KX$9494Y(B,^*W2&0U/L(42GZ9MR3
M1\/O59*OW:D3=P&]$IN;B(3G>I!D-E6%IL+ , V&!!%54"+ B%-LNINU/)Q_
MKXN (@<J>DCUON(K=F#)HK3KW8EJ>2)*V"@ AD)?#>4,$^96AP%4:K,R$H:F
M7._64JQ@SP7T$E\>T=I47J 4<\FQS K[.2_+>)A"S<.BK_D0PX-3)E]3<&?<
M666+W&V+8*QFSJ/,_4@*+Q5B G 5^Z!PDO::\\7[';!E=4"I\"&I@.SX*EVM
MD4C:JFUU,"Y&_4U*7! K!Q@7DM/P#$XE(!ZI0$?'^81EH:1<"3XD7E1)X<.E
ML!3#I1!M"0]86C7ZV@6SBMB.?.\;(GPQN(713Z5;B/^H:"]E4$*4][RO>\[(
M)1AJN^+G:&XM]9YN*6J#1GE"<Y2L=7M]JV@69M1OVAVSVC\:-W'=:+=_-(T"
M74?EFSVO)*Z./<_'3'/"%"PN*K33+>FP!0Z4A)JG(L*(R(R*WZ]0KPQ?2I8J
MTWTW(OZ0!<@I HW(I%54X(N):U%D+,$ &"RDF_I%8*SP8><&? B4C,2YT#FA
MF2DN3EC;548LNX_%881H(<;+BMF7PWA7@78))4B42S>$HL=\?(!T4&B_"]7#
M=M$FSNO/<X7S3<[R(LM$5:'&CVM>5;ICE>XH@Q1CJD;1=, J$L'&ORY-*?D.
MS# &;T+>#7<6(KRW2@QPJ4LD554%(OVQI@7/G0WKH:H%?J0%CN04+$@$=2VN
M0(5KW ;7V*IPC;LQEEW#-58ZZS%TEA-*[I=.%>V.F."F4Z7T8&5$2,A.L2HB
M?7N[94?G:HT>>*X0I1#8><3R/%]_JJ/]3#7.U6:J7JFF"?F0>C]*8!FG5.M6
M+>/S+R-:<D.I2X^IO1&R&V&P(J4$3XI4Z#'NN(QFFUMF(U8.3G[FAX?5P[JK
MPW+O%"MM1N^QLC:32CB'DJ!N3""#Q!J1;A8%,H]@-C2*V"/*JCXG4XI3YG3G
M3)X-#O>XQ,.$;EH49^$C[9+-90,4P0UF ;YB#T8Y,Q6X&8-4"MS,-KJJR,YK
M/J5^"5V!P^7,Z*DM$%13Y4U.J4M:>0;6_FAVYRP1_1"F^(JPZXQV%D:CXO-)
M(0:U*Y0/&V;Y2G-P8'1["[4%<^19,$,R(-4Q1_/S+_(,/ZIZ04V9KBSNC*^G
M2+VUI*).,8&@P#)37<Y3!TJ+JJZ7_^0^&KL<2NK/^+76O'U&G' OT]YF]?\[
ME^F^D_9$+:=Q&4:)&_I>2%M??PI+X'"$[-*;4B!QSS>!J@4=II[O<,E(E$6T
MBI134_6ZZC 5"T=*0-$_7[&!P.OI?\*1&]FTJ[*2\G)%/>-'-'D%HK,5D1^6
M5V))>JS8W!TGPA2$+M1%Y8_T'&%V&-#Q1#I9<5$]PC'^@F;79T6614V(<]"-
M%)-RHR]5\*\/Q;QT*?N-FF+-(*+*4;&CR&K8\8I)N&?JP'@"'5-3P12*P)3:
M ;;GS=IFNVZ]V Q[KW;&IJ49OKX-LZ8*$3,L\([1%LL<!]4=+0WNX#/=?(VZ
M]7[OY19IUU8I,X"TW;JRF57>'*5(G 3ZE0#D7!VO,7+44& A;[+066;U^;KY
ML@[JW?8++NO.K:M:1AB!SY2HWHW,*_:316(2#3,NL&O\(@/0L._#R#%^4=^:
MQM4X\I#T+_N(/:0S)%OV^2_4U(^Z9P<OJ5=O=FQI\<8EKH=\P0J]9:Z0F!*-
MNY]%,"+<W'K]')U9'(UGR7CBJ0H[^"I SS=*"N0VC[ESN_56Z\56=]<6EUK
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M,!Y8@F%X([FK.U89^S"!8Q%-8<YLU"4XCZ4'TMP4EI^6"[^$YT\C6=./A6F
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M%V).<2@?61^9%.8GTV,:RS?ZC[=PMH-W.'OC!32K]*.W,%DC."/4.8OGPUS
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M9K.[)<_[BUA,>TB%I/*0L?':.'6^IG$RD>LE(RMZVCDBK5:[]^H0:&D/='G
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M8B/<__S_N3S]<OZ!+O00)"U@!_2Z;Q&;#5(L?!A3Z+JQ3(SAC-[-F\#M**4
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MCV$6\6(;AOJBR?G85&H/M'S+]+JX0$^WZ'3'];L\G$Z00#YO0G**N@.URD4
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M&YVML77Q_F=CPLXB1SD'0JOUM.?C4XFO9C!(;A6Q/NXMWPAC^35$"&E1;:6
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M^.WF8DVJ#HU)W4$+_4J6\\0@Q(SH5"B(N>F7X$:(A++V<L2Q \]+LQ0.#;:
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M#.YT.C7)+3>/A%H:N$!/,I^FC"U -\9B9+F[V5^_1[*-#;:%[88[WNM.I1+
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M0'F\V)C9N63#RJY"];Y/]&EON/"V^,DPP>@@&V^)"[8;._]"IH@%7,_=^DM
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M4W%WW)U__+,?68[J^3)H&[+I:1QE<.V25_M(RH ]<2SE^I"W'4VA8*(3,I)
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M:,PFE\2N7>"O22/8\L5/6>O-!=TBJW'T+0RFW\[!,&N%T2)"3%Z PH3@&0_
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MQ]-ZVG>1W_IQ'&I^RLOP;=(KW)9L&*U=V=96GX:!"\5!8+Q$;BUY[?NP,^Z
M>1A,::>9!F4I[P9;>U1@FE5W\!)NWN/,)1<Y U,;QRH7"S@W[RY?LG28N8EM
MZG3=&_)SH5<7&FO0[_=NX-^-\)/R83I*O[\;]Q.-H?_I4ST9$KY@XK7!*!)\
ME2TX0_ 9UZKPI O:?9@Y6P-_+K3K3GM=%ZV\BOTRSC=A4LVYT9A<P%HW8@[Y
MI-1:):/A?! ]U)G%:"-(%@6H7!LGJ.0AZYB**+6B]+7@OS6GN[N@>-H<VJ\2
M.JQ5N<CXQ>ET$7RZ2*R[Q/TZIL6/]=KD/?YKAI-ISQMIH['$;=K H6:#@%=6
M@L6@6"!7P/G-&@EL^^8#8$E38=]DAN]P7?DUC'_'Z9R\/:-1)F401#7H%(L)
M7/$":)---FBF<MJL'M#:5QR KKL1WXHCN(Y/<"]Q\!+_:K ,[S&GF/,\@TA1
M@BHF0<Q9@[99>Q3><K:/H_U;(#YMHK35R KN=! 2>2?2.<EYSUEN1' *C*\)
M&_4LP67G07K#6.(I^]PFC&ECB,^&._?0R KN[-;;:!7,BNTD#OJ?YJ%Y[\9X
MUI^=G0POFT8NIEAB4E"TI[6RFMB!!0,TGJ(LTR+XS3ICW>_]3YLB^Q+\"K+L
MGGAW&L8+6[E'QK'F7CNP2=?4+Z4A>D9K'N8HF2^EZ#:[T'<,3YL'.\ITA7KO
M?<![A[-$X(:I_WE9S/_U:+QH0GW>]N8]9CS[/%TN:3VN:.5R9$EY1T:QBEF"
M9Z4N<(8S&@7ZZV4$M_9>MT/TM'GR<,I90;%['_ZN7?46NV(8C[_UAY\68R#W
MO!]B?]"??JMC&0WICWO%.E$P!R#/FP26Z3ORMBP@\E!;V@LF-_-P=P!Q<$1J
MIX(5W-FMF=!:X$>3"7V4?QZ-QZ,_:  UP*+GF.4YJ@0I\1J.XS)$'@0PJ[F,
MN@B4F_5:V.JUA\R/G<6\@A'W/F*]V\R^QN:/IU@;J5]FLV=!YZ3)S??U=-C0
M ((A["):$I>W.36*;-D!]-,FV+ZUMH)Q.[<0NHK](X[/>B9*D9GD((*N-UOS
MI!:1H%A1LN'T'^7W0*2*Y1#YL;6,5ZA]US/7@N,QYH_AZ[*WU60R2OT:Q/=Q
M=).D]1[ARA%RKYB(QBD!.A=BK<T18F09O'$Q>H,B9KOA=K0CE*?-D =0QXH
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MI"38R&P*CXS,3:6L]Q_;OXG0L<SGG0BL;1W)]8_+E^"7\'__QW\#4$L#!!0
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M_Y#KU3/!\\(3OG(G6K>/A 0GJF9W8'+7KEYY1M;?V, E'#MS7<2KXY.),B,
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MM%N<X9 B%@:I E6'9A"PV(Z7P&LB0SV O^ 1Z\)]F2](,![E0E&G \GA'^G
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M9E#3Q(I@59*GV*=/%.D(AZ"UV-!%VX"LFP]_VE^G?9V^SWR_O[>7-YM)6F[
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MB1HZ,!B+_(S%^TF0,>Z)D5YTP+_E&/8#=9R6>A Y.T'KF^<XCSA8"F1#W>$
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M>MQ9?!!>ABZ3.1CY]]4"C!N6Y(B<2J&=T#39ZL)C?_SD-VRK/GGISJ7^)W3
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MJ1Z,Q:N[[XK@@/F7#_8+#7Q0$^ZKZ4'L70)76!#L7 4ARLAT!G@SW:U;JM9
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M'>38Y']9!,5;AF#'%M9W\<< N";#LJ:D-U(8YNL)<CV;X$[PBKIR# @D)QV
MCH2E9[#/CP'D&^!6+%DB]2#Z!AGB7+RQW-'[JOZ]57H*,@H^X'HK9:$'M: 3
MM)9@2/DKNGR5&21?$)Z=FXN'YGF(H0*&@;KID$"8GL#3;QES-0[0OB-6!F+K
M'4P^R8J 3JX'6D&0Q4VH4E[\=O A!Z91_T!(._).8// >;J]XI/4LIIO'(FS
MMT[MCCAQF'P]33>:))D2V7#T&"+X9STV J;_?08JP-'D+AZ1Y?JZ(:<^0E=J
M?>[PS#\%_2=WT1]D$(LS\E.&(U/.R:UPL?KG$P8P?7_&^!;D<O;08VHA\07/
MRV(X$\P\-6XD!3@$0"UJ\A**>P/#N']0M'1G;)5G=M9AU@S7\@_1XH+$-?W]
M0F!;RBRIN=.8<G\1[_;7!/DH-4$ 5HQ8C2FGC0)KNR"S+O^. =Y%."[&2W/T
M[E7$BM%D))8JAFQ$K!A2I'%\;4:(=]@+>PGLUILV?\HAV3]EO]5/R O\VU\^
M@[_\:$$I7(];T;6,V4!KLL=;3E&V8_)HXJRA'/BRNSA\LW]G'$;)U'&W9;/)
MQ[3-J=9#B;/D=W0.%5HU%H<$/;=%G]^PRM2/;I9M3!>JU6O_N(&[VXQ<=W9Y
M-TF3$/T[N3M#D,;=R",>+)N\IW+FE/J!^%Z2ZG7+9VI%!Z4Z&6JI:*@P<;R
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ML:9_@F17%Y<GP3SSV(Y$DCV,09;/.M.^P+R(^BT,D$P7H\J71=J08PB@]N'
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MP&3L_4_'@'<APPRJ%&9,5;%X4E@3/ 3@.$=]+ _%2Y&/ ?3SVGEVZUB"T3$
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M8$OBSA^^>'IZ<GGR<3FZ6'/SB(B(<-_CY>;EY00Y.%V]'=S,O#@=7!G^4/#
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M'B5M*K@DO='%$, XX^*$ QRD$U#^\69:@"4C OC/K&R)RV>SJ$WC D_;AZU
M6O*GG-"( \T-QZVT[U%1%_VGCZXKL7H(':LMRK6C5I%Y&"S9(].3T$0JJO/<
MO72LC&1SN!M*^^DE^[-;$<:7$AJEB%HX&U!Y(=^C!=NZ(8^;GK,I&;:7A4N1
MZ\5+=:%FB-AE*M\8K@UW>S8%3>3@"=$[;H\J;1Y])RQ.3326-A=8,&5;^Y T
M@+:QNO03PC _.\+P,1->U"<ZV/WS19_ 8Z_N@%;8 >B"V@?0G_3%^W31HK0#
MB^>MZW+]*W"V1[A.,V"JU/\K59)3)8[EVQ ;*&.G2,/W.=,2O(SDX0VQEE2"
MH''E\MIA3DO1U]7Q>PH6==YWHJT\'K?<:Y=H$KJ.J_%N.25B4,!?MXW(U.ME
MZ_ WDJ(O>M()AOR",[O+W\XGN^Y*$(?08# FC#_]^U2I7]%.FM[=02Q7\%W.
MRB/.VD_51OF0$,!<: IJD%E\+:>G)%GM1:?;T!X'"SG7,IMT9"JN0$9/9S5J
M\PP-N/5Y\Z*!;B$TT*ABH]^UTDA<WNMV+D(?F(LHK]B;.U<9B'[1)F5?]Q*O
MF0&KX& SFNW]QV17U[DZ":5A&5'\!Q;QAYU?*'??*XP]>-C<9%[GNI_Z+L$X
M+($;N0\_7^A=Z$0#XM.H4WX;RNM_R[+6('=-3Y?0P/&W0M)2A5O++*V"6[@T
M-F#NQ4[5YD$F6A*VT+]Y9Y_@1ZD\_029A6^S:_<YW<%254 7%+F;@#KA]T^!
MG\XS7^S8&5/(0]UG7S<V>],FBB=5)6N\2-GSC)^3?;B77K>%62)]3]5G4(7L
MP2!'O8I 5_\8YSO!N#'#(M)%3+I.O\P?]M6,F.^6:4J[=8] !+P<F7;<G+D!
MKF W!70[6.DK/T.^ V)!:P ^=9F899V#Q]M^N]KYS$"5X'[:M34\^M@Z?B_C
M7.:E7/]G\RR%D,<@UDY31 /;HYD;9&G[J]"+<X%>-UO=C"+_H'V4/S,:0%C%
M?#*!=V>!H6_TNF'[L'6,<$.7^^#G1S;GV,O(,S4T$-!%)J7[CY=M:?]0FMMJ
MYG7WX9C:<1BR3++<&&,9#9 @%G+7(=OR:" CO@9_"\6\2IG8_>6]@9V]Y)K-
MF\RQW:8?N<>*/8%&N4<W2M& 5.$V$@>^\_&,U^2GZ('\(\$:HC19&_CC=<@!
M?B,::+(&T0CTDWO,&;8I?(8/#838_:A+=K/N-8",B'9<7"E![%"@@9:8#1IS
M5*#N],EU-# KS[M%)N=/\N$BN C>PW:.!C#2D"RHYB'H"HD_&GC6C2)VY9IU
M\ZEJ0IQBK2,.AR +@VLDX-)C<W!SE!?;.W(R5W$SBCTH39QL=>OR4;U\V N;
MVNP,Y-^8GD3^\Q%0^/K+?_!$^/^?&.;/1F$[T=2$B["+Q+S)46^$S;YDEY@\
M@M:$KSQRGGD_!VFY*UB6;FM@Y".8*9#2>;OLQ=?3%PPD6D?/T, ;.&H*?I3X
MZ 1<#'I[*E0UN'D^X!^RR'%JUJ+,*U/4XE'6)&C@&E7;] &D#GSJPTXT_MS4
MY3.IL7#;O#;C\/9C3G"6J:GX-E7#84IG-446=2HA@#%49\OF5%7[?C(Z?*]]
MC%H-R>%(!N\)V$:=06;E_[FAXX8&R$>ZYVDDT8#NSM%+@DCS;]55E:57!.7$
M:[3J./C26DE6EF<_)IC-UY7<G)2U1P-X$SKM&P^:'YI]%3%NP']VS<<%VUI$
M*S?KPX7''<WG 2RIIO_:=>>=[S0,7U LNTR'/\-SW_KG'1V5/ VA-ZH$C!Y3
M8\2+ONO]().)E-H1K!$X#BO?O+NM&EGOZ7'3FT5UR&SZG7FLFC2KDMO<F-/8
M\'B>B*R$>6DKN./;=STO<+? 9_ #BAC^SRV2"3_^W@-.:(O&&NKNIXI:>UUU
M93&U\I;/&#^G,' A@LASEH]B;5,T*KAS%K5.+ZXI<L4KZ#H0MR]0$YK%(T*T
M+96TG!9'8,W?VK] =DKKC=' _7/$^0H\Y,\M'\\(ZWXWTQ>UNF$;]509QF-3
M;52*+['WY58I%+&N U>6<TL$PIUG_6^KGIR:98^-RW!&KE@F]4G1$$4Z>,P<
MS0@2%C^PU;+=HN'N2106V#FH:8?_BYCZ3H;;!,\@$>Z<M)TM 13WI,9OR??+
MOPE*7Z8+3/5G*>US6[Y(<^=4W.!,.>72YNP-?Q@AOM*.:4[W..YD<(JZ0)5J
MO$JSA.KN?$W7OS+SH]?PG W^/<J;8605,6ON58<*/H8?]UP>07]J+=EDCFJA
MM*GC-MRF_\4<N?)K;.2C ;8;"D>BCB=Z4UQH(/UB^N( VO).\LX)J&[XM[K%
MU9882[53=1?YTH&8%ZF<(-OA'VST)V6HX"K3WU:Q)7RUSX4]I!=BS',A-^OU
M04/C)9>&Q/VD=DTO<+D0OX+ C]4\<MH(^4;;H21)YU6("DXV?0V*>^T>1\!7
MA-Q/8W8^VF@-)9>%67"!CFG,3Q.#L-YA_?+I4*45WY6_P/F(X$&1_,3W&;BT
MMAACGDDKM@L%N^$\*.+9^9+;\!ZKY7W(K-%*;C&S*DULC?G(2EBTGPKHS]NT
M'_ 08:_Y+X@#\AIDQXFN..NZ\FCKITL6^2@D^-S??_F;9?Q+V@%9#;+-=2Z5
MS9M^1,1\9)I68!=R@;T%_65%C0C>8S*_3Q)4/JO80A/22=M^LIOV K'"Z7P:
MX;2;_ +^BVHFWE6.E[@<W=D->P%=80?[O,%1O<BU,B>>=MR#(B(UXAJ&$:/2
M#0=",A#-'A"G[1//SFW"44$)J">EV"(P%_E/+A_;9W8=&D#G0 =Y5-' \S)P
M%=/?H8'71??[TK2^T;8L&D=]F&OP1 6YHIZ\$W_T$=ZC!/^A<R\W M3,]6AD
MA)851 ,K3$)+K/-ME-,76#G(-G-\K^S.7Y+.<U%VJ""^@">IXBK%\!XYQQ\Z
MPKG1K\!)T9&KV94L[W@O;=J*>:85%@Y>='@JIQ%?B1=!T68+.\);=I"#FV\O
M798P1<&7D.LL6B%<>D<D<07BLH5@6H"<?B_L]5*W&PGO/-/1R\4W*OQ4%&5Z
MHE!AQ?AV%7Y=,^:F+6+_@GM9_TDJJ\O'9@M8%/P1>'NOPD6=ABO43B^2]XN:
M56G H9;/_.UU!?#N#<1[$?=-=>J+SVH=)"FL+<EL&Z1R+X8%P+N7.S[ ;7NS
M01D%9T2N"VNU4>=Q1&& L'?_E'E9E7(H$PU 70+<WXGVMZG$"<KN%JU!]X^9
ME]4H?Z9#%U?1@%(W\1I'T-=Z@2@95$ 6<G5>%P%ZD@\5[2;>[4N,U2=#5)2
M*<^:VL]7ML/3^WMHX+UF-G%1B(4)9?$Q$HD ;10?$9XI#]*K9EN0RC87F(#Q
M=_9%J1ZC FCS(YPROLIV;[)WGY[ 006Z:?L[H )MXEFEK]?,-<"C.'5;E3)D
M&GELF\?:DAC[TG2,S'1_,E_V8ACL*E0E?E9Q= Y&P)GRRM0(U&M5D)'*0F2^
M.0S='\V7W>Q&'MF6*+%BF&]60<".EKUYE$^%3BX^\(EK"[I<J'GQ$7ZZ-@AD
M9V$'>D*1![:2@Y>?SS7[B(1KWZ)\!%AJ+C^E6%N>W3U_@-COZ;O(,#U=L64S
MP%+B8D*=9N\OHD[S0KA]I!27.R_VY=.XC[MX(P#XY7]:/\0T_W<6#-3E?V]P
M5OSZ6=)Q3R^)WDOFAQG/(/^G"1%R7:1#E\![L2KM(OM1 'C7?C640P,?;\%7
MI$N0/I6I\^>8&SN*7-/EUD](.\Y*E+)W-VD.[2%/R@+F5(.A7]@'P3NNL^3<
M:RO[2-(Z3K=JY;CV*&V'4"FM)5]L^O0G$#3Q<-SOE&\O%BZN&W[Z=[  &UV?
MHN_?U!EK?32P^?CA9L2U-T2ZS,P M;O N$%:N:*'IRB;_'L&^X,T$J_^#E*=
M5(;0-:KQ=$Q%9]A"8HA/94_Z8]=#89)U^R(;GZ&2/#_A1WN;'TKUZ.,,H:+1
MVM:U45F^A=;97HJ[N"^BYJ9H#+6%V$(%WDU\JZ<78:\3:?=NTXY85@\ZW_S4
MY4HS-8<&;.3,[LX/;*VG^@RYIB_;U1G:>=[1GFB4+T;2]#NX08F\TM0:I9@K
MHHB:J:E)F\^(NGN&*3QW,8V&W09WCMY;Y\*2AEWPNAK?.BZ$*U/;BS#G,PBW
MVV$(-/B(?=N:'SADK*G&L'KCP$C(@@GP63-C#N6U'KWUGD^9[HK0&Q%5>*.C
M@TL7)'K3=Y"-_?U/@P:<_/.?#X],:2:\=&7+>L6YB[N*,7/&L_+<NEFNC(Q1
MO-RO6V2.]-_^#@V_:6AW)$FZ&_#ZXY-XF]G8SU'GRI:>YH%!Y!"/DCOUJ6A
MH];NO;3AV_QQC.SW;T;F<Q27LHV5=8U%GI+NG>@7.AB:L9\^7A:Y]LY:_,*6
M(<QY$;:&,/Z2;_!SN>XDMT,HE>HD/VLU_@=BE,SCV[+<5TEY;QK/T#6>D&[A
M)G'KE"6&G?,52+ELQ%:\ M>8\FL3.0X%FVFZA&$LHH,V;\O#I=P"5>:!+:YM
MID<CC-4><4&'[:I>"[O;.DQ#%:M;,[5O-0<LJJNP9/BZZ;W*ANVL&7:RJ878
M/OMS?,D;A8UU9/O='_2#WZTI@E62CCVO90@F)UIM[FE7=VC=Z"X1R>KEV*H@
M'.W6J/Q4F;(VI_SA,XLYUV9X)C/@XH4UG%H5X:>]]NAPTBPQ%$\H/E9^^=&&
M>['OPZI[L-JD3.NK]NUBW@M1KNO/G%,"FO-8"FWZS\,VIMF4QD@."9@U^O3)
MM/NWBE*DE*Z]-N!M\G' %- LL:4,+2X4E<SW]/7IC60P^KY'0AOL+%R0^A"Q
MWP6F)0G&MD<#HR9CD1EI?\>M_T#'//]^-\#[CM7O#7SY+1J8OON./AGEC;C8
M@P$9J0UY-__&?1AJ O6X!+Q9="1T67_K%J +_0,'Y]_$]^FA3_@MN@Y>FUV(
M[00%Z0B?/CP0+*;:7S[I0ZS0Y;?P:8$[Q%I#L;+,R'W'\Z74.Z!,U<6^X@L-
M-8/[Q&D3CM]32Q4OVI$%#UAR(_[HN)-P'G6J>1,\=_&R4/,!VKM4:, 9P?90
MBG4N\#?I%(4&JJ<3%4*(=Z5^D\+@"0+*QN*S=O[1(V(.WQ):5)".?G5VGVH>
M)-7VIG_IS4AES1 "]3ZB QEK02W/M-K^(,5!+9.@%@"\@(.$4.L!VC,Q,6#_
M'5GBQ70&-.".8'/)O(1$SS14B0.ISHM/M5HN81 8N5,6WB5R$F:X?*4!AMQ&
M)P="H_SF7T@*FWBV+_9R1'LG*@:$3W'XK"V_VS/%O]Z(1'CEA%RBK%222W0E
MC3&4ROK!$'K)?SFN_4)#-0O_4KV8G0_D^S,,-1K6#VH?D/FSJJ*0[['7E%C&
MIL+VLO']"1<59$)$4XC/(-_3RL$/,!!\J=P>T,SEQW.6O[4(/URZI(!QP ^2
M60I:(7<)/^1B7[Y] ECG4GYU9].1OM)\?$;IA-O3=_.2(5L8<U4*GQ4&2+[:
M@"A)L61G 6>41M0'6?2RPIJ /VL31 DP,'@(43*"*&&Q9&\K8'.)9%WIE6-I
M X@U(GBDL(F?1*ICR))G$@,:_]%.G&QB#9#2)9B=?N'9R#3X[--.V[=>@\7-
MT!PNXDU+BLX'.-IN"ZESS\12V,*.MN*.H!5HP%;?_VW7GM]V^=UN/N'1.N')
M5)ZAY'-7Q7.G,M3 YW.-V"]TY]*.4SAS=:[OGMUGZ'O&K:%7/'>!,:7 4='
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M_$28D:L@[#L9AV"ZT47_08FCJ.J[_LF'0Z0YAFU77>E#/%73'^,*GSZC?CQ
M,-M%5-[6;RC7WQ51N5@AF+^(N7:;O'M6BE8TI2I\6QPZJRSVWF-NS+#+RI#/
MW3I/WFD3DP73+2Z^J-690CP(HT/I;1MEXG&HN#/L.HI]@+FT])S_"GD%-AGP
M[E:_=)/W;.#Y=Z_N2O9ALYVCE_8D]3IGLL\UQI67I<)M(^[ M_,P%QV=NR3]
M;RO5#C @:OHYENICJ+@LJN3B>/JOR\D"WGX&S0.2]&O;12=#VW)IJH/F59_[
M^A[*BQN^>MPVI'+:[FLMP6/T\?V\L2**'L:G9SM6GC2<TE01+]9E($(R#Q.,
M.WI$$1/<2BL\U[!E3*9</9"@D:92EG0F_K3&B_A[]6HHPYT/I@0VBAX.R;+]
M23/?[_)=>S!E1!TV&;F%BS  =MDW';5Z#@C)%;-4& E=YUDYEY)8'SR,B_\R
M)]-BD4<5\[#?\$LJ\^<3NSG6]F+!3KM"N<^O[=2GU6B73P<77^S=P,6Z<95Z
MWV2-WY[COCM>_U-D80>O4<<"U^C$H37Y:?BA@ $W_HD/E4@Q?8_;U\U<MKZF
M).?GL263'-7-'4\/T@FY&P8JMG&\PKZ<&5?6Y:WE<&*>2[-ROU-XDNR3;TG>
M!/ (KW:(M,GOY.H/;XOKXQO9:D[J31CP3<B[EQA.50?@N44Y[48[5^%2+ Q_
M>B_Z=;IBMZQ*R)$L?IA6\S2*UO53):^N^'RV3NG.4EB."56#D%S_QI;>3:NJ
M"H6)X $'3/$>W&2O4WO(O'V*K21]6FN/8'"PKZ-P2-FR@G28!%],?CL[L\I0
MO>P<%>$5O>X26YU@S534E'*=-[ZBN&*9'?6AV3[0P>B^;C+L_V%5]%W4W>SL
M41,Q.0:KZBK%JU(NQ/&B%LNTY6A@(TK(/Q,-6(]M?<8RJ(JOJ?K:/-K1&<O3
MSH+9@F(\B4 #BKLDAZ%OBM>5)1/L'>I^EM+46T:P3BX2U;JX)@0W,U<\76ND
M>VNP*]'06#=_K>2ZP=UP[ ,"QWO/U?@^ZB4@'\-=&X6W34"TN$FE42LD&AIG
MYBXB0Y'D:^'!)H>_$#F/FRVZ?K]W.W[2T:V0*J02D+I;*4^$T<,EWWFBCOMR
MS4/7<XI_=RO3K&2-5"UW56?X)6?"*11F6:%C?''T#I(<W3B8#9O;5+*'J];5
M#SB2XNPH-J8*FP:S<->JIWG".YL[*GR^]?$/)6W)Y(Z]X5:7=UO"_K&"T_/1
M>?^Z<_#86]+P[/L<+C(Y^AV,ZOXI0LKNV/3@^?)X/@2<DVS RS'0[U&!D==/
M*KY\6R%!@]#W8O6>8_6>N?37<,;2O9ECJKV7ZK:??_RV U5U8])_4DL7W?$S
MJ?8<W-@ZMXJ21+G2[.\XC.V,99!,W!NA\\3$'2J2S3$P6%7)A1WMC(X_M5!(
MC[QS=V,9_YYHO UFL[C8G+'\!NVM@>)ZRSQ;T<&IG$I/ _%DL9[[-:%+JC5-
M6O5HP#?ZE6!-@4TC]F![ G_EW':[T$TU?KX7Y/2RPK>JB!9BZGV>-/@VIV+V
M^S%DZ(V]+G9TW"09L+W;JZES?6.DFQ&CCL97IZ>7_X.ULPU_)[3,Z*ME*J0L
MYYO1H96167C3PADXZ>-VHFM(_F$'KHKUUR;M6U?Y\Y\,W6E\LR""0T%[>S_X
M8NB_L?>687$M3:/H(E@2( 2"NQ,@N#L)P4-P#Q828"##!'>&"!)< B2XNR:X
M!Y?@[N[!'8:9,\/>[WZ_[]SSW>>><^^/^YSG_%AK=5=755=7]UK35=/=A5[\
MWEX-0F13LGCIW*>@VU ^*KW$XL\I/V;EI$+V-7(-<^"^@ND^30U#@P<^CIO/
M& %G.:<0L9*ND_Z?%?4?#\)X1,PG3_-2G@TS7YM^SYJ2G@D4-BH:O,F@%CX\
MMI \EJ'1R[_(7M$<JW>:Q@]B])^F-&(JKQ5FFFGY\\L(1(Y3'547 "1&=]AF
M7*@65&:E+LST>7IZ"F8MR7O6E=>RWR_!X3MD6'V4++9<NXK\^.'RM9)$FD6J
MD 4]-WIS?_/!L\@P&=8/6@:@<4/CTLJ1=[M_%K$9.-QB!;$G@-??:,A=\W:&
MW$R-#I]=Q.D0@@R/9YY:L][T*C0HX>+/7U\ !\"6RC("(+P(4Z/>X3&T<9RJ
M",F/_7+S$_,K.\\#0S;>]8T2D]-=M300OI5@QI:N*MB>+=Y:M98HZL6GAC@R
MSN;5XW9^]8.ST/Q^EC&!8)PI;3/)]A^*S1YO/V3S^Y8:&YE>Y'B"7(NV25S.
M7"I=P;8@^\"YL^*U%490[YL']1[W>X9.D^R.M4>\B+FRW,^N\4PLZVN.$WY'
MC4M_=Y5RD+7K7.083Q_YDUH?M8VCR%@=^4RB^^&#'K$[S6\^3&H]4BD-UHA6
M#^J8XGYK_.-5(3N3?2=F690(;40J/OX03'796[9=_55QVN-JL$I/U+2WY=UE
MWOUI"Y(B_WX1#*KDV0GSPS>I=0>_XD\+&>&#XL41ON9DY&9J+SPF[+D#3D#.
M:%"N2+/SH*7V5B/Z")Y5ZLE^A2(UUYRIA7?7X$Q2*1,7]Z& F<A/(6%\]XAE
M)60-1[E8#Z2#WV$5295E3YD:<2:MM37:2JV+^R. Y0[L*@GGH@%"FQ_&;BEM
M]C8^[+6#33^697-FG@I_96$6?A/VPS$,N\A#[XPFJM9^9$+E!XE<%:6Y7;*!
M:+_+"OER\!RERBBK4LG)C$J>Q764VITZ[L'(=AZ)JFN'<]W&X:)ZA67Q$OP6
MIS=UA.UTO@-LK_F4%@_XJYIL^D>=50K4*&P&B&&'6^>T4UO>>3,?HPHMB5L_
MC+G2Y%2]//WC6FN2DGL)G281FC#1^.WCQ7Z-G]NU_)TE,KO+#C?>NX R1CNQ
MG-UK3,.7,OP;VHA A^I#G8^\E*0R&;8DLXJ=K\ZO!CTTJ#1:">7N/[%/]WO^
MU#?5"7 AHOG:P3,"ZDAX@36")_4-%((T+]RS*=)"!"F=\_#DYT"I9+<^HF\=
M?WF&^/A?V+AG"VJ24VI1)(]V(/,:%8HV0OGDE-J6F38A(\@G1%-0_@3E&M(.
MU:A0[PK]V[=DP6@3FB^?.YW[1E6]XL48C@Y]9,5S&]W<4 $^EMSX+)LO>2%_
MNX;2@Y"S=^6D;>PM77^94_33O/E4GPKK']@[JCG2AF#]?Y\ Q5%P(/RA&&::
M^[;J:<ZSA:;J3M,SO;&FN%7<?OO/[EFE6<S$+BZF6()X#J92?1E\FT,?GT=1
MN6LZ3R?7;"O8U5NE&.77NB2!,K<.ID 'A20'Q:-RNW#6^2*] =W<?-5N#AH=
M);:>K7MR1+HL;[X@ )KA&SDYS1R8I\HI,3'@0!$T"_+A:FI(%C^TS9UJQ1"N
M).E85M$-J>$HY8B@]'$L#SG=U2<=OYK/>!!G7Y@95^OE2AH<?$.]]X7R$"/*
M2*'LYYK_9="!400?GH<S$=J&^M;[&6IJ+UE;UV(0KX$2E=%)39)%W.^N.3M9
ML26>?'TJ3(F0XX%M#^<1PVF01T/0+$&&&/N<@F#O)/;W,T42IH@ ;1UR<<<J
MM&K!/Q4QN1<0U3&[^.4M+A++\![7JKI8= 9'/PAGW'MRD7[[Z!T9JO70=(/&
M!F\H)"=KK5[,.>7L39V0/ )@/";8S*%TIPJ9$ ;;.A-75KP76"A[*NR_)S7(
M.+Q>KL$#^+E$1//[&FVL2)QNT/S$Y9UICOA%T4YD0T! A*F##@!B:"_J*OSA
M'9XJY<=TU:'I,7SR:^8?^42I*("CNCZ.74/JG0M'^8:JA50EX@-;/?G:ZM=9
MV(SG_;ST7#C>2\=4QP7+TO@5T3LNTR3?&8R,01J$E8>\A+]9)!*]-Z;=)=6T
M3/R(E##8B&1MY-.TK40 ,ZU-]."?/RM-R4P:2S+F9FW /C0])T8_V9^6@MM:
MU^3(WJ711:GAU7WSLLUY97P1U*]2X+;G],MZDP3,;OR4\'5K"KL0IGZ)P@89
M8\CQG(8,C7FN=56"TS$$#YX&!EO@>K1ESRUYRS]<S'PMA/E]%.L)?QU&'E/5
MPUXKL+MW"7-VC#-7V<V/%/.ZL+F>9B P42GD.=!MIMA%YSC<H%M@"#H;YW88
M+[L$._,F6U0G]<M@'(_X43T02<675/'<\O)\ZU:K8OB[-C-]^?G(^C&N.)/Z
M@%-?Q5#CLX>XW#TB,Y]88E*IQ7I;IS\;OCG8QM9,@ECI&_4_Y!LXK^Z?9VR6
ML+(3F\@8DJ$QAF3U80?LE^_RJ[BG&@5C&^W_J>&TXQ*:8S-GK\9C9 _MD $N
MP]'C?WIGU5<)'U;&.,$9O?7Z?HY*_5YE$A_-(R6;#F3$5+8CI_>_9^?-$ 0<
M?W?"#M^-S_1X%9J7$[CB9G6DWT5W'.TR,BJOW6C_"R/:)/1_SE=E,J#^<U13
M?F1OL58_DU?1[*N( K7VXH&\ K7UG?;_L,;BWY<VP<*TBC?G5SUUR5%V"GT2
M&1,>#Q*35)JIU'N;_VDOW<^]BCFA@5=E0WMV+J8+!17EXF27'[",(GAX)!53
M\>YS2.M/.,UA<8 $;5-^9LWU&+:X\$-B?E;XJ-LGTJ@1I\E@LA)1](TXSXGK
MU396C11[;3E=U@?'3/:N->7066WS/497".)I_!@59,9%.JCQ^81H6AEP>31D
MW>83_")S7Z9;J'.S*8MELH'TB)B:F8=Y!O]<ZXCH7<!UWN5]_RA?EBGL<PN8
M'R8G JBC765'5[0N??2N$OX'&I'16PE?A4;DCW[]PS<19WO3U42OM#8-=>#N
MTK$!I3<;'A5)U^"O/CXJ1 #()WL2??JOUQLQ;Y%VZB(L-J+= I5  (VZ>5IJ
MAB['.*2P!/S+->R;H_+DERG(LB($L!^3CQ4Q!.$I@W:--&W$-"'+W"D@L*-*
M%-G//#QQJ96RC#-O?KC;#'2!0Q%\TG\PC0 6. Q&QS-BSG$H3*V&FS9"2Y!D
MW@E*^W@Y-T<Q7T'9*1Q[)(*-?9G0 1RUZR4VJ5[DA'X 1_IZB8-I1)6JI%I_
MXIHK%"G $Z0 GS.ON8(1@-29Z7F++F\VA5=)]>XZ^"9:%@&D>-(BJ?&R_>;G
M.^$7RJT"(PI(QL?"/IVI2'X5X3<'7[W#9?;!Y@C 2T$?*]YZS;NS=]V)]O4!
M H!=;2& \STQT(^#?4]C:?A-YZO+6^8.C1MJ--%IO^N0,Y),:K[2-/C7_3^2
ME/ /+BD7#U*67JW%G,3R[[_4OEG[(^>L.\$[U\+L]R/G&'OX9YR 1]1>T,:S
M(>@F,=)>]]V"$Z5,BK'>W'F'  [(I5M**)230:XL?S)N/J0A@$&&7@2 %@UC
MDUZB'6S:Q$?VBF\WG-@G2#1KENLW KA0**>]0I^"+O*A=FF$6=.>8)4A@&9]
M!-!2,J0@4!? SS_@#Y-& #)&M##,<!0?BH/S&[0GT@<DT@=%Z')4PWM4O_L1
MP&>KUH#B@!P$L,@$75)%YDU;K>!FAE#X'04X<8Z2@@22U9XEM(5C*?D**PDI
MA3T"\*,_R/$7OX"^1-8H@JRQ@@V/ZFA/RFH6*?-GE9:%$VY0TP4F*6KGT-TX
MOZ9-DQ'HP7WN@R(QMN/>:D>5FKC_#,^ $W#C0 <;LI%"$)DN&?I'A;F[/@"Y
M\B& )<*#JAN<:0@<30ZUN85U"7)%6KX NQ,,XW@9)+HVB]0&4AF?U6[K7$#5
MJ1N:E>7G5SLS.<-9SI%4]BPH2,K7_J7 U\3,\]?@AFY^[ SX5TM\A1MV=O;G
M2M\DF6X>_Z:)\HDA)D(S?R'U_!M^%:,@#?@&"?[[[QH@3@@>Y?/5<F%8;?AG
M!9[1RV$+)4&C:R,BQPJ*];<AO">8@7T&8<_CF:)8]4)'^6H3_;'3L*M3<<BK
M3J)/,E"T*-Y<MRS[FC)3LC1&!7' '&KQ5W U]GG,.<9=SG)O+%6#U'N.D"W6
M+7D4(OOG^)@0]5E5SMU:N7?7K"XQS]HFL7$=CQ+Y#KP5B@S_$RK[ESWZL&41
MIGC!>/47]C^!@;!JZL/(>* B :HDK<R/0M30D"%<1\D?,G.E=*6M0S3Q<.9;
MV[$"04R;_;Z9<-EFAJ0:=M!_HM"QO7DV\^*G;<&61*Y.C J8LY='9]&QFTX=
M\P^*A\8M:@'F6,/$]S/02D)/1"=K[%*ER'8.]=V3/.L[K_Z-E):[+52K\SDN
M[HAL,<3W]\.R;GH9M*=,43( ;I2-D?OP]KSH"B&[8IIOE%"H[[DN\.F/'&!X
MJZA;#>;FAURU)S46/$A@[)IP9#D-$Z%1+4BT>YWZF7SEB4PJGL2_:RIA^H*K
MQE2<1\%FZ2)R'UM3S?RY ],04Z18O5U:S"C*_2G9#NC_!]:Y_UF1)<2GF>?1
MT[+.N'%"UR\&,WWKC?SU'$[)J4).4W%J_MV=H?;+X/O#(F_JQLLW"9<DN@Q5
MRC48$("[DD2XO=Z;AHJ@MGD5Q_N&GX]Q=^GNDI+/U67SSOMR6?[3 3INJTKI
M2@S.;G.R''E=9AX//8.\ 97_LKNT_UY"ZE[2TIM2YF;5?F[D>DFQ^R?!^WV@
M_95>EAX;^*"W12C^8KSH)#3>]UL_R_6+G VF*)?8F=G#$'5L'(L56M)V\Z6!
M1R:VE7HNAO.IL449G39!K_5>2^G1\A.$!:0Q%FF/PIDO,EZ,O$SD^GS5$9<_
MZ]T ^_8KJI\Z1V3&ETP$\,7O'6]@?'D!6:)F-:*H3$E_BK==]O9]OPY^?IJX
MW@&53HT$Z=*E<ZBL3K2J?,-HT?3XWK/]Z\E)3(XJ$?+[6#)8OA+'^A>AQ7+I
M;L%&P\48E9P%<MD@3_ 8K)3T/.KQ8HW%(&^'3=[A0&@Y KCC%K6CKBHO6NCS
M^\S0/R.S**/Q,L88%\I'@T^VD9(M*<2-Z>9"BY/R(#N.8%B)]4__[]GHQ#VF
M2L<%46+YD:7PST^<0F55*H:%#+9-3*?3D>KX?33CX&#*B+'Q47+SSGS054?"
MDNB^Q%,H39YSV=XG.<!/QP6+P%=L<?7-D6V?%_%*$Z6M!SQ!\K=AS'A"KF*W
M"+R38,:(K9]"]!=S*;2>UZ0_DN%9&7LXIYZUU@ U[ZN&E%9:[*VKX>UQ"K$9
MDPP2)8;JF&>$=T749Q0P3HC0VMQ<.Z0>3WB]@1-XNY!EE47M_QX=GA>Z-GMU
M=Y1K+C5/U(PWHL%SG"8TWRV\1?K>J;=-K[&!D(VER.YTOP3'9;/B=0WK>TEQ
MJZ#3'<B="X??H(\3JOIAT8S=EKT<_J&):U_ 4^_.Y^(+6%NE[RK6?JP,^3::
M*#EHD&F\*K04(MP[($*6^D"Z0XKI,-PO3FY(NH*E8=09*]X (G##QO*5W:_-
MOD41&R-9J1\0-*ZW6G$=\A+%S3II4+[6B?JUVC@"^_G$4[X;URIGOI]HA6."
M>,N$X2#[RW*=_B[L:4ZG.]4+0\G?/5UJK_@BY-^+G^7'^J =C*?8YLQ,@QI?
M&8*[:RM,I637>CPJ51Q'TKI2\?GK#H7;**DYVN*XEU64L/WM8H6EI[9JSQW1
M_/_XHL\D9TAN=S3DV5#TIZU\*]RC*WNZM%D<S/E5E3$MP+%C(+2-A]E!:28Q
MZ*0;1IDZ.[U=>3QI%ZP?H>35Z!@NZL_C<]X[Z#VKE7X0&X WMM:BSYW@:5/I
MBIGT3>E^\>#G1R$6X8; <2BCP807^=("ANEV_/:\M7 P%>GC\2]DY0I^$C&S
M:*SF>+%,5M7%$TOC!?D[\V3>5OK?JIMJ8XT40VP:51O_,!R(;KY\J<;P$R9[
M,-\'IS9Q,VT1BHUE<Q53[EA7(E?WU^R_-^MJ#J!GN8B]_2RF&V.;,QU:.MT2
MT2$]I0[ M=%6Q%C#)*R=I/'<HC7'4ZM+1P7?C%C](%$L[#'X26\?YJ/ERR/F
MO/[%A^%B^KCM?,3ZK#:F+RLY?;RE8T;AD<Q0@=E^(O7VQ09@D>7AY8-Q,&O(
M&1M-$X\9ZC=87Q7<'[WZC5#6RD5M7H)009*] @$@!X6-Q]!8B8#^]&4F87F>
M0.3>>\?J_%*,C>3$06SQG&TIWD/2D'J-MSD[0P;3(/YR];9W*RX.AQ&?[*DP
MS>L2-]*6?SI)!];.5R%_M4\+'[W>&Q_?WC$V9>-KH<HOYCW:,Y\AZ_-P24D#
MU>JF03W-P6NO;/CNV2%G7[R^S2*LZ"7O=(RY6RA(@@M,MSTLDR-,;)@2OJ/_
M=/\N*D$HTRVZ>!\XQL=P.^Z8G@ATZ@W.%:1LX(/K&DQ<4RF W^6(6&]HJIB=
MSH6=%AT2<FS!.=V$J%G5PU7KHSBRPK;U/W^4R,;O<6,E!VA6];3,#P9:*$SJ
M:,IR-KLAWH_BE!CC9?(5Z9:$P9MJ9 57"."3$SZ1"E$\/#$N%!=,]38ISJ8,
M8P7#L7DC=U>&1B[_(EA[PHL[^U?1K)RG8];%, =W9<L'DL7'7D+8U-<N[>]L
MX)R'SK^EV"<$&CQZ57\<[!Y/<\6?Y:XOT@.QCL=<?P[#<AA#+!O0).XM59=[
M<K)+<A+V=&S9+7YY8U_YMI\J<2V<-4\0*^-@H46LLM+96^'Y1]MQL]]KLQPI
MNC(N5<N/T:.D6 \5OGC)Y<IEVKI08#;&6("<F?34.8(_";R6K4GXJI%(*&:_
M\VHOIF2;Q)2P(HFPY0_(?CN9+D(EMUYY$8P1^)6'T=&*7-K?=DPP!;@P;:-(
M-/0OR6BU=[[O9R#,M_K@P\<(2IK+[#FW1ZVND2:=]MD!1CMI[J*/%'%>B(G0
M_\B)/K<?'4%/2_?E =)]":-BHSY\49J/C6[@0:7_ @2"\-@R!9K?,G,R\]P'
MY6BI D(1P\,4%I2JDJ#1D?%O=V_+@6E9%450B+*M5EZ1#.Y?:X5>4X!R*$"I
M_UH$E!T/ZH@'^8[<KC'"_<LQ9,8SGOV)NKN6FV#F[O*+$ZD%PT]J(\E7=@YE
M;)<)5_>W&;[0?;'X\BP_#"C<8"IGT=R4&-:,5V[N0IEIRH_3?1\./4WWO:]L
MJ RPX7'2IV*@_CX3^)J-%#WH<2J PKU%0^7N/8)+9ET%!67]:YZWRMI0-@2G
MGS=Q^[C,H;A>ZO>$RRZ1R09=.CYHUY<LZG-8)N"I:Y>7"P+GSLIYYP]D@EI?
M&@A\KDSZ,V[Y>F;J6<PQU<-OLLEWZ7W>I2"ED.A8-S8\PM,$:R( ]8KZ'P=C
M#4O^.'%^FAOOLK[E1_#'_#))3EU\K6JX?JX\<OH4DK=0-^MFOQ^O9&<0U(^_
MH':Y<7[%,D9&ADZ\I:.F.V(^[N39(+25J6BW9&V<0<>#RV,?(0]%OCO&ED=L
MY=XVDJPZ-:.%,W+'W+A5>#Q!*[\I/5+FRBB/R>YC#1V%L<_GY=JH+L_)DPNJ
M2(KMB5?+!=:/,U6:LM[U,7KOQX+K^E&)E2D\SKI$*13#/I];#L =R47OW9,(
M95GH0 !OFVH^::N4\(DT+K#9/V*BK;]K-,'HPQ\>)[)<;.LPIV"_/"<G2'D2
MK5);*129-5*H =\F,2^E+B2+CF@.>PDP16]^5<?^)N<ME+4R\$,M[]7,;&NA
MH@&EWL/,V.W/3+9V/["8(G+$>5J9HAYPN+:[G'&L0!X8V^AI3K<\/W1/ 4=A
M+/@]KN<A9Y7>M\ 6N5.N]>NLVXEL8;XA?9YRZ76'-$<_EZG+;K)Y:](D=\BU
MO3$>X%X>WY^68Q/5*K@V$+G46Q5[F/S,:Y(UTNM'Y\7'MB,:SP[Q("]A.5HE
M&JZQO<(G)9Q,]?,3 ^^RW9GFU@3R>^3;S.Z\>8"/3;PYJH[-D:WF+=W*RY*6
M5YGB</:#?9M4AD.^QIRJ)-%L=_JE?9]#W*/)!>MXIZKH/NH&_PK"5Z9R10.2
M=?[A<4I3'YJ9%< Y[ZE?>NL& <=@*U-X7^4AYY>Q-97*FBIO,>ER?L7!;\N7
M&1O,#K1,]DE3@GIM<1&OH+8*N=MQ*OD*!3(1^NY[I%V$S[4OI9WRR,&KSBN2
M!:.;R!_1T5-C.4(-YAG.\+/3-CW"/BAS/@/&;VM+]3Z*O9-F5G1&B1]'<!4(
MOOZ<B5M0Q]YCD[7Q_AF32)H]J=P\L5WW-R_ ]^4I79D(HK=.U+'I5V;<]NLY
M7P][9],YX_ 1O3@LG>.[0PFB\O4\D0B3$0PMFO>.5W4@K_#<,;8<[*AECI]7
MQ.UAU"(GV+N!;PD7D,RZT:T0;Q$AE96N(+@1*MA=8E?\Y6<LIO_LJVI_OO%M
MTU5LO"AH,!U!Y$<ET>F.Q&&W'8/D?I5?[C>^- 3$HQGG?ED:?GAAK>AD R+=
M?:Y.ZM@)2@7MR[+4,6%9G*O@I>_S;ZJJ?2RQJ+#8?2ZZ,6ADWM%0?G=*LE =
M-C\HZK$5%XC[D<3%''^9&3PP=4_;TI+N(?%!0PV@EXXZS2NUS[G(Y,*%LD]6
MXV$?"/HDMXKO^3!1M4Q"('TU]N395H11]C9%4F?0QSF;6)?XH.VPGX:SMH0<
M]6B!^N._L_LM)GN:H]S>'<EYZ!"AM5_L73I=%ZA\=R;BE7L4.QRMZ2FZI\3A
M'](AJ]B*^8SFP5[J^)NR7HL5/&C;N'W7F])Z/[LEC6,5F_'2RT_44SQ4T%H%
MCQ./Q^B],,9\T-7S9,HXW<;*LE"8$+$)RI@\)EHD84S4;&?J?%DU_$1@)CB8
M4U8W]HQ21(? +\2NI*5&/7>8N)GIK5%8=8E:NJ^H*9J)LD!=$<7>O)%1*(.C
M7>GOGE<R/M9*[,HW+:0??;:*\_^?GG<?,JRICOY37DXHR(Q+CM)/*,J7MMIC
MJ,';1DSY"9_JSH["M\8*8E:/)QCSKZ_@7]V_[%QI$R7E3=Z#C9[>L$E,(H"&
M*VVL;]:E)/6;J#2%Q.U#1UGY"0GGY2%JGT+&+@$4>B*H5D&?TQ/P>G^: ;5&
M&B0U<KLG21N$1Y7[Q/1:6WKA!H_6)N : :05;BM[Y3ZQOLG'O]RZHI":PH:=
M((!.5<MX4$8,9JATI1$"&%"#.0U"P A@(P<N9LL>;[WVU,)HM_*O_4D"*7:5
M"""YZ6*K,$A6@9V674AJP18!2$(/1Y1NTOY.Z6='C*P^[0EMVL51N]R]W>B4
M<2T_ O>$KN3 ..Z.J%(%BFHTW&2AMBPU'8[ B5*F7:"H_4U4TDOZ6/&@:P$I
M;2?::1?3XP4D#((DUNR%>R* E5 X<3]24M2.)X6; HN_=CRA]C1)5Q1"-U9N
MD8NM1U2E+3_%4 N?-03 8% D$5& ?BD"2 F_W1+UZ86-9/P#;9>N[B<VA]5O
MS2,4/%RPBQSB+7/'^=Y%<Z+3*)Q[MSL3=/WH**'$TB7'<"W,(B51T:7]L"./
M7<3,K,2P"$7J'?UZ(4LH"'#!/L]MAI]OJ:8.WKF%VZ!Z)7M(YL%TT_P-FU#)
M>9.RLNQ?N<>WH')U]* 29.\HJQ;<((#AB&%U],K;O-#M'4P$[-X6A-[>O\L!
M(OFH%?(9KZ$#:L/?K%.Q_Z@A>T[SG=KEIC0[F!F0OBV(2(<./+W4 N']G0_]
M@M2-M')8$( J,1V.1D(U+K7PD/B]:I?;TNP22),P.>,H=S/UGD0ULJMS87E_
M/1% (\@_RI?I"*G-Y%;X949O.-P3_WH]/1T)R_@;UO,/[,D3:[J(>T\Q0A*=
M<F&Y31M(/3=:_^/EZ0F^Q0MGY[[\([T?CUJW\W] _V]!?ZU?HAN4@+HO[>-M
MN]9^=O7H[5WN+M^TL/UH(OB87,?5RE?^SH&477J#3_TYG%@=WGM-/HX/"X'.
M),![=\,Y*)%OS?ZP+[]SR9?:G0N]-EO;U.[,G7C>0#7*.07N2"K?TJ]OWU\T
M7[[W.5@O43FD-!IQ6GC0[KT$8AUSSOPJ!Z'^X^X0Y&=$[^([<^0!1F^PWI9^
M8#%:H48\UY?'5Q)8E.:;WMK7%/OA:;_/NT4J,RUP(^W\354KJ4=.H.$5!+^^
MC?>G/FS-64>GI:JW_/%&E#6Z>-L"\5X]M_O:@IL]AD8[433I6)K24V?-9\]]
M0$*Q'0IINWW<,!83EK@5##&YV)B-S6/04'_>V;>X<]7'6/LB<\W,7O6K*X+8
M05)X.8&PI_DV;$5%/VR>OHA4RE'@S\A?)(H,6Z-R("7?BI^/:YY069YC-!ZI
MF'HRW]$ACO/-[T=UK1^M^ZOHHS>GC*S#OA+72Q-A=C#^I1DCSR(L=Z>")./=
M!"W2^W>4&-_?<:9S9J734RGQLBP?\I+U?!UO.&L(.KYK5TP!?YR)M]#KUPCB
MW=W2C5[25\.<<8->FZ4P:E.$IYQ!&KK%A?91@24*;$WOJIX'0DY5N?7+RTF/
M+D?DW--G%LP'-(M8V?%?J6-E;;2)9Q\R]R<@NW?.ED?_;NCN*#^[NXD9!O@9
MWP:V"+&LYD7IM$(P5@PT78$ZKX$DQ9HBD5.8LUQZJK.?M%$-XL-^L]\Z\VO9
MLT^K%<Y<.U1T2LN].Q[17+3^CHR2++&S,W5?7]@40W/%H+I>U5F3' *?C:Q,
MH%0N-+77$I*-V>:-X._'?X\G'9"90GMQ+7WR,!@!/+4Y8=^HEUPR_4/[T/;J
M6_TQ JCD(H1P]\RL[F)8B(K7GC87^]]:,ZC5QM_N*:DHR;1E9F5FW]%TS<K<
ME[FG-!T;70'0_V62,",M'=XOTQ'#9_^8-6"4\?-P1%5D!&G]H'9%O+  H>R-
MOW=#_+4W0@;O]J']EZ%C33;RK\T4@A(C%+Z,@L.;0A,/C7Z^:).'95I5-57H
M#0N$[-;4F3K)POH@NOQQSY]G#;*Q@3@8>6__A!)0MT9#)6X-FSO_F#/_7U@^
MZUD*XUX6[N:NSHYX6:'EW%0D$_AH,9G<<9;/R#Z4 _QAJDP3M>6NKH:6X?9V
MT!^[A$I6HP19[E.?B$UCXJS1'NBO)IXL1A=!T_6W]0AF7S'E25AK6%951]T3
MBH[*BOS $?'@7H=-0Z=?N6<*A_?/G#C\J<YH>R:CE7X7J7'*#B61=Z=2V=]"
M[DD8%QC_<G3.EK/":V@,?Y"MN2SL"EZ:[(SHP<8Y+[N@.N2<"'*VQ5&YY++X
MX4ZJ!%:>LE!H<Q,YFHT^/C7]!AZ0N+^9(COR1EB\2-L[?])0F3CHTT/<.[X/
ML.?MODF,<;JVOM\6$UP54HR<5\EI".%3W*U0/\$N(4=/?"3OZSC_>$R0/VT[
MWJ7@3.'1EN4>2Z6\*?>#_*Z9;WO7O?Z7CI^:"^*2.4?E2SRI_0I4\6)ZC!*<
M1C9B-JZS)E\T,9@) Y_.W3O<)@):/)X9J$*8?RIRT>LS+]@SPCY%!*F\)67=
M*\:NT$^0*4W1\%SF8JB.R(LLVEO[K*CG:Z#A:Q$FBNV+K>PJX\AK:]@8"5KV
M?K:]SC&Y"X%],SMZTU/WA/Z]:^5#R-J=U<0(]W;PA:=>XRA7">?^DHO^,PD]
M4[/XH3=XB<7=#@YWM^]A\&SIKAZ<?1>8^*%B9[J[4[F&6[+6W4P^E916FK&.
M+N&<]T>@2V"(KBIJ"_;;:I?482#$PSUD<F<ZUM=>H\_=L7 !YUX%2/!Q16HD
M[#A!VY>(JR1ESL(.CMT75;VKM246EI:M(I$/-FR!/E2U.22"",1]]5TZ_N#/
MN#;MAIW\7IQ#A=+SD6A%N'GUMS[NWR\WZ.ZX;PV^9V\ZHTE:<X=:74I-G,U"
M(*<S578[._UBGEK59$+)''4);;IG0>"]W;WZTY"G8#[V<@O&1TW=CT7H=M&Q
M)ZC&$<#G#OB"@FO]$;0"M[3E'?P7GV"!HB)3Z.\1;FQ,8"Y,[+ )W\\IV+.M
MQO^>KN)O?^Z3/)?6)O%*KC\L#F[JXA[W-9:\6;NJ@Q29$W;1GD>I.3[Y09W#
M$6#YI%HBA.!35X;,J%6 L]&<G-V(^H?17W3Z&T(.,T^VM:D^1Z]C4'WJIK)J
MT/U!2@*7KJ_RW"D(3%%3:E%ET2'K65E3!Z@ L3<K46J"/RUR6G/DN^W.N<A6
M$X+S6*4_N#!Y8VJ'M\8[&=:,CNQ";25(;;<F":)<=KFK[)0N[3]L*;Y5==5O
M&'%6T=;U'U%S^EWUT[!^DZHV5[8LKI=,='Z!>X1J1:[ U@-<\F4_LZZJ5D55
MMC>(] -<4Y<FX+>(.ADLU;E[0*0X&P$\_S'&HL0=ZW['XOS9NMR74@=A>3(.
MQYM%Q^'OW 'EW6N-[D53"*#\T=M12[VC53)T<?YR(2*\9JNP<FM&#OU#R?F4
M_(6I7[@/+/Q'C>*Z:-X=E9O5#,R18:-CETA]M] 8+3<EL(V+"[45"9S$R6/X
M$N&.MW[GEPIUE@.^[I+2_H>ADL\GYM33DH51-S\$PY;6JZ,4(MB8'7ZWK3[Z
MU2^/+7'??Z?E+-)ZNIQ"I_:F0*.*5XEY]$AIG8I'\T_[EXZ5@5=F+F0>:)#G
MH]EC44=KD21C=LD<FJEK0U*:;1N)U>_,'O".5[ GQYC%ZX:#S$EG*_U>8T^@
MD\,\QGHB_?Z'_^S_^Z+XJB$'$/W/7E_+OP(:?YM&Z+>0UW\;4NU$R.\PKSSR
M4TI*] WY[7VEB2II)TN/0,ZJARJC@@#C<K-A#1F<H!<:BM9H+O%"\<J/_WHH
M \8YTZ'9"7* ."@U[2Q[$%E,:R-$:X.:2 =,1YN?P;;8\ !QY'-STKM)# E>
M#I@YSCP:J-I0!#U&FS= %J RJNF^U&M551L*L4BLMT3 RB-/'R=WU=W+$3PB
M  &P-32)J:%NJ"EW#P32']$ROY D%#&(#HM%<3":.;Z=2\>>FO9'=R/+OR&9
MPV41P,_+H57I:^DD!3E T0QZ!A63"$"B9 A\16.=6AB#BDGUPPLN4:OM4ZR@
M.K#-:_&KD@T-#1D2$I*'8K :)HOX\#\#VTU)]_Y>RR1#>//]1N\XXQ:(6H=_
M9H5D%_Y3.A_NC%JD/Y6"XOG[;YY-EK<\^?_B^;\9Z>T2%1/5Q04RVZN-D,Q/
MVH?$25^'C+N)YFF2?\LO\SP8CB*(A4!D5#WZW$M@='#.<2^5#!.W_&NY*&J:
M-3O"O1YLE8*D''I3NL?8Z'3V,I1-!V7EX1?RR(D-?,#S#%*% *S^3"; ^F8<
M0R=GDB\'*@1@RD.=@?L"YJ \@4H^,>.7E==IONQV\[_Q[[^7V8\<KA%M)+\H
M-QC(F-F.5QKRSQ<DDRW\Z'+92OP:"PM+C;S[A%IHH34^(*!( IK?U2LREN%>
M9%&AQ10<..N0";Q4>QH/<#8^V:HM&BS[.>R\ ^+B?%/]<<^(F.#2)O,R@[OG
M\%?'/3I-?2^5LM(#'S]'C^GD*FA>Q_KCW4+U5R\( BUY.<#JO),(P/!XP)^T
MQ+E (6-*'Q2G:;P5-=/G"=3Q&;R6PO WC7A;>C?$0MJWN*=W:>)+N:ITJYX8
M-3Q6T)MFWA:DN:DX?I099O01L./?E&Y#3QUM9 '5>B<5C7I(U7CCM>?66967
M<=&%,SVB9\)D! UD6:HLBPI*!S42>'-=K5QS:(RP5!_)_LA,86,W$'OC>5)8
M0@KC/N0.JL 13]A54&ED:'LJ4LLO7]I;'?U$B1Q(I/*:M>\2+%C:#YC.CBYR
M4SY:7N[+&'*Z!-MAV+75-?XAZ@D)\USV%:J /J267J:)R:ZX:9&3_'HLF&Z8
MP92 )A[B5\5&)@(\]!SWB3QT?#H..=EQ>W*J;S%JVO-QV].X]#MT(_F@D_.D
MZ[R@=O_SOK-:((5)'<;X#AAD80]A$!<Z&F8#?+%X!R3&,<-;P28S+5*XP_/;
M70.IV^EG:S$+MCGQ Y_%'5Z2/9"A.4'K>;H"?NF90KHS01'^Y23KY_L(1H/,
M""/Z6*:[@W68QXUVWQ=)).+GFPZ3L]+=>MO/[2GGGE%*,LS;VJJ3KX1.H1V3
MHP,%T;&,E;:RVA?.!:9N>AV&;_2$5(3J\G#J+*V\<S\^?R?=&_$^)U70OAX=
MRE6S;/N=JR@6ST+>6(HS*Y@QL)+$/,1"XL :+19*\F3Y(#DRWS;^91Y8*O4Y
M!X6A17_$\Y):9L[8T&!S?-']'=U3Z2 2"FW>7L=4-[\,H2U[_NR4]OPJT#TS
MHK ;>X/8><Q#@6GH9[.Q8J=T.$T#<MC+\P'CFT'YHB:F:Z*;HL0*R]@M?5;M
M\X]KFJIJ1K(JXN<LOD#>)$IF/-XADRU?10">DA[J6,59AT*VIC1;\:JQX=Z>
M.2;3A7 GDI!]EH/[M=3-1 "L+8QMVK1-G!(?WZ8VK"S7Q/12;+3RH<(94YBN
M_<?2CMQ.'[2E+QCG=[[-WSLDCCG_7%+N6<0_,'0R.K(WOO&;O;="E@],SOHI
M9*5"W=2?8E1, .4Z_Q&L%="F:2OT8B:9X:XZH=K7AVZ[\<!LP'+V%Y;0 M,^
MJ[QIE4QVP;G0L=*P)5DJMOM&U#<V"P&-#" :I@E3I?+*4<Z<(ZD1'!,CLMCE
M)RL>;U;#<XG[3+Q$#VDJLMQB-XP:1UY6%3W%JP>]HP:G*4X*:^)0K8Q<'D*,
MA[E@@@53%QWN1:'9 :D5Y9%[X"-EM)D/(691V$P40%;!18!N@OYA95G60A]>
M2L#)L=6[#S_):SK.'0+6GC2Y1GB,>T$?GAXN:L8)!\7O)F>!<4?N:IV?'3_L
MIGME9J<5AFVS,%A/[\GZR^ DZK"XH-!(R5XBFA M'I*PWLSJ*R-!$V/4EH);
M<BH.QCRI2U#DVN4LVG7&YRE56OD2^>$5V^4G^@Z9I3IUK/&*0W&Y(4'/!'*P
MH'C6#W9NNUU.W A#NZUU(;>=28JHC66I&.P@Z5*Z'Z,E$'YLH<JED3<9#,]F
MJC5BND6N6\DWJ"!!/O@+VR9<HTCSP!M?/0C^E$U5TRAWFJ3CKBFS+]WI>AT>
M>@NIAT)X!2=H?M)@3G]F1I;(KCVB(_^!@YA])]/5X)U?A]QR-8,"#9ID$ -G
ME25SO*K81H?>ZA"^O69T<HGDN[F%/FS6>E>C)#PS-BH0Q_=@\"EK!<.XNX-\
M>[1$E#PV<5P&3*!AI)%)J4#%^=TTD;#6@L$T&WA+(C^_+<0"'9LJT<Q>7PS_
M5_ <3ENL(Z4QUE7_^*&E44UVG4I1VCE^I%'O+ ]O9+@AL"7U>&="BG84QF:/
MV;[Z7B@+'HF7]GHD%7UU6NK,FX.V _HPVO" NKWC TM6YH+!MOI31XSFF0$2
M_8-?:K*?.CRI)G16!NYOSS/6#.XYB1<8@4[J,APH5GDQ_"[E@8T(_JZ5HV+#
MG25HH" GK4&<!G+T_"RT(3GG=V<>GQ<(%M%A5K'"]0A_Z3F(K5(,4Q]RXM3=
M;B\\53DKNP^Q+*LX9JP84./]P7LU<@K]$L\2>Z;Q"P]>P+R66Z]XL@,1C$)'
M )QD;\RAAAUC,/SEKE/(0V@+?QY(*<<M("'-D_*[.;-+95\&-EURTXV'XP5Z
M&P564<["!:M&Z<*#V/@W.WD=JWQY79$N4!)/IZM!3!Q36KELK^>'S\\G]"9<
MN*E]1PH9F*?F]74J.\GI[C@H;>T;0]JH7;SQEXH+\F?<8\]Q[$@D;C:3Y>_B
M8^=R3IX2=]LTX0C6[1/9F# $:Y6KZM^$&4MMK+]2(;*)<@\B13/"_I"\H+PE
MQ0RJJNUL 1N.IB<,_&0JCHCJ,10R(..28?+*H;+T%<4G=XO6/XA-6THB42-1
MR3!J3$KHO2QLWZG/YXVZ^T1)XKWGA YH94[\>>DPW42%TG[CG 7SJF&O8>'#
M6<Q>XIG$@MW.WC"W/7N#6O_OR[2/MALI#DL^LPZK=.8\U-( "473;7RF_J&@
MT95UJ. +DUVI\\2!/IH#C1\:SBC_>4)^< Z."'A0<S<#NUBIJQUP-63)CU__
M LIK!]O;4H^^?AZT]JR+Z(3ICDS7KYW!"=(E")$M1?C'>E.HI^OZJZVJB=+I
MIJ^?>A57<#\!9HO(J8''T$@]NH7K363^167/_$:;H9-&SG11,?.];S./F]\^
M_?-2+X\QRZQOD9L,%& RXL6?#^+(L'7LE4AYIX1[0(Y%Q3+TJ9/JRD4 +337
M[;K-=FG@KI)4>:V$6%9=PWKY. </X1V7XEDP>6>.UYG@H"U%8TZV\(<*]XK
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MOH2UD?"X/DUW#%/<%2JR<H"^+Y6RCC#USY"<(R UB.9ZXC[*\3HVX]3JUPW
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M5?0:)SG(?C]8$QA.JD8"HCMYGS=JJ2;6(H<1[Z-FK2R.O 7>Z\!A4Y'OMX(
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MS$]6KU<AAP<8(!(#G!T&-?T"28M08.(SFK5%+V%B1&54L# ':M,YBBW[N#$
MN66&-L  ^Q"L:J41=LNR8A9A^B2[K? E4-L'H-RL'UB,7E3 )<:#2:\]X?),
M :>L'Y__=3@3<<,,;0C?OX<%*0NR6PGNH@K+RY&XW8MJ@"]"T!WQ7M2(4Q\,
MT Z]B(%:$2VL!'<(R%@52!""!!C@-\4=Q.F[2V)$>9#]0?,B59K')NS--PS
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MVV U;4KU1SK$>..2.;KZG$>GX0/K"C6>&A_$LI,?3^P*;M_?88ZRGP B/3A
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M<7^WI=E&$$&7P;C]YPQZU$#U"/<H3^NI> -?78!$6P$D(HKX-*YAWQ4#E W
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MK.:TG1*F#2>0@XP9VXM1U'H92_JUL!$,, 7OB1.\_)="5GHSX?=FZ 0&<,8
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M^KLC87LXW,X*A+\$V.4^MO:1\_[\T/A"3IA2G)W3Q2P]0_% B5-G#U7&8F%
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MAU]\[;(#Y.L%7GT>< 3E$'W\?M]817M9?8WU]Y-#3Y)Y:=,HN6<1Q@GK'_I
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M_0S9X'2ZB#A(WW+:"T9-I2.*#D3\TAHAU+R'#,B;;&@]B\MV1)!!@V5 O3R
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M )=D+_ @A+/#KT!!B/M-6';(=D3NM7#U?:!D18^O0.80"-I8=[$_XOBDKD
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M328'M7\R8_&EW\SZ9Y%NV5_7B^$_J@L40FR2^1^X$JG_!$'1'RP9Z"V0%:;
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M)BZ'NG?X^&C8G8(^J7RX&%?=PO_/SDWDW <RX%HP-N6.7+"BD-\@_4)T8 -
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M7!(,L8G3#SBKM&PHPJCDV@^>EQ39\R[]B.Y2:;8L\XJ&OZ3%WYH6"OB>N_/
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M^3<USUPOY42TV];H0[KDUR5_+.8D""(?,2J7#+'*LT<NC+V$P8#Q*'&XX$F
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M78--C9 NK6QC=,*KYX38 FU@$ON0+>^A-,QCM7$Q [_F66'1#=%!P6ZL9->
MXX9(:JB^%QFI<TW/!AC2T'?2SM56G)\(%PL4P(#Q$")$$4P05ZL91)#C1C$C
M8EZJK#H]AFC?W(@1-D,,.".I,0"KGNYF::)^ 2PM:-4N4AT),"YXKEJ0BW2)
MEU2YYE2U^3/L=]'&6(\F^B(W*BU8[#QQ0%V[327: XS;+^* :GNM( Y]Y\Q
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M8C4S>0+&*C^0$I=0$KN^HU=7\\0X4YN&6N%Y:NL<5@?NE:1FVUS'8-7;C[(
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MML@9?.!^L]XG7JKF%-*C_Y8RSMX^?RVX'.-0#XNJELQ*_JWY,%L6F^UK[(J
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MQ;@5:OJ"M%=DIO>-S/BOR,OYQW2IBL,WV=$A9T+R&H91HII%QW(%&(<!@R)
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M?P3<6&VB$QN9,_?EV??]!@>)F_P9G-1QM][?@,[_&] B8 _06PQNP 8%T,$
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M\G(Y[G^#H$T\-B\,DPG6BF8PXR2%"!GVHB@GAL<(Q:6RJ6%>M>K]PTV-LIJ
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M0T5/JY7Y^LWR0C&EN4WHLA(Z*3$+V#1)8":S7&DB,$F\SL7Z!IO:$G5CJ\W
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MP<&>IX>GN0VNWMEV<9;05^I>F;%^J#:^9+?EK="39C)O!.O*A!.S?L,4TK3
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M9C=.M*KF-6#F_ZS*N36W:2<]5S_MVJ_UR:.V,>9D]Y/4E*8P,N%MO 1[;MZ
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M+FRKX;QD9AF3)A"ALDGF3* J)-$Y-O]%.A4"G[KYU%[[QC[0& A:"]UC+D?
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M*S\QS*B?^GDU#[_WEBM[!G-/.J;EKWFV7-ROQ$NV>2FCRC.",*<^](&,TQ1
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M0F\P0L(!@5&0"NK[H46#J7XR3&U5:FI1L+ 6Y:5YOE'[O[*1MDT-8\]Y,=F
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M0IT,(@&A+ 4,<9](@M,XL K"M0TV-6_MIN*,T<)>G:".L>_V; 2YF5UQ!>3
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MNAY[ER]%+M2';+D6[/EF^=?/:_[7RC6%D<"(BQ3(2"2:$B$$1"($$BI2QJF
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M(?GS_6KY/5.;V@]OO^6ZIKK,[M"-C)G:_1;[7K64J?^PT1FRKZ(,6^Y2#X)
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M& D0C8CZ%5DU*6T;;&J?^Z=&(E"/_E"MN/(TC.(DA2"2. :0\A00%OH@#F7
M?,[4S@S:)$(ZPW6$W,@A<34SIZ[0&MBPMB9/77E?6I!SER[5@&2<1"D]X#12
MI!JJ&R='->]Q;(]W1QN[E$$1),IDA *$*=%=,,(84&V?:0HCR&)$F; Z2; 9
M?'+V^N[_W'[TKK]]NWW\YLBDG(+\0A-S(9#O:7(:)Y_>[^,F;;:@-HY5.B7
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MFW@T#<9/4!Y[<D[F/(\NA-W2R44V^UCM(/]K0U;*UL_?'L2K&FCFAY+[/DM
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M=]DCG57ZW'[F_ TC=Q<X;K/]WVIC];P6_%I;L2=Q^T.L6):+DN+ CV4<8T(
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MX"Y&U7&;N/[RC-P_[F+@CAO+7?[(2TRI[HZ0Y6R^U*P(NY+V-) XC9)$6<A
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MAE)/K5A#,I'?_F#S#1>\S%)^>=VLJ]X_MV2EVZ?G=?/&1E<S)C%-! 2ZH2*
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M'.TV[%!QS4O1-N38=!0&ZI]@H3"YJY\U^66YY']F\_D,$482B"20"%$ A:"
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M__D_ZO^B?JC%1_S/__'_ U!+ P04    " !F?6-3_&.]>#ZI  "&IP< %0
M '!C<G@M,C R,3 Y,S!?<')E+GAM;.2]:7=;.9(F_+U_1;XY7U]48E_J=/4<
MI2UGZ8S3TMC*RJ[YPH,E(+&+(E4DY;3[UT^ I/:-RP4O5%,G2]9Z;RP/ A&!
M0,2__\]O%Z,?OL)T-IR,__(C^Q/]\0<8QTD:CL_^\N-OIQ^(_?%__L>__=N_
M_W^$_.?/GS_^\'X2KRY@//_AW13\'-(/?PSGYS_\GF#VCQ_R='+QP^^3Z3^&
M7STA_['XHW>3R^_3X=GY_ =..7OXT^F?3?EV])'DG!R1.2H2J&'$.9E=XCR;
MI/[_LS_K2*-,BA$M8R12",#?<(;P+((*3$ V<O'0T7#\CS^7#\'/X =D;CQ;
M?/F7'\_G\\L___33'W_\\:=O83KZTV1Z]A.G5/QT_=L_KG[]VZ/?_T,L?IOA
M*W]:_/3F5V?#IWX1'\M^^L]?/WZ)YW#AR7 \F_MQ+"^8#?\\6WSSXR3Z^4+F
MK]+UP[._4;XBU[]&RK<(XT2P/WV;I1__X]]^^&$ICNED!)\A_U#^_>WST;U7
M7OHXG/H_Q<G%3^7'/[V;(!A._%DA=O''\^^7\)<?9\.+R]'-]\ZGD/_RXV6<
M?B-%?=0)6E[Y/V[_^*?;MU].88: 67#[$;^Q>D9YVS:4P+<YC!,L^;M^QV@2
M[_W2J$AW,KW^RY$/,%I\=Y!@.%@\^2#,YE,?YP/E>7+*,N)M%D2::(A+.A'#
MM0I<,<EEN,]X(7J&5"^4,8/XI[/)UY_PP3\5891/%E)92.31ZY:2V8[NZ[5W
MBK\[8%II;[G&%1%PX1@/)'BJB'&.,2<$#<KL1/;=M]VG^JY&#Z;QA\DTP12-
MQ_7K_#0^TNY]X*Y^XZ=+/\4'D7@^'*7KORY6I M=S2<=2&ZI%B3WQQ^0ZPS3
M*:2/2ZT\R]R"LSF:5%C\9A<:_]]7?HI/''W_#)>3Z7S E+'2JDRLD$!D9)X$
MYH DHP3+BID@NE'^@Q>OA0/>/@YVD6<CD#B!Z7"2#L?I/6[#@QR<MU()9, :
M(FFFQ((QN!?HH*/.62G:"2#NO78M.(CVX;"]+!L!P^G4CV?#(O@5H(.2@/IS
M!)A*I'Q.'#6>)&%5$EYD,-#-[O#@S6M!0K8/B9TDVC,J#L?SX?S[A^$(/EU=
M!)@.E+(R,(H0-MZB,!PC5M,B$9^S]R%)%7="P\,WKH4"U2X*=I)@$]K_#&?#
M(H3Q_)._@$&D27&-P1651F/\%!VQ!C+A1C&;G16"BPX0</^M:Z% MXZ"'239
M!!*.,)R?H@E;"/X+RA_>3:[&\^GW=Y,$ ^E1*"EG8JQ1:-9")!ZT)SXSSXU1
MZ"K+#H#Q(A%KX<2TCI/NY-P$;$[]MZ.$XAOFX3)3L;*$$O%ON8J$>H2^%-R2
M$'PB -SXL@8HW<W3?/'U:T'%M@Z5+F3;!$@.4D(5S%;_?!R.@0TL]2(X$0A(
MPXAD'I'N*7I+&%71+)V-EG< D"=>O18X7.O@V%6F+0'C'7YZ/#V=_#$>4.NU
MRN@U4X5^DT2<$P=!$05).!9Q1X4N[,:C%Z^7NJ)O!!5;"K0E3"RVQN/IR73R
M=3B.,-#:4@8>-T4G\(,/C 0N)-'.\A)5::.["$Z>?OMZZ&@XL]F9:%N"R,ED
M-O>C_S.\7+A.W'*7LE3E@,,3:<'AKFB \!@$BTX[F;MP49]Z]WKP:#CAV9%8
M>P9'L7H'4_ +NH4(V5#&"&@=B,PH%&MM)%P*@7+QD.UN<+C[MO4 T'"*<VO1
M]:SR<CXZ.CF?C*\S, 8]'9&8(N@BE[A;1Q) <)(-HSE*DWFV.ZG]X1O74WW#
MJ<R=1-BS^K] O)HB=!D/I\/Y" ; F4_&!O1[-89&4E/BDP:B698VQL3SCBG,
MAV]<3_T-YS!W$F'/ZC^=^E*!\N7[19B,!BQ9B"X9H@RZNY)21YPPFK 09>1.
M:IWS3KJ_][KU%-]PVG)[X36RZ ^_Q7,_/H-%OE6E1*V5D61JD'ZN) F><Z)U
MU#*6RA^U6WG&4V]=#P,-IR1W%F43X<"[JVD1U_($KD :=7 U&T3A*2C0Q%*/
MGJL)N(]YFXA63 OEI$QQM\/-E]Z^'C2:3T%V(-HF('(TQJ>A.(9?X;V?^Q5;
M Y#",N^ ^%Q.:6S9ZYQS1#"FDG<T6^X[.=9XZNWK0:3Y1&0'HFT"(N48=_K.
MS^%L,OT^$#(S+HTD4(Y?I* 1I4,EP>]'FKV)&"%U=!9^\]+URJ::ST%N+\@F
M</#EPH]&/U_-AF.8S08N*&K0\256!XR%N?/$48?RR)%3Z83.R76 @WLO70\'
MS6<;MQ=D$S@XO(#I&6YYOTPG?\S/WTTN+OWX^T!+A7&1XB1J*.DPM&A.9E[B
M)):<#E[XW4HJ7WCY>KAH/LVXNV";P,>7<QB-KJE7&#R%' 2)U)9B8;OPF1-Q
MQ@'SX'A,K LS<>>=ZZ&AX9SCCF)L @1(^$4IXYC$?WPY1[G-CJ_FY19'B:P'
M$#)0)XM;C-9.YH""<4P0'[/*6@,%DSH Q4LTK >2AK.3'8NY#="@Y*9^=#1.
M\.U_P?>!5SPQFR.1#J%?+C21@-X1B4*%)&(RSG6QISQX[7K0:#ASN;LP^SZO
M6H9*'X:SZ$=_!S^]+BW7V;/H (GVRI1[!FSI,SL#UCN,JES>K0SSN3>OAXF&
MDYJ=B+21:OU;)C[@=V8#Z32UW%#TH"/:.4E+1$W1[ 6OI.9>VXZN<CUX\7J@
M:#C+V85 F\+$\B+*D@GM-'<!+")9Q>(W<Q(<AEG4 K(A?&9ZMP//9U^]'BX:
M3G%V(]2>D7& '*0%%R-_-HA,)L.B(L:*5"X@8+Q="$\ 64J538R[G8'=>]UZ
M"&@X@[F]\#K3^K__]$AX'_$;6U[+/O[T_O#3E\/W^,F7XX]'[P].#]__?/#Q
MX-.[PR]_/3P\_7*?_C7O:[_^U"XN<F](^XXWO*]FY,S[R\&B&*Y X#A_&([]
M. [1%$R6=[IN\"6BS4ZZ$F+8@)ZE"P1=S$P4*(/;AE!<O%2LG/TL+&"P>NER
M;<%H/KO^SD+@A++5K?S_L0EUVUJ/ZW<<S&8PG]WPFDH0;IC!^,F)DGYQ)%#E
M<6OD&3=*I2'I*KS>IZ.?N^354'%M=3H0>H\;SGWJ5\[V#1-.9NN9X(2&4BH(
M JTP8"!NI?0TF:!3?.D,?E?D/""G7P#MHM\GH;*+L!M S#L_.S\8I_+/X3^O
MAE_]")F9'<S?^>GT^W!\]C<_NH)!T$%H]+%(C@9W8)4$"2%E8@/7VD@6@+]T
M9+\]@M8BKP5$[02#26V=- "T+^>3Z?P4IA='XZ\PFQ<;/AM0'E.2&-IYJM&?
M+R>1021.E'?""ZH=-ZK._OT$-?UTQZ@'HYTEW@!J#F(LMS!GGR$"+H0P@D\P
MORYE$-Z&(#@0" )Y,<B&U5Z3$#-N\DHZ*^J@YR6J^FFJ40]%G6F@ 325A3#&
M7_F.+ R\5P \H!0L*EG&P(D/0A)F61*"4L-?O#J]/7KN4M%/OXUZ:-E:P@V@
MXV0*EWZ8#K]=PG@&N $?S\]A>D]&@\0@1FL8T0X#"JFC(U[C9Q9 6&,35Z%.
MP+D&<?UT[:B'I:[UT0#$[A/O:.;1H:ZIXF@]578EF^E(RDD$1WTT[*6D8$=Q
M63]M/BIN6%O+>'N 3.9^U E /D[&9X]<-A4]EPAJGP6:46N+0?6.X'>]H=&B
MI_]2J=OV,'F"F!9\Y$Z"]UT%W8 Q.9E.+F$Z_WXR\KATQJG$BI>%D[+W1J4B
M94D2G@!Y0:"C9X9?6@G.Z9"]A)<JJ'?9J)ZGJ@7?N!/T=";Z!F!TC)SX<H?@
M(_@9?"[-?H_S;[CA%G$-/(U,,)%(,#$1&9PBSM! :/;4&A51AG6,SXMDM> V
M=P*D[H3? ))^F4S2'\/1:)!I:5T B1C+@$CF*$&"(^%.%5/JD^$O541L#YIK
M"EIPA3O!QU8B;0 *1RCN\=DPC)9(GJ%=//P61U>E,/"&)XK>G))6$V<5\F1,
M:6& _IYB'  ]>V?U2\6YNT3@KU/7@EO<"80Z5T4#\'J_>FUIVG8!I_[;#6L#
MDUD(SB>2>) 8.B15LE% A 2&=M.#>[&X=WM0/4]3/PWR*D"I(['W"*!21#$H
MWMK\^Z\P/Y^D._[__0S#( $/P4,@'CQR%),E@3M&E$Q!"BI=#@^RRX\K--9_
M73^=\3K$2"7)-F!L5E2C4AD/RA'/</'+#(*4(Q.B&5,LEQQ%U?J+?KKC53LV
MWTB<+21FACX,1\/Y$ J:%S<>SB<C%/ILB?D;T43N@O&H2*^HP^A/JU+\EHB+
MG!D=#(]0Q_==E\)^4SC5"WBJ**H!*W2'KX?94AYYTM)Z(DRY6F&U)J48%J-&
MJ@,#*G!%UH9<4T4^=3#P/-!V44@#T+H^XCWQW\OY[G7JW'MK12KW_4JC?-R8
M<S'WF2!GW-A,DWWQ[N3NQ^OWZ6D&4CMI^YG3]1U$WP: IE?XUD<R&C 1RWPO
M2J(J*75?ZI-*0HLJT,%CR,G\2[<@=L+0TR3UN_W5@U$'"F@ 2??SH=?\7+>[
M&4C-G;.R],O-^$&$,NA'4>*]= P@(F=U:C9>IJO?<XU*F.I0%0T Z]T$P]'I
MO*3!WD.X*6"B61H5@B91%T,+W!(;A2$4 QCGDM2VTO'&T_3T>ZY1"4@=B+[O
MC!&R4%8"DHV?S88)EF,BKEE1(FGEDB-(O\*U8&B9@@E$.:IL9$8H_Z"[Y3.I
MHI??T^^I1L?HZ%JN#=B84_\-'GIR":1-LF1*DN-$<LE(T+JD.9(5&JRUN4[E
M_!/$]'ND4<FZ["KT!G#SA-N68^9,4DZLI*5;0DPD<,T)^""B24&K%SL-=!G2
M]WMZ40DU.XJ\@83D@UWUTV0<KZTF]5278SQF4D277Z%<>*F@\R@0)RV5E4[
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M&66D4XY4ON;5;O/B?@[7ND=,=:$W8'$^3[[[46E-O2">FC*!GF-H5XK#)$1
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M'H6KE97VEBW=M6PF^5%"<Y+O>R@[]!FI1LO>+.BN<JIO;85*@:IH"$ 9G!T
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M6U*F(<LZ)ZZ[T=U* 5+'*'QH=/>HW :<QO<0YD=C%-M5L2/+TR%CC( <$$6
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M_<?5$#<FK3<B4N+F;%W_3;^+R9*$?,$4$E,B;5=+]_#GC_.Z>PP4["?"OE!
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M0CT=P.ZA^OQ_G:Z^_'0"7]X]@M\]KZ^/X^]Q,:VR2 OZ*'R)F_^=J$*"2"R
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MUL[W%UQ/;&*)$OQ$>;^D=(_7>E%C/6@MM,F)Z<S:7&;M06QO-1;#0+2UUCH
MYC!7<-?L_R-,9_55[?4LG5_DNJ;Y55C,Z*\M)QR5RX:38&*B8ZQS#H(6%C2C
MR&.+ELC;W"8<C<7MC.#47B/Z1$@'IK.'=[@_K&^2O='!%@>1*0NJU,3+10/.
M619<#L+Y-N5R Q"_'=Q/[4WBV%KM ,BO9_19="JX*4N=!)T-Y?\<;/()5"
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MC+O^VG%[*+N+K_NK9.1)A&NB+PV@!(8AA 2<QSI@,]2!U24!4SS9K+F,::O
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MR5466:>P^Z*9;'1%<!P&G\T-=!.<CV.6.X'N=.ZL'WU^?O .\DD!!<2L??#
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MYS372W*.KIE^NH&(I8@Q2+ $*%G]];<+4"^VI%9JTD0YQQ]DD0 6"^#99Q]
MN/S^^NU@].N[&Q;;1+%W_WG]\W# *K5&XT-[T&A<CZ[9/T;_^IEUZLV C7*>
M&FFE3KEJ-&[>5%@EMC;K-1JSV:P^:]=U/FF,;AMDJM-06ANH"RLJ5Y?T!C^!
MBZOO+K^OU=BU#HL$4LO"'+@%P0HCTPG[(,#<L5JMK#70V3R7D]BR5K,5L \Z
MOY-3[LNMM JN%G8N&_[YLN$ZN1QK,;^Z%'+*I'A9D1<!!+S5Y=V+H-UIO> \
M"KKMLVZS<QZ\""(X_V^ 3C:PNF]C[%S!RTHBTUH,U'^OTZJ?=3/;GTEAXU[0
M;/Y0<56O+B.=6NPOQ_;^JS>S8<S"O:UQ)2=ISPVIXILNBD.M=-Y[UG1_?2JI
M13R1:M[[<203,.P-S-BM3GCZ8]7@,M0,Y#+R%8W\'= G=,\]SKS+9VA'R106
M0PA:Y/3-?2S'TCY_%KQH]MM!/7CH]G:'0YQAR/]VCSM;/?:N'I&;VR=V<',[
M&OXT'+P:#=^^.2)O#YK4+^/,L,JN^50*]M[R\*[*0LBMC.;,QAR!VCW?O?@9
M%P)YHZ8@LKWVB^SOCZJ_A-$--_L.!S(5B(%>#<.P^\5<#^H+MS]_[_T'$]/J
MT"0,6<RGP'*82IAA8K"Q-.RW@N<8+&J.[S.=6Z93]I/.$S_O0;/V;Z8C]HZ'
M,N?LM=3O0PEI"*;J*PS3L,Y.; SL^;/S5JO9OX6)-!;3F74O@OXIXNSB<)QM
M(?ZO9-E;1[;LK[G!Q<9E3>;L+M4S!6("5;_ZY9H+C0ZD&C4#VN<R93R=LR*U
M>0'H/ZH()R@0!YPE^)1+KEC$0WR5,YU(RZSV]38JI(!8,3R?4Y6$WP$CK"QM
M&GPGT!GL4CDU@GU0!40;J@^L1E!#3P3D;!;+,&:FH(]5^QGD4!JA 232*)0I
MI'AFTL8X0)-!Z!PDNQFZI@4.<XK-!!O/UZ?AJ0&U_;4 %5@D4X0"H6JU]%5$
M*5;'XGRM7*81LA<G*8W?0U4(M(GP6EOG*D)3$N-EB X"-@%>J15R2]"81UUC
M< BGT:M4HU!8 >&J$5.N.^/\";F)6:3TS"RPO&)$QNFE]QN]K*Y!TBR<V?#V
MJ:&R<V2H'#U80DIJP5G?E+@K]131C8XBB8]N<8>,Y^!@A+"08P6TW P0NV,E
M34S5J5J"5$MT2\]"FE!I4V [(N%<*X^G+-<A"'QMV G"1P#BT6/DYCZ,>3H!
M]@KY[;908,J<W>:UH'L"I_Z1C 1=X5^=.IN2Y''J$4T],:+#-:![X)%7AW49
M;78989<T]L>!@#5(C/PU#7H N,]:1P7N$WYZ-.ANUCL!380 @YLF7&"76O\<
MAU7*^B$OS/Y-*/V.@2U[\@E=%SD:0/Z;2N-8%6M!ZNS0_F3%Q^N<GH/B#IIE
M1E^!JEKR/15*Y&;TQ6@EA3L$,<782"%Y+FD TNL.EV52LE08T@(NIHT3#HZ#
MM0%TR"+G4Z,,A;(,"\4I=>"PG!,K38$MO$)9%U;X;0Q4$=D=VX,X@,T)NE\_
MX,=' _C@HG[>V03\WF2X@?O]:71O^&/(X&Z=4@<W.N64.;C!B" =C"\G/!<+
MV&$@2#Z62MHY*8UMW5(0.H0Z\/GX>5!U34>[!'5?#B@K\@S!;YPR"D.="^>
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MV:6Y=UY/+C_]96EW;?OJ?U!+ P04    " !F?6-37VG$4C@(   :+@  %@
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M/U!+ 0(4 Q0    ( &9]8U/NZ875VG<" $/,&P 1              "  0
M  !P8W)X+3(P,C$P.3,P+FAT;5!+ 0(4 Q0    ( &9]8U,J#(G]2!4  !OB
M   1              "  0EX @!P8W)X+3(P,C$P.3,P+GAS9%!+ 0(4 Q0
M   ( &9]8U/\9%2\A"(   Y, 0 5              "  8"- @!P8W)X+3(P
M,C$P.3,P7V-A;"YX;6Q02P$"% ,4    " !F?6-318Z+Y@-_  !RE@4 %0
M            @ $WL ( <&-R>"TR,#(Q,#DS,%]D968N>&UL4$L! A0#%
M  @ 9GUC4]>/$Z$,:0  E&P  !0              ( !;2\# '!C<G@M,C R
M,3 Y,S!?9S$N:G!G4$L! A0#%     @ 9GUC4QFUY5C.8@$ 1:@! !0
M         ( !JY@# '!C<G@M,C R,3 Y,S!?9S(N:G!G4$L! A0#%     @
M9GUC4SIFO"^"%P$ "GL+ !4              ( !J_L$ '!C<G@M,C R,3 Y
M,S!?;&%B+GAM;%!+ 0(4 Q0    ( &9]8U/\8[UX/JD  (:G!P 5
M      "  6 3!@!P8W)X+3(P,C$P.3,P7W!R92YX;6Q02P$"% ,4    " !F
M?6-3Z:3<WC\(   1+@  %@              @ '1O 8 <&-R>"TY,S R,#(Q
M>&5X,S$Q+FAT;5!+ 0(4 Q0    ( &9]8U-?:<12. @  !HN   6
M      "  43%!@!P8W)X+3DS,#(P,C%X97@S,3(N:'1M4$L! A0#%     @
M9GUC4\@KAPBM!   Q!T  !8              ( !L,T& '!C<G@M.3,P,C R
A,7AE>#,R,2YH=&U02P4&      L "P#: @  D=(&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
